Clustering O 0 4.577555223761465e-09
of O 0 1.3450858482588757e-10
missense O 0 2.1365220703728482e-09
mutations O 0 2.605111005388183e-12
in O 0 5.465819311913089e-13
the O 0 2.711547875122733e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.573029900781009e-10
in O 0 2.9082449339370986e-13
a O 0 1.5209330377161795e-13
sporadic B-Disease 0 6.494425441871954e-09
T I-Disease 0 3.550640315097553e-07
- I-Disease 0 9.996263372613612e-08
cell I-Disease 0 2.2061353632807368e-08
leukaemia I-Disease 0 0.007830847054719925
. O 0 6.892539317071567e-10

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.110431829294157e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.2649861193663654e-16
is O 0 1.352964217044676e-18
a O 0 3.3000645161766407e-17
recessive B-Disease 0 1.4301789787174446e-11
multi I-Disease 0 0.0028034334536641836
- I-Disease 1 0.9910016655921936
system I-Disease 0 2.170284396640909e-08
disorder I-Disease 0 4.618934124067664e-09
caused O 0 4.019919688330554e-15
by O 0 3.865574234728215e-18
mutations O 0 5.771967846814909e-16
in O 0 1.7789961675941153e-16
the O 0 1.2941436930338085e-14
ATM O 0 4.928987218377756e-10
gene O 0 2.4098106322922863e-13
at O 0 9.879620038732995e-11
11q22 O 0 5.834874627907993e-07
- O 0 7.188470618757492e-08
q23 O 0 1.4809717185926274e-07
( O 0 8.098517922895329e-14
ref O 0 1.4098476552870665e-10
. O 0 7.792205059366578e-14
3 O 0 1.77456275585533e-13
) O 0 9.034044298500844e-15
. O 0 9.632713897367307e-12

The O 0 1.996130344350533e-10
risk O 0 4.787572560616127e-10
of O 0 3.4019237427074245e-10
cancer B-Disease 0 6.749640419911884e-07
, O 0 8.238274645799848e-12
especially O 0 8.326050404683372e-10
lymphoid B-Disease 0 4.061087111040251e-06
neoplasias I-Disease 1 0.6093363761901855
, O 0 5.295211751715767e-12
is O 0 1.448126693429433e-13
substantially O 0 1.8364712528473603e-10
elevated O 0 1.9030421335997083e-11
in O 0 1.0063928856940407e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 8.170761844894514e-09
and O 0 2.471554319712077e-13
has O 0 3.2582244634791774e-16
long O 0 1.131062576226454e-15
been O 0 4.4126758428408093e-16
associated O 0 1.676034934753809e-13
with O 0 1.3141512617692586e-12
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.029949903141869e-08

By O 0 6.643425094982405e-14
analysing O 0 3.2335936706040513e-10
tumour B-Disease 1 1.0
DNA O 0 6.888399850524252e-10
from O 0 3.1239781269655487e-14
patients O 0 3.2125979749841405e-15
with O 0 2.6183451032661655e-17
sporadic B-Disease 0 5.202913211377336e-09
T I-Disease 0 4.4770655449610786e-07
- I-Disease 0 1.7602592379262205e-06
cell I-Disease 0 2.857943286471709e-07
prolymphocytic I-Disease 0 0.44105276465415955
leukaemia I-Disease 1 0.9999998807907104
( O 0 2.362867117678552e-13
T B-Disease 0 6.9765442312075265e-09
- I-Disease 0 2.2038675329127955e-09
PLL I-Disease 0 7.13342672042927e-07
) O 0 1.2405392976701148e-14
, O 0 1.3759563184201438e-15
a O 0 2.5903429656240137e-14
rare O 0 4.802447935853271e-12
clonal B-Disease 0 7.122534562142846e-09
malignancy I-Disease 0 8.38594882424104e-09
with O 0 4.972846577068219e-15
similarities O 0 4.4373952754438173e-13
to O 0 2.146517989395913e-12
a O 0 4.1322001376187245e-11
mature B-Disease 0 1.2263882354091038e-06
T I-Disease 0 5.269606049296272e-07
- I-Disease 0 8.901279358042302e-08
cell I-Disease 0 1.324829934645777e-08
leukaemia I-Disease 0 0.0001674812810961157
seen O 0 3.1299216690650056e-12
in O 0 6.800298171794061e-13
A B-Disease 1 1.0
- I-Disease 0 0.11586897820234299
T I-Disease 1 0.9999997615814209
, O 0 3.163311626530607e-14
we O 0 1.650325748387099e-15
demonstrate O 0 4.795717317186698e-13
a O 0 6.1013951595072224e-15
high O 0 1.8159203931137832e-14
frequency O 0 2.85810979917811e-13
of O 0 4.657889091791434e-12
ATM O 0 3.243907187311379e-08
mutations O 0 1.2529953463680243e-10
in O 0 3.6173957163043724e-09
T B-Disease 0 3.575081109374878e-06
- I-Disease 0 2.247155407530954e-06
PLL I-Disease 0 6.0002432292094454e-05
. O 0 1.047235453910389e-08

In O 0 2.1131797700579824e-11
marked O 0 2.4244413768248485e-11
contrast O 0 4.522153864480044e-13
to O 0 8.809628374017997e-13
the O 0 5.237125837165291e-12
ATM O 0 2.9126544731639115e-08
mutation O 0 3.053023328938864e-12
pattern O 0 1.7417855352475087e-11
in O 0 1.4072329239389614e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 1.6347260188304819e-13
the O 0 4.883124950943486e-14
most O 0 7.936645776213591e-16
frequent O 0 8.50085908106089e-15
nucleotide O 0 9.11768165308413e-13
changes O 0 1.3691321974805895e-14
in O 0 4.094035494731779e-14
this O 0 4.098555696219197e-12
leukaemia B-Disease 0 4.73175932711456e-05
were O 0 1.5125696251061527e-09
missense O 0 8.756826446187915e-07
mutations O 0 5.489882326514817e-09
. O 0 8.169141807456981e-09

These O 0 1.0566922337140738e-11
clustered O 0 4.180223875382971e-11
in O 0 2.8210842272250944e-14
the O 0 2.2381331813911554e-13
region O 0 9.052790635177832e-12
corresponding O 0 4.107839415845582e-11
to O 0 5.450375567539467e-11
the O 0 3.419723115793971e-10
kinase O 0 7.8890977084356e-10
domain O 0 1.3885573801886153e-09
, O 0 5.94696682306925e-14
which O 0 2.978952618571751e-15
is O 0 1.4206306360033485e-15
highly O 0 1.5916343763799912e-12
conserved O 0 3.8431365728675004e-11
in O 0 2.2940932140058656e-11
ATM O 0 8.113560397760011e-06
- O 0 1.079295430805871e-09
related O 0 4.216130500278581e-10
proteins O 0 8.435582419218102e-13
in O 0 1.1192481403493604e-12
mouse O 0 1.0360464222647359e-11
, O 0 1.0807923566530375e-14
yeast O 0 3.2262961833368076e-12
and O 0 3.634505348591721e-13
Drosophila O 0 6.758671400319827e-10
. O 0 2.93973151377358e-10

The O 0 6.350516779107807e-10
resulting O 0 1.5665849062429515e-08
amino O 0 2.2205691507792835e-08
- O 0 1.7057889822869043e-10
acid O 0 2.0783002055435595e-11
substitutions O 0 2.124094476696481e-11
are O 0 2.3726931064425166e-14
predicted O 0 7.989669689734136e-12
to O 0 2.0121638730219438e-12
interfere O 0 8.574555288021202e-09
with O 0 9.183603313575595e-13
ATP O 0 6.041845068693874e-08
binding O 0 8.916525850999335e-11
or O 0 4.735402174549375e-12
substrate O 0 2.2132601307234268e-10
recognition O 0 2.7515183464998927e-09
. O 0 1.810599670193369e-08

Two O 0 3.8864952922601503e-11
of O 0 2.1165076635742963e-11
seventeen O 0 1.1502606506175184e-10
mutated O 0 4.1291176207380875e-12
T B-Disease 0 1.3490016048667286e-10
- I-Disease 0 4.056490560122583e-11
PLL I-Disease 0 1.045265829446862e-08
samples O 0 1.557465094392807e-12
had O 0 1.2996722770805373e-14
a O 0 1.943476228135287e-15
previously O 0 2.991623469133023e-14
reported O 0 2.1398835394620397e-12
A B-Disease 1 1.0
- I-Disease 0 0.009404932148754597
T I-Disease 1 0.9999669790267944
allele O 0 4.6132551112521014e-09
. O 0 6.501040261674973e-10

In O 0 5.125883051348978e-10
contrast O 0 8.74336436584855e-11
, O 0 2.2214702137274972e-13
no O 0 1.641743923967709e-13
mutations O 0 8.945168282308014e-13
were O 0 1.363132588576288e-12
detected O 0 6.042613783473205e-13
in O 0 2.7622645653018613e-14
the O 0 8.79372963336067e-13
p53 O 0 1.1726130049599659e-12
gene O 0 1.3242252888852335e-13
, O 0 4.4709763370948466e-14
suggesting O 0 8.970972402433386e-12
that O 0 4.2810949284297767e-14
this O 0 4.8754545539653193e-11
tumour B-Disease 1 1.0
suppressor O 0 4.535156605811608e-08
is O 0 1.4675174459964288e-14
not O 0 1.0002107920115827e-13
frequently O 0 9.724974731756264e-13
altered O 0 2.0731494645986892e-11
in O 0 1.680818787104521e-12
this O 0 7.472991669921214e-11
leukaemia B-Disease 0 0.001537382835522294
. O 0 9.16363962488731e-09

Occasional O 0 8.970080784820311e-07
missense O 0 1.7644092054069915e-07
mutations O 0 6.425947274291133e-11
in O 0 5.942062814012772e-12
ATM O 0 6.686552467272122e-08
were O 0 1.821813880309442e-11
also O 0 1.9191982733395528e-14
found O 0 8.421073659627219e-15
in O 0 3.4299457398649993e-14
tumour B-Disease 1 0.9999990463256836
DNA O 0 7.07522262999305e-10
from O 0 3.5443647799712763e-13
patients O 0 1.0616203418743406e-13
with O 0 3.5523066794693452e-15
B B-Disease 0 3.045314556082701e-10
- I-Disease 0 4.1724332322523594e-11
cell I-Disease 0 1.0287915408468962e-08
non I-Disease 1 0.9997442364692688
- I-Disease 1 0.9999911785125732
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 2.787570281270746e-07
( O 0 3.504509880805206e-16
B B-Disease 0 6.04335817500079e-11
- I-Disease 0 1.7384416118020746e-13
NHL I-Disease 0 3.371524726070163e-10
) O 0 4.64913223690734e-18
and O 0 3.02551466819192e-17
a O 0 1.0497840051133626e-14
B B-Disease 0 3.751891158865206e-11
- I-Disease 0 3.027335326866165e-12
NHL I-Disease 0 7.62031859835588e-09
cell O 0 5.733504782057253e-10
line O 0 1.6700256455504103e-10
. O 0 2.992501038634465e-11

The O 0 5.449000625712408e-12
evidence O 0 7.976966526559992e-13
of O 0 1.6725286249279908e-13
a O 0 1.2016610783142055e-14
significant O 0 2.552173797548251e-14
proportion O 0 5.49221692430768e-13
of O 0 1.7009950305929555e-12
loss O 0 8.144940277787782e-11
- O 0 5.3527297178002087e-11
of O 0 1.6724650553356923e-09
- O 0 8.4703188907298e-11
function O 0 9.047297416450717e-13
mutations O 0 4.588374087144756e-14
and O 0 1.5717563221585498e-16
a O 0 1.024952958978895e-15
complete O 0 9.241188543562817e-12
absence O 0 2.983496436015365e-11
of O 0 3.136308487222683e-13
the O 0 2.2312101439440207e-14
normal O 0 6.396190001256574e-13
copy O 0 7.507275183449291e-12
of O 0 4.056016373460425e-12
ATM O 0 3.477102217264161e-10
in O 0 7.990270500368019e-14
the O 0 1.877113102542044e-13
majority O 0 1.9382449204657926e-12
of O 0 2.973804189010387e-11
mutated O 0 2.053306857874304e-08
tumours B-Disease 1 1.0
establishes O 0 5.909289724215228e-11
somatic O 0 3.35590222277915e-10
inactivation O 0 2.1429283347806916e-10
of O 0 1.8030016715742114e-11
this O 0 1.4833646192879274e-13
gene O 0 2.934107221509025e-14
in O 0 3.076971186524724e-14
the O 0 1.4631105029784541e-13
pathogenesis O 0 3.645459489831637e-10
of O 0 1.214308098518302e-10
sporadic B-Disease 0 2.184401819249615e-05
T I-Disease 0 6.907983788551064e-06
- I-Disease 0 2.524518265545339e-07
PLL I-Disease 0 5.84273720960482e-06
and O 0 3.489667322470469e-13
suggests O 0 7.625649921629354e-14
that O 0 2.811240942048347e-16
ATM O 0 4.896593130965243e-10
acts O 0 3.5899514697762536e-12
as O 0 1.1815355985267395e-11
a O 0 3.554309957465307e-09
tumour B-Disease 1 1.0
suppressor O 0 8.288819799417979e-07
. O 0 1.1427517820905564e-09

As O 0 1.1569137141342889e-11
constitutional O 0 3.686888988552184e-11
DNA O 0 1.663801207918425e-09
was O 0 1.1611134146174984e-12
not O 0 8.674179809761012e-15
available O 0 1.7027412466119607e-12
, O 0 6.391110073621347e-15
a O 0 2.0903849397985175e-12
putative O 0 4.2237893183028064e-08
hereditary O 0 3.2319807360181585e-05
predisposition O 0 3.0389553558052285e-06
to O 0 0.0003368952893652022
T B-Disease 1 0.9999997615814209
- I-Disease 1 0.999523401260376
PLL I-Disease 1 0.9997479319572449
will O 0 1.963410163619006e-11
require O 0 3.8243271396898315e-12
further O 0 3.1648820933774524e-13
investigation O 0 2.0427947527990042e-12
. O 0 1.172420667494567e-12
. O 0 6.353081949406203e-11

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 4.6421823185482936e-07
kinase O 0 1.1072481820306734e-10
is O 0 2.1848996498742963e-16
involved O 0 1.0541052919245462e-15
in O 0 2.7950623480579937e-16
the O 0 1.3717950573085202e-15
modulation O 0 6.68481112478525e-14
of O 0 2.9711362493564653e-13
the O 0 4.4874759290436383e-13
Ca2 O 0 2.5840848558167373e-11
+ O 0 5.266952429749949e-10
homeostasis O 0 1.1901480689857635e-08
in O 0 6.874364966158453e-11
skeletal O 0 8.463419476356648e-08
muscle O 0 4.7246553336321995e-09
cells O 0 1.8354505471052107e-08
. O 0 2.5635817912927905e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.00701397115688e-09
DM B-Disease 1 1.0
) O 0 5.330026242415797e-13
, O 0 2.0616820052652297e-15
the O 0 1.0980719981836147e-14
most O 0 4.047326371075209e-14
prevalent O 0 2.385150921213608e-08
muscular B-Disease 0 1.297931504495864e-07
disorder I-Disease 0 1.5816923326639198e-09
in O 0 4.734379121379417e-13
adults O 0 4.316028784367987e-11
, O 0 5.38513986414425e-15
is O 0 6.547136401241786e-16
caused O 0 1.2546029753285337e-13
by O 0 4.0810623381116323e-14
( O 0 5.094057415336783e-15
CTG O 0 1.4009053639352231e-10
) O 0 2.1586212467791197e-16
n O 0 2.8258003796204642e-15
- O 0 3.2410462117923866e-14
repeat O 0 7.468374199235892e-15
expansion O 0 7.804011851618355e-15
in O 0 2.412298217710024e-17
a O 0 6.721674289817333e-17
gene O 0 5.662895017150279e-17
encoding O 0 2.2644853928197733e-13
a O 0 3.846304177934634e-11
protein O 0 3.173966922620508e-10
kinase O 0 8.137476248393227e-10
( O 0 5.340123308827938e-12
DM B-Disease 1 1.0
protein O 0 7.134527191254847e-09
kinase O 0 1.5867406000236173e-10
; O 0 3.7859231944098806e-14
DMPK O 0 1.4439099231822183e-06
) O 0 3.7072091002478963e-16
and O 0 3.5701147001524196e-16
involves O 0 4.457326909369612e-14
changes O 0 3.248224985426956e-14
in O 0 6.580447992066141e-13
cytoarchitecture O 0 7.370782384441554e-08
and O 0 8.548908109196063e-11
ion O 0 4.519923280099647e-08
homeostasis O 0 1.409009769304248e-06
. O 0 5.984876594311572e-08

To O 0 9.711231124809316e-11
obtain O 0 2.1942538896979613e-09
clues O 0 3.4535391213452726e-10
to O 0 3.2083328506925246e-13
the O 0 4.5011829550092863e-13
normal O 0 6.828899945521272e-11
biological O 0 1.0085912140189723e-11
role O 0 1.267967762036415e-11
of O 0 1.0903611347146125e-09
DMPK O 1 0.9999922513961792
in O 0 7.435708226921633e-08
cellular O 0 3.699821249369961e-08
ion O 0 3.5311462642795277e-09
homeostasis O 0 3.179399143959927e-08
, O 0 7.176959222233992e-13
we O 0 2.310271928190194e-13
have O 0 1.7464335370660083e-14
compared O 0 5.867470138226638e-13
the O 0 4.482779165232431e-13
resting O 0 3.093949818566699e-10
[ O 0 1.381185638950344e-12
Ca2 O 0 1.0396744229423938e-12
+ O 0 3.3096542000066176e-12
] O 0 9.165374188768727e-12
i O 0 7.057528931923851e-13
, O 0 1.5117278912800256e-16
the O 0 3.554378945574803e-16
amplitude O 0 1.7905302417066567e-15
and O 0 1.435283564837019e-15
shape O 0 1.538358156139008e-11
of O 0 3.4315886243696525e-10
depolarization O 0 4.2425107871224554e-09
- O 0 8.392237127452518e-09
induced O 0 2.200506166172289e-10
Ca2 O 0 1.5886203810766553e-11
+ O 0 6.244951604450488e-12
transients O 0 2.7476347586041783e-11
, O 0 2.303499978921537e-17
and O 0 2.7411446146930315e-18
the O 0 2.310109515975305e-16
content O 0 7.502443219627175e-14
of O 0 2.9054672079711907e-13
ATP O 0 1.7213298841856073e-10
- O 0 1.4032259729179763e-11
driven O 0 1.5096254107893614e-11
ion O 0 5.079220898041026e-12
pumps O 0 1.6487937751219484e-11
in O 0 1.85787010775762e-11
cultured O 0 1.6750365716688975e-07
skeletal O 0 2.2990816361811994e-08
muscle O 0 7.819896119531933e-11
cells O 0 1.381192382687857e-10
of O 0 3.030161885297922e-11
wild O 0 2.4547551491505004e-12
- O 0 2.3445965221385867e-12
type O 0 7.247915375513392e-13
and O 0 1.0828899625961452e-12
DMPK O 0 9.13178373593837e-05
[ O 0 2.1135436456543033e-10
- O 0 1.6212489684086506e-10
/ O 0 4.12509713887399e-11
- O 0 6.12612608211216e-12
] O 0 3.906513242231402e-13
knockout O 0 9.996287825275729e-11
mice O 0 6.913269436081837e-12
. O 0 3.2815939635805202e-12

In O 0 3.186038544100711e-09
vitro O 0 4.602444647616721e-09
- O 0 1.5134642428193956e-09
differentiated O 0 3.3710183533486315e-09
DMPK O 0 2.6089333005074877e-06
[ O 0 6.139229402624125e-11
- O 0 9.414118096184865e-11
/ O 0 9.07750333234425e-11
- O 0 5.17323198168107e-11
] O 0 2.5460549467337668e-12
myotubes O 0 3.1113364662438414e-10
exhibit O 0 2.76646669575319e-14
a O 0 1.6780366430147603e-14
higher O 0 1.1085112862352364e-11
resting O 0 1.431722518319134e-09
[ O 0 1.6563996702023687e-11
Ca2 O 0 4.285979210427726e-11
+ O 0 4.533558597974441e-11
] O 0 4.5809394472184906e-11
i O 0 2.8050335491858203e-12
than O 0 4.416502970630565e-14
do O 0 6.029834292466119e-13
wild O 0 5.099936965791141e-12
- O 0 1.929304155670608e-12
type O 0 7.285198377719737e-13
myotubes O 0 3.4755260891472517e-09
because O 0 4.0645621362991186e-14
of O 0 8.819564002726654e-13
an O 0 1.79277890242338e-15
altered O 0 2.119308960095434e-13
open O 0 2.0811144149125715e-13
probability O 0 1.4375323847959365e-12
of O 0 6.76833979487701e-12
voltage O 0 4.327775290913216e-11
- O 0 3.1313102111241164e-10
dependent O 0 2.84488682611439e-10
l O 0 9.379911127330165e-13
- O 0 1.0564014940595001e-12
type O 0 1.2211852724517119e-14
Ca2 O 0 1.2723781988958904e-13
+ O 0 1.879807480465942e-13
and O 0 1.4724303048531395e-13
Na O 0 9.47753073937685e-12
+ O 0 5.714706594224517e-13
channels O 0 8.887435926085985e-12
. O 0 2.5008242005020165e-11

The O 0 3.0813367413173864e-09
mutant O 0 1.486242129367099e-09
myotubes O 0 2.8493428061437953e-08
exhibit O 0 3.618370360281009e-12
smaller O 0 1.4619753433038618e-13
and O 0 1.6224521387302702e-14
slower O 0 4.816678653152273e-11
Ca2 O 0 1.5381769469247075e-10
+ O 0 1.108723252096766e-10
responses O 0 5.790700492898371e-13
upon O 0 4.434791509716485e-12
triggering O 0 5.5075982836882975e-12
by O 0 9.028256522372255e-15
acetylcholine O 0 2.2408876143575895e-10
or O 0 9.536632594731032e-11
high O 0 2.7708554894978477e-10
external O 0 6.256108076030387e-09
K O 0 3.175361307228286e-09
+ O 0 1.0100631442355734e-09
. O 0 6.136821051327956e-10

In O 0 1.1250410325569504e-10
addition O 0 1.8093783415995546e-11
, O 0 6.42102405859317e-14
we O 0 5.88300973691433e-14
observed O 0 6.165294647421729e-14
that O 0 3.5179038539814606e-16
these O 0 1.6135149246972007e-14
Ca2 O 0 3.124328573633761e-11
+ O 0 2.5922217150586846e-10
transients O 0 1.8277219737683481e-09
partially O 0 2.4732450462638944e-11
result O 0 7.161425857708792e-13
from O 0 3.994617679171919e-13
an O 0 1.537170828721634e-14
influx O 0 5.204093991677261e-13
of O 0 1.834876434819721e-12
extracellular O 0 1.2648390364591866e-12
Ca2 O 0 4.820497299939941e-13
+ O 0 5.400090639408328e-13
through O 0 3.8937183013433574e-13
the O 0 4.754196710789194e-13
l O 0 3.088797663822196e-13
- O 0 4.031026543376698e-13
type O 0 4.295703875077661e-14
Ca2 O 0 1.487663616427104e-12
+ O 0 2.0946924750298024e-11
channel O 0 3.451719812752607e-11
. O 0 2.9466349499296385e-11

Neither O 0 4.0889576169433894e-09
the O 0 2.1002602868663844e-12
content O 0 2.5851139805188605e-12
nor O 0 2.299141508687458e-13
the O 0 2.836665271234895e-15
activity O 0 2.4134627673103037e-13
of O 0 1.0051296139802421e-13
Na O 0 1.433143859662367e-12
+ O 0 4.1257541003383857e-13
/ O 0 2.0151020609093795e-12
K O 0 7.681798448212762e-13
+ O 0 1.5260094078130282e-13
ATPase O 0 1.1570747832090333e-11
and O 0 1.6287690055190318e-13
sarcoplasmic O 0 2.4135859977292284e-10
reticulum O 0 1.0349354706562508e-09
Ca2 O 0 2.077453209459179e-10
+ O 0 1.1505875419093314e-10
- O 0 1.7881996230983965e-11
ATPase O 0 3.2872211896961545e-11
are O 0 1.8091848718205118e-15
affected O 0 8.749489847914571e-14
by O 0 7.699044310069403e-14
DMPK O 1 0.8283541202545166
absence O 0 2.703756933897239e-07
. O 0 3.3509406360821004e-09

In O 0 3.209574273022042e-10
conclusion O 0 1.974377772384628e-09
, O 0 6.531256655298301e-13
our O 0 1.7700516399821176e-11
data O 0 9.164531113159402e-13
suggest O 0 3.1655342409842024e-13
that O 0 4.162234352479959e-15
DMPK O 0 8.056862498051487e-06
is O 0 3.588631687412346e-15
involved O 0 7.442837849942069e-14
in O 0 5.917694719664857e-14
modulating O 0 3.799962514788868e-12
the O 0 1.7574673270501218e-14
initial O 0 1.7214716793983315e-13
events O 0 2.1275051897062455e-14
of O 0 6.20942576870509e-12
excitation O 0 6.351273640348154e-08
- O 0 1.6817014625303273e-07
contraction O 0 2.2220031370423499e-10
coupling O 0 3.7080937279054815e-12
in O 0 3.2448041649424386e-12
skeletal O 0 1.4544748516698291e-08
muscle O 0 3.392217340358883e-10
. O 0 1.935035812139496e-11
. O 0 1.9657792060812085e-10

Constitutional O 0 5.092196033729124e-07
RB1 O 0 3.4934189898194745e-05
- O 0 2.459469072846332e-09
gene O 0 5.189047976028593e-13
mutations O 0 3.4904661084210475e-13
in O 0 1.810815156134092e-14
patients O 0 2.611223683026548e-13
with O 0 1.1899651626752234e-14
isolated O 0 1.351406903049579e-10
unilateral B-Disease 0 8.418465036186262e-09
retinoblastoma I-Disease 1 1.0
. O 0 4.3557579374464694e-06

In O 0 1.948230812787166e-11
most O 0 3.3646970301094703e-13
patients O 0 9.107028282537288e-13
with O 0 1.951281001469525e-14
isolated O 0 2.9873457874085574e-11
unilateral B-Disease 0 8.7780910318358e-10
retinoblastoma I-Disease 1 0.8504640460014343
, O 0 2.9612484339636147e-12
tumor B-Disease 0 2.217220407274567e-09
development O 0 8.773877624435045e-09
is O 0 2.6396890299003285e-15
initiated O 0 6.027121076529474e-13
by O 0 2.803831309584003e-15
somatic O 0 7.491429698802676e-11
inactivation O 0 9.406095347053167e-11
of O 0 5.059370457305423e-12
both O 0 7.322365370293626e-13
alleles O 0 4.139540273062625e-13
of O 0 1.3258314585096187e-11
the O 0 8.400059120505787e-11
RB1 O 0 2.3391524450744328e-07
gene O 0 5.0140010199317686e-11
. O 0 2.0128234634597675e-09

However O 0 1.5530200736524336e-10
, O 0 3.858628436844043e-14
some O 0 2.7533576750483034e-15
of O 0 3.1009697305621475e-13
these O 0 8.908798720431987e-13
patients O 0 6.725897616632892e-12
can O 0 7.901773679819257e-11
transmit O 0 2.9453975258775245e-08
retinoblastoma B-Disease 0 2.0814986783079803e-06
predisposition O 0 2.4262677200681537e-08
to O 0 7.623047193483501e-10
their O 0 4.513408313755463e-09
offspring O 0 3.746984020835953e-07
. O 0 8.02318655956924e-09

To O 0 6.203498825740894e-11
determine O 0 2.686454184108733e-11
the O 0 8.322782567293796e-13
frequency O 0 3.86062015689248e-12
and O 0 1.512441871233134e-14
nature O 0 8.966794320941496e-13
of O 0 1.3238268987969537e-12
constitutional O 0 7.870986640234889e-10
RB1 O 0 4.2070882955158595e-06
- O 0 5.001052350017687e-10
gene O 0 4.063711715220075e-13
mutations O 0 1.9948266129221626e-12
in O 0 1.9640635417952218e-13
patients O 0 1.646628493279234e-11
with O 0 5.53634828953653e-13
isolated O 0 5.532451718970322e-10
unilateral B-Disease 0 2.0016479584938907e-09
retinoblastoma I-Disease 0 0.022765975445508957
, O 0 4.57888230370046e-13
we O 0 5.891049773649668e-14
analyzed O 0 5.017641575670584e-13
DNA O 0 3.085999233931602e-10
from O 0 8.804572197186611e-13
peripheral O 0 9.772890274817314e-10
blood O 0 2.420842970529691e-10
and O 0 4.184036450638473e-11
from O 0 2.3662001247259923e-09
tumor B-Disease 0 1.2627657497432665e-06
tissue O 0 1.7383273132054455e-07
. O 0 1.1216375384037747e-08

The O 0 5.221687665590835e-11
analysis O 0 7.200413182362198e-11
of O 0 8.544804863674926e-10
tumors B-Disease 1 1.0
from O 0 8.330827694358334e-11
54 O 0 3.630125366971271e-10
( O 0 9.369298244958201e-15
71 O 0 3.92665872039899e-10
% O 0 2.1578652059650594e-11
) O 0 8.008510698436606e-16
of O 0 3.9671689327711035e-13
76 O 0 1.0129371647016328e-10
informative O 0 1.307756541946148e-10
patients O 0 4.3555708085368794e-13
showed O 0 1.898361849661523e-11
loss O 0 3.546586635483351e-11
of O 0 9.106689013993474e-11
constitutional O 0 1.2650636094235779e-08
heterozygosity O 0 0.31714436411857605
( O 0 1.694506408966845e-06
LOH O 0 0.08742836862802505
) O 0 3.427470763803231e-12
at O 0 3.172702101039704e-10
intragenic O 0 5.07424466889006e-08
loci O 0 7.266765522651042e-10
. O 0 3.2277847061834564e-09

Three O 0 1.8647047794750904e-10
of O 0 1.0125875832267539e-10
13 O 0 5.735484864821672e-10
uninformative O 0 5.586942734225886e-06
patients O 0 4.2672124167530967e-10
had O 0 5.3868461774575493e-11
constitutional O 0 3.4652132274715086e-09
deletions O 0 5.130749514137278e-08
. O 0 7.552915626263257e-09

For O 0 7.086675690715083e-10
39 O 0 3.3641649466176204e-09
randomly O 0 7.03053448791735e-10
selected O 0 1.5783605533670197e-07
tumors B-Disease 1 1.0
, O 0 9.08736072502414e-11
SSCP O 0 0.010871569626033306
, O 0 6.618822157022919e-11
hetero O 0 3.858963992797726e-08
- O 0 4.5416937571873817e-11
duplex O 0 1.3019500755273583e-10
analysis O 0 1.432790518174354e-13
, O 0 1.1502149076799925e-17
sequencing O 0 5.834292467546409e-13
, O 0 1.5411744358259497e-15
and O 0 3.752064238189516e-14
Southern O 0 7.205361862716586e-10
blot O 0 8.267534212791361e-09
analysis O 0 3.895897059819076e-12
were O 0 2.2652587000192986e-13
used O 0 1.6517202102578343e-12
to O 0 1.5391131424902227e-10
identify O 0 5.091695598480328e-08
mutations O 0 5.6611064280787105e-08
. O 0 5.155627036401711e-08

Mutations O 0 1.3801160214654828e-09
were O 0 8.787764786688523e-12
detected O 0 2.6583980242828043e-12
in O 0 9.917983318299961e-15
21 O 0 1.2119229502328271e-13
( O 0 3.475418865104002e-17
91 O 0 2.490826121748224e-12
% O 0 1.7502602015287416e-12
) O 0 1.0973846521227415e-15
of O 0 8.196786999148387e-12
23 O 0 3.7004568298470986e-07
tumors B-Disease 1 1.0
with O 1 0.999902606010437
LOH O 1 0.9999994039535522
. O 0 9.668926850281423e-07

In O 0 1.6835251248625838e-10
6 O 0 3.374068602637892e-12
( O 0 1.9979524639236778e-16
38 O 0 1.840308938225177e-12
% O 0 5.773716465866385e-13
) O 0 1.1270398050017066e-15
of O 0 6.99980611668094e-12
16 O 0 9.145972512669687e-08
tumors B-Disease 1 1.0
without O 1 0.9999983310699463
LOH O 1 0.9985291957855225
, O 0 5.259338103913436e-12
one O 0 2.6507021404220676e-12
mutation O 0 7.701398655086955e-13
was O 0 1.8983753371365486e-12
detected O 0 4.897074065701723e-12
, O 0 9.435900445600807e-16
and O 0 4.556939000406254e-15
in O 0 1.788832211697955e-13
9 O 0 1.947791537434962e-12
( O 0 7.065868377865384e-16
56 O 0 2.210900559851403e-11
% O 0 6.546201081203407e-12
) O 0 7.595713744394314e-15
of O 0 2.0299510336552196e-11
the O 0 3.105096979538757e-08
tumors B-Disease 1 1.0
without O 1 0.9998854398727417
LOH O 1 0.998271107673645
, O 0 7.236978377678227e-12
both O 0 3.152113986493177e-11
mutations O 0 3.713261989557459e-11
were O 0 1.589005142743627e-11
found O 0 1.4416764657076975e-11
. O 0 3.5998562464278905e-10

Thus O 0 2.638507745622576e-10
, O 0 2.5339119366120377e-14
a O 0 2.003002527294767e-14
total O 0 9.629254858756209e-13
of O 0 8.071365299212874e-13
45 O 0 3.922060939909322e-11
mutations O 0 4.731258353846135e-12
were O 0 5.463966952501398e-12
identified O 0 3.0981824744591435e-11
in O 0 1.4854591168234066e-10
tumors B-Disease 1 1.0
of O 0 8.358402858732461e-09
36 O 0 2.978884765525436e-07
patients O 0 1.3241579388534319e-08
. O 0 2.57389729085844e-07

Thirty O 0 7.424102221875728e-08
- O 0 4.367212841360768e-11
nine O 0 4.71892013312325e-12
of O 0 3.056272682849803e-13
the O 0 4.569529433659514e-13
mutations O 0 1.1951364377316143e-12
- O 0 5.191156207152992e-13
including O 0 3.157386122844795e-14
34 O 0 5.114927148497372e-09
small O 0 5.6996254937935475e-11
mutations O 0 1.083503065046898e-09
, O 0 3.6108689822900164e-12
2 O 0 2.5076846155158705e-10
large O 0 6.619681192088223e-11
structural O 0 2.9842411208846897e-07
alterations O 0 5.823711148877919e-07
, O 0 6.590952610074918e-12
and O 0 5.827403143365828e-11
hypermethylation O 0 0.001679324428550899
in O 0 1.882002891306911e-07
3 O 0 8.800805062492145e-07
tumors O 1 1.0
- O 0 2.1873206024203284e-10
were O 0 2.893710661713844e-12
not O 0 5.477463575482948e-14
detected O 0 3.494116617135806e-13
in O 0 3.932795149925398e-15
the O 0 4.911390440393362e-14
corresponding O 0 1.009033741977694e-11
peripheral O 0 5.102559486047653e-10
blood O 0 4.687188415175569e-10
DNA O 0 4.122634322811791e-07
. O 0 5.7827133304044764e-08

In O 0 5.563742799807869e-10
6 O 0 1.3355115624502645e-11
( O 0 4.336514875388439e-16
17 O 0 3.922713255567409e-14
% O 0 2.5635460618980872e-14
) O 0 6.138037073577782e-18
of O 0 4.634955393529585e-15
the O 0 1.7155912378653132e-13
36 O 0 3.3506836194518996e-10
patients O 0 3.4957665234758295e-11
, O 0 6.088915179350285e-13
a O 0 1.3102474834270073e-11
mutation O 0 1.6644279704491893e-11
was O 0 2.9067893925205368e-11
detected O 0 2.0469886202745258e-11
in O 0 1.8893040072947426e-13
constitutional O 0 1.6581382100699926e-11
DNA O 0 1.3120901698471243e-08
, O 0 1.0604187883692107e-12
and O 0 6.068602109547683e-13
1 O 0 5.150279508425726e-12
of O 0 3.135657965919192e-12
these O 0 8.510714919265916e-13
mutations O 0 2.625492922028738e-12
is O 0 1.778447316714074e-15
known O 0 6.700483775408297e-15
to O 0 7.463227084947288e-13
be O 0 1.6832857807277946e-12
associated O 0 4.1723871579968375e-10
with O 0 2.1697873532622314e-12
reduced O 0 8.382909477688827e-09
expressivity O 0 4.699623787018936e-06
. O 0 5.661114688138014e-09

The O 0 1.1832163027136744e-10
presence O 0 3.611654378343765e-12
of O 0 1.9973364975833796e-11
a O 0 3.6914885211125625e-12
constitutional O 0 2.510056919258208e-11
mutation O 0 3.0495357216005214e-13
was O 0 1.1897473058011896e-14
not O 0 1.9970153013768797e-16
associated O 0 6.760768380813806e-15
with O 0 7.216339545780374e-17
an O 0 5.908144804349391e-17
early O 0 5.149137951958316e-13
age O 0 3.846640020399583e-12
at O 0 2.646276860834851e-12
treatment O 0 1.5237903161491317e-09
. O 0 2.1590407239813203e-09

In O 0 2.417889777284188e-10
1 O 0 3.4994443454117174e-10
patient O 0 5.954007065156475e-09
, O 0 3.2987997641668876e-13
somatic O 0 8.220750191689774e-10
mosaicism O 0 2.5436721173832666e-08
was O 0 3.3599704507385197e-13
demonstrated O 0 6.320317939801853e-14
by O 0 1.3152864089765847e-17
molecular O 0 1.2951875976138284e-15
analysis O 0 6.261376813353984e-15
of O 0 7.620673264251056e-15
DNA O 0 4.72380121130378e-12
and O 0 5.933585735381705e-14
RNA O 0 2.1464095778522818e-10
from O 0 1.0520873755526239e-10
peripheral O 0 2.1067042155209492e-07
blood O 0 9.156847369240495e-08
. O 0 1.3167763768251461e-07

In O 0 2.3043605912320686e-10
2 O 0 1.3112082253297075e-10
patients O 0 8.302365739343287e-12
without O 0 1.2863836731935585e-11
a O 0 3.0575937615129334e-11
detectable O 0 3.881950760842301e-09
mutation O 0 5.156462496574976e-12
in O 0 5.3475331801555726e-12
peripheral O 0 5.643749290129563e-08
blood O 0 4.793160002236618e-08
, O 0 4.0466918010961805e-11
mosaicism O 0 1.2237256896696636e-06
was O 0 2.7030919169668266e-11
suggested O 0 5.633090782025674e-12
because O 0 1.1920322618797028e-14
1 O 0 1.389370525095926e-13
of O 0 8.578611454014562e-13
the O 0 3.0954754818429686e-12
patients O 0 2.1934985078297942e-11
showed O 0 1.3984828406421457e-08
multifocal O 1 0.9999970197677612
tumors B-Disease 1 1.0
and O 0 4.168135888521496e-12
the O 0 3.989527458392317e-11
other O 0 7.830200788976061e-13
later O 0 1.0293244034897953e-10
developed O 0 8.607551893469179e-10
bilateral B-Disease 0 0.0003023198514711112
retinoblastoma I-Disease 0 0.0010893926955759525
. O 0 4.213771376271325e-08

In O 0 1.5239000339395403e-10
conclusion O 0 1.0883705048314596e-09
, O 0 4.669727061631934e-13
our O 0 1.7539504570951436e-11
results O 0 6.116221895266505e-13
emphasize O 0 8.327360502546899e-12
that O 0 2.7461096141186483e-15
the O 0 4.0089977236361374e-13
manifestation O 0 1.2448657660257822e-09
and O 0 4.147603701459834e-12
transmissibility O 0 1.332356589500705e-07
of O 0 1.3791968955789713e-10
retinoblastoma B-Disease 0 2.7913015898661797e-08
depend O 0 2.883619731886e-10
on O 0 5.952147195259494e-12
the O 0 4.0025263919191145e-13
nature O 0 2.5666604258622883e-12
of O 0 2.6786656660143793e-12
the O 0 5.545342288658384e-13
first O 0 3.654896697791177e-12
mutation O 0 3.1113851187321295e-13
, O 0 3.695449318324691e-15
its O 0 4.203048211526934e-15
time O 0 2.4337189164988504e-13
in O 0 3.9841854858682635e-13
development O 0 1.5877100745242956e-09
, O 0 1.3639114252068929e-14
and O 0 2.4327616337431815e-14
the O 0 1.9992716249889186e-12
number O 0 9.924163270683128e-13
and O 0 9.216030716352464e-13
types O 0 7.26390683714051e-11
of O 0 2.3497820009210635e-11
cells O 0 1.0850406510776178e-11
that O 0 1.0100476227972721e-13
are O 0 5.5950290380564136e-14
affected O 0 1.2193367843194025e-11
. O 0 1.4314889551503285e-11
. O 0 3.2145812678407992e-09

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 0.25929415225982666
the I-Disease 0 4.521371721466494e-08
fifth I-Disease 0 9.440110488867504e-07
component I-Disease 0 2.439337842830014e-09
of I-Disease 0 1.0026342950331113e-10
complement I-Disease 0 8.075859425638043e-10
in O 0 4.0529893330365496e-10
man O 0 2.3559367434700107e-07
. O 0 1.1576410230418333e-07

I O 0 9.932609827956185e-05
. O 0 3.896833788985532e-08

Clinical O 0 1.271915976985838e-07
, O 0 2.4065228976244413e-12
immunochemical O 0 4.2608000683230784e-08
, O 0 8.927998992229805e-14
and O 0 9.592330998519499e-14
family O 0 9.274964693842258e-13
studies O 0 2.8857917791502707e-11
. O 0 2.792788569849769e-11

The O 0 3.9588960581982136e-11
first O 0 7.649982535461175e-13
recognized O 0 3.5364574224767964e-13
human O 0 1.5855863714012153e-12
kindred O 0 1.2753552880440111e-08
with O 0 2.38455360058315e-13
hereditary B-Disease 0 0.005142445210367441
deficiency I-Disease 1 0.9988260865211487
of I-Disease 0 0.31533095240592957
the I-Disease 0 1.0651323378851885e-07
fifth I-Disease 0 0.4497446119785309
component I-Disease 0 0.41874200105667114
of I-Disease 1 0.9949421286582947
complement I-Disease 1 0.998839795589447
( O 0 7.15523751360081e-10
C5 O 0 0.028193969279527664
) O 0 3.102166310289811e-12
is O 0 2.3739980792823745e-13
described O 0 4.805712078281843e-11
. O 0 4.5685104588244485e-09

The O 0 6.863537294066191e-09
proband O 0 8.579971790823038e-07
, O 0 5.4058174630460323e-14
a O 0 2.183943503201568e-14
20 O 0 1.7728601179873953e-14
- O 0 7.481458740688602e-16
year O 0 2.3971703257390925e-14
- O 0 1.0767975053282974e-12
old O 0 6.181467664123641e-12
black O 0 5.781758128904982e-14
female O 0 4.310456939299323e-12
with O 0 4.737163786239229e-12
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.005528900306671858
age O 0 1.8445299474478816e-06
11 O 0 1.7451127209966444e-09
, O 0 6.89919746766493e-13
lacked O 0 3.2299463104124015e-09
serum O 0 1.3495787820616556e-09
hemolytic O 0 3.3411313715703272e-09
complement O 0 3.438723750193162e-10
activity O 0 3.216290567209512e-10
, O 0 1.6445763004993737e-14
even O 0 3.727291573800938e-14
during O 0 7.508184629578807e-10
remission O 0 4.1162229535984807e-07
. O 0 4.750831950062206e-10

C5 O 0 4.10138181905495e-06
was O 0 1.3675539589641517e-09
undetectable O 0 9.663417843697175e-10
in O 0 6.126528321118152e-14
her O 0 5.710574157644088e-14
serum O 0 2.956539906558836e-13
by O 0 9.520070109569467e-16
both O 0 2.4886037241350634e-12
immunodiffusion O 0 1.4040786311397824e-07
and O 0 7.533499518652675e-11
hemolytic O 0 1.4232480793907598e-07
assays O 0 2.388683917331491e-08
. O 0 5.817527792828514e-08

Other O 0 1.93769414576217e-12
complement O 0 3.819953034445156e-12
components O 0 5.401157299189663e-11
were O 0 5.982841717704079e-13
normal O 0 6.113105577298938e-10
during O 0 8.241661797470101e-10
remission O 0 9.336227435596811e-07
of O 0 7.061120577134261e-10
lupus O 0 1.3550417454766261e-09
, O 0 1.8828093598100004e-11
but O 0 3.977160545343139e-10
C1 O 0 1.7430898878956214e-05
, O 0 2.8240618177299837e-10
C4 O 0 6.117554818274584e-08
, O 0 1.0128265413855697e-11
C2 O 0 1.4388465530146277e-08
, O 0 2.6932713871608005e-12
and O 0 1.9799982833856866e-11
C3 O 0 3.5855799751516315e-07
levels O 0 1.0246829162952054e-08
fell O 0 1.9666774875304327e-08
during O 0 1.1663389187788198e-07
exacerbations O 0 0.0007070109713822603
. O 0 8.630807002418805e-08

A O 0 1.2979253938283364e-07
younger O 0 4.6319112989579025e-09
half O 0 2.7731605900527256e-10
- O 0 4.542334910984103e-11
sister O 0 2.0928673724607272e-11
, O 0 1.4667142893558423e-14
who O 0 6.993299168922551e-14
had O 0 4.157210600069794e-12
no O 0 8.369217862139178e-13
underlying O 0 9.478933193918238e-10
disease O 0 5.867353131128183e-11
, O 0 1.2973633076179695e-15
was O 0 5.280083661962642e-12
also O 0 3.042610109173227e-13
found O 0 1.98635326936758e-11
to O 0 4.833527356140621e-08
lack O 1 0.999964714050293
immunochemically O 1 0.9999598264694214
detectable O 0 0.0005558488192036748
C5 O 0 7.780578744132072e-05
. O 0 2.6743222747427353e-07

By O 0 2.2914038722010588e-11
hemolytic O 0 4.191859090951766e-07
assay O 0 3.5595748570926844e-09
, O 0 1.3246250884363375e-12
she O 0 5.43444344971826e-14
exhibited O 0 1.1402783285738988e-13
1 O 0 3.5487126339708505e-14
- O 0 4.290487846188469e-14
2 O 0 2.2890749879774614e-15
% O 0 7.218084772464897e-14
of O 0 1.5897393874941303e-14
the O 0 2.976740490386043e-13
normal O 0 6.085789650001061e-10
serum O 0 1.0886441054180906e-10
C5 O 0 1.2410913408089641e-09
level O 0 4.184677049323682e-10
and O 0 4.734812802248412e-13
normal O 0 1.3671204446286112e-10
concentrations O 0 6.366750009145772e-12
of O 0 2.4271932120428774e-12
other O 0 5.24071996736708e-13
complement O 0 3.524288361145267e-10
components O 0 7.404134549915398e-08
. O 0 2.5750408028102356e-08

C5 O 0 1.295872607443016e-06
levels O 0 2.791235020893623e-10
of O 0 1.2002450248960184e-11
other O 0 1.0047864639926504e-13
family O 0 1.6096028860896477e-13
members O 0 5.585536848036303e-15
were O 0 1.209332249141673e-13
either O 0 1.5154839189124303e-12
normal O 0 4.822646726410085e-10
or O 0 2.5094607381676015e-13
approximately O 0 4.809503489910938e-13
half O 0 4.010875659377078e-11
- O 0 7.173873300958533e-11
normal O 0 3.2948701544910364e-09
, O 0 3.3685112533522743e-13
consistent O 0 3.139215831726716e-10
with O 0 2.8738749119176787e-13
autosomal O 0 9.308408266406332e-09
codominant O 0 1.6674746916578442e-08
inheritance O 0 2.5288376948040536e-10
of O 0 1.879468802812312e-11
the O 0 3.8462160539820545e-11
gene O 0 9.994290950388063e-10
determining O 0 3.5269258660264313e-06
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.233586459647995e-07

Normal O 0 1.1065145372413099e-05
hemolytic O 0 1.4946340343158226e-06
titers O 0 3.45751729469157e-08
were O 0 2.6531602435875268e-12
restored O 0 5.35811291169086e-11
to O 0 6.590396089099781e-13
both O 0 7.540209776002449e-12
homozygous O 0 7.89191744843265e-07
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 1.7990118283961465e-09
C5D B-Disease 1 1.0
) O 0 7.699132401495917e-14
sera O 0 1.3766777431575838e-12
by O 0 6.1253361288623365e-18
addition O 0 3.0360696595677084e-14
of O 0 4.650601084787986e-12
highly O 0 2.8581264022164987e-09
purified O 0 3.5743127568821365e-08
human O 0 8.664929218582529e-09
C5 O 0 1.0660824955266435e-05
. O 0 3.846618312763894e-08

In O 0 6.049246437100919e-09
specific O 0 1.4121143143697168e-09
C5 O 0 1.6659652146699955e-07
titrations O 0 1.1562982393797938e-07
, O 0 4.248640556123867e-13
however O 0 5.940450496962069e-13
, O 0 5.117663800060287e-15
it O 0 4.286614311581116e-16
was O 0 2.1910710821648055e-13
noted O 0 6.371080285517625e-14
that O 0 5.386267159117927e-16
when O 0 2.017480522649006e-14
limited O 0 2.736513923448647e-12
amounts O 0 1.3202772208842362e-11
of O 0 2.6208227255075656e-10
C5 O 0 9.541081702479914e-09
were O 0 2.3110466318421174e-10
assayed O 0 1.0834995123332192e-08
in O 0 8.644013781665405e-13
the O 0 1.3083290961030114e-12
presence O 0 2.0428650090997813e-12
of O 0 3.03589479944133e-11
low O 0 5.520645607326458e-10
dilutions O 0 1.0845130304915074e-07
of O 0 8.019498842770645e-09
either O 0 2.1744044715887867e-06
C5D B-Disease 1 1.0
serum O 0 3.343180026149639e-07
, O 0 4.400755747226842e-13
curving O 0 3.071622470263158e-11
rather O 0 5.328155451567174e-13
than O 0 2.1660555226082727e-14
linear O 0 6.124855483902181e-11
dose O 0 7.557610093300582e-10
- O 0 2.6452387155706525e-11
response O 0 1.8355124007090468e-13
plots O 0 6.788942741309256e-10
were O 0 1.2697853185583696e-11
consistently O 0 1.2062188921302397e-11
obtained O 0 4.3645707707706816e-12
, O 0 1.8466958105929632e-14
suggesting O 0 1.6302989774147347e-12
some O 0 2.422168131485051e-14
inhibitory O 0 2.1796907334614701e-10
effect O 0 5.2136468753349874e-11
. O 0 5.664603008881386e-09

Further O 0 3.9321151890092665e-10
studies O 0 6.333962000726334e-12
suggested O 0 6.504155937794853e-13
that O 0 7.79823847504987e-15
low O 0 3.8402933610903744e-11
dilutions O 0 1.0367917013809347e-07
of O 0 1.1845491343365211e-07
C5D B-Disease 1 1.0
serum O 0 4.610319308540056e-07
contain O 0 2.662098146088976e-11
a O 0 7.777806176889612e-13
factor O 0 6.400692692878907e-13
( O 0 2.498082697053065e-15
or O 0 1.8102705478303255e-13
factors O 0 5.507217403465103e-13
) O 0 6.3907200149491365e-15
interfering O 0 5.124748958529324e-10
at O 0 1.0282745488421341e-10
some O 0 4.632412007698865e-14
step O 0 1.1683985376431671e-11
in O 0 8.483325803984587e-13
the O 0 3.332230671948544e-11
hemolytic O 0 5.1307786463894445e-08
assay O 0 4.749320936525692e-09
of O 0 1.3293963263549813e-08
C5 O 0 8.6218555850337e-08
, O 0 1.8323012649246878e-13
rather O 0 1.027534394376639e-12
than O 0 1.9561674328982814e-13
a O 0 1.3495541489882967e-11
true O 0 7.897860143657454e-10
C5 O 0 5.654804269283886e-08
inhibitor O 0 2.7512228606418887e-10
or O 0 4.275699932998478e-11
inactivator O 0 2.9968813919367676e-07
. O 0 4.088840821481199e-09

Of O 0 3.161686734642899e-08
clinical O 0 1.0702025932118886e-08
interest O 0 5.1913005144621494e-11
are O 0 4.815090925806842e-14
( O 0 3.930185441414907e-15
a O 0 1.4955976724000813e-13
) O 0 4.4114807322917927e-16
the O 0 1.5851287838743178e-13
documentation O 0 5.1837986347891274e-08
of O 0 1.348703704273646e-09
membranous O 0 5.971296559437178e-05
glomerulonephritis B-Disease 1 1.0
, O 0 8.576480636790507e-10
vasculitis B-Disease 1 1.0
, O 0 6.72425934378218e-11
and O 0 4.790514096519871e-10
arthritis B-Disease 1 1.0
in O 0 2.2087309758944684e-10
an O 0 1.252532284704358e-13
individual O 0 1.019427771364878e-11
lacking O 0 0.016078852117061615
C5 O 0 5.58339479539427e-06
( O 0 1.8681159863389446e-13
and O 0 8.536967926195752e-14
its O 0 8.395081098388005e-14
biologic O 0 4.129340272496229e-11
functions O 0 9.005564306427405e-13
) O 0 5.289951572081232e-16
, O 0 1.5071969796962644e-15
and O 0 1.279271319139328e-14
( O 0 1.1184994894318967e-15
b O 0 7.416083806083273e-14
) O 0 1.77891477302184e-16
a O 0 5.296165998705353e-14
remarkable O 0 5.698299471168511e-11
propensity O 0 3.2345515155185467e-09
to O 0 3.021339289865921e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 9.8712476994528e-13
the O 0 9.971369433273147e-13
proband O 0 5.909430722539355e-09
, O 0 9.923622016629833e-15
even O 0 4.987969503308497e-15
during O 0 2.2299159047056705e-11
periods O 0 2.7577704564407668e-09
of O 0 5.407073400132134e-11
low O 0 7.419321407242663e-11
- O 0 1.5198665893542684e-12
dose O 0 7.991753417889436e-13
or O 0 2.2015426455598494e-14
alternate O 0 8.599068124226505e-10
- O 0 4.78583783714015e-10
day O 0 2.5605995102040424e-10
corticosteroid O 0 1.3067314057479962e-06
therapy O 0 1.2155472006725176e-07
. O 0 6.225949616966986e-11

Other O 0 3.2622604704407587e-12
observations O 0 1.0983370246284152e-12
indicate O 0 2.7739219409417433e-14
that O 0 3.9044493246944307e-17
the O 0 1.0822595532429535e-13
C5D B-Disease 1 1.0
state O 0 4.007363451491441e-12
is O 0 4.733170875466971e-16
compatible O 0 8.932901640612556e-11
with O 0 8.007874047297626e-15
normal O 0 1.0868639321870432e-10
coagulation O 0 3.1183376193733015e-12
function O 0 3.4283337887325294e-12
and O 0 1.5033389775555815e-14
the O 0 4.0491969586359255e-13
capacity O 0 2.7126623863837906e-11
to O 0 7.231201054613834e-11
mount O 0 3.0912428883311804e-07
a O 0 2.7533099355991908e-08
neutrophilic O 1 0.6321289539337158
leukocytosis O 0 0.00014347367687150836
during O 0 2.9012990125920624e-06
pyogenic B-Disease 0 0.00015651661669835448
infection I-Disease 0 1.861928069502028e-07
. O 0 7.410336233526493e-12
. O 0 1.5058645996823827e-10

Susceptibility O 0 2.1616806407109834e-06
to O 0 1.0349813237553462e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 3.093498435191577e-08
twins O 0 1.1338566752172596e-09
: O 0 4.3966108703793964e-17
the O 0 1.3594590812229454e-15
role O 0 9.311545675141919e-14
of O 0 1.918684178550678e-12
genes O 0 7.326109120395219e-13
, O 0 2.455240871723774e-13
HLA O 0 3.4604576981678292e-09
, O 0 1.8197943152387097e-13
and O 0 1.9625880781637406e-13
the O 0 5.072640224534908e-11
environment O 0 4.878222270576771e-09
. O 0 2.4011154176051264e-10

OBJECTIVE O 0 1.2807373650502996e-06
To O 0 1.2211616266799563e-11
determine O 0 3.5748372578109366e-12
the O 0 1.1216475339671794e-13
relative O 0 1.6718765261103385e-11
effects O 0 3.9008488279812514e-12
of O 0 3.9443681610837333e-13
genetic O 0 5.304875896200434e-12
and O 0 1.3535116393837993e-14
environmental O 0 8.844356182754337e-14
factors O 0 6.019417616806057e-15
in O 0 5.561850418699284e-15
susceptibility O 0 7.326089040970984e-11
to O 0 3.5074666726586656e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.866741428102614e-09
AS B-Disease 1 1.0
) O 0 2.953558350584501e-13
. O 0 2.8578290775516102e-11

METHODS O 0 4.112455940230575e-07
Twins O 0 6.652254302963456e-09
with O 0 7.253910539188786e-15
AS B-Disease 1 0.9999406337738037
were O 0 5.930595624374603e-15
identified O 0 2.428810436802477e-15
from O 0 5.991511375204935e-16
the O 0 1.8656224229861816e-14
Royal O 0 3.591151681581195e-11
National O 0 3.8108893818389333e-10
Hospital O 0 7.295784598682076e-08
for O 0 2.416424838003195e-09
Rheumatic B-Disease 1 0.9973026514053345
Diseases I-Disease 0 0.00023974443320184946
database O 0 1.4136134929287891e-08
. O 0 1.5767621874829274e-08

Clinical O 0 5.8854855211620816e-08
and O 0 4.0748905985599215e-12
radiographic O 0 1.2392186832244079e-08
examinations O 0 4.449727697419803e-09
were O 0 3.499887879510055e-12
performed O 0 2.7691091607218166e-12
to O 0 3.0485601022756104e-12
establish O 0 7.243172173154733e-10
diagnoses O 0 1.1164317470502283e-08
, O 0 7.495696229507798e-13
and O 0 9.828361215158399e-12
disease O 0 6.653487361063526e-08
severity O 0 2.672177479290383e-10
was O 0 1.2100983735018056e-13
assessed O 0 4.576594637116516e-13
using O 0 1.7878898706034756e-14
a O 0 7.025560282191215e-14
combination O 0 1.516472087877488e-13
of O 0 1.3116797144968606e-12
validated O 0 6.812927999533258e-10
scoring O 0 4.764582506311399e-09
systems O 0 6.084878378942449e-08
. O 0 7.403016422102837e-09

HLA O 0 6.791940450057155e-07
typing O 0 2.1082794177118558e-08
for O 0 2.976062452031414e-11
HLA O 0 3.2843431085893826e-08
- O 0 5.145650017190917e-10
B27 O 0 5.651304979537031e-10
, O 0 1.23877001524989e-15
HLA O 0 9.379396564979103e-12
- O 0 3.3700792807442315e-13
B60 O 0 3.79494265873026e-12
, O 0 3.138209299896808e-18
and O 0 3.0955146620930977e-17
HLA O 0 7.870697843470609e-11
- O 0 6.033372412783677e-11
DR1 O 0 1.7010622741508996e-06
was O 0 3.955953538923099e-14
performed O 0 1.5314809907775715e-15
by O 0 4.102956458967151e-17
polymerase O 0 1.1141251360065677e-13
chain O 0 3.5760951762765086e-14
reaction O 0 5.648119453827713e-16
with O 0 5.406833119077261e-16
sequence O 0 6.744508922705561e-13
- O 0 2.610660982099028e-13
specific O 0 6.781435900023516e-14
primers O 0 4.374632947556911e-11
, O 0 2.995260289795354e-14
and O 0 1.4695825123218348e-13
zygosity O 0 3.791419445065003e-08
was O 0 1.5191565453515077e-12
assessed O 0 2.149915662164048e-11
using O 0 1.4271481132283048e-12
microsatellite O 0 4.696389943603663e-09
markers O 0 1.752250455844262e-09
. O 0 8.964674336198186e-09

Genetic O 0 4.458894586889528e-09
and O 0 1.0894026837311027e-13
environmental O 0 1.266030737277074e-13
variance O 0 5.427472029749178e-14
components O 0 6.616724095714899e-12
were O 0 1.8510660940249807e-13
assessed O 0 1.5777917167225652e-11
with O 0 1.788711831375491e-14
the O 0 4.370233016616487e-13
program O 0 3.253635425318202e-12
Mx O 0 2.500412637357341e-12
, O 0 2.164350498225009e-17
using O 0 1.529687636739777e-16
data O 0 2.1659728521926207e-14
from O 0 6.039655139740093e-16
this O 0 9.381811039171515e-16
and O 0 1.7699739167470973e-15
previous O 0 8.959276029396612e-12
studies O 0 2.300906210353504e-12
of O 0 2.743698822825491e-13
twins O 0 1.1612408257200002e-10
with O 0 1.28899874714955e-12
AS B-Disease 1 1.0
. O 0 4.4642661123361904e-08

RESULTS O 0 3.725768138451713e-08
Six O 0 3.9236662807695666e-09
of O 0 1.773804159110881e-10
8 O 0 1.8816541380584084e-10
monozygotic O 0 1.413444152831289e-07
( O 0 1.3137359256010228e-11
MZ O 0 8.141781222548161e-07
) O 0 2.287017688944182e-13
twin O 0 1.1884387918215111e-10
pairs O 0 4.594912124400441e-12
were O 0 9.433188952190363e-11
disease O 0 2.3314036812216443e-10
concordant O 0 6.964893661809413e-10
, O 0 3.835234742093595e-15
compared O 0 1.7310737262035691e-12
with O 0 9.82767181843076e-15
4 O 0 3.1600401548953494e-12
of O 0 1.2611323443878497e-11
15 O 0 1.1311209781317277e-11
B27 O 0 2.1104549219330693e-09
- O 0 1.1336354771573909e-10
positive O 0 1.1272264588760295e-12
dizygotic O 0 1.1137220923274072e-08
( O 0 6.60667877285144e-14
DZ O 0 2.2090649309802757e-09
) O 0 1.104431648606542e-15
twin O 0 7.701368839527212e-13
pairs O 0 3.6613541246153375e-14
( O 0 1.179519584133419e-16
27 O 0 1.1771890970693755e-12
% O 0 3.4875780648840893e-13
) O 0 3.0284366009877025e-17
and O 0 2.373904914128506e-15
4 O 0 2.599153802341353e-13
of O 0 2.5471251843822706e-11
32 O 0 4.5816234139905987e-10
DZ O 0 2.994315551063664e-08
twin O 0 6.697085941365089e-11
pairs O 0 1.5559862426295368e-12
overall O 0 7.0645462812990445e-09
( O 0 1.925368738953711e-14
12 O 0 2.0896752210564085e-12
. O 0 4.809675335955277e-14
5 O 0 1.8634861720118884e-13
% O 0 2.1975666729054377e-13
) O 0 1.946726081795665e-15
. O 0 1.1097466695586533e-11

Nonsignificant O 0 4.330855972511927e-06
increases O 0 4.102403746569783e-12
in O 0 1.8428255476503688e-14
similarity O 0 5.704535151543344e-13
with O 0 6.825262845846288e-16
regard O 0 4.355340307155009e-12
to O 0 1.0756833791758513e-11
age O 0 3.219316480063128e-10
at O 0 5.5310877405956305e-11
disease O 0 3.9881448143930243e-10
onset O 0 5.025337090902582e-11
and O 0 1.1973233378880215e-14
all O 0 3.960831093446568e-14
of O 0 5.2900231937991204e-12
the O 0 2.0470364292535237e-10
disease O 0 6.519504935909026e-10
severity O 0 1.6992828585221664e-12
scores O 0 3.1063920966772907e-13
assessed O 0 2.732649176384605e-12
were O 0 2.1339733365793867e-12
noted O 0 9.552734037826527e-13
in O 0 6.975921576501953e-12
disease O 0 2.502830831474512e-09
- O 0 1.3134535126191338e-10
concordant O 0 1.2784728831150005e-08
MZ O 0 5.329007990440005e-07
twins O 0 3.782848756461732e-10
compared O 0 5.793951689953003e-12
with O 0 2.9830779231347637e-13
concordant O 0 1.1560924804143724e-06
DZ O 0 3.4057833545375615e-05
twins O 0 3.253760496590985e-07
. O 0 9.850897875196551e-09

HLA O 0 0.00012252412852831185
- O 0 5.528015663003316e-07
B27 O 0 3.998110997827098e-08
and O 0 8.948167185517109e-14
B60 O 0 2.3913709901179914e-10
were O 0 6.082641003022065e-15
associated O 0 3.6655045860568836e-14
with O 0 8.540965667596908e-16
the O 0 3.6881863665558234e-13
disease O 0 3.970199169422983e-12
in O 0 2.982035394983283e-14
probands O 0 1.454336207018514e-08
, O 0 4.6799760417090986e-15
and O 0 2.7280570126720543e-15
the O 0 2.2315743003487043e-12
rate O 0 5.83561185485415e-11
of O 0 2.1655414007143436e-12
disease O 0 5.866816060740021e-11
concordance O 0 6.533282248533112e-11
was O 0 1.6247796294152628e-12
significantly O 0 2.041480318126787e-10
increased O 0 2.974883395179262e-10
among O 0 2.0221489413496663e-11
DZ O 0 5.989684126461725e-08
twin O 0 1.4369636036626332e-10
pairs O 0 7.099828537582287e-13
in O 0 8.24238843410291e-13
which O 0 4.1895560778200044e-14
the O 0 1.2911550301142327e-11
co O 0 7.470653956564988e-11
- O 0 2.2243299216406776e-11
twin O 0 6.140772352419832e-12
was O 0 2.6756806880269372e-14
positive O 0 3.201819057213856e-15
for O 0 1.1515814199780975e-15
both O 0 1.1410555660062993e-12
B27 O 0 1.5681694165436966e-08
and O 0 7.926363732035924e-11
DR1 O 0 0.00031087445677258074
. O 0 8.517227811921657e-09

Additive O 0 2.52485787832768e-09
genetic O 0 6.529329594356925e-12
effects O 0 1.0820964485786302e-13
were O 0 5.2130892613485354e-15
estimated O 0 7.014657189390863e-15
to O 0 1.3241488187507554e-14
contribute O 0 3.4823554630192266e-12
97 O 0 1.5204429937298869e-09
% O 0 2.0133819958467747e-11
of O 0 5.4630233577981566e-14
the O 0 4.0309630497869717e-14
population O 0 1.6229063389724117e-15
variance O 0 5.494312145006008e-13
. O 0 4.239734119337868e-10

CONCLUSION O 0 6.033324098098092e-07
Susceptibility O 0 3.9149647967917645e-09
to O 0 1.7627727055824494e-09
AS B-Disease 1 1.0
is O 0 8.708819798121381e-13
largely O 0 3.1436344413021677e-12
genetically O 0 4.840164117485106e-14
determined O 0 2.8863973711157342e-11
, O 0 2.1335326083962713e-13
and O 0 5.636688490094632e-13
the O 0 1.2536544718999565e-11
environmental O 0 1.0117838858403339e-11
trigger O 0 4.7803592681527896e-12
for O 0 6.736059328599567e-14
the O 0 2.343261001902519e-11
disease O 0 9.52961820566145e-10
is O 0 3.584084391035011e-14
probably O 0 1.8697836334791162e-10
ubiquitous O 0 2.3866983056564095e-08
. O 0 6.419938358703803e-09

HLA O 0 5.335408422979526e-05
- O 0 8.882115309916117e-08
B27 O 0 1.1814112355068573e-08
accounts O 0 4.5164626839887603e-14
for O 0 2.348620133620018e-16
a O 0 7.752916283141134e-15
minority O 0 2.8089550542335917e-14
of O 0 3.32109014768156e-14
the O 0 1.588821711999075e-13
overall O 0 5.872312358601306e-11
genetic O 0 1.4067410430973482e-12
susceptibility O 0 2.55758543683815e-12
to O 0 1.6803276547960877e-09
AS B-Disease 1 1.0
. O 0 1.964417151611997e-06

Cell O 0 1.9798578776430986e-08
cycle O 0 8.453009847642079e-09
- O 0 2.9117738775674695e-10
dependent O 0 7.406115304364747e-11
colocalization O 0 1.132502518430556e-07
of O 0 2.237432461527078e-10
BARD1 O 1 0.9998388290405273
and O 0 3.0720892409824563e-12
BRCA1 O 0 4.69403682590297e-12
proteins O 0 2.600565806264426e-14
in O 0 5.4427630073261915e-14
discrete O 0 7.668821133677284e-11
nuclear O 0 1.9865760592097104e-08
domains O 0 7.429031256833696e-08
. O 0 7.432387594263901e-09

Germ O 0 2.638178557390347e-05
- O 0 1.3963004619199637e-07
line O 0 3.509617596542114e-10
mutations O 0 1.9891881111039345e-12
of O 0 7.781430881592666e-12
the O 0 2.2105843197617325e-11
BRCA1 O 0 4.3755086359675843e-11
gene O 0 3.9639071782978166e-14
predispose O 0 2.6424801582991542e-11
women O 0 3.3687887328754653e-16
to O 0 4.385341983753795e-15
early O 0 1.3074927807110726e-09
- O 0 3.1507906328442914e-07
onset O 1 0.9993492960929871
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.741964103345317e-12
compromising O 0 3.949779392442565e-10
the O 0 3.543852928125646e-12
genes O 0 1.4039702560253442e-11
presumptive O 0 5.808292158349104e-08
function O 0 8.647799143446377e-11
as O 0 9.37068348264014e-13
a O 0 4.059811167800298e-11
tumor B-Disease 0 2.4020383904144182e-08
suppressor O 0 2.5642776790846256e-08
. O 0 3.2000828653622193e-09

Although O 0 8.550184449340748e-10
the O 0 5.073917674902617e-11
biochemical O 0 3.3904709595411475e-10
properties O 0 7.291729442471251e-10
of O 0 6.08151917713684e-10
BRCA1 O 0 6.18990914080797e-10
polypeptides O 0 2.091395806536056e-10
are O 0 1.599420296454889e-14
not O 0 2.2303293990854657e-14
understood O 0 1.4258067383005057e-12
, O 0 8.76956344879749e-16
their O 0 2.9916461696160093e-14
expression O 0 7.120795381294898e-13
pattern O 0 6.2702065761754966e-12
and O 0 6.415980485612038e-14
subcellular O 0 6.596020796223456e-08
localization O 0 2.796418243633525e-07
suggest O 0 1.1169162816848655e-10
a O 0 1.7808875034386329e-12
role O 0 1.0423793772584844e-11
in O 0 1.562142602773431e-11
cell O 0 5.0489791902919023e-08
- O 0 5.173285799742189e-09
cycle O 0 1.4950481741493604e-08
regulation O 0 5.89218507318634e-10
. O 0 3.031787598750668e-10

When O 0 8.568179055146175e-09
resting O 0 1.7929036175701185e-06
cells O 0 4.737288339384804e-09
are O 0 8.723998628536178e-13
induced O 0 8.918515925770976e-11
to O 0 1.5516572401952367e-11
proliferate O 0 2.567712042989001e-09
, O 0 5.933560239689993e-15
the O 0 9.740568811603123e-13
steady O 0 4.833414113392109e-09
- O 0 1.0743706271854059e-12
state O 0 3.266779208255244e-13
levels O 0 1.1624922378883351e-11
of O 0 5.033466590580182e-13
BRCA1 O 0 1.2516988042842597e-13
increase O 0 2.9555405432063475e-14
in O 0 3.5430365391363574e-15
late O 0 2.9267152937273444e-12
G1 O 0 3.542300133774212e-11
and O 0 3.886383673646493e-15
reach O 0 7.525495851479214e-12
a O 0 4.441999339969277e-14
maximum O 0 4.175655481108986e-12
during O 0 2.2819753031644296e-10
S O 0 8.836942733125852e-09
phase O 0 1.9390510530570282e-08
. O 0 7.702927184993769e-09

Moreover O 0 1.4931872627244047e-08
, O 0 7.031851229771791e-13
in O 0 3.645393448908907e-12
S O 0 2.5196960073969876e-09
phase O 0 2.940058196898576e-09
cells O 0 2.515301023020555e-10
, O 0 1.208373570475707e-12
BRCA1 O 0 5.182011417192989e-11
polypeptides O 0 1.031146001917449e-10
are O 0 1.1412770143000295e-13
hyperphosphorylated O 0 1.3765807160837085e-08
and O 0 2.865818910305351e-12
accumulate O 0 1.3229448092566543e-10
into O 0 6.084324710720068e-11
discrete O 0 6.077304703921982e-08
subnuclear O 0 5.691806290997192e-05
foci O 0 1.2710662531389971e-06
termed O 0 1.468802111048717e-07
" O 0 2.7316383821585077e-08
BRCA1 O 0 7.019660586138343e-08
nuclear O 0 5.060336505380292e-08
dots O 0 1.8593048878301488e-08
. O 0 8.020524688845398e-09

" O 0 2.4360784500743193e-09
BRCA1 O 0 1.7634631532814637e-08
associates O 0 3.403279880132004e-10
in O 0 7.103593971727329e-13
vivo O 0 2.4684098515193043e-11
with O 0 3.240735562458981e-15
a O 0 1.4071141170649004e-12
structurally O 0 1.0708187669905556e-09
related O 0 8.119556582641962e-09
protein O 0 3.889452671046456e-08
termed O 0 8.712263621646343e-08
BARD1 O 1 0.9998900890350342
. O 0 4.794247843165067e-08

Here O 0 2.2936974541920563e-09
we O 0 7.930922086597791e-13
show O 0 4.0566104620408383e-13
that O 0 1.9328508350866924e-16
the O 0 4.0166573409342043e-14
steady O 0 1.1547919287480113e-09
- O 0 5.049429299165686e-13
state O 0 2.2266879366825837e-13
levels O 0 9.953327745337859e-11
of O 0 1.1402272355465204e-11
BARD1 O 0 1.1515784535731655e-05
, O 0 1.9223709199467885e-14
unlike O 0 8.822672139304627e-14
those O 0 1.85259827498261e-14
of O 0 1.2777582811263066e-12
BRCA1 O 0 5.698157570788176e-11
, O 0 7.117655125227565e-14
remain O 0 4.062475703059398e-11
relatively O 0 5.115261079297051e-12
constant O 0 2.293160019511964e-12
during O 0 4.260592156857257e-10
cell O 0 2.059417703037525e-08
cycle O 0 2.9502778886580927e-08
progression O 0 6.136929631139765e-09
. O 0 1.3493547390552862e-09

However O 0 1.688120865317444e-09
, O 0 1.5407123276842127e-12
immunostaining O 0 1.4059982511582803e-08
revealed O 0 1.0859728394319035e-10
that O 0 7.149033426877283e-13
BARD1 O 0 0.002867976436391473
resides O 0 4.63270422024209e-10
within O 0 9.376110304826213e-11
BRCA1 O 0 8.573565468683597e-11
nuclear O 0 2.953737532340739e-10
dots O 0 4.359631058936664e-11
during O 0 6.179339817613538e-10
S O 0 2.178349500780996e-09
phase O 0 3.5927055108686545e-08
of O 0 9.99896165865266e-10
the O 0 6.30734631190677e-11
cell O 0 6.023472692850973e-11
cycle O 0 4.030846142977218e-11
, O 0 3.5982528699624115e-16
but O 0 3.938693410914044e-16
not O 0 3.355234511653502e-15
during O 0 1.9939144085823202e-11
the O 0 3.3414323825226022e-12
G1 O 0 2.667860155014523e-09
phase O 0 2.591753256453444e-09
. O 0 1.7227103077388506e-09

Nevertheless O 0 1.6335415011781151e-06
, O 0 2.2212955086420294e-10
BARD1 O 0 0.00012324206181801856
polypeptides O 0 4.326814462274342e-09
are O 0 5.291571353186267e-14
found O 0 3.525565256401464e-14
exclusively O 0 5.415221764927536e-13
in O 0 3.546053289329651e-14
the O 0 2.4591965833500873e-13
nuclear O 0 2.8802158574814385e-11
fractions O 0 2.728313686084505e-10
of O 0 1.2785293657113783e-11
both O 0 6.730234859003703e-12
G1 O 0 5.925401058703983e-09
- O 0 1.7165464882840098e-10
and O 0 1.2658453929156877e-12
S O 0 6.802712171349867e-09
- O 0 1.460165321987006e-11
phase O 0 3.090847300324384e-10
cells O 0 6.184407153053684e-11
. O 0 1.2838173232831984e-11

Therefore O 0 3.174492266277973e-11
, O 0 5.956010847956968e-15
progression O 0 2.740426375408278e-12
to O 0 1.0737458014734025e-12
S O 0 1.012941119871158e-10
phase O 0 1.7813581165704306e-10
is O 0 2.2872856308763867e-15
accompanied O 0 1.442128887011243e-13
by O 0 6.055480891568356e-16
the O 0 3.143213228758157e-13
aggregation O 0 2.669455802239984e-11
of O 0 1.0810372562397585e-11
nuclear O 0 2.5568445138901552e-08
BARD1 O 0 0.00038481465890072286
polypeptides O 0 5.141927417184888e-08
into O 0 5.718720164082924e-09
BRCA1 O 0 4.985685819747232e-08
nuclear O 0 3.016229044305874e-08
dots O 0 1.4679613968837657e-08
. O 0 7.289077341710026e-09

This O 0 1.4295381718654188e-11
cell O 0 1.435407626093621e-10
cycle O 0 9.180167181987997e-10
- O 0 3.7427852483951085e-11
dependent O 0 2.593916748061531e-11
colocalization O 0 2.6838566924425322e-08
of O 0 1.067934074505672e-10
BARD1 O 1 0.9982221722602844
and O 0 2.2556626705361182e-12
BRCA1 O 0 7.66066377000385e-11
indicates O 0 4.368124785492089e-13
a O 0 8.308372537863245e-15
role O 0 5.6607652322137464e-14
for O 0 8.145351797564371e-13
BARD1 O 0 2.2017729861545376e-05
in O 0 9.832458180980552e-10
BRCA1 O 0 3.1750121820550703e-07
- O 0 1.2720076547623194e-08
mediated O 0 3.905159573491801e-08
tumor B-Disease 0 2.4125254682871855e-08
suppression O 0 7.509420640872122e-09
. O 0 3.825206540408743e-10

Ethnic O 0 6.407314234735395e-09
differences O 0 2.732125636839555e-10
in O 0 3.947491476492121e-13
the O 0 2.1914900449893082e-12
HFE O 0 7.800450703143724e-07
codon O 0 1.7316123646082815e-08
282 O 0 3.0231866787744366e-08
( O 0 4.4218032013709774e-11
Cys O 0 0.00010427078086649999
/ O 0 2.7600556506968132e-08
Tyr O 0 6.11040462672463e-09
) O 0 1.005117586112391e-14
polymorphism O 0 3.6413524973077926e-10
. O 0 1.9582460653033706e-10

Recent O 0 4.724182156579104e-11
studies O 0 3.3164771384881775e-13
have O 0 1.6507720553409633e-16
shown O 0 1.210869945977855e-12
that O 0 7.718051892036115e-11
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 2.9098082277023707e-10
HH B-Disease 0 0.0053244116716086864
) O 0 2.2537766263181803e-14
is O 0 2.345969449890704e-16
likely O 0 3.732663117939246e-14
to O 0 2.6429764410015877e-13
be O 0 7.771400168353482e-13
caused O 0 6.712940533309952e-12
by O 0 7.962035165291065e-14
homozygosity O 0 7.378969257842982e-08
for O 0 1.0201761310724144e-12
a O 0 9.376070232713918e-12
Cys282Tyr O 0 4.637341532998107e-08
mutation O 0 1.0830324267616098e-12
in O 0 6.302946310493204e-14
the O 0 7.040913858891162e-12
HFE O 0 1.61566749738995e-05
gene O 0 1.3299249201903507e-10
located O 0 3.4977607615838124e-11
4 O 0 1.0477557710331098e-10
. O 0 1.4420850069640778e-09

5 O 0 4.152699517590008e-09
Mb O 0 1.1610275407747395e-07
telomeric O 0 5.143261816442646e-08
to O 0 5.127564484119773e-10
HLA O 0 4.0761355535323673e-07
- O 0 2.0046099891146696e-08
A O 0 1.4207685694600514e-08
. O 0 1.5900276928437762e-10

Population O 0 5.6727469943673725e-12
studies O 0 1.2553934671324929e-12
of O 0 1.6425143851365315e-13
this O 0 3.1502341154513586e-14
polymorphism O 0 1.7741695612638608e-10
are O 0 1.0192337289915629e-14
facilitated O 0 1.562804399779516e-11
by O 0 2.101575351256776e-15
the O 0 1.723574218461324e-13
fact O 0 4.251621231183937e-14
that O 0 7.60199947001677e-16
the O 0 7.572186150675564e-13
Cys282Tyr O 0 2.3145707928051706e-06
mutation O 0 2.7466298679890144e-10
creates O 0 5.366128548456306e-12
a O 0 8.90250581586649e-11
Rsal O 0 2.0506531654973514e-06
restriction O 0 7.124053014173626e-10
site O 0 2.4074999771528383e-09
. O 0 1.5585639445703237e-09

We O 0 5.299397379254778e-11
have O 0 3.684247053487369e-14
studied O 0 1.7608168341367442e-13
the O 0 4.160824042622781e-14
codon O 0 3.0063126987833755e-10
282 O 0 8.01293964514116e-09
( O 0 5.6980819368446234e-11
Cys O 0 0.0004281482251826674
/ O 0 4.690743438118261e-08
Tyr O 0 4.6824992772087626e-09
) O 0 1.5025241106844992e-15
polymorphism O 0 1.4175012075581805e-12
in O 0 7.266230845164837e-16
different O 0 7.345075001235872e-15
ethnic O 0 2.3143613761544835e-12
groups O 0 2.7066540740465495e-13
. O 0 3.080113109010796e-10

In O 0 3.6308902932880027e-12
agreement O 0 6.00659660898728e-11
with O 0 7.266515405883467e-14
previous O 0 5.640288791575188e-10
observations O 0 2.6363534619266993e-11
the O 0 2.4544368273926587e-12
Tyr O 0 6.372454230962887e-10
allele O 0 1.0488810341102717e-11
appeared O 0 3.496498446678431e-12
to O 0 7.0228076826106545e-12
be O 0 1.1320749893073412e-11
rare O 0 1.4084211574783012e-09
or O 0 5.166597705219544e-10
absent O 0 3.4687570860114647e-07
in O 0 5.946283743174519e-11
Asiatic O 0 1.965882390209117e-08
( O 0 5.524971451208779e-15
Indian O 0 1.3524246826601694e-11
, O 0 6.702886807879657e-15
Chinese O 0 4.122451945781647e-12
) O 0 5.1217971514362984e-14
populations O 0 1.876459057581492e-12
. O 0 1.1019515161470039e-10

The O 0 9.731437010385147e-12
highest O 0 2.0589117216696096e-11
allele O 0 4.473051161239805e-13
frequency O 0 2.0471163826585315e-12
( O 0 9.343091707314643e-17
7 O 0 1.9349746685579788e-13
. O 0 6.498494793091879e-15
5 O 0 9.446714515238402e-14
% O 0 1.668389818659799e-13
) O 0 3.5555296530685377e-17
was O 0 5.2137879788267255e-14
found O 0 8.479923984143142e-14
in O 0 1.1767983506064117e-12
Swedes O 0 1.8750002084289008e-07
. O 0 3.1185759752361264e-08

Saamis O 0 0.0005700939800590277
( O 0 2.936805529665798e-14
2 O 0 2.1888780122204105e-13
% O 0 6.460043004002936e-13
) O 0 6.00297014279451e-17
and O 0 5.047654663497235e-14
Mordvinians O 0 7.554618264293822e-07
( O 0 4.393762655919805e-16
1 O 0 2.1646087903343623e-15
. O 0 1.0179781720538478e-15
8 O 0 8.895613703931073e-15
% O 0 1.7357272100193034e-14
) O 0 1.4564225293502812e-17
had O 0 3.0590690181295623e-15
significantly O 0 1.0044761111207764e-13
lower O 0 1.6589378525402876e-12
frequencies O 0 3.412278922962364e-12
of O 0 1.3411553985431812e-11
the O 0 1.4586991337051103e-10
Tyr O 0 2.58510439721249e-08
allele O 0 1.8329971984698545e-09
. O 0 1.7174095034988568e-08

Comparisons O 0 1.8808646307100219e-10
with O 0 5.217229981911188e-14
allele O 0 1.857050754491829e-12
frequencies O 0 7.700300466706445e-12
based O 0 3.725456307514122e-15
on O 0 5.240090588005952e-13
prevalence O 0 7.333411655707778e-12
estimates O 0 3.0643104156555245e-13
of O 0 2.7609240848408545e-12
HH B-Disease 0 0.00014031759928911924
showed O 0 4.672489062329532e-09
some O 0 2.4372322736387897e-12
disagreements O 0 1.3385022867851148e-08
with O 0 9.361764564518732e-14
the O 0 7.293794908325157e-12
RFLP O 0 1.106848035448138e-08
data O 0 6.522025974842194e-11
, O 0 1.735592192967511e-13
particularly O 0 2.3331094001211028e-12
in O 0 1.6071135741646536e-11
Finns O 0 1.2217759604027378e-06
. O 0 1.5673322195652872e-08

The O 0 1.3045807767397832e-09
newly O 0 1.6034928940200643e-09
described O 0 2.1035768613120176e-11
HFE O 0 2.471399784553796e-05
marker O 0 7.24629867221438e-09
provides O 0 1.1786134134633697e-12
a O 0 4.338546123923426e-14
new O 0 2.0349127995166784e-15
approach O 0 1.1355295230584123e-13
to O 0 4.683880778892646e-14
the O 0 4.501188985883871e-14
screening O 0 8.547241039935649e-12
of O 0 1.3919952863983287e-11
HH B-Disease 0 1.867283572209999e-05
as O 0 3.3827595672525357e-13
well O 0 2.2129612595525594e-13
as O 0 4.453619615566069e-15
studies O 0 3.159043935729161e-13
of O 0 8.096849606802417e-14
the O 0 3.3872145539792786e-13
relationship O 0 5.102362629627599e-11
between O 0 6.523357548582354e-11
the O 0 7.502998916608661e-11
HFE O 0 2.2071544947266375e-07
Tyr O 0 7.248590061514903e-10
allele O 0 1.9244647542215887e-11
and O 0 1.9362336983307776e-13
different O 0 1.1479330680463917e-10
disorders O 0 8.917474769987166e-05
including O 0 2.53591991850044e-09
cancer B-Disease 1 0.9998059868812561

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9989035129547119
associated O 0 9.342692591784996e-11
with O 0 2.249271766291503e-14
a O 0 4.735761479149336e-13
missense O 0 7.094326515133531e-11
mutation O 0 4.4321168371670716e-13
encoding O 0 2.804212695384223e-10
Gly23 O 0 1.4388294857781148e-06
- O 0 2.8761524717424436e-08
- O 0 7.022309400639415e-09
> O 0 7.82955589251344e-10
Val O 0 1.1085520001952176e-10
in O 0 4.231196827370748e-13
neurophysin O 0 1.7310044952978387e-08
II O 0 1.4362929334765795e-07
. O 0 3.2956368745118425e-09

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 2.775514193475992e-11
ADNDI B-Disease 1 1.0
) O 0 2.391635134835375e-14
is O 0 5.0331925923624045e-15
an O 0 2.387393397123433e-13
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.3781660535006068e-10
by O 0 3.382538661059892e-14
progressive O 0 1.6164236740223714e-06
degeneration O 1 0.9999998807907104
of O 0 4.3088439483085494e-09
the O 0 8.199105283601682e-11
magnocellular O 0 1.4394778702353506e-08
neurons O 0 2.2813846367597534e-09
of O 0 1.6588572182563155e-10
the O 0 7.967135978725892e-11
hypothalamus O 0 3.933645353892956e-10
leading O 0 2.1049613441181947e-11
to O 0 7.728625898983932e-12
decreased O 0 4.435193323715225e-10
ability O 0 1.381847761217081e-11
to O 0 1.0648011986025274e-11
produce O 0 6.813915542913662e-10
the O 0 1.2172020336098655e-10
hormone O 0 5.2102568787182335e-11
arginine O 0 9.115770360779152e-09
vasopressin O 0 8.583374899728824e-09
( O 0 5.267828816386821e-13
AVP O 0 4.016761323555329e-08
) O 0 9.43901098775235e-13
. O 0 3.996833697339497e-10

Affected O 0 1.2856663511584543e-09
individuals O 0 4.2031406567027974e-13
are O 0 3.6314826606974673e-14
not O 0 7.786386010781576e-13
symptomatic O 0 3.8535757918012337e-10
at O 0 1.0336674008057378e-12
birth O 0 4.068368905651987e-11
, O 0 6.933122560217816e-14
but O 0 6.298142888293279e-13
usually O 0 1.3786900510126543e-09
develop O 0 5.136084291734733e-05
diabetes B-Disease 1 0.9726807475090027
insipidus I-Disease 0 0.0018392998026683927
at O 0 1.0171452125007363e-08
1 O 0 1.7238672711528125e-09
- O 0 1.565011054083243e-08
6 O 0 3.3483640859977015e-10
yr O 0 1.7700045873425552e-07
of O 0 2.0181186582979294e-11
age O 0 1.5247403339913035e-10
. O 0 1.670076715809543e-10

The O 0 2.9924267924696935e-11
genetic O 0 2.1219228631130793e-12
locus O 0 2.4275126180028916e-12
of O 0 1.994396618340555e-12
the O 0 4.3671190795568915e-12
disease O 0 8.93314033856285e-11
is O 0 1.009732518070564e-15
the O 0 4.628036669174218e-12
AVP O 1 0.9989355206489563
- O 1 0.9891721606254578
neurophysin O 1 0.933441698551178
II O 1 0.997832715511322
( O 0 6.125498025477683e-11
NPII O 1 0.9999995231628418
) O 0 7.925428434189807e-14
gene O 0 8.788627513462224e-14
, O 0 3.073422796102086e-14
and O 0 4.2562405423024474e-13
mutations O 0 2.2734980564820262e-11
that O 0 4.157050138148266e-13
cause O 0 1.8289321168651895e-09
ADNDI B-Disease 0 0.017709221690893173
have O 0 8.841544033369453e-13
been O 0 1.117078570487054e-13
found O 0 7.884204695899656e-15
in O 0 2.7171828036952035e-15
both O 0 1.5272463130852447e-14
the O 0 7.267374636105162e-14
signal O 0 9.458190307343184e-12
peptide O 0 3.7912676470464035e-12
of O 0 4.3207895594754575e-11
the O 0 6.216281933646428e-10
prepro O 0 9.566753578837961e-05
- O 0 1.0720569662225898e-05
AVP O 0 0.049190767109394073
- O 0 8.574084858992137e-06
NPII O 0 0.11965344846248627
precursor O 0 1.1066956240313175e-09
and O 0 1.290597836933749e-12
within O 0 4.932569908078221e-10
NPII O 0 0.05750840902328491
itself O 0 3.4216983413326574e-11
. O 0 2.703078039179019e-10

An O 0 7.978902261118748e-12
affected O 0 8.144459412440241e-11
girl O 0 7.486020692226703e-10
who O 0 1.5281268546558924e-13
presented O 0 3.4778881163877173e-12
at O 0 5.771129017381749e-13
9 O 0 5.843521738539692e-14
months O 0 4.762344151302243e-14
of O 0 5.3887592359278674e-14
age O 0 2.37445219736232e-12
and O 0 3.6357256181368536e-13
her O 0 6.27548273762768e-12
similarly O 0 6.358557777530471e-12
affected O 0 2.1182887041670817e-11
younger O 0 2.236574814240555e-10
brother O 0 3.4103822543762874e-10
and O 0 1.8750135992451344e-12
father O 0 1.2503215129910927e-10
were O 0 1.507507660369889e-11
all O 0 1.6285204521709895e-13
found O 0 6.50203157916314e-14
to O 0 2.1952208659799938e-13
have O 0 2.6275592216341154e-14
a O 0 4.3355930282561184e-14
novel O 0 1.8119345948771834e-14
missense O 0 1.5443150924721039e-10
mutation O 0 7.612744527644988e-14
( O 0 1.0573145012383458e-16
G1758 O 0 5.0788071664920054e-11
- O 0 3.428551192952156e-11
- O 0 2.730399760453306e-11
> O 0 1.2644145713086585e-12
T O 0 8.124401216884347e-14
) O 0 3.2004817311564843e-19
encoding O 0 7.124416142212549e-15
the O 0 1.189375119524166e-14
amino O 0 3.487391853160965e-13
acid O 0 4.2870763362901076e-14
substitution O 0 1.9558887929399527e-12
Gly23 O 0 7.679415148231783e-08
- O 0 1.1330357985173123e-08
- O 0 7.497598986105913e-09
> O 0 2.629937601028587e-09
Val O 0 1.270653915419473e-09
within O 0 9.293537051036083e-10
NPII O 0 0.008838348090648651
. O 0 1.0670508920895827e-09

The O 0 2.5473351206173334e-10
mutation O 0 2.204217277451681e-12
was O 0 1.6693321258729604e-13
confirmed O 0 2.4313469193146774e-14
by O 0 1.7794985640109555e-16
restriction O 0 6.89364337098583e-14
endonuclease O 0 4.049417398621635e-11
analysis O 0 1.7592207204875088e-11
. O 0 4.562351330061887e-10

A O 0 8.523029393359138e-09
T1 O 0 7.958138148467242e-09
- O 0 1.996653710423235e-12
weighted O 0 8.060035183222493e-15
magnetic O 0 4.17157526241569e-14
resonance O 0 2.336413831502404e-12
imaging O 0 8.236900050917484e-10
of O 0 4.634858469243497e-11
the O 0 2.2756641016030699e-10
fathers O 0 1.1761954255007367e-07
pituitary O 0 1.5081604942679405e-06
gland O 0 4.3560969942291194e-08
demonstrates O 0 1.7915563477188812e-10
an O 0 5.335783355951695e-13
attenuated O 0 1.6218537624013152e-08
posterior O 0 2.440577191009652e-05
pituitary O 0 0.0059475162997841835
bright O 0 4.288551735953661e-06
spot O 0 2.5461496989009902e-05
. O 0 8.521652006265867e-08

This O 0 6.803889673889785e-10
mutation O 0 4.9215628100673925e-11
may O 0 4.46144586118552e-13
be O 0 1.5173399917165625e-13
valuable O 0 2.2229654228489437e-10
for O 0 8.949634924208111e-14
developing O 0 6.414729858406076e-11
models O 0 5.354772181220824e-11
of O 0 9.565433861657979e-11
dominantly B-Disease 0 0.0001860603370005265
inherited I-Disease 1 0.9932360053062439
neurodegeneration I-Disease 1 1.0
, O 0 5.0236236611572727e-14
as O 0 2.847429630626399e-16
the O 0 1.1597946749511488e-15
early O 0 1.9944830021486476e-13
age O 0 3.833746742374494e-13
of O 0 9.994905294033463e-13
onset O 0 1.262162214743512e-07
of O 0 1.02974571092318e-08
symptoms O 0 1.3484876944858115e-05
suggests O 0 2.9983515670295446e-11
that O 0 3.237796315780361e-14
this O 0 1.5274400667897314e-12
mutation O 0 2.322016363909274e-11
may O 0 5.256349609045197e-12
be O 0 4.611807463694717e-11
particularly O 0 4.164881772794615e-10
deleterious O 0 3.6673877268356136e-09
to O 0 2.425622203094946e-10
the O 0 2.053783809685683e-09
magnocellular O 0 2.058535983451293e-06
neuron O 0 2.009188193596856e-08
. O 0 4.8617481568369314e-11
. O 0 2.909193774769392e-09

Frequent O 0 3.934532699645388e-09
inactivation O 0 1.3357963624116564e-08
of O 0 2.989533598451999e-08
PTEN O 0 4.9018697609426454e-05
/ O 0 1.1515893675095867e-05
MMAC1 O 1 0.9999805688858032
in O 0 3.350581201377878e-10
primary O 1 0.8572189807891846
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.988165093142925e-08

Sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 3.2586380815935456e-10
the O 0 1.4920925606176638e-10
most O 0 2.6231506116553005e-12
common O 0 2.851242575374613e-10
male B-Disease 0 1.0925990112653494e-09
cancer I-Disease 0 1.972976226838341e-10
in O 0 2.1787710524634463e-11
the O 0 1.0733276489816035e-09
Western O 0 1.0267606320724099e-08
world O 0 4.501191357576123e-13
, O 0 5.022988386446832e-15
yet O 0 6.280242439375e-14
many O 0 1.0201667993104345e-15
of O 0 7.91665113997718e-14
the O 0 9.888861647947e-14
major O 0 1.990963546371488e-13
genetic O 0 2.4154476704375816e-13
events O 0 1.1415660388822916e-14
involved O 0 9.172907659144025e-13
in O 0 4.1623418579016247e-13
the O 0 9.729502360028564e-13
progression O 0 1.3837191392696013e-09
of O 0 5.618497420784019e-12
this O 0 4.3668711008360006e-11
often O 0 4.8901302562853743e-08
fatal O 1 0.9997420907020569
cancer B-Disease 1 0.9124096632003784
remain O 0 4.180165902312183e-08
to O 0 8.128385742267596e-10
be O 0 1.5598397018479204e-09
elucidated O 0 1.1345578968757764e-05
. O 0 4.4259781617483895e-08

Numerous O 0 9.097562148063787e-10
cytogenetic O 0 5.496296466844797e-07
and O 0 1.2618975309131031e-11
allelotype O 0 2.7173687300319216e-08
studies O 0 1.6023409812535028e-12
have O 0 4.600550397519773e-16
reported O 0 1.877398722051858e-14
frequent O 0 2.368941089299359e-13
loss O 0 2.926493769539462e-11
of O 0 5.497129973441872e-10
heterozygosity O 0 4.698386419477174e-06
on O 0 7.526039347283131e-09
chromosomal O 0 2.9713817184529034e-06
arm O 0 2.9182550065343094e-07
10q O 0 1.7751605696503248e-07
in O 0 3.7791203499892845e-10
sporadic B-Disease 1 0.9999946355819702
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1679106393103211e-07

Deletion O 0 8.387247873997694e-08
mapping O 0 1.0469397793144708e-08
studies O 0 1.5096808525516536e-10
have O 0 3.9091963715577605e-13
unambiguously O 0 8.69042615647686e-11
identified O 0 1.0813672873810631e-11
a O 0 4.233176309487163e-12
region O 0 1.3425235367847677e-09
of O 0 5.76017081255209e-11
chromosome O 0 5.527389101978031e-10
10q23 O 0 1.4119481583918514e-08
to O 0 2.8796704604205914e-12
be O 0 3.126727663674972e-13
the O 0 1.7416518531196412e-12
minimal O 0 1.653052694727819e-09
area O 0 6.152769266298819e-11
of O 0 4.0827036196233735e-11
loss O 0 7.166577997708146e-09
. O 0 3.358050548740721e-08

A O 0 1.6680621683917707e-06
new O 0 9.355138885780434e-11
tumor B-Disease 0 5.33828536930514e-10
suppressor O 0 1.9048623789430508e-10
gene O 0 4.058903387005319e-12
, O 0 5.818259936340997e-12
PTEN O 0 6.664742613793351e-06
/ O 0 2.9948807878099615e-06
MMAC1 O 1 0.9999911785125732
, O 0 6.319935351960237e-13
was O 0 4.305403689813803e-12
isolated O 0 2.0506335345060744e-12
recently O 0 2.253192173584575e-14
at O 0 6.9273293630783654e-15
this O 0 2.29184499747322e-15
region O 0 2.211512049876685e-11
of O 0 1.2551133092911226e-12
chromosome O 0 7.034957338891701e-11
10q23 O 0 8.765196568560896e-09
and O 0 5.877696875218608e-13
found O 0 7.207248578326719e-13
to O 0 5.360959614598981e-13
be O 0 4.948170813248807e-15
inactivated O 0 4.238939115084467e-15
by O 0 5.708855818961685e-17
mutation O 0 9.357449710922783e-13
in O 0 2.7127542833599305e-12
three O 0 5.6298475215044164e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 1.4114096558159872e-08
lines O 0 9.339110734751799e-11
. O 0 2.478970362318478e-10

We O 0 3.168125983776804e-09
screened O 0 7.034162052832471e-08
80 O 0 1.0182831289284877e-07
prostate B-Disease 0 0.001665056450292468
tumors I-Disease 1 1.0
by O 0 2.754325833707015e-14
microsatellite O 0 3.184682240142678e-10
analysis O 0 1.060328300855895e-11
and O 0 2.0405195816450977e-13
found O 0 1.7467817556987564e-12
chromosome O 0 1.950171621412089e-11
10q23 O 0 2.7695201687549797e-09
to O 0 8.01196435584739e-12
be O 0 8.612289700837827e-12
deleted O 0 3.90026511087882e-10
in O 0 1.456815245694243e-12
23 O 0 1.742125332881983e-10
cases O 0 7.206633293593834e-12
. O 0 2.501962192980045e-09

We O 0 1.433942981715619e-11
then O 0 2.199205004032017e-14
proceeded O 0 4.282052956574439e-13
with O 0 1.117435911353624e-18
sequence O 0 1.3925945601332804e-16
analysis O 0 2.2387972298108143e-15
of O 0 1.2928583205363501e-14
the O 0 7.16678181644087e-13
entire O 0 5.424083937555224e-08
PTEN O 0 8.166158295352943e-06
/ O 0 9.324475058747339e-08
MMAC1 O 0 0.0010918930638581514
coding O 0 2.447306428621232e-07
region O 0 5.980397843607932e-10
and O 0 3.773746248760153e-14
tested O 0 5.0008348156938e-13
for O 0 3.772746072256035e-14
homozygous O 0 7.22648199960596e-12
deletion O 0 4.841637073899063e-12
with O 0 4.678978491007117e-14
new O 0 1.5981685376129096e-12
intragenic O 0 4.738953762739584e-08
markers O 0 6.203250413339134e-11
in O 0 6.646292674203358e-13
these O 0 1.1633939254671044e-13
23 O 0 2.0623537599906427e-12
cases O 0 2.0527758773413243e-14
with O 0 1.1884914439316135e-13
10q23 O 0 6.205850411333813e-08
loss O 0 2.046986580239718e-09
of O 0 6.204072811044625e-09
heterozygosity O 0 3.776238736463711e-05
. O 0 5.996840286570659e-07

The O 0 3.4485904258120537e-13
identification O 0 1.2197166887606414e-10
of O 0 1.7643756247687215e-11
the O 0 2.5187358709127805e-12
second O 0 3.0736267697673014e-11
mutational O 0 4.449954293939129e-10
event O 0 4.705472123056609e-13
in O 0 3.938045907165427e-13
10 O 0 8.630011310607755e-13
( O 0 1.5946704956756896e-15
43 O 0 8.36618219146601e-10
% O 0 3.787977043145929e-09
) O 0 1.0949872952803474e-10
tumors B-Disease 1 1.0
establishes O 0 1.682562977833868e-09
PTEN O 0 1.8922860363090876e-06
/ O 0 1.9016772512259195e-06
MMAC1 O 1 0.9943313598632812
as O 0 8.129566898135154e-13
a O 0 3.353971018017071e-13
main O 0 9.437210127943851e-13
inactivation O 0 1.3897528960971073e-12
target O 0 3.731706350179609e-12
of O 0 3.814247181987973e-11
10q O 0 1.1243239583791365e-07
loss O 0 2.394768161551042e-09
in O 0 5.709855921409712e-10
sporadic B-Disease 1 0.9997047781944275
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.551419988789277e-11
. O 0 5.777974626530735e-11

Risk O 0 2.4345654381363602e-08
reversals O 0 1.2389060888295944e-09
in O 0 5.793550860409835e-13
predictive O 0 3.7119041174094036e-10
testing O 0 6.145494269721441e-12
for O 0 2.6166806568750367e-11
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 6.59210352971229e-10

The O 0 1.1617602496336032e-12
first O 0 6.055256258430744e-14
predictive O 0 2.6580595363645543e-11
testing O 0 3.1194781458486476e-13
for O 0 1.1137034870711826e-11
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 6.450379827676927e-16
HD B-Disease 0 3.7033898170335533e-10
) O 0 4.383096393531505e-17
was O 0 1.559525616386451e-15
based O 0 1.816056175142206e-17
on O 0 1.8212831281094397e-14
analysis O 0 6.322539605578548e-13
of O 0 5.400512936154511e-13
linked O 0 4.7364525496140786e-11
polymorphic O 0 1.9606892498469364e-11
DNA O 0 6.474546454526831e-10
markers O 0 4.199641068930449e-12
to O 0 1.835506356281935e-12
estimate O 0 1.3422353506431506e-11
the O 0 2.362119018179537e-13
likelihood O 0 5.2973458952720875e-11
of O 0 1.4847702928255657e-11
inheriting O 0 2.7056495710553463e-08
the O 0 1.3998370518297776e-10
mutation O 0 6.6280409979913024e-12
for O 0 1.641989842704472e-11
HD B-Disease 0 3.586616685424815e-06
. O 0 2.111486807621077e-08

Limits O 0 1.0775588754619037e-10
to O 0 2.730846365012196e-12
accuracy O 0 8.488146296947718e-10
included O 0 6.519270800281474e-13
recombination O 0 7.390758144376619e-12
between O 0 1.6712315125538835e-12
the O 0 6.838225732191949e-13
DNA O 0 7.248548983262992e-10
markers O 0 1.0977518200006031e-10
and O 0 2.0140185092581975e-12
the O 0 5.650364204301539e-11
mutation O 0 3.836376702426314e-11
, O 0 7.143390696670582e-13
pedigree O 0 2.268285337336806e-09
structure O 0 2.1462949473249893e-10
, O 0 1.0832322858795804e-13
and O 0 1.9123942270808485e-14
whether O 0 1.6099397680334297e-14
DNA O 0 2.695468570568238e-10
samples O 0 8.023169802140462e-13
were O 0 4.778712893601343e-14
available O 0 5.614873258182052e-13
from O 0 3.0739869200449577e-13
family O 0 3.566623558992621e-12
members O 0 6.068512446028018e-12
. O 0 3.993779973399114e-09

With O 0 1.3735146917395746e-12
direct O 0 4.3259350962499e-11
tests O 0 1.1015895660937414e-11
for O 0 1.0806079338634977e-12
the O 0 1.6748958123202762e-11
HD B-Disease 0 1.2050323050516454e-07
mutation O 0 2.030403189329233e-12
, O 0 1.4518541127358023e-14
we O 0 4.2614695138550734e-14
have O 0 1.890794802222569e-15
assessed O 0 7.526095632121033e-13
the O 0 4.353757819216576e-14
accuracy O 0 3.2489130830093416e-10
of O 0 8.182473795748102e-13
results O 0 8.99539706502965e-14
obtained O 0 2.168517318837382e-12
by O 0 6.428021228363848e-14
linkage O 0 1.691840778583753e-09
approaches O 0 3.7030774280299994e-11
when O 0 1.582754245591303e-13
requested O 0 1.3490445739672285e-11
to O 0 2.2847090538902215e-11
do O 0 6.989412954655494e-12
so O 0 4.0682541835096106e-14
by O 0 4.193727460975348e-15
the O 0 2.2181125751245812e-13
test O 0 2.1265135919518174e-12
individuals O 0 1.8557759495774206e-12
. O 0 1.6516281675649225e-09

For O 0 5.519484522209517e-11
six O 0 6.6378335120131915e-12
such O 0 3.2576417048114665e-15
individuals O 0 1.0931528543424354e-14
, O 0 4.3789731430233896e-15
there O 0 3.102137890640365e-15
was O 0 3.067187617170758e-13
significant O 0 1.2883917023531755e-12
disparity O 0 5.84706519313194e-11
between O 0 5.809931095251963e-12
the O 0 1.942701902124533e-11
tests O 0 3.8287395476288566e-10
. O 0 7.155950942916434e-09

Three O 0 7.427749526556227e-10
went O 0 1.102248514683879e-09
from O 0 3.1342109896997927e-12
a O 0 7.0063507946749315e-12
decreased O 0 8.232644010952583e-10
risk O 0 2.2525325788641526e-12
to O 0 7.541575003378043e-12
an O 0 1.597887403989584e-13
increased O 0 2.974229543206697e-11
risk O 0 3.4012649467729528e-12
, O 0 3.7261385925531354e-15
while O 0 1.793590402338497e-14
in O 0 5.838965378909822e-14
another O 0 7.435760991311713e-13
three O 0 5.233258488016035e-13
the O 0 2.551933057232114e-12
risk O 0 7.987551592369968e-12
was O 0 2.2093365331654624e-11
decreased O 0 1.4346208665472204e-08
. O 0 2.4717479174540813e-09

Knowledge O 0 5.083476821710065e-07
of O 0 3.618656763126893e-10
the O 0 7.309782987241498e-12
potential O 0 2.8705564401182437e-12
reasons O 0 7.466644490194962e-13
for O 0 2.215494125234075e-14
these O 0 2.735217109230137e-14
changes O 0 5.017399324247669e-14
in O 0 3.873523680628099e-14
results O 0 2.997680879565645e-12
and O 0 4.4596338883047537e-13
impact O 0 7.273622676384761e-12
of O 0 3.8015133575763915e-12
these O 0 8.850638321192261e-13
risk O 0 1.4677120196288085e-12
reversals O 0 4.287344784748015e-11
on O 0 6.573326518516387e-12
both O 0 2.1524585499393956e-12
patients O 0 1.4027657507797997e-11
and O 0 7.250832421458464e-13
the O 0 5.412005218974336e-11
counseling O 0 4.4606532356716855e-10
team O 0 3.308648927752289e-13
can O 0 8.557148994383854e-14
assist O 0 3.1604052708189556e-10
in O 0 5.900205454420493e-13
the O 0 2.3013453122333605e-12
development O 0 1.0413788720242678e-09
of O 0 6.407386557091832e-13
strategies O 0 9.844402203140756e-12
for O 0 4.317602726082795e-14
the O 0 9.894867043780398e-13
prevention O 0 1.335331289986641e-10
and O 0 1.7457208435441886e-14
, O 0 1.8776554153865236e-15
where O 0 4.491187220842692e-15
necessary O 0 7.057993078873892e-11
, O 0 5.375701714826174e-14
management O 0 2.8829693840548565e-11
of O 0 5.172489173088657e-12
a O 0 3.9856180855668555e-11
risk O 0 4.040066892141425e-11
reversal O 0 4.022421284943789e-11
in O 0 6.212064825213137e-13
any O 0 1.7095687929527537e-12
predictive O 0 1.5151019328030202e-09
testing O 0 7.796213327693202e-12
program O 0 1.0453664323062384e-10
. O 0 2.168174060429573e-12
. O 0 4.22012091938484e-10

A O 0 5.702523342421273e-09
novel O 0 3.4296334218766877e-13
common O 0 2.0919004375952177e-12
missense O 0 9.105460829772483e-10
mutation O 0 1.4853244502399665e-12
G301C O 0 1.0909846637208176e-10
in O 0 2.5932992800165207e-14
the O 0 4.330793265238525e-13
N O 0 4.9840236104881086e-11
- O 0 1.3644761709397102e-10
acetylgalactosamine O 0 2.403081680313335e-07
- O 0 1.0044761689087522e-09
6 O 0 5.682452772215463e-11
- O 0 1.925694846638404e-11
sulfate O 0 1.0438092447676017e-12
sulfatase O 0 1.0032082109479035e-10
gene O 0 5.964539707406166e-14
in O 0 5.201890892862771e-13
mucopolysaccharidosis B-Disease 0 6.12522683240968e-07
IVA I-Disease 0 0.010431640781462193
. O 0 9.170917536494017e-08

Mucopolysaccharidosis B-Disease 0 0.0044084698893129826
IVA I-Disease 1 0.9999984502792358
( O 0 2.4172084334139754e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.2929558682386877e-12
is O 0 1.108083148349849e-13
an O 0 5.897306514651701e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 4.2435852054545364e-10
by O 0 1.1259429396866596e-13
a O 0 1.6040383243876022e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.5817200807742857e-11
N O 0 2.059093590078831e-10
- O 0 9.303499637347556e-11
acetylgalactosamine O 0 1.4480012566764344e-07
- O 0 9.619394170101714e-10
6 O 0 9.729401312386088e-11
- O 0 1.0009528622623165e-10
sulfate O 0 7.41657256442263e-12
sulfatase O 0 1.2515414260505509e-09
( O 0 4.21473684268257e-15
GALNS O 0 2.0590078975146753e-07
) O 0 7.820182218801208e-14
. O 0 2.253595227097449e-11

In O 0 7.466228191255198e-10
previous O 0 2.45981612856383e-09
studies O 0 2.0368779579671425e-11
, O 0 1.025845329364651e-14
we O 0 2.846297687559424e-14
have O 0 1.5383851351548176e-14
found O 0 1.0324176274089866e-13
two O 0 2.6608808201527417e-14
common O 0 1.5225292543646213e-13
mutations O 0 3.867160430315146e-14
in O 0 6.816514583687927e-14
Caucasians O 0 1.9208683255111936e-10
and O 0 2.1623990846628832e-13
Japanese O 0 4.008096077257051e-09
, O 0 6.490177319184998e-13
respectively O 0 8.187189592945288e-09
. O 0 1.7415489494965186e-08

To O 0 2.0221673224796177e-08
characterize O 0 3.834371113953239e-07
the O 0 4.513698581565251e-10
mutational O 0 8.14548073435617e-08
spectrum O 0 6.757353010478084e-11
in O 0 2.115366360539144e-14
various O 0 9.158252362853267e-14
ethnic O 0 1.3346832319904856e-12
groups O 0 5.568389513052087e-15
, O 0 9.460593997112111e-15
mutations O 0 2.1643053831326559e-13
in O 0 4.2427858643924454e-13
the O 0 6.077098546608539e-11
GALNS O 0 5.147327101440169e-05
gene O 0 2.0325973543178222e-11
in O 0 6.915093497816827e-11
Colombian O 0 0.00033749191788956523
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 4.5062883202717785e-08
were O 0 6.917256351046674e-11
investigated O 0 7.499335874516788e-11
, O 0 7.871210871675596e-14
and O 0 8.014141921700718e-14
genetic O 0 4.84740329473321e-12
backgrounds O 0 4.222340879711517e-11
were O 0 1.7910249021715896e-12
extensively O 0 1.0522193359674414e-11
analyzed O 0 9.278539308404943e-13
to O 0 6.598043509123408e-13
identify O 0 1.5783456139284446e-11
racial O 0 6.801374242450253e-13
origin O 0 4.960877628829019e-13
, O 0 2.1851496569426344e-16
based O 0 1.0903364115592997e-16
on O 0 3.2480826838918175e-14
mitochondrial O 0 8.420535861468348e-13
DNA O 0 3.061020326100561e-10
( O 0 2.895933140642168e-14
mtDNA O 0 3.252135366560438e-11
) O 0 1.294369071560414e-13
lineages O 0 7.41558620065419e-11
. O 0 8.598280976102046e-10

Three O 0 8.327908918026594e-10
novel O 0 4.9010386027337205e-11
missense O 0 1.110449687757864e-07
mutations O 0 7.499053600312777e-10
never O 0 1.0054513471802196e-10
identified O 0 4.0132480672028237e-11
previously O 0 1.9900392098093356e-11
in O 0 9.36140745542817e-14
other O 0 4.292239510323391e-14
populations O 0 4.299761162895009e-14
and O 0 2.0768057785384552e-15
found O 0 4.185937891882513e-14
in O 0 3.40044425993849e-14
16 O 0 9.509127860130029e-12
out O 0 8.944775801121574e-13
of O 0 2.5851300267110133e-11
19 O 0 8.668628592722882e-10
Colombian O 0 0.00010629234748193994
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 6.64696242491658e-10
alleles O 0 4.2506666589336994e-13
account O 0 1.2814772301032035e-13
for O 0 8.467289369651354e-13
84 O 0 1.3404132914729416e-08
. O 0 2.3025791051622946e-08

2 O 0 1.3874976168004594e-10
% O 0 5.631310348586105e-11
of O 0 2.1308974550160453e-13
the O 0 5.164094588690389e-14
alleles O 0 1.0075783015274595e-14
in O 0 2.9087592523426714e-14
this O 0 1.8274777849845714e-13
study O 0 2.6521380577793074e-12
. O 0 2.2865195847820985e-10

The O 0 3.4340195131932205e-09
G301C O 0 9.710856119227174e-08
and O 0 7.398950159151485e-13
S162F O 0 1.0527040350538641e-09
mutations O 0 2.0351710768029552e-13
account O 0 2.0640319287707973e-14
for O 0 3.97518281312903e-13
68 O 0 6.236417249283477e-08
. O 0 5.587005347251761e-08

4 O 0 2.9560878744838703e-10
% O 0 6.191122614573885e-11
and O 0 9.812823161458803e-14
10 O 0 1.7249804015739834e-11
. O 0 2.7417831893750133e-10

5 O 0 2.3219468014978872e-10
% O 0 2.3163190115971233e-11
of O 0 2.8643745903812745e-13
mutations O 0 2.3400103401727095e-14
, O 0 4.118390656580656e-15
respectively O 0 1.5913497949937572e-11
, O 0 1.663803440182278e-14
whereas O 0 6.596033181455185e-12
the O 0 8.448935127913781e-12
remaining O 0 4.214976812022542e-08
F69V O 1 0.9063069820404053
is O 0 6.427313108819943e-13
limited O 0 3.415319676375317e-12
to O 0 4.303679374678682e-12
a O 0 3.729685397330096e-12
single O 0 5.1036862236397695e-11
allele O 0 2.4028483647242638e-09
. O 0 8.166337828185988e-09

The O 0 3.949222060484203e-10
skewed O 0 1.632211921176463e-09
prevalence O 0 3.339034049254508e-10
of O 0 2.466078990320808e-12
G301C O 0 1.4306633655536416e-09
in O 0 3.002478704571855e-14
only O 0 2.4474827275532823e-14
Colombian O 0 6.233544791456325e-10
patients O 0 3.4983194726473377e-12
and O 0 4.526872041284158e-14
haplotype O 0 4.503598449029367e-12
analysis O 0 3.769070626891309e-14
by O 0 5.386431801147049e-16
restriction O 0 2.122395412629957e-13
fragment O 0 8.338644878758128e-12
length O 0 1.1797385984779751e-11
polymorphisms O 0 2.257287412543718e-10
in O 0 7.517648829835633e-12
the O 0 3.4389927017208777e-10
GALNS O 0 0.039581771939992905
gene O 0 1.3367482121218188e-10
suggest O 0 5.8206713754449524e-11
that O 0 7.350572245063552e-14
G301C O 0 8.409542395781955e-09
originated O 0 1.8617258776276735e-11
from O 0 3.133217155778384e-13
a O 0 1.7543377774792424e-12
common O 0 1.9100240486458198e-11
ancestor O 0 9.981151016802414e-09
. O 0 1.0876074263421742e-08

Investigation O 0 2.334443971463429e-09
of O 0 1.396266574582583e-10
the O 0 4.836487113579757e-12
genetic O 0 8.433105017253972e-13
background O 0 2.016484987885439e-13
by O 0 9.654397888300974e-16
means O 0 1.0151614965314693e-10
of O 0 3.4200753340485335e-10
mtDNA O 0 7.340643648490186e-09
lineages O 0 3.787857527637328e-11
indicate O 0 1.038133294606336e-11
that O 0 3.0764253584935133e-14
all O 0 2.452466615204818e-12
our O 0 1.871204524661607e-09
patients O 0 2.9353470609033705e-12
are O 0 9.540324361404211e-15
probably O 0 6.1415685904953055e-12
of O 0 7.941976937209105e-12
native O 0 7.39962049967069e-11
American O 0 2.1447736919810723e-09
descent O 0 6.625230889767408e-05

Low O 0 7.022389336697188e-09
frequency O 0 5.734191246831166e-11
of O 0 4.8953306686083664e-11
BRCA1 O 0 6.551325454351442e-11
germline O 0 1.0530615268677934e-09
mutations O 0 4.2364518875381493e-14
in O 0 6.509138185590603e-15
45 O 0 1.687803716232672e-11
German O 1 0.7222172021865845
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.1104465125200136e-09
. O 0 2.1374217673564289e-10

In O 0 8.206766863305681e-12
this O 0 3.9378111096324483e-14
study O 0 4.65941897559571e-15
we O 0 3.888561765930798e-16
investigated O 0 1.5602404486664626e-14
45 O 0 7.522324776965128e-12
German O 0 4.354273187345825e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.39987890671145e-10
for O 0 6.14424006464831e-12
germline O 0 1.338134758555043e-08
mutations O 0 2.029775869952233e-12
in O 0 2.1946179140468203e-13
the O 0 6.625500929141603e-12
BRCA1 O 0 1.774487640160416e-10
gene O 0 7.969791493422917e-12
. O 0 1.635992563642219e-09

We O 0 7.201061968942213e-10
identified O 0 1.7898486859291296e-10
four O 0 5.570034017354786e-12
germline O 0 4.111012330554331e-08
mutations O 0 1.9828026373569507e-11
in O 0 5.263510439133812e-13
three O 0 2.6600832647716288e-11
breast B-Disease 0 2.8958850872840003e-09
cancer I-Disease 0 1.1051445869547649e-10
families O 0 6.155215768501032e-13
and O 0 4.6140178402162904e-14
in O 0 8.049285682432128e-10
one O 1 1.0
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.189092380116108e-09
. O 0 1.7040522435501394e-14
among O 0 2.858801709687778e-17
these O 0 5.189036993187641e-17
were O 0 4.75858468026915e-14
one O 0 1.7725129361229747e-13
frameshift O 0 1.3048444547081317e-09
mutation O 0 1.1577105593629788e-11
, O 0 1.1366829786446653e-12
one O 0 1.8930863820987298e-11
nonsense O 0 3.906955114985067e-08
mutation O 0 5.753823806298186e-11
, O 0 1.4920958349082247e-13
one O 0 1.5625523065113806e-13
novel O 0 7.87384317902512e-13
splice O 0 1.2359352652424604e-08
site O 0 3.5528018027530806e-11
mutation O 0 8.614803315154518e-12
, O 0 6.586020655707445e-14
and O 0 3.7996699970427317e-13
one O 0 3.854757485433069e-11
missense O 0 5.119771913086879e-07
mutation O 0 4.884264548365991e-09
. O 0 5.582805329140683e-09

The O 0 2.8623654557691225e-09
missense O 0 3.830408701332999e-08
mutation O 0 2.6992125548574997e-11
was O 0 4.304911028346625e-12
also O 0 4.6771228112262725e-14
found O 0 2.284776643053654e-13
in O 0 8.346437690293085e-13
2 O 0 1.594735454801821e-10
. O 0 2.4094755080028563e-09

8 O 0 3.0801836081728595e-10
% O 0 1.393922199888209e-10
of O 0 8.352967297876879e-13
the O 0 1.05140418940608e-12
general O 0 2.2766777612454048e-12
population O 0 4.46392936178687e-14
, O 0 3.079357574798671e-16
suggesting O 0 4.171456000176717e-14
that O 0 6.075611688351038e-16
it O 0 6.807269748464238e-16
is O 0 8.539308447635605e-15
not O 0 1.0724016293039984e-11
disease O 0 4.081866400440504e-09
associated O 0 2.79570144812169e-09
. O 0 3.3139059496534173e-08

The O 0 1.5235963532478358e-12
average O 0 7.298744941763857e-13
age O 0 7.654331270375014e-13
of O 0 7.329827933846844e-13
disease O 0 1.681776107265165e-10
onset O 0 7.413040320480846e-11
in O 0 2.0638558136804042e-13
those O 0 5.883372131490483e-13
families O 0 1.0690503170207588e-11
harbouring O 0 1.3633641771093608e-08
causative O 0 7.88052192945976e-11
mutations O 0 1.9827648203851744e-11
was O 0 1.4440018625272444e-11
between O 0 9.70352964646537e-11
32 O 0 1.9995693989471874e-08
. O 0 9.96878402048651e-09

3 O 0 2.053336112251003e-10
and O 0 4.461158872870463e-12
37 O 0 5.173325767771075e-09
. O 0 1.1835170621310453e-09

4 O 0 1.6427111060313138e-10
years O 0 4.688006059738736e-12
, O 0 6.613231335028105e-15
whereas O 0 1.1596901824256767e-12
the O 0 5.166294367135726e-13
family O 0 3.682543853189557e-12
harbouring O 0 2.0009343071336616e-09
the O 0 2.049695049105571e-12
missense O 0 1.9815633856001824e-10
mutation O 0 2.518950759783367e-13
had O 0 5.22958141634805e-15
an O 0 2.31965431997633e-17
average O 0 1.9540035347685898e-14
age O 0 2.722637924574417e-13
of O 0 2.0531618939723106e-12
onset O 0 9.018818580841526e-09
of O 0 5.062583241510765e-09
51 O 0 2.828939216215076e-07
. O 0 5.031099021834962e-07

2 O 0 6.375809324943305e-10
years O 0 1.1262948212964474e-10
. O 0 8.003954166113658e-10

These O 0 2.52024130731332e-11
findings O 0 4.323021541435823e-12
show O 0 1.9726243208340044e-12
that O 0 3.0182978918947764e-14
BRCA1 O 0 3.1983421466819095e-10
is O 0 3.4620926730923735e-14
implicated O 0 1.3415725128029798e-11
in O 0 3.8458602621971316e-13
a O 0 3.049570687120584e-13
small O 0 5.576594721212139e-15
fraction O 0 3.531688483326967e-11
of O 0 3.1674693445893354e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.38578882812246e-12
suggesting O 0 1.9609256574201414e-14
the O 0 7.872809667539362e-16
involvement O 0 5.38402601581861e-13
of O 0 4.777294011770739e-13
another O 0 2.0867983448018268e-13
susceptibility O 0 3.0284902190202967e-12
gene O 0 2.114428640856425e-12
( O 0 6.774871462444931e-13
s O 0 5.405160763416461e-09
) O 0 3.6716762963351357e-10

Paternal O 0 2.0224844774929807e-05
transmission O 1 0.9989162683486938
of O 0 8.243996774126572e-08
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 2.8491906505223596e-06

We O 0 1.8540442792147616e-10
report O 0 1.3432207819977227e-12
a O 0 2.0005322404073947e-14
rare O 0 2.8077554861736902e-14
case O 0 7.690528918444066e-15
of O 0 5.507514583280582e-12
paternally O 0 0.03887143358588219
transmitted O 1 0.9996057152748108
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.046645881075392e-09
DM B-Disease 1 1.0
) O 0 3.660247452352827e-12
. O 0 7.2033663756077e-11

The O 0 1.4058044728315622e-09
proband O 0 9.59529302235751e-07
is O 0 4.3288008404586756e-14
a O 0 6.549579265437491e-14
23 O 0 3.681046082098377e-13
year O 0 2.0662044124264423e-12
old O 0 4.8416655573646494e-08
, O 0 3.871651697157086e-12
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 3.326672626258187e-08
who O 0 9.263870920372952e-11
suffers O 1 0.9987409710884094
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9996230602264404

He O 0 1.7522684692128365e-11
presented O 0 2.871390278325059e-11
with O 0 2.1164381011629096e-12
respiratory O 0 7.036107376734435e-07
and O 0 4.316800389370101e-12
feeding O 0 7.252407008273565e-10
difficulties O 0 1.3840947055143715e-08
at O 0 1.0205278844210852e-09
birth O 0 2.9493392617041536e-07
. O 0 3.516879019116459e-07

His O 0 1.5435951183917496e-08
two O 0 2.5067378728316214e-10
sibs O 0 8.067742783168796e-06
suffer O 0 1.4279080140511269e-08
from O 0 2.1738078004318595e-10
childhood O 0 0.0022137537598609924
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 7.580006240459625e-07

Their O 0 2.6771957914450972e-11
late O 0 1.314648945260899e-10
father O 0 1.4536628845096544e-11
had O 0 3.3499990433581706e-14
the O 0 3.3274079970285406e-16
adult O 0 1.261834828282743e-15
type O 0 1.1086490680025686e-14
of O 0 2.7135563761271353e-12
DM B-Disease 1 1.0
, O 0 2.132650826769389e-12
with O 0 2.5345993207893935e-13
onset O 0 2.6401718145052655e-08
around O 0 3.8750426478717515e-12
30 O 0 9.889078271541063e-12
years O 0 3.413185359346649e-11
. O 0 1.168557917097246e-09

Only O 0 3.258280581105999e-12
six O 0 8.392983844810603e-14
other O 0 2.113729691714724e-17
cases O 0 1.4411258422418076e-16
of O 0 1.355796442996382e-13
paternal O 0 5.114179302267985e-08
transmission O 1 0.9999710321426392
of O 0 3.1895430652184587e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 2.436528201421595e-10
been O 0 9.27687614227235e-13
reported O 0 3.921062422234528e-13
recently O 0 1.448083189817262e-12
. O 0 4.065584327528349e-11

We O 0 4.455495868083137e-12
review O 0 4.905969429530935e-14
the O 0 2.3178347211520603e-15
sex O 0 9.247465260989879e-16
related O 0 1.1849822372531158e-14
effects O 0 1.1436189079332571e-14
on O 0 2.4011652719315227e-14
transmission O 0 2.121810496191756e-07
of O 0 3.99742849932494e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 5.688154487870634e-06

Decreased O 0 1.453770437365165e-08
fertility O 0 2.6965880917106944e-11
of O 0 3.357361792548884e-14
males O 0 3.256214538998638e-14
with O 0 4.266432494298251e-17
adult O 0 4.3666253338875416e-13
onset O 0 5.678728598468297e-10
DM B-Disease 1 1.0
and O 0 5.220059410768196e-13
contraction O 0 1.651104530875358e-10
of O 0 8.912661407511902e-12
the O 0 1.8536110146794016e-12
repeat O 0 3.830262496062886e-12
upon O 0 3.710385731298116e-12
male O 0 4.509890724757604e-12
transmission O 0 3.1248632154090572e-12
contribute O 0 1.2407191227648169e-14
to O 0 4.6038205799708853e-14
the O 0 2.6080626915926663e-13
almost O 0 1.3764151493914079e-12
absent O 0 6.902784593920686e-11
occurrence O 0 1.5049794743760003e-11
of O 0 3.252125944843559e-13
paternal O 0 4.581267365466601e-09
transmission O 0 4.298243311495753e-06
of O 0 5.514901868508559e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.5127023971217568e-06

Also O 0 2.3741498350604573e-11
the O 0 2.455635738154993e-12
fathers O 0 2.0135826339640062e-10
of O 0 2.9949319933775254e-12
the O 0 2.5150777727828144e-12
reported O 0 1.123369973432542e-11
congenitally O 0 1.777666085445162e-07
affected O 0 1.365011836201857e-11
children O 0 3.6147674480416225e-13
showed O 0 1.0346305409636436e-11
, O 0 1.6886244489763206e-15
on O 0 1.7402836983981818e-12
average O 0 1.5312277834578225e-10
, O 0 2.6739437487127704e-12
shorter O 0 5.282290160835146e-08
CTG O 0 1.642799588807975e-06
repeat O 0 1.6205048414263956e-09
lengths O 0 2.5823002403058126e-08
and O 0 9.74481086102319e-12
hence O 0 1.197056898050164e-09
less O 0 8.232105969119274e-11
severe O 0 2.7854711870389792e-09
clinical O 0 1.0255251092772255e-09
symptoms O 0 1.278548881350483e-11
than O 0 1.1107942424689612e-16
the O 0 6.28108938761896e-15
mothers O 0 2.2113242497973778e-13
of O 0 1.6914434805039014e-13
children O 0 6.48364825370229e-12
with O 0 2.7693708437581677e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.8675542378332466e-05

We O 0 2.72421321612093e-12
conclude O 0 2.94967272829183e-10
that O 0 2.642348925112944e-15
paternal O 0 5.765691812875673e-10
transmission O 0 8.733782692615932e-07
of O 0 3.601325904156738e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 6.234790461689954e-11
rare O 0 2.7477221886673675e-12
and O 0 7.564196495459929e-15
preferentially O 0 1.191897058480662e-12
occurs O 0 2.276450783520595e-13
with O 0 1.0438534404056906e-15
onset O 0 4.324256508425606e-09
of O 0 5.3338711225592306e-09
DM B-Disease 1 1.0
past O 0 1.363712698321251e-08
30 O 0 6.2637876656335134e-12
years O 0 6.321789066624645e-14
in O 0 1.7018815733920345e-15
the O 0 2.3350658700464072e-14
father O 0 4.925607664796328e-12
. O 0 4.221630423711931e-12
. O 0 2.9204563767315506e-10

The O 0 1.0245763959471077e-10
RB1 O 0 1.3879781768366684e-08
gene O 0 1.8674676334397983e-13
mutation O 0 1.3943880772249173e-13
in O 0 7.155332505974152e-14
a O 0 5.615050785445774e-11
child O 0 2.900259516991355e-07
with O 0 2.63700119518262e-08
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 4.6523175114998594e-05

The O 0 3.2957986340065304e-10
RB1 O 0 5.6205347931381766e-08
gene O 0 1.1756138597329713e-12
mutation O 0 5.282115890514749e-13
was O 0 2.930248139401334e-14
investigated O 0 7.370704524153893e-14
in O 0 2.432720129128766e-14
a O 0 1.0283034840297134e-11
child O 0 2.608437554840748e-08
with O 0 3.062275988341412e-10
ectopic B-Disease 0 0.22350691258907318
intracranial I-Disease 0 2.183499873353867e-06
retinoblastoma I-Disease 0 1.2895334293716587e-06
using O 0 3.799085178390893e-12
DNA O 0 2.788596908942509e-09
obtained O 0 7.712636779233506e-11
from O 0 2.2716722166554737e-12
both O 0 2.7620408130785146e-12
the O 0 2.721752857814952e-11
pineal B-Disease 0 3.3126673315564403e-07
and I-Disease 0 1.3161945144890552e-10
retinal I-Disease 0 3.528740126057528e-05
tumours I-Disease 1 1.0
of O 0 1.1888031536955168e-07
the O 0 7.757406272901335e-09
patient O 0 1.1251198372974613e-07
. O 0 1.060439203115493e-08

A O 0 1.6841731564909423e-07
nonsense O 0 4.800378761160573e-08
mutation O 0 2.9571846273807045e-12
in O 0 4.79890432947272e-12
exon O 0 2.168862728302301e-10
17 O 0 2.0754164012370957e-11
( O 0 1.0366912474410635e-14
codon O 0 1.345116656947809e-10
556 O 0 1.2214323996673215e-10
) O 0 2.6835364103929525e-14
of O 0 4.6131249861747214e-12
the O 0 1.0615207324260467e-10
RB1 O 0 4.1774165993047063e-07
gene O 0 6.282500995130613e-12
was O 0 1.2382622704976143e-11
found O 0 3.9522001665272255e-13
to O 0 5.824041336005559e-13
be O 0 1.0164973246809539e-12
present O 0 1.369231533709936e-10
homozygously O 0 1.1136040711789974e-06
in O 0 1.0842276729206013e-11
both O 0 4.5032397949507086e-11
the O 0 2.002223525865432e-10
retinal B-Disease 0 1.5533304065229459e-07
and I-Disease 0 4.200639003304474e-10
the I-Disease 0 9.171879611358236e-08
pineal I-Disease 1 0.9494032263755798
tumours I-Disease 1 1.0
. O 0 3.753207238332834e-07

The O 0 6.010730541766707e-12
same O 0 2.840306657404812e-13
mutation O 0 9.544533945745476e-14
was O 0 3.737757174084033e-14
present O 0 4.423477372155621e-13
heterozygously O 0 7.863498741045305e-10
in O 0 2.176030860221497e-14
the O 0 3.1961954784220925e-14
DNA O 0 1.6481940812163032e-10
from O 0 1.239476186618016e-12
the O 0 1.321470602215491e-12
constitutional O 0 4.270907238979049e-11
cells O 0 2.8903598958684995e-10
of O 0 7.930037876358043e-11
the O 0 1.1004099020883729e-10
patient O 0 2.7652973244585155e-09
, O 0 4.4913549333662484e-13
proving O 0 4.2907091768462635e-10
it O 0 2.1790824658205702e-15
to O 0 1.0502858348651611e-12
be O 0 9.04970022530538e-12
of O 0 4.64073474093496e-10
germline O 0 6.975175779189158e-07
origin O 0 2.8288613673765894e-09
. O 0 7.1205517038208654e-09

The O 0 5.413678186294568e-11
initial O 0 4.056011082553823e-11
mutation O 0 2.4843625420767346e-13
was O 0 4.124996581832997e-14
shown O 0 2.528414218445907e-13
to O 0 8.13716823956645e-13
have O 0 8.910119820779161e-14
occurred O 0 1.7055677703492478e-10
in O 0 8.601495573743942e-14
the O 0 1.9807528013615627e-12
paternally O 0 1.2285576111992214e-08
derived O 0 2.0727036753598327e-10
RB1 O 0 4.481794917410298e-07
allele O 0 4.325989344522441e-09
. O 0 1.7818084785403698e-08

The O 0 1.2341555555295258e-10
mutation O 0 3.2126317123064296e-13
is O 0 1.897028620607226e-16
in O 0 6.010741140689976e-16
an O 0 5.653249826510114e-16
area O 0 6.330841883714355e-13
of O 0 5.227469593803956e-14
the O 0 7.270674676467664e-14
gene O 0 1.0153453395438973e-14
that O 0 9.334764711698643e-15
encodes O 0 5.48127027707318e-13
the O 0 1.011245687881912e-11
protein O 0 1.0062124744525391e-11
- O 0 7.756399147094972e-13
binding O 0 1.5282334425714694e-11
region O 0 3.509333623696875e-08
known O 0 2.616036727520754e-11
as O 0 8.352106441351925e-13
the O 0 3.017766592172677e-11
pocket O 0 1.3185147054173285e-06
region O 0 1.0403533678982058e-07
and O 0 1.6328897955997235e-10
has O 0 9.037672953765563e-13
been O 0 2.973916035306501e-12
detected O 0 9.12769165806182e-12
in O 0 1.4436085858074606e-14
other O 0 7.361175403497282e-15
cases O 0 1.159503943597498e-13
of O 0 1.4824129770940608e-11
retinoblastoma B-Disease 0 1.2372895241696824e-07
. O 0 4.651794227594763e-10
. O 0 1.252081638369873e-08

Low O 0 6.60132970509153e-09
levels O 0 4.0651114419087975e-11
of O 0 1.082719070649718e-11
beta O 0 2.519680297741189e-10
hexosaminidase O 0 2.269139010024901e-08
A O 0 1.5998384561566326e-10
in O 0 1.0049282911893387e-13
healthy O 0 1.219385703521425e-11
individuals O 0 4.7152422584680314e-15
with O 0 5.5248056021577063e-14
apparent O 0 4.721279722730287e-08
deficiency O 0 0.07308885455131531
of O 0 1.1224126694742154e-07
this O 0 7.901702625545681e-10
enzyme O 0 3.824843552990842e-09
. O 0 7.022979087167869e-09

Appreciable O 0 2.2416122291701868e-08
beta O 0 5.915585243876365e-10
hexosaminidase O 0 3.4893244560407766e-07
A O 0 1.4757875987925217e-07
( O 0 5.688745102153808e-14
hex O 0 4.654485685762211e-09
A O 0 2.282659838925838e-09
) O 0 3.891382862101188e-15
activity O 0 5.154308837379551e-12
has O 0 8.178778614515705e-16
been O 0 9.428983743960118e-14
detected O 0 6.10382855370517e-11
in O 0 2.9805956314188364e-11
cultured O 0 0.00023956257791724056
skin O 0 0.0007282106671482325
fibroblasts O 0 0.07513111084699631
and O 0 1.8484133113005896e-09
melanoma B-Disease 0 7.498726517951582e-06
tissue O 0 1.825744000427676e-08
from O 0 8.939987639067226e-12
healthy O 0 2.572317185645101e-11
individuals O 0 1.816113389570815e-15
previously O 0 1.0152379154373947e-12
reported O 0 7.001991759840454e-13
as O 0 6.443724677104856e-13
having O 0 1.8824521941240846e-09
deficiency B-Disease 0 7.552131137344986e-05
of I-Disease 0 1.118878913075605e-06
hex I-Disease 0 3.7615490100506577e-07
A I-Disease 0 5.1135908840649336e-09
activity O 0 1.598446722206326e-11
indistinguishable O 0 1.0737667699434184e-11
from O 0 9.265119545193027e-16
that O 0 2.0448401050678376e-17
of O 0 3.0872866502179184e-15
patients O 0 1.0349999767552808e-14
with O 0 1.8925918124357288e-11
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.9406651632913885e-11
TSD B-Disease 1 0.998802661895752
) O 0 1.3679353873599642e-12
. O 0 1.7645378214137253e-10

Identification O 0 1.9805451501042626e-08
and O 0 9.75915181999909e-12
quantitation O 0 4.8612389946356416e-05
of O 0 8.61814015706841e-08
hex O 0 3.77995377220941e-07
A O 0 1.4862429509321373e-08
, O 0 1.1618365537496237e-14
amounting O 0 6.607595720575787e-11
to O 0 7.674894053621983e-11
3 O 0 8.750508651012012e-10
. O 0 2.9133528922642427e-09

5 O 0 9.948246670887784e-10
% O 0 2.3895803114015735e-09
- O 0 2.20380755311389e-10
6 O 0 2.3896098641507102e-11
. O 0 1.0061401017891214e-10

9 O 0 4.606163714337974e-11
% O 0 6.325100599530176e-12
of O 0 4.644570860724839e-13
total O 0 1.322187411639808e-11
beta O 0 6.791543022410806e-11
hexosaminidase O 0 4.1428420693989665e-09
activity O 0 7.750935310246732e-11
, O 0 1.3704279884832991e-14
has O 0 1.2800438661267832e-16
been O 0 1.9531455327446686e-15
obtained O 0 1.2386010999395486e-13
by O 0 1.38884790576747e-14
cellulose O 0 1.772390567644777e-10
acetate O 0 4.863260141818593e-11
gel O 0 1.668618437866698e-10
electrophoresis O 0 9.291299674085707e-11
, O 0 4.037022452441086e-12
DEAE O 0 7.802796972100623e-06
- O 0 8.310406807154891e-10
cellulose O 0 4.252881602440084e-09
ion O 0 2.3893114153850092e-09
- O 0 8.808851426067577e-10
exchange O 0 2.4109485241563533e-11
chromatography O 0 2.381334851531136e-10
, O 0 1.3277146580521065e-14
radial O 0 1.5867359509647017e-12
immunodiffusion O 0 4.14383816149666e-09
, O 0 5.801487897938787e-14
and O 0 5.86960818491078e-13
radioimmunoassay O 0 6.440109814320749e-07
. O 0 6.5879963706549916e-09

Previous O 0 1.5773538279972854e-06
family O 0 5.5250460456734984e-11
studies O 0 9.193733014473127e-13
suggested O 0 2.04520984024327e-14
that O 0 4.6903728152712735e-17
these O 0 5.352430310457486e-16
individuals O 0 2.989927624469325e-15
may O 0 5.885894392319499e-14
be O 0 6.1204669533476e-14
compound O 0 7.215384539849268e-11
heterozygotes O 0 9.282239865626707e-09
for O 0 2.977900478290385e-12
the O 0 1.8885854685679604e-11
common O 0 4.746995765220197e-12
mutant O 0 1.720200024091234e-11
TSD B-Disease 0 3.615300769865826e-08
gene O 0 2.805493684587823e-12
and O 0 1.4959637261585668e-12
a O 0 4.732587585709602e-11
rare O 0 1.4946588411390849e-10
( O 0 1.3115282819465505e-14
allelic O 0 5.915130885103537e-11
) O 0 2.3017629062526204e-15
mutant O 0 2.499335157238325e-12
gene O 0 4.642305637125865e-12
. O 0 7.192263451472058e-10

Thus O 0 1.9418850971675283e-09
, O 0 9.116934637787288e-13
the O 0 3.437795837932245e-12
postulated O 0 1.0419584639542734e-10
rate O 0 1.853179719055187e-12
mutant O 0 1.2216285925556458e-13
gene O 0 1.563672626168737e-14
appears O 0 3.6757259020379907e-14
to O 0 1.0229345853447064e-13
code O 0 3.1630100828013846e-14
for O 0 6.533844781409295e-14
the O 0 8.570940723644227e-13
expression O 0 8.979652091345436e-12
of O 0 9.505646270113743e-12
low O 0 1.6229776203524615e-11
amounts O 0 8.295998436824714e-13
of O 0 5.95738597342077e-11
hex O 0 9.002528855717173e-08
A O 0 8.211220006160147e-07
. O 0 6.14046768987464e-08

Heterozygotes O 0 2.0943614345014794e-06
for O 0 1.371591867860289e-10
the O 0 7.926438672090086e-11
rare O 0 2.4805392115356817e-11
mutant O 0 8.625852636334752e-12
may O 0 6.81229026097338e-14
be O 0 3.954143260108227e-14
indistinguishable O 0 5.237780209554899e-10
from O 0 4.272988755361917e-13
heterozygotes O 0 2.379760388748764e-09
for O 0 5.798882207752598e-12
the O 0 1.2129955373474388e-10
common O 0 5.265827218714492e-10
TSD B-Disease 0 8.801065405350528e-07
mutant O 0 1.2730482223943795e-09
. O 0 1.1852113734889258e-09

However O 0 1.6533789962136503e-11
, O 0 3.089265954457415e-15
direct O 0 1.627512144150578e-12
visualization O 0 3.5381579888138504e-09
and O 0 8.986021020167267e-13
quantitation O 0 7.836984877940267e-05
of O 0 6.897793269899921e-08
hex O 0 6.269010555115528e-08
A O 0 4.80977702110863e-10
by O 0 5.568559343158011e-15
the O 0 8.878192777304894e-14
methods O 0 3.1835752783981874e-11
described O 0 9.914433911437787e-14
may O 0 5.352739159845878e-15
prevent O 0 5.3273401992961e-14
false O 0 5.064282868928738e-13
- O 0 1.3101019834954597e-12
positive O 0 1.4510407578185308e-13
prenatal O 0 9.849652204962922e-10
diagnosis O 0 6.186840484367906e-10
of O 0 2.110536355057202e-12
TSD B-Disease 0 1.281214565551636e-07
in O 0 2.0735012665196173e-11
fetuses O 0 7.508535304623365e-08
having O 0 1.702066786124501e-11
the O 0 3.646215621100346e-11
incomplete O 0 2.7405999958318716e-07
hex B-Disease 0 1.0973770940836403e-06
A I-Disease 0 5.215405280978302e-07
deficiency I-Disease 0 6.3344969021272846e-06
of O 0 1.6014725101598515e-09
the O 0 5.992589757752853e-11
type O 0 1.0340811540388017e-09
described O 0 2.4173432353058466e-12
in O 0 1.9464497288262939e-13
the O 0 1.655820879714609e-12
four O 0 1.9469604747857083e-11
healthy O 0 3.867420605985217e-09
individuals O 0 3.478480350982416e-11

The O 0 3.719645702560115e-09
tumor B-Disease 0 5.90523940857679e-09
suppressor O 0 1.4540830761688994e-09
gene O 0 1.5542785808397852e-11
Smad4 O 0 7.076631391100818e-06
/ O 0 3.367337697568473e-08
Dpc4 O 0 1.1563115265289525e-07
is O 0 2.720023169865143e-16
required O 0 9.28157832709442e-14
for O 0 1.3343764027756722e-14
gastrulation O 0 2.5121065050370817e-07
and O 0 1.1437061523268243e-14
later O 0 7.359259686021136e-13
for O 0 1.8644530092992023e-13
anterior O 0 2.6823784082807833e-07
development O 0 1.5576345546719494e-08
of O 0 3.113857782732765e-11
the O 0 2.2963039456036505e-11
mouse O 0 1.6256056223351578e-10
embryo O 0 5.105745604083722e-09
. O 0 4.641179440767473e-09

Mutations O 0 7.387521150370446e-11
in O 0 7.338164364351085e-13
the O 0 2.870678347810518e-11
SMAD4 O 1 0.9999991655349731
/ O 0 1.3974129160487792e-06
DPC4 O 0 3.646469485829584e-05
tumor B-Disease 0 7.795368517360401e-11
suppressor O 0 1.5330592698092893e-11
gene O 0 1.457039648438893e-13
, O 0 1.1845528762521526e-14
a O 0 3.211377561443407e-12
key O 0 2.3178770014453676e-09
signal O 0 3.8465522322894685e-08
transducer O 0 1.6562790250418402e-08
in O 0 1.7962713261265861e-10
most O 0 4.5743844823142865e-10
TGFbeta O 1 0.9889322519302368
- O 0 1.126742876778053e-08
related O 0 3.160786743450217e-09
pathways O 0 6.663871121581622e-10
, O 0 2.1714058856289433e-16
are O 0 3.0861868771975822e-18
involved O 0 8.259640085429745e-16
in O 0 1.7707040803234542e-14
50 O 0 2.163062506888025e-10
% O 0 2.1099207714314616e-08
of O 0 2.367406715109155e-08
pancreatic B-Disease 1 0.99977046251297
cancers I-Disease 1 0.999997615814209
. O 0 7.961802475620061e-05

Homozygous O 0 7.584359309475985e-07
Smad4 O 0 1.198315999317856e-06
mutant O 0 1.3472452320417716e-10
mice O 0 1.3523447119079268e-11
die O 0 1.825738588090431e-10
before O 0 8.096873865826026e-12
day O 0 3.5601366299431447e-10
7 O 0 1.8066456108911666e-09
. O 0 1.2236132107545927e-09

5 O 0 9.834933978325466e-10
of O 0 4.731723346473871e-10
embryogenesis O 0 6.3781353674130514e-06
. O 0 6.764984306073529e-08

Mutant O 0 3.3274203392608115e-09
embryos O 0 8.325590217239665e-10
have O 0 3.3580229525861927e-13
reduced O 0 3.1507778157358057e-12
size O 0 6.387716419177514e-13
, O 0 1.0432315276399928e-13
fail O 0 8.442005317021994e-09
to O 0 2.9242197552292737e-09
gastrulate O 0 0.006021886132657528
or O 0 1.1035570235407022e-09
express O 0 1.0642575709596258e-10
a O 0 2.6615029624643682e-12
mesodermal O 0 4.367302608443424e-08
marker O 0 8.115481620052378e-10
, O 0 1.0875216607244761e-13
and O 0 4.5451207901503476e-13
show O 0 2.989423375510114e-09
abnormal O 0 2.588785363855095e-08
visceral O 0 7.2546515461624494e-09
endoderm O 0 5.00926773838728e-07
development O 0 5.039646922000429e-08
. O 0 2.4488011618473138e-09

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 4.134679709721922e-09
the O 0 5.474947162298349e-10
Smad4 O 0 8.252668521890882e-06
- O 0 1.8229975307093582e-09
deficient O 0 7.589530393037336e-11
embryos O 0 1.0521430948706723e-11
results O 0 6.213679310668185e-12
from O 0 4.620125029081157e-12
reduced O 0 8.253518701817342e-11
cell O 0 6.913062483571153e-11
proliferation O 0 4.244823936794262e-10
rather O 0 2.5830043399316382e-12
than O 0 2.783245639167986e-13
increased O 0 9.405615175595017e-10
apoptosis O 0 4.6946997400709733e-08
. O 0 1.936293969606595e-08

Aggregation O 0 1.5973481426456715e-09
of O 0 5.39276012734291e-10
mutant O 0 1.4760205557795558e-10
Smad4 O 0 5.196861252443341e-07
ES O 0 9.624830710208698e-09
cells O 0 4.4699210695678393e-13
with O 0 1.2915070276997716e-15
wild O 0 3.3478992148006093e-13
- O 0 2.890311145802016e-13
type O 0 9.627179695798072e-13
tetraploid O 0 1.695485352115611e-08
morulae O 0 2.2638232621829957e-06
rescues O 0 2.3899508150293514e-08
the O 0 4.072546119782139e-11
gastrulation B-Disease 0 2.56878793152282e-05
defect I-Disease 0 5.1928855100413784e-06
. O 0 2.0290900071273654e-09

These O 0 1.3477406690665106e-11
results O 0 9.627166251691133e-12
indicate O 0 1.8449349686866512e-11
that O 0 4.5976426604667914e-14
Smad4 O 0 1.1896707974301535e-07
is O 0 2.2781249695518315e-15
initially O 0 2.2027649141027374e-14
required O 0 4.642270508975477e-12
for O 0 2.412864558761635e-13
the O 0 4.614603404257123e-12
differentiation O 0 9.734436590136397e-10
of O 0 5.83543352528082e-11
the O 0 4.8447437034360163e-11
visceral O 0 1.2356659029322259e-09
endoderm O 0 7.690525904990864e-08
and O 0 1.1944362599686231e-13
that O 0 2.8345887699647012e-15
the O 0 3.1604544827555647e-13
gastrulation B-Disease 0 7.565505910633874e-08
defect I-Disease 0 1.6399069879824424e-09
in O 0 2.7141087771340167e-13
the O 0 4.182040130862319e-12
epiblast O 0 1.8416825753320154e-07
is O 0 1.4020205894686721e-13
secondary O 0 2.8194453438601386e-09
and O 0 1.5017986854104493e-12
non O 0 1.6662450263993378e-07
- O 0 2.4830802303199562e-08
cell O 0 1.5232063788062078e-07
autonomous O 0 9.000619684229605e-06
. O 0 7.439748372917165e-09

Rescued O 0 2.211456973100212e-07
embryos O 0 4.142180642929816e-08
show O 0 5.551764048483676e-10
severe O 0 9.281562185492476e-10
anterior O 0 3.411114084883593e-05
truncations O 0 2.693650094443001e-05
, O 0 1.786569156503326e-12
indicating O 0 1.575473917991843e-10
a O 0 3.6174108413583594e-12
second O 0 1.4194993791516453e-10
important O 0 6.892075798958786e-11
role O 0 1.661617718418107e-11
for O 0 2.193071765854704e-11
Smad4 O 0 1.9434392015682533e-05
in O 0 7.213182828813558e-11
anterior O 0 3.643869058578275e-05
patterning O 0 2.087296934405458e-06
during O 0 1.4489144177787239e-06
embryogenesis O 0 0.001094795297831297
. O 0 4.6070404380316177e-08

Prevalence O 0 3.656061409174072e-08
of O 0 3.1682453882631023e-10
p16 O 0 2.6656843843397837e-08
and O 0 1.2915207792119077e-09
CDK4 O 1 0.9979268312454224
germline O 0 0.0001251528738066554
mutations O 0 2.417724909165031e-09
in O 0 2.2632486162965648e-11
48 O 0 5.1199766204490516e-08
melanoma B-Disease 0 0.0009961017640307546
- O 0 2.018090938804562e-08
prone O 0 5.121858936973922e-09
families O 0 1.4791931568503003e-11
in O 0 8.602214079944659e-11
France O 0 5.885797182969554e-09
. O 0 1.1446961600825034e-08

The O 0 2.4431386691503576e-08
French O 0 1.953589077174911e-07
Familial B-Disease 0 0.008832089602947235
Melanoma I-Disease 1 0.9470899701118469
Study O 0 2.4657995090215934e-10
Group O 0 9.747240991772599e-13
. O 0 7.39947894623505e-11

Germline O 0 4.067164991283789e-05
mutations O 0 4.4532744158942705e-10
in O 0 3.146267968379135e-12
the O 0 1.2923696834921117e-11
p16 O 0 5.1917212751106945e-09
and O 0 1.6979164602082264e-11
CDK4 O 0 2.5371355150127783e-05
genes O 0 1.889789019715593e-11
have O 0 5.470572454237266e-14
been O 0 4.6607195099829246e-14
reported O 0 1.5546091703452086e-13
in O 0 9.285085043496052e-14
a O 0 4.521819984421027e-12
subset O 0 2.2979174119086565e-10
of O 0 5.551520909641283e-10
melanoma B-Disease 0 1.224239213115652e-06
pedigrees O 0 1.101505517908663e-07
, O 0 2.640287294353172e-12
but O 0 1.174269340618872e-12
their O 0 6.067566588052742e-11
prevalence O 0 1.4334057274467682e-09
is O 0 5.497490526026297e-16
not O 0 3.4147428537145e-14
well O 0 1.6657364723671186e-11
known O 0 1.5054713031759093e-10
. O 0 1.1496498864005389e-08

We O 0 3.932032754949688e-10
searched O 0 5.558874471844888e-10
for O 0 5.129835900681556e-13
such O 0 7.032373815218929e-13
germline O 0 2.2395144583242654e-07
mutations O 0 1.1180117942544143e-10
in O 0 1.1037895424059752e-11
48 O 0 1.9830936537346133e-07
French O 0 7.090237090778828e-07
melanoma B-Disease 1 0.9938039779663086
- O 0 5.249046353128506e-08
prone O 0 1.2084468981043983e-09
families O 0 2.284916234083362e-13
selected O 0 2.42225293642373e-13
according O 0 5.957127152678154e-14
to O 0 1.0723412040064204e-13
two O 0 2.717816511394692e-14
major O 0 3.812250265900624e-13
criteria O 0 1.4029951245914107e-12
families O 0 9.812430138171277e-14
with O 0 1.4883424498068573e-15
at O 0 2.50780028254044e-13
least O 0 1.6104012654644118e-13
three O 0 2.2611545882206263e-12
affected O 0 2.8376576088895433e-10
members O 0 2.7040047284598856e-11
( O 0 8.701149067751046e-13
n O 0 3.796667494282424e-11
= O 0 6.941942246735389e-12
20 O 0 8.465824395675892e-12
) O 0 9.256147348699235e-16
or O 0 1.947878639526994e-14
families O 0 9.243894847710613e-14
with O 0 7.09052465992701e-15
two O 0 4.4782583132237097e-13
affected O 0 6.7969171957393826e-12
members O 0 8.839196058039664e-14
, O 0 4.520648720814091e-15
one O 0 7.886069015416563e-15
of O 0 1.0890495048734156e-13
them O 0 4.85565228433224e-14
affected O 0 1.5434057027211012e-13
before O 0 3.792507350915478e-14
the O 0 5.2890387246739765e-14
age O 0 4.5340662647996854e-12
of O 0 1.9551959010155606e-11
50 O 0 2.1342033695859186e-10
( O 0 4.4494613614214085e-14
n O 0 5.856389592023836e-13
= O 0 1.3265838351862042e-13
28 O 0 1.1029597374312416e-12
) O 0 3.0270749955249913e-16
, O 0 4.868463742362756e-16
and O 0 1.1899462950163233e-15
one O 0 1.0489633995940627e-14
additional O 0 4.590416046411361e-13
minor O 0 5.0087441139101685e-11
criterion O 0 7.561261838873179e-09
. O 0 1.0894241064818289e-08

Sixteen O 0 6.406241226386555e-08
different O 0 2.145378041884527e-10
p16 O 0 8.37629343664048e-09
germline O 0 3.1398538880011984e-08
mutations O 0 7.718401438816525e-12
were O 0 4.4780618015799467e-13
found O 0 3.891103002415415e-14
in O 0 5.757391362704728e-15
21 O 0 7.879822554006377e-13
families O 0 1.2251457444031888e-12
, O 0 4.471794909735073e-14
while O 0 1.5963253939196842e-12
one O 0 2.6917475193233287e-11
germline O 0 1.261812371922133e-06
mutation O 0 5.846466089032276e-10
, O 0 5.245172785689478e-12
Arg24His O 0 1.1636469025688712e-05
, O 0 9.891470238374e-13
was O 0 7.935269628889241e-12
detected O 0 5.606743368191669e-12
in O 0 5.768793103801129e-14
the O 0 5.881983268507529e-12
CDK4 O 0 3.913195905624889e-05
gene O 0 3.861271857807935e-10
. O 0 7.376489641330863e-09

The O 0 3.5795448636438687e-12
frequency O 0 1.788488519609277e-12
of O 0 6.175984203216078e-13
p16 O 0 3.7451257373088964e-12
gene O 0 8.620082356518722e-15
mutation O 0 9.91454097640232e-15
in O 0 2.2164367034977796e-14
our O 0 2.3767005724595336e-11
sample O 0 8.733788432052636e-13
( O 0 1.6229983743960868e-16
44 O 0 1.73650469004194e-11
% O 0 8.061168919881734e-12
) O 0 2.430690479368467e-16
is O 0 2.4496052544762477e-16
among O 0 6.537054591587092e-16
the O 0 9.15430586694542e-14
highest O 0 3.548711324796727e-11
rates O 0 4.2050252711291203e-13
yet O 0 3.389293918220834e-14
reported O 0 4.2025554585801983e-13
and O 0 7.523293105030429e-14
the O 0 8.666122507106078e-12
CDK4 O 0 1.3156434761185665e-05
mutation O 0 1.0489730611906722e-11
is O 0 1.5595799323741937e-14
the O 0 5.250435503034723e-13
second O 0 3.628007338996042e-10
mutation O 0 2.3820376227057238e-11
detected O 0 7.036215360356479e-12
in O 0 4.9265990863679027e-14
this O 0 3.43429413596566e-13
gene O 0 3.967822164580026e-12
worldwide O 0 3.1046127474398943e-11
. O 0 5.3470721184112335e-09

In O 0 1.3866212865421002e-11
summary O 0 6.082058467971052e-12
, O 0 5.927723335650463e-15
our O 0 5.122317500716456e-13
results O 0 4.258164730108066e-13
show O 0 3.08718545519171e-12
frequent O 0 8.952404789708268e-13
involvement O 0 2.5988194235493367e-11
of O 0 1.5654684146215736e-11
the O 0 1.7882815020464626e-11
p16 O 0 6.170859934151451e-10
gene O 0 2.8124050397565492e-12
in O 0 1.352365355117291e-11
familial B-Disease 0 2.646177108545089e-07
melanoma I-Disease 0 3.504562300804537e-06
and O 0 7.44900506294971e-13
confirm O 0 6.781795264254598e-11
the O 0 1.5409062914528704e-12
role O 0 1.0479112369510268e-11
of O 0 1.0034033326444813e-10
the O 0 6.580696543245779e-10
CDK4 O 1 0.9991408586502075
gene O 0 5.821570309150204e-11
as O 0 8.401930193246976e-12
a O 0 2.296121071054813e-10
melanoma B-Disease 0 5.418812634161441e-06
- O 0 3.192693664999524e-09
predisposing O 0 5.575928052614643e-10
gene O 0 1.0600567732638178e-12
. O 0 5.197014259911148e-12
. O 0 2.054135334050855e-10

Progression O 0 1.127743644246948e-06
of O 0 2.7405414826375818e-08
somatic O 0 2.0349614260339877e-07
CTG O 0 6.069906703487504e-06
repeat O 0 1.36592992472373e-09
length O 0 8.124196454462052e-11
heterogeneity O 0 1.584260916898117e-10
in O 0 3.482172436139984e-14
the O 0 3.535787588822108e-14
blood O 0 1.3849263532858536e-12
cells O 0 1.4768061773473562e-10
of O 0 2.9878713392328393e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 3.543904938396736e-07
. O 0 4.5958303829252145e-09

The O 0 2.534908860509638e-13
genetic O 0 3.757371069010654e-14
basis O 0 8.936811794063582e-13
of O 0 4.410850591024529e-12
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.7298938670418096e-10
DM B-Disease 1 1.0
) O 0 3.16978600756624e-14
is O 0 1.139476498598666e-16
the O 0 1.2354900919198846e-15
expansion O 0 4.4950336855476e-12
of O 0 3.971925652962449e-12
an O 0 9.056689317769873e-13
unstable O 0 3.1785379661641855e-08
CTG O 0 6.164876964476207e-08
repeat O 0 7.295937291817989e-12
in O 0 5.155818060356178e-14
the O 0 9.336639534424096e-14
34 O 0 7.223160871511203e-12
UTR O 0 4.110338025498095e-08
of O 0 1.2988465337981925e-11
the O 0 5.19409570909346e-10
DM B-Disease 1 1.0
protein O 0 3.864029096689592e-09
kinase O 0 2.0844824477617152e-10
gene O 0 1.8543747266897004e-12
on O 0 3.17212540956735e-11
chromosome O 0 1.0150724011337431e-10
19 O 0 1.2022097761743566e-09
. O 0 3.2058435905923943e-09

One O 0 2.1880192969947476e-12
of O 0 8.717777476470456e-13
the O 0 2.2270743192318032e-13
principal O 0 4.5467011232369625e-12
features O 0 4.181214158542265e-14
of O 0 4.992943450181364e-13
the O 0 9.931103162053034e-11
DM B-Disease 1 1.0
mutation O 0 1.7607514404827107e-11
is O 0 1.0594554273051122e-14
an O 0 1.1828460201601405e-14
extraordinarily O 0 7.640223453897477e-10
high O 0 4.6441792078688593e-10
level O 0 9.302713266379214e-08
of O 0 1.4117750302133913e-09
somatic O 0 1.1985745729248265e-08
mosaicism O 0 9.941616241349038e-08
, O 0 2.7513801919296435e-14
due O 0 9.335580052061143e-12
to O 0 1.568163134069156e-12
an O 0 4.1535131318484395e-14
extremely O 0 9.783287027720355e-12
high O 0 6.094867666117665e-12
degree O 0 5.9406555230623326e-09
of O 0 5.789306811720962e-10
somatic O 0 6.415436359930027e-08
instability O 0 1.4578216855909432e-08
both O 0 2.359422986847326e-12
within O 0 2.3110145741522814e-11
and O 0 4.4961010283763037e-14
between O 0 5.053111575004099e-12
different O 0 5.331078287151847e-11
tissues O 0 4.638064599049585e-09
. O 0 3.285976823974579e-09

This O 0 6.097478633115827e-10
instability O 0 2.0708165848759563e-08
appears O 0 2.350631354060967e-13
to O 0 1.8667721855087846e-14
be O 0 1.5988377071937676e-14
biased O 0 2.1709144898407473e-11
towards O 0 9.459097394248772e-11
further O 0 2.3107622586227006e-12
expansion O 0 1.3373296914309662e-10
and O 0 1.8557537776429933e-13
continuous O 0 1.3659436248758539e-08
throughout O 0 1.2429338114294808e-10
the O 0 4.36783552035247e-12
life O 0 2.672629652311631e-11
of O 0 1.077759669704248e-11
an O 0 5.1615738186393603e-14
individual O 0 1.57588709876616e-12
, O 0 7.512557199593206e-13
features O 0 1.4390521109811094e-12
that O 0 4.392775968415372e-15
could O 0 2.0540693982957353e-13
be O 0 2.1245583959640657e-13
associated O 0 3.363051503946224e-11
with O 0 2.0418470516800347e-13
the O 0 5.4366910279268765e-11
progressive O 0 4.7717694684479284e-08
nature O 0 6.9200370260424915e-12
of O 0 7.459782574645302e-13
the O 0 3.990151264954278e-11
disease O 0 2.7860398432721922e-09
. O 0 4.188174251851251e-10

Although O 0 3.554889715928766e-11
increasing O 0 1.3411676283436869e-12
measured O 0 8.329432656844007e-14
allele O 0 1.6758888114060122e-12
size O 0 3.234816657159828e-13
between O 0 1.4655363728133253e-11
patients O 0 9.89875976326049e-12
clearly O 0 3.6160037637789078e-12
correlates O 0 9.766660397092508e-11
with O 0 4.618664408855043e-15
an O 0 4.488549983761416e-15
increased O 0 1.6001328951090188e-12
severity O 0 1.1501224972398916e-10
of O 0 9.203177282757213e-12
symptoms O 0 4.306653991759113e-11
and O 0 2.3102340827581107e-15
an O 0 1.2339210692642144e-16
earlier O 0 3.472166131002208e-13
age O 0 1.305258852390967e-11
of O 0 8.654394909046736e-12
onset O 0 7.656354023000134e-11
, O 0 1.917773648625566e-15
this O 0 6.131938320552265e-15
correlation O 0 9.458757968495643e-14
is O 0 5.443982395957059e-16
not O 0 2.252581971049373e-14
precise O 0 3.862840880497487e-10
and O 0 2.4263692183917884e-12
measured O 0 5.628990676354029e-11
allele O 0 2.4857929603605555e-10
length O 0 1.8671748869270033e-10
cannot O 0 4.317790916474884e-11
be O 0 4.0716022675808816e-13
used O 0 7.858254520189123e-13
as O 0 9.654807640489208e-15
an O 0 7.841218514980329e-16
accurate O 0 1.8328039086412673e-10
predictor O 0 5.5188582592791136e-09
of O 0 4.304639977803504e-12
age O 0 1.2584449038399725e-09
of O 0 1.174790820179794e-09
onset O 0 7.653298439436185e-07
. O 0 1.687799766614262e-08

In O 0 4.3084103992785394e-12
order O 0 4.819890146723349e-13
to O 0 7.063885067160047e-13
further O 0 6.184329849438785e-13
characterize O 0 1.22549290160201e-10
the O 0 1.5245584742556995e-12
dynamics O 0 2.6313926593246606e-09
of O 0 3.698266084484203e-07
DM B-Disease 1 1.0
CTG O 0 0.0004576759529300034
repeat O 0 8.178827215488127e-08
somatic O 0 1.5749894544114795e-07
instability O 0 2.957382427837274e-08
, O 0 1.3781370894461447e-14
we O 0 1.0138977602370397e-14
have O 0 2.356770072880262e-15
studied O 0 9.164875482874438e-14
repeat O 0 6.457086384678568e-13
length O 0 8.803126955690688e-13
changes O 0 1.2647509721377265e-14
over O 0 1.1242235475070281e-14
time O 0 2.21221017849757e-13
in O 0 6.925116946901455e-13
111 O 0 2.7951056580377553e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.8516339850283003e-10
with O 0 6.337311199492964e-15
varying O 0 1.0289602286536748e-12
clinical O 0 3.915573074109169e-11
severity O 0 1.9196816358757474e-10
and O 0 9.233419584475655e-12
CTG O 0 3.980336771292059e-08
repeat O 0 3.279931534705405e-11
size O 0 4.0973027379785643e-13
over O 0 7.507482049223801e-14
time O 0 9.719837781863028e-13
intervals O 0 7.129245527259798e-10
of O 0 3.2338142580412566e-11
1 O 0 2.1028546959289685e-11
- O 0 1.562244777986166e-10
7 O 0 7.942386331949436e-12
years O 0 1.2461710482969401e-11
. O 0 1.2029431617488484e-10

We O 0 5.484497231367236e-11
have O 0 3.319595642749425e-14
found O 0 4.448016492619982e-15
a O 0 6.322699139998998e-16
direct O 0 1.2868463347866232e-13
progression O 0 7.162676007865798e-11
of O 0 7.663421980330654e-12
the O 0 2.0853005086585163e-11
size O 0 4.602677267095956e-11
heterogeneity O 0 3.1083009499610625e-09
over O 0 2.5270605920335587e-12
time O 0 4.621596941950523e-12
related O 0 1.209403271973386e-10
to O 0 9.186275351513729e-11
initial O 0 4.3906700497586826e-09
CTG O 0 4.3455247578094713e-07
repeat O 0 6.113569372967476e-11
size O 0 2.1771404395010824e-13
and O 0 1.712148184459996e-14
the O 0 2.2191577460188572e-13
time O 0 1.4407055192941498e-12
interval O 0 6.77086095524082e-11
and O 0 1.9071307643466102e-14
always O 0 2.1599834822225855e-13
biased O 0 1.3341748712758505e-11
towards O 0 5.7842158146526046e-11
further O 0 3.042352134108306e-11
expansion O 0 3.5494798211743728e-09
. O 0 2.9739488649482837e-09

Attempts O 0 6.575645983275535e-08
to O 0 9.943005446766406e-11
mathematically O 0 2.4530646403064793e-09
model O 0 2.420841652139849e-11
the O 0 1.1792166201840537e-11
dynamics O 0 7.425638992586414e-10
have O 0 5.8643736568220195e-12
proved O 0 1.6413379100299608e-08
only O 0 6.720896408851651e-12
partially O 0 1.1298363633560626e-10
successful O 0 1.755801407044011e-11
suggesting O 0 1.6554798981313623e-12
that O 0 1.3317257137524023e-16
individual O 0 2.3147066284778502e-15
specific O 0 1.2082163340556423e-13
genetic O 0 1.5422156607325377e-11
and O 0 7.048676421185507e-13
/ O 0 5.803579838925543e-10
or O 0 1.221368275614032e-12
environmental O 0 3.5505240240929492e-12
factors O 0 1.228084149131059e-12
also O 0 1.3701039983809744e-14
play O 0 4.296146494109365e-10
a O 0 3.348134269831604e-10
role O 0 4.905427175572186e-10
in O 0 2.2732564441962921e-10
somatic O 0 6.93925557015973e-08
mosaicism O 0 3.007552322742413e-07
. O 0 3.012039229144392e-11
. O 0 7.975167748419665e-10

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 1.4635837680687658e-11
Palestinian O 0 6.851989837741712e-07
Arabs O 0 7.94844794427263e-08
. O 0 1.8706192150830248e-09

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 2.7195776297617158e-08
AGU B-Disease 1 1.0
) O 0 1.5826605976286545e-13
is O 0 5.214322541319738e-15
a O 0 1.0381169665216183e-12
rare O 0 1.4066098508180858e-08
disorder B-Disease 1 0.676874577999115
of I-Disease 0 8.87459261633694e-09
glycoprotein I-Disease 0 5.94987481505882e-09
metabolism I-Disease 0 0.002173504326492548
caused O 0 2.2315583408927253e-11
by O 0 1.62152016955423e-15
the O 0 3.534537246219216e-12
deficiency B-Disease 0 5.232112016528845e-06
of I-Disease 0 3.583567442788649e-09
the I-Disease 0 4.711119272471365e-10
lysosomal I-Disease 0 4.750338078451932e-08
enzyme I-Disease 0 9.93719950076466e-12
aspartylglucosaminidase I-Disease 0 6.624449433445534e-09
( O 0 2.6816634511399838e-14
AGA O 0 2.9529306289077795e-07
) O 0 6.384622648278326e-13
. O 0 2.2913873576335675e-10

AGU B-Disease 1 1.0
is O 0 2.9770064191581014e-10
inherited O 0 1.1560682651179377e-06
as O 0 8.697220894859914e-12
an O 0 1.829008678452121e-13
autosomal O 0 1.3731088266411007e-08
recessive O 0 1.1074557937362783e-09
trait O 0 4.141400417045915e-11
and O 0 4.976392680501899e-16
occurs O 0 2.2338034200153345e-14
with O 0 8.91282610163355e-17
a O 0 9.311141267731582e-13
high O 0 1.5035363579163352e-11
frequency O 0 6.265033630770134e-11
in O 0 4.882813337686587e-12
Finland O 0 2.080674077475919e-09
because O 0 4.2351129656177655e-13
of O 0 1.3384491431844836e-11
a O 0 1.5984651102751712e-11
founder O 0 4.569292166856087e-10
effect O 0 4.553985313848763e-11
. O 0 9.835197101182303e-10

While O 0 4.819476817630175e-09
very O 0 1.2914584679446506e-10
few O 0 1.6158364576912554e-11
patients O 0 1.4988919827541025e-11
with O 0 1.2008008519817648e-12
AGU B-Disease 1 1.0
have O 0 2.6544697971815634e-13
been O 0 1.4554639977504107e-14
reported O 0 3.212262338178791e-14
from O 0 9.299795634097607e-14
non O 0 7.21341666953812e-11
- O 0 1.0216326482709315e-12
Finnish O 0 2.5511129320143766e-10
origin O 0 2.3807476823289875e-11
, O 0 1.7244951126815788e-13
we O 0 5.725226716324361e-12
diagnosed O 0 0.00017775989545043558
the O 0 4.066708775285477e-11
disorder O 0 3.570522544293908e-09
in O 0 7.920774496364413e-14
8 O 0 8.809800111642119e-12
patients O 0 2.2423505923168524e-13
originating O 0 2.5215168841796753e-10
from O 0 1.245315656150936e-11
3 O 0 1.6195052243705987e-11
unrelated O 0 8.370455717443548e-11
families O 0 2.00443004208517e-12
, O 0 1.1021763810328301e-14
all O 0 1.0778074125469134e-14
Palestinian O 0 3.746647792013391e-08
Arabs O 0 2.625446970938583e-09
from O 0 3.450018049022674e-13
the O 0 5.114000043750233e-13
region O 0 8.644072263530589e-11
of O 0 5.109364320521337e-11
Jerusalem O 0 8.465697646897752e-06
. O 0 1.7566475207786425e-07

The O 0 1.4128680170255592e-10
clinical O 0 9.098226172454815e-09
diagnosis O 1 0.8562972545623779
of O 0 1.3819540981785394e-05
AGU B-Disease 1 1.0
is O 0 1.371160268659466e-10
often O 0 1.3568500706676034e-12
difficult O 0 3.040174112456384e-09
, O 0 5.198000301129442e-14
in O 0 6.232284111527819e-14
particular O 0 3.0806252188965433e-13
early O 0 1.0342714532041164e-11
in O 0 1.134730601582562e-13
the O 0 1.0834890927166607e-12
course O 0 5.55679613434279e-10
of O 0 6.7207810497404985e-12
the O 0 4.701787570393634e-12
disease O 0 1.3599079327908381e-11
, O 0 7.095689231564656e-16
and O 0 2.032756041874732e-15
most O 0 2.1620722654705146e-14
of O 0 7.221352422287497e-13
the O 0 1.2127167759584667e-12
patients O 0 6.471339306438062e-13
are O 0 1.3840033855289438e-14
diagnosed O 0 3.647834638520475e-12
after O 0 9.467493927500445e-14
the O 0 2.267627817291451e-13
age O 0 1.705553753783562e-11
of O 0 9.150981188088547e-12
5 O 0 1.4089599278954701e-11
years O 0 3.425688205327404e-11
. O 0 4.17221412973845e-09

However O 0 1.0408902628711303e-09
, O 0 1.9535349900234866e-13
since O 0 3.387195038340174e-13
these O 0 1.162983419419547e-13
patients O 0 1.3544550138584743e-13
excrete O 0 6.64365090718988e-11
early O 0 1.9619039465929022e-12
large O 0 6.44022909071615e-15
amounts O 0 9.892828743696125e-13
of O 0 8.282413643811992e-10
aspartylglucosamine O 0 3.6142848784948e-06
in O 0 1.9572499176945257e-09
urine O 0 1.7653679407203526e-08
, O 0 1.0634204020837368e-12
biochemical O 0 1.2928849831006506e-11
screening O 0 6.314399697560091e-11
is O 0 1.3728434892796432e-13
easy O 0 8.64334714911763e-11
by O 0 4.578140167313394e-13
urine O 0 3.909441104177347e-10
chromatography O 0 2.658983866421494e-10
. O 0 3.080534438648641e-11
. O 0 6.114563300130271e-10

Detection O 0 9.78479430813195e-09
of O 0 7.03261884490991e-12
heterozygous O 0 2.7662715393621425e-14
carriers O 0 6.755661089779218e-16
of O 0 9.860760482888892e-14
the O 0 1.6574949190939492e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.5265831014051905e-12
ATM O 0 1.16576464037621e-08
) O 0 1.6058654125021945e-16
gene O 0 2.7422021651061806e-17
by O 0 9.969561907315354e-17
G2 O 0 1.312648861134802e-11
phase O 0 4.9102735766304306e-11
chromosomal O 0 3.1496889540960638e-09
radiosensitivity O 0 5.9211789249502544e-08
of O 0 1.1490945972525424e-09
peripheral O 0 4.866018912252912e-07
blood O 0 6.189254122546117e-07
lymphocytes O 0 7.890862185888636e-09
. O 0 1.8750210273310586e-08

In O 0 4.2845394432333705e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.823063282088924e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.6384723941265398e-14
patients O 0 1.3871852647953046e-14
, O 0 2.2717529524478742e-17
mutations O 0 9.792222986662355e-17
in O 0 2.8973717519876964e-16
a O 0 1.2718916504654934e-15
single O 0 1.471674344888374e-14
gene O 0 1.0570090267468524e-14
, O 0 8.481230786574166e-15
ATM O 0 8.289209318945723e-10
, O 0 3.290652272831861e-15
result O 0 1.9920042449318026e-13
in O 0 2.737464118232613e-12
an O 0 2.0719941318247947e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 7.870389995105753e-13
embraces O 0 1.7711789066648942e-12
a O 0 8.836594989265235e-15
variety O 0 3.6427136399517016e-14
of O 0 1.7215012239075317e-13
clinical O 0 4.5718005770023495e-11
features O 0 1.1952755408703442e-12
and O 0 1.5714798982501693e-13
manifests O 0 2.3193341344707186e-11
extreme O 0 1.0228425051383994e-10
radiosensitivity O 0 1.6494605858952127e-07
and O 0 8.533667479257434e-13
a O 0 2.137273864832867e-11
strong O 0 1.708451609350181e-11
pre O 0 3.651479971722438e-07
- O 0 5.27745633860377e-08
disposition O 0 1.0991989540798386e-07
to O 0 1.5013148058073966e-08
malignancy B-Disease 0 0.0023860253859311342
. O 0 3.1828619739826536e-09

Heterozygotes O 0 1.3078900629182044e-08
for O 0 3.2397762857877543e-12
the O 0 1.5654713636514828e-11
ATM O 0 9.227640873632481e-09
gene O 0 2.80250811706545e-13
have O 0 3.844787579672729e-14
no O 0 4.276734572223901e-15
clinical O 0 7.40207930214655e-14
expression O 0 5.4208611070024476e-14
of O 0 1.1517645170933122e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 2.588342040699132e-11
may O 0 9.781957145335585e-13
be O 0 3.5775026062216664e-13
cancer B-Disease 0 1.9875744106112592e-10
prone O 0 2.992385202474357e-12
with O 0 5.312317477053482e-16
a O 0 8.118612119384361e-13
moderate O 0 4.138816026011405e-12
increase O 0 7.478245453440557e-13
in O 0 4.796696351748453e-13
in O 0 7.14575551508112e-11
vitro O 0 2.7495051568848794e-08
radiosensitivity O 0 3.5758380363404285e-06
. O 0 3.998690800699478e-08

We O 0 8.640083093425233e-11
performed O 0 1.2415003747268116e-10
a O 0 1.7608118088596747e-11
blind O 0 7.078745922761698e-10
chromosomal O 0 2.5403736891860262e-09
analysis O 0 4.538807697740399e-12
on O 0 3.047490428412236e-12
G2 O 0 2.8941551932781806e-10
- O 0 1.1285106963493385e-12
phase O 0 4.890029353665781e-11
lymphocytes O 0 6.822435953852957e-13
from O 0 6.377426256358454e-14
7 O 0 3.6465183086628605e-13
unrelated O 0 4.762090166643418e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.368917944612804e-08
, O 0 6.053844000397787e-15
13 O 0 4.384928563912899e-13
obligate O 0 5.246434042760484e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 2.7194065665980816e-08
( O 0 2.085451232072843e-15
parents O 0 3.783575473189976e-15
of O 0 5.5456221144628386e-15
the O 0 3.633884422619407e-15
patients O 0 7.170735821295795e-16
) O 0 1.5195372993072357e-18
, O 0 2.1956936951236233e-17
and O 0 5.042202905338822e-16
14 O 0 4.742558884669734e-13
normal O 0 3.0901695091678505e-10
controls O 0 5.67190305139631e-12
following O 0 1.7611023858839225e-13
X O 0 8.856287231351345e-11
- O 0 2.6471009412221136e-11
irradiation O 0 5.338676983129842e-12
with O 0 1.7546270561713886e-14
1 O 0 5.780228184114333e-13
Gy O 0 2.6515933546078507e-11
in O 0 3.726236107221188e-16
order O 0 4.287532124719025e-15
to O 0 1.0755223209431286e-13
evaluate O 0 2.827481304645829e-12
this O 0 4.4370713022821515e-14
cytogenetic O 0 6.5265504112232975e-09
method O 0 1.3293798006852597e-10
as O 0 2.2049393832036107e-13
a O 0 1.2676647925813356e-12
tool O 0 8.831731457270564e-10
for O 0 1.4791210519848191e-13
detection O 0 8.203836721065727e-09
of O 0 5.223393939601806e-10
ATM O 0 1.804936800908763e-06
carriers O 0 7.246157007756437e-10
. O 0 1.6999020857610958e-08

Both O 0 2.729378145716055e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 1.8372547856415622e-06
and O 0 1.5564307655202558e-13
heterozygotes O 0 1.3621827277265908e-10
showed O 0 3.2490880103562547e-13
significantly O 0 1.746714345428682e-13
increased O 0 4.488483491675056e-14
levels O 0 2.047424946596821e-12
of O 0 1.072823080372487e-11
radiation O 0 4.880588676314801e-06
- O 0 3.924993734472082e-07
induced O 0 5.3035716263138966e-08
chromatid O 0 3.828287390206242e-06
damage O 0 4.913979445575478e-09
relative O 0 2.952125349731105e-11
to O 0 2.0814080981760436e-13
that O 0 7.405733571687594e-15
of O 0 2.839733873397088e-12
normal O 0 8.173287824320141e-09
controls O 0 5.92132254340072e-09
. O 0 2.3869792808994816e-09

These O 0 1.688220418495645e-13
results O 0 1.4064292265525413e-13
show O 0 1.961222254476952e-13
that O 0 9.871810996479758e-17
the O 0 1.0467055146885437e-13
G2 O 0 4.746876225425467e-09
- O 0 1.1297156959910737e-10
phase O 0 3.267882853208448e-09
chromosomal O 0 2.3583598363074998e-07
radiosensitivity O 0 1.2185208220216737e-07
assay O 0 1.0816457104989574e-11
can O 0 6.367942451964521e-15
be O 0 1.9866739555331908e-16
used O 0 2.355376015467759e-16
for O 0 1.2899651365681932e-16
the O 0 4.961759127546897e-16
detection O 0 2.4790494310145128e-11
of O 0 1.3732855130843546e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.4424605069507379e-05
. O 0 1.3385686337130664e-08

In O 0 1.5336361347539906e-10
combination O 0 4.092089861407189e-11
with O 0 1.261951562128369e-13
molecular O 0 2.9554423144895203e-12
genetic O 0 5.229719001603739e-12
analyses O 0 2.8594267578729848e-11
, O 0 9.445448200982257e-15
this O 0 3.20342744572575e-14
test O 0 6.409134290993879e-13
may O 0 1.3992201630197779e-14
be O 0 8.427726256394954e-15
of O 0 6.16287281081894e-14
value O 0 4.863997117403318e-13
in O 0 9.460489981466189e-14
studies O 0 1.4420807430137739e-11
of O 0 1.3156165393213293e-11
familial B-Disease 0 1.1896624130258715e-08
and I-Disease 0 4.3598824550628024e-10
sporadic I-Disease 0 1.8587820704851765e-06
cancers I-Disease 0 4.605402068591502e-07
aimed O 0 2.4200224046921903e-09
at O 0 3.0376365485473844e-12
determination O 0 2.9195151851624246e-10
of O 0 1.5882265988476085e-11
the O 0 1.0134038790424182e-12
potential O 0 2.1767969371477847e-12
involvement O 0 2.849013802652678e-10
of O 0 1.1851169823273722e-08
ATM O 0 1.941088521562051e-05
mutations O 0 7.314116867718212e-09
in O 0 9.862548555616968e-10
tumor B-Disease 0 2.0558429980610526e-07
risk O 0 3.8716238548452964e-11
or O 0 5.002599896830606e-13
development O 0 9.047931848193969e-10
. O 0 7.430449484868706e-12
. O 0 4.095144778837323e-10

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 9.383829433981528e-13
identification O 0 8.375358739876049e-11
and O 0 3.6351721244574703e-16
detection O 0 1.001750678936153e-11
of O 0 9.621140689697327e-13
founder O 0 1.3885725902440527e-10
- O 0 2.1300544661428944e-11
effect O 0 2.4084824846309916e-13
mutations O 0 1.6846050108262206e-13
in O 0 1.9075564831059003e-14
the O 0 6.004413546228937e-13
ATM O 0 2.131357090817687e-09
gene O 0 1.2025399935815945e-13
in O 0 2.390482560163387e-13
ethnic O 0 7.097750859275109e-11
populations O 0 5.714731205613832e-12
. O 0 6.353784165469278e-11

To O 0 1.7313091932313895e-11
facilitate O 0 4.984045398614967e-10
the O 0 1.3922309485825402e-12
evaluation O 0 1.7757312287258742e-09
of O 0 2.957097344769011e-10
ATM O 0 1.1420251411209392e-07
heterozygotes O 0 4.5437347218069135e-09
for O 0 7.776564114880813e-12
susceptibility O 0 4.968394029525314e-10
to O 0 2.425210587908566e-10
other O 0 8.605610668510622e-11
diseases O 0 1.3509115888155065e-06
, O 0 2.866484176758388e-13
such O 0 1.111623054890487e-12
as O 0 1.3007841470624726e-09
breast B-Disease 0 4.027602358291915e-07
cancer I-Disease 0 3.772606405050283e-08
, O 0 2.7533934333912047e-12
we O 0 2.422891531503324e-12
have O 0 6.957166098645398e-14
attempted O 0 3.6080982646069515e-10
to O 0 1.299136492827202e-11
define O 0 4.5853912333804203e-10
the O 0 4.811432936097093e-12
most O 0 2.6555523052881544e-14
common O 0 2.847524868893406e-14
mutations O 0 5.661302674618779e-15
and O 0 2.9517687372559596e-16
their O 0 4.714588433736046e-14
frequencies O 0 2.4887283206487254e-11
in O 0 9.778371445889888e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 7.463939688534538e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 9.158580164603854e-15
homozygotes O 0 6.138436425828786e-10
from O 0 7.739028330937953e-15
10 O 0 1.3446497265797407e-14
ethnic O 0 1.8330843299437655e-13
populations O 0 3.645827671878987e-14
. O 0 3.8597068249823785e-12

Both O 0 5.366000976891883e-10
genomic O 0 3.652003144338778e-09
mutations O 0 4.380349815508167e-12
and O 0 6.442504814135538e-14
their O 0 2.381845588816933e-12
effects O 0 7.095297006182166e-12
on O 0 3.296002793612418e-12
cDNA O 0 7.764453080483236e-09
were O 0 7.865370160731189e-11
characterized O 0 2.7647317768497714e-10
. O 0 2.2807320476658788e-09

Protein O 0 2.7911033484429026e-09
- O 0 3.066155315756269e-11
truncation O 0 3.139180027034172e-10
testing O 0 3.5318952623653033e-12
of O 0 5.025207138430188e-13
the O 0 1.9208873586803316e-13
entire O 0 1.3219257632979264e-10
ATM O 0 2.035251828180762e-10
cDNA O 0 2.2284289691310022e-10
detected O 0 1.1389534280981106e-11
92 O 0 3.731978268084468e-11
( O 0 2.9079145063843747e-15
66 O 0 3.475033871769284e-10
% O 0 1.1867935453824252e-11
) O 0 2.1963407621208766e-15
truncating O 0 3.9556427577913666e-11
mutations O 0 4.489855752812244e-13
in O 0 1.4111422533963358e-13
140 O 0 1.9983756403135766e-12
mutant O 0 2.6849776742221554e-12
alleles O 0 2.277138113487842e-12
screened O 0 1.1917125064542233e-09
. O 0 1.0088966995169812e-08

The O 0 2.2741812877313805e-09
haplotyping O 0 0.0016989479772746563
of O 0 1.7020953535507033e-08
patients O 0 7.728603312884275e-10
with O 0 2.305052849982392e-12
identical O 0 3.5062389103224234e-10
mutations O 0 7.637025560558452e-12
indicates O 0 3.957731278120269e-12
that O 0 1.1361269015147928e-14
almost O 0 2.3145157665438454e-12
all O 0 1.398399218687299e-13
of O 0 1.4828619018456002e-12
these O 0 1.7847290485761835e-13
represent O 0 7.191433212816456e-12
common O 0 2.715622214946589e-12
ancestry O 0 3.334119091924492e-11
and O 0 4.460254865099045e-13
that O 0 1.869737952788983e-13
very O 0 5.2722968352236776e-11
few O 0 7.943727342585305e-10
spontaneously O 0 5.031463956584048e-07
recurring O 0 2.1175967503950233e-06
ATM O 0 1.0332858437323011e-05
mutations O 0 2.7560680848637276e-08
exist O 0 4.3808100258502236e-08
. O 0 3.226105960152381e-08

Assays O 0 4.940827746935383e-10
requiring O 0 2.110376456920804e-11
minimal O 0 9.238127623989456e-11
amounts O 0 7.991951284785914e-13
of O 0 1.334199677821557e-12
genomic O 0 9.057113392607619e-11
DNA O 0 8.191403111368345e-10
were O 0 3.124470083701314e-12
designed O 0 2.982846174920395e-12
to O 0 3.4772447508185644e-12
allow O 0 2.312152205807827e-11
rapid O 0 5.3124626225864446e-11
screening O 0 7.25002046245149e-12
for O 0 1.855884695055321e-13
common O 0 2.1563181795691833e-11
ethnic O 0 4.896555938493918e-10
mutations O 0 3.839022877372145e-09
. O 0 3.771583045875104e-09

These O 0 2.728750836400451e-10
rapid O 0 2.267994403393203e-10
assays O 0 2.7810464001132296e-11
detected O 0 3.091581244479835e-12
mutations O 0 1.2309979797390635e-14
in O 0 2.971711333905674e-15
76 O 0 1.4475150245107926e-11
% O 0 6.589092552827802e-12
of O 0 2.122165724399716e-12
Costa O 0 7.285250736011051e-10
Rican O 0 1.879834314877371e-07
patients O 0 1.5117188612023824e-09
( O 0 2.081317578941344e-16
3 O 0 1.1362346652815073e-15
) O 0 1.1759779648458394e-18
, O 0 8.73536124273229e-19
50 O 0 7.359094243545878e-16
% O 0 3.3717623690917436e-14
of O 0 3.3747492105516697e-13
Norwegian O 0 3.2554721656197216e-06
patients O 0 3.1648161868957914e-09
( O 0 2.7032772755583665e-15
1 O 0 1.1132515062247696e-14
) O 0 2.843422767739192e-17
, O 0 1.2980203371785203e-17
25 O 0 4.188355578023861e-15
% O 0 1.6053533556745908e-13
of O 0 3.127747897919281e-13
Polish O 0 1.2058623610755603e-07
patients O 0 3.50146245331473e-09
( O 0 4.751988665302291e-15
4 O 0 5.5176444468084396e-14
) O 0 7.000161517517806e-17
, O 0 3.6399163030554824e-17
and O 0 2.0483374246977118e-17
14 O 0 3.444392987923253e-15
% O 0 1.5321545302014045e-13
of O 0 2.6276409433728665e-13
Italian O 0 7.728928053118977e-10
patients O 0 5.341605491260282e-10
( O 0 2.761878614739445e-15
1 O 0 3.936692009702536e-14
) O 0 1.6191465714777867e-15
, O 0 1.8923461430654653e-15
as O 0 2.6387325179446416e-15
well O 0 4.058814170719051e-14
as O 0 7.641516203984143e-15
in O 0 1.1567758198809813e-13
patients O 0 1.6654656169803883e-12
of O 0 1.4235419787400616e-10
Amish O 0 5.636497917294037e-07
/ O 0 1.5658044860700215e-09
Mennonite O 0 1.3592928560512973e-08
and O 0 9.797249816978493e-13
Irish O 0 4.9051533668187375e-11
English O 0 5.483451193111222e-11
backgrounds O 0 3.314751140237604e-09
. O 0 8.810699947403577e-10

Additional O 0 1.3340668569838954e-09
mutations O 0 9.224024322129765e-11
were O 0 4.648224079945029e-12
observed O 0 1.0088293048160502e-12
in O 0 4.377307706842498e-13
Japanese O 0 4.886274718174377e-10
, O 0 1.4014591082685962e-13
Utah O 0 5.730418917160307e-11
Mormon O 0 1.5218000470884618e-10
, O 0 1.1596220919881457e-15
and O 0 2.7612465164025563e-15
African O 0 1.4819465099513707e-11
American O 0 5.2842543708797596e-12
patients O 0 1.3058889039574417e-11
. O 0 1.087216983108874e-09

These O 0 5.171953902476101e-13
assays O 0 5.3970913296234185e-14
should O 0 2.1441207574061753e-15
facilitate O 0 1.3384562555507351e-12
screening O 0 7.513588817960326e-13
for O 0 1.198298404947451e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 6.389803530737481e-08
in O 0 3.788388331336934e-13
the O 0 9.97265827860569e-14
populations O 0 3.1736200598503394e-15
studied O 0 7.0291219710311246e-15
. O 0 7.226267788361732e-14
. O 0 5.130516150808617e-11

The O 0 2.0062088879058138e-08
von B-Disease 1 0.9992190599441528
Hippel I-Disease 1 0.9998500347137451
- I-Disease 1 0.9684491753578186
Lindau I-Disease 0 0.00011154601816087961
tumor I-Disease 0 2.007532140524404e-09
suppressor O 0 6.173490538219362e-12
gene O 0 1.5768316641691588e-15
is O 0 5.015554388550365e-17
required O 0 2.6637259021786153e-13
for O 0 5.5890130712518346e-14
cell O 0 5.358082380557683e-11
cycle O 0 3.63239716083541e-10
exit O 0 1.0275236217438533e-10
upon O 0 7.01089620386286e-12
serum O 0 1.7463880341850313e-09
withdrawal O 0 3.160611772301536e-09
. O 0 2.4824160504977044e-09

The O 0 2.9601938955625684e-11
inactivation O 0 3.4281999461427404e-10
of O 0 8.706652759871147e-11
the O 0 1.5622902971301755e-09
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 1.0651272086548147e-09
VHL I-Disease 0 0.00014489429304376245
) I-Disease 0 1.53322025214786e-11
tumor I-Disease 0 3.1154769875030297e-09
suppressor O 0 1.4807076675893427e-09
gene O 0 8.436230013175727e-12
predisposes O 0 1.2947772631832777e-08
affected O 0 2.024603401595826e-11
individuals O 0 6.031323935429137e-15
to O 0 5.554965125040279e-13
the O 0 3.560221345164094e-12
human O 0 1.9677392160133422e-08
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 0 0.00019362148304935545
and O 0 8.243937047499716e-15
is O 0 2.353786240504881e-16
associated O 0 2.544676275251234e-12
with O 0 7.331676932231801e-12
sporadic B-Disease 1 1.0
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 4.905275144406751e-11
RCC B-Disease 0 2.398221795374411e-06
) O 0 1.2718019345991927e-11
and O 0 8.408976293061698e-10
brain B-Disease 1 0.6282864212989807
hemangioblastomas I-Disease 0 1.7646023479755968e-05
. O 0 9.180889826154726e-09

VHL O 0 6.241571099963039e-05
- O 0 4.4911351437804115e-07
negative O 0 2.788494712913092e-10
786 O 0 2.735179407409305e-07
- O 0 1.7205577762524626e-07
0 O 0 4.664299328716037e-12
RCC B-Disease 0 1.1613062511628414e-08
cells O 0 2.676727728356809e-10
are O 0 6.839765299276879e-13
tumorigenic O 0 6.05555072752395e-08
in O 0 5.364278812813872e-11
nude O 0 4.303160938690098e-09
mice O 0 5.564833316373807e-11
which O 0 1.7939017716499077e-14
is O 0 1.951440031905372e-15
suppressed O 0 2.067082399345721e-13
by O 0 3.7030980258383975e-15
the O 0 3.535534929058337e-12
reintroduction O 0 1.5404861386514312e-08
of O 0 3.919819469011543e-10
VHL B-Disease 0 4.832581907976419e-06
. O 0 9.872984207959234e-08

Remarkably O 0 3.335680105465144e-07
, O 0 1.522258474872043e-14
this O 0 8.202431480172189e-16
occurs O 0 1.5998748143343858e-14
without O 0 2.2863447043269293e-14
affecting O 0 6.444179499916214e-13
the O 0 1.6659507703475213e-13
growth O 0 4.176366197317094e-11
rate O 0 8.066552634189428e-12
and O 0 8.224560491204916e-14
cell O 0 9.374881981827343e-10
cycle O 0 5.271055592004359e-09
profile O 0 6.819008552261252e-11
of O 0 3.8168090216172956e-11
these O 0 2.229247385646116e-12
cells O 0 6.377484651487464e-11
in O 0 6.4169659169666105e-12
culture O 0 5.3994524407130484e-09
. O 0 1.3260377240698062e-09

The O 0 1.6744025055359657e-09
786 O 0 5.440920745058975e-07
- O 0 2.9786734856429575e-08
0 O 0 3.5291124948592933e-13
cell O 0 7.59103283703988e-12
line O 0 3.8337066160520905e-11
, O 0 4.795602815272889e-15
like O 0 1.0467928776667235e-14
many O 0 7.10730370498576e-14
cancer B-Disease 0 4.0704783293987745e-12
cells O 0 1.114616753929154e-12
, O 0 1.973328633811844e-15
fails O 0 3.665067815211698e-12
to O 0 1.466999091648269e-11
exit O 0 8.629868375464866e-08
the O 0 8.791374572769683e-11
cell O 0 4.5546044713518086e-10
cycle O 0 2.5098137457213454e-10
upon O 0 1.5035306333288645e-11
serum O 0 1.4299214035062846e-09
withdrawal O 0 6.481135628177981e-09
. O 0 3.3727742820843787e-09

Here O 0 9.79723235872143e-09
, O 0 1.3194123799162988e-13
it O 0 1.6819568967831104e-16
is O 0 4.372956896300891e-18
shown O 0 8.429811122115502e-16
that O 0 3.81513797221259e-17
reintroduction O 0 3.330064349271744e-11
of O 0 1.748500839558395e-13
the O 0 5.453552106432502e-13
wild O 0 9.423226088323133e-11
- O 0 2.98453373126506e-10
type O 0 5.899649518914529e-11
VHL B-Disease 0 6.24148626116039e-08
gene O 0 3.4085839619585334e-12
restores O 0 8.866547079877662e-11
the O 0 1.2501002837062014e-13
ability O 0 8.719449468008733e-11
of O 0 6.932132090575749e-10
VHL O 0 0.0014197924174368382
- O 0 3.925453256670153e-06
negative O 0 1.4339163190157933e-10
RCC B-Disease 0 1.8463177653416096e-08
cancer I-Disease 0 1.2637376388402455e-11
cells O 0 1.0356679977594624e-13
to O 0 1.981817623420215e-13
exit O 0 2.2402467381166247e-10
the O 0 1.3849315574562815e-12
cell O 0 5.118874768506032e-11
cycle O 0 3.552966254538603e-10
and O 0 4.3240497987762083e-13
enter O 0 4.682903522734705e-07
G0 O 0 0.03136518597602844
/ O 0 3.6592047081285273e-07
quiescence O 0 1.8455064036970725e-06
in O 0 4.7232093236537764e-11
low O 0 1.509347646866388e-09
serum O 0 1.4231138489861905e-09
. O 0 2.803250132021873e-10

Both O 0 4.098983819034174e-09
VHL O 0 1.838518414842838e-06
- O 0 1.0541808537212205e-09
positive O 0 7.244391176351728e-13
and O 0 6.889843919997626e-14
VHL O 0 3.593630637510614e-08
- O 0 1.20617807408685e-10
negative O 0 1.499774154693767e-13
RCC B-Disease 0 2.2777442432175832e-10
cells O 0 3.9193766288025955e-11
exit O 0 6.842320043887185e-10
the O 0 5.099525944747552e-13
cell O 0 5.721646247069945e-12
cycle O 0 4.513384457838221e-12
by O 0 6.601108175970528e-15
contact O 0 3.0866587064082296e-10
inhibition O 0 3.394136527390401e-08
. O 0 1.7283480202578971e-09

The O 0 1.0163772046212216e-08
cyclin O 0 6.262694682845904e-07
- O 0 1.1911545527709677e-07
dependent O 0 7.344648889073824e-09
kinase O 0 5.549721238118366e-10
inhibitor O 0 7.362173370939473e-11
, O 0 9.994137678895343e-14
p27 O 0 2.644533758644485e-10
, O 0 2.4220930420142768e-15
accumulates O 0 6.494706438235284e-14
upon O 0 2.0539361769537912e-13
serum O 0 4.4289103634520544e-11
withdrawal O 0 7.68723001920435e-11
, O 0 9.402452808579629e-15
only O 0 7.299266612415412e-15
in O 0 5.326344427363308e-14
the O 0 1.6273848588155282e-12
presence O 0 9.226835441522585e-12
of O 0 3.024567818421531e-10
VHL B-Disease 0 4.592556706484174e-06
, O 0 2.1854666513998477e-12
as O 0 5.103162087783525e-14
a O 0 9.644580056464291e-14
result O 0 3.688411338506614e-13
of O 0 5.600092329964557e-13
the O 0 1.7203426183609594e-13
stabilization O 0 1.510228830881033e-09
of O 0 1.5698638569650036e-11
the O 0 8.525167377593235e-11
protein O 0 6.538370955766482e-10
. O 0 7.468008988986696e-10

We O 0 3.392384290146211e-11
propose O 0 6.248406739933765e-12
that O 0 8.24059931417106e-16
the O 0 4.7347471402543403e-14
loss O 0 4.52668675113288e-12
of O 0 3.4046333460824307e-12
wild O 0 5.846861189651165e-12
- O 0 1.0591130836928864e-12
type O 0 9.052539940530499e-14
VHL B-Disease 0 1.370085850327385e-10
gene O 0 7.935045307459754e-15
results O 0 2.2396320908946166e-13
in O 0 6.272831917526062e-14
a O 0 3.438692202078347e-13
specific O 0 7.859712880531333e-12
cellular O 0 1.8562495984753014e-09
defect O 0 4.109881324154685e-09
in O 0 3.791413710763081e-11
serum O 0 2.934087994788115e-08
- O 0 1.7037803390351769e-09
dependent O 0 2.48552400883284e-09
growth O 0 8.784228552882745e-12
control O 0 1.5121412802465706e-11
, O 0 4.685281432574226e-15
which O 0 2.9863027469715503e-15
may O 0 2.3553717570096167e-12
initiate O 0 5.27928589733051e-09
tumor B-Disease 0 1.3971568080251018e-07
formation O 0 2.8051998057776473e-08
. O 0 4.9128857426694594e-08

This O 0 3.268353296337345e-11
is O 0 4.146919149760654e-14
corrected O 0 1.3681082308703019e-11
by O 0 2.298567897975577e-16
the O 0 5.047375142624641e-14
reintroduction O 0 6.257441231838357e-10
of O 0 3.2416183452788072e-12
wild O 0 2.168875218311328e-10
- O 0 2.846342939122337e-09
type O 0 1.7435889398953464e-09
VHL B-Disease 0 3.5156637750333175e-05
, O 0 6.235837540780054e-11
implicating O 0 8.653454642626457e-06
VHL B-Disease 1 0.8493611216545105
as O 0 5.134645313098485e-12
the O 0 6.644572479036492e-12
first O 0 7.294754210407373e-12
tumor B-Disease 0 1.1803688235167975e-11
suppressor O 0 1.6380101485261034e-12
involved O 0 1.5084638995809668e-13
in O 0 2.909348922799232e-13
the O 0 1.0405478562125481e-11
regulation O 0 1.6041926120813343e-10
of O 0 8.574514015480261e-11
cell O 0 9.15276604507298e-11
cycle O 0 2.0304526948677903e-09
exit O 0 1.4414799354156571e-09
, O 0 3.733494226667092e-15
which O 0 8.143257758477004e-16
is O 0 2.504055126364155e-15
consistent O 0 9.46113604127774e-11
with O 0 2.1494286046668497e-14
its O 0 7.972281146871596e-13
gatekeeper O 0 3.0733762756973704e-10
function O 0 7.8455584043291e-12
in O 0 1.3155908654138848e-12
the O 0 2.664241917360588e-11
kidney O 0 5.030367233871402e-09
. O 0 4.5220983208027477e-11
. O 0 1.060042276179729e-09

Piebaldism B-Disease 1 1.0
with O 0 0.0023084646090865135
deafness B-Disease 1 1.0
: O 0 5.486834944723462e-13
molecular O 0 9.940108496508601e-14
evidence O 0 1.7039482279042166e-14
for O 0 6.67731488320205e-15
an O 0 1.3774387446624514e-13
expanded O 0 1.9370807180507654e-08
syndrome O 0 0.0004616987134795636
. O 0 4.618044613380334e-09

In O 0 1.8184394962039718e-11
a O 0 2.0044070569991135e-12
South O 0 7.0702237467412665e-12
African O 0 1.0838197743792688e-12
girl O 0 9.53953843002564e-12
of O 0 3.947529152517615e-13
Xhosa O 0 3.9099711557355477e-07
stock O 0 5.120832685841237e-13
with O 0 3.841999570726841e-15
severe O 0 1.9093628900179738e-09
piebaldism B-Disease 0 0.03618663549423218
and O 0 1.8142700675127799e-09
profound O 0 0.00964169017970562
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 2.3252962055853033e-11
identified O 0 1.908062161775411e-14
a O 0 1.7269743156495123e-16
novel O 0 8.959971426082133e-17
missense O 0 2.8063929218696826e-12
substitution O 0 6.094018952657043e-12
at O 0 4.375607081524846e-12
a O 0 5.156469869149749e-13
highly O 0 7.290109488300445e-12
conserved O 0 1.0996105415106427e-10
residue O 0 2.415586175530393e-09
in O 0 3.547815903906515e-12
the O 0 4.4202936450021824e-11
intracellular O 0 1.147084427444156e-09
kinase O 0 2.3211318977978124e-10
domain O 0 2.490562478474345e-10
of O 0 1.2927277304175533e-10
the O 0 3.1678841772020405e-09
KIT O 1 0.7243309020996094
proto O 0 2.1638050384353846e-05
- O 0 1.9406390094900416e-07
oncogene O 0 1.1325781201776408e-07
, O 0 8.810601987568889e-13
R796G O 0 2.097190154870532e-08
. O 0 1.4260666258980592e-10

Though O 0 4.2390837506900425e-07
auditory B-Disease 0 0.0007773604593239725
anomalies I-Disease 0 5.586067786111926e-08
have O 0 4.657151834314144e-12
been O 0 1.319926481481437e-12
observed O 0 3.606682281390855e-13
in O 0 2.987918072683282e-13
mice O 0 9.091447213116499e-12
with O 0 9.255238312940242e-14
dominant O 0 1.333235655209819e-08
white O 0 8.443171856109544e-11
spotting O 0 5.421205969469156e-06
( O 0 1.3098272466649519e-12
W O 0 8.248428606805192e-09
) O 0 3.112635678175456e-14
due O 0 6.907783678400392e-09
to O 0 1.4508002577073853e-09
KIT O 0 0.49822482466697693
mutations O 0 1.2786780700935196e-07
, O 0 1.1570357172363543e-10
deafness B-Disease 1 1.0
is O 0 7.252561723923578e-13
not O 0 1.2571611503545133e-13
typical O 0 1.3749491128978164e-11
in O 0 3.043469068344379e-13
human O 0 8.822399061303443e-11
piebaldism B-Disease 0 4.77860066894209e-06
. O 0 1.1338162408947028e-08

Thus O 0 1.0437963687826013e-10
, O 0 4.085701961080218e-15
the O 0 5.959169433817279e-15
occurrence O 0 5.5956354133579467e-11
of O 0 8.126303796540668e-11
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 2.472007043508029e-09
this O 0 2.1217501713910458e-11
patient O 0 2.9670577106344354e-10
extends O 0 1.1625088099185416e-13
considerably O 0 2.810033835395215e-13
the O 0 2.6282409137500656e-14
phenotypic O 0 2.3806477622567712e-11
range O 0 6.574031596873198e-11
of O 0 1.1880013639498088e-10
piebaldism B-Disease 0 2.9063568263154593e-07
due O 0 3.3581340375121727e-08
to O 0 4.5162669159992674e-09
KIT O 0 6.258691428229213e-06
gene O 0 3.9378996591343807e-11
mutation O 0 2.1210247100333923e-12
in O 0 9.955211432771324e-14
humans O 0 2.1693374527287368e-11
and O 0 5.245540330225951e-13
tightens O 0 1.2282464108281932e-11
the O 0 4.404542865415334e-13
clinical O 0 1.788953533921056e-11
similarity O 0 1.3781889691977245e-11
between O 0 1.985944048099597e-11
piebaldism B-Disease 0 2.7951696068839738e-08
and O 0 1.7775565768667415e-14
the O 0 1.1835817529781256e-14
various O 0 5.818530878463901e-14
forms O 0 1.9049341964949562e-11
of O 0 2.0790831278816313e-09
Waardenburg B-Disease 1 0.9999982118606567
syndrome I-Disease 0 4.142799753026338e-06
. O 0 5.7584898655038685e-11
. O 0 2.4342718951686493e-09

Cycloheximide O 0 1.3958679119241424e-06
facilitates O 0 9.262192401937597e-11
the O 0 2.811400743284176e-13
identification O 0 1.2181177178050007e-09
of O 0 2.6507096517747186e-10
aberrant O 0 1.240996749807266e-09
transcripts O 0 3.789904501338981e-10
resulting O 0 2.7947175823550552e-11
from O 0 7.876727156803931e-13
a O 0 4.707599869820112e-13
novel O 0 1.232933026507066e-12
splice O 0 5.172618244841942e-08
- O 0 5.3889937651208086e-11
site O 0 8.46695456802049e-12
mutation O 0 2.603758408967899e-13
in O 0 4.376219777725045e-14
COL17A1 O 0 0.0002659349993336946
in O 0 1.3912645991862038e-12
a O 0 4.2957595813852834e-11
patient O 0 1.805544158628436e-08
with O 0 1.2649265315745062e-11
generalized O 0 3.6782093957299367e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999983310699463
epidermolysis I-Disease 1 0.9984948635101318
bullosa I-Disease 0 0.012594467028975487
. O 0 3.406861992516497e-08

Patients O 0 1.812744244489295e-06
with O 0 5.453123508303293e-10
generalized O 0 1.0699436643335503e-05
atrophic B-Disease 1 0.9999996423721313
benign I-Disease 1 0.9999938011169434
epidermolysis I-Disease 1 0.9201878309249878
bullosa I-Disease 0 8.00309790065512e-05
often O 0 4.982260264074778e-13
show O 0 4.763009648148242e-13
decreased O 0 1.619295149357658e-11
expression O 0 9.68879815786694e-13
of O 0 4.18707603311308e-12
type O 0 4.0945882101572906e-11
XVII O 0 1.618797362823443e-08
collagen O 0 2.107514385230047e-09
, O 0 9.326379078744562e-12
a O 0 1.935472476732869e-10
transmembrane O 0 4.743861747869005e-09
hemidesmosomal O 0 4.40643388444073e-09
protein O 0 4.1106647166028187e-13
encoded O 0 3.1050872593627044e-14
by O 0 3.0249555030975595e-13
COL17A1 O 0 0.001187040121294558
. O 0 1.6814441394785717e-08

This O 0 1.5346420315087705e-11
report O 0 3.450913328966604e-13
documents O 0 2.3231314875277187e-12
a O 0 3.5384409703513586e-13
novel O 0 3.858483357040837e-13
splice O 0 3.9140704899409684e-08
- O 0 3.095311854051097e-11
site O 0 6.460292370502607e-12
mutation O 0 3.3985721138371505e-13
in O 0 1.1477080950113988e-13
COL17A1 O 0 0.4801698625087738
in O 0 4.787375790932247e-12
a O 0 2.0627807795214892e-10
patient O 0 9.769114939217616e-08
with O 0 5.204486147603049e-11
generalized O 0 2.2102807633928023e-05
atrophic B-Disease 1 0.9999995231628418
benign I-Disease 1 0.9997419714927673
epidermolysis I-Disease 0 0.12034958600997925
bullosa I-Disease 0 0.00012388326285872608
, O 0 2.9664026226713935e-13
and O 0 1.5560649150496778e-14
applies O 0 2.753381561377416e-13
a O 0 1.2623199198164708e-13
new O 0 6.707439609971149e-15
methodology O 0 4.683403404676101e-12
to O 0 4.670546176373247e-13
define O 0 1.0407587985872269e-10
and O 0 7.11680280679472e-13
characterize O 0 3.2999016852386376e-09
the O 0 4.731925788703517e-12
resulting O 0 1.0398063660099766e-10
mRNA O 0 5.34047783773417e-09
splice O 0 3.979016227617649e-08
variants O 0 1.3143387489478187e-09
. O 0 7.551878233869047e-09

Mutational O 0 5.094755692880426e-07
analysis O 0 1.5627305005594394e-10
of O 0 5.116554402384565e-10
COL17A1 O 1 0.9999550580978394
identified O 0 1.5452469304122474e-09
a O 0 7.949755437275385e-11
maternally O 0 6.727526624672464e-08
inherited O 0 1.7082131265055978e-08
G O 0 2.2666885035604878e-10
- O 0 2.231711516975654e-11
to O 0 4.604126108143092e-11
- O 0 4.51800774570188e-09
T O 0 3.544505522423691e-10
transversion O 0 6.758610560098077e-09
at O 0 2.708162199268477e-13
the O 0 3.391046259982114e-14
- O 0 2.2990527396345856e-14
1 O 0 1.009624733128026e-15
position O 0 2.878614772765242e-13
of O 0 4.0073386232616914e-13
exon O 0 3.8835313437290964e-11
32 O 0 6.220219339603261e-10
. O 0 2.4283266508717816e-09

This O 0 7.047702005325007e-11
acceptor O 0 6.798084228876178e-08
splice O 0 2.670545200089691e-06
- O 0 3.3332130389140957e-09
site O 0 1.2618765754535133e-10
mutation O 0 1.1406051884238488e-12
led O 0 1.038387786671778e-13
to O 0 3.0661638592693885e-13
the O 0 1.3727393787660302e-12
formation O 0 4.721815161090603e-10
of O 0 1.834339347084324e-10
aberrant O 0 3.348155086513316e-09
transcripts O 0 3.076957000303082e-08
present O 0 2.9682536428765616e-09
at O 0 1.4819790949971434e-09
extremely O 0 6.528778850878325e-09
low O 0 2.285662858980686e-08
levels O 0 3.853778451912149e-08
. O 0 1.471111854556284e-08

Based O 0 8.067164015794492e-13
on O 0 1.2653071949572658e-12
our O 0 1.593554064746594e-12
recent O 0 1.2427843584968123e-14
finding O 0 3.7703957252339937e-13
that O 0 5.5550229096279404e-15
cycloheximide O 0 1.0268683681147195e-08
stabilized O 0 6.290271414854942e-08
mutant O 0 1.8846362248581272e-09
COL17A1 O 0 9.538257472740952e-06
transcripts O 0 2.959434697302754e-09
in O 0 4.8585293774272564e-12
keratinocytes O 0 1.639179885160047e-07
homozygous O 0 2.6137139674808907e-10
for O 0 3.537012262938566e-12
a O 0 1.0858487026199626e-10
frameshift O 0 1.984959254741625e-07
mutation O 0 3.3152914441503256e-11
, O 0 2.0895535396913377e-14
the O 0 2.1242502114965367e-13
effects O 0 8.549588988160384e-12
of O 0 6.730594814124968e-12
the O 0 6.475024683094688e-11
splice O 0 2.7986692074932762e-08
- O 0 2.7941206640069716e-11
site O 0 3.494218369509694e-12
mutation O 0 2.7294583016283444e-14
on O 0 5.86089065734291e-14
splicing O 0 5.362580865475586e-11
of O 0 1.6963927484958674e-10
COL17A1 O 0 0.0002407057472737506
transcripts O 0 1.3852031743866178e-09
were O 0 1.146071762882575e-13
determined O 0 8.374722492094158e-14
using O 0 1.4853429155582167e-14
reverse O 0 1.1829397053922386e-12
transcriptase O 0 9.499153850664466e-13
polymerase O 0 9.821193202230391e-14
chain O 0 1.5237023272339327e-14
reaction O 0 1.3520325080996565e-15
of O 0 1.2012354273175513e-13
total O 0 2.2679922176416234e-12
RNA O 0 5.162596045105161e-11
from O 0 6.9194298728259e-12
keratinocytes O 0 2.161312409043603e-07
incubated O 0 1.0179734832860277e-09
for O 0 1.4670039271899582e-12
2 O 0 5.629463215028885e-11
. O 0 4.424471344854908e-10

5 O 0 8.131808421074638e-11
h O 0 1.6039126407227378e-12
in O 0 4.1767662191296434e-14
the O 0 1.532002606371985e-13
presence O 0 1.7737710172188725e-13
or O 0 2.8550694252359177e-13
absence O 0 1.3065355464192407e-09
of O 0 1.6542474334801938e-10
10 O 0 7.959283926384231e-11
microg O 0 3.4350890132373024e-08
cycloheximide O 0 3.2062427379742076e-08
per O 0 1.6765284271968994e-08
ml O 0 1.8253579980864743e-07
. O 0 7.239916666179624e-09

Using O 0 2.485368681692801e-12
this O 0 1.0007146072086096e-13
approach O 0 2.8800016191321554e-11
, O 0 2.0531762867561504e-13
an O 0 2.0573474835642452e-13
abnormally O 0 8.38606892261673e-11
spliced O 0 1.4846781581923096e-09
transcript O 0 2.898012274599182e-09
was O 0 3.414004105459223e-12
identified O 0 2.7185348156627542e-12
that O 0 8.007655724555471e-16
contains O 0 4.876620801993713e-17
an O 0 2.1563238684330394e-17
extra O 0 4.7640975095030597e-14
264 O 0 5.1673738205026964e-11
bases O 0 3.8959455106457597e-10
upstream O 0 2.2689505829731615e-10
from O 0 1.2193484937028654e-11
exon O 0 2.1132050276317926e-10
32 O 0 1.4011138083080965e-10
, O 0 2.0566480037564026e-14
resulting O 0 4.266752316045563e-12
in O 0 1.7264509049805254e-12
a O 0 3.0290653318942873e-10
premature O 0 5.863412866347062e-08
termination O 0 6.787913520156508e-08
codon O 0 9.38276087936174e-08
27 O 0 1.6739370778395823e-08
bp O 0 2.701338530641806e-08
downstream O 0 4.2922035703441e-08
from O 0 9.468321265915236e-11
the O 0 1.4664633951610995e-09
cryptic O 0 6.74830786806524e-08
splice O 0 8.2381473021087e-07
site O 0 1.0148798246234492e-08
. O 0 7.263527113110513e-09

Three O 0 8.133845263991191e-10
other O 0 1.217730235224257e-12
splice O 0 1.538952520974135e-09
variants O 0 1.3988107547269202e-12
, O 0 1.1742002701642211e-15
including O 0 1.4412027369515505e-16
one O 0 1.6703909001163694e-15
derived O 0 1.0889164868193787e-13
from O 0 2.1570974715647007e-13
the O 0 5.248785781009069e-12
skipping O 0 3.2736423349888355e-08
of O 0 2.0731167893472957e-08
exon O 0 1.3358473438529472e-08
32 O 0 1.0994564370037097e-08
, O 0 5.712398869900381e-12
were O 0 6.450839168392619e-11
also O 0 2.5212642303790167e-12
identified O 0 7.964602866117332e-10
. O 0 4.097952199799693e-09

These O 0 9.40454203228469e-13
results O 0 4.3888945754598507e-13
indicate O 0 5.205106636506363e-13
the O 0 2.4213275359881957e-14
usefulness O 0 1.0710733688856777e-10
of O 0 2.193589494076109e-12
cycloheximide O 0 2.561714840254581e-09
treatment O 0 1.3606941094701508e-11
in O 0 3.902868967679135e-14
evaluating O 0 7.874683977809882e-13
the O 0 1.8130635881519197e-12
abnormal O 0 4.0823840835590985e-11
processing O 0 2.8869397983299905e-09
of O 0 9.749593493646458e-11
mRNA O 0 3.790593172681156e-09
due O 0 9.474566553535624e-08
to O 0 6.370369476371707e-08
splice O 0 5.3329262300394475e-05
- O 0 1.909305780145587e-08
site O 0 5.756098930831399e-10
mutations O 0 2.957028025218911e-11
, O 0 2.5123424120167964e-14
because O 0 1.7330021695027148e-13
( O 0 1.1521752112499464e-14
i O 0 4.510466652951628e-12
) O 0 7.919316540903952e-16
aberrant O 0 1.440221856705004e-12
splicing O 0 1.717315005478337e-11
often O 0 6.251976611111945e-14
generates O 0 1.9336503156042878e-13
a O 0 6.568735898097866e-13
premature O 0 6.859895429478513e-10
termination O 0 1.5567991340503795e-09
codon O 0 3.3113849440269405e-08
, O 0 1.6670356501463646e-12
( O 0 2.648262062117726e-15
ii O 0 1.6929978252644418e-11
) O 0 6.923898710235396e-14
transcripts O 0 1.0591731935960524e-09
with O 0 1.0521144502492752e-12
premature O 0 5.1483035612420736e-09
termination O 0 1.8977772686668004e-09
codons O 0 8.961200115287227e-10
can O 0 5.807696337734036e-11
occur O 0 4.174984802318704e-09
at O 0 3.370425327720028e-10
low O 0 1.5117649354579044e-09
or O 0 2.5444058318613294e-11
undetectable O 0 1.971223323460336e-10
levels O 0 5.630652194499319e-12
due O 0 1.2267808296995142e-11
to O 0 1.8412297728143123e-11
nonsense O 0 1.505101598908709e-09
- O 0 1.5397702210484532e-11
mediated O 0 2.9595462192055777e-10
mRNA O 0 4.1779776860373374e-10
decay O 0 5.023099713952206e-09
, O 0 2.1838686254890306e-14
and O 0 4.948447793022559e-14
( O 0 3.7089910458106825e-16
iii O 0 3.781776974909334e-12
) O 0 9.71465814150925e-15
the O 0 1.3835006274290351e-12
levels O 0 3.729168016053386e-11
of O 0 5.267790977731002e-12
these O 0 2.668364878014029e-12
transcripts O 0 3.6012570703292113e-10
can O 0 8.424616256344497e-13
be O 0 3.208584114545998e-13
increased O 0 8.080550985278823e-12
by O 0 1.677346954907788e-12
cycloheximide O 0 4.051876203448046e-06
. O 0 3.343338761396808e-08

A O 0 7.956320047242116e-08
deletion O 0 8.884190605407127e-10
mutation O 0 3.1192537702090517e-12
in O 0 6.656974776107771e-13
COL17A1 O 0 3.334812936373055e-05
in O 0 3.197257454450042e-13
five O 0 4.302528385652371e-13
Austrian O 0 2.7595475904362843e-10
families O 0 1.875726483857587e-11
with O 0 8.513982921454222e-12
generalized O 0 3.7474346754606813e-06
atrophic B-Disease 1 0.9999996423721313
benign I-Disease 1 0.9999986886978149
epidermolysis I-Disease 1 0.997509241104126
bullosa I-Disease 0 6.186107930261642e-05
represents O 0 4.4188836617609084e-12
propagation O 0 1.3953832533886157e-09
of O 0 3.7560368010280953e-11
an O 0 6.625661933164217e-13
ancestral O 0 9.745216189571693e-09
allele O 0 1.5796963737102487e-09
. O 0 3.196203302024969e-09

Patients O 0 1.9888866518158466e-06
with O 0 5.243267486854108e-10
generalized O 0 0.0001161124964710325
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999381303787231
bullosa I-Disease 0 0.27929723262786865
, O 0 2.1764981310290477e-12
a O 0 1.451044254370537e-12
usually O 0 1.3030593314436456e-12
nonlethal O 0 5.8835105676280364e-08
form O 0 9.82896040113701e-08
of O 0 3.76865136786364e-05
junctional B-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9989776611328125
bullosa I-Disease 0 0.010381017811596394
, O 0 2.836173483566906e-11
have O 0 1.6219743647141738e-12
generalized O 0 6.482909348237698e-11
blistering B-Disease 0 2.4359438910437348e-09
, O 0 5.183913736640788e-13
nail B-Disease 0 0.024291327223181725
dystrophy I-Disease 0 0.00015398026152979583
, O 0 1.498658280807419e-10
patchy B-Disease 1 0.9999889135360718
alopecia I-Disease 1 1.0
, O 0 7.904973897687739e-10
and O 0 6.41033011561376e-07
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.0005693226121366024

Skin B-Disease 1 1.0
fragility I-Disease 0 0.18648971617221832
in O 0 3.0952866138245216e-12
most O 0 2.8000262258267e-15
cases O 0 5.184567967948589e-16
is O 0 2.2375908894578017e-17
due O 0 2.1501267292219767e-13
to O 0 2.5334251298365917e-13
mutations O 0 2.8216724746663036e-13
in O 0 3.7074533845498844e-14
the O 0 2.0375171547789422e-13
gene O 0 6.832277528023151e-14
encoding O 0 7.529420142926568e-11
type O 0 2.030104306882663e-09
XVII O 0 5.239384108790546e-07
collagen O 0 5.193576413375922e-08
( O 0 8.048786463710211e-12
COL17A1 O 1 0.9988335967063904
) O 0 8.179930799552537e-13
. O 0 9.378757492850553e-11

Recently O 0 7.20162540712721e-10
, O 0 2.3518859114998042e-14
we O 0 3.1725305637219335e-15
reported O 0 4.151293227900275e-15
five O 0 3.816553430441901e-15
Austrian O 0 1.4747984083962606e-11
families O 0 3.0409234158534915e-12
with O 0 5.412570565355157e-12
generalized O 0 3.5905250115320086e-06
atrophic B-Disease 1 0.9999674558639526
benign I-Disease 1 0.9999463558197021
epidermolysis I-Disease 1 0.9960546493530273
bullosa I-Disease 0 0.14054647088050842
who O 0 2.4848673466082438e-11
share O 0 1.1934907229171898e-10
the O 0 4.211868354087045e-11
same O 0 3.198714348950915e-10
COL17A1 O 0 0.003104050876572728
mutation O 0 4.246559104359449e-09
. O 0 1.167179131122964e-09

Affected O 0 7.003845836628386e-10
individuals O 0 4.174257646353055e-14
in O 0 4.5776743669550396e-14
three O 0 2.451123342923217e-13
families O 0 1.0127444401760582e-13
are O 0 4.476050742075258e-15
homozygous O 0 2.0911892280751215e-13
for O 0 3.9920505594780165e-13
4003delTC O 0 2.941024490610289e-08
, O 0 2.4203962402033485e-13
whereas O 0 4.46195268233307e-11
those O 0 6.54568630201191e-13
in O 0 1.497073949183192e-12
two O 0 1.2116953274077247e-11
others O 0 3.4296173540004915e-11
are O 0 7.647180957047472e-13
compound O 0 1.6406548342118299e-09
heterozygotes O 0 7.145942504394043e-08
. O 0 4.020010990757328e-08

To O 0 5.684927528726291e-10
determine O 0 1.7104706540038705e-10
if O 0 2.297436329720681e-13
the O 0 3.0697097424745023e-13
occurrence O 0 2.059422424260937e-11
of O 0 3.696228978271321e-13
4003delTC O 0 5.056366436662074e-10
in O 0 4.400558083618271e-15
these O 0 1.1631662895976945e-15
unrelated O 0 3.8856908684582747e-13
families O 0 8.657981151677721e-15
signifies O 0 8.226823627714708e-13
propagation O 0 1.0858444698946812e-10
of O 0 8.411005399111549e-12
an O 0 4.4307477608737655e-13
ancestral O 0 6.743418623500474e-08
allele O 0 1.5941044040346242e-08
or O 0 1.4923438040881365e-09
a O 0 2.8994623590961055e-08
mutational O 0 1.2903544302389491e-05
hot O 0 5.7959528731998944e-08
spot O 0 1.4744553311629716e-07
, O 0 9.230068966081806e-13
haplotypes O 0 9.824729918506137e-11
were O 0 9.418508724670649e-13
determined O 0 1.2298123457099575e-11
for O 0 3.0363563226221135e-12
polymorphisms O 0 5.295037741603892e-09
both O 0 2.4239754647936707e-10
within O 0 1.3620230276956136e-08
and O 0 7.081703001787787e-10
flanking O 0 9.883612801786512e-05
COL17A1 O 1 0.9999746084213257
. O 0 7.000673463153362e-07

Five O 0 2.620865124924876e-08
intragenic O 0 1.552352841827087e-07
polymorphisms O 0 1.7101771387917353e-10
were O 0 4.509862264450576e-13
chosen O 0 1.2389585885008714e-12
based O 0 1.0604096099201942e-14
on O 0 6.782167275704021e-12
their O 0 2.2740241634178204e-10
informativeness O 0 7.050386557239108e-06
. O 0 2.5138168879834666e-08

One O 0 1.6188110574244519e-10
of O 0 1.4777266216237095e-11
these O 0 1.7657640486497955e-13
, O 0 2.3964880830517265e-15
not O 0 4.736677697747722e-15
previously O 0 7.39546499126803e-13
reported O 0 3.2091408523615694e-13
, O 0 2.3365393262098034e-15
was O 0 3.0600467906122253e-13
2988 O 0 5.940644420832086e-09
A O 0 3.2809668315536555e-09
or O 0 4.702612431406461e-12
C O 0 8.571432452697536e-09
that O 0 1.5992654249508131e-13
introduces O 0 2.7312110906230203e-12
a O 0 4.350016440807236e-13
new O 0 1.7781227336886862e-14
restriction O 0 2.1368723576633414e-13
site O 0 1.5275565101030564e-12
for O 0 4.978953989549784e-13
Eco0109 O 0 4.774173021360184e-07
I O 0 8.560078867958509e-07
. O 0 7.344438390788355e-09

All O 0 2.5711792070448602e-11
the O 0 1.6711391385287877e-12
4003delTC O 0 2.0486926044505083e-10
alleles O 0 1.4072609451441093e-13
showed O 0 5.147291555658573e-13
the O 0 7.432762393034479e-15
same O 0 2.5780697970314778e-14
haplotype O 0 1.1431453006416348e-11
for O 0 1.0876047377159428e-13
these O 0 5.353275873802577e-13
five O 0 4.6462590719276164e-11
polymorphic O 0 1.0105141168281762e-09
markers O 0 3.607308673991838e-09
. O 0 3.9083712266574366e-08

Fourteen O 0 3.0747142609754974e-09
microsatellite O 0 2.252852765449731e-10
polymorphisms O 0 2.6056141619323903e-11
were O 0 6.490322873326654e-14
selected O 0 1.1624890232288937e-13
based O 0 7.943975787580893e-16
on O 0 6.051910275001182e-13
their O 0 5.3437913816178906e-12
high O 0 2.2847003802728416e-11
heterozygosity O 0 2.6661776786340852e-08
and O 0 2.896294749171746e-12
their O 0 1.3819566324624333e-10
location O 0 2.171372193160437e-09
within O 0 4.160952915555072e-09
10q23 O 0 1.9996321043436183e-06
- O 0 5.967311267340847e-08
q25 O 0 7.52987546093209e-07
near O 0 1.4784626500841114e-07
COL17A1 O 0 0.0030477435793727636
. O 0 5.127559887796451e-08

Three O 0 7.727347234309789e-11
families O 0 1.9305336409342067e-12
shared O 0 3.015982949494678e-11
microsatellite O 0 1.5742580572464249e-09
polymorphisms O 0 2.5929149938264118e-09
covering O 0 1.2065958010509803e-08
at O 0 1.4873537956816563e-09
most O 0 1.7431547524870972e-11
19 O 0 2.5590177199497077e-10
cM O 0 3.6336322839503055e-09
, O 0 7.942791389881076e-13
whereas O 0 4.1013026308434064e-11
the O 0 8.403441137394552e-11
others O 0 7.841777227568514e-11
shared O 0 5.360081267724581e-09
smaller O 0 1.032308440118701e-11
regions O 0 1.633858742744465e-10
consistent O 0 3.055857789036054e-10
with O 0 9.999170409854749e-14
cross O 0 2.771633811349261e-09
- O 0 4.287766586230646e-09
over O 0 6.6317719545072595e-12
events O 0 2.5816696870573086e-12
during O 0 8.510302185182894e-11
passage O 0 2.2054798959336708e-11
of O 0 6.434523053266972e-14
this O 0 5.621533207195769e-15
mutation O 0 9.830076206154836e-14
through O 0 2.822582120289019e-13
several O 0 7.145270703237672e-13
generations O 0 1.0073296863311043e-08
. O 0 4.891900218240153e-09

These O 0 2.541610585188314e-12
results O 0 5.067683469042739e-13
indicate O 0 1.344053666106626e-12
that O 0 5.857031659938514e-15
4003delTC O 0 1.6063612662264859e-09
occurs O 0 5.403078700595698e-13
on O 0 2.3714727013721126e-13
a O 0 9.065654721059427e-14
single O 0 2.129131072836632e-12
ancestral O 0 4.582698109878436e-10
allele O 0 4.6084837335147455e-11
. O 0 1.008829825233093e-11
. O 0 1.0578063980304364e-09

The O 0 1.3013126132221942e-09
haptoglobin O 0 2.470844719937304e-07
- O 0 2.5688717819605245e-10
gene O 0 1.2933424676283417e-13
deletion O 0 2.651056024011167e-12
responsible O 0 6.1509707917351e-12
for O 0 2.135362893451731e-11
anhaptoglobinemia B-Disease 0 0.0034369355998933315
. O 0 1.7256510886909382e-08

We O 0 6.769956817365141e-11
have O 0 3.825862830751994e-14
found O 0 2.0235955923084137e-15
an O 0 8.049237465291246e-18
allelic O 0 2.8410771998887974e-12
deletion O 0 2.8598795207002148e-11
of O 0 2.743164029261891e-10
the O 0 2.3332820120458564e-09
haptoglobin O 0 2.4888138796086423e-05
( O 0 4.3436903921813264e-13
Hp O 0 1.9126852879303158e-11
) O 0 7.620727897876154e-16
gene O 0 2.094835933611947e-15
from O 0 2.8463468154703644e-14
an O 0 1.2786145509678507e-15
individual O 0 8.310230758742931e-14
with O 0 8.917218526083293e-12
anhaptoglobinemia B-Disease 0 0.00011672451364574954
. O 0 9.41750784022588e-08

The O 0 9.262563632761456e-11
Hp O 0 1.25484822185995e-11
gene O 0 7.902391340310153e-15
cluster O 0 8.351879707572604e-14
consists O 0 5.17007438718812e-15
of O 0 1.578382877957113e-13
coding O 0 4.246874851787652e-09
regions O 0 2.9095823528280107e-09
of O 0 1.7878365454748746e-09
the O 0 7.56796736389731e-10
alpha O 0 1.114483332009808e-11
chain O 0 2.440980631599615e-13
and O 0 1.6321486330972586e-14
beta O 0 1.2860181669571702e-11
chain O 0 7.153889568407845e-13
of O 0 1.4463717766879935e-12
the O 0 3.5984659262772167e-12
haptoglobin O 0 7.937309476346854e-09
gene O 0 5.023405736520603e-13
( O 0 5.325830828935741e-16
Hp O 0 4.323917797161708e-13
) O 0 6.157763428671763e-17
and O 0 3.4909821293628443e-15
of O 0 3.089082158472256e-12
the O 0 7.002783769527454e-12
alpha O 0 1.367985043819464e-12
chain O 0 1.5075951825902628e-13
and O 0 2.2052579014730962e-14
beta O 0 8.083586751361782e-12
chain O 0 5.88502174509592e-13
of O 0 8.624005914774358e-13
the O 0 1.4274591925156344e-11
haptoglobin O 0 8.728586635697866e-07
- O 0 1.3426029177310284e-09
related O 0 2.609211180448767e-10
gene O 0 9.44960255877536e-13
( O 0 3.2994887322958548e-15
Hpr O 0 2.3988184771894794e-09
) O 0 1.6031791533890958e-15
, O 0 8.128981018151033e-16
in O 0 4.4658346776984235e-15
tandem O 0 3.462963249489803e-11
from O 0 5.12795101520469e-12
the O 0 3.050942276594526e-10
5 O 0 8.888869085232898e-10
side O 0 6.192344859101695e-09
. O 0 1.787598691294079e-08

Southern O 0 1.616269514670421e-06
blot O 0 5.337226980373089e-07
and O 0 1.0741021787274985e-12
PCR O 0 2.322806114118947e-10
analyses O 0 2.3907757284308273e-12
have O 0 4.3437003617591155e-16
indicated O 0 7.541953410265031e-15
that O 0 1.3442854380577697e-18
the O 0 9.668619042089782e-17
individual O 0 7.236880624146883e-16
with O 0 1.0843479468557269e-14
anhaptoglobinemia B-Disease 0 1.6913316969180414e-08
was O 0 5.358590741272318e-12
homozygous O 0 4.807222328540028e-12
for O 0 6.699567116352778e-14
the O 0 2.4577113347939994e-12
gene O 0 6.913292095907242e-13
deletion O 0 1.050594854168363e-11
and O 0 3.1872765603006836e-14
that O 0 2.5094867251384233e-15
the O 0 1.2814822445382512e-13
gene O 0 2.981250703660947e-14
deletion O 0 1.5570997182606794e-12
was O 0 2.502367616504658e-13
included O 0 1.3363764847333648e-13
at O 0 6.196018633060352e-13
least O 0 5.36725950684748e-14
from O 0 4.74935439283633e-14
the O 0 4.305844689047461e-13
promoter O 0 7.707718019389631e-09
region O 0 4.14094820655464e-08
of O 0 5.001474345789347e-09
Hp O 0 1.1270131494711677e-09
to O 0 2.052632508409147e-09
Hpr O 0 7.519829381408272e-08
alpha O 0 3.167661879327488e-12
but O 0 6.972774544171043e-14
not O 0 1.5096008210840894e-13
to O 0 1.0524526389277256e-10
Hpr O 0 2.5643785761531035e-07
beta O 0 4.436166434196309e-10
( O 0 1.8851970494653675e-13
Hpdel O 0 1.6953018189269642e-07
) O 0 1.2972614519060621e-12
. O 0 3.5125241604205826e-10

In O 0 1.681064037972746e-10
addition O 0 7.544812864745953e-12
, O 0 4.927359721954537e-14
we O 0 5.0163083458116056e-14
found O 0 3.149380983866884e-14
seven O 0 1.0574955624717552e-13
individuals O 0 5.200734438779884e-15
with O 0 1.5870612387215016e-14
hypohaptoglobinemia B-Disease 0 6.242138361756133e-09
in O 0 1.214404119799506e-12
three O 0 6.101567601862756e-12
families O 0 5.27195257934987e-12
, O 0 3.839745700757492e-14
and O 0 3.061627354091802e-14
the O 0 2.8281771456001303e-12
genotypes O 0 3.027518902243287e-09
of O 0 3.2157940199617485e-10
six O 0 7.681136282577938e-10
of O 0 2.80180684208986e-10
the O 0 1.75462300938678e-11
seven O 0 1.2013329567239772e-11
individuals O 0 8.423679641192741e-14
were O 0 5.779790274856866e-12
found O 0 1.3920264680528094e-12
to O 0 6.3131715133391e-11
be O 0 8.174223076196085e-09
Hp2 O 1 0.8920453190803528
/ O 0 0.00017593738448340446
Hpdel O 0 0.00034570309799164534
. O 0 3.6183635643283196e-08

The O 0 4.368075234850721e-09
phenotypes O 0 6.1614979784963e-10
and O 0 4.961445208666315e-13
genotypes O 0 1.342537452736492e-11
in O 0 4.177650521526577e-14
one O 0 1.881721978214644e-14
of O 0 4.9970373298220336e-14
these O 0 1.3607926287192789e-15
three O 0 2.3225309682731697e-14
families O 0 1.0944781729136863e-13
showed O 0 2.901116196232789e-12
the O 0 2.426247679328253e-13
father O 0 5.268604996722104e-12
to O 0 5.24697681136832e-11
be O 0 1.217404621556284e-09
hypohaptoglobinemic B-Disease 0 0.008874332532286644
( O 0 5.002640662832292e-12
Hp2 O 0 5.4298720897349995e-06
) O 0 8.126838503368095e-13
and O 0 2.7702357768832897e-11
Hp2 O 0 0.0005072766216471791
/ O 0 1.160281541956465e-07
Hpdel O 0 4.650406424389075e-07
, O 0 8.966511208649205e-15
the O 0 2.1378791749057657e-13
mother O 0 2.452816324615553e-13
to O 0 2.201813818075715e-12
be O 0 3.682285726336332e-11
Hp2 O 0 0.006624618079513311
- O 0 1.1155334433965436e-08
1 O 0 2.4268750203892964e-11
and O 0 3.550369720439761e-11
Hp1 O 0 3.197650585207157e-05
/ O 0 1.9767478764975976e-09
Hp2 O 0 1.1674601729794176e-08
, O 0 2.23733615091636e-16
one O 0 2.7783088304546917e-16
of O 0 1.0355686746760673e-14
the O 0 5.4227432142112467e-14
two O 0 6.115356295357047e-14
children O 0 3.9992504750549496e-14
to O 0 4.501039298221432e-12
be O 0 2.672523868874066e-10
hypohaptoglobinemic B-Disease 0 0.0003261309175286442
( O 0 5.904036374376753e-12
Hp2 O 0 1.0430051588627975e-05
) O 0 7.759432744773587e-13
and O 0 4.133075132140007e-11
Hp2 O 0 0.00041108299046754837
/ O 0 6.326886392571396e-08
Hpdel O 0 3.539169313171442e-07
, O 0 6.390354520232396e-15
and O 0 2.6135578517192965e-15
the O 0 1.5494139445852012e-13
other O 0 2.2655341212524278e-14
child O 0 2.3221127711664513e-12
to O 0 6.707270589628722e-12
be O 0 2.0777542186767306e-10
Hp1 O 0 0.0003013004024978727
and O 0 4.20150625402016e-09
Hp1 O 1 0.9954116940498352
/ O 0 6.6204811446368694e-06
Hpdel O 0 5.423620677902363e-06
, O 0 1.6780693046052064e-13
showing O 0 2.971706214438541e-11
an O 0 5.5282628518352195e-14
anomalous O 0 7.873284246784351e-10
inheritance O 0 5.017222903802576e-08
of O 0 5.796970015126135e-08
Hp O 0 5.293129934358376e-09
phenotypes O 0 1.5028260580418618e-10
in O 0 4.584545091647352e-13
the O 0 1.7810811419466388e-12
child O 0 2.639709457963324e-11
with O 0 3.4323035407769764e-13
Hp1 O 0 8.672663170727901e-06
. O 0 1.2484806966028827e-08

The O 0 6.366664706547454e-08
Hp2 O 0 0.0008555793901905417
/ O 0 8.632172665556936e-08
Hpdel O 0 5.616816167730576e-08
individuals O 0 5.864692818836545e-14
had O 0 6.442323887898005e-13
an O 0 7.347428905796292e-15
extremely O 0 2.1289211712960388e-11
low O 0 5.97094929055686e-10
level O 0 5.2267477457235145e-08
of O 0 5.083551357643046e-09
Hp O 0 8.853466570979407e-11
( O 0 3.367865466962958e-15
mean O 0 2.3554706362477473e-12
+ O 0 2.322573340249323e-12
/ O 0 3.221280187037934e-11
- O 0 2.6114204548788322e-11
SD O 0 1.4612554222193097e-10
= O 0 9.212440787434092e-14
0 O 0 5.957371182870258e-16
. O 0 2.312137365790591e-16
049 O 0 8.2981820200001e-13
+ O 0 8.997542430078456e-14
/ O 0 4.220181062247752e-12
- O 0 9.252189943007028e-13
0 O 0 2.5380495231527855e-16
. O 0 2.316968206447019e-15
043 O 0 3.784347835100732e-11
mg O 0 1.769318415736909e-12
/ O 0 2.2465343387650938e-12
ml O 0 2.2451933975181637e-12
; O 0 8.825709557101834e-16
n O 0 1.0871063943517553e-14
= O 0 2.0290526020710995e-15
6 O 0 9.182433247673246e-16
) O 0 4.679466707728461e-19
, O 0 3.225460259210113e-19
compared O 0 1.3392347931787097e-16
with O 0 8.826209703587408e-17
the O 0 2.564280981564443e-13
level O 0 1.1935749610891833e-10
( O 0 2.2882432942674863e-17
1 O 0 1.900962162204936e-16
. O 0 2.856263390172873e-16
64 O 0 1.6755492121805354e-13
+ O 0 1.0083983344524872e-12
/ O 0 3.4330271264648715e-11
- O 0 3.7405638482479464e-12
1 O 0 3.4615826745548316e-15
. O 0 5.759895615613285e-15
07 O 0 4.820220828385957e-13
mg O 0 2.453097132978227e-13
/ O 0 8.371592535947464e-14
ml O 0 7.269783936620332e-15
) O 0 1.438168912468284e-19
obtained O 0 5.76750324202905e-15
from O 0 3.0776345827290136e-14
52 O 0 8.941339335599707e-11
healthy O 0 4.0006245538570795e-10
volunteers O 0 1.0724855031840619e-11
having O 0 2.1112056547423208e-11
phenotype O 0 1.852387243594933e-09
Hp2 O 0 4.7274883741010854e-07
, O 0 4.594296405986686e-13
whereas O 0 9.579505591550408e-12
the O 0 4.042177183249951e-12
serum O 0 3.1194456739935816e-11
Hp O 0 5.944602449181602e-12
level O 0 1.8094439141469465e-11
of O 0 6.875878989440198e-13
an O 0 1.4434427155805645e-15
individual O 0 4.036425734670404e-14
with O 0 3.995335746270756e-12
Hp1 O 0 0.0007021974888630211
/ O 0 1.0027673624790623e-06
Hpdel O 0 1.0787730388983618e-06
was O 0 8.627090708479557e-11
0 O 0 5.138838139739921e-12
. O 0 3.604608972418433e-11

50 O 0 7.513905053713188e-09
mg O 0 8.933280781775466e-10
/ O 0 3.8967851168081324e-10
ml O 0 6.075603214972247e-11
, O 0 3.5548535487230613e-16
which O 0 3.4492265218797554e-18
was O 0 1.6733501155967207e-15
approximately O 0 2.325256000319429e-15
half O 0 4.522910637596439e-14
the O 0 2.8356296802832526e-13
level O 0 1.614513522874006e-09
of O 0 1.8547728630746718e-10
Hp O 0 5.866916674701628e-11
in O 0 1.8793076470013936e-11
control O 0 2.6488475413088963e-08
sera O 0 4.529327579660958e-09
from O 0 8.750111637860492e-13
the O 0 9.866846922834682e-12
Hp1 O 0 2.7495190124682267e-07
phenotype O 0 7.17109635561819e-11
( O 0 3.7689374203724415e-16
1 O 0 6.597558260888585e-15
. O 0 5.872535751005057e-15
26 O 0 2.2720609844494727e-13
+ O 0 5.124545536180913e-13
/ O 0 6.3433676714130804e-12
- O 0 8.419379559851392e-13
0 O 0 8.569255641592915e-17
. O 0 3.5350422421801713e-16
33 O 0 1.63484135083658e-13
mg O 0 2.862834481195259e-13
/ O 0 1.0881157086473081e-12
ml O 0 1.0241650192852059e-12
; O 0 5.651913102640229e-16
n O 0 1.2502974560356633e-14
= O 0 4.247193874671934e-15
9 O 0 1.910050148102617e-14
) O 0 3.2235939846518284e-17
, O 0 1.178898867801759e-16
showing O 0 5.6526950411054863e-14
a O 0 1.096540528733661e-13
gene O 0 1.878984164441211e-12
- O 0 3.2315945058813966e-11
dosage O 0 1.4338205622799194e-10
effect O 0 1.3329513708082441e-11
. O 0 5.521593182677975e-10

The O 0 1.3723297498380305e-10
other O 0 2.6226338266897853e-13
allele O 0 1.2457266988785687e-11
( O 0 6.533243049203566e-15
Hp2 O 0 1.226363899320404e-08
) O 0 2.8163623150056832e-15
of O 0 4.798426196314654e-13
individuals O 0 1.7365567534302628e-12
with O 0 5.081203235945964e-10
Hp2 O 1 1.0
/ O 1 0.9985528588294983
Hpdel O 0 0.00019790134683717042
was O 0 1.2267808296995142e-11
found O 0 3.1594705015213984e-14
to O 0 3.1770753020597675e-13
have O 0 8.547036098619995e-14
, O 0 3.0853676970759138e-15
in O 0 1.2704235179041706e-13
all O 0 4.514055795823424e-12
exons O 0 5.048687690134557e-09
, O 0 2.1347091032786897e-13
no O 0 7.187421502147934e-14
mutation O 0 6.4116226705050045e-15
, O 0 2.999726485414967e-17
by O 0 7.814936406116008e-17
DNA O 0 8.235183368565657e-11
sequencing O 0 1.1259345678027444e-09
. O 0 3.3842251223603625e-09

On O 0 1.100838170620122e-10
the O 0 1.0975114317791218e-13
basis O 0 7.775941349152937e-12
of O 0 2.4603696901007166e-13
the O 0 1.0073482304383263e-13
present O 0 1.2557048499964307e-12
study O 0 6.659537016891898e-14
, O 0 6.112621204794539e-16
the O 0 2.6046461333779393e-14
mechanism O 0 3.09547699972601e-11
of O 0 4.4040601027139914e-11
anhaptoglobinemia B-Disease 0 1.271961082238704e-06
and O 0 1.515444367217178e-11
the O 0 1.8518778177600836e-10
mechanism O 0 5.1973190196008545e-09
of O 0 3.590201469449994e-10
anomalous O 0 3.7133438546277375e-09
inheritance O 0 5.569832595142543e-08
of O 0 3.54963027859867e-08
Hp O 0 2.865402359830682e-09
phenotypes O 0 3.1118407850527774e-10
were O 0 2.6123520013854318e-11
well O 0 2.1591660750996944e-11
explained O 0 4.3064099508605125e-10
. O 0 1.1820529000061697e-09

However O 0 3.1930391664047875e-10
, O 0 3.2668088882897156e-14
the O 0 9.058862194448805e-14
mechanism O 0 8.395014544637647e-11
of O 0 4.060454056320495e-11
hypohaptoglobinemia B-Disease 0 2.5580900910426863e-05
remains O 0 1.643628735337188e-07
unknown O 0 2.9396636819001287e-05

ATM O 0 9.365224286739249e-06
mutations O 0 3.761228828391694e-10
and O 0 1.7949372457110035e-12
phenotypes O 0 6.661253215689555e-10
in O 0 2.4270210285948224e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 2.4509119733728824e-10
in O 0 6.044893996167214e-14
the O 0 5.978048188848978e-14
British O 0 5.098407590206633e-13
Isles O 0 1.550448769371826e-09
: O 0 1.7997329899807786e-16
expression O 0 6.146965532069504e-14
of O 0 2.8725047514222e-13
mutant O 0 8.106557959630667e-13
ATM O 0 1.7960599674182731e-09
and O 0 1.8709223081371518e-13
the O 0 4.1056364037672655e-12
risk O 0 5.110202885849624e-11
of O 0 9.354103602809971e-11
leukemia B-Disease 1 0.9988226294517517
, O 0 7.412142899454466e-09
lymphoma B-Disease 1 1.0
, O 0 3.1407625389334726e-09
and O 0 1.6980163053403885e-08
breast B-Disease 1 0.9999785423278809
cancer I-Disease 1 0.999908447265625
. O 0 0.0004791836836375296

We O 0 7.521822574518833e-12
report O 0 2.972013639964549e-14
the O 0 3.803588744151227e-15
spectrum O 0 2.925995383484814e-12
of O 0 1.4163553142820806e-12
59 O 0 1.3311184376973983e-09
ATM O 0 1.7254001249966677e-07
mutations O 0 8.600392620294883e-11
observed O 0 1.4622083058246638e-11
in O 0 2.6312119150162516e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.338615244847688e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.2508113333764325e-15
patients O 0 2.624315858363696e-16
in O 0 2.9639644896840945e-17
the O 0 3.155752958619194e-15
British O 0 2.06407742460446e-12
Isles O 0 3.197082776296156e-08
. O 0 3.816679750023866e-10

Of O 0 5.35415779268078e-07
51 O 0 1.9889548639184795e-06
ATM O 0 3.526075670379214e-05
mutations O 0 1.720837361496308e-10
identified O 0 3.4990203009316323e-12
in O 0 1.1216624417470511e-13
families O 0 2.7291892162016607e-13
native O 0 1.5853555176536388e-13
to O 0 2.1289961709813204e-13
the O 0 5.732941898983768e-12
British O 0 1.9097699810455282e-10
Isles O 0 5.105324589749216e-07
, O 0 3.28738094688627e-13
11 O 0 4.5764746159360215e-12
were O 0 2.6416386439409578e-11
founder O 0 5.0846712257301974e-11
mutations O 0 2.3263240292448195e-12
, O 0 1.0129119832930251e-14
and O 0 8.209040984138733e-15
2 O 0 2.9735060442549754e-13
of O 0 3.6030124196673174e-12
these O 0 1.8173558090275183e-13
11 O 0 5.931475362958016e-12
conferred O 0 2.5424289340492123e-09
a O 0 9.073816698013104e-11
milder O 0 5.1133420414517516e-11
clinical O 0 1.060524064400159e-12
phenotype O 0 1.0698595872063454e-12
with O 0 1.976568111318618e-15
respect O 0 9.046628897391162e-12
to O 0 7.943666835430463e-10
both O 0 5.105609268696298e-09
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 8.762668368689219e-10
cellular O 0 3.5722391711345836e-09
features O 0 3.404453455257972e-11
. O 0 3.335844656060516e-10

We O 0 1.2003899263479667e-10
report O 0 4.0719595121967156e-13
, O 0 2.6303382295314493e-17
in O 0 6.101924105113003e-17
two O 0 1.6281718134098996e-14
A B-Disease 1 1.0
- I-Disease 1 0.9996433258056641
T I-Disease 1 1.0
families O 0 1.9227661129939122e-11
, O 0 5.2548979605920604e-15
an O 0 2.3594958249045263e-15
ATM O 0 3.3323486192671226e-09
mutation O 0 2.4949009871932937e-12
( O 0 5.512929183797664e-15
7271T O 0 3.12261754231713e-08
- O 0 8.34202928956529e-09
- O 0 2.3802233517500326e-09
> O 0 1.1128207383359623e-10
G O 0 3.5154162567052616e-12
) O 0 1.1061133928186461e-16
that O 0 4.641992675604272e-17
may O 0 2.32952509931315e-16
be O 0 2.538340161332812e-16
associated O 0 4.077980832249521e-14
with O 0 4.311508874598716e-16
an O 0 4.885430341691852e-16
increased O 0 5.675525154014149e-13
risk O 0 2.3637258816933127e-11
of O 0 1.9284314145551207e-09
breast B-Disease 0 3.999811269750353e-06
cancer I-Disease 0 1.2440266061730654e-07
in O 0 1.2923635495099006e-09
both O 0 4.287799004742965e-09
homozygotes O 0 3.9104560300984303e-07
and O 0 4.781200435566291e-11
heterozygotes O 0 1.2541563343404505e-08
( O 0 4.1022290815997953e-13
relative O 0 1.8400660994899454e-09
risk O 0 2.0404905196058643e-11
12 O 0 2.815448395254716e-12
. O 0 1.932676973103939e-13
7 O 0 5.430366659814334e-12
; O 0 3.4141976355470116e-13
P O 0 3.337690124283199e-10
= O 0 1.439471507486481e-13
. O 0 3.016162691241338e-14
0025 O 0 1.604795601961584e-10
) O 0 6.65345769731682e-17
, O 0 1.3092543597956642e-17
although O 0 2.984831874258643e-16
there O 0 1.6500794735576849e-16
is O 0 6.698428777525307e-18
a O 0 7.144037660435695e-15
less O 0 2.6801169790424684e-12
severe O 0 2.0522112720300356e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.1922575426925874e-10
in O 0 1.4358420771866148e-15
terms O 0 1.7688002890712054e-14
of O 0 2.8945783961463294e-15
the O 0 5.214680836256426e-15
degree O 0 1.9692579511509933e-10
of O 0 2.1388328608207274e-10
cerebellar B-Disease 0 0.0003795424709096551
degeneration I-Disease 1 0.9819415807723999
. O 0 8.817786323334076e-08

This O 0 9.824856206375188e-12
mutation O 0 2.1894419328753745e-13
( O 0 1.2385850444300334e-16
7271T O 0 9.715789284214793e-11
- O 0 2.577562469019412e-11
- O 0 1.054920040211016e-11
> O 0 9.496652596252542e-13
G O 0 1.2366514333828765e-13
) O 0 2.0621587855528603e-18
also O 0 3.0784601830957244e-19
allows O 0 1.2784077400982808e-18
expression O 0 6.330181087901214e-16
of O 0 2.5496681046836833e-14
full O 0 3.999582783020816e-12
- O 0 1.3841974441652916e-12
length O 0 1.6900779387096776e-11
ATM O 0 5.5923681685499105e-08
protein O 0 9.417117086130133e-11
at O 0 4.881996543137923e-11
a O 0 4.940530623498418e-12
level O 0 7.151632064328339e-11
comparable O 0 1.0770280500782548e-11
with O 0 3.4432107416871227e-15
that O 0 5.0349976195730034e-15
in O 0 4.34022853464458e-13
unaffected O 0 1.8529952017232176e-09
individuals O 0 3.807616114764878e-12
. O 0 3.3221567719010636e-09

In O 0 2.5572747044955157e-11
addition O 0 1.623472406855897e-12
, O 0 8.93158804023391e-15
we O 0 1.2438752522295812e-14
have O 0 2.4269766104716714e-15
studied O 0 2.035939911668519e-13
18 O 0 4.4830316542343596e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.0777978509679542e-09
, O 0 1.2918421351095291e-15
in O 0 3.769958624469475e-16
15 O 0 5.688188770914052e-15
families O 0 1.0205409549390605e-14
, O 0 4.755506816648712e-15
who O 0 1.838792247806087e-13
developed O 0 1.2251505587812517e-08
leukemia B-Disease 1 1.0
, O 0 3.54825608894771e-08
lymphoma B-Disease 1 1.0
, O 0 8.09770384080366e-09
preleukemic O 1 0.9999933242797852
T O 1 0.5600482225418091
- O 0 5.524258313016617e-07
cell O 0 3.476084486919717e-08
proliferation O 0 3.0286262244771933e-06
, O 0 8.639052472524111e-13
or O 0 1.4030701933620549e-08
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 4.616927500034063e-12
mostly O 0 5.000756143273659e-14
in O 0 8.732972027816754e-13
childhood O 0 1.3911089808971155e-06
. O 0 8.589208988496466e-08

A O 0 4.0682439816919214e-07
wide O 0 4.706574574520062e-10
variety O 0 3.206915202141891e-12
of O 0 6.727851609156232e-11
ATM O 0 3.5627289207695867e-07
mutation O 0 1.7149321893117353e-11
types O 0 1.6919615014598932e-11
, O 0 2.7285698657106283e-13
including O 0 2.673530884525488e-12
missense O 0 2.1593058363578166e-07
mutations O 0 9.892163754798844e-10
and O 0 2.0202058775842247e-11
in O 0 1.4297795170037375e-09
- O 0 2.4816018129314443e-09
frame O 0 4.6633719108513105e-09
deletions O 0 4.052533308929185e-10
, O 0 7.653652492052403e-15
were O 0 1.666710389494619e-13
seen O 0 2.5140850772736867e-12
in O 0 6.669376151607204e-14
these O 0 2.643754356060346e-12
patients O 0 1.1203279276505995e-10
. O 0 4.676403264625151e-09

We O 0 1.3839981938268409e-10
also O 0 5.8938339709472924e-15
show O 0 1.5705801798535958e-14
that O 0 4.4025831971200906e-18
25 O 0 1.0622592545912897e-15
% O 0 1.1653609731398541e-14
of O 0 5.822413846900704e-15
all O 0 1.4817450651877229e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.4353084882022813e-08
carried O 0 4.0179221061364956e-10
in O 0 1.0810378286985056e-10
- O 0 1.336137089857914e-09
frame O 0 6.966305754474433e-09
deletions O 0 9.43435018996297e-09
or O 0 3.302107892677597e-11
missense O 0 9.858265315187964e-09
mutations O 0 1.5627506233517607e-11
, O 0 3.495926048917731e-15
many O 0 6.024467838995824e-16
of O 0 1.654215704845717e-14
which O 0 9.286805706225105e-17
were O 0 1.1314563787842916e-13
also O 0 5.464038547961265e-16
associated O 0 6.311752742639218e-14
with O 0 3.0909399033194262e-15
expression O 0 7.043949624974122e-12
of O 0 3.517181684786763e-11
mutant O 0 1.4166243178515003e-10
ATM O 0 1.4940056303203164e-07
protein O 0 1.686531803102298e-08
. O 0 8.104657389651493e-09

The O 0 3.1587479853989464e-10
DMPK O 0 2.688212407520041e-05
gene O 0 4.3649226594277835e-11
of O 0 4.907493161843135e-11
severely O 0 1.8548455045674928e-05
affected O 0 1.6636391819702112e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.3443973934101905e-08
is O 0 2.7067042861596627e-14
hypermethylated O 0 1.0540200934272548e-09
proximal O 0 6.268425067901262e-07
to O 0 6.709734434728887e-10
the O 0 7.259534640091658e-10
largely O 0 1.2613092792435054e-09
expanded O 0 9.561608171893e-10
CTG O 0 2.354564685447258e-06
repeat O 0 1.7390993534149857e-08
. O 0 1.2808134108865943e-08

Using O 0 5.06324937532554e-09
methylation O 0 5.536605272027373e-07
- O 0 2.9817974223078636e-07
sensitive O 0 2.806150867229462e-09
restriction O 0 4.223925896551517e-12
enzymes O 0 1.0297670919104385e-12
, O 0 6.19818370856584e-16
we O 0 3.591301958778565e-15
characterized O 0 1.3708593823633358e-14
the O 0 4.949152947951148e-15
methylation O 0 5.843115487985662e-12
pattern O 0 9.85281734672272e-12
on O 0 1.2012590358198572e-12
the O 0 6.824231934751679e-13
5 O 0 2.643759560230774e-12
side O 0 2.036015800399582e-11
of O 0 1.53085391585428e-10
the O 0 5.97399074653282e-10
CTG O 0 6.104640988269239e-07
repeat O 0 8.112303884200145e-11
in O 0 9.862646723618473e-13
the O 0 3.788217135813898e-12
DMPK O 0 1.5917489690764342e-06
gene O 0 3.060788113847662e-13
of O 0 4.97949554853494e-13
normal O 0 3.753723720745228e-11
individuals O 0 3.302670230397389e-14
and O 0 2.2587051044624384e-13
of O 0 7.800660291323869e-12
patients O 0 8.954168136121599e-12
affected O 0 6.190450235754597e-11
with O 0 1.0308485835774928e-11
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.231245791086244e-12
showing O 0 2.026894624362896e-11
expansions O 0 2.5821400573278197e-10
of O 0 1.3323489880812112e-11
the O 0 4.063374983709345e-11
repetitive O 0 1.2343561728300756e-09
sequence O 0 1.4661606650978598e-10
. O 0 6.880183534008211e-09

The O 0 3.3874569815850464e-11
gene O 0 1.1703244168041749e-13
segment O 0 3.7312240103171135e-11
analyzed O 0 2.715221981714616e-13
corresponds O 0 6.037245898517229e-13
to O 0 1.6033039696231044e-12
the O 0 1.7863929085981667e-11
genomic O 0 2.9056518968673117e-08
SacI O 0 2.708797183004208e-06
- O 0 2.035012380829926e-09
HindIII O 0 1.784399827897687e-08
fragment O 0 5.070454126010482e-11
carrying O 0 5.870341712732596e-11
exons O 0 8.64446025872212e-09
11 O 0 1.7173552857574492e-10
- O 0 4.970744371668445e-10
15 O 0 7.187487410797999e-11
. O 0 3.0701710618252775e-10

There O 0 4.697370617479102e-11
is O 0 1.5945527369201976e-14
constitutive O 0 8.708982424110445e-10
methylation O 0 7.45562611648154e-10
in O 0 4.851163359909094e-10
intron O 0 1.7306851418652514e-07
12 O 0 2.539820298519402e-10
at O 0 1.047311803253903e-11
restriction O 0 1.293338157924706e-12
sites O 0 3.1246383952465706e-11
of O 0 2.477399708988859e-11
SacII O 0 2.7068010695074918e-06
and O 0 8.287944774920675e-10
HhaI O 0 0.00022357873967848718
, O 0 5.2763383939780084e-12
localized O 0 1.67428029773653e-10
1 O 0 6.154770161408141e-13
, O 0 6.275533275001445e-15
159 O 0 5.742772229977433e-11
- O 0 4.664212766014586e-11
1 O 0 5.18426989705445e-13
, O 0 2.7460115277033563e-14
232 O 0 4.718416629634348e-12
bp O 0 8.26779408824585e-11
upstream O 0 9.49398670790913e-10
of O 0 9.55947432323967e-10
the O 0 1.6853228146374022e-08
CTG O 0 1.2561474250105675e-05
repeat O 0 4.131654662842266e-08
, O 0 6.9829372319196725e-12
whereas O 0 3.537474757564496e-10
most O 0 1.2697119831234227e-12
, O 0 1.7234059299553635e-14
if O 0 7.262188592182302e-15
not O 0 6.459940817948179e-14
all O 0 3.0870011408223874e-13
, O 0 3.0761322850937634e-14
of O 0 5.076158135323972e-13
the O 0 4.4890168513812834e-13
other O 0 1.0021471770916418e-13
sites O 0 3.3018390799277597e-10
of O 0 3.861154174167325e-10
SacII O 0 3.563840436981991e-06
, O 0 4.14391299052852e-11
HhaI O 0 1.3711946849070955e-05
, O 0 1.0135860033233524e-11
and O 0 2.5706154219151678e-11
HpaII O 0 3.321016492918716e-06
in O 0 9.936327802217981e-12
this O 0 1.1794753541904957e-11
region O 0 4.370166895029115e-09
are O 0 2.9184651657160332e-12
unmethylated O 0 1.201393757810365e-07
, O 0 4.6741439657573686e-14
in O 0 4.9304059912460424e-14
normal O 0 8.968872866610411e-11
individuals O 0 8.12138035858126e-14
and O 0 1.289984422449611e-13
most O 0 2.1948691779002938e-13
of O 0 6.6239210297358575e-12
the O 0 1.4203309361970895e-10
patients O 0 3.596438424846582e-10
. O 0 7.857506645336798e-09

In O 0 1.3215973454494545e-11
a O 0 6.093144109924065e-13
number O 0 2.731114420446816e-14
of O 0 2.5280394097548786e-12
young O 0 7.354524628189196e-11
and O 0 1.7913059924268282e-11
severely O 0 1.1640119737421628e-05
affected O 0 2.4230106809852714e-09
patients O 0 1.565366933298229e-11
, O 0 6.9041401420813844e-15
however O 0 5.207330877263217e-13
, O 0 6.1464581593340985e-15
complete O 0 8.369693271781387e-10
methylation O 0 3.4950902172425913e-09
of O 0 3.583811580831764e-10
these O 0 3.832052730690094e-12
restriction O 0 7.120622234207952e-12
sites O 0 3.616874508227674e-11
was O 0 3.0605327300259333e-12
found O 0 5.433472140096984e-13
in O 0 5.397564990447523e-14
the O 0 5.321015980261357e-13
mutated O 0 5.010222705464917e-12
allele O 0 5.637030286997913e-10
. O 0 3.7630463189941565e-09

In O 0 3.013188309974879e-11
most O 0 1.2815531242552775e-13
of O 0 1.377609506504618e-13
these O 0 2.0255275050545113e-14
patients O 0 4.666421058157483e-14
, O 0 1.0515022670334052e-16
the O 0 4.084813847035022e-15
onset O 0 3.427772996000833e-11
of O 0 1.1959369041955603e-12
the O 0 1.3246062580130058e-10
disease O 0 1.2615862488019047e-06
was O 0 1.2969498364157062e-08
congenital O 1 0.9999997615814209
. O 0 9.157367458101362e-06

Preliminary O 0 1.8121475875432225e-08
in O 0 9.701942582651668e-10
vivo O 0 5.507284228656317e-08
footprinting O 0 1.0724645562731894e-06
data O 0 1.3524118457064471e-11
gave O 0 5.982210847564964e-14
evidence O 0 2.117256565382919e-13
for O 0 1.460147107390508e-13
protein O 0 2.9708431895092424e-12
- O 0 5.74989058102493e-13
DNA O 0 1.5114209883648755e-10
contact O 0 6.438030664135397e-11
in O 0 7.403848042465688e-13
normal O 0 2.9348925512096002e-09
genes O 0 7.324660843133213e-12
at O 0 7.787488535970777e-12
an O 0 3.685891991470937e-14
Sp1 O 0 5.231410304951112e-10
consensus O 0 2.027796680570404e-10
binding O 0 2.0335396561099728e-11
site O 0 2.167237639350006e-10
upstream O 0 1.385578429768941e-09
of O 0 5.285880066985271e-11
the O 0 3.109882629193095e-10
CTG O 0 1.7410080772606307e-06
repeat O 0 1.4493915789781653e-10
and O 0 8.691905160028435e-14
for O 0 4.3169769381413634e-14
a O 0 4.4771200364678715e-14
significant O 0 2.2698594102942872e-14
reduction O 0 1.7072364355552594e-11
of O 0 1.0499854024431654e-12
this O 0 1.4451025825198277e-13
interaction O 0 2.98317759384048e-11
in O 0 6.784764265167775e-13
cells O 0 2.3831466314239158e-11
with O 0 1.6845728913368607e-13
a O 0 6.41743463924982e-11
hypermethylated O 0 3.261608298998908e-07
DMPK O 0 1.248661101271864e-05
gene O 0 5.304734516237142e-12
. O 0 1.6776007666363668e-11
. O 0 3.771163659127552e-10

The O 0 2.3188864162193568e-08
hemochromatosis B-Disease 1 1.0
gene O 0 5.584139053937953e-12
product O 0 1.972868916844117e-12
complexes O 0 2.344166256506436e-13
with O 0 9.73602115947195e-16
the O 0 7.589189693346654e-13
transferrin O 0 1.3759867689699945e-09
receptor O 0 2.180187671022016e-12
and O 0 2.0724841114094783e-12
lowers O 0 6.798560195711567e-13
its O 0 2.775121974869766e-15
affinity O 0 1.9605965004168384e-14
for O 0 2.9570577486214694e-14
ligand O 0 4.6657764457558315e-12
binding O 0 1.0566368890962963e-09
. O 0 1.2911471891641213e-08

We O 0 8.37184488400311e-11
recently O 0 3.6546088963244905e-13
reported O 0 1.0179281971099598e-14
the O 0 1.44487515417349e-15
positional O 0 7.934251671469494e-13
cloning O 0 1.9227935216248326e-13
of O 0 3.511914134610335e-14
a O 0 1.2527617289891102e-13
candidate O 0 1.5447951251523762e-10
gene O 0 1.2015077821558862e-10
for O 0 6.409944575125337e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 1.8022088852376328e-06
HFE O 0 0.015973716974258423
. O 0 1.0399338057354157e-09

The O 0 3.820144547916904e-11
gene O 0 4.0992156094240076e-14
product O 0 7.051285011612507e-13
, O 0 3.8648114914853796e-16
a O 0 2.946798824377504e-14
member O 0 4.884972092632223e-13
of O 0 2.5775723569432252e-11
the O 0 3.669226034119788e-10
major O 0 8.275686802505788e-10
histocompatibility O 0 1.6602706764956565e-08
complex O 0 1.5722355639624652e-09
class O 0 2.652367214750484e-11
I O 0 4.3634891255805996e-08
- O 0 4.313940316080789e-10
like O 0 1.3608432685840305e-13
family O 0 6.884080978875051e-13
, O 0 5.523830603707946e-16
was O 0 2.2792259006250253e-14
found O 0 4.0351607756669745e-15
to O 0 1.4803826567377776e-13
have O 0 1.200410891565376e-13
a O 0 4.60640770319487e-12
mutation O 0 6.418704543570408e-12
, O 0 3.007214431898636e-13
Cys O 0 2.4591565761511447e-07
- O 0 5.330877961284841e-10
282 O 0 1.7405369590051123e-07
- O 0 2.935137126769405e-05
- O 0 1.780933757800085e-06
> O 0 1.6752018439092353e-08
Tyr O 0 2.037304547286567e-08
( O 0 2.9761455513845504e-16
C282Y O 0 6.929322567128526e-12
) O 0 2.6337293701899447e-19
, O 0 8.782668994433905e-20
in O 0 2.6912244715206094e-18
85 O 0 1.8678202701963992e-13
% O 0 2.2351055468244896e-12
of O 0 1.173290956578421e-12
patient O 0 3.2678623695936437e-10
chromosomes O 0 4.184519841743395e-09
. O 0 8.897239922589506e-08

This O 0 1.6389119228410465e-10
mutation O 0 8.802141307495681e-12
eliminates O 0 5.534725889405623e-12
the O 0 1.1651371870351895e-13
ability O 0 4.535149686346607e-11
of O 0 8.002210005741972e-11
HFE O 0 2.688886524992995e-05
to O 0 5.831386484800305e-10
associate O 0 1.1323179061051292e-09
with O 0 1.817837736893188e-13
beta2 O 0 0.0015770446043461561
- O 0 5.297561642692017e-07
microglobulin O 0 5.386818520491943e-05
( O 0 7.907400184940447e-14
beta2m O 0 1.2532599669157207e-07
) O 0 4.374148443355829e-15
and O 0 2.335694029680091e-14
prevents O 0 2.1904119143489886e-12
cell O 0 2.861404668763612e-09
- O 0 6.368383598243099e-10
surface O 0 1.0119224569393737e-08
expression O 0 2.6763421701048173e-08
. O 0 5.16750731094362e-09

A O 0 1.0635854152951651e-07
second O 0 2.502385798575091e-10
mutation O 0 1.5684474118787817e-12
that O 0 9.401520225304702e-15
has O 0 1.78565344951284e-15
no O 0 8.047284796267474e-15
effect O 0 1.3377478480156284e-14
on O 0 8.822058535085109e-12
beta2m O 0 1.0871303857129533e-06
association O 0 1.3740768245451562e-10
, O 0 7.761034870323869e-12
H63D O 0 0.00016837252769619226
, O 0 1.2078845681908618e-13
was O 0 4.303660563770989e-13
found O 0 1.7064461280656695e-14
in O 0 1.6388201822271887e-15
eight O 0 7.860158379204008e-13
out O 0 5.82379400238496e-14
of O 0 1.7275510449249465e-12
nine O 0 8.591981986993957e-11
patients O 0 9.124135908616937e-13
heterozygous O 0 1.0912727969533687e-12
for O 0 1.4725321656472445e-12
the O 0 6.178514921906242e-10
C282Y O 0 1.8467866880200745e-07
mutant O 0 2.4639434936801763e-09
. O 0 6.984746114824247e-09

In O 0 2.2922167636219015e-11
this O 0 4.974559176043614e-13
report O 0 2.9838346962511586e-13
, O 0 8.222355812673979e-16
we O 0 2.746130578184093e-15
demonstrate O 0 6.883270429330901e-12
in O 0 2.120369418240342e-12
cultured O 0 7.777748223247727e-09
293 O 0 3.53821028031831e-10
cells O 0 1.3042896762627265e-09
overexpressing O 0 3.1716677995063947e-07
wild O 0 4.018744004241626e-09
- O 0 1.9903751979910567e-09
type O 0 1.550989336962516e-10
or O 0 4.1569116204787093e-11
mutant O 0 8.846866988987401e-11
HFE O 0 1.6785656953288708e-07
proteins O 0 1.845200560271834e-13
that O 0 5.748061930065432e-16
both O 0 9.814970559386682e-15
the O 0 9.205450393926992e-14
wild O 0 4.017044509529999e-12
- O 0 2.886588537642787e-12
type O 0 3.796941060174586e-12
and O 0 4.183970878091081e-12
H63D O 0 0.00010753398237284273
HFE O 0 1.4358041653395048e-06
proteins O 0 2.500379460770863e-12
form O 0 1.5355430685662363e-12
stable O 0 8.901814285700027e-10
complexes O 0 1.7313709060190474e-12
with O 0 2.2923868868012258e-15
the O 0 1.106472227209443e-12
transferrin O 0 2.0568688974265115e-09
receptor O 0 3.828823109258694e-12
( O 0 9.038698744546006e-15
TfR O 0 1.8558777847843544e-09
) O 0 1.0095872434497805e-13
. O 0 7.461270490338734e-11

The O 0 3.1474971518008488e-09
C282Y O 0 2.561628775765712e-07
mutation O 0 9.13479795278116e-12
nearly O 0 8.357269412097301e-13
completely O 0 1.4467912545085282e-12
prevents O 0 3.901968402249614e-14
the O 0 7.186831967216645e-14
association O 0 1.9153995338590246e-13
of O 0 6.56116057751871e-13
the O 0 6.77900823583405e-13
mutant O 0 1.0132168541676645e-11
HFE O 0 6.384078119481273e-07
protein O 0 3.053426608778942e-11
with O 0 1.1431267987315613e-13
the O 0 9.910023496262355e-11
TfR O 0 3.1451095310330857e-06
. O 0 2.4272894805221767e-09

Studies O 0 2.143841104640387e-09
on O 0 2.2101669452934125e-11
cell O 0 4.635919426121404e-11
- O 0 2.7628470258139748e-12
associated O 0 4.736728045386107e-13
transferrin O 0 3.0344504686752316e-09
at O 0 1.2945111128870312e-11
37 O 0 9.239109477476859e-12
degrees O 0 3.7167499633561363e-10
C O 0 1.066389643256116e-09
suggest O 0 1.5871354794652626e-12
that O 0 1.8786729137144128e-15
the O 0 1.9776574041591166e-12
overexpressed O 0 1.0821529450311118e-08
wild O 0 1.3651582642104643e-10
- O 0 9.437777642729017e-11
type O 0 3.562954098423887e-11
HFE O 0 1.825084723350301e-07
protein O 0 2.040501014682894e-12
decreases O 0 8.847814787684566e-14
the O 0 6.592904238359896e-15
affinity O 0 1.335095662496899e-12
of O 0 5.457509010681205e-12
the O 0 1.702245289170179e-11
TfR O 0 3.045067842322169e-08
for O 0 6.611967917624639e-12
transferrin O 0 9.998436922842302e-08
. O 0 3.6756809151938796e-08

The O 0 3.1234894777298905e-06
overexpressed O 0 4.8975802201312035e-05
H63D O 1 0.9995074272155762
protein O 0 1.2971741458756014e-09
does O 0 4.978144429340116e-14
not O 0 2.0428782973526578e-14
have O 0 1.6428887991102063e-15
this O 0 8.131089600794104e-16
effect O 0 2.4601978779376955e-15
, O 0 2.1876435072278082e-16
providing O 0 1.3155324269167878e-13
the O 0 1.1493174914924999e-14
first O 0 2.1523343003704287e-13
direct O 0 4.242237637563928e-12
evidence O 0 4.242836550844009e-12
for O 0 6.056530060458143e-13
a O 0 2.3662159037707298e-11
functional O 0 3.1977599235233356e-08
consequence O 0 2.0499668629270218e-10
of O 0 3.648929075561469e-11
the O 0 3.1316688131610704e-10
H63D O 0 0.00041878788033500314
mutation O 0 1.4156282812649579e-09
. O 0 2.066822490931486e-09

Addition O 0 1.2648772029777433e-09
of O 0 5.478522524526852e-09
soluble O 0 7.089950404548517e-09
wild O 0 4.053198054965179e-10
- O 0 2.2961572643254158e-09
type O 0 3.817584470766633e-09
HFE O 1 0.9991839528083801
/ O 0 0.0008845721604302526
beta2m O 0 1.3743143426836468e-05
heterodimers O 0 1.290194351355467e-08
to O 0 5.978193634570417e-11
cultured O 0 1.3797686326810776e-09
cells O 0 2.9570169229886645e-11
also O 0 9.190984045275778e-16
decreased O 0 9.245534025870139e-14
the O 0 1.0430176306449874e-15
apparent O 0 2.6514592387991143e-13
affinity O 0 2.231123055404516e-12
of O 0 2.0677312292938232e-11
the O 0 1.867305615688153e-11
TfR O 0 3.999718334313229e-09
for O 0 1.794028487778817e-14
its O 0 6.6604233521679046e-15
ligand O 0 3.73065104199502e-13
under O 0 4.15051014390766e-11
steady O 0 3.522564639979464e-08
- O 0 2.0362760089209786e-11
state O 0 1.3765228106671357e-12
conditions O 0 7.067315482833791e-11
, O 0 3.6269048711340315e-15
both O 0 7.369913395381157e-15
in O 0 2.287443983685876e-14
293 O 0 2.7515455192084204e-12
cells O 0 7.88030751763813e-12
and O 0 2.0101806504080333e-12
in O 0 4.618180837745456e-11
HeLa O 0 6.275411124079255e-08
cells O 0 3.6012590687306556e-09
. O 0 7.687413372536867e-09

Furthermore O 0 4.405341869073709e-09
, O 0 2.5380633467304847e-13
at O 0 5.259174714646042e-13
4 O 0 6.484506806297627e-14
degrees O 0 5.3314751918831504e-11
C O 0 5.723944651592205e-10
, O 0 4.9630326839347413e-14
the O 0 1.0578754669129942e-12
added O 0 1.9855842664506795e-11
soluble O 0 2.3639151400245417e-11
complex O 0 1.2170203213257569e-11
of O 0 8.635239745480305e-11
HFE O 0 4.112528586119879e-06
/ O 0 1.5084957727395931e-09
beta2m O 0 5.943180392264935e-10
inhibited O 0 4.136322361014688e-12
binding O 0 1.3586861670467076e-12
of O 0 3.7637320343675285e-11
transferrin O 0 2.0657594745898678e-08
to O 0 1.8911872956550724e-08
HeLa O 0 1.1421191175031709e-06
cell O 0 8.026737496891201e-09
TfR O 0 2.218414429933091e-08
in O 0 3.9477023538146694e-13
a O 0 4.3199055443921e-12
concentration O 0 2.003477606038473e-09
- O 0 6.785408901421874e-10
dependent O 0 5.518529522241522e-10
manner O 0 2.4960613576041624e-09
. O 0 2.1493808954886617e-09

Scatchard O 0 7.86411328590475e-06
plots O 0 1.0499294766930234e-08
of O 0 4.898982608469993e-11
these O 0 7.888434100811886e-14
data O 0 1.0199114773221107e-12
indicate O 0 1.6657006720113832e-12
that O 0 7.044099631120949e-15
the O 0 1.1497226781731484e-11
added O 0 4.2876067279928876e-11
heterodimer O 0 1.8490072320465067e-11
substantially O 0 6.903254877455023e-12
reduced O 0 3.449143097869478e-13
the O 0 9.861963947300351e-14
affinity O 0 2.001726215339339e-11
of O 0 3.233704692906514e-10
TfR O 0 6.71368312055165e-08
for O 0 1.8943648733005247e-11
transferrin O 0 8.510119897664481e-08
. O 0 3.4806092230610375e-08

These O 0 1.0213019666083234e-11
results O 0 1.8346881305864038e-11
establish O 0 1.776038344170061e-10
a O 0 5.399730142185977e-13
molecular O 0 1.4826835505882263e-12
link O 0 5.136057898424973e-11
between O 0 3.367512865781741e-11
HFE O 0 0.0010612084297463298
and O 0 5.4052998188502954e-11
a O 0 7.499482701511795e-10
key O 0 1.7892018533416376e-08
protein O 0 3.9497623921525005e-11
involved O 0 3.1628276386808096e-11
in O 0 4.14607931320532e-11
iron O 0 6.785039374790358e-08
transport O 0 1.3941713916665321e-07
, O 0 5.846266938440425e-13
the O 0 6.840107907163384e-12
TfR O 0 1.0644742332033275e-07
, O 0 2.0020858682392485e-14
and O 0 1.992345328159003e-14
raise O 0 9.265734880747889e-13
the O 0 2.3754338340092884e-13
possibility O 0 1.2986329676542563e-12
that O 0 2.8136577811567476e-14
alterations O 0 1.4461690178713127e-10
in O 0 3.305658969211117e-13
this O 0 3.4821809064694564e-13
regulatory O 0 1.303597507718024e-10
mechanism O 0 3.459809105876843e-10
may O 0 6.300513496343418e-12
play O 0 7.107643917869666e-10
a O 0 3.992001521013755e-11
role O 0 2.417741007398888e-11
in O 0 9.463708029039397e-13
the O 0 4.523173936094027e-12
pathogenesis O 0 5.106795128995145e-07
of O 0 7.265095547381861e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.4709799600609585e-08
. O 0 3.766828793327903e-10

Genomic O 0 7.3700205938109775e-09
organization O 0 1.1049812323818409e-12
of O 0 8.430455986085938e-12
the O 0 6.065784680098218e-11
UBE3A O 0 6.817042594775558e-05
/ O 0 2.2056600101905133e-08
E6 O 0 4.874448222835781e-08
- O 0 2.6868363089960212e-09
AP O 0 2.1179202391863328e-08
gene O 0 5.6351269001530743e-14
and O 0 3.4962195458339545e-15
related O 0 9.548931090286317e-12
pseudogenes O 0 2.096609108548364e-09
. O 0 6.672618013681131e-11

The O 0 3.5261507602690756e-10
UBE3A O 0 4.3229644575148996e-07
gene O 0 2.10433707677031e-13
encodes O 0 1.3864797710535365e-13
the O 0 8.493930385433668e-13
E6 O 0 1.4506903234234869e-08
- O 0 1.8740269780437302e-08
AP O 0 3.4191666031802015e-07
ubiquitin O 0 3.2935631999464476e-09
- O 0 2.8600866466832464e-11
protein O 0 2.39550217905277e-14
ligase O 0 3.534452664897235e-14
and O 0 6.003708967282752e-15
has O 0 1.9628994612394367e-16
recently O 0 2.372474698997067e-15
been O 0 3.528844872682026e-16
shown O 0 4.511156869607159e-15
to O 0 1.149194671715148e-14
be O 0 5.066714598876351e-14
mutated O 0 5.885940068672824e-10
in O 0 1.0309084697013304e-09
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.2995758630628416e-09
who O 0 2.1843000498622533e-12
lack O 0 2.7006793246187044e-08
15q11 O 0 2.5158371954603354e-06
- O 0 1.8235793319831828e-08
q13 O 0 2.9679833701834468e-08
deletions O 0 6.035873467702402e-10
or O 0 1.7101296507365804e-12
chromosome O 0 4.086741223208179e-10
15 O 0 1.0094217683942475e-09
paternal O 0 7.36780918941804e-07
uniparental B-Disease 0 0.0009551456896588206
disomy I-Disease 0 8.963034633779898e-05
. O 0 1.5638717343335884e-07

Previous O 0 4.0769823073105727e-08
UBE3A O 0 6.330911901386571e-07
cDNA O 0 7.87109577515821e-09
analysis O 0 3.656660911566245e-12
has O 0 2.0501367079661371e-16
shown O 0 1.0706034820338103e-14
a O 0 4.551772777054361e-14
coding O 0 2.656516340238113e-09
region O 0 6.278422781669235e-10
of O 0 2.2247542350029015e-11
approximately O 0 6.432406256945411e-12
2 O 0 1.194242205126983e-10
. O 0 1.931671045340977e-09

6 O 0 4.1595646926850804e-09
kb O 0 1.6419022585978382e-07
and O 0 8.103683197570322e-13
a O 0 6.692319441670147e-12
3 O 0 1.4770286382859155e-10
- O 0 2.8660762652066296e-08
untranslated O 0 0.00012780475663021207
region O 0 4.867394487462207e-09
( O 0 1.4807265859956807e-14
UTR O 0 7.98953294633975e-08
) O 0 2.305661798908832e-14
of O 0 1.5947831596974105e-11
< O 0 7.551097525038131e-10
50 O 0 7.35596930589999e-11
bp O 0 8.862776484930279e-11
, O 0 8.843563359915707e-14
whereas O 0 7.353079256589012e-11
Northern O 0 1.793536014149666e-10
analysis O 0 3.981338696223968e-12
has O 0 8.831266093235822e-16
indicated O 0 5.471741359704477e-14
mRNA O 0 8.613078132657659e-12
sizes O 0 7.773613350248176e-12
of O 0 4.3307257779900965e-10
5 O 0 4.608057491140016e-09
- O 0 5.8090233068242014e-08
8 O 0 1.2033477547745974e-09
kb O 0 3.4589095321280183e-07
. O 0 2.025146272899292e-09

We O 0 5.221023058332719e-10
have O 0 4.591265518813503e-13
analyzed O 0 6.021651276569284e-13
additional O 0 6.024014972830574e-14
cDNA O 0 1.3423878675311585e-09
clones O 0 2.470879334470766e-10
and O 0 6.813655000457997e-14
provide O 0 8.239291952698291e-13
evidence O 0 8.443179965941794e-13
for O 0 9.671492664890813e-14
an O 0 6.858089671244599e-14
additional O 0 1.967589979834372e-11
0 O 0 6.519501605239952e-11
. O 0 5.138415026806342e-09

5 O 0 2.2237796326596282e-10
kb O 0 5.522062451746024e-08
of O 0 1.2833038798287788e-10
5 O 0 1.9226496783542046e-10
- O 0 3.3261258192140986e-09
UTR O 0 1.3741625082275277e-07
and O 0 1.555417426801764e-11
> O 0 3.119195873813041e-11
2 O 0 5.367937539781098e-13
kb O 0 1.7504031557535882e-09
of O 0 4.671949979662138e-11
3 O 0 5.743092668097916e-10
- O 0 2.3822002148676802e-08
UTR O 0 1.9150720618199557e-06
. O 0 1.9770267645213835e-09

We O 0 8.653062988361881e-11
have O 0 1.6666809805106902e-14
established O 0 7.952560254743078e-15
the O 0 5.669836849199722e-16
genomic O 0 5.686187740279458e-13
organization O 0 6.0107215530530705e-15
of O 0 5.127830668763544e-13
UBE3A O 0 3.4740571663860464e-07
and O 0 1.9524361511216726e-13
the O 0 7.129750891239628e-13
sequence O 0 1.7976072019809664e-11
of O 0 9.453402505243957e-10
intron O 0 4.358149681138457e-07
- O 0 4.6968494871180155e-07
exon O 0 1.9009698704053335e-08
borders O 0 7.199898455212406e-09
. O 0 1.532365878631481e-08

We O 0 6.505840866033452e-10
have O 0 1.0852036500322293e-12
also O 0 1.0572575800948947e-13
mapped O 0 5.266769312339825e-11
two O 0 8.388346983169426e-13
highly O 0 1.701333345038858e-11
homologous O 0 2.1965056162809304e-10
processed O 0 2.4859495018070277e-10
pseudogenes O 0 7.331772078345011e-09
, O 0 1.1062844433931684e-12
UBE3AP1 O 0 0.000989378895610571
and O 0 5.54140448805196e-11
UBE3AP2 O 1 0.9999998807907104
, O 0 3.9621404030951157e-13
to O 0 3.720477051438742e-12
chromosomes O 0 4.090217053942524e-11
2 O 0 6.693260854416516e-13
and O 0 7.25626630722169e-14
21 O 0 3.284374291631642e-12
, O 0 1.1100201602342891e-14
respectively O 0 1.8778886431980446e-11
, O 0 8.636737565360583e-15
and O 0 6.2406075654873085e-15
determined O 0 4.9227804992113544e-12
their O 0 2.608408801452189e-11
genomic O 0 1.5783290230331204e-09
organization O 0 1.4606341136591539e-10
. O 0 4.501612860252635e-09

These O 0 1.8535128293306613e-11
results O 0 1.9309423851532337e-12
will O 0 5.668047343867881e-14
form O 0 1.6931858272764035e-14
the O 0 3.8523609012541295e-15
basis O 0 2.0704641614469749e-13
for O 0 1.780837220174752e-15
studies O 0 1.3171796010673364e-13
of O 0 9.359247182599492e-14
mutation O 0 4.1876627897763016e-14
and O 0 4.911992579174906e-13
imprinting O 0 1.5286912002920872e-07
of O 0 2.519312758408887e-08
UBE3A O 0 0.000751738902181387
. O 0 3.0972688591646147e-07

Mutation O 0 2.500558371476558e-10
spectrum O 0 1.3007288302002706e-10
and O 0 5.250935862337325e-13
genotype O 0 5.3315107884088775e-09
- O 0 6.956516473977103e-10
phenotype O 0 7.684487768333526e-11
analyses O 0 5.064680879546257e-12
in O 0 1.4958573388203916e-13
Cowden B-Disease 0 3.536615338362026e-07
disease I-Disease 0 5.26201249240188e-10
and O 0 2.8429311856037476e-12
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.5700487784875428e-12
two O 0 2.0150761267934136e-11
hamartoma B-Disease 1 0.9950897693634033
syndromes I-Disease 0 5.96307927480666e-07
with O 0 1.2482705979977027e-09
germline O 1 0.7184886336326599
PTEN O 0 0.007374354638159275
mutation O 0 2.2817816969222804e-08
. O 0 2.5342177245590847e-09

The O 0 6.101234703237424e-06
tumour B-Disease 1 1.0
suppressor O 0 1.1073960877183708e-06
gene O 0 1.8320350791967144e-10
PTEN O 0 3.686043825723573e-08
, O 0 5.516276996818392e-14
which O 0 5.431039203127421e-16
maps O 0 5.175331517504045e-12
to O 0 2.584692460061433e-10
10q23 O 0 3.938190729968483e-06
. O 0 1.584706765811461e-08

3 O 0 3.7983583834645673e-13
and O 0 8.45202826692639e-16
encodes O 0 1.9743140242970764e-16
a O 0 9.241288273222027e-17
403 O 0 9.033695320926575e-16
amino O 0 4.569140933527926e-15
acid O 0 1.3279653798044938e-14
dual O 0 1.724664508429008e-11
specificity O 0 4.266693665044841e-09
phosphatase O 0 4.628965143638197e-06
( O 0 9.703676751016133e-11
protein O 0 6.306235889042e-08
tyrosine O 0 3.50657103354024e-07
phosphatase O 0 7.298609716599458e-08
; O 0 2.9954673724102987e-13
PTPase O 0 1.1080310002853366e-08
) O 0 4.581950083393661e-16
, O 0 7.306502232548654e-17
was O 0 2.7038341997211862e-15
shown O 0 5.4249570195221905e-14
recently O 0 7.586696570451024e-14
to O 0 2.4817305328828088e-12
play O 0 1.162386964459472e-09
a O 0 5.708680195226634e-10
broad O 0 4.5460121778084783e-10
role O 0 4.0896633302089924e-11
in O 0 3.159553868536946e-11
human O 0 6.90260737457038e-09
malignancy B-Disease 0 0.0008469707099720836
. O 0 8.650843597024505e-09

Somatic O 0 1.789809175534174e-05
PTEN O 0 3.7136614992050454e-06
deletions O 0 9.59660084731695e-09
and O 0 2.020999036525528e-12
mutations O 0 4.298650411321825e-12
were O 0 1.8905981381128756e-13
observed O 0 8.254891724606556e-14
in O 0 9.171258045538588e-14
sporadic B-Disease 0 2.9842066595620054e-08
breast I-Disease 0 9.231868602910254e-08
, I-Disease 0 5.508420802824432e-11
brain I-Disease 1 1.0
, I-Disease 0 2.5376183376835115e-09
prostate I-Disease 1 1.0
and I-Disease 1 0.9999656677246094
kidney I-Disease 1 1.0
cancer I-Disease 0 0.13980616629123688
cell O 0 2.1921886528275536e-08
lines O 0 3.2242063185972114e-11
and O 0 2.5061490765130624e-14
in O 0 6.718627824225942e-12
several O 0 1.984665209953107e-10
primary O 1 0.9612352848052979
tumours B-Disease 1 1.0
such O 0 1.338111177418e-09
as O 0 7.051853856410162e-08
endometrial B-Disease 1 0.998867392539978
carcinomas I-Disease 1 1.0
, O 1 0.800287663936615
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9993247985839844
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 8.23746267997194e-06

In O 0 1.553899196815589e-11
addition O 0 3.0985589528215174e-12
, O 0 1.6628334180510823e-13
PTEN O 0 1.2369847368631781e-08
was O 0 1.1172432336920002e-12
identified O 0 6.33978384113193e-13
as O 0 1.0702477281959635e-15
the O 0 5.565394828067069e-15
susceptibility O 0 7.8400454802275e-14
gene O 0 1.1616282683478939e-14
for O 0 4.991790943272012e-13
two O 0 8.512985316677657e-10
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 0.9999990463256836
Cowden B-Disease 1 0.999994158744812
disease I-Disease 0 0.15367920696735382
( O 0 5.276433519166117e-14
CD B-Disease 0 0.00036729880957864225
; O 0 1.0258214416802858e-11
MIM O 0 2.4784392849142023e-07
158350 O 0 3.2663620697093165e-09
) O 0 1.2527555880002426e-15
and O 0 1.5231335615505104e-13
Bannayan B-Disease 1 0.9971722960472107
- I-Disease 0 1.5678017007303424e-05
Zonana I-Disease 0 9.953031985787675e-05
( I-Disease 0 3.02865046410139e-13
BZS I-Disease 0 3.973342899143972e-08
) I-Disease 0 4.1199756669832053e-16
or I-Disease 0 1.6139921430596837e-14
Ruvalcaba I-Disease 0 2.10032347069955e-09
- I-Disease 0 1.9248695692919426e-10
Riley I-Disease 0 8.765616144046362e-07
- I-Disease 1 1.0
Smith I-Disease 1 0.9999532699584961
syndrome I-Disease 1 1.0
( O 0 2.58702158003124e-13
MIM O 0 2.3339032395597314e-06
153480 O 0 1.0158617058664277e-08
) O 0 3.3082372697399234e-14
. O 0 3.848681789930808e-11

Constitutive O 0 2.5909342227237175e-08
DNA O 0 4.4728727388587686e-09
from O 0 1.9613466666762447e-12
37 O 0 2.717773922578104e-11
CD B-Disease 0 3.0366273939819166e-09
families O 0 8.187532140983833e-13
and O 0 3.167797851832445e-14
seven O 0 6.181596901022601e-12
BZS B-Disease 0 2.4885193283807894e-07
families O 0 4.731842630396887e-13
was O 0 8.883143786525549e-13
screened O 0 2.991713474176372e-11
for O 0 2.4390808817109644e-10
germline O 0 1.2213333320687525e-05
PTEN O 0 9.242629857908469e-06
mutations O 0 2.0114965693096565e-08
. O 0 1.6936301250325414e-08

PTEN O 0 4.246502612659242e-06
mutations O 0 7.49001555222506e-11
were O 0 2.148298493308623e-13
identified O 0 4.679371514294643e-14
in O 0 1.7883938128554445e-15
30 O 0 2.0768319518565254e-13
of O 0 1.4081585290176557e-12
37 O 0 1.4538216464021758e-10
( O 0 1.6093565011459504e-14
81 O 0 2.3141474847498955e-10
% O 0 1.1486421189199625e-11
) O 0 5.17403723083185e-16
CD B-Disease 0 5.06204966832513e-10
families O 0 5.597668053906879e-13
, O 0 1.4943766913472732e-14
including O 0 1.137283084547136e-13
missense O 0 1.4067090603475663e-08
and O 0 1.364432788975023e-09
nonsense O 0 3.427229842145607e-07
point O 0 4.674637565926787e-09
mutations O 0 2.5775921327908513e-11
, O 0 1.397445310510892e-12
deletions O 0 1.3872569759598719e-10
, O 0 1.6664211785651084e-13
insertions O 0 7.650154398852749e-10
, O 0 1.3818621540009207e-13
a O 0 1.3778500042305186e-11
deletion O 0 4.5359067613048865e-09
/ O 0 9.228732444910293e-09
insertion O 0 1.0304450626108519e-08
and O 0 5.898313504282271e-10
splice O 0 6.521023806271842e-06
site O 0 1.9012309948607253e-08
mutations O 0 3.1606599559808046e-09
. O 0 1.867535459609826e-09

These O 0 1.729827045493515e-11
mutations O 0 1.9131003205219432e-12
were O 0 3.1831471052762295e-13
scattered O 0 3.3325722823690507e-12
over O 0 1.380807614922248e-14
the O 0 1.6322240867922e-13
entire O 0 1.1425186352553851e-09
length O 0 2.0661709843050602e-10
of O 0 3.272034865275941e-10
PTEN O 0 3.8513537248263674e-08
, O 0 5.288817140854975e-14
with O 0 1.4026986308726197e-15
the O 0 3.511326429270212e-13
exception O 0 5.227871087420954e-13
of O 0 3.93785075077438e-13
the O 0 4.353045972727704e-13
first O 0 7.270127208580668e-12
, O 0 1.110253721099165e-13
fourth O 0 1.596598853126352e-09
and O 0 4.892294468844538e-12
last O 0 2.5333237729796565e-09
exons O 0 1.0327397603759891e-07
. O 0 5.051192353278111e-09

A O 0 1.9677449017763138e-05
hot O 0 9.372883802427623e-09
spot O 0 5.4148920902719055e-09
for O 0 5.8578671427444995e-12
PTEN O 0 2.3614132871330185e-08
mutation O 0 1.0065689601268524e-12
in O 0 1.608823209202359e-13
CD B-Disease 0 2.604217108626017e-08
was O 0 3.087670050194724e-11
identified O 0 4.136758297024201e-11
in O 0 1.3585287408912627e-11
exon O 0 7.09830971779013e-10
5 O 0 6.08130473062074e-12
that O 0 4.40401973786711e-14
contains O 0 2.364885664954495e-14
the O 0 5.371935101611269e-12
PTPase O 0 1.1963417136939825e-06
core O 0 6.72554900660316e-09
motif O 0 3.527077241383125e-11
, O 0 3.431553662508772e-15
with O 0 8.803583468332775e-16
13 O 0 3.0087822424501587e-12
of O 0 2.8962575393531864e-11
30 O 0 1.2995355659628505e-11
( O 0 5.586495265816121e-15
43 O 0 1.6459228424636763e-10
% O 0 1.1243946745898015e-11
) O 0 6.605264143126231e-15
CD B-Disease 0 8.835370768345285e-10
mutations O 0 6.639792882179307e-13
identified O 0 1.7552916585505951e-12
in O 0 7.194200747281942e-13
this O 0 2.553292646756411e-11
exon O 0 1.0253359938872109e-08
. O 0 7.233208254575629e-09

Seven O 0 8.142836627200722e-09
of O 0 1.7836632171253086e-10
30 O 0 3.231125783598188e-11
( O 0 2.6746793256766932e-15
23 O 0 4.168994576642104e-12
% O 0 3.190107900064021e-12
) O 0 6.593454280380019e-16
were O 0 1.2412434361591673e-12
within O 0 9.867981431987971e-11
the O 0 2.352701367058785e-11
core O 0 8.585220312440356e-10
motif O 0 9.190722835561438e-12
, O 0 8.941986216694404e-15
the O 0 3.9606141174867993e-13
majority O 0 6.865072312706166e-12
( O 0 1.261719864735977e-14
five O 0 3.669805084816069e-11
of O 0 2.8926968459463964e-11
seven O 0 9.658143035329303e-11
) O 0 2.225115741888526e-14
of O 0 4.1292672406378905e-12
which O 0 3.716035454608829e-13
were O 0 7.20175252766353e-09
missense O 0 2.3826757455935876e-07
mutations O 0 4.308003676012362e-10
, O 0 1.7118136335508849e-12
possibly O 0 6.682326358919966e-10
pointing O 0 2.8369715465714762e-09
to O 0 6.991802969924521e-11
the O 0 2.2889062867292864e-10
functional O 0 4.734093295155617e-08
significance O 0 1.080388556395917e-10
of O 0 4.509581076617142e-12
this O 0 2.9873100521049523e-12
region O 0 4.058421598784889e-09
. O 0 4.9841708538167495e-09

Germline O 0 0.0006459677824750543
PTEN O 0 2.8249321530893212e-06
mutations O 0 7.232179438654285e-11
were O 0 1.4108301386959315e-13
identified O 0 2.9662483949123575e-14
in O 0 2.7359147255654956e-15
four O 0 5.963937297574079e-14
of O 0 3.486760034344949e-13
seven O 0 5.720805773545834e-12
( O 0 3.8366831684334e-15
57 O 0 4.3599326926546667e-10
% O 0 1.9171567111619936e-10
) O 0 8.920394804767806e-13
BZS B-Disease 0 8.104419180199329e-07
families O 0 3.5022471034373837e-11
studied O 0 1.1253098453067878e-09
. O 0 6.016038778255961e-09

Interestingly O 0 1.37402311750634e-08
, O 0 1.6661192282600712e-13
none O 0 4.4883680105911594e-12
of O 0 5.968275461516737e-13
these O 0 1.2232584194714347e-13
mutations O 0 6.027488621065946e-13
was O 0 5.453936998203734e-13
observed O 0 4.347486455037741e-13
in O 0 9.433430599170567e-13
the O 0 2.5786800472715754e-10
PTPase O 0 5.653339758282527e-05
core O 0 2.563535019817209e-07
motif O 0 1.7175993960449887e-08
. O 0 8.811275264974938e-09

It O 0 1.8400632580128917e-12
is O 0 6.546016306048161e-15
also O 0 3.45465537441439e-16
worthy O 0 4.8367202604149284e-11
of O 0 8.475453845691039e-12
note O 0 1.3148257439407618e-12
that O 0 2.923597533161025e-15
a O 0 2.928712773599823e-13
single O 0 2.0813241408124128e-10
nonsense O 0 2.5058557895363265e-08
point O 0 2.787675645876675e-10
mutation O 0 2.8203878035121255e-12
, O 0 1.3085031376567496e-13
R233X O 0 1.0975372610744216e-08
, O 0 4.3798440622997564e-14
was O 0 4.154600654390078e-13
observed O 0 1.5244791919718365e-13
in O 0 3.732727492443237e-14
the O 0 5.731495464865455e-13
germline O 0 4.745011494833307e-09
DNA O 0 1.8912078569854884e-09
from O 0 1.7838551816251602e-12
two O 0 3.226750192996536e-13
unrelated O 0 1.8928482045654782e-11
CD B-Disease 0 2.6233808014808346e-08
families O 0 5.976981930222447e-12
and O 0 1.494523471992637e-12
one O 0 1.2872607146885429e-10
BZS B-Disease 0 5.203932960284874e-05
family O 0 3.755945554573259e-10
. O 0 3.6415557236324503e-09

Genotype O 0 1.0220907142866054e-06
- O 0 3.5067826420487336e-09
phenotype O 0 1.3164624772243894e-11
studies O 0 1.7982020223978462e-13
were O 0 6.34912010932711e-15
not O 0 1.4207716669890663e-15
performed O 0 9.994046605912854e-13
on O 0 1.1605133087150277e-12
this O 0 9.50077893419575e-14
small O 0 9.237320516787204e-14
group O 0 1.8473193962487318e-14
of O 0 3.520812807966678e-11
BZS B-Disease 0 4.835158688365482e-05
families O 0 2.1151094209415078e-09
. O 0 3.6459919527942475e-08

However O 0 6.559978255049614e-11
, O 0 1.5091488443034345e-13
genotype O 0 3.571726525652963e-10
- O 0 4.4273480714895896e-11
phenotype O 0 2.7875412048072867e-11
analysis O 0 8.162085373894512e-13
inthe O 0 1.2124023562876118e-08
group O 0 1.099270719210569e-14
of O 0 1.0844338664897646e-12
CD B-Disease 0 5.806358785775956e-06
families O 0 1.8083201602792087e-10
revealed O 0 3.7598088531431983e-10
two O 0 5.722906957356111e-14
possible O 0 2.0949259308625928e-13
associations O 0 1.335232515916121e-13
worthy O 0 7.706258964290669e-10
of O 0 7.373669036470076e-11
follow O 0 6.017837339555854e-10
- O 0 9.818809654227323e-11
up O 0 3.423726796861204e-12
in O 0 8.769694497499925e-13
independent O 0 2.9663264899948416e-11
analyses O 0 2.3486776967729384e-09
. O 0 5.155877391693764e-10

The O 0 1.3202727799921377e-10
first O 0 8.866237605209548e-12
was O 0 1.4732513169482542e-12
an O 0 2.6705398756634614e-15
association O 0 4.099583221723116e-14
noted O 0 2.0297159135720944e-14
in O 0 4.543365720942978e-15
the O 0 4.352080693981013e-14
group O 0 2.299611601385272e-16
of O 0 4.547052431845902e-14
CD B-Disease 0 1.1656161547080046e-07
families O 0 1.3431938894470363e-10
with O 0 4.90266771624448e-10
breast B-Disease 0 0.24622374773025513
disease I-Disease 0 0.0023679006844758987
. O 0 2.7152685788678355e-07

A O 0 6.396032148359154e-09
correlation O 0 4.672455131138342e-12
was O 0 1.8544719118619366e-14
observed O 0 4.6280647805036716e-15
between O 0 1.1559304471183036e-14
the O 0 3.3042138632404655e-14
presence O 0 1.3600343724481934e-12
/ O 0 3.853319052726789e-10
absence O 0 1.1141210176646155e-09
of O 0 1.3450730806940925e-10
a O 0 3.2995960130843827e-11
PTEN O 0 7.559227910292066e-09
mutation O 0 2.128862136487747e-13
and O 0 9.200315171980968e-16
the O 0 1.3648743322613316e-14
type O 0 1.699180032788128e-11
of O 0 8.64567167857544e-11
breast O 0 4.306699885603393e-09
involvement O 0 1.7152136422282638e-07
( O 0 1.4833887590492978e-11
unaffected O 0 6.581304887731676e-07
versus O 0 6.688667053822428e-05
benign O 0 8.536424138583243e-05
versus O 0 2.1405730876722373e-06
malignant O 0 2.4469170512020355e-06
) O 0 2.9822090977238425e-12
. O 0 6.659297002720166e-10

Specifically O 0 7.431486676034993e-11
and O 0 5.5500485392386e-14
more O 0 1.6079075030589062e-15
directly O 0 6.448655086484234e-13
, O 0 3.360153020219971e-15
an O 0 3.1032504684165834e-15
association O 0 1.3627679984907354e-13
was O 0 4.180189614594321e-12
also O 0 2.3343300525251274e-15
observed O 0 1.5576951146599634e-14
between O 0 4.911018423522928e-13
the O 0 3.191092138796203e-13
presence O 0 7.310504198526635e-13
of O 0 5.878933190955893e-12
a O 0 2.0458225391539742e-10
PTEN O 0 3.5455588658805937e-05
mutation O 0 1.2350972156127682e-06
and O 0 1.5237554862324032e-06
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9999138116836548
. O 0 3.441200746578943e-08

Secondly O 0 1.062466708390275e-06
, O 0 8.300466217137092e-12
there O 0 2.5719663486641064e-13
appeared O 0 1.3284709703825781e-12
to O 0 1.702436043700406e-12
be O 0 4.483585377967891e-12
an O 0 2.020066405816756e-12
interdependent O 0 1.2634015433832246e-07
association O 0 1.0136175926378499e-10
between O 0 6.069004743203266e-10
mutations O 0 6.696154047913794e-11
upstream O 0 3.151929273137455e-10
and O 0 3.303144162272037e-13
within O 0 5.474675157657316e-10
the O 0 1.105324387573603e-09
PTPase O 0 7.97129760030657e-05
core O 0 3.216662776139856e-07
motif O 0 6.907217464657833e-09
, O 0 2.856835644785005e-12
the O 0 6.690204640280584e-11
core O 0 6.95301816122651e-09
motif O 0 4.3681374489734637e-11
containing O 0 1.2717473287567754e-13
the O 0 1.0598728925753642e-12
majority O 0 1.196612947618192e-11
of O 0 2.1086635215716854e-10
missense O 0 1.2680567706979673e-08
mutations O 0 1.6168415564732364e-11
, O 0 6.74747419870665e-15
and O 0 1.4558297254012114e-15
the O 0 6.20378517979768e-14
involvement O 0 4.2256927124117993e-11
of O 0 3.8980191297000033e-10
all O 0 1.048877044246277e-11
major O 0 2.3190609155232522e-10
organ O 0 8.104135673647761e-08
systems O 0 0.0003937065484933555
( O 0 2.7213389874880534e-10
central O 1 0.9999974966049194
nervous O 0 0.000204157768166624
system O 0 2.001837310672272e-05
, O 0 9.432181424795516e-11
thyroid O 0 1.05633898783708e-06
, O 0 5.84397669145531e-11
breast O 0 6.199838389875367e-05
, O 0 3.4453893071884067e-09
skin O 1 1.0
and O 1 0.9999711513519287
gastrointestinal O 1 1.0
tract O 0 0.04199320450425148
) O 0 1.5779128004211884e-10
. O 0 4.655305474443594e-07

However O 0 4.248948748397652e-09
, O 0 2.23342964131637e-13
these O 0 3.5963626418252306e-14
observations O 0 1.7112913733643986e-12
would O 0 8.223524400503834e-14
need O 0 2.2089730218610715e-12
to O 0 1.5990344898880737e-12
be O 0 3.986176894208576e-13
confirmed O 0 2.063833479115651e-12
by O 0 1.3101431289679055e-14
studying O 0 3.2815189367901842e-12
a O 0 7.288613479037795e-14
larger O 0 1.9047749963137066e-14
number O 0 1.087081491583106e-14
of O 0 6.245579140667923e-13
CD B-Disease 0 1.0313284093399488e-07
families O 0 5.361284749483275e-10
. O 0 1.0629482183333039e-08

Molecular O 0 4.713748325002598e-08
defects O 0 6.648439921264071e-06
leading O 0 1.5092202487743123e-10
to O 0 8.171904125608975e-12
human O 0 1.9220870228764397e-08
complement B-Disease 1 1.0
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 6.751999675515263e-13
an O 0 3.9606156823801693e-16
African O 0 3.1721223954853106e-13
- O 0 1.1305373819178385e-13
American O 0 2.020811903230557e-14
family O 0 2.6395007598871423e-13
. O 0 7.781698029007966e-12

Complement B-Disease 0 4.991248351871036e-05
component I-Disease 1 0.9996311664581299
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 7.632143072915099e-13
C6D B-Disease 0 0.0031507110688835382
) O 0 2.2456237647942683e-14
was O 0 4.722684049385251e-12
diagnosed O 0 1.1894281115587546e-09
in O 0 5.4387155450910316e-14
a O 0 5.464180065990927e-14
16 O 0 1.3044960619525148e-13
- O 0 4.16727038686786e-15
year O 0 1.4096438859939608e-13
- O 0 2.620238824090765e-13
old O 0 2.251653204166093e-11
African O 0 4.8508991962181724e-12
- O 0 4.252365434331395e-15
American O 0 2.1005151505569442e-17
male O 0 3.031317465920433e-15
with O 0 3.217612410031886e-16
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.3498355211361002e-10

The O 0 7.38585859139107e-11
patients O 0 1.288827378154167e-11
father O 0 4.4871377447019967e-11
and O 0 2.9247050202692304e-13
two O 0 2.6659384335520064e-12
brothers O 0 2.930459347405545e-11
also O 0 5.46686231440302e-13
had O 0 2.7516466535870698e-11
C6D B-Disease 0 0.002157852752134204
, O 0 4.111556540652324e-14
but O 0 1.0952064010197587e-14
gave O 0 1.5098744466073705e-13
no O 0 4.050274384544833e-15
history O 0 2.1186312253174133e-12
of O 0 1.502991481272531e-11
meningitis B-Disease 1 1.0
or O 0 2.4553699351503866e-11
other O 0 6.960530676142218e-12
neisserial B-Disease 0 4.743502358905971e-06
infection I-Disease 0 2.846756251528859e-05
. O 0 1.788475145758639e-08

By O 0 1.5679852097163875e-14
using O 0 1.4768545273432382e-13
exon O 0 1.494643818433783e-11
- O 0 7.958330581992953e-14
specific O 0 8.522869338074412e-16
polymerase O 0 1.8964724640680147e-15
chain O 0 3.467265206839724e-15
reaction O 0 4.205610234729472e-17
( O 0 2.0422655054112663e-19
PCR O 0 9.997182592934133e-15
) O 0 1.974974982965537e-18
/ O 0 6.514351991018308e-16
single O 0 1.2013396293107225e-15
- O 0 5.458581008802987e-16
strand O 0 1.2351036331376998e-15
conformation O 0 1.4751160303354814e-15
polymorphism O 0 1.0346235044915442e-13
as O 0 1.5187962488759648e-17
a O 0 1.7188508726386496e-16
screening O 0 7.404236864469796e-15
step O 0 1.9838523998474272e-13
and O 0 1.311605001955748e-15
nucleotide O 0 1.0302622470426126e-12
sequencing O 0 1.6325098217695455e-10
of O 0 1.1176493064368742e-10
target O 0 3.511950064094549e-09
exons O 0 9.635924946849173e-09
, O 0 1.1611039549535435e-13
we O 0 1.9479565665581414e-14
determined O 0 1.3070171030540867e-12
that O 0 4.456134879902941e-15
the O 0 1.43111163111026e-12
proband O 0 8.75218617579776e-08
was O 0 1.2734956318649626e-12
a O 0 1.2606597352398524e-13
compound O 0 7.103326607471594e-12
heterozygote O 0 5.425881521858855e-09
for O 0 8.138336358987086e-12
two O 0 3.4069494447841464e-10
C6 O 0 1.1096024536527693e-05
gene O 0 5.985932305385688e-10
mutations O 0 5.870612884706361e-10
. O 0 6.317345313533451e-09

The O 0 5.371571520917939e-10
first O 0 5.665018801281896e-11
, O 0 2.9184190871237026e-13
1195delC O 0 1.2521174319601869e-08
located O 0 2.614668681219512e-12
in O 0 8.289750721805766e-13
exon O 0 6.135990049394024e-10
7 O 0 2.5687688087749905e-10
, O 0 1.824462672952998e-12
is O 0 5.6934640921095514e-15
a O 0 3.322762868345798e-14
novel O 0 2.9224618737369937e-14
mutation O 0 2.3257106960758445e-13
, O 0 5.806310903540453e-15
while O 0 2.1357518347180776e-13
the O 0 3.3225824435517692e-12
second O 0 5.546842429815513e-10
, O 0 1.2792361571076216e-12
1936delG O 0 2.3736280496677864e-08
in O 0 2.3050188494022628e-11
exon O 0 4.364342498508478e-10
12 O 0 4.1517456139672504e-11
, O 0 7.130865993174029e-13
has O 0 2.311284403612706e-14
been O 0 3.2748895826065216e-13
described O 0 1.0859883955646743e-12
before O 0 7.63077882132146e-12
to O 0 5.075700970635921e-10
cause O 0 1.7622433290398476e-07
C6D B-Disease 1 0.9272918105125427
in O 0 6.979541510715448e-12
an O 0 8.281796879143141e-14
unrelated O 0 7.157963805015655e-11
African O 0 1.2396997317587477e-10
- O 0 2.346882887679924e-12
American O 0 9.570729625485441e-14
individual O 0 2.433984871291761e-12
. O 0 1.3915162355715438e-09

Both O 0 5.4091980894455105e-11
mutations O 0 7.602131597839179e-12
result O 0 5.9753638669002296e-12
in O 0 4.710997651008464e-12
premature O 0 4.414122400930864e-09
termination O 0 5.599441799120086e-09
codons O 0 4.156535116095483e-09
and O 0 1.472033883676005e-10
C6 O 0 4.194218377051584e-07
null O 0 3.1974349834484883e-09
alleles O 0 7.451926575807732e-11
. O 0 6.595150203736466e-09

Allele O 0 1.8699628512308664e-09
- O 0 2.827535297914019e-12
specific O 0 2.3092222171993207e-14
PCR O 0 1.0153598881817993e-12
indicated O 0 3.694302351010814e-14
that O 0 2.084733371650045e-17
the O 0 4.372463271307267e-15
probands O 0 2.034472812439958e-09
two O 0 1.0877374847194365e-13
brothers O 0 6.921924838865223e-12
also O 0 4.219033840823991e-14
inherited O 0 3.714537011312302e-11
the O 0 3.999504178363311e-13
1195delC O 0 1.858214693228888e-10
mutation O 0 5.617248745141967e-14
from O 0 2.5071722923133456e-14
their O 0 4.453745532095876e-12
heterozygous O 0 3.844675966480082e-11
mother O 0 4.1899279185075855e-12
and O 0 4.226476211111746e-14
the O 0 2.5105917778739384e-12
1936delG O 0 2.0129693467652032e-09
mutation O 0 4.910268697720654e-13
from O 0 7.443434161136936e-14
their O 0 2.089699073504203e-12
homozygous O 0 3.30105630330646e-11
father O 0 4.53830792390697e-11
. O 0 1.7720989606284654e-11
. O 0 7.180214756097314e-10

PAX6 O 0 0.00044912766315974295
mutations O 0 8.121554984086288e-09
reviewed O 0 2.9699751546985453e-09
. O 0 2.3827853024016576e-09

Mutations O 0 1.4286190896939388e-08
in O 0 8.863604988862406e-11
PAX6 O 0 2.181104355258867e-05
are O 0 5.778740116632597e-13
responsible O 0 8.30344213526013e-12
for O 0 3.8322496218046176e-12
human O 0 3.5407838883116938e-09
aniridia B-Disease 1 1.0
and O 0 1.520128294074663e-11
have O 0 9.748891147479122e-14
also O 0 3.2472198114284496e-15
been O 0 1.259786512033869e-14
found O 0 1.2660205051190712e-14
in O 0 9.865006489646888e-15
patients O 0 2.1527284078601272e-13
with O 0 3.8362994963896113e-13
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 9.083721275171541e-11
with O 0 3.258571412700917e-09
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 4.4050558756225655e-09
with O 0 1.9335132106501618e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9968448877334595
keratitis I-Disease 1 1.0
, O 0 5.80742431140896e-13
and O 0 1.0461473267525667e-12
with O 0 3.1330802396922763e-09
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9998637437820435

No O 0 1.1856086945538635e-10
locus O 0 2.116007195851477e-11
other O 0 9.555863180821592e-14
than O 0 3.0489887416045025e-13
chromosome O 0 4.4211054262000005e-10
11p13 O 0 1.396380184814916e-07
has O 0 3.0094061465903155e-13
been O 0 4.4046628323857195e-12
implicated O 0 1.1282843548343635e-09
in O 0 3.564546435796956e-10
aniridia B-Disease 1 1.0
, O 0 1.7067547028459806e-11
and O 0 1.0265319844160459e-11
PAX6 O 0 0.00039231209666468203
is O 0 2.4996402517296623e-12
clearly O 0 8.355807365467705e-12
the O 0 5.981692571821462e-12
major O 0 1.0573661390900213e-10
, O 0 1.4662255513452765e-13
if O 0 6.009050949971201e-14
not O 0 1.2560442865915816e-13
only O 0 6.029328512152654e-13
, O 0 4.617424945543326e-14
gene O 0 1.440496701955729e-12
responsible O 0 1.2269927296415517e-09
. O 0 2.9295639691895303e-08

Twenty O 0 7.878155017237987e-09
- O 0 3.358532549291304e-11
eight O 0 7.704693653909356e-12
percent O 0 3.3169977181612964e-12
of O 0 7.363510165113094e-14
identified O 0 4.537777705676538e-12
PAX6 O 0 7.018188341589848e-08
mutations O 0 7.765225962241828e-12
are O 0 2.795967667459931e-13
C O 0 7.803099606462638e-07
- O 0 1.6677233816153603e-06
T O 0 4.6938044562239156e-08
changes O 0 4.887400206765591e-11
at O 0 1.5077326886991926e-10
CpG O 0 1.0728574473262142e-08
dinucleotides O 0 2.472305382639206e-08
, O 0 2.1781196434694262e-14
20 O 0 1.9771068462959285e-12
% O 0 2.0367761296991027e-12
are O 0 1.3640825046864146e-15
splicing O 0 1.568329355272624e-10
errors O 0 1.638597879605186e-08
, O 0 5.369310139731465e-13
and O 0 8.955901612765077e-14
more O 0 1.9538917264195522e-14
than O 0 3.374960087874218e-14
30 O 0 2.0169026171412696e-11
% O 0 4.011778409473976e-11
are O 0 2.855912189137118e-14
deletion O 0 7.2565365175081276e-12
or O 0 2.323171386167666e-12
insertion O 0 3.306256657342743e-10
events O 0 4.0580946936152884e-10
. O 0 1.0201513589436217e-07

There O 0 2.192019066260542e-10
is O 0 4.617330281141141e-13
a O 0 1.5011523274433003e-11
noticeably O 0 4.294127720072538e-08
elevated O 0 3.722993857646628e-10
level O 0 4.899722849671662e-10
of O 0 1.189159101050441e-11
mutation O 0 1.774231125515821e-13
in O 0 4.238466402937263e-13
the O 0 2.2946739994256227e-12
paired O 0 9.810231620110965e-12
domain O 0 7.629992991586843e-12
compared O 0 2.6211286830238323e-13
with O 0 1.149724723757716e-15
the O 0 2.3759276880988556e-13
rest O 0 7.428114373597694e-11
of O 0 2.270944283316867e-12
the O 0 6.14737037316071e-12
gene O 0 9.00897065281292e-12
. O 0 2.65893951301166e-09

Increased O 0 6.540416541689353e-10
mutation O 0 1.9561422794078798e-12
in O 0 1.1527890729674806e-13
the O 0 9.29235312828458e-13
homeodomain O 0 2.4820845379025513e-09
is O 0 1.4398462136865227e-15
accounted O 0 1.1077208594834076e-11
for O 0 3.724404716110106e-15
by O 0 2.045330796548138e-14
the O 0 4.089070748669599e-11
hypermutable O 0 7.379271664831322e-07
CpG O 0 2.8355557901704742e-08
dinucleotide O 0 3.181716579092608e-08
in O 0 4.359780592100293e-11
codon O 0 1.6531986446466362e-08
240 O 0 1.9219577040985314e-09
. O 0 4.275320542035388e-09

Very O 0 1.2772655155757207e-09
nearly O 0 5.0698160947160176e-11
all O 0 2.6104118866498993e-13
mutations O 0 6.328620353462933e-13
appear O 0 2.617383306618981e-12
to O 0 6.255155681617053e-12
cause O 0 2.265747145457908e-09
loss O 0 1.2655776870929003e-08
of O 0 1.4025698824582378e-08
function O 0 4.916707929680797e-09
of O 0 3.1654665000324655e-10
the O 0 4.673204097999095e-12
mutant O 0 3.3413031998337506e-13
allele O 0 4.509380607635449e-13
, O 0 5.002544293352784e-16
and O 0 1.4329359600841445e-16
more O 0 5.5442630898036384e-17
than O 0 5.996381814651647e-16
80 O 0 1.3199742947972437e-12
% O 0 9.599186029385365e-12
of O 0 5.189704135183382e-12
exonic O 0 1.4456079888702789e-08
substitutions O 0 1.3843202972818602e-10
result O 0 1.508471958455715e-10
in O 0 4.402029851746647e-10
nonsense O 0 1.0718739673620803e-07
codons O 0 2.3761330680827086e-08
. O 0 4.041845969027236e-08

In O 0 4.609081519224567e-11
a O 0 2.5172663432881937e-12
gene O 0 2.2422694126791876e-13
with O 0 5.323337799213734e-14
such O 0 1.5335527986382047e-12
extraordinarily O 0 6.0274549795735766e-09
high O 0 1.0720421772525413e-10
sequence O 0 4.7355130233794895e-11
conservation O 0 1.813500218050823e-11
throughout O 0 5.798218676023037e-12
evolution O 0 3.344162793905703e-11
, O 0 3.903196600023133e-14
there O 0 3.912978610836476e-13
are O 0 6.563166243117591e-12
presumed O 0 8.605946641182527e-05
undiscovered O 0 6.916350685060024e-05
missense O 0 6.0713077800755855e-06
mutations O 0 2.015179312309101e-08
, O 0 7.701490487010965e-12
these O 0 1.1968228491587851e-11
are O 0 3.072112659749382e-12
hypothesized O 0 8.85544276796324e-11
to O 0 7.418330533193185e-11
exist O 0 1.011658046223829e-08
in O 0 1.718226672053902e-10
as O 0 4.489597582590932e-10
- O 0 1.0804983574530524e-09
yet O 0 1.4561028771620244e-10
unidentified O 0 2.6368805805532247e-08
phenotypes O 0 8.927046879492195e-10
. O 0 4.730491172388884e-12
. O 0 4.25843138529558e-10

Genetic O 0 6.338914282366659e-09
heterogeneity O 0 8.336999979263737e-10
and O 0 2.620029030970389e-13
penetrance O 0 1.1163150759330165e-07
analysis O 0 5.413778800256175e-12
of O 0 2.0900430691694893e-11
the O 0 2.7228239107834895e-10
BRCA1 O 0 4.218996263460895e-09
and O 0 4.628586403043755e-11
BRCA2 O 0 3.6954959092838635e-09
genes O 0 2.910267686562218e-11
in O 0 5.36626403035978e-11
breast B-Disease 0 1.9752524949012695e-08
cancer I-Disease 0 3.041415341797915e-09
families O 0 2.0061188821252074e-10
. O 0 9.596823957735978e-08

The O 0 7.487913990189554e-06
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 2.1461052313043183e-07
Consortium O 0 5.313303616527598e-11
. O 0 6.966829890764359e-11

The O 0 3.5737736554797284e-12
contribution O 0 5.025624708054899e-11
of O 0 1.4798450659325724e-11
BRCA1 O 0 3.813628926541135e-11
and O 0 2.1109793600648796e-12
BRCA2 O 0 6.914298467108893e-08
to O 0 0.000563557434361428
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 7.739003327067451e-10
assessed O 0 3.219300910919931e-12
by O 0 1.248676997304271e-14
linkage O 0 9.149314084133664e-10
and O 0 7.380509777551308e-14
mutation O 0 2.843893808055116e-14
analysis O 0 7.839010405965956e-15
in O 0 2.2421389865459693e-15
237 O 0 1.494150072764433e-12
families O 0 3.9829925924279863e-13
, O 0 1.1339397353900401e-15
each O 0 2.0884578178707695e-14
with O 0 5.4097883535027605e-14
at O 0 5.6224855500552895e-12
least O 0 8.226604076774779e-13
four O 0 4.845311977162703e-13
cases O 0 2.070386180205719e-12
of O 0 9.849351334523249e-10
breast B-Disease 0 4.1403303008280545e-09
cancer I-Disease 0 2.8945457142270925e-11
, O 0 4.529642516648037e-15
collected O 0 2.031463647474141e-13
by O 0 1.2096966765968997e-13
the O 0 1.3166081203053182e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 5.427996185858319e-08
Consortium O 0 2.7985369230321133e-11
. O 0 1.3466107395831983e-10

Families O 0 4.600386391273581e-11
were O 0 3.8489131044643077e-13
included O 0 1.8879414023331535e-14
without O 0 1.4966221079278086e-13
regard O 0 5.431350681706082e-12
to O 0 1.0914289220662066e-12
the O 0 1.0040537845590336e-11
occurrence O 0 3.872815341310343e-06
of O 0 1.521863168818527e-06
ovarian B-Disease 1 0.9999796152114868
or I-Disease 0 2.4447142976669056e-08
other I-Disease 0 1.947267946889042e-08
cancers I-Disease 1 0.999969482421875
. O 0 4.070031991432188e-06

Overall O 0 2.643023253767751e-05
, O 0 1.7137175012393868e-09
disease O 0 1.900535409049553e-07
was O 0 1.1913732500534735e-10
linked O 0 1.0553794643763936e-10
to O 0 6.506830491082027e-11
BRCA1 O 0 2.005785953995698e-10
in O 0 9.177978066128925e-14
an O 0 1.51366680263585e-16
estimated O 0 5.18789468984893e-15
52 O 0 4.1718260790357675e-12
% O 0 1.8687201092104644e-11
of O 0 1.3434845683862884e-12
families O 0 2.7737081294970656e-12
, O 0 5.89052461322237e-13
to O 0 9.173336396051113e-11
BRCA2 O 0 4.860211677559789e-10
in O 0 5.129261598790791e-12
32 O 0 2.4866703141057656e-10
% O 0 9.262735543857925e-12
of O 0 2.7739816737051837e-13
families O 0 5.644122322290279e-13
, O 0 1.7855928866571114e-14
and O 0 1.1466549281261007e-14
to O 0 1.7896864545896563e-12
neither O 0 1.6512737358032048e-11
gene O 0 4.708333603640341e-14
in O 0 3.08057805610204e-13
16 O 0 1.2834397173505652e-12
% O 0 1.6745268095318816e-13
( O 0 6.373424965359853e-18
95 O 0 1.149529690186446e-11
% O 0 3.3183157610583436e-11
confidence O 0 4.1351531088196225e-09
interval O 0 2.0252544086218904e-09
[ O 0 1.650688891130514e-10
CI O 0 8.111461724524816e-09
] O 0 5.751023355454743e-12
6 O 0 1.3313550565816068e-12
% O 0 1.7227732912114546e-12
- O 0 2.7958662945568036e-13
28 O 0 2.1829826629075205e-13
% O 0 7.171855340507016e-13
) O 0 3.62047530872922e-16
, O 0 1.9412163442320126e-15
suggesting O 0 2.390751713352707e-13
other O 0 1.1746202968621056e-13
predisposition O 0 8.037380760939072e-10
genes O 0 7.099663079657148e-10
. O 0 1.9616349433704272e-08

The O 0 1.5989812252037439e-10
majority O 0 7.456571818331703e-12
( O 0 4.703867770656709e-16
81 O 0 1.2497271446865188e-11
% O 0 1.5413766183552946e-12
) O 0 1.444940534529106e-16
of O 0 1.1787910057792228e-12
the O 0 2.796317062347953e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.024319822879761e-09
were O 0 5.159243800408053e-13
due O 0 4.726110822139695e-11
to O 0 2.446394302413335e-11
BRCA1 O 0 1.3854983826888656e-10
, O 0 1.3128322044655538e-14
with O 0 2.062437135137707e-15
most O 0 4.026859344564114e-14
others O 0 1.5325263844415127e-12
( O 0 1.3596043473733995e-15
14 O 0 3.0940115920696787e-12
% O 0 2.1215869772800433e-12
) O 0 2.263950720212478e-16
due O 0 1.518569124614455e-11
to O 0 1.242664304790253e-09
BRCA2 O 0 2.768690308130317e-07
. O 0 7.897627085640124e-08

Conversely O 0 4.096591954549922e-09
, O 0 3.4490868210004626e-15
the O 0 1.0470998000551611e-15
majority O 0 1.0368133260645865e-15
of O 0 4.998865311625503e-15
families O 0 2.2858957768648845e-14
with O 0 4.564872734506712e-15
male B-Disease 0 1.6030649030440713e-09
and I-Disease 0 4.747117698933323e-10
female I-Disease 1 0.9824986457824707
breast I-Disease 1 0.98436039686203
cancer I-Disease 1 0.9999967813491821
were O 0 1.4526885024679359e-05
due O 1 0.9965620636940002
to O 0 8.262121014013246e-07
BRCA2 O 0 1.827409761290255e-07
( O 0 4.1783219137218885e-13
76 O 0 3.4060547715597522e-09
% O 0 1.3727198544533081e-10
) O 0 6.39123560390413e-14
. O 0 1.3376154350819291e-10

The O 0 2.191981457455583e-10
largest O 0 4.739883832649561e-12
proportion O 0 2.6751528509755262e-12
( O 0 3.2175880578346524e-16
67 O 0 3.5486724669908654e-10
% O 0 2.287246780863228e-11
) O 0 1.3875259414466903e-15
of O 0 1.0549397726905552e-12
families O 0 3.803493544424219e-12
due O 0 8.109666715938602e-09
to O 0 4.3266301652522543e-10
other O 0 1.7371408131405808e-11
genes O 0 1.9960985989109226e-11
was O 0 4.079338863233195e-12
found O 0 7.276126180516193e-14
in O 0 6.131330150896137e-15
families O 0 1.4696693840209052e-13
with O 0 2.6012837090388713e-15
four O 0 1.816025357436607e-13
or O 0 2.401119532152371e-14
five O 0 2.6785658516518748e-14
cases O 0 1.780841540042783e-14
of O 0 1.851104269867676e-10
female O 0 7.044882863738167e-07
breast B-Disease 0 1.1021460295523866e-06
cancer I-Disease 0 3.398458261472115e-07
only O 0 1.5823268029180326e-08
. O 0 7.39298570806568e-07

These O 0 1.0613967170447491e-11
estimates O 0 7.380658584299482e-12
were O 0 3.930976909000822e-13
not O 0 7.414626909413996e-14
substantially O 0 1.2626751207112097e-11
affected O 0 1.5594855051412337e-13
either O 0 4.3686395104734765e-14
by O 0 2.3699238592764108e-15
changing O 0 1.158461607891903e-11
the O 0 2.2896287730361786e-12
assumed O 0 9.039031745317061e-10
penetrance O 0 3.453575914136309e-08
model O 0 3.153549687009982e-12
for O 0 3.287644136963641e-13
BRCA1 O 0 4.025237781979385e-11
or O 0 3.4777055231893436e-14
by O 0 7.685806709763123e-15
including O 0 2.2099833627605564e-13
or O 0 9.845096959892885e-12
excluding O 0 3.2638072799962004e-10
BRCA1 O 0 1.8839390047986626e-09
mutation O 0 8.003736562400832e-11
data O 0 6.655931916732527e-10
. O 0 1.9288912689319204e-09

Among O 0 3.262229245418191e-12
those O 0 9.411572134696358e-14
families O 0 4.591370686424234e-13
with O 0 1.5552912690369736e-13
disease O 0 7.88560772235769e-10
due O 0 2.668705034736263e-09
to O 0 5.68141533818789e-10
BRCA1 O 0 5.4135593785531455e-09
that O 0 9.229958784036027e-14
were O 0 2.6319985213106752e-14
tested O 0 1.6536405059470603e-15
by O 0 3.7678143076239415e-17
one O 0 2.6519621137895697e-15
of O 0 2.8368724131421462e-14
the O 0 3.3603728252697834e-14
standard O 0 1.964228205000168e-13
screening O 0 1.3871171464056864e-13
methods O 0 5.594728152980011e-11
, O 0 1.4906650946163585e-13
mutations O 0 9.12093534380376e-13
were O 0 1.4523485495840371e-12
detected O 0 4.485766359058063e-12
in O 0 6.980439175904157e-14
the O 0 1.5115464218826147e-12
coding O 0 7.193830864338224e-09
sequence O 0 4.5454723318627543e-11
or O 0 2.0238390824323105e-11
splice O 0 8.832174103190482e-09
sites O 0 1.3633777266874869e-11
in O 0 1.520360951663604e-14
an O 0 9.409085500073104e-16
estimated O 0 6.624701330039395e-13
63 O 0 4.657458307910645e-10
% O 0 1.8937363829851783e-11
( O 0 7.238840976024185e-16
95 O 0 2.717055191947537e-10
% O 0 9.929621361259855e-12
CI O 0 1.3067293080926135e-10
51 O 0 1.477157632323589e-11
% O 0 2.983016828342344e-12
- O 0 1.4934548823314353e-12
77 O 0 2.885190567361584e-12
% O 0 6.796087997917866e-12
) O 0 1.9513667212037872e-14
. O 0 2.522920240777271e-11

The O 0 6.31304730713822e-12
estimated O 0 2.5367904933799867e-13
sensitivity O 0 2.345106530840524e-12
was O 0 6.192731061022833e-14
identical O 0 1.1545598631063515e-14
for O 0 2.313972780308173e-16
direct O 0 4.4420840432640024e-14
sequencing O 0 5.646453790641992e-11
and O 0 7.055617483493759e-13
other O 0 2.0726935792692025e-12
techniques O 0 1.577272712438571e-07
. O 0 8.202882817442969e-09

The O 0 3.4100848811391415e-09
penetrance O 0 2.56757721217582e-06
of O 0 7.368962662290812e-10
BRCA2 O 0 5.658078450210269e-10
was O 0 1.023493356039351e-12
estimated O 0 2.012257717496236e-14
by O 0 1.250468599042656e-15
maximizing O 0 6.21487084018213e-10
the O 0 6.602821761569899e-11
LOD O 0 3.5898026453651255e-06
score O 0 4.290932498207667e-09
in O 0 2.350258321293097e-10
BRCA2 O 0 4.064884961962889e-08
- O 0 1.1582058923043093e-10
mutation O 0 1.745388772747547e-13
families O 0 6.497060512202293e-14
, O 0 7.671332822518678e-16
over O 0 5.271039443951412e-15
all O 0 2.315153819522353e-14
possible O 0 2.0767389544151804e-11
penetrance O 0 7.104661108314758e-07
functions O 0 6.381749795281166e-09
. O 0 6.185097323196942e-09

The O 0 1.336280370210774e-12
estimated O 0 1.866951282155152e-13
cumulative O 0 2.2732770527111867e-11
risk O 0 5.1029951098069404e-11
of O 0 9.602308947975757e-10
breast B-Disease 0 8.571157650294481e-08
cancer I-Disease 0 2.190256642720101e-09
reached O 0 1.5806856268341107e-08
28 O 0 1.9077603385930786e-10
% O 0 7.822263670131946e-12
( O 0 1.9710029195667001e-16
95 O 0 1.3380593855139011e-10
% O 0 1.1641253065686197e-11
CI O 0 1.5323906032982393e-10
9 O 0 8.72812618620683e-13
% O 0 2.7541169215009043e-13
- O 0 4.545560976232377e-14
44 O 0 4.6655221867938565e-14
% O 0 3.427158196787233e-15
) O 0 5.925627871471522e-20
by O 0 1.7760380456465338e-18
age O 0 4.040151493792197e-15
50 O 0 5.2415648149693305e-15
years O 0 1.010314810870154e-14
and O 0 6.963012637684703e-16
84 O 0 3.834668043170564e-13
% O 0 1.188500524124808e-13
( O 0 9.547189589911487e-18
95 O 0 1.7591091343999166e-12
% O 0 5.037519880402019e-13
CI O 0 1.7348461209265587e-11
43 O 0 2.5343494663987443e-12
% O 0 2.565283868573992e-13
- O 0 5.1483692526180236e-14
95 O 0 4.917936175484472e-13
% O 0 7.582454290637995e-15
) O 0 7.596592162435165e-20
by O 0 3.991766427437467e-18
age O 0 1.2920258396151296e-13
70 O 0 1.7919816021685908e-12
years O 0 5.246734036817857e-12
. O 0 3.6024527805267326e-10

The O 0 3.194230302483447e-08
corresponding O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 3.368953171989375e-10
were O 0 7.350719859189336e-12
0 O 0 1.6199779365178024e-11
. O 0 2.365228846112899e-10

4 O 0 2.941906440678821e-11
% O 0 4.021383486624286e-12
( O 0 1.5052368395771995e-16
95 O 0 9.708749776349279e-11
% O 0 1.0055179779089318e-11
CI O 0 3.449530106003351e-10
0 O 0 4.6057264041022075e-14
% O 0 9.536768076634505e-13
- O 0 7.055667221268422e-14
1 O 0 1.099437859986886e-15
% O 0 2.7114363204227936e-15
) O 0 3.01165765843731e-20
by O 0 1.051553457105613e-18
age O 0 3.243976310515176e-15
50 O 0 3.4540904563781305e-15
years O 0 4.316217742510739e-15
and O 0 1.4850192219174234e-15
27 O 0 2.1506025584504262e-13
% O 0 6.68453058747312e-14
( O 0 9.421718698696381e-18
95 O 0 4.472234214902837e-12
% O 0 2.0465035915906427e-12
CI O 0 2.7833122959175505e-11
0 O 0 4.437644574180853e-15
% O 0 1.0678345821512128e-13
- O 0 5.079719942748494e-14
47 O 0 1.868279971917533e-13
% O 0 6.504049635159973e-15
) O 0 1.1749954552238854e-19
by O 0 4.375893801065761e-18
age O 0 2.283826881950557e-13
70 O 0 3.302119211748278e-12
years O 0 1.4137136773728631e-11
. O 0 4.901462014039737e-10

The O 0 8.884067786985028e-11
lifetime O 0 4.409816511952158e-08
risk O 0 1.4499931921818643e-08
of O 0 2.704266854891557e-08
breast B-Disease 0 0.032760389149188995
cancer I-Disease 0 5.275131798043731e-07
appears O 0 2.716949928927015e-11
similar O 0 1.0791208421637166e-12
to O 0 3.0604424550162435e-10
the O 0 4.711301127002798e-09
risk O 0 7.489348030631504e-10
in O 0 4.402766692890303e-11
BRCA1 O 0 4.72149985775161e-10
carriers O 0 6.848328328035169e-13
, O 0 2.470954349334878e-14
but O 0 4.6322442951753084e-14
there O 0 6.509998432251834e-14
was O 0 6.153607896679236e-13
some O 0 2.096719777238288e-14
suggestion O 0 3.033932480245305e-11
of O 0 8.893968894696513e-11
a O 0 1.371647462278247e-09
lower O 0 2.858051573184639e-08
risk O 0 3.0229529990322135e-10
in O 0 7.175433164308131e-11
BRCA2 O 0 1.2435272811472942e-09
carriers O 0 5.1376624309040775e-12
< O 0 1.52570026057397e-10
50 O 0 2.8591851108927813e-12
years O 0 6.142667212556685e-13
of O 0 1.0113941802114557e-11
age O 0 1.866762744384687e-09
. O 0 3.6186653673553337e-09

Eye B-Disease 1 0.5034903883934021
movement I-Disease 0 6.946392261397705e-08
abnormalities I-Disease 0 1.9802135398094833e-07
correlate O 0 1.7581122113696779e-09
with O 0 1.3099181570171148e-14
genotype O 0 4.355793226107352e-10
in O 0 1.2691145877263832e-11
autosomal O 0 0.005595737602561712
dominant O 0 4.421819176059216e-05
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 1.8462372963767848e-07

We O 0 1.185405107406723e-10
compared O 0 1.2276521466070278e-10
horizontal O 0 5.074696662887845e-09
eye O 0 5.942771963418636e-07
movements O 0 4.365129413486102e-08
( O 0 6.635352423761676e-12
visually O 0 1.0599436883751423e-08
guided O 0 4.8134804586652535e-08
saccades O 0 6.58701253541949e-07
, O 0 4.636427960308387e-13
antisaccades O 0 1.8718408156814803e-08
, O 0 1.6439052809985588e-14
and O 0 1.1529622742645351e-14
smooth O 0 4.687561103167148e-11
pursuit O 0 3.290484829054918e-10
) O 0 1.9146889663899025e-15
in O 0 1.4595318226576226e-13
control O 0 8.370698578730185e-10
subjects O 0 3.192531039530877e-08
( O 0 1.4757360372770478e-14
n O 0 1.7976841803352128e-13
= O 0 5.975414932822554e-14
14 O 0 4.862816827813296e-14
) O 0 5.658101340064411e-17
and O 0 3.7674712592803035e-16
patients O 0 6.712120419916795e-16
with O 0 1.604144082734696e-17
three O 0 3.4991282569748258e-15
forms O 0 6.055342859079271e-12
of O 0 4.033940126380031e-10
autosomal O 0 0.00010936218313872814
dominant O 0 9.3510199803859e-05
cerebellar B-Disease 1 0.9999971389770508
ataxias I-Disease 1 0.9175795912742615
type I-Disease 1 0.9996324777603149
I I-Disease 1 0.9999997615814209
spinocerebellar B-Disease 1 0.999954104423523
ataxias I-Disease 0 0.0005637159338220954
1 I-Disease 0 3.0139241796733884e-11
and I-Disease 0 5.152890917778374e-13
2 I-Disease 0 2.430018859744809e-12
( O 0 3.150684736979298e-14
SCA1 B-Disease 0 1.7089191715058405e-06
, O 0 8.622980395044458e-14
n O 0 3.686622811497828e-14
= O 0 1.9151904522463244e-14
11 O 0 5.6212785890918243e-14
; O 0 2.0683149085169413e-15
SCA2 B-Disease 0 2.8264896201335432e-08
, O 0 1.0405344053293457e-14
n O 0 8.285679678173355e-15
= O 0 7.211091329639187e-15
10 O 0 9.304368087353476e-15
) O 0 2.9040334014200555e-16
and O 0 4.470262322201629e-13
SCA3 B-Disease 1 1.0
/ O 0 4.698665900804144e-09
Machado B-Disease 0 2.3689004091664856e-09
- I-Disease 0 4.235999884194541e-10
Joseph I-Disease 0 2.5895183219937223e-10
disease I-Disease 0 6.09355188530003e-09
( O 0 2.8074165882914937e-15
MJD B-Disease 1 1.0
) O 0 8.729453114140681e-14
( O 0 7.772485497079787e-16
n O 0 1.190687766482526e-13
= O 0 1.1732746664407795e-13
16 O 0 5.557741766804014e-13
) O 0 8.649100858258707e-15
. O 0 8.470606160937422e-12

In O 0 2.4294374845190703e-10
SCA1 B-Disease 0 2.7314117687637918e-05
, O 0 4.27396460507979e-14
saccade O 0 1.2797456427904308e-09
amplitude O 0 1.3342556226536573e-12
was O 0 1.8269865058751639e-13
significantly O 0 3.0693132497400244e-12
increased O 0 1.1390984726647457e-12
, O 0 2.1694199374747668e-15
resulting O 0 2.9217847759277493e-12
in O 0 1.1882069113344773e-11
hypermetria B-Disease 0 2.94320147986582e-06
. O 0 4.919787244261897e-08

The O 0 1.1321883430781554e-09
smooth O 0 5.478752562737554e-09
pursuit O 0 2.0517722632007462e-08
gain O 0 2.39732393936265e-08
was O 0 5.615618733911809e-11
decreased O 0 1.9365524295267278e-08
. O 0 6.836827770584364e-10

In O 0 2.2806798671837214e-09
SCA2 B-Disease 0 2.9201166398706846e-05
, O 0 1.3968797093425606e-13
saccade O 0 2.515767816291259e-09
velocity O 0 1.192457660392776e-10
was O 0 2.8595847911816463e-11
markedly O 0 1.988653330897705e-08
decreased O 0 2.507376173355169e-08
. O 0 8.215529923027987e-10

The O 0 1.0750666329384373e-10
percentage O 0 2.7606230634802387e-09
of O 0 9.949659152130863e-12
errors O 0 4.673650266795448e-08
in O 0 4.6485040816612866e-10
antisaccades O 0 2.2296230781648774e-06
was O 0 6.191698195823214e-12
greatly O 0 8.669297051067115e-12
increased O 0 2.8714927571144022e-12
and O 0 2.243174992543756e-14
was O 0 3.568377418636942e-13
significantly O 0 3.836777250076917e-12
correlated O 0 1.728646392695765e-11
with O 0 1.878061101816611e-14
age O 0 2.0183314741739622e-10
at O 0 6.785849104851138e-10
disease O 0 5.1269047673940804e-08
onset O 0 3.362735867540323e-08
. O 0 3.1020701563022612e-09

In O 0 4.430380368125597e-11
addition O 0 6.426593198577413e-12
, O 0 1.1119485154420083e-14
a O 0 4.81381427774874e-14
correlation O 0 5.558038838199275e-13
between O 0 1.749949794446759e-12
smooth O 0 1.5157342048155442e-10
pursuit O 0 9.096608466485634e-10
gain O 0 2.533410592420182e-09
and O 0 1.1658818984024155e-13
the O 0 1.9743256508830687e-12
number O 0 2.9192169515024347e-12
of O 0 1.6986234641080955e-10
trinucleotide O 0 9.595726169209229e-08
repeats O 0 5.56798940287706e-10
was O 0 7.763793080650672e-11
found O 0 8.768214626586612e-11
. O 0 1.1384443387996157e-09

In O 0 6.62135732909519e-08
SCA3 B-Disease 1 1.0
, O 0 2.6651136852962054e-09
gaze B-Disease 0 5.801232691737823e-05
- I-Disease 0 3.427373940212419e-07
evoked I-Disease 0 1.5304986167308243e-09
nystagmus I-Disease 0 9.943441903192962e-11
was O 0 3.455985226729491e-13
often O 0 2.7114774015207354e-15
present O 0 3.576763654678482e-14
as O 0 4.69125227369854e-16
was O 0 6.293672316160306e-14
saccade O 0 2.063199922019976e-08
hypometria O 0 1.5160775035383267e-07
and O 0 2.3860425354266246e-12
smooth O 0 9.048489069130028e-09
pursuit O 0 7.45442463312429e-08
gain O 0 1.2439174668088526e-07
was O 0 1.6381554446276425e-10
markedly O 0 5.199334651706522e-08
decreased O 0 3.12552508319186e-08
. O 0 8.495482650694441e-10

Three O 0 1.4527433422895086e-10
major O 0 1.684317615935349e-11
criteria O 0 3.3878708866064144e-11
, O 0 4.588408984902183e-14
saccade O 0 1.3713963298300769e-09
amplitude O 0 5.058724272810622e-12
, O 0 3.3101813797604615e-14
saccade O 0 1.514076419795174e-09
velocity O 0 1.0671622613367404e-10
, O 0 1.1326656030197918e-13
and O 0 4.605717594959556e-14
presence O 0 5.8847891837299215e-12
of O 0 7.868453444359602e-09
gaze B-Disease 0 0.009196930564939976
- I-Disease 0 6.498121820186498e-06
evoked I-Disease 0 8.228267844856418e-09
nystagmus I-Disease 0 1.4738853193474455e-10
, O 0 1.5611267204149984e-15
permitted O 0 7.840558172329815e-13
the O 0 2.996574546116314e-14
correct O 0 9.592103153432952e-12
assignment O 0 3.3942480770488004e-11
of O 0 5.701881024625099e-13
90 O 0 3.257548744639571e-11
% O 0 1.8879913257774383e-11
of O 0 5.716363797245161e-13
the O 0 5.5018342312584956e-12
SCA1 B-Disease 0 2.285221853526309e-06
, O 0 3.289518180418782e-14
90 O 0 1.634328609945168e-11
% O 0 8.000893350623706e-12
of O 0 4.4935569479785664e-13
the O 0 1.752561854320711e-12
SCA2 B-Disease 0 6.103488203734742e-07
, O 0 8.605461720816165e-15
and O 0 1.1316970039039476e-15
93 O 0 1.5338336070008785e-12
% O 0 4.538857625250442e-13
of O 0 1.3639381236853904e-13
the O 0 6.096596751742345e-13
patients O 0 1.1984533374378992e-12
with O 0 8.52259408878897e-12
SCA3 B-Disease 1 1.0
to O 0 3.2499498647808878e-09
their O 0 5.371202926873764e-10
genetically O 0 1.5850066051315004e-11
confirmed O 0 1.4737250308982652e-10
patient O 0 2.490630368612301e-09
group O 0 5.0760973522396766e-14
and O 0 2.0423728897336901e-13
, O 0 2.972778680122509e-14
therefore O 0 1.254972775005525e-11
, O 0 1.8322523403016544e-13
may O 0 2.9668358048073884e-11
help O 0 4.0543156387684576e-08
orient O 0 4.036156042275252e-06
diagnoses O 0 2.2629685645370046e-06
of O 0 2.1931008120645856e-07
SCA1 B-Disease 1 0.984226405620575
, O 0 5.449658085909803e-11
SCA2 B-Disease 0 0.0007507895352318883
, O 0 6.89414616974332e-13
and O 0 1.5317703702666385e-11
SCA3 B-Disease 1 1.0
at O 0 6.462045482047429e-11
early O 0 3.9300195042724084e-12
clinical O 0 6.101540713648879e-13
stages O 0 9.40209108485357e-12
of O 0 3.9703353452158474e-12
the O 0 7.631525272833173e-11
diseases O 0 1.6852673700995524e-09
. O 0 4.913581000409728e-11
. O 0 3.457647279603293e-09

Genetic O 0 2.0350023749449164e-11
basis O 0 2.7033124003206233e-12
and O 0 2.894168379260299e-16
molecular O 0 5.46631696071026e-14
mechanism O 0 1.5774283268488176e-10
for O 0 2.123780484808435e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9971238970756531

Ventricular B-Disease 1 0.9999935626983643
fibrillation I-Disease 0 0.000688489933963865
causes O 0 3.0254696525844338e-09
more O 0 2.359807533029116e-14
than O 0 6.094645577467027e-16
300 O 0 1.4223049279137034e-13
, O 0 4.754327746786134e-15
000 O 0 7.104238725075263e-11
sudden O 0 4.10074491724588e-12
deaths O 0 3.129287193953667e-13
each O 0 6.448614971003852e-14
year O 0 3.2017322820765415e-12
in O 0 2.662421932225767e-12
the O 0 2.3317982961179595e-11
USA O 0 2.2261774368370624e-10
alone O 0 7.519219691332069e-10
. O 0 2.2288126899638883e-09

In O 0 2.1810339645433885e-10
approximately O 0 8.813985132027913e-12
5 O 0 4.6760212889240815e-12
- O 0 2.6681714563464576e-12
12 O 0 1.2844976818304765e-12
% O 0 3.2706652056818664e-12
of O 0 2.4545700216295485e-14
these O 0 2.2050380964232837e-15
cases O 0 4.662619489586911e-15
, O 0 2.4086775224374263e-15
there O 0 1.1297220618841294e-14
are O 0 2.466946697648239e-14
no O 0 3.298814129845673e-12
demonstrable O 0 1.5029155520096538e-07
cardiac O 0 7.612732133566169e-06
or O 0 3.3803686960709456e-08
non O 1 1.0
- O 1 0.9999998807907104
cardiac O 1 0.9995343685150146
causes O 0 4.232742975562864e-11
to O 0 5.55827194166636e-13
account O 0 6.733001878473158e-14
for O 0 1.100873644359953e-14
the O 0 3.0626510442305355e-13
episode O 0 8.575392999865539e-12
, O 0 2.4492780880003707e-16
which O 0 1.538189002028903e-17
is O 0 8.365988082894952e-18
therefore O 0 3.4556735186049015e-14
classified O 0 1.2069076293919068e-10
as O 0 1.3264069842477966e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 1.2530397164312035e-08
IVF B-Disease 1 1.0
) O 0 2.7411319741821316e-12
. O 0 2.739251880878868e-11

A O 0 4.711436130122593e-09
distinct O 0 1.3580080636399483e-11
group O 0 6.991138896093874e-14
of O 0 9.062401523651786e-11
IVF B-Disease 1 1.0
patients O 0 1.3496243012056652e-10
has O 0 3.235990113311548e-16
been O 0 9.098540986994812e-16
found O 0 7.598433461308829e-16
to O 0 1.3623566962322076e-14
present O 0 4.756521131826785e-12
with O 0 9.712272896729782e-14
a O 0 8.671418444405887e-11
characteristic O 0 3.788287461503614e-09
electrocardiographic O 0 9.863955483524478e-07
pattern O 0 4.7227295851826057e-08
. O 0 1.1562492296945948e-08

Because O 0 1.4438154838369854e-10
of O 0 2.830586876001462e-10
the O 0 2.5343265680488614e-11
small O 0 1.0094177690976938e-13
size O 0 1.0453308818591037e-13
of O 0 1.078314412587822e-12
most O 0 2.496599118845949e-13
pedigrees O 0 4.687932264602068e-09
and O 0 1.2940266263042344e-12
the O 0 2.2640861407907664e-11
high O 0 2.851061747799477e-11
incidence O 0 9.059947236877974e-11
of O 0 1.955113848595147e-11
sudden B-Disease 0 1.1178875533590649e-11
death I-Disease 0 4.193751942938029e-11
, O 0 2.943946627274874e-13
however O 0 1.9727821806703183e-12
, O 0 4.715314256268548e-15
molecular O 0 1.758313140269932e-13
genetic O 0 1.2379002987603083e-12
studies O 0 9.070627929319564e-12
of O 0 9.368280456945044e-11
IVF B-Disease 1 1.0
have O 0 2.0615750859903637e-12
not O 0 1.6118118124908154e-13
yet O 0 1.4141446260523827e-12
been O 0 2.217682201072213e-12
done O 0 9.067731010503621e-10
. O 0 4.318997604002561e-09

Because O 0 1.5814613618658768e-07
IVF B-Disease 1 1.0
causes O 0 0.00020314165158197284
cardiac O 1 0.9999873638153076
rhythm O 0 0.008594903163611889
disturbance O 0 1.7870863677771354e-09
, O 0 2.5173260150652618e-14
we O 0 6.387823077566232e-14
investigated O 0 3.589294226419293e-12
whether O 0 1.1048126389440194e-12
malfunction O 0 1.0861857191457602e-07
of O 0 1.0333564733067124e-11
ion O 0 6.00338112555221e-10
channels O 0 2.6427195987110963e-09
could O 0 4.5305849349919214e-11
cause O 0 1.970074325896576e-09
the O 0 5.277405682596603e-12
disorder O 0 6.939374422310074e-12
by O 0 2.099137398528676e-17
studying O 0 6.614240151268285e-15
mutations O 0 1.4055005735104896e-14
in O 0 2.81939507412168e-14
the O 0 5.30783099764176e-12
cardiac O 0 4.9350754594001955e-09
sodium O 0 5.3279072126377613e-11
channel O 0 5.609465669742519e-10
gene O 0 8.588131594766679e-11
SCN5A O 0 0.0002917909587267786
. O 0 3.687956251496871e-08

We O 0 1.5083999327369924e-10
have O 0 3.379528915829072e-13
now O 0 1.090101045455455e-13
identified O 0 1.1531701158210006e-12
a O 0 9.904950123984513e-13
missense O 0 2.8789610695412193e-09
mutation O 0 3.480190744961642e-12
, O 0 3.0040999256329e-14
a O 0 1.5044190936411295e-12
splice O 0 3.034775986066052e-08
- O 0 8.466345680080423e-11
donor O 0 1.2356322909301554e-10
mutation O 0 3.797782921477477e-11
, O 0 2.8317531154155307e-14
and O 0 3.453472927007935e-14
a O 0 2.4675658651801546e-12
frameshift O 0 1.5476064874064832e-09
mutation O 0 2.2746279686181037e-13
in O 0 8.745046821293043e-15
the O 0 1.8043724880120043e-13
coding O 0 1.9623385583145136e-08
region O 0 4.829237565395772e-10
of O 0 4.359631058936664e-11
SCN5A O 0 0.061933789402246475
in O 0 7.006885523186401e-12
three O 0 8.707383425399229e-11
IVF B-Disease 1 1.0
families O 0 7.04680203078567e-11
. O 0 3.018309491231719e-10

We O 0 2.063326766388318e-11
show O 0 7.601286136985075e-13
that O 0 1.3862660328772087e-16
sodium O 0 1.8331455280742046e-15
channels O 0 2.792518041078943e-14
with O 0 1.0513458968104081e-16
the O 0 6.245493082120482e-14
missense O 0 1.4296813732883606e-09
mutation O 0 1.2922365434653305e-11
recover O 0 8.302473375465524e-09
from O 0 3.0991341437580644e-11
inactivation O 0 9.772461728729809e-10
more O 0 2.5213096110161988e-14
rapidly O 0 7.711599371226785e-13
than O 0 2.0827483499381546e-15
normal O 0 3.695823508342855e-11
and O 0 2.4615604151366488e-14
that O 0 6.678206808895509e-15
the O 0 7.63275814080755e-12
frameshift O 0 8.175910437557832e-08
mutation O 0 2.6332375516191497e-11
causes O 0 2.8753071971976407e-12
the O 0 2.9321128858228462e-12
sodium O 0 8.252093669849914e-13
channel O 0 6.94294502532472e-13
to O 0 7.450013913071207e-13
be O 0 3.2828210635993393e-12
non O 0 4.485518800834143e-08
- O 0 1.4109951429475132e-08
functional O 0 1.8944081148219993e-07
. O 0 9.6870389487691e-10

Our O 0 1.853189490752527e-09
results O 0 4.740390371904546e-12
indicate O 0 4.896467346166e-12
that O 0 7.208341013659452e-15
mutations O 0 8.911755881857442e-13
in O 0 1.843294831008202e-12
cardiac O 0 2.235791107807472e-09
ion O 0 9.413817503300947e-10
- O 0 2.6775970329850907e-09
channel O 0 3.4646150531836284e-11
genes O 0 2.345801843246266e-14
contribute O 0 9.153729884541287e-14
to O 0 1.8181628281383443e-14
the O 0 4.398261269078496e-14
risk O 0 3.879966009937008e-13
of O 0 4.609305016660403e-13
developing O 0 2.848058899829198e-09
IVF B-Disease 1 1.0
. O 0 5.151864004848683e-11
. O 0 2.487894334990415e-10

Molecular O 0 5.166393535205316e-09
heterogeneity O 0 2.4351738403538548e-08
in O 0 3.8935016322128035e-10
mucopolysaccharidosis B-Disease 0 6.201997166499496e-05
IVA I-Disease 1 0.8331520557403564
in O 0 3.309657548022926e-10
Australia O 0 7.007780640500005e-12
and O 0 2.0878893232378903e-13
Northern O 0 3.5762475203426902e-09
Ireland O 0 2.0754412077828022e-10
: O 0 3.40686127566777e-16
nine O 0 1.7642525352960792e-13
novel O 0 1.6207170764411145e-14
mutations O 0 5.818267959437073e-13
including O 0 3.6535008417042103e-13
T312S O 0 4.8658840512416646e-08
, O 0 1.7755615771067323e-13
a O 0 1.8083276575372315e-13
common O 0 3.709782318579019e-13
allele O 0 9.67609759677801e-12
that O 0 1.182783526069292e-13
confers O 0 1.098531487997434e-09
a O 0 9.824547841930098e-10
mild O 0 5.8078355458235364e-09
phenotype O 0 1.1677742328686236e-08
. O 0 2.9742097673590706e-09

Mucopolysaccharidosis B-Disease 0 0.0010762925958260894
IVA I-Disease 1 0.9999942779541016
( O 0 1.711489727718174e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.327557851317108e-12
is O 0 2.0669285781624996e-13
an O 0 6.820539792673497e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
caused O 0 1.756847584077903e-10
by O 0 5.0738323861387186e-14
a O 0 8.288707498138592e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.7766068130531387e-11
N O 0 7.354075681753613e-11
- O 0 3.9013420966016454e-11
acetylgalactosamine O 0 1.0276093576067069e-07
- O 0 2.719258429539906e-10
6 O 0 3.7267858937761744e-11
- O 0 3.5628180961033706e-11
sulfate O 0 1.1249346723238296e-12
sulfatase O 0 5.013716664059586e-10
( O 0 8.852988253168158e-16
GALNS O 0 6.959827203445457e-08
) O 0 1.4921493335091733e-14
. O 0 6.40790285416637e-12

Previous O 0 1.4213505927784809e-09
studies O 0 1.366637445571195e-11
of O 0 1.4261413230909348e-12
patients O 0 2.164094912385922e-13
from O 0 3.6364956727298614e-13
a O 0 8.715749476306822e-13
British O 0 2.3594468392951207e-11
- O 0 3.436427184477786e-11
Irish O 0 8.366652856639512e-12
population O 0 2.6570354176271493e-15
showed O 0 2.876072250908128e-14
that O 0 3.28484207679995e-17
the O 0 1.1070733495514504e-13
I113F O 0 1.921331094223433e-09
mutation O 0 1.3692562708667033e-12
is O 0 2.340348433373606e-15
the O 0 6.049565552277911e-14
most O 0 8.639636959139035e-15
common O 0 4.1391196703823366e-14
single O 0 1.2655461531160817e-12
mutation O 0 8.071708232360031e-12
among O 0 7.1516013597228145e-12
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.2531128962555158e-08
and O 0 9.895357103162361e-13
produces O 0 4.395271906848519e-12
a O 0 2.1984577353029167e-11
severe O 0 1.3809217103144533e-09
clinical O 0 2.5964435046432754e-09
phenotype O 0 1.7649023353882853e-09
. O 0 4.329571812178301e-09

We O 0 4.893792038274114e-10
studied O 0 1.264950730966996e-11
mutations O 0 1.6042085737057177e-13
in O 0 8.729115825621084e-15
the O 0 1.5371040486440724e-13
GALNS O 0 4.6675256726302905e-07
gene O 0 1.8953749973595752e-13
from O 0 2.578140337935325e-13
23 O 0 5.420660014604506e-12
additional O 0 9.454466098901548e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 3.983242322647129e-07
( O 0 3.181828105570765e-14
15 O 0 6.109416358229813e-12
from O 0 6.448609007891903e-12
Australia O 0 2.263195490390113e-12
, O 0 2.2778384606574227e-15
8 O 0 7.454743745048675e-14
from O 0 3.866321325596278e-13
Northern O 0 9.988820881545735e-10
Ireland O 0 5.041417977524887e-11
) O 0 1.694121692804001e-15
, O 0 1.266425640977743e-15
with O 0 9.612467639829518e-16
various O 0 3.807151642554185e-12
clinical O 0 2.22599924604161e-10
phenotypes O 0 1.0017325857702986e-09
( O 0 4.914110568118857e-13
severe O 0 3.258041614273566e-10
, O 0 2.77108360129813e-13
16 O 0 2.4009570373517697e-12
cases O 0 8.443416864116482e-14
; O 0 2.416288325226743e-15
intermediate O 0 8.217073722838197e-12
, O 0 5.916856326453664e-15
4 O 0 3.8817107622830804e-14
cases O 0 6.611405894323477e-14
; O 0 1.0440621891344426e-12
mild O 0 4.900234731874953e-11
, O 0 2.9588402447556714e-14
3 O 0 4.016986328530918e-14
cases O 0 1.500734859462543e-14
) O 0 2.496593020208729e-14
. O 0 6.921849204921671e-11

We O 0 1.5916427065221228e-09
found O 0 9.467340973678962e-12
two O 0 1.887739808491707e-14
common O 0 1.4333693127278717e-14
mutations O 0 3.1097663223028963e-16
that O 0 1.3155122292838117e-17
together O 0 2.4030242127892143e-15
accounted O 0 9.467901289361702e-12
for O 0 5.007618804212313e-14
32 O 0 2.00889216372957e-09
% O 0 1.24680477053829e-09
of O 0 1.7972573082558618e-11
the O 0 1.8070505161671413e-11
44 O 0 5.885757159429517e-11
unrelated O 0 1.6180078110661356e-11
alleles O 0 6.124300285653694e-13
in O 0 1.8216044991858915e-12
these O 0 1.2861554703202938e-11
patients O 0 2.5581101126270767e-10
. O 0 2.9513174126805097e-09

One O 0 1.496222035157757e-10
is O 0 6.035585442890068e-14
the O 0 6.387984759215204e-13
T312S O 0 1.754739642478853e-08
mutation O 0 5.497837428369845e-12
, O 0 3.846575242707909e-15
a O 0 2.349787302669687e-14
novel O 0 2.1999307418612245e-14
mutation O 0 7.480527699013639e-13
found O 0 5.954287898238958e-14
exclusively O 0 2.0764607481377206e-12
in O 0 9.001992402370151e-13
milder O 0 6.119548423555443e-09
patients O 0 4.78611150711572e-10
. O 0 6.340897584777849e-09

The O 0 1.934335608355653e-10
other O 0 2.6205288481719047e-13
is O 0 5.628270930774703e-15
the O 0 5.5273456845599325e-14
previously O 0 2.8767392114270596e-12
described O 0 7.7073942931008e-13
I113F O 0 3.1788882637329152e-09
that O 0 6.727247475442691e-15
produces O 0 2.5577061085399477e-13
a O 0 3.0618990416036995e-12
severe O 0 1.9885273427888706e-09
phenotype O 0 2.5523128499571612e-08
. O 0 8.042552401832381e-09

The O 0 4.28973789823317e-09
I113F O 0 1.461458225548995e-07
and O 0 2.0663108810797803e-12
T312S O 0 2.1545731865302287e-09
mutations O 0 8.78385634627693e-13
accounted O 0 9.790086796801489e-11
for O 0 2.3402661102414624e-13
8 O 0 3.4162644501484207e-12
( O 0 4.403797084669012e-16
18 O 0 8.434262945174187e-13
% O 0 3.5110315262792957e-13
) O 0 7.301932886844912e-17
and O 0 1.1647253596162345e-14
6 O 0 1.0461466762312632e-13
( O 0 4.307643625032378e-17
14 O 0 2.507363721759425e-14
% O 0 6.995941234091627e-14
) O 0 3.5785530673660936e-17
of O 0 1.618576285370224e-14
44 O 0 9.451400301502613e-14
unrelated O 0 3.898020686614323e-13
alleles O 0 1.207750940273103e-13
, O 0 2.0492367026371527e-13
respectively O 0 4.853717983088757e-10
. O 0 8.823906050281494e-09

The O 0 1.521792025727109e-09
relatively O 0 3.6437980410752857e-10
high O 0 1.3424555737884258e-11
residual O 0 6.951250686171306e-10
GALNS O 0 9.962608373825788e-07
activity O 0 2.6047049933586308e-11
seen O 0 1.4405123415720672e-13
when O 0 1.2474575027942854e-15
the O 0 5.3831505225643284e-14
T312S O 0 9.926344468613735e-12
mutant O 0 1.850469647304842e-13
cDNA O 0 7.527241052684985e-10
is O 0 2.5736593303564426e-13
overexpressed O 0 5.677038839024817e-10
in O 0 1.916188833040594e-13
mutant O 0 1.0533277375324168e-11
cells O 0 2.7849533443258245e-11
provides O 0 2.8895434629012604e-14
an O 0 2.5424490652203836e-16
explanation O 0 8.413215328399726e-13
for O 0 1.672318154181257e-13
the O 0 4.2335582955965734e-11
mild O 0 8.619080449356886e-11
phenotype O 0 8.356577235746343e-11
in O 0 1.785815148102471e-13
patients O 0 2.6320850880778845e-13
with O 0 3.4209278459437038e-15
this O 0 1.9762282088553462e-12
mutation O 0 1.2637021984396313e-10
. O 0 1.8879606766830648e-09

The O 0 3.687266637852904e-12
distribution O 0 2.5875200419800404e-13
and O 0 3.1627776146090107e-16
relative O 0 7.510981311735498e-13
frequencies O 0 6.2580197100758905e-12
of O 0 2.9122928027480732e-12
the O 0 2.1016757778546946e-11
I113F O 0 8.830509301560596e-08
and O 0 2.662728024183103e-11
T312S O 0 5.595985186346297e-08
mutations O 0 2.008211999471321e-11
in O 0 2.384968741594995e-12
Australia O 0 1.8207429921396345e-12
corresponded O 0 7.25221922445729e-12
to O 0 1.0349285664568164e-11
those O 0 4.22101850000578e-12
observed O 0 3.3165754864672436e-11
in O 0 5.966039468008333e-11
Northern O 0 3.697112731515517e-07
Ireland O 0 6.401511765119494e-09
and O 0 1.7441492694558747e-11
are O 0 2.27757244487814e-12
unique O 0 4.016081217583789e-11
to O 0 6.920120032560817e-11
these O 0 1.5131769101617287e-11
two O 0 5.5859528808044345e-11
populations O 0 8.963481866464118e-12
, O 0 3.348843012791758e-14
suggesting O 0 3.1860399735128553e-12
that O 0 1.9351472261099935e-14
both O 0 9.011891927146465e-12
mutations O 0 4.4699768192435485e-11
were O 0 3.528395978169563e-11
probably O 0 1.64851708672753e-11
introduced O 0 2.9048906834659716e-13
to O 0 6.075229729007869e-12
Australia O 0 7.005438438546785e-13
by O 0 2.7027630418560884e-14
Irish O 0 1.1085372203512023e-10
migrants O 0 1.1831892410274492e-10
during O 0 2.1186039034226667e-11
the O 0 7.09115383600023e-13
19th O 0 9.970124725811047e-11
century O 0 2.6640806227717917e-10
. O 0 2.090714934510629e-09

Haplotype O 0 4.174047063543185e-08
analysis O 0 3.925788513714501e-11
using O 0 1.8177806482277958e-11
6 O 0 1.45889456071302e-09
RFLPs O 0 1.0401790859759785e-05
provides O 0 1.7573116356181528e-12
additional O 0 3.9361236167136104e-13
data O 0 2.5094379699219793e-12
that O 0 2.902993668477301e-15
the O 0 8.654093067161917e-13
I113F O 0 6.7964740502191034e-09
mutation O 0 3.969933756731159e-12
originated O 0 2.6843989271024826e-12
from O 0 1.5731503827474264e-13
a O 0 9.792392591245758e-13
common O 0 9.961547212111732e-12
ancestor O 0 1.016867834380264e-08
. O 0 1.0636661329499475e-08

The O 0 1.5695091892808932e-09
other O 0 1.0261713354053903e-12
9 O 0 3.769254439817127e-12
novel O 0 1.8258881074304824e-14
mutations O 0 4.4800355916349566e-13
identified O 0 1.352271295157817e-13
in O 0 2.0879001313782973e-14
these O 0 3.88451816828346e-14
23 O 0 6.894347072405882e-12
patients O 0 1.0712624363973244e-12
were O 0 7.123117742348362e-13
each O 0 3.104798861584823e-13
limited O 0 6.83339192522614e-12
to O 0 9.187287215717266e-12
a O 0 5.498532532066669e-11
single O 0 3.5294493994086906e-09
family O 0 1.1596078541842303e-09
. O 0 1.4182477414692585e-08

These O 0 8.072081891796756e-11
data O 0 2.6900539087937325e-11
provide O 0 1.91021149093841e-13
further O 0 8.540794482238268e-14
evidence O 0 1.0953705390642776e-12
for O 0 1.0649855563399369e-12
extensive O 0 4.609895132290376e-09
allelic O 0 1.8897559073138837e-08
heterogeneity O 0 1.195193632952396e-08
in O 0 2.8757558556691265e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 3.1747540707449673e-10
British O 0 2.8988527134288233e-09
- O 0 1.3252392960794168e-08
Irish O 0 1.5602019676208556e-10
patients O 0 3.097422763154861e-13
and O 0 6.73623174215598e-16
provide O 0 1.844144039136065e-14
evidence O 0 3.1144710291655664e-14
for O 0 1.509850797447483e-14
their O 0 9.690799378236914e-12
transmission O 0 3.3920915853968836e-08
to O 0 5.88992092945273e-12
Australia O 0 1.162192412619556e-12
by O 0 2.3269252057969356e-14
British O 0 2.3005443383627977e-10
- O 0 1.6944912140104407e-10
Irish O 0 4.255530650087991e-11
migrants O 0 4.8160538057562263e-11
. O 0 3.7755914930950873e-13
. O 0 3.879614685065036e-11

Identification O 0 4.954237624588131e-07
of O 0 5.451597395733643e-09
constitutional O 0 2.8757739300999674e-08
WT1 O 0 5.5900702136568725e-05
mutations O 0 1.6869290686560845e-10
, O 0 1.0535029032682827e-14
in O 0 2.9266343580351684e-14
patients O 0 2.4121846013691606e-12
with O 0 1.2528602287564805e-12
isolated O 0 5.353023979637328e-08
diffuse B-Disease 0 0.0001756872661644593
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.686555761585065e-14
and O 0 2.4274659308173884e-16
analysis O 0 9.8452051632697e-13
of O 0 4.73863032146582e-11
genotype O 0 1.1626974938394596e-09
/ O 0 1.982513486709081e-09
phenotype O 0 9.444971931296675e-13
correlations O 0 3.667658421435162e-14
by O 0 2.200868603210204e-16
use O 0 3.6092697298754917e-13
of O 0 7.94502311163292e-12
a O 0 1.3600117559908753e-11
computerized O 0 3.2773330715940574e-09
mutation O 0 5.467608310549821e-11
database O 0 8.058057554549691e-10
. O 0 1.5646252071732647e-09

Constitutional O 0 1.2789842518401429e-09
mutations O 0 3.1542895465724863e-12
of O 0 3.135986912858324e-12
the O 0 1.4972396152751477e-12
WT1 O 0 1.6964485372028548e-09
gene O 0 1.0970126987797785e-14
, O 0 6.121417641951775e-16
encoding O 0 2.9640964162302996e-12
a O 0 3.9551525249370556e-11
zinc O 0 2.8063757984142512e-09
- O 0 4.475816606230865e-09
finger O 0 1.305838637222223e-08
transcription O 0 2.0676347300963016e-09
factor O 0 5.190983753955436e-11
involved O 0 1.1614756378897084e-10
in O 0 2.640049512336873e-09
renal O 1 1.0
and O 0 7.982814764773138e-08
gonadal O 1 0.9999932050704956
development O 0 3.8821628550067544e-05
, O 0 8.840843706528663e-15
are O 0 2.259128191066845e-16
found O 0 2.303467136542496e-15
in O 0 3.014539225542983e-15
most O 0 2.3642891843530384e-15
patients O 0 6.322726562690666e-15
with O 0 3.5992652543288817e-14
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.136818905630673e-12
DDS B-Disease 1 1.0
) O 0 1.5644130684899088e-13
, O 0 1.3205143697806766e-14
or O 0 1.5629832497698892e-11
diffuse B-Disease 0 0.2385653257369995
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.1797402247812339e-12
DMS B-Disease 0 6.94899748854283e-10
) O 0 4.939528880195106e-17
associated O 0 1.033891210627325e-14
with O 0 1.6441466853885263e-14
pseudohermaphroditism B-Disease 1 1.0
and O 0 5.018366833198229e-10
/ O 0 1.0586586540739518e-06
or O 0 4.4104342400430596e-10
Wilms B-Disease 0 2.20782499127381e-06
tumor I-Disease 0 2.9876865426103905e-08
( O 0 1.1627157570082147e-12
WT B-Disease 1 0.9998379945755005
) O 0 3.1834929657692523e-13
. O 0 6.217784620510258e-11

Most O 0 1.718908626546778e-10
mutations O 0 5.895692822832643e-10
in O 0 3.5550948296325657e-10
DDS B-Disease 1 1.0
patients O 0 1.1994714554930397e-07
lie O 0 1.6671158675762854e-07
in O 0 1.7969395416095324e-10
exon O 0 1.4406801307487171e-09
8 O 0 8.158872188968047e-11
or O 0 5.099958996779286e-11
exon O 0 2.2974222524396737e-10
9 O 0 1.4681133045368888e-11
, O 0 1.519065906049888e-13
encoding O 0 1.1800209698265007e-09
zinc O 0 1.2054138665007486e-07
finger O 0 0.00671633705496788
2 O 0 1.365065283032152e-09
or O 0 1.2473525323741796e-08
zinc O 0 1.0516454551634524e-07
finger O 0 2.7823693926620763e-06
3 O 0 4.5799848288896605e-12
, O 0 4.806335146231074e-15
respectively O 0 3.7481129311345285e-12
, O 0 2.6996911498179286e-15
with O 0 5.475976947957222e-15
a O 0 1.4883682827870892e-11
hot O 0 5.483610787671012e-10
spot O 0 6.395153739902071e-09
( O 0 1.6465410781238247e-14
R394W O 0 6.933123519736739e-10
) O 0 3.4942194892872503e-15
in O 0 1.4351104939830384e-12
exon O 0 1.293980894656599e-10
9 O 0 3.5764571859608907e-10
. O 0 2.820252253954436e-09

We O 0 7.420948577863129e-11
analyzed O 0 3.744039800412935e-12
a O 0 8.870943869342292e-15
series O 0 3.946546306307598e-15
of O 0 5.884109524493045e-14
24 O 0 5.948163836477782e-12
patients O 0 1.0309227430060908e-12
, O 0 1.0290632075312701e-14
10 O 0 2.9631694233728245e-12
with O 0 1.569250111799203e-11
isolated B-Disease 0 2.316726067874697e-06
DMS I-Disease 0 3.553543865564279e-05
( O 0 4.0633724683603045e-12
IDMS B-Disease 0 1.9664916180772707e-05
) O 0 3.159506754531541e-14
, O 0 2.8574199077832305e-15
10 O 0 3.9819723581836775e-14
with O 0 7.144013435293403e-14
DDS B-Disease 1 1.0
, O 0 2.882444174838461e-13
and O 0 2.119210873680142e-14
4 O 0 6.224803116537669e-13
with O 0 2.1115338752659973e-13
urogenital B-Disease 0 2.011360749065716e-07
abnormalities I-Disease 0 4.960326691616501e-07
and O 0 2.0977121428789047e-10
/ O 0 5.113954557600664e-07
or O 0 2.3543165639239305e-08
WT B-Disease 1 1.0
. O 0 3.3541440735973538e-09

We O 0 5.27570254149623e-09
report O 0 2.0516449650287427e-10
WT1 O 0 5.343032967175532e-07
heterozygous O 0 9.770163844624591e-11
mutations O 0 1.9312417984251873e-11
in O 0 3.778329103580613e-13
16 O 0 4.927198232751451e-11
patients O 0 4.408764586044667e-12
, O 0 1.464757304434506e-14
4 O 0 1.4066713288976573e-12
of O 0 4.867303608768747e-12
whom O 0 1.7139455132930692e-10
presented O 0 8.957410813081879e-09
with O 0 2.288165212860349e-09
IDMS B-Disease 1 0.9999935626983643
. O 0 2.0110674370243942e-07

One O 0 5.229569381703936e-12
male O 0 2.3397317069906443e-12
and O 0 2.97713509762518e-15
two O 0 1.230580714368587e-13
female O 0 9.872914291664259e-11
IDMS B-Disease 1 0.9809367060661316
patients O 0 1.4353501720520967e-10
with O 0 1.4342083076712697e-11
WT1 O 1 0.9999991655349731
mutations O 0 5.589148713625036e-06
underwent O 0 3.8204183510970324e-05
normal O 0 5.010336735722376e-06
puberty O 0 1.7762979496183107e-06
. O 0 1.0067126021695572e-09

Two O 0 9.256850397321159e-09
mutations O 0 8.674665430419282e-10
associated O 0 1.627811635485088e-10
with O 0 1.717025935495109e-12
IDMS B-Disease 0 0.0005144539754837751
are O 0 3.847235928406767e-15
different O 0 3.4588634870359085e-15
from O 0 2.6081311657361224e-14
those O 0 7.14646712033501e-14
described O 0 1.1528452671660805e-11
in O 0 9.056754790570665e-10
DDS B-Disease 1 1.0
patients O 0 8.606559021018256e-08
. O 0 7.771356891339565e-09

No O 0 6.367781679728068e-08
WT1 O 0 7.584354989376152e-06
mutations O 0 1.8791292133446547e-10
were O 0 1.5618916750226308e-12
detected O 0 1.0882027700817587e-12
in O 0 1.396908271293542e-14
the O 0 6.934527821758629e-13
six O 0 4.457078803254966e-11
other O 0 4.1824248925292906e-11
IDMS B-Disease 1 0.9999997615814209
patients O 0 1.939623572866367e-09
, O 0 1.2593962331330921e-12
suggesting O 0 5.2953051665749484e-11
genetic O 0 8.694355652094643e-11
heterogeneity O 0 4.1090011948519134e-10
of O 0 2.6711721376471154e-11
this O 0 2.2838345103970425e-10
disease O 0 4.40616787500403e-07
. O 0 1.6887520271069434e-09

We O 0 1.5440037026692721e-09
analyzed O 0 2.0132995270927267e-09
genotype O 0 1.1922452358703595e-08
/ O 0 2.2641142294332894e-09
phenotype O 0 1.4305364184896696e-11
correlations O 0 6.41970851478213e-12
, O 0 2.95985313734191e-16
on O 0 3.3599351209942898e-15
the O 0 8.555574338959084e-16
basis O 0 8.006873701386918e-13
of O 0 5.807765428517478e-14
the O 0 7.4404959732495e-14
constitution O 0 9.577084405468922e-14
of O 0 2.393056889801737e-12
a O 0 1.5655371096712223e-11
WT1 O 0 6.515657560157706e-07
mutation O 0 2.5123654892600378e-11
database O 0 1.1705539315620683e-10
of O 0 9.447449766941673e-11
84 O 0 4.903243322473827e-08
germ O 0 0.00022749928757548332
- O 0 5.357065674616024e-06
line O 0 3.868581188726239e-08
mutations O 0 1.4272386224256639e-11
, O 0 4.108850100979257e-15
to O 0 2.0565116992145305e-13
compare O 0 1.6699612179205126e-11
the O 0 3.5389608452930654e-13
distribution O 0 5.795985219547717e-12
and O 0 1.9472769073212645e-14
type O 0 3.725506708684989e-11
of O 0 9.842957178485268e-12
mutations O 0 4.728179653357145e-13
, O 0 7.712999961380894e-16
according O 0 7.306499426752017e-14
to O 0 3.478224652742057e-13
the O 0 8.321354673032633e-13
different O 0 1.5706702605200462e-10
symptoms O 0 8.971006337787912e-08
. O 0 6.035919541957924e-10

This O 0 1.0046289494747285e-10
demonstrated O 0 2.0006556411544807e-09
( O 0 3.848498007498176e-15
1 O 0 3.2638131021618666e-14
) O 0 1.8712548638601556e-16
the O 0 9.785772486661879e-15
association O 0 2.313410286903725e-14
between O 0 5.1596500509620835e-12
mutations O 0 6.388118658183506e-13
in O 0 1.0257367871746581e-12
exons O 0 1.4773274270574177e-10
8 O 0 2.2487422080691433e-12
and O 0 1.0820537174605072e-12
9 O 0 3.25838141190804e-11
and O 0 6.382570860719028e-11
DMS B-Disease 0 2.5598606612220465e-07
; O 0 1.0300342393257389e-12
( O 0 2.4141230972553242e-15
2 O 0 3.2017110181614336e-14
) O 0 7.441666191617779e-16
among O 0 1.4800988075268232e-15
patients O 0 2.0488058339175434e-14
with O 0 2.6380597196746375e-14
DMS B-Disease 0 7.102074484066634e-10
, O 0 1.0066908651086212e-14
a O 0 1.097289576909577e-13
higher O 0 7.980668209617292e-12
frequency O 0 1.925867625096611e-11
of O 0 1.7812561148300432e-10
exon O 0 2.10237438569294e-10
8 O 0 1.8566689852228535e-11
mutations O 0 2.4402975300208407e-12
among O 0 1.7272206614179358e-13
46 O 0 2.1691855256467107e-10
, O 0 1.6413316018815127e-12
XY O 0 1.9577887542254757e-06
patients O 0 3.633225014246233e-12
with O 0 4.724767143959906e-15
female O 0 5.234915691036679e-13
phenotype O 0 1.8645989700166732e-13
than O 0 1.876137532345044e-15
among O 0 9.601735097113095e-15
46 O 0 3.531225589714637e-10
, O 0 2.836198940633916e-12
XY O 0 0.03360616788268089
patients O 0 1.4571086004444567e-10
with O 0 3.4708797928871896e-14
sexual O 0 1.652586813054302e-12
ambiguity O 0 1.2059099378791682e-12
or O 0 9.650910441898891e-14
male O 0 1.8272347610676087e-12
phenotype O 0 3.9238846546996164e-12
; O 0 2.1234037206503686e-13
and O 0 2.791804565305256e-10
( O 0 7.663183781113359e-13
3 O 0 3.627825470586821e-11
) O 0 1.1349536084169151e-13
statistically O 0 9.911975483011676e-14
significant O 0 1.4640833203183757e-15
evidence O 0 2.6522468439147892e-14
that O 0 6.153871815204942e-15
mutations O 0 7.928850718347258e-13
in O 0 1.1994783638558104e-11
exons O 0 2.701136203597798e-09
8 O 0 2.3301622784077658e-11
and O 0 2.8996056857660824e-12
9 O 0 3.130866746414718e-11
preferentially O 0 1.2554161876732195e-10
affect O 0 1.2585120723329624e-09
amino O 0 1.0547696743801183e-10
acids O 0 9.168780101473373e-13
with O 0 2.0828754048802427e-15
different O 0 2.3972447291131793e-13
functions O 0 2.1267659508494852e-11
. O 0 5.965365354465568e-12
. O 0 5.041564943297772e-10

The O 0 2.2043804559501723e-09
185delAG O 0 1.6172208461284754e-07
BRCA1 O 0 3.9700287501887033e-10
mutation O 0 5.860074117581757e-14
originated O 0 3.181300234638036e-14
before O 0 7.072667934849468e-15
the O 0 3.2402531771955198e-15
dispersion O 0 2.9781162345227097e-12
of O 0 1.0729677779944269e-12
Jews O 0 1.2344703384514766e-11
in O 0 1.129481924655451e-12
the O 0 2.686616771066519e-12
diaspora O 0 7.509673993766341e-10
and O 0 1.4592736741203538e-12
is O 0 6.520449463568237e-14
not O 0 7.756443599384044e-13
limited O 0 3.7825748089304057e-10
to O 0 1.7353153580756953e-08
Ashkenazim O 0 0.001087658922187984
. O 0 2.3614678923422616e-07

The O 0 8.184734001659422e-10
185delAG O 0 5.7281440035694686e-08
mutation O 0 3.2948776085978126e-12
in O 0 1.18511006130112e-12
BRCA1 O 0 2.5842586404145607e-10
is O 0 5.4133804508254765e-14
detected O 0 3.0363797413890392e-12
in O 0 1.09852509304776e-13
Ashkenazi O 0 2.6070023917412755e-10
Jews O 0 3.1470900104663135e-12
both O 0 3.719709002619753e-13
in O 0 7.2511545379239095e-12
familial B-Disease 1 0.999300479888916
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 9.575605863787473e-10
in O 0 2.1402467471898223e-12
the O 0 3.3211630060675512e-12
general O 0 8.111987102009388e-13
population O 0 3.271878549885622e-14
. O 0 1.0279701569138044e-11

All O 0 7.241652832945533e-10
tested O 0 2.129689757879305e-10
Ashkenazi O 0 2.9343760754585446e-10
mutation O 0 8.512443950680487e-15
carriers O 0 8.828302536711616e-16
share O 0 2.5771271510051375e-13
the O 0 1.0651576192247103e-13
same O 0 1.9335186663554937e-12
allelic O 0 3.583430663312015e-09
pattern O 0 2.797844178559217e-10
at O 0 4.63014002138884e-11
the O 0 1.9840018516958935e-11
BRCA1 O 0 3.126953418419731e-10
locus O 0 1.6664079838246693e-10
. O 0 3.1111717646581383e-09

Our O 0 2.7371147126586948e-08
previous O 0 6.393637841384248e-10
study O 0 6.348157134510035e-13
showed O 0 2.6313977039005287e-13
that O 0 1.047630797068861e-16
this O 0 3.843057260768078e-14
Ashkenazi O 0 1.7786099704153457e-08
mutation O 0 6.586064593000485e-12
also O 0 8.26011622382522e-15
occurs O 0 5.4160763872899975e-14
in O 0 5.349371356847595e-15
Iraqi O 0 7.053078121543876e-08
Jews O 0 3.482611143912351e-10
with O 0 3.4147641311821353e-13
a O 0 9.852493170273147e-13
similar O 0 3.149778615013643e-13
allelic O 0 2.059734827142279e-09
pattern O 0 2.3468416099348133e-09
. O 0 8.374807514144322e-09

We O 0 1.1494995927341378e-10
extended O 0 1.372625624274093e-10
our O 0 7.40180486347164e-12
analysis O 0 4.5887854063439426e-14
to O 0 2.716558802993291e-13
other O 0 8.16591640227099e-13
non O 0 3.7806309194365895e-08
- O 0 3.6004899062191953e-09
Ashkenazi O 0 2.7114252176829723e-08
subsets O 0 3.293622666267204e-11
354 O 0 7.71440203384266e-11
of O 0 2.142677094779666e-12
Moroccan O 0 5.264040314756357e-10
origin O 0 6.6640165607978474e-12
, O 0 7.313704289001362e-15
200 O 0 4.884151893688737e-13
Yemenites O 0 5.307862593895152e-08
and O 0 3.9407713203765127e-14
150 O 0 1.349615297990825e-12
Iranian O 0 7.435138282829712e-09
Jews O 0 5.131969960103788e-09
. O 0 1.30529071995511e-08

Heteroduplex O 0 1.7329177808278473e-06
analysis O 0 1.1534831249881972e-11
complemented O 0 2.324346010801337e-12
by O 0 6.03012151922095e-17
direct O 0 1.294941936883301e-13
DNA O 0 1.0797827909581059e-10
sequencing O 0 2.0790791310787426e-09
of O 0 2.0356402674615026e-10
abnormally O 0 2.2798336135609887e-11
migrating O 0 1.75028351187545e-12
bands O 0 3.1944431908709214e-12
were O 0 1.591595605310303e-11
employed O 0 1.7769957949553827e-08
. O 0 1.675457639294109e-08

Four O 0 1.3164305756596661e-10
of O 0 5.888553533672791e-11
Moroccan O 0 3.3344992544925844e-08
origin O 0 3.0696192115931e-11
( O 0 1.403163413732646e-16
1 O 0 4.664114079222341e-15
. O 0 4.877907100933458e-16
1 O 0 2.624858118268616e-15
% O 0 1.584943656353366e-14
) O 0 3.907993710901159e-18
and O 0 5.404049027658755e-16
none O 0 3.8926210345346934e-12
of O 0 6.591933162519714e-12
the O 0 2.4979972951255647e-11
Yemenites O 0 1.477690148021793e-07
or O 0 1.3755464866108125e-12
Iranians O 0 1.9171615406321507e-09
was O 0 1.1088976958895103e-12
a O 0 3.465852144125467e-14
carrier O 0 1.196693839942281e-13
of O 0 5.866149579980551e-13
the O 0 8.932964611074734e-12
185delAG O 0 8.262099271405532e-08
mutation O 0 5.185019080755637e-10
. O 0 1.1796137400210682e-09

BRCA1 O 0 1.176309183392732e-06
allelic O 0 3.009161275713268e-08
patterns O 0 5.654493540063754e-11
were O 0 1.3925355822879543e-13
determined O 0 5.859629730216309e-13
for O 0 3.0995727360629e-14
four O 0 1.1484723220177295e-13
of O 0 1.8418943196281574e-14
these O 0 3.3667463246813984e-16
individuals O 0 7.669459820914062e-16
and O 0 3.922786185104167e-15
for O 0 1.1067988431139042e-13
12 O 0 1.3436262519261888e-11
additional O 0 1.4882413357231172e-10
non O 0 1.8371918031334644e-07
- O 0 2.800885212650428e-08
Ashkenazi O 0 2.4694260858382222e-08
185delAG O 0 5.294025218205434e-10
mutation O 0 2.6368723488891764e-14
carriers O 0 5.331220287820883e-15
who O 0 3.315130017288864e-13
had O 0 4.906372623736388e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.000378473341697827

Six O 0 1.180679447543298e-07
non O 0 2.056333272548727e-07
- O 0 4.237141304486158e-09
Ashkenazi O 0 1.337100874465591e-09
individuals O 0 1.8323362304447505e-13
shared O 0 8.087273038748233e-12
the O 0 8.455331161789925e-13
common O 0 3.18948730274049e-12
Ashkenazi O 0 1.6047075890313067e-09
haplotype O 0 8.288245090248836e-10
, O 0 9.405027754857964e-13
four O 0 4.1590054317142133e-11
had O 0 5.0358727604615794e-11
a O 0 1.8725583150053238e-12
closely O 0 1.92477490109505e-13
related O 0 7.341682817241235e-12
pattern O 0 5.0339711565872136e-11
, O 0 1.8977968000810468e-15
and O 0 9.862146906416958e-15
the O 0 2.408481469817758e-10
rest O 0 3.797108263370319e-07
( O 0 2.50114599170681e-13
n O 0 2.2070201569079906e-11
= O 0 1.7258229567662653e-11
6 O 0 1.0249160027619997e-11
) O 0 7.123056654332206e-15
displayed O 0 6.450036251631763e-12
a O 0 3.761189276696442e-12
distinct O 0 1.208533360191888e-11
BRCA1 O 0 3.9428846299038867e-10
allelic O 0 2.6977742262346283e-09
pattern O 0 2.2671478028257752e-09
. O 0 7.56134799217989e-09

We O 0 3.956563549012415e-11
conclude O 0 1.5237816564095397e-09
that O 0 1.729619763656421e-14
the O 0 6.570790461214726e-13
185delAG O 0 1.1255014698008381e-08
BRCA1 O 0 9.754174135068183e-10
mutation O 0 6.360446566135158e-13
occurs O 0 5.435781084148564e-14
in O 0 2.663333319348222e-14
some O 0 1.944973695988672e-12
non O 0 3.0758503726247e-06
- O 0 2.7996945846098242e-06
Ashkenazi O 0 0.00018701903172768652
populations O 0 1.6266580304957756e-09
at O 0 8.199507912920456e-12
rates O 0 9.04981249444034e-14
comparable O 0 2.3657126062802403e-13
with O 0 9.841396293275122e-16
that O 0 8.579948410818508e-14
of O 0 3.504707635215709e-10
Ashkenazim O 0 6.560696419910528e-06
. O 0 5.224734778153106e-08

The O 0 7.059743761805848e-11
majority O 0 6.107726303883343e-12
of O 0 6.731570596080205e-12
Jewish O 0 5.115539658540058e-10
185delAG O 0 6.927525220135067e-08
mutation O 0 2.6303651097514535e-12
carriers O 0 1.786874820200804e-13
have O 0 3.9126425081630056e-13
a O 0 4.596270846563e-12
common O 0 9.022245624212832e-12
allelic O 0 4.98627272804697e-09
pattern O 0 2.3081786482137545e-10
, O 0 9.568010310911576e-14
supporting O 0 5.8052156831633894e-11
the O 0 1.2227983903212447e-10
founder O 0 9.122479438516962e-10
effect O 0 6.570556165125252e-12
notion O 0 2.5637847747561615e-11
, O 0 2.020364669834407e-14
but O 0 1.3055208701747388e-14
dating O 0 6.668394308961823e-11
the O 0 4.6013797698300773e-14
mutations O 0 1.414032482278298e-14
origin O 0 3.87565210501796e-14
to O 0 2.7997295779479126e-13
an O 0 1.0532015289456496e-14
earlier O 0 1.5191304160791508e-12
date O 0 6.346589920269707e-11
than O 0 2.1537593486008894e-13
currently O 0 2.5601478402526023e-12
estimated O 0 2.1964345620073544e-10
. O 0 1.242636482601256e-08

However O 0 4.858580759936615e-10
, O 0 5.291571353186267e-14
the O 0 2.3125500402424934e-14
different O 0 9.635992497631848e-14
allelic O 0 8.733368472846337e-10
pattern O 0 2.3288126982379254e-10
at O 0 5.648608317199155e-11
the O 0 5.5697602779902766e-11
BRCA1 O 0 5.423364535239728e-10
locus O 0 7.682685737586681e-11
even O 0 7.444946568957445e-12
in O 0 2.964791823503732e-12
some O 0 1.1794792573183166e-12
Jewish O 0 9.794201005774994e-10
mutation O 0 1.7247139480480733e-11
carriers O 0 2.6665028692030024e-12
, O 0 2.1825299813954535e-12
might O 0 7.833256959743906e-11
suggest O 0 2.502414386817975e-10
that O 0 2.2212455128272496e-13
the O 0 4.827418412928219e-12
mutation O 0 1.0388498871902185e-12
arose O 0 4.270383525961652e-12
independently O 0 1.0505954439743448e-10
. O 0 1.602931849753464e-11
. O 0 2.37412955961247e-09

Crystal O 0 6.206525426932785e-08
structure O 0 3.116790603385766e-09
of O 0 2.235249763060665e-09
the O 0 1.1977610903102232e-08
hemochromatosis B-Disease 1 1.0
protein O 0 2.9263680367819234e-09
HFE O 0 3.2713708719711576e-07
and O 0 5.770983192189549e-14
characterization O 0 2.244326668954244e-10
of O 0 4.295505270923705e-11
its O 0 2.6156464147386593e-12
interaction O 0 9.99939644974468e-11
with O 0 8.196594444842553e-13
transferrin O 0 4.508910222966733e-08
receptor O 0 2.76074801908166e-10
. O 0 1.08078679339485e-09

HFE O 0 0.0005630669184029102
is O 0 6.49590234033659e-12
an O 0 3.6432158288454697e-13
MHC O 0 4.7863174756912485e-08
- O 0 6.41890984809379e-09
related O 0 7.711467908677605e-09
protein O 0 3.503970724683114e-11
that O 0 4.0177258200576064e-16
is O 0 2.049751283159718e-18
mutated O 0 5.278804089099774e-16
in O 0 8.956660850747348e-16
the O 0 2.354491601685993e-12
iron B-Disease 0 0.14358051121234894
- I-Disease 1 0.999990701675415
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 2.998667980591563e-07

HFE O 0 5.579252047027694e-07
binds O 0 1.1254610091104844e-11
to O 0 3.892675418115665e-11
transferrin O 0 5.474177111608469e-09
receptor O 0 4.0048043006835066e-12
( O 0 3.3927265192395823e-15
TfR O 0 3.8632239074409824e-10
) O 0 2.7726551502295653e-16
and O 0 2.0554311138727297e-15
reduces O 0 4.810005678804706e-14
its O 0 2.0643036569402765e-14
affinity O 0 3.1006458251631175e-12
for O 0 7.123832079791725e-11
iron O 0 6.702219224052897e-08
- O 0 1.6053198770293875e-09
loaded O 0 2.4704704948419476e-09
transferrin O 0 1.0975753639286268e-07
, O 0 1.3800435620658913e-11
implicating O 0 1.6753720899487234e-07
HFE O 0 1.8674865714274347e-05
in O 0 2.2702029145449387e-09
iron O 0 4.471045940590557e-06
metabolism O 0 1.8602913769427687e-05
. O 0 1.6241507694303436e-08

The O 0 1.1763698459787975e-08
2 O 0 3.3460800796802914e-09
. O 0 1.2566794271862136e-09

6 O 0 6.881758274346339e-09
A O 0 2.0819136636873736e-08
crystal O 0 2.0776602660532717e-09
structure O 0 1.8520235345320657e-09
of O 0 1.819888240106593e-09
HFE O 0 0.00017130425840150565
reveals O 0 9.368960468547627e-11
the O 0 3.3956238970796193e-13
locations O 0 1.9377209906079607e-11
of O 0 2.549468969270663e-10
hemochromatosis B-Disease 1 1.0
mutations O 0 1.1022679657912704e-08
and O 0 5.530989728719238e-12
a O 0 3.832685002702618e-10
patch O 1 0.945509672164917
of O 0 2.8292486149439355e-06
histidines O 0 0.007977641187608242
that O 0 2.7365765903342165e-12
could O 0 5.067686287968387e-12
be O 0 1.0297003050566134e-12
involved O 0 1.0230161856528142e-10
in O 0 3.464710962575168e-09
pH O 0 5.005618277209578e-06
- O 0 4.681195431288643e-09
dependent O 0 3.4685128103006946e-09
interactions O 0 3.3514073738416528e-09
. O 0 1.4084373667344607e-09

We O 0 2.3732815712662614e-10
also O 0 2.813562642416112e-13
demonstrate O 0 3.590776842532506e-10
that O 0 6.456842872870627e-12
soluble O 0 3.0093321168322973e-09
TfR O 0 1.5782877227366043e-08
and O 0 1.614443279583655e-12
HFE O 0 3.504234200590872e-07
bind O 0 1.860353121552194e-10
tightly O 0 5.918499912382913e-09
at O 0 9.719125504403792e-11
the O 0 2.1760716492624788e-11
basic O 0 7.62535279363874e-08
pH O 0 1.0160283281379634e-08
of O 0 3.989938240911428e-11
the O 0 1.4543562534830023e-11
cell O 0 3.399612882870606e-11
surface O 0 1.3059462365683228e-11
, O 0 2.6686066076646482e-14
but O 0 3.296747776030187e-14
not O 0 7.988598931668589e-13
at O 0 2.553858791110031e-10
the O 0 5.273388836712911e-09
acidic O 0 1.4059467048355145e-06
pH O 0 1.5442701339907217e-07
of O 0 2.1161435270755646e-08
intracellular O 0 5.808292158349104e-08
vesicles O 0 1.7968459076200816e-07
. O 0 4.96272534178388e-08

TfR O 0 2.9913298931205645e-06
HFE O 0 8.826855264487676e-06
stoichiometry O 0 1.642089308973027e-08
( O 0 9.5955700525098e-14
2 O 0 2.9795865210888173e-13
1 O 0 4.11429415113785e-14
) O 0 5.418681852694818e-17
differs O 0 7.368005538370762e-14
from O 0 1.4127742487164696e-13
TfR O 0 4.947070531002851e-10
transferrin O 0 2.6328772495531894e-10
stoichiometry O 0 2.4802624398745365e-09
( O 0 1.6680772296209442e-14
2 O 0 1.1635225389498155e-13
2 O 0 3.329824073807289e-14
) O 0 1.1113628133348056e-15
, O 0 1.0870062750573898e-15
implying O 0 3.7283603938551013e-13
a O 0 7.102652477665797e-15
different O 0 4.699511586088098e-15
mode O 0 1.486133091588293e-11
of O 0 2.987638890623867e-13
binding O 0 3.5380309792998332e-12
for O 0 4.796563840558932e-11
HFE O 0 3.514936179271899e-05
and O 0 1.0155992019589277e-10
transferrin O 0 6.333780788736476e-08
to O 0 2.029159507088707e-09
TfR O 0 7.02676572927885e-07
, O 0 1.0052676464693266e-13
consistent O 0 3.965690276164224e-11
with O 0 2.2336628125460903e-14
our O 0 5.319002530090877e-11
demonstration O 0 3.9880210245257786e-11
that O 0 1.1662532376464918e-13
HFE O 0 2.9714931315538706e-07
, O 0 1.1026605111841628e-13
transferrin O 0 2.383962804941575e-09
, O 0 6.05311102890721e-13
and O 0 1.240015360358393e-12
TfR O 0 4.901625771935869e-08
form O 0 7.632351348152433e-12
a O 0 1.2228000730030164e-11
ternary O 0 3.307105771455099e-07
complex O 0 4.327641889290135e-08
. O 0 2.7598295204711576e-08

Identification O 0 9.064899053612407e-09
of O 0 1.3829526065989306e-11
three O 0 6.81975296005187e-14
novel O 0 3.905048891672189e-15
mutations O 0 5.6416975041315154e-14
and O 0 2.3843238428962075e-15
a O 0 3.67195626660953e-14
high O 0 1.5060259354708616e-13
frequency O 0 6.304837836708377e-13
of O 0 5.614574018382446e-13
the O 0 5.32011544193689e-12
Arg778Leu O 0 6.864456736366265e-08
mutation O 0 2.4142836167750925e-12
in O 0 1.0356621024101495e-13
Korean O 0 1.8242706234516959e-09
patients O 0 1.1240494646180821e-11
with O 0 6.136039484676281e-13
Wilson B-Disease 0 8.877658501660335e-07
disease I-Disease 0 6.270074948133697e-08
. O 0 5.538057790133166e-10

Four O 0 1.1163295177141208e-08
mutations O 0 7.611394847728548e-10
- O 0 8.583091459790637e-10
- O 0 1.6888607179410542e-10
R778L O 0 1.5413730292124228e-09
, O 0 4.8598193476195525e-15
A874V O 0 6.346916742172581e-11
, O 0 6.293342036838348e-16
L1083F O 0 1.930674543848543e-11
, O 0 8.494594319503879e-17
and O 0 4.501150022368297e-16
2304delC O 0 9.800249500813152e-11
- O 0 3.592367831158072e-13
- O 0 1.4284409701088852e-13
in O 0 4.289039419848664e-14
the O 0 6.939568819759601e-13
copper O 0 5.276006194432359e-12
- O 0 4.233285339568134e-14
transporting O 0 2.614040494480774e-12
enzyme O 0 1.9774160607555213e-12
, O 0 1.4242459208529956e-13
P O 0 1.2490332323977782e-08
- O 0 1.0212011097854301e-10
type O 0 2.843577803779418e-11
ATPase O 0 6.739134583710893e-09
( O 0 6.131844723411594e-15
ATP7B O 0 1.4073310694584507e-06
) O 0 6.293626851666863e-17
, O 0 5.516897225444363e-18
were O 0 1.9317158109373716e-16
identified O 0 9.62123972478952e-15
in O 0 2.0064925147956917e-15
Korean O 0 1.0279078976882516e-10
Patients O 0 1.6813581776853326e-11
with O 0 1.1558522151552952e-12
Wilson B-Disease 0 2.8285605822020443e-06
disease I-Disease 0 0.00019103851809632033
. O 0 7.82996707471284e-08

Arg778Leu O 0 9.392529318574816e-05
, O 0 1.7222737992705905e-12
the O 0 9.221587252486452e-13
most O 0 1.6457657041639082e-14
frequently O 0 5.809969747059412e-14
reported O 0 1.2005048105785676e-13
mutation O 0 5.434840403238661e-13
of O 0 1.383970412230373e-12
this O 0 2.6738556030761473e-13
enzyme O 0 1.555517433610154e-12
, O 0 3.5033306415360385e-14
was O 0 3.871390783904277e-13
found O 0 1.636082084697718e-14
in O 0 3.027803973255222e-15
six O 0 4.406996685982212e-13
of O 0 2.125758065667921e-13
eight O 0 7.351322675597238e-12
unrelated O 0 2.1391347027055474e-10
patients O 0 7.703381660860431e-13
studied O 0 6.778930173277631e-13
, O 0 6.703522506106572e-16
an O 0 4.662597082918478e-17
allele O 0 2.3115325842662515e-13
frequency O 0 2.2826272122467017e-11
of O 0 1.8866566642294913e-10
37 O 0 1.6636853672480356e-07
. O 0 6.227121929214263e-08

5 O 0 1.5589296520346352e-09
% O 0 5.886389153886284e-10
, O 0 1.4666275531820434e-14
which O 0 6.566996676876939e-16
is O 0 2.765429959189486e-16
considerably O 0 1.788225925843101e-12
higher O 0 1.0254258379915893e-12
than O 0 1.1506642738786342e-14
those O 0 2.1661061074158827e-13
in O 0 2.597207605231633e-12
other O 0 3.1874563752309903e-12
Asian O 0 8.572015874896977e-10
populations O 0 9.504450178277057e-12
. O 0 8.082434027611995e-11

The O 0 4.138784800988837e-12
novel O 0 9.56389982942514e-15
single O 0 3.788489433189518e-13
nucleotide O 0 6.340331471649252e-12
deletion O 0 9.874848334867625e-12
, O 0 4.028672333884417e-14
2304delC O 0 2.5977613393735055e-09
, O 0 1.1985160449810503e-14
was O 0 1.3426591652723752e-13
found O 0 1.8550024933000966e-14
in O 0 1.403373673779934e-14
one O 0 1.826398624352188e-12
patient O 0 4.285174437512751e-09
. O 0 5.4545097327718395e-09

Since O 0 8.321739131122996e-12
a O 0 5.426874227776324e-13
mutation O 0 1.1659352953594104e-13
at O 0 5.536908279958619e-13
cDNA O 0 9.810821044453633e-10
nucleotide O 0 3.5146503485350422e-09
2302 O 0 1.8824212588697264e-07
( O 0 1.2789078573016612e-14
2302insC O 0 1.076400746313766e-09
) O 0 5.466543542023651e-15
had O 0 3.533180421410459e-13
been O 0 3.2336321662863876e-13
previously O 0 2.4439541102677653e-12
described O 0 8.175871004517665e-14
, O 0 1.9582026635469116e-16
this O 0 2.587171716621141e-15
region O 0 8.157673841990842e-11
of O 0 2.057577025427193e-11
the O 0 2.4579199786600725e-10
ATP7B O 1 0.9330540895462036
gene O 0 7.005779290025771e-11
may O 0 2.1024295152050065e-11
be O 0 2.5298783901117616e-11
susceptible O 0 9.98941263041786e-10
to O 0 1.5363510463828334e-09
gene O 0 3.923765490299047e-08
rearrangements O 0 7.263727457029745e-05
causing O 0 0.0001693288650130853
Wilson B-Disease 0 0.0008727258536964655
disease I-Disease 0 1.1902786354767159e-05
. O 0 1.030247998023981e-09

Disruption O 0 1.4934670389266103e-07
of O 0 7.548274782998021e-10
splicing O 0 1.3889486782936444e-10
regulated O 0 2.1597706262310723e-12
by O 0 1.0540937934522873e-14
a O 0 5.287158297978545e-12
CUG O 0 3.082072453253204e-06
- O 0 3.089708350278997e-11
binding O 0 2.557181896789551e-11
protein O 0 1.588118248019299e-10
in O 0 1.329957324824882e-11
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.559157141173273e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.409620668610614e-09
DM B-Disease 1 1.0
) O 0 1.170061660407673e-12
is O 0 5.215078518225162e-15
caused O 0 6.729022178873778e-14
by O 0 1.2993401554619189e-14
a O 0 8.10948443813464e-12
CTG O 0 2.1792606830217665e-08
expansion O 0 4.181858678786732e-11
in O 0 4.0363429287294805e-13
the O 0 1.7027088289670034e-12
3 O 0 9.600229465556165e-12
untranslated O 0 9.491918717685621e-07
region O 0 1.1377924991062827e-10
of O 0 1.3385435988777505e-11
the O 0 7.73093311590145e-10
DM B-Disease 1 1.0
gene O 0 2.970206025576516e-10
. O 0 6.528007023831606e-09

One O 0 3.1841749289357457e-12
model O 0 2.6424347085440836e-11
of O 0 7.240382737805362e-10
DM B-Disease 1 1.0
pathogenesis O 0 6.24440374963342e-08
suggests O 0 3.950898202348396e-12
that O 0 6.576301122044291e-15
RNAs O 0 1.102932415536495e-12
from O 0 1.0420249732523423e-12
the O 0 7.252064075126408e-13
expanded O 0 7.335450064212268e-13
allele O 0 5.28797220854943e-13
create O 0 1.6653376540189807e-13
a O 0 1.5326864668922802e-13
gain O 0 7.642818045106026e-10
- O 0 4.28994617607259e-11
of O 0 1.634432172936684e-10
- O 0 7.453902078902175e-11
function O 0 7.038953621363309e-12
mutation O 0 5.7573032712782135e-15
by O 0 5.156557580999624e-17
the O 0 2.9061734301612935e-15
inappropriate O 0 4.191778353460421e-14
binding O 0 4.856004311225119e-14
of O 0 1.2116139255086145e-12
proteins O 0 4.264274548163201e-14
to O 0 5.109078958509539e-12
the O 0 2.2264576293729021e-10
CUG O 1 0.8060591220855713
repeats O 0 1.64170657512841e-07
. O 0 4.999996416898966e-09

Data O 0 5.257057011931465e-10
presented O 0 5.650922438316108e-12
here O 0 6.136838433257186e-12
indicate O 0 2.2352602407904598e-11
that O 0 1.0175515215583159e-14
the O 0 1.0004961269183266e-11
conserved O 0 3.9678127450315515e-09
heterogeneous O 0 1.5094979488594618e-08
nuclear O 0 3.2195533350432015e-08
ribonucleoprotein O 0 2.5615403131951098e-08
, O 0 1.4044837341742333e-12
CUG O 0 2.696602905416512e-06
- O 0 1.1897768881219406e-10
binding O 0 1.1838595381785666e-10
protein O 0 1.8849445615476412e-10
( O 0 1.9816954135065852e-14
CUG O 0 0.0005152455996721983
- O 0 2.540854637800294e-08
BP O 0 1.1237553110277076e-08
) O 0 1.8991230842698575e-14
, O 0 2.1093993522389165e-14
may O 0 4.824038304235279e-13
mediate O 0 4.145561671720088e-09
the O 0 4.5403774490138105e-11
trans O 0 2.4967075629156454e-10
- O 0 4.6226397709681066e-11
dominant O 0 1.0081860346566884e-10
effect O 0 2.7064359461219725e-14
of O 0 1.1826008380032282e-13
the O 0 1.066896679509377e-12
RNA O 0 1.0480820655800471e-09
. O 0 1.8991785921684823e-09

CUG O 1 0.9978383183479309
- O 0 3.245682364649838e-06
BP O 0 2.756005024195929e-08
was O 0 2.3532703563589052e-12
found O 0 4.575437352941341e-15
to O 0 9.714726751177977e-16
bind O 0 9.204391941556103e-15
to O 0 1.55140413319807e-13
the O 0 1.196646514517452e-12
human O 0 1.6521818635428787e-10
cardiac O 0 2.8999909318372374e-06
troponin O 0 1.7211104932357557e-06
T O 0 2.8454595124571824e-08
( O 0 2.391466405872282e-14
cTNT O 0 1.1128531429704935e-09
) O 0 8.673910665042022e-16
pre O 0 3.9517441402514564e-11
- O 0 7.649515244324834e-13
messenger O 0 1.253931312082679e-12
RNA O 0 2.0964059481431985e-12
and O 0 1.275893944668741e-14
regulate O 0 2.323009372481779e-14
its O 0 2.838505662071042e-15
alternative O 0 3.384820418741996e-12
splicing O 0 5.331396435437341e-10
. O 0 1.1314889025726416e-09

Splicing O 0 2.4523347796900907e-09
of O 0 7.733307882951124e-10
cTNT O 0 2.133338284693309e-06
was O 0 4.019961308276976e-10
disrupted O 0 2.7934169111176743e-07
in O 0 2.646955710172705e-10
DM B-Disease 1 1.0
striated O 0 3.7083978554619534e-08
muscle O 0 8.029811260357178e-10
and O 0 8.276336972527776e-13
in O 0 3.3856337872117948e-12
normal O 0 2.549022992681671e-09
cells O 0 1.1113846648536096e-10
expressing O 0 9.964202856913018e-13
transcripts O 0 2.868003612377379e-10
that O 0 1.9602086609709496e-13
contain O 0 7.481462671599104e-11
CUG O 0 6.295808270806447e-05
repeats O 0 2.7342137443042702e-08
. O 0 5.653356449641933e-09

Altered O 0 1.2175469521480409e-08
expression O 0 2.8678340258103674e-10
of O 0 3.8941252999968867e-10
genes O 0 1.3797724247865961e-11
regulated O 0 3.514371779700376e-11
posttranscriptionally O 0 2.123727860237068e-09
by O 0 2.8524144851660438e-12
CUG O 1 0.9999070167541504
- O 0 1.0035770259264609e-07
BP O 0 5.3144444400743396e-09
therefore O 0 3.238676471103985e-12
may O 0 3.317097031080296e-13
contribute O 0 1.2182192754561783e-10
to O 0 4.004825360226505e-09
DM B-Disease 1 1.0
pathogenesis O 0 1.647011771410689e-07
. O 0 8.110385973925105e-11
. O 0 4.764507122168027e-10

Identification O 0 6.730476620475656e-09
of O 0 1.4731143388457824e-11
a O 0 3.235365534509649e-13
novel O 0 3.422580618982034e-14
nonsense O 0 5.0900273579346234e-11
mutation O 0 3.7147581966870055e-14
and O 0 7.90000577789333e-16
a O 0 1.0932612745596839e-14
missense O 0 4.168588651348726e-12
substitution O 0 2.758007038895782e-13
in O 0 2.897170486371517e-14
the O 0 7.650784302967728e-13
vasopressin O 0 5.6928510794307385e-09
- O 0 2.856229919245834e-09
neurophysin O 0 3.2862215171292064e-09
II O 0 1.3973407986256348e-09
gene O 0 1.1571178856664005e-13
in O 0 4.293222068542206e-14
two O 0 3.091377861704804e-14
Spanish O 0 1.4682083673833723e-11
kindreds O 0 4.1999939526249364e-08
with O 0 9.62283377980988e-12
familial B-Disease 1 0.9731557965278625
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
. O 0 1.93995947483927e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 4.6865775149562694e-11
FNDI B-Disease 1 1.0
) O 0 4.1555571917567535e-14
is O 0 1.3076883216076442e-15
an O 0 1.3911809733173873e-14
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9998793601989746
caused O 0 2.8836183441072194e-11
by O 0 5.635148245383345e-14
deficiency O 1 0.9999996423721313
in O 0 1.8494686671033378e-08
the O 0 8.664801498525776e-08
antidiuretic O 0 3.1897537944303167e-09
hormone O 0 1.0535246286469402e-11
arginine O 0 8.306445531403028e-10
vasopressin O 0 3.8403466517955565e-10
( O 0 7.201112434487584e-15
AVP O 0 6.926524631634123e-11
) O 0 4.4931168743931006e-18
encoded O 0 5.0419887648218444e-17
by O 0 4.540607993424955e-16
the O 0 4.611814402588621e-12
AVP O 0 2.8309461868047947e-06
- O 0 6.134848717920249e-08
neurophysin O 0 1.0395420702025149e-07
II O 0 3.391470571045829e-08
( O 0 1.6249499575765602e-12
AVP O 0 4.608205472322879e-06
- O 0 2.7920258105496032e-08
NPII O 0 1.4839457435300574e-05
) O 0 3.5085915208197876e-15
gene O 0 4.475709387797514e-15
on O 0 4.551636303105899e-13
chromosome O 0 1.6520802087471864e-11
20p13 O 0 2.4324535274899972e-08
. O 0 5.60613888644923e-10

In O 0 7.79009218243587e-11
this O 0 4.4853709505257577e-13
study O 0 5.829795739036026e-14
, O 0 3.6841732451539275e-16
we O 0 6.551183630542886e-16
analyzed O 0 2.3513521113364445e-14
two O 0 7.24765541263155e-16
families O 0 3.7017650500893035e-14
with O 0 2.113789354597946e-14
FNDI B-Disease 1 1.0
using O 0 4.69167369884782e-12
direct O 0 3.059496822555019e-10
automated O 0 4.492983318726829e-09
fluorescent O 0 5.419600879186248e-10
, O 0 8.782193451194881e-14
solid O 0 1.7390899484381883e-11
phase O 0 2.2608411670566042e-11
, O 0 8.688448926790458e-16
single O 0 2.3434719944215483e-14
- O 0 1.1657256208236471e-14
stranded O 0 1.0625238210971999e-13
DNA O 0 2.5809099323849394e-13
sequencing O 0 2.501691128559136e-12
of O 0 1.1820135148443711e-11
PCR O 0 1.7703877253083533e-09
- O 0 7.792923639726723e-09
amplified O 0 6.981495825897355e-09
AVP O 0 4.4366929614625406e-06
- O 0 1.1591131610089178e-08
NPII O 0 4.429332420841092e-06
DNA O 0 1.1374920561024737e-08
. O 0 1.2990751530050915e-10

In O 0 1.852760132814435e-11
one O 0 2.215144571677402e-13
of O 0 8.527252119477566e-14
the O 0 3.906384493223419e-14
families O 0 6.081390951798507e-14
, O 0 6.032885228909163e-16
affected O 0 1.2135831517501045e-14
individuals O 0 8.803919634533717e-16
presented O 0 4.6321254124070954e-12
a O 0 1.6817742944791325e-12
novel O 0 2.1541587957862873e-12
nonsense O 0 5.041278505757418e-09
mutation O 0 2.8616948220816507e-12
in O 0 1.735458304841231e-11
exon O 0 2.7388405432482443e-10
3 O 0 2.4423232533599126e-12
of O 0 6.291554950632605e-12
the O 0 9.324738247176723e-13
gene O 0 1.9238195156931828e-14
, O 0 1.4053873252054417e-15
consisting O 0 3.438380536305405e-15
in O 0 7.240917053777905e-15
a O 0 1.7097895365150717e-13
G O 0 1.1924428458542913e-12
to O 0 1.196483467857945e-10
T O 0 3.0354401214793825e-09
transition O 0 1.0904452807380949e-07
at O 0 2.1099830216364523e-10
nucleotide O 0 3.4757873662583094e-11
2101 O 0 9.143701795721881e-09
, O 0 9.437268403810622e-16
which O 0 3.555704519050031e-18
produces O 0 8.315625522171906e-17
a O 0 1.5538309080029419e-15
stop O 0 6.576458128071394e-13
signal O 0 2.2315467529399058e-10
in O 0 2.238964048884018e-11
codon O 0 2.3943673710391522e-08
82 O 0 2.1744941847146038e-08
( O 0 2.6743620339109153e-12
Glu O 0 4.8772012206654836e-08
) O 0 2.702388280598905e-13
of O 0 2.1922699766641074e-10
NPII O 0 0.049557119607925415
. O 0 8.220773395350989e-08

The O 0 2.3502415569254254e-09
premature O 0 9.822492152977702e-09
termination O 0 1.129877857941608e-09
eliminates O 0 8.251090782840365e-12
part O 0 2.826751961844398e-13
of O 0 6.084622822949415e-12
the O 0 6.826048754016156e-11
C O 0 2.1070579236948106e-07
- O 0 3.89220933261214e-10
terminal O 0 2.6291174098913572e-11
domain O 0 9.465661761354216e-12
of O 0 2.1751576234629866e-12
NPII O 0 0.0010758854914456606
, O 0 5.743990623852807e-14
including O 0 2.4935948623886275e-14
a O 0 9.060404336513894e-13
cysteine O 0 1.0828791197070586e-09
residue O 0 2.3333498688771215e-08
in O 0 8.19587973877045e-12
position O 0 1.877611177647509e-09
85 O 0 5.804557279276423e-09
, O 0 2.508106298603624e-13
which O 0 5.879484809304331e-15
could O 0 2.5765129504744244e-13
be O 0 2.880712975019545e-13
involved O 0 1.7753061173908513e-11
in O 0 8.88485986172416e-12
the O 0 4.1349437762683294e-11
correct O 0 4.254708940720775e-08
folding O 0 5.5094870887728575e-09
of O 0 2.2782699338197432e-10
the O 0 4.212081794463529e-09
prohormone O 0 0.00010865015065064654
. O 0 4.383250384876192e-08

In O 0 4.0040631400783955e-12
the O 0 4.997116544343261e-13
second O 0 1.1390033881342188e-11
family O 0 1.7067658321812812e-13
, O 0 2.1383694831036574e-16
a O 0 1.2655127512188396e-15
G279A O 0 1.3563454829765287e-12
substitution O 0 2.654484976011978e-13
at O 0 1.1120790703242345e-12
position O 0 9.462092914747089e-11
- O 0 8.254144763519822e-12
1 O 0 1.7559135298116785e-13
of O 0 1.1749189945606253e-12
the O 0 4.504197308099339e-13
signal O 0 1.3336558420118383e-11
peptide O 0 2.0978928501075994e-13
was O 0 9.16751551516444e-14
observed O 0 3.4845177009643416e-14
in O 0 1.5862865423879428e-14
all O 0 5.826482823772725e-14
affected O 0 6.561300981700047e-12
individuals O 0 1.35400360628396e-12
. O 0 2.214152194923713e-09

This O 0 2.679240718173048e-10
missense O 0 6.33889314372027e-08
mutation O 0 3.7933451518812333e-11
, O 0 2.6590456724505385e-13
which O 0 2.6381213836731976e-13
replaces O 0 8.837552911700186e-08
Ala O 0 3.2926047310866124e-07
with O 0 4.340926489793118e-12
Thr O 0 1.4625984476879239e-05
, O 0 9.477069465562565e-14
is O 0 1.046421623125942e-14
frequent O 0 6.999459171985745e-12
among O 0 2.1347642403801714e-11
FNDI B-Disease 1 1.0
patients O 0 1.922704996104585e-06
and O 0 6.007796257007092e-12
is O 0 5.405624407296694e-13
thought O 0 8.711315523102225e-12
to O 0 3.702286047180259e-11
reduce O 0 2.5014312843296693e-10
the O 0 2.32747935507982e-11
efficiency O 0 8.938261686353144e-09
of O 0 2.1135345210088197e-11
cleavage O 0 6.987843637062952e-11
by O 0 6.532527340244454e-13
signal O 0 1.1531789745333754e-08
peptidases O 0 2.0315249003033387e-06
. O 0 1.061524756984511e-10
. O 0 1.740229960134343e-09

Genetic O 0 5.091333576956458e-09
heterogeneity O 0 3.7703888899898175e-09
of O 0 7.4006014649796725e-09
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.3411263907840117e-14
due O 0 9.587356464280106e-10
to O 0 1.8054113759546908e-10
TWIST O 1 0.9993212223052979
and O 0 7.252627942655465e-10
FGFR O 1 0.9999994039535522
mutations O 0 4.252161645013075e-08
. O 0 6.709839794893924e-09

Thirty O 0 1.7634919231568347e-06
- O 0 3.591155595117357e-09
two O 0 7.594587529387645e-14
unrelated O 0 2.861067285864216e-12
patients O 0 8.319409377165968e-15
with O 0 1.0763512358556411e-17
features O 0 5.478529142930594e-14
of O 0 1.8323285944088497e-10
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.827185971969847e-12
a O 0 1.6714716416510456e-11
common O 0 2.608396387770995e-09
autosomal B-Disease 1 0.9999992847442627
dominant I-Disease 1 0.7013890743255615
condition I-Disease 1 0.9999998807907104
of O 0 0.07499677687883377
craniosynostosis B-Disease 1 1.0
and O 0 2.691328882065136e-05
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9359666705131531
, O 0 9.209955714739593e-12
were O 0 7.46302117327069e-11
screened O 0 2.7063434826501975e-10
for O 0 5.5245402003079036e-11
mutations O 0 8.397801204429456e-11
in O 0 6.928189272281671e-11
TWIST O 0 2.7476760351419216e-06
, O 0 9.536281486699494e-12
FGFR2 O 0 0.0022433737758547068
, O 0 4.891967907150185e-12
and O 0 2.4210911053756945e-11
FGFR3 O 1 0.955693244934082
. O 0 4.223539562531187e-08

Nine O 0 1.9630561620687104e-09
novel O 0 8.491857390879876e-13
and O 0 6.77577622915787e-13
three O 0 3.248168053970879e-11
recurrent O 0 9.554361213304219e-08
TWIST O 0 8.402507489790878e-08
mutations O 0 1.4856936861318282e-11
were O 0 7.630469064760781e-13
found O 0 9.471467528462604e-14
in O 0 5.6578619420837375e-14
12 O 0 1.1728641495512004e-11
families O 0 2.099544323119762e-11
. O 0 2.300957868683895e-09

Seven O 0 1.154296436212121e-09
families O 0 2.305760834001025e-12
were O 0 4.179533509649641e-13
found O 0 4.254200954728095e-14
to O 0 4.738688825015047e-13
have O 0 1.8754026380896766e-13
the O 0 4.530878797148752e-11
FGFR3 O 0 0.00034012438845820725
P250R O 0 9.241593801334602e-08
mutation O 0 1.2096540782935428e-11
, O 0 3.2563636167973545e-14
and O 0 8.512025855217722e-14
one O 0 1.9504448783066314e-13
individual O 0 1.374022288091678e-13
was O 0 9.43854716606296e-12
found O 0 5.165742508229931e-13
to O 0 1.3220404588773493e-12
have O 0 4.801392031357488e-13
an O 0 6.142163600647566e-13
FGFR2 O 0 8.701613842276856e-05
VV269 O 0 1.1116593441329314e-06
- O 0 2.3847495089768245e-09
270 O 0 2.0378010390231793e-09
deletion O 0 1.4421764227279255e-08
. O 0 3.947589810593399e-09

To O 0 8.093325315483568e-11
date O 0 4.73834360636971e-10
, O 0 3.3734350897559814e-14
our O 0 3.711631696434736e-12
detection O 0 1.868731697163284e-10
rate O 0 5.720028400588162e-13
for O 0 1.4781643113302365e-14
TWIST O 0 5.8495498223010145e-08
or O 0 1.449787095930688e-10
FGFR O 0 6.217777990968898e-05
mutations O 0 2.3263873466516927e-11
is O 0 1.4234278564325374e-14
68 O 0 1.6496061461257483e-10
% O 0 1.0460000920975432e-11
in O 0 3.0176314463718767e-13
our O 0 1.2452654019057263e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
patients O 0 9.583654182743206e-12
, O 0 6.882416393962272e-16
including O 0 1.1506555494392775e-14
our O 0 1.5893856231130599e-09
five O 0 9.960279129250793e-11
patients O 0 1.6085141031629835e-12
elsewhere O 0 1.5404096184376548e-12
reported O 0 2.0114003778520795e-12
with O 0 2.4806171656718834e-13
TWIST O 0 2.6614075068209786e-06
mutations O 0 5.7329723190946424e-09
. O 0 7.2462160716213475e-09

More O 0 3.5165158545485964e-12
than O 0 1.537080738297364e-13
35 O 0 3.124072181504012e-11
different O 0 2.372206597822668e-12
TWIST O 0 2.8479192337727e-08
mutations O 0 1.6700694646654135e-11
are O 0 2.6541140433437166e-14
now O 0 4.5708344064993717e-14
known O 0 8.643889911567199e-15
in O 0 5.102890020800867e-14
the O 0 4.812026970467398e-13
literature O 0 1.2702607021797263e-10
. O 0 1.8698058656951844e-09

The O 0 3.3550209277422027e-09
most O 0 1.0551932591584823e-12
common O 0 7.464622453143277e-13
phenotypic O 0 9.69634615655135e-12
features O 0 4.0087835937070715e-13
, O 0 2.6728230529727854e-15
present O 0 1.3548735158970537e-13
in O 0 1.2715889844176157e-14
more O 0 5.090072442957307e-16
than O 0 1.89184808769248e-15
a O 0 1.352415629572029e-13
third O 0 5.398378966070538e-10
of O 0 1.4082673915893906e-10
our O 0 1.4467720355071378e-08
patients O 0 1.4901443967652028e-10
with O 0 1.869952977184841e-12
TWIST O 0 1.286547217205225e-06
mutations O 0 1.3017942279702766e-09
, O 0 1.2239848891371086e-12
are O 0 1.237060042076632e-12
coronal B-Disease 0 2.3302418128423596e-07
synostosis I-Disease 0 2.362027089475305e-06
, O 0 4.864104258262003e-11
brachycephaly B-Disease 0 4.355678811407415e-06
, O 0 1.0901608782365457e-10
low B-Disease 0 2.3611578399140853e-06
frontal I-Disease 1 0.9999963045120239
hairline I-Disease 1 1.0
, O 0 1.5849309420445934e-07
facial B-Disease 1 1.0
asymmetry I-Disease 1 0.9999984502792358
, O 0 2.9799278600251e-09
ptosis B-Disease 1 0.9247793555259705
, O 0 3.9587397249185585e-10
hypertelorism B-Disease 0 3.863740494125523e-05
, O 0 8.382534250062079e-11
broad B-Disease 0 4.870654102262506e-09
great I-Disease 0 1.5608769388109067e-07
toes I-Disease 0 0.0001345617201877758
, O 0 1.2355421373511088e-11
and O 0 9.791020078031565e-11
clinodactyly B-Disease 0 0.00018899446877185255
. O 0 4.799696853297064e-07

Significant O 0 4.826194555107577e-08
intra O 0 0.002391151851043105
- O 0 2.581714966254367e-07
and O 0 1.5927830235296092e-11
interfamilial O 0 1.6426022284576902e-06
phenotypic O 0 9.962601854596187e-10
variability O 0 3.579096394257242e-11
is O 0 2.484396603389126e-16
present O 0 7.42293325330795e-14
for O 0 7.147612308879697e-14
either O 0 9.69702207420653e-10
TWIST O 0 2.156269874831196e-05
mutations O 0 9.827963332043055e-09
or O 0 9.211580942469766e-10
FGFR O 0 0.0020794470328837633
mutations O 0 3.588398200804477e-08
. O 0 4.784799223500613e-09

The O 0 3.284723826268987e-09
overlap O 0 4.7865338359542875e-09
in O 0 3.270365749041826e-12
clinical O 0 2.8126709294973296e-10
features O 0 4.262603724852765e-12
and O 0 1.701685260801014e-13
the O 0 1.675084376762115e-11
presence O 0 5.488439563938741e-12
, O 0 5.0263165483031835e-14
in O 0 1.0791388128147256e-13
the O 0 2.2577962719913525e-13
same O 0 4.605957000351768e-13
genes O 0 5.824729804385087e-13
, O 0 3.561698326678617e-14
of O 0 4.690140962236578e-13
mutations O 0 6.72081273554899e-14
for O 0 9.181812076061377e-14
more O 0 2.2767058082003543e-14
than O 0 6.671618552750447e-13
one O 0 2.2261720244998173e-11
craniosynostotic B-Disease 0 3.920529707102105e-06
condition I-Disease 0 0.00012922947644256055
- O 0 1.640316882323134e-09
such O 0 2.971749799365875e-12
as O 0 3.3890664580260577e-11
Saethre B-Disease 0 0.00865376926958561
- I-Disease 0 5.929485524802658e-08
Chotzen I-Disease 0 1.2975857316632755e-05
, I-Disease 0 1.4454368691546593e-12
Crouzon I-Disease 0 1.0298545930709224e-05
, I-Disease 0 1.7504271686633044e-12
and I-Disease 0 2.024031983682839e-11
Pfeiffer I-Disease 0 1.929834979819134e-05
syndromes I-Disease 0 3.3001160772982985e-06
- O 0 3.4595355913324966e-08
support O 0 6.585936240810497e-09
the O 0 7.315592576162544e-10
hypothesis O 0 1.0735134309269867e-10
that O 0 1.5966100105424888e-14
TWIST O 0 1.4609035758894606e-07
and O 0 4.942121473346106e-13
FGFRs O 0 1.7191374013236782e-07
are O 0 3.395562173788753e-15
components O 0 1.1409413691598758e-10
of O 0 9.534390638110679e-12
the O 0 1.9238180926778314e-12
same O 0 3.6069094217459907e-13
molecular O 0 1.538708667859351e-13
pathway O 0 2.6068394404915596e-13
involved O 0 4.6043650527493804e-14
in O 0 1.0940372414426636e-14
the O 0 1.0011040390764392e-13
modulation O 0 9.568079661903539e-11
of O 0 5.708810646432028e-10
craniofacial O 1 0.5397789478302002
and O 0 5.558243287850928e-07
limb O 0 0.2023226022720337
development O 0 2.1085655532715464e-07
in O 0 1.320291532352913e-12
humans O 0 3.4795998547776374e-12
. O 0 4.497973174477643e-13
. O 0 1.0267263428342943e-10

Mutation O 0 8.40620975606221e-12
analysis O 0 5.765605549414021e-13
of O 0 9.68654930572077e-12
UBE3A O 1 0.9987025260925293
in O 0 5.5011705626384355e-06
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 3.049898111839866e-08
. O 0 7.620110653583367e-10

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.1134278915525542e-10
AS B-Disease 1 1.0
) O 0 2.1067052792468795e-14
is O 0 5.915250881381262e-16
caused O 0 3.819847202760594e-14
by O 0 1.5867827342884444e-14
chromosome O 0 7.583152994428133e-10
15q11 O 0 5.627839527733158e-07
- O 0 3.2396081373065044e-09
q13 O 0 7.999471307584827e-09
deletions O 0 5.4733155507857845e-11
of O 0 4.262552767350658e-13
maternal O 0 7.213660658395016e-12
origin O 0 5.434830103318022e-13
, O 0 1.2695114878837088e-15
by O 0 2.925797150670102e-14
paternal O 0 4.796132202500303e-07
uniparental B-Disease 0 0.004638446029275656
disomy I-Disease 0 0.0007348465733230114
( O 0 2.0499238417848176e-10
UPD B-Disease 1 1.0
) O 0 5.478928942481698e-13
15 O 0 4.893544770789848e-12
, O 0 3.839494470785337e-15
by O 0 5.148319785893904e-14
imprinting O 0 1.9894746401405428e-06
defects O 0 6.869727826597227e-07
, O 0 3.5489155830650126e-14
and O 0 3.141004632699839e-15
by O 0 1.6614820616870328e-14
mutations O 0 1.4365839247354462e-12
in O 0 3.783066796023832e-13
the O 0 3.337573967199248e-11
UBE3A O 0 2.3368120309896767e-06
gene O 0 1.6765652754990867e-10
. O 0 4.499895567278145e-09

UBE3A O 0 0.0002257103187730536
encodes O 0 9.780124488045772e-10
a O 0 4.8495232135570276e-11
ubiquitin O 0 1.6607512032251748e-09
- O 0 1.7640869320878494e-10
protein O 0 3.0768142482602567e-13
ligase O 0 1.165139924645675e-12
and O 0 1.5907835758301875e-13
shows O 0 1.8199254603334936e-10
brain O 0 8.443989685247288e-08
- O 0 2.6440077557920993e-11
specific O 0 2.0022377852924045e-11
imprinting O 0 1.3554357281009288e-07
. O 0 6.251917872290846e-10

Here O 0 3.24148707875338e-09
we O 0 9.72054815112644e-12
describe O 0 5.936371394454909e-10
UBE3A O 0 0.0002111580834025517
coding O 0 2.8508096875157207e-05
- O 0 9.258687150293099e-09
region O 0 6.743528513375452e-10
mutations O 0 1.6180693937495327e-11
detected O 0 3.402755507919686e-13
by O 0 6.736206331167563e-16
SSCP O 0 3.0171959224389866e-05
analysis O 0 7.465077275954635e-13
in O 0 7.966011137945476e-15
13 O 0 2.6669300448589617e-12
AS B-Disease 1 0.9999998807907104
individuals O 0 2.734696963237887e-13
or O 0 3.0489497645364017e-12
families O 0 2.29837208293171e-11
. O 0 1.9991641675431993e-09

Two O 0 4.2102160646706466e-10
identical O 0 3.5263794662121484e-10
de O 0 4.3614045708295635e-10
novo O 0 1.1752911532880717e-08
5 O 0 1.6632936139515664e-09
- O 0 1.1265467447785227e-09
bp O 0 1.4413308047078743e-10
duplications O 0 1.462620513592583e-08
in O 0 8.7956843197734e-11
exon O 0 8.937336981595934e-10
16 O 0 7.030986209910495e-11
were O 0 3.939770384930874e-11
found O 0 1.0594090882332097e-10
. O 0 1.0568020902823605e-09

Among O 0 1.908302682540608e-10
the O 0 1.493045444223018e-11
other O 0 6.245662624235204e-13
11 O 0 1.2130088600237343e-11
unique O 0 3.3900621893012683e-11
mutations O 0 6.95880505996449e-12
, O 0 1.3306968916527995e-13
8 O 0 4.0611354557018586e-11
were O 0 4.625517469047935e-10
small O 0 1.9286428357134788e-11
deletions O 0 1.1849716763379092e-09
or O 0 2.632665266344425e-11
insertions O 0 4.712307877241528e-09
predicted O 0 1.134152993742532e-09
to O 0 8.068453682952281e-10
cause O 0 4.482269275740691e-07
frameshifts O 1 0.9927541613578796
, O 0 3.5605064903354577e-12
1 O 0 5.096562494949497e-12
was O 0 1.3299870102803646e-12
a O 0 1.0023956626770483e-13
mutation O 0 3.501747028737852e-14
to O 0 6.890951568042092e-13
a O 0 1.746555157444707e-12
stop O 0 8.299868431427271e-11
codon O 0 7.617619246502727e-08
, O 0 3.4937985664285076e-12
1 O 0 3.6828877621186695e-12
was O 0 5.537935995197918e-12
a O 0 2.1961724973318386e-12
missense O 0 3.456743780105853e-09
mutation O 0 1.0600270661242917e-11
, O 0 4.456434475456385e-14
and O 0 7.500354775192425e-14
1 O 0 6.503523305827208e-13
was O 0 3.023163316906441e-12
predicted O 0 4.041637684248922e-12
to O 0 3.5850573269595454e-13
cause O 0 7.115015174252726e-12
insertion O 0 5.068039321542983e-10
of O 0 8.888411673346752e-10
an O 0 2.7025300400329577e-11
isoleucine O 0 1.4400909094547387e-05
in O 0 3.179067079028819e-11
the O 0 1.2593853737641325e-10
hect O 0 1.35108905396919e-07
domain O 0 2.838312362918316e-10
of O 0 1.2329548840228632e-11
the O 0 4.7787298423918045e-11
UBE3A O 0 2.817509084707126e-06
protein O 0 2.3622026210090574e-11
, O 0 6.766316023101848e-15
which O 0 1.4958151862257715e-16
functions O 0 1.1212431943194781e-13
in O 0 5.596085796361408e-14
E2 O 0 8.52054624772558e-12
binding O 0 3.525326731923517e-12
and O 0 1.5247329223852524e-12
ubiquitin O 0 1.4420656890834493e-09
transfer O 0 4.438489753511021e-08
. O 0 2.187735859138229e-08

Eight O 0 7.430786208573181e-09
of O 0 1.5908460312963335e-11
the O 0 3.1323207916322815e-13
cases O 0 4.683172744052036e-15
were O 0 3.0830351292754354e-13
familial O 0 2.1982145270715847e-11
, O 0 2.3904997718728754e-14
and O 0 1.6849225126561694e-14
five O 0 6.95487721233401e-12
were O 0 1.6568515656678606e-11
sporadic O 0 5.6049795915669165e-08
. O 0 3.689806860052158e-08

In O 0 4.050583826686882e-11
two O 0 2.29820004173098e-12
familial O 0 1.3307038804200033e-10
cases O 0 6.430927567812467e-14
and O 0 2.9424237297983463e-14
one O 0 5.265425140170421e-14
sporadic O 0 4.923574881132708e-10
case O 0 5.551660476818543e-13
, O 0 5.210708709131595e-13
mosaicism O 0 3.179324039592757e-07
for O 0 4.992513069623783e-10
UBE3A O 0 6.468707579188049e-05
mutations O 0 7.167640370120409e-10
was O 0 5.073498912655516e-12
detected O 0 3.6677022638605117e-13
in O 0 1.7209972011874328e-15
the O 0 4.4175478704742976e-14
mother O 0 1.6305103968383694e-12
of O 0 2.7180473583660048e-12
three O 0 2.4981069296492464e-11
AS B-Disease 1 1.0
sons O 0 4.9945345637070204e-09
, O 0 7.849363689680245e-15
in O 0 5.5985705675121785e-15
the O 0 1.2181384102371434e-13
maternal O 0 3.562643235976992e-10
grandfather O 0 5.08581843305933e-10
of O 0 2.600734627655754e-10
two O 0 2.011318056549527e-10
AS B-Disease 1 1.0
first O 0 1.271643124134414e-09
cousins O 0 1.2379753888680511e-09
, O 0 8.439822733914693e-15
and O 0 1.069521185685456e-15
in O 0 1.3044182026840032e-14
the O 0 2.918424779185108e-13
mother O 0 2.033348532951007e-12
of O 0 1.2520987718867005e-11
an O 0 7.758993100792644e-12
AS B-Disease 1 1.0
daughter O 0 7.743151400063653e-06
. O 0 7.21716958196339e-07

The O 0 3.937676296139614e-10
frequencies O 0 3.85389740953368e-11
with O 0 1.0211095681565523e-14
which O 0 3.1880594305021834e-15
we O 0 1.263654437165529e-13
detected O 0 2.9543884699778644e-12
mutations O 0 4.694445786962431e-13
were O 0 5.185743327806858e-13
5 O 0 2.4040537898069314e-13
( O 0 1.6738281598163273e-16
14 O 0 2.358049736375656e-13
% O 0 5.746404328939303e-13
) O 0 1.5327016181941242e-16
of O 0 1.18244295106186e-13
35 O 0 6.385088638372061e-12
in O 0 3.6488208830266766e-13
sporadic O 0 1.6748943343358746e-09
cases O 0 2.5402776670374605e-12
and O 0 3.701627546148778e-12
8 O 0 1.6314561463934285e-12
( O 0 4.743075866993926e-16
80 O 0 5.233398350096286e-13
% O 0 7.617745410165577e-13
) O 0 6.067829043752547e-16
of O 0 8.953681708816913e-14
10 O 0 1.144767467669075e-13
in O 0 2.0028621231134303e-13
familial O 0 1.2143266947539644e-10
cases O 0 2.405714245434093e-13
. O 0 1.2161292806123214e-11
. O 0 8.881531066151638e-10

The O 0 9.317398763641904e-08
hemochromatosis B-Disease 1 1.0
845 O 0 7.25047399896539e-09
G O 0 2.6124580276842835e-10
- O 0 1.2754999834108105e-10
- O 0 1.622798076472698e-11
> O 0 1.1707089291046469e-12
A O 0 5.588217063569323e-13
and O 0 1.2377814880957749e-17
187 O 0 4.974456680821831e-16
C O 0 4.783773030481164e-11
- O 0 7.994200440508692e-11
- O 0 1.2852978403810056e-10
> O 0 2.4516133567686893e-10
G O 0 1.9433774034460782e-10
mutations O 0 9.613991026891089e-12
: O 0 2.477167759519462e-15
prevalence O 0 1.5628601928233121e-12
in O 0 2.778852350321121e-14
non O 0 4.2913395059684944e-10
- O 0 4.529152608512277e-10
Caucasian O 0 3.3256330311814963e-07
populations O 0 2.0136096956502314e-10
. O 0 9.741842055266403e-11

Hemochromatosis B-Disease 0 0.00726141594350338
, O 0 1.0969286243223131e-11
the O 0 5.484251275333918e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 3.1334432271101775e-10
leads O 0 3.3793440934459795e-08
, O 0 1.4005192405103228e-12
if O 0 8.834405429425374e-11
untreated O 1 0.9983096122741699
, O 0 3.5154276950381813e-13
to O 0 4.260076380546707e-08
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 1.0678658846074995e-08
premature B-Disease 0 8.572090337111149e-06
death I-Disease 0 6.545251807210661e-08
. O 0 2.37295374461155e-08

The O 0 5.172258283892006e-07
hemochromatosis B-Disease 1 1.0
gene O 0 1.994141074490585e-09
, O 0 5.896260476395687e-12
HFE O 0 5.577684351010248e-05
, O 0 1.9863672338915617e-12
recently O 0 2.273523166604341e-12
has O 0 6.610226591526839e-16
been O 0 1.244543815334849e-15
identified O 0 2.168746715688289e-14
, O 0 1.8275795951684578e-16
and O 0 9.29053159240184e-16
characterization O 0 8.142144597433898e-11
of O 0 8.092272511805998e-12
this O 0 8.249622773098819e-13
gene O 0 6.053896533381176e-13
has O 0 1.986409787132766e-15
shown O 0 3.797134319211831e-13
that O 0 1.7450340904063785e-15
it O 0 1.5244564141970936e-16
contains O 0 3.670466068310536e-17
two O 0 1.2056689205832576e-15
mutations O 0 6.6775698401191734e-15
that O 0 1.9358911539717433e-16
result O 0 1.8007864893265085e-13
in O 0 1.3574351061598766e-12
amino O 0 2.903154452948975e-11
acid O 0 8.976565693021021e-13
substitutions O 0 9.23915674869158e-13
- O 0 1.9672352397255566e-13
cDNA O 0 2.8992075667283457e-12
nucleotides O 0 3.38550314085001e-13
845 O 0 4.412013809851345e-11
G O 0 1.2958821515862695e-11
- O 0 4.56901322332115e-10
- O 0 3.1889796359152456e-10
> O 0 1.2242236738235768e-11
A O 0 9.899595726503563e-11
( O 0 4.644313082658606e-17
C282Y O 0 8.887215616204536e-12
) O 0 2.7595350110591933e-19
and O 0 3.827687294721755e-18
187 O 0 3.4677018523240335e-15
C O 0 8.23556084439403e-11
- O 0 1.9088741698425338e-10
- O 0 3.315950847238014e-10
> O 0 7.536359730719866e-11
G O 0 5.601187916259853e-11
( O 0 9.156065323783456e-15
H63D O 0 3.055708930332912e-06
) O 0 4.9902939311223526e-14
. O 0 1.0014947204872726e-11

Although O 0 4.2124455035263964e-07
hemochromatosis B-Disease 1 1.0
is O 0 8.682067651616387e-13
common O 0 3.623767545800696e-14
in O 0 1.3915240216610253e-13
Caucasians O 0 3.3678309030449327e-09
, O 0 5.556494066943918e-12
affecting O 0 1.1366109164967497e-09
> O 0 1.7852297418130547e-09
= O 0 1.2466892969353882e-11
1 O 0 1.887410583725768e-12
/ O 0 2.418394694572723e-12
300 O 0 8.707569170915419e-14
individuals O 0 5.164105091898935e-14
of O 0 2.1966721844290937e-11
northern O 0 1.3242398844148795e-10
European O 0 3.700653498917017e-12
origin O 0 5.076434411721564e-11
, O 0 8.143219578466906e-14
it O 0 1.5601683026351802e-15
has O 0 4.99396437899269e-16
not O 0 1.673446910286768e-14
been O 0 4.4606633382675287e-13
recognized O 0 3.733415052803446e-12
in O 0 1.039620863355073e-12
other O 0 1.4654964524893344e-12
populations O 0 1.7851801634161113e-11
. O 0 2.0902314601389804e-10

The O 0 1.404768489032815e-11
present O 0 4.867393922809715e-13
study O 0 4.2165840097822945e-16
used O 0 9.671459911185534e-17
PCR O 0 1.8531115769486461e-13
and O 0 1.1634420199978495e-14
restriction O 0 3.853675191456407e-12
- O 0 1.2655485383608611e-12
enzyme O 0 6.538781967052251e-14
digestion O 0 2.9804533840938063e-11
to O 0 1.1993147631689932e-13
analyze O 0 1.2228974343581056e-12
the O 0 2.276059013841831e-14
frequency O 0 5.607552725113429e-13
of O 0 1.378718780852342e-13
the O 0 1.5205616984721032e-13
845 O 0 1.7579661684696823e-11
G O 0 3.1133752260298353e-12
- O 0 1.2232898721764585e-11
- O 0 3.0182661925337584e-12
> O 0 7.645077469307579e-14
A O 0 3.210622414630271e-13
and O 0 3.7285801385538163e-17
187 O 0 2.271148806198245e-15
C O 0 8.846845131471603e-12
- O 0 5.0642844952319965e-12
- O 0 6.818745221237599e-12
> O 0 4.452794469950172e-12
G O 0 3.86810115188263e-12
mutations O 0 1.0478580893605316e-13
in O 0 6.01656311577381e-14
HLA O 0 9.216075819162839e-11
- O 0 1.4433431663393725e-12
typed O 0 2.117229568748824e-12
samples O 0 1.5999976679930555e-13
from O 0 2.5023437640568635e-13
non O 0 5.868205921188974e-10
- O 0 1.2286266448668925e-10
Caucasian O 0 7.78783117993953e-08
populations O 0 5.1245678707456666e-12
, O 0 3.5263146264499e-16
comprising O 0 1.6858193511407223e-14
Australian O 0 5.4294062301618595e-11
Aboriginal O 0 6.808709596128892e-09
, O 0 2.762827079882133e-15
Chinese O 0 1.2020618875285827e-11
, O 0 1.5432083779257089e-13
and O 0 7.52668760650721e-12
Pacific O 0 1.161011065065054e-09
Islanders O 0 3.741241982879728e-08
. O 0 3.708763962606554e-09

Results O 0 4.686687704591463e-10
showed O 0 1.2649940990538955e-11
that O 0 4.93582033172401e-16
the O 0 1.3579049451713232e-14
845 O 0 2.607954650846178e-12
G O 0 2.5352789312371726e-11
- O 0 4.0903752607235333e-10
- O 0 2.0813875623026945e-10
> O 0 4.63565401342958e-11
A O 0 3.569082182575123e-11
mutation O 0 3.570901509057124e-14
was O 0 2.1582600666364546e-15
present O 0 5.305475144905562e-15
in O 0 1.6266995642684533e-15
these O 0 1.8539969381367637e-15
populations O 0 1.0610038458843405e-15
( O 0 1.2895801584393049e-18
allele O 0 3.637950604282701e-14
frequency O 0 6.675335197797727e-13
0 O 0 7.272640131718473e-15
. O 0 1.9291475223380018e-14
32 O 0 1.5487744767228584e-11
% O 0 3.261874494467354e-12
) O 0 2.9080904245396076e-16
, O 0 2.205239902022967e-15
and O 0 1.8457698341750248e-14
, O 0 4.678744032287317e-15
furthermore O 0 4.682820429167955e-13
, O 0 9.60304863345605e-16
it O 0 2.4025372217841023e-16
was O 0 1.4955499946095463e-12
always O 0 2.765593960438184e-12
seen O 0 8.74476012435732e-12
in O 0 1.0063616606714731e-12
conjunction O 0 4.801747333083028e-10
with O 0 1.8613469099371116e-10
HLA O 0 7.320858458115254e-06
haplotypes O 0 2.4463375325467496e-08
common O 0 4.383210461256226e-11
in O 0 7.908042276572047e-12
Caucasians O 0 1.9420147712168045e-09
, O 0 1.4726241059914713e-13
suggesting O 0 7.657577696940088e-12
that O 0 7.331725423173965e-14
845 O 0 3.3227126605694934e-10
G O 0 2.8772153548572987e-09
- O 0 1.0803260863667674e-07
- O 0 1.569884915397779e-07
> O 0 1.6497148536132045e-08
A O 0 1.1720294956774069e-08
may O 0 4.890360577429476e-13
have O 0 7.98776802622865e-15
been O 0 7.450788948217945e-15
introduced O 0 3.196778787661219e-15
into O 0 5.7243443722676014e-15
these O 0 1.287561759989698e-15
populations O 0 2.477394552591089e-15
by O 0 2.565804675251941e-15
Caucasian O 0 4.029038080943792e-08
admixture O 0 4.695174027347093e-08
. O 0 2.806468302196663e-08

187 O 0 1.2005450453211886e-11
C O 0 1.7078766179068339e-09
- O 0 5.7595997415837985e-11
- O 0 8.599191671232465e-12
> O 0 6.848014451506235e-13
G O 0 9.853766023623645e-14
was O 0 1.9137542655326073e-15
present O 0 9.847142353031058e-16
at O 0 2.634848713062803e-16
an O 0 2.0748617206716548e-19
allele O 0 3.844228537927541e-15
frequency O 0 2.5574245412357532e-12
of O 0 2.048070393834145e-11
2 O 0 8.648958771395598e-10
. O 0 2.8125235473908106e-08

68 O 0 1.450743525310827e-07
% O 0 3.5334621339977446e-10
in O 0 5.49770630766961e-14
the O 0 2.493325099335586e-13
two O 0 1.201331785785631e-13
populations O 0 6.99109527389709e-15
analyzed O 0 1.1912783856159875e-13
( O 0 1.2791121828243626e-15
Australian O 0 2.0778245443664467e-11
Aboriginal O 0 4.566053313226348e-09
and O 0 7.458100028398876e-14
Chinese O 0 1.489368628426746e-10
) O 0 4.741102801152086e-13
. O 0 8.540045892679871e-10

In O 0 3.2485646117574873e-11
the O 0 3.3770883225286985e-12
Australian O 0 5.939343634964178e-12
Aboriginal O 0 3.293421785288686e-11
samples O 0 3.0929685472281003e-15
, O 0 1.4202174956833252e-17
187 O 0 7.240419845437867e-15
C O 0 3.7052338974774557e-10
- O 0 2.971158041820132e-10
- O 0 3.5040123580465377e-10
> O 0 1.0564246699651392e-10
G O 0 1.49103351193558e-11
was O 0 5.366790995983695e-13
found O 0 5.63170691992524e-15
to O 0 1.5856089160301394e-14
be O 0 4.0018298597859284e-14
associated O 0 4.659197680445537e-11
with O 0 1.9553265256933017e-11
HLA O 0 2.19454104808392e-05
haplotypes O 0 2.8148686936901868e-08
common O 0 1.3750644720089689e-11
in O 0 1.385544673784822e-12
Caucasians O 0 8.866297696030756e-10
, O 0 3.7402176353892175e-14
suggesting O 0 2.2023344519589427e-12
that O 0 3.313274617028892e-15
it O 0 1.2138511529746158e-15
was O 0 1.2957522424819623e-13
introduced O 0 2.0226513199788146e-14
by O 0 3.8601870621702856e-15
recent O 0 1.2390200627640513e-12
admixture O 0 1.7779069327872321e-09
. O 0 2.021491640746831e-09

In O 0 5.539491781947348e-11
the O 0 2.1942840339878034e-12
Chinese O 0 1.0321981984418027e-11
samples O 0 2.888465020552816e-13
analyzed O 0 5.151374864328061e-14
, O 0 1.0390814553042069e-16
187 O 0 1.1566184919813583e-14
C O 0 1.9222830272003222e-10
- O 0 9.355959756929266e-11
- O 0 6.815979031182806e-11
> O 0 8.443731824847589e-12
G O 0 1.4136698539210513e-12
was O 0 7.772033477947485e-14
present O 0 8.571524837564654e-14
in O 0 4.583158905288511e-15
association O 0 1.8678050574846665e-14
with O 0 2.582813308591044e-15
a O 0 9.6874678418013e-13
wide O 0 1.8591283026947458e-11
variety O 0 6.000238066822261e-12
of O 0 8.35973734680806e-10
HLA O 0 4.9880401320479e-07
haplotypes O 0 2.090656181508166e-08
, O 0 1.6912830727924821e-12
showing O 0 3.962295422321738e-11
this O 0 2.167263222184468e-13
mutation O 0 6.227201913844294e-13
to O 0 2.56063616491109e-12
be O 0 9.021764238448249e-12
widespread O 0 1.4494082323235347e-10
and O 0 3.2745271880303684e-13
likely O 0 4.443523327068988e-11
to O 0 6.158886595164503e-11
predate O 0 3.888611388447316e-07
the O 0 1.1040252913263604e-11
more O 0 5.1961961209517904e-14
genetically O 0 8.383480812768768e-14
restricted O 0 9.041901775919126e-12
845 O 0 2.92456447947842e-10
G O 0 9.098534148321846e-10
- O 0 1.5403452735540668e-08
- O 0 6.126509521919843e-09
> O 0 4.846012480186346e-10
A O 0 6.586410306042012e-10
mutation O 0 5.130826753046991e-12
. O 0 5.790670026817324e-12

Genotype O 0 2.5011725028889487e-06
- O 0 3.903320333620286e-08
phenotype O 0 6.318631173840572e-10
correlations O 0 2.2367839525028188e-10
in O 0 1.7647028283107602e-10
attenuated B-Disease 1 0.9947622418403625
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 9.522638038106379e-07

Germ O 0 2.629653135954868e-05
- O 0 1.9459727695902984e-07
line O 0 7.608056962205012e-10
mutations O 0 8.847048094118293e-12
of O 0 5.3400242561174593e-11
the O 0 8.822483715809071e-11
tumor B-Disease 0 1.2947813932129293e-09
suppressor O 0 2.7033666971654213e-10
APC O 0 3.9514974625731725e-10
are O 0 1.098575372923509e-13
implicated O 0 4.762319871787213e-09
in O 0 1.427643869789108e-08
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 2.645997032590941e-10
AAPC B-Disease 1 1.0
) O 0 3.4678871407812454e-15
, O 0 1.9894181768461722e-17
a O 0 5.344921363380076e-16
variant O 0 9.286520441520452e-10
of O 0 1.6065558838818106e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 5.291395360068618e-12
FAP B-Disease 0 5.571303973717079e-10
) O 0 1.487220313263829e-13
. O 0 2.6759908525186837e-11

AAPC B-Disease 1 1.0
is O 0 4.963158248098842e-13
recognized O 0 8.963951136269424e-14
by O 0 3.2117260604440606e-16
the O 0 7.309955998803172e-14
occurrence O 0 1.051702128163079e-10
of O 0 1.4502012438133427e-11
< O 0 4.982773749162561e-09
100 O 0 2.530463616423617e-10
colonic B-Disease 0 1.079399254422242e-07
adenomas I-Disease 0 1.1347144379669771e-07
and O 0 4.538292417105398e-14
a O 0 9.899052470742006e-14
later O 0 3.0125895267990588e-12
onset O 0 1.276788566428877e-06
of O 0 3.7432735098263947e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.98282306543091e-14
age O 0 1.369564509544341e-12
> O 0 2.9559946070761844e-12
40 O 0 2.644933154872381e-13
years O 0 1.974098781578476e-13
) O 0 2.6056847651778625e-14
. O 0 7.481077562987437e-11

The O 0 5.03717900723899e-11
aim O 0 8.500621317963919e-10
of O 0 3.3908685321409893e-12
this O 0 2.7243561139672634e-14
study O 0 7.423439948416998e-15
was O 0 1.4511647973233267e-14
to O 0 8.661326321955654e-13
assess O 0 2.33396746374126e-09
genotype O 0 3.937831252187607e-07
- O 0 2.301938017978955e-08
phenotype O 0 1.8087557007717692e-09
correlations O 0 6.536400865009284e-10
in O 0 1.1091377816185854e-10
AAPC B-Disease 1 1.0
families O 0 3.242239809964076e-10
. O 0 1.1029236413051535e-09

By O 0 1.975923114364009e-12
protein O 0 2.437335576421784e-11
- O 0 9.930605816832472e-12
truncation O 0 1.0656799886987756e-09
test O 0 1.6075374364987738e-10
( O 0 1.4844875816880793e-14
PTT O 0 1.0636067582225905e-09
) O 0 2.4502300736237457e-17
assay O 0 3.570581669416241e-14
, O 0 2.1020221081968933e-17
the O 0 4.2080999160243587e-16
entire O 0 7.080439966972163e-12
coding O 0 2.4181536772971413e-09
region O 0 9.893065533450596e-11
of O 0 5.433267551147036e-12
the O 0 1.0504846992276384e-11
APC B-Disease 0 5.255643142909605e-10
gene O 0 3.920800587409873e-13
was O 0 1.3821001634828356e-12
screened O 0 4.710476366603933e-12
in O 0 4.7641974593908357e-14
affected O 0 3.0447307002023916e-12
individuals O 0 1.0589696437454665e-12
from O 0 4.042412515836702e-10
11 O 0 5.562910487810768e-08
AAPC B-Disease 1 1.0
kindreds O 0 8.50078504299745e-06
, O 0 7.892020912649012e-13
and O 0 3.4869394698044953e-13
their O 0 9.964421648911426e-11
phenotypic O 0 1.5222072491383187e-09
differences O 0 1.091517987106272e-09
were O 0 1.89032359210195e-10
examined O 0 2.2175472125240958e-08
. O 0 1.0055847710077614e-08

Five O 0 1.8945331969888457e-09
novel O 0 9.065473198510698e-12
germ O 0 1.1014529377462168e-07
- O 0 3.2957250262199977e-09
line O 0 2.2869425797544807e-10
APC B-Disease 0 2.08275771629296e-10
mutations O 0 1.9018872848136636e-12
were O 0 1.850444981705418e-13
identified O 0 6.952977148026729e-13
in O 0 1.791249575966783e-13
seven O 0 7.324747752779359e-11
kindreds O 0 2.8716638666992367e-07
. O 0 5.239121581013251e-09

Mutations O 0 7.442743754637604e-09
were O 0 6.670226176952454e-11
located O 0 9.586154569793393e-13
in O 0 3.1531536262623073e-15
three O 0 4.578440931772305e-15
different O 0 2.535748981668043e-14
regions O 0 1.527254364641628e-11
of O 0 3.9553694521077265e-12
the O 0 1.9666671069451525e-11
APC B-Disease 0 1.967381813017255e-09
gene O 0 6.966959561344188e-12
( O 0 1.1064184067359744e-14
1 O 0 1.6349699372142368e-12
) O 0 1.839198213757047e-14
at O 0 1.0084681353883518e-11
the O 0 1.1063013569470592e-12
5 O 0 4.785930766276758e-13
end O 0 3.7100425509528634e-10
spanning O 0 1.2909936453198156e-09
exons O 0 1.561220042134437e-10
4 O 0 2.1810682329214542e-13
and O 0 4.629632181091248e-13
5 O 0 2.72341329175807e-12
, O 0 5.473873307751398e-13
( O 0 1.0128109534382414e-15
2 O 0 6.095373094065423e-14
) O 0 2.2120138362603965e-15
within O 0 2.143036616220062e-12
exon O 0 1.7056797597600482e-12
9 O 0 3.3256240101163514e-13
, O 0 3.655443528709397e-14
and O 0 3.4908656369216085e-13
( O 0 4.670681549178877e-16
3 O 0 3.150431982347837e-14
) O 0 1.3174621289068931e-15
at O 0 2.4719503245555774e-13
the O 0 8.623409332528947e-14
3 O 0 1.3611574161635082e-13
distal O 0 1.1760080687039931e-09
end O 0 1.2566938600855337e-09
of O 0 3.1503424868795094e-10
the O 0 6.044133527005613e-10
gene O 0 2.276662608435842e-10
. O 0 1.7989474798696392e-08

Variability O 0 1.574985830643527e-08
in O 0 7.834892673877492e-13
the O 0 1.350848903222679e-12
number O 0 7.577738783681731e-12
of O 0 2.8112847161310128e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 4.2830886060052364e-10
most O 0 4.1700956652634263e-14
apparent O 0 2.570614077504474e-12
in O 0 8.530065624115166e-14
individuals O 0 2.550812480076742e-13
with O 0 8.211961926435363e-13
mutations O 0 2.43342568317928e-10
in O 0 3.5303027168254175e-10
region O 0 2.77061872111517e-07
1 O 0 4.701532496653726e-10
, O 0 1.0408654840809994e-11
and O 0 1.6528823865158415e-09
upper O 1 0.9999998807907104
- O 0 5.288092506816611e-05
gastrointestinal O 0 1.1263265520256027e-07
manifestations O 0 8.286087194164793e-08
were O 0 1.51997182201713e-11
more O 0 2.8160201560466398e-14
severe O 0 5.789091428454185e-12
in O 0 3.921161572523202e-12
them O 0 9.275610834968973e-11
. O 0 2.6280584819460273e-08

In O 0 1.4524601139875859e-11
individuals O 0 3.3927944004599753e-13
with O 0 9.7282350632142e-14
mutations O 0 1.085686011578768e-12
in O 0 6.840182175012199e-13
either O 0 1.2003767979607005e-09
region O 0 9.504286424544262e-08
2 O 0 1.3002353360658248e-10
or O 0 9.976516140985936e-11
region O 0 9.077737672669173e-09
3 O 0 2.4086446812759954e-12
, O 0 3.547594211667296e-15
the O 0 7.72437262807138e-14
average O 0 1.3224370383480011e-11
number O 0 1.0345595040373023e-11
of O 0 1.2866574472525372e-09
adenomas B-Disease 0 2.552834985181107e-06
tended O 0 1.0140013273485238e-08
to O 0 3.141000515238801e-10
be O 0 1.1517732600996311e-10
lower O 0 8.379213434217547e-10
than O 0 3.745816590933204e-13
those O 0 5.072189955372675e-13
in O 0 5.60744593119944e-13
individuals O 0 2.264616228916938e-12
with O 0 1.989005965138957e-12
mutations O 0 1.6792045184899074e-11
in O 0 6.543641930395472e-12
region O 0 7.471556151550374e-10
1 O 0 5.169093777145084e-13
, O 0 2.250528000855576e-15
although O 0 5.439359290130945e-14
age O 0 4.846275290792956e-12
at O 0 7.024254441989619e-12
diagnosis O 0 2.607670079868285e-09
was O 0 3.969638853740243e-12
similar O 0 1.2462043549876789e-11
. O 0 2.3505464241679874e-09

In O 0 1.1102734731593955e-08
all O 0 2.0270407574685123e-08
AAPC B-Disease 1 1.0
kindreds O 0 2.029843926720787e-06
, O 0 4.7786674926353703e-14
a O 0 9.034256226144247e-14
predominance O 0 2.016243172420218e-09
of O 0 2.377124719288304e-09
right O 0 0.13197138905525208
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 1.626833068257838e-06
rectal B-Disease 1 1.0
polyp I-Disease 0 1.3314564739630441e-06
sparing O 0 2.412983146626857e-10
was O 0 5.9174071892487135e-12
observed O 0 1.312729005359392e-11
. O 0 4.0222158936842334e-10

No O 0 4.981654456059914e-06
desmoid B-Disease 1 0.9676719903945923
tumors I-Disease 1 1.0
were O 0 1.9329710054805105e-10
found O 0 1.8047898245332483e-12
in O 0 3.567336313500813e-13
these O 0 7.923094472173098e-12
kindreds O 0 3.1237377129400556e-07
. O 0 9.434206305058979e-09

Our O 0 4.127764441363979e-07
data O 0 7.720765138330421e-10
suggest O 0 7.150441697079124e-12
that O 0 1.4603302020323866e-14
, O 0 2.2163818157627975e-14
in O 0 4.1620344323756164e-12
AAPC B-Disease 1 1.0
families O 0 4.0905445697347886e-11
, O 0 4.708088641711995e-15
the O 0 2.155636339730687e-14
location O 0 1.4435667938794694e-11
of O 0 4.856092524624378e-12
the O 0 9.43275665910015e-11
APC B-Disease 0 1.0030813513139947e-07
mutation O 0 7.835651572030145e-10
may O 0 1.2846312902325963e-10
partially O 0 1.28732258186659e-09
predict O 0 1.3174401847226846e-10
specific O 0 2.7263667018440074e-11
phenotypic O 0 2.99441094142594e-09
expression O 0 2.266063958700215e-08
. O 0 9.601639305856224e-08

This O 0 1.2349695918678627e-11
should O 0 1.702318299344474e-13
help O 0 6.642262694728229e-13
in O 0 3.563177500314407e-15
the O 0 5.048460784753137e-15
design O 0 6.921330262393832e-12
of O 0 2.2908606435445567e-12
tailored O 0 7.342011998368037e-10
clinical O 0 7.572937832378557e-09
- O 0 1.6968207949830116e-09
management O 0 1.337402931456122e-11
protocols O 0 1.4981059795471374e-11
in O 0 5.480219312473545e-15
this O 0 8.485728531524087e-15
subset O 0 2.2419785754464183e-13
of O 0 1.594775608229279e-13
FAP B-Disease 0 3.2228122948119164e-10
patients O 0 2.222662375331308e-12
. O 0 8.581167894317066e-12
. O 0 1.4708164686183522e-09

Wilms B-Disease 0 0.3399510085582733
' I-Disease 0 1.0335615030498957e-07
tumor I-Disease 0 5.006187131506579e-10
1 O 0 8.985386761896363e-13
and O 0 1.4683329693180452e-13
Dax O 0 5.187319374044819e-08
- O 0 3.5257793212783994e-11
1 O 0 3.0537207419863155e-13
modulate O 0 2.9100678464177854e-11
the O 0 4.986987819227684e-12
orphan O 0 1.4197450506903131e-11
nuclear O 0 1.5510633055715317e-10
receptor O 0 6.156789487954395e-13
SF O 0 4.1819443907797904e-08
- O 0 5.403156047578683e-11
1 O 0 8.320075992095458e-15
in O 0 8.01902714187236e-16
sex O 0 4.5470066920667504e-15
- O 0 4.366510429633082e-16
specific O 0 1.9385366760940349e-16
gene O 0 1.5220109506690316e-15
expression O 0 3.895189021590334e-13
. O 0 3.970428152921812e-11

Products O 0 1.0357456226017803e-08
of O 0 2.566497903089271e-09
steroidogenic O 0 1.8743565988188493e-07
factor O 0 1.1373167164985265e-11
1 O 0 5.113473663595491e-13
( O 0 1.945018886890474e-15
SF O 0 6.32667873645687e-09
- O 0 1.3139019039432043e-10
1 O 0 8.124447295476678e-14
) O 0 4.9055083047944495e-15
and O 0 1.5170118633500707e-11
Wilms B-Disease 0 4.41577285528183e-05
tumor I-Disease 0 2.8253900552499545e-08
1 O 0 8.510151784657527e-12
( O 0 1.079939225068563e-14
WT1 O 0 8.88530971021595e-10
) O 0 4.617111479825371e-16
genes O 0 7.533728720347192e-15
are O 0 6.204050999912352e-16
essential O 0 9.556037385005656e-12
for O 0 7.257931235182813e-13
mammalian O 0 6.685669795558624e-09
gonadogenesis O 0 2.2773294361400076e-08
prior O 0 1.9372941029160984e-09
to O 0 3.9928180206594277e-10
sexual O 0 4.138441256351655e-10
differentiation O 0 6.7735550501879516e-09
. O 0 3.0614892843061625e-09

In O 0 1.0376008212353849e-11
males O 0 4.112982524007158e-11
, O 0 1.0165394865929364e-13
SF O 0 5.533480020858406e-07
- O 0 1.3251172381600895e-09
1 O 0 3.936446708961011e-13
participates O 0 1.2363784041707904e-12
in O 0 4.557999485656217e-15
sexual O 0 4.386178428789208e-15
development O 0 7.168825232604144e-15
by O 0 3.243290602602788e-18
regulating O 0 1.531873315262916e-14
expression O 0 4.0993353460014315e-13
of O 0 4.773653260875532e-12
the O 0 4.1498453978716654e-11
polypeptide O 0 5.923420642872657e-10
hormone O 0 1.5486561685817968e-11
Mullerian O 0 3.3473954719198673e-09
inhibiting O 0 1.241296787579671e-10
substance O 0 1.2188241527155697e-09
( O 0 3.6999952255679924e-13
MIS O 0 2.63380485421294e-07
) O 0 1.3452764293167552e-13
. O 0 7.620252345796885e-11

Here O 0 4.271090592311566e-09
, O 0 1.9802608446257974e-13
we O 0 4.229443536932567e-14
show O 0 7.130009473457766e-13
that O 0 3.421366990175208e-14
WT1 O 0 4.182820703135803e-06
- O 0 1.0581398868225733e-08
KTS O 0 7.496392981920508e-07
isoforms O 0 1.5819810739170492e-10
associate O 0 7.447280292449676e-11
and O 0 1.0029191968010873e-14
synergize O 0 2.1089621160541583e-09
with O 0 3.991205694935107e-13
SF O 0 4.5769246526106144e-07
- O 0 1.934095938960212e-10
1 O 0 1.7992139896005899e-13
to O 0 3.771166972449391e-12
promote O 0 8.620897773425895e-09
MIS O 0 2.934518988695345e-06
expression O 0 1.38906525171123e-10
. O 0 8.370982379490854e-11

In O 0 5.829239868582192e-10
contrast O 0 2.571788615401971e-10
, O 0 4.563556563891291e-12
WT1 O 0 4.482901942992612e-07
missense O 0 7.897894782615822e-09
mutations O 0 1.0338611911020479e-11
, O 0 1.091735365881029e-15
associated O 0 2.4083952063561065e-13
with O 0 3.456326072787466e-14
male B-Disease 0 4.7297317173899955e-09
pseudohermaphroditism I-Disease 1 1.0
in O 0 2.532759957318831e-08
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.877951999977202e-12
fail O 0 7.308594618393727e-09
to O 0 6.575636563033171e-11
synergize O 0 3.3608387184358435e-07
with O 0 4.5165642059696864e-11
SF O 1 0.9999943971633911
- O 0 5.6102912822098006e-06
1 O 0 1.8511158161871322e-09
. O 0 5.849789541656492e-10

Additionally O 0 2.2635098240186835e-09
, O 0 5.137872820335648e-14
the O 0 1.1155391389273961e-13
X O 0 3.836848616600719e-09
- O 0 7.681693059424788e-10
linked O 0 1.6037582373229498e-10
, O 0 4.450511851682593e-15
candidate O 0 3.794233590509455e-12
dosage O 0 4.2844364167571314e-10
- O 0 1.0936049808785153e-11
sensitive O 0 8.809767151896075e-12
sex O 0 3.191298950360605e-13
- O 0 3.5517682545060936e-13
reversal O 0 1.0936002537570433e-12
gene O 0 1.7281391500646205e-14
, O 0 8.112535979359209e-15
Dax O 0 1.7205373126216728e-08
- O 0 1.0587438911691116e-11
1 O 0 2.2277668533694783e-13
, O 0 1.5237487446394422e-14
antagonizes O 0 3.372668117007649e-11
synergy O 0 3.779284177274356e-11
between O 0 6.460480067582708e-11
SF O 0 6.394143383658957e-07
- O 0 6.743039460133105e-10
1 O 0 3.224713519215522e-13
and O 0 5.568469405199672e-13
WT1 O 0 9.864457695130113e-08
, O 0 8.32591797833267e-15
most O 0 1.650488696350327e-16
likely O 0 1.2110997358520496e-14
through O 0 1.8363030551433318e-14
a O 0 5.595562330000005e-14
direct O 0 2.703570440437675e-12
interaction O 0 3.776533530341908e-10
with O 0 7.837232252061455e-11
SF O 0 0.0009729865123517811
- O 0 5.468887707138492e-07
1 O 0 3.7671524233395814e-10
. O 0 5.890566923127949e-10

We O 0 2.728953729658201e-10
propose O 0 7.0976287347424e-11
that O 0 2.181151309912921e-13
WT1 O 0 8.580053076912009e-07
and O 0 9.365636738367655e-11
Dax O 0 3.885163096128963e-06
- O 0 2.9140181934117493e-10
1 O 0 3.549397917506497e-13
functionally O 0 5.665667240917216e-11
oppose O 0 1.089926421143049e-13
each O 0 3.6951672563532555e-15
other O 0 5.449782454063383e-15
in O 0 2.1383726224195182e-13
testis O 0 1.7521391282304677e-10
development O 0 1.9193429397906803e-12
by O 0 1.1817094713515146e-14
modulating O 0 3.36813105183964e-10
SF O 0 3.295824626547983e-07
- O 0 3.6821772297912503e-09
1 O 0 2.241758514931469e-11
- O 0 9.518714289002972e-11
mediated O 0 1.7017310893763238e-09
transactivation O 0 1.1874411853796119e-07
. O 0 1.3987734581721867e-12
. O 0 9.3061574071851e-12

A O 0 3.7818534415201555e-10
mouse O 0 2.110048247239149e-13
model O 0 9.690419446690621e-14
for O 0 1.694487085368568e-11
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 0 0.00012209669512230903
centre O 0 4.841753109552371e-10
mutations O 0 9.547251227440268e-13
. O 0 6.420133522033744e-13

Imprinting O 0 3.029074377991492e-07
in O 0 4.485955010236076e-12
the O 0 7.688956242535294e-12
15q11 O 0 4.0798763478733235e-08
- O 0 1.9179395571722324e-10
q13 O 0 2.1882438083764555e-09
region O 0 3.99345400498019e-12
involves O 0 1.8329734431665745e-12
an O 0 9.859557018477433e-14
imprinting O 0 6.15949829807505e-06
centre O 0 5.676644576624312e-08
( O 0 2.4169165272120742e-14
IC O 0 1.995500866769362e-07
) O 0 2.1882132268820874e-14
, O 0 2.8713732932815874e-15
mapping O 0 1.6899869090952757e-12
in O 0 6.503405043087112e-15
part O 0 3.7330192105902715e-14
to O 0 6.017449451049817e-13
the O 0 1.6780990659548412e-12
promoter O 0 1.1937008048690245e-09
and O 0 5.4731245577310794e-12
first O 0 1.5709527012575109e-09
exon O 0 2.2236800845121252e-08
of O 0 5.775964151411017e-09
SNRPN O 1 0.988248348236084
. O 0 1.8902575504853303e-07

Deletion O 0 7.773461874194254e-09
of O 0 1.5767936956123663e-10
this O 0 3.650662411258665e-11
IC O 0 3.1869935810391326e-06
abolishes O 0 2.2416839495775776e-09
local O 0 1.447832652379244e-11
paternally O 0 1.884620931535963e-10
derived O 0 3.304112896913153e-14
gene O 0 2.1338233778664048e-15
expression O 0 1.543060587617072e-14
and O 0 2.5240110108432296e-16
results O 0 1.2542942487599185e-13
in O 0 7.063357121417368e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.760886186337075e-09
PWS B-Disease 1 1.0
) O 0 1.7764770774211791e-12
. O 0 3.1761700908239376e-11

We O 0 2.1459918564392666e-10
have O 0 1.6702588476798924e-13
created O 0 4.932399906803879e-14
two O 0 7.73743726424983e-14
deletion O 0 9.217178235931822e-12
mutations O 0 9.341702758569603e-13
in O 0 4.3389291183408563e-13
mice O 0 3.691462760468944e-11
to O 0 6.299819693689201e-11
understand O 0 8.007733498516245e-08
PWS B-Disease 1 1.0
and O 0 1.533152944876992e-11
the O 0 5.755928719763936e-12
mechanism O 0 4.788556356993823e-11
of O 0 1.6312725909656267e-12
this O 0 2.5740533836360324e-12
IC O 0 3.0303278890642105e-06
. O 0 2.5255818769664984e-08

Mice O 0 2.1131874916591187e-07
harbouring O 0 2.729425659708795e-06
an O 0 6.2515179664879295e-12
intragenic O 0 2.068253024845035e-06
deletion O 0 3.8523307210880375e-08
in O 0 1.0643088632633635e-09
Snrpn O 1 0.8958193063735962
are O 0 7.728422762864895e-11
phenotypically O 0 5.720271474274341e-07
normal O 0 7.108111077513968e-08
, O 0 1.609658044875173e-13
suggesting O 0 4.876354094823787e-12
that O 0 5.687540960115992e-14
mutations O 0 5.875416125844524e-11
of O 0 2.022355616304594e-09
SNRPN O 1 0.704174816608429
are O 0 5.201436937413151e-12
not O 0 5.942368992706282e-12
sufficient O 0 6.111103623140934e-09
to O 0 1.2913785596424532e-08
induce O 0 0.00018044249736703932
PWS B-Disease 1 1.0
. O 0 1.023147774503741e-06

Mice O 0 2.385654784831104e-09
with O 0 6.029475286021754e-14
a O 0 4.1824600423637226e-13
larger O 0 2.5008120574376846e-13
deletion O 0 3.324173618660109e-12
involving O 0 5.490711618011401e-12
both O 0 4.020258084769246e-11
Snrpn O 0 1.731302654661704e-05
and O 0 8.109372548470439e-13
the O 0 2.4966778644497367e-11
putative O 0 1.5289653276795434e-07
PWS O 1 1.0
- O 0 2.2390100440361493e-08
IC O 0 2.4975253154480015e-07
lack O 0 1.3106463692125203e-09
expression O 0 3.544420833223594e-12
of O 0 3.0619924998309678e-12
the O 0 3.4250265384255796e-12
imprinted O 0 5.024601845704524e-10
genes O 0 3.5470192755182595e-11
Zfp127 O 0 1.729530225702547e-07
( O 0 3.749968001051651e-14
mouse O 0 1.5724440846631715e-11
homologue O 0 2.2203139327103827e-09
of O 0 2.373350849182998e-09
ZNF127 O 1 0.9999988079071045
) O 0 4.273441323032756e-11
, O 0 7.041105198890563e-11
Ndn O 0 7.316729124795529e-07
and O 0 2.991508082916816e-11
Ipw O 0 2.3589958431102787e-08
, O 0 3.7200779024089414e-13
and O 0 2.4388911029626925e-13
manifest O 0 1.4348007226772097e-09
several O 0 1.8344494760041963e-12
phenotypes O 0 3.0571870035522863e-10
common O 0 6.661643459082711e-11
to O 0 1.3384875785504846e-07
PWS B-Disease 1 1.0
infants O 0 3.5350516554899514e-05
. O 0 3.149913041511354e-08

These O 0 1.3210731987511881e-11
data O 0 5.014368911412936e-13
demonstrate O 0 6.718688105866732e-13
that O 0 1.4216438197571626e-16
both O 0 4.563114294108212e-15
the O 0 5.56973053561418e-14
position O 0 2.58679579492882e-12
of O 0 6.855071523446943e-13
the O 0 6.494833425414737e-13
IC O 0 4.639217365820514e-08
and O 0 1.3667142233480395e-13
its O 0 3.7508905893378006e-14
role O 0 1.2989740847627745e-13
in O 0 5.639771690022638e-14
the O 0 5.151731363554901e-13
coordinate O 0 2.1632513488856198e-11
expression O 0 1.7584365907818977e-10
of O 0 1.6161216809251755e-09
genes O 0 3.796377795461936e-11
is O 0 1.7121456433611543e-13
conserved O 0 6.426523896374547e-11
between O 0 1.0631883567979727e-10
mouse O 0 8.276503787874034e-11
and O 0 4.433215947119429e-13
human O 0 6.527324254018696e-12
, O 0 1.361133411249783e-14
and O 0 3.573632004465893e-15
indicate O 0 1.178644963746589e-12
that O 0 6.057468242620851e-16
the O 0 3.8195651069078407e-13
mouse O 0 8.39643545663682e-12
is O 0 5.1324047144413534e-15
a O 0 1.234608118863556e-13
suitable O 0 9.046723925543176e-10
model O 0 1.6318583637153772e-11
system O 0 5.8328151336661804e-12
in O 0 2.4241616743483907e-13
which O 0 1.7712039991689237e-14
to O 0 1.0572002474840136e-11
investigate O 0 3.1601579686402204e-10
the O 0 2.9287159503121885e-11
molecular O 0 1.2127427534425195e-11
mechanisms O 0 3.7144257114540835e-10
of O 0 5.3239149200301483e-11
imprinting O 0 3.040278473420699e-09
in O 0 1.8488222021037504e-13
this O 0 4.4954149316890277e-14
region O 0 2.819130692777172e-11
of O 0 3.9843220953419967e-13
the O 0 1.7150220317247583e-13
genome O 0 3.084013296475452e-12
. O 0 2.562043025650107e-12
. O 0 7.383524347481796e-10

Mutations O 0 2.177658886548528e-10
of O 0 9.648789406346836e-11
the O 0 5.876436143248398e-11
ATM O 0 5.123786195326829e-08
gene O 0 7.122302964415739e-13
detected O 0 2.8156255538897e-12
in O 0 1.932934877695719e-13
Japanese O 1 0.984580934047699
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.33174172043800354
: O 0 4.997950092525995e-15
possible O 0 1.627491815359844e-14
preponderance O 0 6.160642200374322e-13
of O 0 7.70832762176472e-15
the O 0 3.7361535713082913e-14
two O 0 2.3294265279714954e-13
founder O 0 9.582543786246234e-11
mutations O 0 3.7579144657184926e-11
4612del165 O 0 1.184095754780401e-08
and O 0 2.3226542217313906e-11
7883del5 O 0 5.689771001016197e-07
. O 0 6.484709214049644e-09

The O 0 6.47428360922575e-11
ATM O 0 2.579479740916213e-08
( O 0 1.845813866335755e-12
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 2.8067432818017213e-14
mutated O 0 1.4670072780522975e-15
) O 0 2.3930951370715443e-18
gene O 0 5.017238528277523e-17
on O 0 8.701787154610872e-15
human O 0 4.34493071946665e-14
chromosome O 0 2.4916351967774197e-11
11q22 O 0 4.2602877670105954e-08
. O 0 7.566148818582974e-10

3 O 0 1.5644782691559556e-10
has O 0 3.3473166594208056e-14
recently O 0 1.257357136837849e-14
been O 0 1.7455001702856052e-15
identified O 0 1.0972429223348422e-14
as O 0 5.472672593020644e-17
the O 0 1.556594697100494e-16
gene O 0 2.561471042935551e-16
responsible O 0 9.408695441400893e-15
for O 0 1.1744959905419313e-15
the O 0 5.1162219805774706e-14
human O 0 4.880115755945269e-11
recessive B-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.419881068111863e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.6768970612205123e-13
. O 0 8.821519903445818e-12

In O 0 5.137390512999218e-11
order O 0 2.2394367176631347e-12
to O 0 2.696926232684249e-12
define O 0 1.2601056482985928e-11
the O 0 7.151948439943281e-14
types O 0 2.037013136294008e-12
of O 0 2.2184786993562078e-11
disease O 0 4.190128422010275e-08
- O 0 2.9362906550645107e-10
causing O 0 1.5929682919968435e-11
ATM O 0 3.6668073022383396e-09
mutations O 0 2.6687197373850835e-13
in O 0 7.613961375177013e-15
Japanese O 0 4.293895905504996e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.0907965903613785e-10
as O 0 1.2084876556493068e-14
well O 0 5.598250389058116e-15
as O 0 3.4570678301272886e-16
to O 0 2.5933403102924857e-13
look O 0 2.260926255243101e-12
for O 0 5.219561761971026e-13
possible O 0 3.9876885127299033e-10
mutational O 0 1.2330089305123693e-07
hotspots O 0 5.373272937703177e-10
, O 0 5.07677497859748e-14
reverse O 0 4.030615424754913e-11
- O 0 3.8128775310675156e-12
transcribed O 0 5.607769890808578e-12
RNA O 0 3.455031399868247e-12
derived O 0 4.94793117068737e-13
from O 0 3.1795956655349816e-14
ten O 0 1.2689742485971767e-11
patients O 0 5.901083658180206e-13
belonging O 0 1.479164880857642e-11
to O 0 2.1229149081009036e-12
eight O 0 2.3508667235105918e-11
unrelated O 0 1.0115451531955699e-10
Japanese O 0 1.260593620600048e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.5281116649834559e-10
was O 0 1.911597399470444e-12
analyzed O 0 1.271213765762641e-13
for O 0 3.1052736066111003e-16
mutations O 0 3.852447192735631e-16
by O 0 2.2768890823073384e-17
the O 0 2.768143905692048e-15
restriction O 0 6.70462576652037e-15
endonuclease O 0 1.0750121496108656e-12
fingerprinting O 0 2.474514169958919e-11
method O 0 5.699921645785366e-10
. O 0 5.312062789641914e-09

As O 0 7.347877861718644e-11
has O 0 1.0213199711406502e-14
been O 0 3.2702544489125566e-15
reported O 0 1.6287610307038334e-15
by O 0 1.4475169705266373e-16
others O 0 2.0863048972880743e-13
, O 0 1.3884241351839587e-14
mutations O 0 1.481475803578186e-13
that O 0 8.00198039205063e-15
lead O 0 4.072988821213208e-11
to O 0 7.076005337225411e-10
exon O 0 3.4142193072739246e-08
skipping O 0 5.606507897937263e-07
or O 0 5.351000087472357e-09
premature O 0 3.3572763413758366e-07
protein O 0 1.553883022253899e-09
truncation O 0 8.613840236648684e-07
were O 0 1.2345751088105317e-09
also O 0 2.014525699034486e-12
predominant O 0 4.940469700009942e-10
in O 0 1.6166680624415952e-12
our O 0 5.725257601341127e-09
mutants O 0 1.678342620436979e-08
. O 0 2.493843576090171e-09

Six O 0 6.797326035368201e-10
different O 0 2.8515807336954024e-13
mutations O 0 3.79708166764383e-14
were O 0 8.566192426348509e-15
identified O 0 3.914917503134059e-14
on O 0 7.552277217232756e-14
12 O 0 4.3639275678318545e-13
of O 0 1.3515884375245313e-12
the O 0 5.467146266951994e-12
16 O 0 1.4508548529246212e-10
alleles O 0 1.1981567647756375e-11
examined O 0 8.149905639243116e-09
. O 0 8.309320520538677e-08

Four O 0 2.013221672703125e-10
were O 0 5.338269756793856e-12
deletions O 0 3.321811228862437e-11
involving O 0 3.350200542331927e-12
a O 0 5.38773756511568e-12
loss O 0 2.2927613141376924e-09
of O 0 1.2131934568060387e-08
a O 0 1.8528008016716058e-09
single O 0 1.234467461586064e-08
exon O 0 1.811287120290217e-08
exon O 0 6.657319140401796e-09
7 O 0 1.4189101005257498e-09
, O 0 3.289146732754489e-11
exon O 0 8.815187468869112e-10
16 O 0 2.3224340506278196e-10
, O 0 1.3950040775312367e-11
exon O 0 1.099953017558164e-09
33 O 0 2.2218897832715356e-09
or O 0 5.235163413885857e-10
exon O 0 2.371134932843688e-08
35 O 0 4.358299321438608e-08
. O 0 1.8270155166533186e-08

The O 0 5.549403159221811e-10
others O 0 7.571034944808819e-12
were O 0 1.0509235842670606e-11
minute O 0 6.941234254043138e-10
deletions O 0 4.952584453654651e-10
, O 0 4.6886092556173986e-14
4649delA O 0 4.36051444951957e-10
in O 0 7.470180724000741e-12
exon O 0 7.056839557151307e-10
33 O 0 6.486511328063216e-10
and O 0 1.694341715541281e-11
7883del5 O 0 5.27716466081074e-08
in O 0 1.2308268293459435e-10
exon O 0 6.571406085953413e-09
55 O 0 2.016444078378754e-08
. O 0 1.949486438945769e-08

The O 0 1.7282209796576353e-07
mutations O 0 3.064873510538746e-08
4612del165 O 0 1.8732734474724566e-07
and O 0 6.912214724208443e-12
7883del5 O 0 6.364416105242299e-09
were O 0 1.149869045466434e-12
found O 0 2.7726366531475796e-14
in O 0 1.6516987887945983e-15
more O 0 7.245855335269737e-17
than O 0 1.310864086354917e-16
two O 0 1.829491851456223e-15
unrelated O 0 9.63473007972726e-13
families O 0 8.746353115504299e-14
; O 0 2.0861027856977388e-16
44 O 0 7.290790367264766e-12
% O 0 7.857044008463543e-12
( O 0 5.263160978750763e-16
7 O 0 3.7341982804528495e-12
of O 0 1.8289198280840857e-11
16 O 0 7.843463725731858e-12
) O 0 2.058618202391716e-14
of O 0 4.3587285473642434e-13
the O 0 7.250289642745864e-14
mutant O 0 3.789723323024442e-14
alleles O 0 1.9041575092951582e-14
had O 0 1.7949090293494646e-13
one O 0 4.047233875077369e-14
of O 0 1.2950536910222299e-12
the O 0 2.4605302604424617e-12
two O 0 1.7161789350739198e-11
mutations O 0 4.805027487009284e-10
. O 0 7.489023623463709e-09

The O 0 1.94443607881567e-08
4612del165 O 0 1.418776065520433e-07
mutations O 0 1.4568374718387789e-12
in O 0 3.3183087455926612e-15
three O 0 1.1808932068760694e-15
different O 0 1.0949301623998354e-15
families O 0 1.6686913285077036e-14
were O 0 5.0906700458774184e-14
all O 0 1.001099770030385e-14
ascribed O 0 2.8974329446124214e-12
to O 0 4.878807861180556e-13
the O 0 1.5272011086309156e-12
same O 0 9.701340425438687e-12
T O 0 1.756813999831408e-10
- O 0 2.8084090608615497e-10
- O 0 1.0365647923338273e-10
> O 0 5.880188697071631e-12
A O 0 3.686204987085606e-12
substitution O 0 1.4625051115903925e-13
at O 0 1.2912195658932972e-14
the O 0 3.5527403603383394e-15
splice O 0 7.249637001827125e-11
donor O 0 4.168803757059747e-12
site O 0 1.149884961554326e-11
in O 0 3.3910819031285344e-12
intron O 0 9.421155056088537e-08
33 O 0 8.470605905586126e-08
. O 0 3.518012192671449e-08

Microsatellite O 0 4.968484290657216e-08
genotyping O 0 7.323361472799661e-08
around O 0 6.652663229328448e-12
the O 0 1.2729838884395495e-11
ATM O 0 1.0055045862600309e-07
locus O 0 5.120378773759704e-11
also O 0 1.529882584548961e-13
indicated O 0 6.626334897452679e-12
that O 0 5.090424914542483e-15
a O 0 1.8468977432475886e-13
common O 0 2.6309507415549216e-13
haplotype O 0 8.183450445065077e-11
was O 0 2.724977144971663e-12
shared O 0 4.888507133815612e-12
by O 0 1.539482169876454e-15
the O 0 3.141257937902715e-14
mutant O 0 1.733471629043401e-13
alleles O 0 2.525636763530542e-14
in O 0 1.1148371857833475e-13
both O 0 2.679750171763473e-11
mutations O 0 8.990457822655173e-10
. O 0 7.943580015989937e-09

This O 0 2.4530339565176362e-11
suggests O 0 1.0398251270443692e-12
that O 0 4.267541247191317e-16
these O 0 4.109226183607838e-15
two O 0 1.879144219786924e-13
founder O 0 3.012476032515643e-11
mutations O 0 5.0603258562598175e-12
may O 0 9.628993294982097e-14
be O 0 1.9932737101505116e-13
predominant O 0 2.7961691295708135e-10
among O 0 2.949126809729738e-14
Japanese O 0 1.2985226782724624e-10
ATM O 0 9.113580112796171e-09
mutant O 0 2.990652170353769e-11
alleles O 0 5.263836588831339e-11
. O 0 4.954608279206241e-09

W474C O 0 2.9172062543381116e-09
amino O 0 3.228204379160382e-12
acid O 0 1.6276656265206205e-14
substitution O 0 8.926586141273785e-14
affects O 0 2.5203082063143074e-15
early O 0 1.5756059651428345e-14
processing O 0 1.1114789644217637e-12
of O 0 5.244917117264679e-14
the O 0 4.148453973461079e-14
alpha O 0 6.452942631737964e-15
- O 0 9.766380514367439e-15
subunit O 0 7.090118507628801e-15
of O 0 5.029186702504296e-13
beta O 0 1.3893560781019776e-11
- O 0 2.455037388660042e-11
hexosaminidase O 0 9.75698410954351e-10
A O 0 1.6682587256067194e-10
and O 0 7.292865584433011e-15
is O 0 1.5053114843556763e-16
associated O 0 4.173702399315471e-13
with O 0 8.861753561864583e-13
subacute O 0 7.51864499761723e-05
G B-Disease 0 8.15018219579855e-10
( I-Disease 0 4.5802944092674866e-14
M2 I-Disease 0 3.1571352199222247e-09
) I-Disease 0 4.5134593762083397e-13
gangliosidosis I-Disease 0 2.3236819401972753e-07
. O 0 5.591608065458331e-09

Mutations O 0 2.58395180252613e-11
in O 0 2.2291142456193347e-13
the O 0 5.023233348375178e-13
HEXA O 0 2.3536508297894443e-09
gene O 0 1.0638692524657834e-15
, O 0 1.9564470885020535e-17
encoding O 0 1.699954573437031e-15
the O 0 4.302228146353887e-15
alpha O 0 2.1571229249047657e-16
- O 0 7.492997447012574e-16
subunit O 0 6.870611931051099e-16
of O 0 1.7234493996862166e-13
beta O 0 3.4378236368759474e-11
- O 0 2.1574998732010187e-10
hexosaminidase O 0 4.091713634579719e-08
A O 0 9.143318102644571e-09
( O 0 8.889536666050997e-16
Hex O 0 1.9072510237805318e-10
A O 0 2.5246051776894873e-11
) O 0 1.0364687557086214e-16
, O 0 1.939616643101784e-16
that O 0 3.818066125406579e-16
abolish O 0 1.2823643535941898e-10
Hex O 0 3.873139864385422e-10
A O 0 2.406900720397509e-11
enzyme O 0 4.167364803936424e-12
activity O 0 4.3236667718327126e-11
cause O 0 0.00011460517271189019
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 4.18724386760938e-12
TSD B-Disease 1 0.8468424677848816
) O 0 1.3345749472985086e-14
, O 0 2.830945575379442e-16
the O 0 1.0770716797289283e-14
fatal O 0 2.4077145832634983e-10
infantile B-Disease 0 6.948311259691309e-09
form I-Disease 0 4.6915683143966547e-11
of I-Disease 0 1.5953029119941675e-08
G I-Disease 0 3.5650427054889633e-10
( I-Disease 0 5.283362587487836e-14
M2 I-Disease 0 6.234615046452063e-10
) I-Disease 0 5.46317955067363e-14
gangliosidosis I-Disease 0 8.329104517201813e-09
, I-Disease 0 7.614487382637258e-14
Type I-Disease 0 1.1075053200915175e-11
1 I-Disease 0 9.68311281851486e-12
. O 0 9.856863936175131e-11

Less O 0 2.1888043377771282e-08
severe O 0 7.53652784624137e-07
, O 0 2.686064912160724e-11
subacute O 0 0.28297072649002075
( O 0 2.9440405462880653e-14
juvenile O 0 1.2725463349738675e-08
- O 0 4.970225564449038e-09
onset O 0 2.996709724811808e-07
) O 0 4.1638269438273867e-13
and O 0 3.6140992420996554e-09
chronic O 1 1.0
( O 0 9.801479072812924e-12
adult O 0 7.391225517494604e-05
- O 0 1.09260174241399e-08
onset O 0 8.801512851874804e-10
) O 0 4.291933731429432e-15
variants O 0 2.1409774994540776e-12
are O 0 8.83285449177016e-15
characterized O 0 7.987889998973055e-15
by O 0 3.662134241959759e-15
a O 0 1.8624494307895034e-12
broad O 0 5.664195241311676e-12
spectrum O 0 3.897370273731049e-11
of O 0 2.807865268419918e-12
clinical O 0 3.827640461528947e-12
manifestations O 0 1.6922447601194768e-12
and O 0 1.6310376646836398e-14
are O 0 6.727705826146274e-16
associated O 0 1.1631810152654826e-13
with O 0 1.1974649617968024e-14
residual O 0 2.920110819815136e-10
levels O 0 4.586685753427133e-10
of O 0 6.014314601898718e-10
Hex O 0 1.2386373704487141e-08
A O 0 1.4198392683795191e-08
enzyme O 0 1.4121837033087559e-10
activity O 0 1.0577982934023566e-09
. O 0 7.517240718790674e-10

We O 0 5.0705314946775104e-11
identified O 0 1.923975735673711e-12
a O 0 1.6729427562765624e-14
1422 O 0 1.046930250825362e-11
G O 0 2.8431480260382447e-12
- O 0 7.41239014612205e-11
- O 0 6.270484825821043e-11
> O 0 1.5346304088614815e-11
C O 0 7.073842900329197e-11
( O 0 1.1059362438186617e-16
amino O 0 5.438456353009172e-14
acid O 0 6.817459872457063e-15
W474C O 0 2.0670272405601958e-13
) O 0 2.5935784433092756e-20
substitution O 0 6.230804006155787e-16
in O 0 8.933560144693355e-16
the O 0 3.3657159091010636e-14
first O 0 1.2738867035885781e-12
position O 0 1.340256100546e-10
of O 0 1.2664143345109125e-10
exon O 0 2.0914955878303942e-10
13 O 0 2.626330750099548e-11
of O 0 1.111264413822255e-09
HEXA O 0 3.190661118424032e-06
of O 0 1.1249062792373365e-09
a O 0 3.734883582962034e-11
non O 0 1.92927132047771e-08
- O 0 1.3603944637452514e-09
Jewish O 0 1.0656556748145363e-09
proband O 0 8.128373156068847e-05
who O 0 5.380794768083952e-12
manifested O 0 3.884170207690829e-10
a O 0 2.3691816737614335e-12
subacute O 0 6.341928582287437e-08
variant O 0 2.9705740645091794e-10
of O 0 3.3194474724496104e-08
G B-Disease 0 4.054060198654952e-08
( I-Disease 0 3.4708635705121837e-12
M2 I-Disease 0 6.607378821854581e-08
) I-Disease 0 2.5054253376816105e-12
gangliosidosis I-Disease 0 2.838716852693324e-07
. O 0 5.379787282322468e-09

On O 0 4.7881956177775464e-09
the O 0 5.2545176543183914e-11
second O 0 1.3443350876940485e-09
maternally O 0 1.1251370324316667e-07
inherited O 0 1.6366143995583116e-08
allele O 0 5.458326568508198e-10
, O 0 7.696210476641069e-14
we O 0 5.998447452724293e-14
identified O 0 7.680303875517991e-13
the O 0 2.2593298759643332e-13
common O 0 1.853061315504334e-10
infantile O 1 0.9615018963813782
disease O 0 0.00023550557671114802
- O 0 5.039435180265173e-08
causing O 0 5.789654977661485e-08
4 O 0 2.3662569219595753e-06
- O 0 3.9978090171644e-06
bp O 0 3.146746863080807e-09
insertion O 0 2.304301283118093e-08
, O 0 8.920314140126173e-12
+ O 0 1.084143996799014e-09
TATC O 0 1.0459324585099239e-05
1278 O 0 1.172322416920224e-08
, O 0 1.630833055404901e-13
in O 0 9.757322987774542e-13
exon O 0 4.879438519900248e-10
11 O 0 1.487001355382489e-10
. O 0 2.5151536409140363e-09

Pulse O 0 4.844316663366044e-07
- O 0 9.908706077865759e-10
chase O 0 8.159894634984788e-12
analysis O 0 5.131516685099452e-14
using O 0 3.90318203105644e-14
proband O 0 3.8468366270194565e-09
fibroblasts O 0 1.5482265469657364e-09
revealed O 0 5.586842295214611e-13
that O 0 1.3395663106246087e-17
the O 0 2.02560348390988e-15
W474C O 0 3.5777292586858245e-12
- O 0 5.981146974183213e-15
containing O 0 1.1504265964336347e-15
alpha O 0 5.470757530936241e-15
- O 0 2.923398353363478e-14
subunit O 0 1.432524820879459e-14
precursor O 0 3.562619166688763e-12
was O 0 1.2219065819926711e-12
normally O 0 4.876289476374307e-12
synthesized O 0 4.5943797377656637e-11
, O 0 2.2133401204492073e-14
but O 0 1.7107803956567698e-14
not O 0 1.8048370686429144e-13
phosphorylated O 0 4.038328005329106e-10
or O 0 3.7623140822402867e-13
secreted O 0 3.0033753262159735e-12
, O 0 4.093642894960727e-15
and O 0 8.944067376645808e-15
the O 0 4.655322568408726e-12
mature O 0 1.279351025118558e-08
lysosomal O 0 4.5634784839876374e-08
alpha O 0 6.433142647060963e-12
- O 0 9.001241592365705e-12
subunit O 0 2.15374810000335e-12
was O 0 1.1510721195651108e-11
not O 0 5.112569222143204e-12
detected O 0 1.171523877907532e-09
. O 0 1.7342283165078243e-10

When O 0 8.692705301231729e-13
the O 0 4.4747322167082437e-13
W474C O 0 9.775569242975735e-11
- O 0 3.845542794248501e-14
containing O 0 3.9613864823621707e-16
alpha O 0 8.60115900520235e-16
- O 0 3.0871219023096775e-15
subunit O 0 1.9715981455006035e-15
was O 0 1.0800716332588778e-13
transiently O 0 1.9258135364186302e-10
co O 0 3.1898873191320287e-13
- O 0 3.1763830389726355e-14
expressed O 0 2.2893807668714202e-15
with O 0 2.2085209503186056e-17
the O 0 1.7426259757373345e-15
beta O 0 3.1750246522351238e-15
- O 0 8.545164833432921e-17
subunit O 0 8.705890658663404e-18
to O 0 2.0144995172460866e-15
produce O 0 8.386411140190453e-13
Hex O 0 4.6242494278203594e-09
A O 0 1.4512604451510924e-08
( O 0 2.6923182785834956e-14
alphabeta O 0 2.0264184996676704e-08
) O 0 3.4855662006981003e-15
in O 0 2.9934013167504103e-12
COS O 0 8.806458140497853e-08
- O 0 1.239723462775899e-10
7 O 0 8.108259072839297e-13
cells O 0 5.653840568463353e-13
, O 0 6.277157884194279e-16
the O 0 7.75865577839173e-15
mature O 0 5.160722977431975e-12
alpha O 0 2.0656743256555234e-14
- O 0 5.5733859910013506e-14
subunit O 0 7.942494962230855e-15
was O 0 2.7522686278473596e-13
present O 0 3.1532426409547343e-12
, O 0 3.4111024755137907e-15
but O 0 3.130525776351119e-15
its O 0 6.441457288489669e-15
level O 0 1.2942814354988119e-11
was O 0 2.5477588246579363e-13
much O 0 1.1774354278029642e-13
lower O 0 3.146344133581752e-13
than O 0 1.5816693869682833e-15
that O 0 3.941054991710548e-15
from O 0 5.4627162168752186e-12
normal O 0 1.1554710077632535e-08
alpha O 0 9.568335013199203e-11
- O 0 2.4908949902702204e-10
subunit O 0 3.2642395730864138e-12
transfections O 0 1.1102565089515792e-08
, O 0 8.056899467251757e-15
although O 0 2.2390276227724675e-15
higher O 0 9.131479345456453e-14
than O 0 4.3992780315465124e-17
in O 0 2.4191936482358253e-15
those O 0 1.5539058280671265e-14
cells O 0 2.3964276743559942e-12
transfected O 0 1.546165973032032e-10
with O 0 4.664416469984511e-15
an O 0 1.9390932137980724e-14
alpha O 0 4.396552566454659e-13
- O 0 2.676878033472385e-12
subunit O 0 1.0604227999172489e-12
associated O 0 2.288539635575404e-10
with O 0 1.4639725542942017e-10
infantile O 1 0.9642694592475891
TSD B-Disease 0 0.0001388323144055903
. O 0 1.8046205640942503e-09

Furthermore O 0 1.6491665810747236e-09
, O 0 5.9752634833315846e-15
the O 0 2.1527672697317472e-15
precursor O 0 1.839978093932243e-13
level O 0 1.1137204873612472e-11
of O 0 1.9977203485205264e-12
the O 0 4.390688333744119e-12
W474C O 0 8.711507626379955e-10
alpha O 0 1.8409900340299323e-12
- O 0 2.3835451841425215e-12
subunit O 0 1.0717032865531842e-13
was O 0 3.6077420890144596e-13
found O 0 1.4271331173570066e-14
to O 0 3.308597089335917e-14
accumulate O 0 1.1357201393528624e-13
in O 0 5.4959838661713684e-15
comparison O 0 4.3172261013531277e-13
to O 0 5.080923745973132e-13
the O 0 9.613514845296933e-12
normal O 0 1.5672632969199185e-08
alpha O 0 8.909878390639392e-11
- O 0 6.758874709911211e-11
subunit O 0 1.4735752548733494e-11
precursor O 0 1.766100321543007e-10
levels O 0 1.2298019269607607e-09
. O 0 4.741905201832708e-10

We O 0 2.8481321467932474e-11
conclude O 0 6.935067520252858e-10
that O 0 4.075070850559229e-15
the O 0 1.5656811106932664e-14
1422 O 0 3.641885751304308e-11
G O 0 9.807949591378318e-12
- O 0 7.683183950168981e-11
- O 0 1.943309749230515e-11
> O 0 3.693524219111621e-12
C O 0 9.309140264202043e-12
mutation O 0 1.5311070257313588e-15
is O 0 6.709831669064503e-19
the O 0 3.37009825904681e-17
cause O 0 1.7720945153995582e-12
of O 0 6.856007428446276e-11
Hex B-Disease 0 2.4203220164054073e-05
A I-Disease 1 0.9233986139297485
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.006532605682622e-11
the O 0 1.9872713197255365e-10
proband O 0 2.63607171291369e-06
. O 0 5.2330890731866475e-09

The O 0 1.0119440875533403e-11
resulting O 0 4.3036958545517034e-12
W474C O 0 6.791698453634254e-11
substitution O 0 6.499744752835879e-12
clearly O 0 1.074253750191212e-12
interferes O 0 1.3813629060055455e-11
with O 0 6.499093391275704e-14
alpha O 0 4.700502682399021e-13
- O 0 2.331493559413339e-13
subunit O 0 4.025991644012947e-14
processing O 0 1.0015099860538612e-11
, O 0 9.902210214863326e-17
but O 0 2.8701221726789336e-17
because O 0 3.275532655314033e-17
the O 0 5.361625911891115e-16
base O 0 2.450262012059813e-14
substitution O 0 1.857121444473475e-12
falls O 0 1.1999704181697712e-11
at O 0 2.431960340575079e-13
the O 0 2.8336778453222355e-13
first O 0 1.462040905009232e-11
position O 0 2.4979425194970872e-09
of O 0 2.0720840598897894e-09
exon O 0 1.7928732942706915e-09
13 O 0 2.1429692742547246e-10
, O 0 4.956772297302903e-13
aberrant O 0 1.0724118641725067e-11
splicing O 0 5.116151599593444e-11
may O 0 5.057566778571276e-12
also O 0 1.862619081324443e-13
contribute O 0 1.088661272241609e-09
to O 0 8.24824368805821e-08
Hex B-Disease 0 0.003219237318262458
A I-Disease 0 5.135545870871283e-05
deficiency I-Disease 0 1.4158364365357556e-06
in O 0 5.6794052967490405e-12
this O 0 3.4459095733102574e-12
proband O 0 8.923718297637606e-08
. O 0 1.6957157900066022e-11
. O 0 5.548853043713109e-10

Two O 0 1.7589028844522403e-10
frequent O 0 1.571191787785864e-10
missense O 0 3.494718470165026e-08
mutations O 0 4.157946431604387e-09
in O 0 1.2335989119094393e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.8953738251402683e-07

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 3.096677358982447e-10
an O 0 1.3465869130868668e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 3.087772550668111e-13
by O 0 3.454836253998937e-18
early O 0 2.3627254666647168e-11
childhood O 1 0.9999752044677734
deafness B-Disease 1 1.0
and O 1 0.9999982118606567
goiter B-Disease 1 1.0
. O 0 4.268742122803815e-05

A O 0 1.9657415972762493e-10
century O 0 3.856805554178916e-13
after O 0 4.467197553710556e-15
its O 0 4.3120660634593316e-17
recognition O 0 7.05969625206665e-13
as O 0 1.561026969579965e-13
a O 0 1.4861677166688736e-10
syndrome O 0 7.548879854546442e-10
by O 0 1.5874335944051146e-14
Vaughan O 0 1.138413918688741e-09
Pendred O 0 6.619388386752689e-06
, O 0 4.4987861228191e-14
the O 0 1.5657325425338237e-13
disease O 0 9.223381607081915e-13
gene O 0 1.2151906508774037e-14
( O 0 1.9800547106877536e-15
PDS O 0 6.191474000161179e-08
) O 0 4.144109964991085e-15
was O 0 2.9032193316069765e-12
mapped O 0 8.613554314251815e-12
to O 0 1.3059884770849628e-11
chromosome O 0 1.5126850883007137e-09
7q22 O 0 2.6655375222617295e-06
- O 0 1.0122202098727939e-07
q31 O 0 2.991798453422234e-07
. O 0 5.517887258221776e-10

1 O 0 1.1820906753445826e-10
and O 0 1.842138420971029e-12
, O 0 6.479635350411378e-14
recently O 0 2.242774244315751e-13
, O 0 7.332948454046506e-16
found O 0 2.733400731778045e-15
to O 0 3.4746570854934933e-13
encode O 0 2.987837199874832e-10
a O 0 5.476126774262013e-10
putative O 0 3.7794634977217356e-07
sulfate O 0 1.307631123381725e-07
transporter O 0 7.803278094797861e-07
. O 0 3.312989349524287e-08

We O 0 1.8125457731943406e-11
performed O 0 2.724306674348198e-12
mutation O 0 3.33710415258235e-14
analysis O 0 4.311800889207282e-14
of O 0 3.6696896064426776e-13
the O 0 4.343079281626805e-12
PDS B-Disease 0 6.800742085033562e-07
gene O 0 1.2846593363743941e-12
in O 0 6.777857897329043e-13
patients O 0 2.8250988787920095e-12
from O 0 5.742766830650614e-13
14 O 0 1.3600323992002394e-11
Pendred B-Disease 0 7.350607944545118e-08
families O 0 1.5348754168684198e-12
originating O 0 5.550798015674374e-11
from O 0 2.9727801709004964e-13
seven O 0 3.922942266171292e-12
countries O 0 2.222912392352283e-12
and O 0 1.8093187538481548e-12
identified O 0 2.3266681636879838e-10
all O 0 3.2138298966533085e-11
mutations O 0 1.4577263840465093e-09
. O 0 3.912456580934531e-09

The O 0 2.7655649992297526e-10
mutations O 0 1.4791761565602357e-11
include O 0 2.1200973106001025e-13
three O 0 9.243704976805156e-13
single O 0 5.819106307924926e-11
base O 0 1.185261111480429e-09
deletions O 0 2.062588988493985e-09
, O 0 7.636832247311098e-13
one O 0 3.390105470651994e-12
splice O 0 1.4157808436721098e-07
site O 0 4.2259526433774397e-10
mutation O 0 7.019677200625907e-11
and O 0 4.290786476124353e-12
10 O 0 4.212330484421045e-09
missense O 0 2.9704608550673584e-06
mutations O 0 5.668594482699518e-08
. O 0 2.7566255056399314e-08

One O 0 3.736070564031024e-09
missense O 0 1.8047562377887516e-07
mutation O 0 1.554816136950521e-10
( O 0 6.219352967741856e-14
L236P O 0 5.1176400894803464e-09
) O 0 9.911743226577539e-15
was O 0 1.4371567087431703e-12
found O 0 9.624623282600622e-14
in O 0 1.5335892346074638e-14
a O 0 1.202299165174031e-13
homozygous O 0 2.6054091609856167e-12
state O 0 1.7359498441591598e-13
in O 0 1.742252311387818e-13
two O 0 1.6506525963785879e-12
consanguineous O 0 1.0915966868196847e-06
families O 0 2.3956657838053452e-11
and O 0 5.724175473897919e-13
in O 0 1.5235874627900214e-12
a O 0 1.1527391454574376e-12
heterozygous O 0 1.903796347998976e-12
state O 0 3.9525015747311765e-13
in O 0 6.263664717107154e-13
five O 0 1.2068816432342366e-11
additional O 0 4.631111466535387e-11
non O 0 6.074569114389305e-08
- O 0 2.997521164616046e-08
consanguineous O 0 1.111837354983436e-05
families O 0 1.1533171084820992e-09
. O 0 7.700825754852758e-09

Another O 0 4.5270391879626e-09
missense O 0 2.433997394746257e-07
mutation O 0 6.251604789397902e-11
( O 0 1.792786737478142e-14
T416P O 0 1.4837100437148365e-09
) O 0 1.9762214630849543e-15
was O 0 3.2112715806810466e-13
found O 0 6.132841765893807e-14
in O 0 7.400029651820784e-15
a O 0 5.617645156561282e-14
homozygous O 0 7.913409511006719e-13
state O 0 5.890937287674272e-14
in O 0 2.8565946266420617e-13
one O 0 3.149257764289981e-12
family O 0 6.647665490994159e-12
and O 0 1.58776447935563e-13
in O 0 2.764632598371841e-13
a O 0 4.0972089544906443e-13
heterozygous O 0 8.187344574007993e-13
state O 0 8.121131669707946e-14
in O 0 2.013648715002217e-13
four O 0 7.262837033172875e-12
families O 0 4.438263298545131e-11
. O 0 3.825894268061347e-09

Pendred B-Disease 0 0.0008452574256807566
patients O 0 2.9987778926710007e-09
in O 0 1.1940184084513472e-11
three O 0 5.037044392697254e-11
non O 0 9.052666172237878e-09
- O 0 4.17539669506084e-10
consanguineous O 0 1.3205894333623291e-07
families O 0 6.854600979704084e-13
were O 0 6.663501808711406e-14
shown O 0 5.809928276326315e-13
to O 0 8.567802500455968e-13
be O 0 8.626143961458499e-13
compound O 0 2.1690903240223491e-10
heterozygotes O 0 3.619659461051583e-09
for O 0 1.8761343173467893e-11
L236P O 0 3.3944868960134045e-07
and O 0 8.502416826150494e-11
T416P O 0 1.288364501306205e-06
. O 0 4.6448280777156015e-09

In O 0 7.108223037954886e-11
total O 0 7.664481826985536e-10
, O 0 2.3110297855087614e-13
one O 0 1.116739825070788e-13
or O 0 2.117995720214011e-13
both O 0 2.561061172162704e-12
of O 0 7.348112569804943e-12
these O 0 2.567452272918963e-13
mutations O 0 4.216051878273841e-13
were O 0 9.036448889512827e-13
found O 0 1.634289491930785e-13
in O 0 4.6890920643973336e-14
nine O 0 8.864805417507782e-11
of O 0 1.176148241299746e-11
the O 0 5.144938728524062e-12
14 O 0 4.1147873303115645e-11
families O 0 1.484481287894468e-11
analyzed O 0 2.20047779997401e-09
. O 0 9.053080951559878e-09

The O 0 4.285460332952018e-13
identification O 0 1.6090129228985006e-10
of O 0 3.922928995536701e-11
two O 0 2.1439372846487892e-11
frequent O 0 3.681627225304851e-10
PDS B-Disease 0 6.03483158556628e-07
mutations O 0 5.113476048840271e-12
will O 0 7.721294171527879e-14
facilitate O 0 1.1387304293952738e-10
the O 0 4.0941859277832116e-13
molecular O 0 8.319919059252001e-11
diagnosis O 0 1.0947379450954031e-05
of O 0 3.1454229088012653e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.6339483011051925e-07

Insertional O 0 5.806204171676654e-06
mutation O 0 2.3776708032996474e-11
by O 0 8.597034081804164e-14
transposable O 0 2.0712906945163923e-08
element O 0 6.411858821664396e-10
, O 0 9.013727264584048e-13
L1 O 0 1.1298567414996796e-06
, O 0 1.0667917490678712e-14
in O 0 1.8336779306332013e-14
the O 0 3.088068863121851e-12
DMD B-Disease 1 1.0
gene O 0 1.1753178725398827e-12
results O 0 8.286762660618396e-13
in O 0 1.6875387805898034e-12
X B-Disease 0 0.0012483615428209305
- I-Disease 0 0.0341683067381382
linked I-Disease 0 5.2207040425855666e-05
dilated I-Disease 1 0.9810402393341064
cardiomyopathy I-Disease 1 1.0
. O 0 1.2645132301258855e-06

X B-Disease 0 0.03739003464579582
- I-Disease 1 0.9726703763008118
linked I-Disease 0 9.47609714785358e-06
dilated I-Disease 1 0.9385411739349365
cardiomyopathy I-Disease 1 1.0
( O 0 2.939831017512162e-11
XLDCM B-Disease 1 0.9999966621398926
) O 0 1.4263540376279458e-15
is O 0 2.887913835038214e-17
a O 0 8.142201614270896e-16
clinical O 0 4.0369663449786597e-13
phenotype O 0 1.589556958281335e-11
of O 0 2.4818359173339744e-11
dystrophinopathy B-Disease 0 5.4106511271356794e-08
which O 0 6.941643711667195e-14
is O 0 1.2322236152379168e-15
characterized O 0 1.1263828038961688e-14
by O 0 1.3164931655668816e-14
preferential O 0 5.841155115149377e-08
myocardial B-Disease 0 0.4973979890346527
involvement I-Disease 0 5.39497468921013e-09
without O 0 1.2044831278201773e-11
any O 0 4.366400632987294e-13
overt O 0 8.545072635590678e-12
clinical O 0 4.954215857000399e-11
signs O 0 4.661971156338929e-11
of O 0 7.053411188451264e-09
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 4.194825123704504e-06

To O 0 1.9581714028049646e-10
date O 0 1.719365205765655e-09
, O 0 1.5271596107927637e-13
several O 0 6.812706323557072e-14
mutations O 0 1.3627641549940339e-11
in O 0 4.225037854299618e-12
the O 0 1.0177449105697178e-08
Duchenne B-Disease 0 0.00013255089288577437
muscular I-Disease 0 2.1947130335320253e-06
dystrophy I-Disease 0 0.03225483372807503
gene O 0 1.6125730439853214e-07
, O 0 1.145005645852848e-09
DMD O 1 1.0
, O 0 5.37527661270687e-12
have O 0 1.1735829525522622e-14
been O 0 5.107853887981661e-15
identified O 0 2.3421089490028267e-14
in O 0 1.2975867125578078e-14
patients O 0 2.0273141347094958e-13
with O 0 2.743332633541734e-13
XLDCM B-Disease 1 0.9909635782241821
, O 0 1.2485305758008769e-12
but O 0 5.046595533499988e-14
a O 0 4.233866742983129e-14
pathogenic O 0 2.5635437782972614e-12
correlation O 0 3.6061268988279993e-12
of O 0 5.714739120289691e-13
these O 0 2.9714764177880826e-13
cardiospecific O 0 5.4497468759961976e-09
mutations O 0 3.27063549854234e-11
in O 0 9.912344382800864e-12
DMD O 1 1.0
with O 0 3.935862920301236e-12
the O 0 2.406002064248014e-10
XLDCM B-Disease 1 0.9996342658996582
phenotype O 0 4.9751221808946866e-08
has O 0 1.8523729642186404e-13
remained O 0 1.0080648121801872e-10
to O 0 1.932557065764673e-11
be O 0 1.9616629154395326e-10
elucidated O 0 3.236242946513812e-06
. O 0 3.5348072913166106e-08

We O 0 5.253295368157218e-11
report O 0 1.1760304373126945e-13
here O 0 2.361603031119058e-15
the O 0 2.139781116449816e-16
identification O 0 5.439427120529361e-12
of O 0 1.9783326452721406e-12
a O 0 4.039464075733523e-12
unique O 0 3.003216425545574e-11
de O 0 1.678238520375075e-10
novo O 0 2.8352675762732815e-09
L1 O 0 4.562033950605837e-07
insertion O 0 5.273708136854793e-10
in O 0 2.0739009468084824e-11
the O 0 2.3698529250104627e-10
muscle O 0 1.8819781288925697e-09
exon O 0 5.675079295386354e-10
1 O 0 2.767836524211753e-12
in O 0 1.878716279768433e-11
DMD O 1 1.0
in O 0 7.510401328625349e-11
three O 0 1.4297733830215265e-10
XLDCM B-Disease 1 0.7319855093955994
patients O 0 2.7122588897032784e-11
from O 0 3.731305629056658e-13
two O 0 2.4743512902665465e-13
unrelated O 0 3.084897268190723e-11
Japanese O 0 5.016528858980962e-10
families O 0 3.022000358288146e-11
. O 0 2.51816323348919e-09

The O 0 5.308178202545477e-11
insertion O 0 5.115158852042612e-10
was O 0 1.1915249169269782e-11
a O 0 1.244778368922339e-12
5 O 0 1.058579873064458e-12
- O 0 4.871852704244062e-13
truncated O 0 2.918966283960156e-12
form O 0 2.625020968823055e-13
of O 0 3.4258039113832517e-12
human O 0 1.9270397777493287e-11
L1 O 0 8.76229151458574e-08
inversely O 0 8.377674942661173e-11
integrated O 0 4.679372445082208e-10
in O 0 4.2470039529445003e-13
the O 0 3.4149094142732483e-12
5 O 0 1.1494513674215057e-10
- O 0 2.2991548664919037e-09
untranslated O 0 4.134643677389249e-05
region O 0 2.44391107351305e-09
in O 0 5.328270376997457e-12
the O 0 2.777245794449712e-11
muscle O 0 7.86034640154476e-11
exon O 0 2.9872999907087916e-11
1 O 0 1.742983470227888e-13
, O 0 2.9740703206637773e-15
which O 0 7.776044623645031e-16
affected O 0 3.562936621084867e-13
the O 0 8.517742311172152e-14
transcription O 0 1.7885533548991916e-12
or O 0 1.1972737525792893e-13
the O 0 4.588694008100802e-12
stability O 0 1.861810460468405e-06
of O 0 7.739106577808741e-10
the O 0 5.218910026361101e-11
muscle O 0 8.099039494613436e-11
form O 0 4.8551686976372466e-11
of O 0 4.13457545977991e-10
dystrophin O 0 6.940735097771267e-09
transcripts O 0 7.634877730033907e-10
but O 0 5.028721105433849e-15
not O 0 1.2627930343043245e-15
that O 0 4.333226164091606e-15
of O 0 7.270546664717159e-11
the O 0 2.893400630199494e-09
brain O 0 0.000325705244904384
or O 0 1.5453374690999055e-10
Purkinje O 0 1.0835242392204236e-06
cell O 0 4.075720649865389e-09
form O 0 2.7915067479789e-10
, O 0 7.38100661319685e-13
probably O 0 4.143596923911197e-11
due O 0 1.3505572216132578e-09
to O 0 1.9748839716338118e-11
its O 0 7.975992370908014e-13
unique O 0 2.002951970947464e-11
site O 0 1.6962989346502866e-10
of O 0 3.345017665634664e-11
integration O 0 1.9024753328267252e-08
. O 0 1.9747814050674606e-08

We O 0 3.669721124199832e-11
speculate O 0 4.797961507263526e-12
that O 0 3.6547059615356855e-17
this O 0 3.2437640228827704e-16
insertion O 0 1.8308080745876865e-11
of O 0 1.8023414358192547e-11
an O 0 9.261317841097183e-13
L1 O 0 1.920524255183409e-06
sequence O 0 7.387027795013879e-11
in O 0 1.55432083870366e-10
DMD O 1 1.0
is O 0 5.199152740276158e-13
responsible O 0 9.739565924593574e-13
for O 0 2.593052115802512e-14
some O 0 1.92235884972729e-15
of O 0 1.5487838198350798e-14
the O 0 1.0403279834000998e-14
population O 0 8.391726932620172e-16
of O 0 2.8203298173306223e-15
Japanese O 0 1.9197905418155692e-11
patients O 0 8.474932452866291e-13
with O 0 6.379728559671727e-13
XLDCM B-Disease 0 0.0001904560049297288
. O 0 9.4176610954122e-10
. O 0 1.1065061755743955e-08

Severe O 0 1.4840002222626936e-06
early O 0 0.0006302407709881663
- O 1 0.9995100498199463
onset O 1 0.9999417066574097
obesity B-Disease 1 1.0
, O 0 9.029183650755002e-12
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 9.332532080463807e-09
red O 0 7.71849045122508e-06
hair O 1 0.9999996423721313
pigmentation O 0 0.00031331132049672306
caused O 0 1.1234107688551376e-07
by O 0 1.8418241931605905e-10
POMC O 0 0.0001589661551406607
mutations O 0 3.623776612116103e-09
in O 0 8.029665474196257e-12
humans O 0 1.408116956369554e-10
. O 0 3.4511751789700895e-10

Sequential O 0 1.4524060842902031e-09
cleavage O 0 4.546688303630475e-10
of O 0 2.7521556214549214e-11
the O 0 5.439154443682981e-13
precursor O 0 1.1012360728174242e-12
protein O 0 1.0544804639927088e-13
pre O 0 6.978479599739629e-11
- O 0 3.008318941177812e-11
pro O 0 8.020064612423994e-09
- O 0 3.9673150098451515e-08
opiomelanocortin O 0 2.5179517137985385e-07
( O 0 1.0729824799452924e-15
POMC O 0 1.0906251457498684e-09
) O 0 4.0989985651722076e-17
generates O 0 1.6687095397160696e-15
the O 0 9.5553668195145e-15
melanocortin O 0 1.8810154822634928e-10
peptides O 0 1.4672509734969807e-11
adrenocorticotrophin O 0 9.773677867030983e-09
( O 0 1.1333997095345182e-14
ACTH O 0 3.5576879220400315e-09
) O 0 7.726285567279459e-15
, O 0 7.447949863185338e-14
melanocyte O 0 5.745717501781655e-08
- O 0 9.516185883740036e-08
stimulating O 0 1.2439400620678498e-09
hormones O 0 9.076759482917751e-11
( O 0 9.911775202071297e-16
MSH O 0 1.8739501617126564e-10
) O 0 3.559220863833994e-17
alpha O 0 3.7068411703114327e-16
, O 0 2.542961817938493e-17
beta O 0 1.0767959281529496e-15
and O 0 3.6677945396297856e-16
gamma O 0 1.8484744950789025e-15
as O 0 6.277062063592121e-16
well O 0 6.785055356510429e-15
as O 0 1.0793909194659816e-15
the O 0 7.296847994537822e-14
opioid O 0 8.057157371843537e-12
- O 0 4.320175131262288e-13
receptor O 0 9.616359967980388e-15
ligand O 0 1.8063061463235996e-11
beta O 0 3.080843136160638e-09
- O 0 7.88907250637294e-09
endorphin O 0 1.5489841587168485e-07
. O 0 1.8004560342621545e-10

While O 0 8.452534505654086e-11
a O 0 3.64180040290929e-12
few O 0 1.7576693952300187e-13
cases O 0 1.5719626392674685e-13
of O 0 3.3691141543279457e-10
isolated O 0 2.2130730314984248e-07
ACTH B-Disease 1 0.7161501049995422
deficiency I-Disease 0 1.4482580809271894e-05
have O 0 3.1747491462987e-13
been O 0 4.378910970805061e-13
reported O 0 1.3072022631011038e-11
( O 0 3.7350775006520995e-14
OMIM O 0 1.1856023718337383e-07
201400 O 0 1.4099297729330829e-08
) O 0 3.3243619987875783e-13
, O 0 1.353120740454905e-12
an O 0 2.8340753355227122e-11
inherited O 1 0.998993456363678
POMC O 1 0.9999996423721313
defect O 1 0.9999173879623413
has O 0 7.80815895880943e-13
not O 0 1.7697158300432336e-13
been O 0 1.250572995853405e-12
described O 0 8.542624073404337e-13
so O 0 3.308895041645443e-13
far O 0 1.2330701563978419e-11
. O 0 3.1824173851724424e-10

Recent O 0 1.1280233691568498e-10
studies O 0 1.7029491965886434e-12
in O 0 5.3826957505749475e-15
animal O 0 1.0475598660004623e-14
models O 0 2.85855527074573e-14
elucidated O 0 1.124676254904422e-10
a O 0 4.862744863894097e-13
central O 0 1.2535283921977225e-10
role O 0 1.5904272690492327e-11
of O 0 9.0188354562315e-09
alpha O 0 4.199840031304802e-09
- O 0 7.713001082265691e-08
MSH O 0 9.512988867754757e-07
in O 0 2.3801368319829874e-13
the O 0 1.168807482439596e-13
regulation O 0 2.681148488989371e-13
of O 0 8.14121651495324e-14
food O 0 1.3631391005655864e-14
intake O 0 1.2191174479752714e-16
by O 0 4.5712761364974705e-19
activation O 0 1.1014708025877673e-13
of O 0 2.4169386977912488e-11
the O 0 1.5218704074726475e-09
brain O 0 2.6253690066369018e-06
melanocortin O 0 9.92202870975234e-08
- O 0 2.396275844418483e-09
4 O 0 1.7174494465477252e-11
- O 0 5.956898169179325e-11
receptor O 0 1.2892409816318059e-14
( O 0 3.2999527475322725e-16
MC4 O 0 1.3072769888822222e-07
- O 0 1.4707435269656344e-09
R O 0 3.9914911653671226e-11
; O 0 6.262305690859767e-16
refs O 0 8.997589479031731e-11
3 O 0 1.001126942847333e-13
- O 0 5.0412754889648734e-14
5 O 0 3.366924201600322e-17
) O 0 6.589694283342774e-20
and O 0 1.5156644396792624e-18
the O 0 1.0581178987539267e-15
linkage O 0 1.344272887449094e-10
of O 0 1.0101020497463309e-12
human O 0 1.7866536028421365e-09
obesity B-Disease 1 1.0
to O 0 2.630864415209544e-10
chromosome O 0 8.198510620394117e-11
2 O 0 2.9326608416008204e-12
in O 0 1.3735546554316524e-11
close O 0 4.654390650671303e-08
proximity O 0 3.0896892155851674e-08
to O 0 1.5192138658193244e-09
the O 0 7.013849057102561e-09
POMC O 0 4.690565219789278e-06
locus O 0 3.5768868422714206e-10
, O 0 1.8352569355721549e-13
led O 0 1.419413225194413e-13
to O 0 1.6476414416849439e-13
the O 0 1.534775046852302e-13
proposal O 0 2.5981674494149343e-13
of O 0 4.1875690740510174e-13
an O 0 4.791819881427156e-14
association O 0 3.607977631936432e-12
of O 0 3.0093477709769445e-10
POMC O 0 2.2239986719796434e-05
with O 0 2.5780197421276796e-11
human O 0 2.533016640882124e-07
obesity B-Disease 1 1.0
. O 0 1.134917493317289e-08

The O 0 1.20349797835817e-11
dual O 0 4.0722453187314045e-10
role O 0 1.562557583323354e-10
of O 0 1.4074583987166989e-07
alpha O 0 2.338027726977998e-08
- O 0 3.240200499021739e-07
MSH O 0 1.3166162716515828e-05
in O 0 2.454310409419347e-12
regulating O 0 6.100438296879895e-12
food O 0 3.1049956442791293e-12
intake O 0 6.200064333466981e-12
and O 0 5.3012495516415944e-14
influencing O 0 2.020848732797731e-08
hair O 0 3.7178110687818844e-06
pigmentation O 0 5.667956415322806e-08
predicts O 0 2.7702926758133017e-12
that O 0 2.7949982911913576e-16
the O 0 1.4699994219384734e-14
phenotype O 0 2.263873333588351e-12
associated O 0 1.428125738327235e-12
with O 0 6.699502741848787e-14
a O 0 4.920305135547309e-11
defect O 0 1.547640522403526e-07
in O 0 3.400377895923512e-11
POMC O 0 1.850832745731168e-06
function O 0 1.8107015886670297e-10
would O 0 2.3570930363786546e-12
include O 0 1.9929146874431147e-11
obesity B-Disease 1 1.0
, O 0 2.075354997447057e-13
alteration O 0 6.33416732398473e-08
in O 0 1.9966289732664677e-10
pigmentation O 0 0.3416597843170166
and O 0 3.6629014488198663e-08
ACTH B-Disease 1 0.9999957084655762
deficiency I-Disease 0 0.3911445438861847
. O 0 1.7565813692499432e-08

The O 0 3.4432637296966107e-11
observation O 0 2.04850603147122e-09
of O 0 5.303135968554029e-12
these O 0 1.649201825451585e-12
symptoms O 0 1.3084706651511624e-09
in O 0 1.3191941029139231e-12
two O 0 1.534483998200109e-11
probands O 0 1.4829134897809126e-07
prompted O 0 4.872635281372162e-12
us O 0 5.035992239540987e-13
to O 0 5.3000041855266744e-11
search O 0 7.743894414602437e-09
for O 0 7.551885505829858e-11
mutations O 0 1.1141465527941818e-09
within O 0 1.0172650499740143e-09
their O 0 3.1172364689524557e-09
POMC O 0 3.27898669638671e-05
genes O 0 4.995249103245669e-09
. O 0 8.359965164572714e-09

Patient O 0 0.004412555135786533
1 O 0 4.195920347283e-11
was O 0 1.035787016052947e-12
found O 0 7.119525373975102e-15
to O 0 3.245778754275286e-14
be O 0 2.009101503328177e-14
a O 0 1.0679201663602034e-13
compound O 0 1.467388016651583e-11
heterozygote O 0 1.4503409584420979e-09
for O 0 1.5299241908073302e-12
two O 0 3.690075675577553e-11
mutations O 0 3.9255338563082276e-11
in O 0 6.055958512440895e-11
exon O 0 6.913803973773724e-10
3 O 0 1.4305637403844162e-11
( O 0 1.692463443697667e-13
G7013T O 0 2.0154983459974574e-08
, O 0 2.2439165868297362e-13
C7133delta O 0 8.645565152676227e-09
) O 0 1.2381362493168866e-16
which O 0 2.4048926351219593e-17
interfere O 0 1.3379967706700358e-12
with O 0 7.244642092921693e-16
appropriate O 0 3.0014855618293312e-12
synthesis O 0 7.954598091330922e-10
of O 0 2.9768304488086983e-10
ACTH O 0 4.6647801354993135e-07
and O 0 5.225386789931008e-10
alpha O 0 2.3757342759722633e-08
- O 0 2.8596036827366333e-07
MSH O 0 8.923409950511996e-06
. O 0 1.533830062960817e-09

Patient O 0 0.0001162202752311714
2 O 0 7.600551264752564e-12
was O 0 7.990061520399272e-13
homozygous O 0 8.975584625580194e-14
for O 0 5.441722512053784e-15
a O 0 9.369625030269252e-14
mutation O 0 2.74984807873465e-14
in O 0 5.364375935644483e-13
exon O 0 9.845007448161525e-11
2 O 0 5.187645452098266e-12
( O 0 6.249353519480888e-14
C3804A O 0 7.912007049526437e-09
) O 0 3.2865625860042805e-15
which O 0 8.26717793750648e-15
abolishes O 0 2.9363916853597516e-10
POMC O 0 1.8346146646308625e-07
translation O 0 1.4807310044773203e-08
. O 0 1.717867981199106e-08

These O 0 3.191592823359457e-12
findings O 0 1.8171617368386433e-13
represent O 0 5.3307351073486955e-14
the O 0 3.8003835714788166e-15
first O 0 8.885405262850764e-15
examples O 0 1.1733955549830116e-13
of O 0 1.2322490033564448e-12
a O 0 1.943329247522385e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 3.2184138687441077e-10
the O 0 3.244711357236474e-12
POMC O 0 3.603769016535807e-08
gene O 0 3.35136839070202e-13
and O 0 2.6722229301296557e-14
define O 0 2.1396936999984462e-10
a O 0 1.8830903503186391e-10
new O 0 6.496007620704347e-10
monogenic B-Disease 1 0.9999967813491821
endocrine I-Disease 0 0.0001228082546731457
disorder I-Disease 0 2.8748251779120437e-08
resulting O 0 3.3352938466624238e-12
in O 0 5.721684519406633e-14
early O 0 7.521628617723763e-07
- O 0 0.0001968849974218756
onset O 1 0.8092745542526245
obesity B-Disease 1 1.0
, O 0 6.005413180631969e-12
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 8.91561580118605e-09
red O 0 1.4043277474229399e-07
hair O 0 0.0012344480492174625
pigmentation O 0 4.79201275993546e-07
. O 0 2.264316095734742e-10
. O 0 1.551395456544924e-09

A O 0 1.2395519277674794e-08
European O 0 3.029578324320603e-11
multicenter O 0 8.017376984525981e-08
study O 0 1.1987928705270434e-10
of O 0 3.338636531680095e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 8.614437288501087e-13
classification O 0 7.045128369576048e-13
of O 0 9.190577986151194e-13
105 O 0 4.972932482472103e-11
mutations O 0 5.921231387151504e-13
and O 0 7.807648164060918e-14
a O 0 3.231504961623971e-13
general O 0 8.31422604374854e-14
system O 0 6.053050584636094e-14
for O 0 1.3232543519584548e-15
genotype O 0 8.988986855210102e-13
- O 0 9.336870605012107e-14
based O 0 2.8183507248493627e-15
prediction O 0 3.3463978810210904e-10
of O 0 1.0305300016111296e-11
metabolic O 0 1.227929202762823e-09
phenotype O 0 3.589297747907949e-10
. O 0 9.795694255743115e-10

Phenylketonuria B-Disease 0 0.000819081615190953
( O 0 6.206498531259597e-13
PKU B-Disease 0 1.8251144240366557e-07
) O 0 1.603147275304126e-13
and O 0 2.6573537207502662e-12
mild B-Disease 0 2.9652400712620874e-07
hyperphenylalaninemia I-Disease 1 1.0
( O 0 7.254616352092569e-11
MHP B-Disease 1 1.0
) O 0 4.561987723347705e-13
are O 0 9.797767659041126e-14
allelic B-Disease 0 2.2067783156387577e-09
disorders I-Disease 0 5.2330542676948255e-11
caused O 0 1.178239092663319e-14
by O 0 5.571932281293537e-17
mutations O 0 1.275214560717572e-15
in O 0 1.0440366112805344e-15
the O 0 1.2028948665051761e-14
gene O 0 7.085620339162407e-14
encoding O 0 4.755491556096558e-10
phenylalanine O 0 4.238681412971346e-06
hydroxylase O 0 5.892808621865697e-05
( O 0 2.3183255662417857e-11
PAH O 0 3.227940226224746e-08
) O 0 2.4476988903614216e-13
. O 0 1.2861194054192282e-10

Previous O 0 1.0281794970978808e-08
studies O 0 9.791070731957063e-12
have O 0 1.5423035307446397e-15
suggested O 0 4.282644321096894e-15
that O 0 2.7803641426663145e-17
the O 0 8.436443072455148e-15
highly O 0 1.0772088950006253e-11
variable O 0 6.647443706597755e-10
metabolic O 0 8.88941968923973e-08
phenotypes O 0 3.115559366051457e-07
of O 0 4.724622340290807e-05
PAH B-Disease 1 0.9999656677246094
deficiency I-Disease 1 0.9998685121536255
correlate O 0 0.000159994131536223
with O 0 8.39790126327955e-10
PAH O 0 0.0005863313563168049
genotypes O 0 9.659427746555593e-08
. O 0 4.735605241279472e-10

We O 0 6.627998150321446e-10
identified O 0 1.1965038682060225e-10
both O 0 2.392550133706317e-12
causative O 0 1.7936445731447925e-11
mutations O 0 4.559151992565569e-13
in O 0 5.962993364057659e-14
686 O 0 1.2570217089447056e-10
patients O 0 6.538489367990952e-12
from O 0 4.282392149224101e-11
seven O 0 1.5993603108555021e-09
European O 0 1.4874304010703554e-09
centers O 0 2.4265764952957625e-09
. O 0 1.9441570575651212e-09

On O 0 1.2188561271386789e-10
the O 0 1.4427285863378991e-13
basis O 0 3.4003828398854186e-12
of O 0 4.652361666485777e-14
the O 0 2.4124951846339962e-14
phenotypic O 0 3.91227154838969e-12
characteristics O 0 1.9171230575265596e-11
of O 0 3.6146193677089045e-11
297 O 0 9.342572271364702e-10
functionally O 0 1.6731175378481566e-07
hemizygous O 0 3.6031852346241067e-07
patients O 0 1.4461077300909064e-11
, O 0 7.232744879902796e-15
105 O 0 4.5294271805440545e-11
of O 0 7.183043656405763e-12
the O 0 1.082915267874851e-11
mutations O 0 5.456944032929123e-13
were O 0 2.1948606398081855e-13
assigned O 0 6.44487989451964e-13
to O 0 2.3316858426686293e-12
one O 0 2.4902037897012175e-12
of O 0 1.5117029156241912e-11
four O 0 3.4199869498874325e-12
arbitrary O 0 2.5558557006921667e-11
phenotype O 0 1.991752734964436e-10
categories O 0 1.782442249353977e-10
. O 0 2.8968296650333514e-09

We O 0 6.478421965550041e-11
proposed O 0 1.853497823972594e-12
and O 0 1.4746386213905852e-14
tested O 0 9.440343472222334e-13
a O 0 1.1286021149212698e-14
simple O 0 9.749145934989656e-15
model O 0 2.66716000244568e-15
for O 0 6.06056520683425e-16
correlation O 0 9.816398995748932e-14
between O 0 2.3543195388012195e-13
genotype O 0 2.4812443766286663e-11
and O 0 7.315636811611181e-13
phenotypic O 0 2.86364709722875e-10
outcome O 0 7.868653284504035e-08
. O 0 7.973882532041898e-08

The O 0 3.490205069400787e-10
observed O 0 1.456260459442582e-11
phenotype O 0 4.276254003676705e-11
matched O 0 6.34737609694902e-11
the O 0 4.087579233424954e-12
predicted O 0 1.0020186763659567e-10
phenotype O 0 1.0332481398256377e-11
in O 0 1.127724690431868e-13
79 O 0 2.821568811928188e-10
% O 0 9.979332638021532e-11
of O 0 3.6533336035191044e-13
the O 0 8.778709096463055e-14
cases O 0 1.6880716117474714e-14
, O 0 4.59951722908236e-15
and O 0 6.792824342702645e-15
in O 0 1.196575119804394e-13
only O 0 3.9286605110593065e-13
5 O 0 1.4855256781631798e-12
of O 0 1.90867569145603e-12
184 O 0 7.745422359040077e-11
patients O 0 3.287333946722093e-11
was O 0 5.3046660813960145e-11
the O 0 5.834896368156484e-12
observed O 0 4.272045391051638e-12
phenotype O 0 1.752171671642877e-11
more O 0 1.8351604076974858e-15
than O 0 1.916018596358855e-15
one O 0 2.0594310152079014e-14
category O 0 2.586256946449095e-13
away O 0 1.1304085922522744e-12
from O 0 1.23000351223701e-13
that O 0 8.297038051182856e-14
expected O 0 2.3469712839840895e-09
. O 0 1.9505391080087975e-08

Among O 0 1.175834846156576e-10
the O 0 3.3790921449838862e-12
seven O 0 3.128202774940747e-12
contributing O 0 5.033277180460649e-12
centers O 0 7.468951672418012e-13
, O 0 1.1105188244122055e-16
the O 0 7.523561783881298e-15
proportion O 0 8.665655541230388e-13
of O 0 5.003220060473268e-13
patients O 0 3.47573098774534e-13
for O 0 4.66924806111213e-12
whom O 0 1.1834742075222948e-09
the O 0 4.95541885303652e-10
observed O 0 3.871653692089083e-11
phenotype O 0 2.3705525389883242e-11
did O 0 1.7548365104785857e-12
not O 0 3.8379095366157523e-13
match O 0 3.119542402174602e-10
the O 0 5.755953352837295e-11
predicted O 0 8.402707973864665e-10
phenotype O 0 1.6395614033104522e-11
was O 0 5.756998339417202e-14
4 O 0 5.234483704233579e-14
% O 0 4.4067947533275864e-13
- O 0 1.3563732385521443e-13
23 O 0 4.0929285243136715e-13
% O 0 1.2096218124368896e-11
( O 0 8.880733198520299e-14
P O 0 2.088555639545575e-08
< O 0 2.0328232153143944e-10
. O 0 1.5906471018817259e-13
0001 O 0 1.0072032617658433e-11
) O 0 4.1987994942635064e-16
, O 0 1.5614655335939001e-16
suggesting O 0 7.743697176543218e-14
that O 0 3.910786322279975e-16
differences O 0 7.658070141566831e-13
in O 0 2.2009539153098603e-15
methods O 0 8.684224346577896e-12
used O 0 2.2745423166464773e-12
for O 0 5.476006800786415e-12
mutation O 0 7.699896831248054e-10
detection O 0 4.7233061195584014e-07
or O 0 1.704823837656022e-09
phenotype O 0 1.0994208210490797e-08
classification O 0 2.2900492266386685e-11
may O 0 5.817635327469428e-13
account O 0 3.44966947802422e-13
for O 0 4.987534297780198e-14
a O 0 5.892805232492193e-13
considerable O 0 1.4277259929862396e-11
proportion O 0 9.201247402890189e-12
of O 0 3.2372948072234564e-11
genotype O 0 5.80892333346128e-07
- O 0 2.963740598715958e-06
phenotype O 0 2.039241309148565e-07
inconsistencies O 0 6.649275405834487e-07
. O 0 2.687698774650471e-08

Our O 0 1.5862188007531586e-08
data O 0 1.570600594025251e-11
indicate O 0 3.6896920523228627e-13
that O 0 5.689466308356748e-16
the O 0 6.336435282722208e-13
PAH O 0 6.002911501212793e-10
- O 0 5.448166874241767e-13
mutation O 0 7.600060717479623e-15
genotype O 0 5.564424246894129e-13
is O 0 7.845014678421907e-17
the O 0 4.432653432539157e-15
main O 0 4.912126261302774e-12
determinant O 0 1.4227982680914408e-10
of O 0 1.4605588960492355e-10
metabolic O 0 3.071463083870185e-08
phenotype O 0 8.952623642421997e-10
in O 0 4.005980443200219e-12
most O 0 1.487553830115118e-11
patients O 0 5.626634713706835e-09
with O 0 4.14508924961865e-08
PAH B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999996423721313
. O 0 7.486547701773816e-07

In O 0 1.7989516126748484e-11
the O 0 1.3778967116601093e-12
present O 0 9.649332114586295e-13
study O 0 1.3739586759173392e-14
, O 0 1.0243543978527618e-16
the O 0 2.8737185157542977e-15
classification O 0 4.558335046228601e-13
of O 0 2.6527365373785194e-11
105 O 0 3.756175317448651e-07
PAH O 0 1.1319480108795688e-06
mutations O 0 9.476144174902501e-11
may O 0 1.5506586086792146e-13
allow O 0 3.2804409687801905e-13
the O 0 1.3171550438881297e-12
prediction O 0 2.0262900246592608e-09
of O 0 7.543603762483198e-12
the O 0 1.463226588505062e-11
biochemical O 0 9.294046782182264e-11
phenotype O 0 1.6247192480278727e-10
in O 0 6.858583839752797e-11
> O 0 6.423756526707791e-10
10 O 0 4.689526111184561e-12
, O 0 7.692145396120606e-14
000 O 0 9.278761092801346e-11
genotypes O 0 1.2797554127530475e-09
, O 0 1.6770998923377328e-13
which O 0 2.620835982318579e-15
may O 0 2.124026425391872e-14
be O 0 2.918490305653908e-14
useful O 0 2.1411093384382518e-11
for O 0 9.691990862214367e-14
the O 0 1.2253262640649076e-11
management O 0 8.740134171958402e-10
of O 0 4.0949965640635355e-10
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.9274342949747734e-09
newborns O 0 3.800324677172284e-08
. O 0 2.1164614505408963e-09

Somatic O 0 1.3427731573756319e-05
instability O 0 2.2772203010390513e-05
of O 0 2.0868202454948914e-07
the O 0 9.468569572845809e-08
CTG O 0 2.1348492737160996e-05
repeat O 0 1.2587473285918804e-09
in O 0 6.118722282316691e-12
mice O 0 2.2697924269288183e-12
transgenic O 0 7.30911338397977e-12
for O 0 5.910385164143231e-14
the O 0 9.347896762212926e-11
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 2.853411444903031e-07
is O 0 2.3475440883748144e-13
age O 0 9.465120527629711e-12
dependent O 0 1.0796320434880435e-11
but O 0 4.116129078611487e-15
not O 0 3.637574098137647e-15
correlated O 0 3.0441326542840486e-12
to O 0 3.590031917577452e-13
the O 0 1.8209444369032823e-12
relative O 0 3.138385329393145e-09
intertissue O 0 3.855370493965893e-07
transcription O 0 4.815507548272535e-09
levels O 0 1.1799158983194502e-08
and O 0 2.694594825047858e-10
proliferative O 0 1.3502403817255981e-05
capacities O 0 2.349441501792171e-06
. O 0 1.4839371509367538e-08

A O 0 9.231530384568032e-06
( O 0 3.5312623051370062e-12
CTG O 0 1.329500776137138e-07
) O 0 8.092908531905432e-15
nexpansion O 0 6.727430834629899e-10
in O 0 9.9954712475675e-14
the O 0 5.170523839810592e-13
3 O 0 1.2648421372773999e-11
- O 0 3.0420186369894964e-09
untranslated O 0 6.477704573626397e-06
region O 0 1.747433309162716e-10
( O 0 3.02269027653397e-16
UTR O 0 8.133845263991191e-10
) O 0 6.656047103506356e-17
of O 0 1.4097272340359707e-13
the O 0 1.1444460656928612e-10
DM O 1 1.0
protein O 0 1.0131661731804797e-08
kinase O 0 4.990028390494672e-10
gene O 0 1.0512844067500637e-11
( O 0 3.2757688028057716e-14
DMPK O 0 0.00020105302974116057
) O 0 9.647072112098408e-16
is O 0 4.240471265337152e-17
responsible O 0 3.677142479938979e-14
for O 0 2.1977343176663583e-13
causing O 0 1.70598170257108e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.016390884435509e-10
DM B-Disease 1 1.0
) O 0 3.2986380554128614e-12
. O 0 1.026816409677167e-10

Major O 0 4.5238476786835236e-07
instability O 0 1.2075765880581457e-05
, O 0 1.3352052753365373e-12
with O 0 5.278386777142485e-14
very O 0 3.212735795714988e-13
large O 0 8.759972388856611e-15
expansions O 0 4.450314682741263e-12
between O 0 1.3020407235025955e-12
generations O 0 9.671839718006225e-11
and O 0 3.6846987592174807e-13
high O 0 1.82778653323723e-11
levels O 0 1.2833920037813584e-10
of O 0 8.724023586870189e-11
somatic O 0 2.4552553323786697e-09
mosaicism O 0 8.926986794222103e-08
, O 0 2.6263431533724013e-13
is O 0 6.0206809664468865e-15
observed O 0 5.411143538455732e-13
in O 0 6.864129490496973e-12
patients O 0 4.877159232030692e-10
. O 0 7.70558639118235e-09

There O 0 5.870857272549657e-11
is O 0 2.0574091475628054e-14
a O 0 2.6992202418509026e-13
good O 0 1.4707280532322287e-11
correlation O 0 8.653273410319517e-12
between O 0 5.526845908015998e-12
repeat O 0 1.372217200978909e-10
size O 0 5.082554602880984e-12
( O 0 6.871087645930101e-15
at O 0 5.422808469629503e-13
least O 0 7.094857064045626e-14
in O 0 2.1298408999989582e-13
leucocytes O 0 9.250549659611806e-09
) O 0 1.85480089945865e-14
, O 0 5.8259904435204856e-15
clinical O 0 3.028061200220644e-13
severity O 0 5.265066269251328e-13
and O 0 8.50621148225459e-15
age O 0 2.379004632180326e-11
of O 0 1.9095150460834986e-10
onset O 0 7.94043231167052e-08
. O 0 1.4188700880879423e-08

The O 0 3.581823477816215e-07
trinucleotide O 0 0.0010925625683739781
repeat O 0 8.973049148153223e-07
instability O 0 1.2947816685482394e-06
mechanisms O 0 1.4145190574410549e-09
involved O 0 2.9443635030101944e-12
in O 0 7.524606805697776e-12
DM B-Disease 1 1.0
and O 0 5.072405169503913e-12
other O 0 3.2887169550133155e-13
human O 0 5.356184940019659e-10
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.1017469776802196e-15
unknown O 0 1.7210401506706496e-11
. O 0 1.327403464923549e-10

We O 0 2.6751416637438297e-09
studied O 0 6.563573573536985e-10
somatic O 0 4.67335370402111e-09
instability O 0 2.4714824631288934e-10
by O 0 2.4958455983360717e-14
measuring O 0 1.8140123084209314e-11
the O 0 3.4076218409506698e-12
CTG O 0 3.4939318993565394e-08
repeat O 0 2.1501290331515932e-11
length O 0 1.546648920047744e-11
at O 0 7.499528342086448e-13
several O 0 5.0752455759079176e-14
ages O 0 3.08426201245382e-11
in O 0 4.046803853390707e-13
various O 0 3.312933608001778e-11
tissues O 0 7.542461100129572e-10
of O 0 1.5103288064644005e-10
transgenic O 0 2.1306963138290058e-11
mice O 0 2.5485232413996473e-12
carrying O 0 1.2071148247638774e-10
a O 0 7.331628082418717e-10
( O 0 5.398003224965642e-12
CTG O 0 3.071996559356194e-07
) O 0 3.133456222357417e-13
55expansion O 0 8.128901995974047e-09
surrounded O 0 1.041316251976232e-11
by O 0 1.3301430168085899e-14
45 O 0 3.151711183702055e-11
kb O 0 1.2668794902026548e-08
of O 0 2.495987444506298e-11
the O 0 6.874899521197575e-12
human O 0 1.1404133193337884e-09
DM B-Disease 1 1.0
region O 0 8.639565507451152e-09
, O 0 7.201634206783093e-15
using O 0 4.639134671031997e-13
small O 0 5.813145971533817e-12
- O 0 1.0071692785329489e-10
pool O 0 1.721270626031668e-10
PCR O 0 1.0069007849722311e-09
. O 0 1.2342925570507646e-09

These O 0 1.2184261932723928e-10
mice O 0 3.971577840905516e-12
have O 0 6.918162243127587e-16
been O 0 2.815888241253017e-16
shown O 0 2.947978105998319e-15
to O 0 4.780326999585631e-14
reproduce O 0 1.2786323388969123e-10
the O 0 1.8645324000032826e-12
intergenerational O 0 8.672969187273338e-08
and O 0 3.407557005660755e-12
somatic O 0 1.6928073875988048e-07
instability O 0 3.0712848797520564e-07
of O 0 2.3118194025784078e-09
the O 0 2.5490034527564376e-09
55 O 0 1.0886289913969449e-07
CTG O 0 5.730204520659754e-06
repeat O 0 7.097470389183513e-10
suggesting O 0 7.276179658788351e-11
that O 0 4.257610431747383e-14
surrounding O 0 1.8396570725109918e-11
sequences O 0 4.3266592565649464e-12
and O 0 9.56723090507483e-13
the O 0 1.9265177994554072e-11
chromatin O 0 2.5227639977032368e-09
environment O 0 2.632587481343762e-09
are O 0 7.716494544035557e-14
involved O 0 3.835952042119395e-11
in O 0 1.3885355365506058e-10
instability O 0 1.9700662790000933e-07
mechanisms O 0 1.9327782752043277e-07
. O 0 6.732042923118797e-09

As O 0 4.9386371728243894e-12
observed O 0 2.1846612789210712e-13
in O 0 1.5883634671746104e-14
some O 0 2.7677004839441605e-15
of O 0 1.645675376570413e-13
the O 0 7.121351577009383e-13
tissues O 0 3.8899974907913304e-10
of O 0 6.419984543981627e-10
DM B-Disease 1 1.0
patients O 0 5.379114514925121e-11
, O 0 4.3588010533845284e-14
there O 0 1.4803142503569573e-14
is O 0 3.4685467147493605e-16
a O 0 2.2397761881396035e-14
tendency O 0 1.4080510845823624e-12
for O 0 1.2148344396417654e-13
repeat O 0 2.959647527056575e-10
length O 0 9.45982403521839e-10
and O 0 1.350305978142785e-11
somatic O 0 2.4774304829833227e-09
mosaicism O 0 5.940304692586551e-09
to O 0 5.385638766550183e-13
increase O 0 5.244089667719165e-13
with O 0 8.104706112673909e-16
the O 0 1.5048602826101681e-13
age O 0 1.2731416615396896e-11
of O 0 2.974437753391901e-12
the O 0 5.584650363682497e-12
mouse O 0 1.3721544733780178e-10
. O 0 1.7575355615306876e-09

Furthermore O 0 2.5356345911831113e-09
, O 0 3.1267919704163274e-14
we O 0 3.2048376708796334e-15
observed O 0 2.749610613047887e-15
no O 0 1.1290918746653282e-16
correlation O 0 2.0667449329492054e-15
between O 0 6.599572505237156e-15
the O 0 2.267851433989526e-14
somatic O 0 4.2121198196021226e-10
mutation O 0 9.543364709596602e-11
rate O 0 2.190836262405682e-10
and O 0 8.362380926607571e-11
tissue O 0 9.902177566800674e-08
proliferation O 0 8.148772963068041e-07
capacity O 0 1.0193577537620513e-07
. O 0 4.07639699773199e-09

The O 0 3.955624272578007e-09
somatic O 0 5.152550031084502e-08
mutation O 0 3.7648086037567197e-11
rates O 0 2.7917365684818063e-13
in O 0 9.138055073984225e-16
different O 0 1.1289471961439812e-13
tissues O 0 3.0729876976387516e-11
were O 0 7.36207102225439e-12
also O 0 4.239893297699549e-15
not O 0 1.2667499698932466e-14
correlated O 0 3.5181529998290495e-12
to O 0 1.481267474130743e-12
the O 0 1.867348289885662e-11
relative O 0 6.903044891259924e-08
inter O 0 2.8196885978104547e-05
- O 0 1.2462329834761476e-07
tissue O 0 1.0750512480228736e-08
difference O 0 1.8030670706492558e-11
in O 0 1.607908244212735e-14
transcriptional O 0 9.11444856220578e-13
levels O 0 1.246522308116782e-12
of O 0 1.7552372587065906e-13
the O 0 2.9462440516783706e-13
three O 0 2.4118992393573624e-12
genes O 0 2.4468972854851945e-12
( O 0 7.531749881975816e-14
DMAHP O 0 1.1301152881060261e-05
, O 0 6.429769043581057e-12
DMPK O 0 0.0004809961246792227
and O 0 1.805520837006025e-11
59 O 0 2.775490504092204e-09
) O 0 1.1287232406327272e-13
surrounding O 0 8.346123271663064e-12
the O 0 2.666146817209558e-12
repeat O 0 1.0491357088637798e-10
. O 0 1.4658746438911407e-11
. O 0 1.0271322681276729e-09

A O 0 4.60455229500667e-09
novel O 0 8.744572991062349e-13
missense O 0 2.703553603211617e-09
mutation O 0 2.71729058524961e-12
in O 0 8.223430888066458e-14
patients O 0 1.9468664961413973e-12
from O 0 4.5398705411300866e-13
a O 0 2.240534797623428e-12
retinoblastoma B-Disease 0 2.3613239363839966e-07
pedigree O 0 2.6393245367017926e-09
showing O 0 1.1194072752074291e-10
only O 0 9.86129255510504e-13
mild O 0 2.2116839609731542e-12
expression O 0 4.682402902911331e-12
of O 0 1.5346245108016632e-11
the O 0 2.173043862907509e-11
tumor B-Disease 0 1.6105520250775385e-09
phenotype O 0 4.400015352068465e-10
. O 0 1.314734876523005e-09

We O 0 8.756343740368155e-12
have O 0 7.349695354204907e-16
used O 0 1.604408118786223e-16
single O 0 3.1653259132308252e-15
strand O 0 2.8915285693164455e-14
conformation O 0 3.9004952425477496e-14
polymorphism O 0 1.01790832707227e-11
analysis O 0 1.7337327862416985e-13
to O 0 3.8817129306874254e-13
study O 0 1.2545030118882305e-12
the O 0 1.0457822758810909e-12
27 O 0 9.250280541550637e-10
exons O 0 6.894570958593249e-08
of O 0 7.895792353274089e-11
the O 0 1.6479761999477205e-11
RB1 O 0 1.5807158249003805e-08
gene O 0 2.5632868698162274e-14
in O 0 4.094845258229354e-15
individuals O 0 5.009116104353175e-15
from O 0 1.699842659208875e-13
a O 0 8.47876890225363e-12
family O 0 1.074655989197204e-11
showing O 0 1.839465912922833e-09
mild O 0 5.145333811795716e-11
expression O 0 5.6976472151415436e-11
of O 0 5.2977400244458295e-11
the O 0 7.866435280945439e-11
retinoblastoma B-Disease 0 3.09387104380221e-07
phenotype O 0 8.22633783315041e-09
. O 0 2.5964337346806587e-09

In O 0 6.093763514625206e-12
this O 0 1.5359992466303096e-13
family O 0 3.775224219609158e-13
affected O 0 8.178838465863758e-13
individuals O 0 1.0406136876132087e-14
developed O 0 1.1546062023137793e-10
unilateral B-Disease 0 3.75589195300563e-08
tumors I-Disease 1 1.0
and O 0 2.0978630291268452e-11
, O 0 4.904706333999989e-14
as O 0 4.408121071397715e-14
a O 0 4.626745492807005e-13
result O 0 4.685344473509545e-11
of O 0 2.232483226061177e-10
linkage O 0 2.449096569989706e-08
analysis O 0 3.652642355245206e-10
, O 0 3.694398086062645e-12
unaffected O 0 2.413498567666039e-10
mutation O 0 4.917841849895466e-13
carriers O 0 7.326301701806107e-14
were O 0 1.2898110531012197e-11
also O 0 8.161291737904253e-13
identified O 0 4.727391048064966e-11
within O 0 1.0107563397365738e-10
the O 0 1.9995052488730458e-11
pedigree O 0 1.7264412122131034e-08
. O 0 4.371909501088567e-09

A O 0 3.3733531523694182e-09
single O 0 2.5088217961433124e-11
band O 0 1.3605980925257555e-11
shift O 0 3.525348762911662e-11
using O 0 9.87978362315678e-12
SSCP O 0 0.0006553836283273995
was O 0 4.210607557064705e-11
identified O 0 3.4199493931241776e-11
in O 0 2.1909466428604585e-12
exon O 0 5.575298209214985e-11
21 O 0 1.1839487723541708e-12
which O 0 8.378803856823032e-16
resulted O 0 1.3020555770723585e-12
in O 0 8.687761474850467e-14
a O 0 8.245505840609457e-12
missense O 0 7.065691587371248e-09
mutation O 0 7.614147159995532e-12
converting O 0 6.150366882451408e-10
a O 0 2.230142598369511e-10
cys O 0 2.099402445310261e-05
- O 0 1.8079688288707985e-06
- O 0 2.357323296564573e-07
> O 0 1.299070850890871e-09
arg O 0 1.2965867962622113e-11
at O 0 3.2364147711620717e-13
nucleotide O 0 1.901334856701728e-13
position O 0 1.345659369524077e-12
28 O 0 1.3296497149845043e-12
in O 0 2.181563442263737e-13
the O 0 3.638712595122051e-11
exon O 0 9.155568747587495e-09
. O 0 6.46449338503885e-09

The O 0 3.470105869318729e-10
mutation O 0 9.83327932968514e-11
destroyed O 0 1.4557646199619967e-09
an O 0 6.291287477956653e-13
NdeI O 0 1.5648147666524892e-07
restriction O 0 1.513654063201031e-10
enzyme O 0 4.845300272116049e-10
site O 0 9.483236418361685e-10
. O 0 8.705826615162948e-10

Analysis O 0 2.039261953745708e-10
of O 0 3.0429905123474654e-11
all O 0 4.329664231306207e-12
family O 0 1.164024931131491e-12
members O 0 2.850213139709754e-15
demonstrated O 0 1.1036858276261552e-12
that O 0 1.0572867476744334e-15
the O 0 1.5139873946537485e-12
missense O 0 1.1328995519477303e-08
mutation O 0 7.258911249863331e-10
co O 0 1.4061645181584481e-08
- O 0 2.0909757836307108e-07
segregated O 0 2.03824921385376e-08
with O 0 3.4966365740352057e-13
patients O 0 3.2195746069163533e-10
with O 0 1.0064389426023279e-11
tumors B-Disease 1 1.0
or O 0 9.8919950008991e-10
who O 0 4.0641344456471273e-11
, O 0 1.5988446189826172e-13
as O 0 2.621538511445032e-13
a O 0 1.879994857706402e-12
result O 0 1.7062153079283604e-10
of O 0 7.579017968772916e-10
linkage O 0 4.1020047802931003e-08
analysis O 0 5.060637672804624e-11
had O 0 3.5892326437358957e-12
been O 0 8.682100719782648e-13
predicted O 0 8.854712102435158e-12
to O 0 9.581072914210953e-13
carry O 0 2.4298871248440435e-10
the O 0 5.4477356653537257e-11
predisposing O 0 9.586634064362443e-08
mutation O 0 9.8932257941442e-09
. O 0 8.127149619951979e-09

These O 0 6.080889958237634e-11
observations O 0 2.060484283195052e-10
point O 0 2.540176185714116e-12
to O 0 7.667040017190346e-14
another O 0 5.305925512323617e-13
region O 0 1.161883297906563e-10
of O 0 7.536413333675274e-12
the O 0 1.8919346991830288e-11
RB1 O 0 1.9160188458045013e-07
gene O 0 1.207051385926361e-12
where O 0 9.905024933934414e-13
mutations O 0 7.250500655593684e-13
only O 0 1.308690298056775e-13
modify O 0 4.619748680823044e-11
the O 0 5.7651253562718274e-12
function O 0 8.01051724952373e-11
of O 0 2.394363700364277e-11
the O 0 1.7263069446160628e-11
gene O 0 2.56605825997569e-12
and O 0 2.0848262352601843e-12
raise O 0 4.2020147777988015e-11
important O 0 5.1878161488883023e-11
questions O 0 7.904754975585071e-12
for O 0 4.991067780422964e-13
genetic O 0 6.545117919865007e-11
counseling O 0 3.050161165307763e-11
in O 0 1.3289764830336313e-14
families O 0 4.033433743250159e-13
with O 0 2.5104311668746118e-14
these O 0 6.410503638337728e-13
distinctive O 0 1.928598773737189e-11
phenotypes O 0 3.3008675653922737e-11
. O 0 2.4667342821138583e-11
. O 0 3.218114885683576e-09

Maternal B-Disease 0 4.914713258585834e-07
disomy I-Disease 0 9.455824283577385e-07
and O 0 7.110020572298481e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 4.455472662812099e-06
with O 0 1.7115693009680188e-15
gamete O 0 1.2312781905166048e-09
complementation O 0 1.2615937627913354e-08
in O 0 5.046643983784571e-14
a O 0 3.451016870274076e-14
case O 0 1.579499606194773e-14
of O 0 7.833954838998292e-12
familial O 0 2.861375858476123e-10
translocation O 0 7.83741871401844e-09
( O 0 9.754799879912578e-15
3 O 0 4.4893591882172457e-13
; O 0 2.6915570924254456e-15
15 O 0 2.8191492651603867e-13
) O 0 2.2540491697568713e-16
( O 0 3.775295659956116e-17
p25 O 0 7.352276773509026e-12
; O 0 3.9734501902947625e-15
q11 O 0 6.12325537496794e-11
. O 0 4.441872285027189e-14
2 O 0 9.093935457102353e-14
) O 0 1.5287675842585134e-14
. O 0 2.6007930184479555e-11

Maternal B-Disease 0 0.013855546712875366
uniparental I-Disease 1 0.9998059868812561
disomy I-Disease 1 0.9997958540916443
( I-Disease 0 2.684412137021752e-10
UPD I-Disease 1 1.0
) I-Disease 0 2.4652174290644424e-13
for I-Disease 0 1.137623659554568e-13
chromosome I-Disease 0 7.822801434409499e-12
15 I-Disease 0 6.550319097894941e-13
is O 0 1.394912651081899e-16
responsible O 0 1.4985839039962853e-14
for O 0 6.3928655494045316e-15
an O 0 5.209249449240395e-16
estimated O 0 1.3205319880659795e-14
30 O 0 8.788862649808382e-14
% O 0 6.569823352876869e-14
of O 0 7.952643449260366e-17
cases O 0 3.7991063516734755e-16
of O 0 5.624832155604054e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.869189140777053e-08
PWS B-Disease 1 1.0
) O 0 3.592157170675958e-12
. O 0 1.80229338397897e-11

We O 0 5.784745252257473e-11
report O 0 2.592445301399099e-13
on O 0 2.6518726247586923e-14
an O 0 5.93715369755938e-17
unusual O 0 4.959071915521733e-16
case O 0 5.491561930670227e-15
of O 0 1.497560235541595e-11
maternal B-Disease 0 3.863317203922634e-07
disomy I-Disease 0 3.09570059471298e-05
15 I-Disease 0 1.4610025411698757e-09
in O 0 2.243333852014473e-10
PWS B-Disease 1 1.0
that O 0 6.997505873351795e-13
is O 0 6.810727654592286e-15
most O 0 5.952399522986349e-15
consistent O 0 3.1418079943223987e-11
with O 0 1.3326170137002713e-13
adjacent O 0 7.963965042989685e-10
- O 0 2.7356283904822476e-11
1 O 0 1.1002466028097596e-13
segregation O 0 3.899705211529714e-11
of O 0 1.026348805748499e-13
a O 0 5.34401245044086e-13
paternal O 0 8.803329620832301e-09
t O 0 7.144756574567479e-12
( O 0 7.603971997992688e-16
3 O 0 5.6308724230656054e-14
; O 0 3.9411884523393e-16
15 O 0 6.154109746759825e-14
) O 0 2.6899018510801678e-17
( O 0 3.0214883252012877e-18
p25 O 0 6.468611453772088e-13
; O 0 1.338473787015161e-16
q11 O 0 3.0755838414248116e-12
. O 0 2.1772451190090776e-16
2 O 0 1.2824679685427066e-16
) O 0 1.4601824374656103e-18
with O 0 5.668990345648059e-17
simultaneous O 0 1.1859178569717521e-11
maternal O 0 2.281249633639959e-09
meiotic O 0 3.701000252931408e-07
nondisjunction O 0 9.83498011919437e-08
for O 0 2.5206692635948436e-11
chromosome O 0 3.258520120397179e-10
15 O 0 9.270362810731569e-10
. O 0 2.434406454199234e-09

The O 0 7.236713006619766e-09
patient O 0 1.2962466655608296e-07
( O 0 1.3006121448388107e-14
J O 0 1.2525867842949623e-10
. O 0 6.405612124711288e-14
B O 0 2.7400811654365587e-12
. O 0 4.607012729511732e-16
) O 0 3.973277699975988e-18
, O 0 1.632360867790105e-17
a O 0 9.83145318526554e-16
17 O 0 1.0664865630969755e-14
- O 0 1.0106617555653494e-14
year O 0 1.8942484299871998e-12
- O 0 4.200550740574016e-10
old O 0 3.610669807585509e-08
white O 0 8.455335390178398e-12
male O 0 1.5023982058437468e-11
with O 0 4.840302692075277e-14
PWS B-Disease 1 1.0
, O 0 4.589899966177258e-13
was O 0 3.3462154488267393e-12
found O 0 2.73964607510474e-13
to O 0 1.554746956178299e-11
have O 0 5.771428907702658e-12
47 O 0 2.5516191937136057e-10
chromosomes O 0 1.977410457598694e-10
with O 0 4.664672727944241e-12
a O 0 5.333267716345347e-10
supernumerary O 0 3.383872171980329e-05
, O 0 2.077127185529104e-11
paternal O 0 2.5392060365447833e-07
der O 0 1.955400819042552e-07
( O 0 2.542608322237544e-13
15 O 0 1.8946749551218556e-12
) O 0 1.1593384947694932e-16
consisting O 0 1.202784752222033e-14
of O 0 1.7929585496411632e-13
the O 0 8.152921155031578e-13
short O 0 4.700077133046321e-11
arm O 0 3.707250506579385e-09
and O 0 1.3399582008202793e-12
the O 0 1.1139399125337235e-10
proximal O 0 1.7095751900342293e-05
long O 0 7.623749631591181e-09
arm O 0 1.7254066619898367e-07
of O 0 7.57085505398436e-10
chromosome O 0 1.2966102636013943e-09
15 O 0 5.562713623064042e-10
, O 0 2.0462058154639695e-13
and O 0 7.610048658943103e-13
distal O 0 1.8790025535508903e-07
chromosome O 0 1.7979668598400167e-07
arm O 0 7.264067244250327e-05
3p O 0 0.0013302103616297245
. O 0 5.72517251384852e-07

The O 0 2.392681324181467e-07
t O 0 5.221232335372861e-10
( O 0 5.301812997958108e-15
3 O 0 1.6130696225361701e-13
; O 0 4.4182342318593696e-16
15 O 0 2.0516799861141667e-14
) O 0 2.586024675191881e-17
was O 0 8.084053649474836e-15
present O 0 2.8940832206853645e-14
in O 0 1.1890298053673942e-15
the O 0 2.420888772921518e-14
balanced O 0 1.4443070220707122e-12
state O 0 1.426803790947114e-14
in O 0 1.804777674692653e-14
the O 0 2.277614674552758e-13
patients O 0 9.403340736277577e-13
father O 0 8.685057534263407e-11
and O 0 9.637527755013142e-12
a O 0 1.120869175252892e-09
sister O 0 5.463331831379037e-08
. O 0 2.2680703537503177e-08

Fluorescent O 0 6.543402708558688e-09
in O 0 1.040702680282779e-11
situ O 0 1.13295950399106e-09
hybridization O 0 2.0467611980268252e-12
analysis O 0 8.272024829437258e-14
demonstrated O 0 3.5405269753312207e-13
that O 0 1.181262724999309e-15
the O 0 1.5157441274338268e-12
PWS B-Disease 1 1.0
critical O 0 8.136393780944218e-09
region O 0 5.397517099936522e-09
resided O 0 1.438300500922196e-08
on O 0 2.588193721841936e-11
the O 0 1.8189624069117616e-12
derivative O 0 2.44286934431015e-11
chromosome O 0 4.805783375416706e-12
3 O 0 1.448110023821031e-13
and O 0 9.136038076778576e-15
that O 0 4.517011561338581e-15
there O 0 2.8178792239592736e-14
was O 0 4.407534721310308e-13
no O 0 4.0431677781173694e-14
deletion O 0 6.130754758026935e-12
of O 0 5.192307521439954e-12
the O 0 1.228026985655717e-10
PWS B-Disease 1 1.0
region O 0 3.100770484820714e-08
on O 0 1.6338704694751627e-11
the O 0 1.1493976343618373e-12
normal O 0 2.114640546002633e-10
pair O 0 8.21576071063923e-11
of O 0 3.173565923941801e-11
15s O 0 8.082654545660262e-10
present O 0 4.5953262028941566e-11
in O 0 1.917983410981705e-10
J O 0 3.850898337987019e-07
. O 0 1.5753823134900813e-08

B O 0 1.2376756785670295e-05
. O 0 9.83514603092317e-09

Methylation O 0 1.2478847954966454e-09
analysis O 0 4.246028181831285e-11
at O 0 2.3728640580200633e-11
exon O 0 8.095606650326825e-12
alpha O 0 1.5733725086675143e-13
of O 0 3.86200446622631e-12
the O 0 1.6423530938003417e-11
small O 0 4.791002230358776e-12
nuclear O 0 7.883611097270204e-09
ribonucleoprotein O 0 2.2175180447447929e-07
- O 0 4.2353132112538106e-10
associated O 0 7.894542658481996e-11
polypeptide O 0 2.4456925373783633e-09
N O 0 2.1851563614116998e-10
( O 0 1.2050941028494272e-15
SNRPN O 0 1.6938587066306354e-07
) O 0 4.2794907644947073e-16
gene O 0 3.4284658038995566e-15
showed O 0 2.3913764848546015e-13
a O 0 4.895656464584935e-15
pattern O 0 1.5433946438589419e-12
characteristic O 0 1.0503479596496446e-12
of O 0 3.571407492658496e-13
only O 0 1.8585804282319346e-13
the O 0 1.5831989582174022e-12
maternal O 0 3.164325745874663e-10
chromosome O 0 8.651952418392561e-12
15 O 0 2.3723887437876456e-11
in O 0 5.650677148416605e-11
J O 0 3.251595330766577e-07
. O 0 1.749586253652069e-08

B O 0 1.652237551752478e-05
. O 0 1.1101146668579531e-08

Maternal B-Disease 0 5.2386181778274477e-05
disomy I-Disease 0 1.1250913303229026e-06
was O 0 1.8839684586685612e-12
confirmed O 0 1.2965229238793511e-14
by O 0 6.677279423623551e-18
polymerase O 0 3.9498598991972566e-15
chain O 0 6.335278108661317e-16
reaction O 0 4.1731685419773873e-17
analysis O 0 4.810095125483936e-15
of O 0 2.88920736022779e-14
microsatellite O 0 4.133871717160176e-11
repeats O 0 1.2643766242326215e-11
at O 0 1.323904636092721e-13
the O 0 5.531669957162255e-14
gamma O 0 3.567372092172505e-12
- O 0 6.775395522407024e-11
aminobutyric O 0 3.5988902968853154e-09
acid O 0 7.007049107610186e-11
receptor O 0 3.6740177415152397e-13
beta3 O 0 1.712031738598796e-09
subunit O 0 4.038131374423104e-12
( O 0 1.2261379587976025e-14
GABRB3 O 0 4.5786839564243564e-07
) O 0 4.6413800537312144e-14
locus O 0 2.5442651457874277e-11
. O 0 2.514485564208968e-10

A O 0 3.64470270142192e-06
niece O 0 6.573959012712294e-07
( O 0 5.446345956693077e-14
B O 0 2.7006235789328592e-11
. O 0 1.2825812062598426e-15
B O 0 7.309970228956686e-14
. O 0 1.2898317454226129e-17
) O 0 1.571807824491439e-19
with O 0 5.816655071724392e-18
45 O 0 1.7634812609756273e-14
chromosomes O 0 7.800686095335574e-13
and O 0 5.990809248419132e-14
the O 0 1.824010343806637e-12
derivative O 0 4.6796082633915326e-12
3 O 0 1.1256316381378847e-13
but O 0 1.2509939712281905e-14
without O 0 1.865649345081377e-12
the O 0 1.1282723887118262e-11
der O 0 3.166327289250148e-08
( O 0 9.887258383984437e-14
15 O 0 4.299905050075825e-12
) O 0 3.918299451582561e-15
demonstrated O 0 3.709395204193333e-12
a O 0 9.316009335486042e-13
phenotype O 0 2.4416257210502224e-11
consistent O 0 6.51804348342222e-12
with O 0 7.037864939233565e-16
that O 0 6.702755411893714e-16
reported O 0 1.1246874335709214e-13
for O 0 2.088263644037941e-13
haploinsufficiency O 0 2.8713077426800737e-07
of O 0 7.207492380700842e-10
distal O 0 1.8556294207883184e-06
3 O 0 2.0873292427836532e-08
p O 0 6.546513020566636e-08
. O 0 2.810966792665681e-09

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 4.8621702219975305e-09
with O 0 1.6151055102706091e-12
unbalanced O 0 1.2365062218577805e-07
segregation O 0 1.2180764841218661e-08
of O 0 3.731797093564637e-09
non O 0 7.866017767810263e-06
- O 0 6.676535235783376e-07
Robertsonian O 0 0.010451022535562515
translocations O 0 3.276770075899549e-05
has O 0 3.418307845982904e-14
been O 0 1.3138743091005607e-14
reported O 0 1.4478614704729886e-13
previously O 0 1.5414207453837148e-12
but O 0 1.761491241769348e-14
has O 0 2.8578327834054577e-16
not O 0 5.611591581493845e-15
, O 0 3.4197273884992076e-15
to O 0 2.724961749300814e-12
our O 0 5.704522409999413e-10
knowledge O 0 2.1097999791663824e-08
, O 0 9.520842095397594e-14
been O 0 2.5515960871969057e-13
observed O 0 3.5891626584856617e-13
in O 0 5.161485049586488e-14
a O 0 6.995544551621768e-13
case O 0 2.561745086893108e-12
of O 0 2.5354653931941584e-09
PWS B-Disease 1 1.0
. O 0 3.853587884350418e-07

Furthermore O 0 8.17101550865118e-08
, O 0 3.6089549317747105e-12
our O 0 5.196858221534484e-11
findings O 0 2.2782925719611047e-13
are O 0 2.4229883028999654e-16
best O 0 7.61462883713945e-15
interpreted O 0 3.4757956332998746e-14
as O 0 2.2242543093811684e-14
true O 0 1.4879368570586138e-11
gamete O 0 4.2188215587657396e-08
complementation O 0 8.699809939116676e-08
resulting O 0 7.395744017202333e-10
in O 0 3.314243879337653e-10
maternal B-Disease 0 0.0015983186895027757
UPD I-Disease 1 1.0
15 I-Disease 0 2.0776025166924228e-07
and O 0 3.575362583774222e-08
PWS B-Disease 1 1.0

Schwartz B-Disease 1 1.0
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 8.399278494941598e-10
2 I-Disease 0 1.278987224288819e-12
and O 0 3.171656188551142e-13
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 8.578263154066651e-14
a O 0 3.8058769189549396e-14
case O 0 5.867830271224822e-16
for O 0 4.904628661078726e-15
" O 0 3.722171496804011e-13
lumping O 0 3.5035696566154684e-11
" O 0 1.54440852467852e-11
. O 0 1.3870055104447943e-10

Recent O 0 6.358076565238235e-11
studies O 0 2.297467988424118e-12
demonstrated O 0 3.8198128471042536e-13
the O 0 5.134444369778342e-14
existence O 0 1.105226327124953e-11
of O 0 2.7690829230292424e-12
a O 0 1.3204578489661722e-12
genetically O 0 1.7809451829942091e-12
distinct O 0 6.828089309240948e-12
, O 0 8.81918507406737e-15
usually O 0 3.0578207033235463e-15
lethal O 0 2.973986887918473e-14
form O 0 1.3525266247694373e-13
of O 0 3.16743246214779e-12
the O 0 1.7678798702736032e-10
Schwartz B-Disease 1 1.0
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.869708473611734e-13
SJS B-Disease 1 0.6059563159942627
) O 0 2.5540791812224406e-13
of O 0 3.753842126030804e-09
myotonia B-Disease 1 1.0
and O 0 1.971311348825111e-06
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 1.3181125028266516e-12
which O 0 1.0746815899210019e-13
we O 0 5.7527267671719784e-11
called O 0 2.0581060411473118e-08
SJS B-Disease 1 0.9999991655349731
type I-Disease 0 1.1688410239685254e-07
2 I-Disease 0 5.614799736264331e-09
. O 0 1.8591373995846538e-09

This O 0 1.0757440493947001e-09
disorder O 0 2.7357114049664233e-06
is O 0 3.424585376561595e-14
reminiscent O 0 2.1610695871698837e-11
of O 0 1.8458808700300144e-12
another O 0 2.4209237045602627e-12
rare O 0 1.8770686394109504e-11
condition O 0 1.4012067595103872e-07
, O 0 1.4095382101634614e-14
the O 0 1.6747681366724443e-11
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.4174932328490115e-10
SWS B-Disease 1 1.0
) O 0 4.242886288618672e-15
, O 0 2.8883561450553585e-16
which O 0 2.819757858332989e-16
comprises O 0 1.774315693285275e-13
campomelia B-Disease 0 4.993251323526238e-08
at O 0 3.2927510718039343e-10
birth O 0 5.697481597621845e-08
with O 0 1.3367125462071527e-10
skeletal B-Disease 0 7.586799620185047e-05
dysplasia I-Disease 0 0.001668485696427524
, O 0 6.526353676233887e-12
contractures B-Disease 0 3.6108685890212655e-05
, O 0 3.9571937306831506e-13
and O 0 5.161278712360537e-14
early B-Disease 0 1.949734595996233e-09
death I-Disease 0 1.1631632323982899e-09
. O 0 2.634918505606265e-09

To O 0 7.375993149594251e-10
test O 0 3.3910124708214084e-11
for O 0 2.0538265370090986e-13
possible O 0 5.242295139651354e-11
nosologic O 0 1.1310816034892923e-06
identity O 0 1.3766168205364693e-09
between O 0 9.343226886615597e-11
these O 0 3.2573486009185304e-12
disorders O 0 3.805715811933119e-11
, O 0 6.685977806790975e-16
we O 0 1.678208590703053e-15
reviewed O 0 1.6151446499690358e-13
the O 0 4.8964247234680944e-14
literature O 0 6.964856751230653e-13
and O 0 4.6331876357686656e-15
obtained O 0 3.0738126887558392e-12
a O 0 3.494689617983965e-13
follow O 0 3.3070731483147986e-12
- O 0 6.309601278953192e-13
up O 0 2.1582868413479173e-13
of O 0 3.7283603938551013e-13
the O 0 9.994137678895343e-14
only O 0 3.300365284341321e-14
two O 0 2.1890522977196375e-14
surviving O 0 4.3637096713844414e-10
patients O 0 2.814825412686406e-12
, O 0 6.847381311318821e-15
one O 0 2.533971025630438e-13
with O 0 7.463316423206301e-12
SJS B-Disease 0 0.050417833030223846
type I-Disease 0 1.081133760294506e-08
2 I-Disease 0 1.4626859445865392e-10
at O 0 3.19224612022051e-11
age O 0 4.751669977626216e-12
10 O 0 4.9883050977621995e-14
years O 0 1.1101683910000586e-14
and O 0 6.327669635212605e-16
another O 0 1.2353193554887065e-13
with O 0 1.2834128291366875e-12
SWS B-Disease 0 0.00012577140296343714
at O 0 1.0223349077020938e-11
age O 0 8.658622430157692e-12
7 O 0 1.3262841346006748e-11
years O 0 1.2386118172780236e-11
. O 0 5.931595215002972e-10

Patients O 0 4.0133113499152273e-10
reported O 0 1.7890549068241834e-12
as O 0 3.656650042439466e-14
having O 0 1.7649779207595806e-11
either O 0 1.9284698282717727e-07
neonatal O 1 1.0
SJS B-Disease 1 0.999998927116394
or O 0 1.5279589149486128e-08
SWS B-Disease 0 0.24407385289669037
presented O 0 1.6426554669442262e-13
a O 0 1.752893391486596e-15
combination O 0 3.369471864947426e-15
of O 0 2.862309320767961e-14
a O 0 3.1341135199244863e-13
severe O 0 1.714824116039182e-11
, O 0 1.689857021675012e-13
prenatal O 0 0.23981338739395142
- O 0 1.3537679478758946e-05
onset O 0 8.743892976781353e-05
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
( O 0 1.3443656994918673e-13
with O 0 1.759301211656794e-11
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 0 0.08105802536010742
respiratory O 1 1.0
and O 0 1.1314578841847833e-05
feeding O 0 0.00288614840246737
difficulties O 0 0.08950766921043396
, O 0 3.512870896948961e-11
tendency O 0 1.7261449158922915e-08
to O 0 9.949427948185985e-09
hyperthermia B-Disease 0 0.1762935221195221
, O 0 7.450966384679736e-13
and O 0 2.413564140213431e-13
frequent O 0 1.2208983823924768e-11
death O 0 1.9194904346542252e-11
in O 0 5.10054975685903e-12
infancy O 0 3.005272475320453e-08
) O 0 9.039245504313459e-16
with O 0 7.353229069781734e-16
a O 0 6.60305414946355e-13
distinct O 0 8.220620018040137e-11
campomelic B-Disease 0 0.00020406165276654065
- I-Disease 0 0.0031858691945672035
metaphyseal I-Disease 0 0.00022398500004783273
skeletal I-Disease 0 0.15727682411670685
dysplasia I-Disease 1 0.9999877214431763
. O 0 1.6288142035136843e-07

The O 0 2.0863788127711835e-11
similarity O 0 2.7437710437006047e-10
of O 0 1.7003803920445648e-10
the O 0 5.531330254937572e-11
clinical O 0 5.254690571554477e-10
and O 0 1.41797251024256e-11
radiographic O 0 8.999558787081696e-08
findings O 0 7.595004486438128e-11
is O 0 8.163296292195907e-14
so O 0 3.1206507104981906e-13
extensive O 0 2.1907828884337732e-09
that O 0 3.317630458549159e-12
these O 0 1.5144914489173544e-10
disorders O 0 2.1003634387284364e-09
appear O 0 2.1532562191617366e-11
to O 0 3.486302826288812e-12
be O 0 1.8773147099360177e-12
a O 0 5.635756184646512e-12
single O 0 9.015610480389569e-11
entity O 0 7.414179048481628e-09
. O 0 4.372362027993404e-08

The O 0 4.1008429985112116e-10
follow O 0 2.1875834477214084e-10
- O 0 2.3901294138317652e-11
up O 0 6.612607596906406e-13
observation O 0 1.0033230496420131e-10
of O 0 1.9116693362845882e-13
an O 0 5.828433180661249e-16
identical O 0 1.206121113357314e-13
and O 0 4.3866279915259635e-16
unique O 0 1.6734859754462955e-13
pattern O 0 1.1062011723295129e-10
of O 0 1.9340451462568353e-09
progressive O 1 0.9616472721099854
bone B-Disease 1 0.9883368611335754
dysplasia I-Disease 0 2.1163712062843842e-06
in O 0 7.470693334787892e-12
the O 0 1.8621592115519725e-11
two O 0 7.386995529157225e-12
patients O 0 1.859678036564283e-11
( O 0 3.7899311849096985e-15
one O 0 4.982706955369842e-13
with O 0 3.350941702937038e-12
SJS B-Disease 0 0.00020217050041537732
type I-Disease 0 5.297520200286954e-10
2 I-Disease 0 2.0492661387261357e-11
, O 0 4.361495634596334e-14
one O 0 1.0457995960107963e-13
with O 0 1.847109921612744e-12
SWS B-Disease 1 0.9950476884841919
) O 0 3.584982245959101e-13
surviving O 0 6.243198402700045e-09
beyond O 0 8.706366116939535e-08
infancy O 0 2.348106590943644e-06
adds O 0 4.1222320695810666e-12
to O 0 1.1734319028608442e-12
the O 0 4.906861050292533e-13
evidence O 0 7.986557378977799e-13
in O 0 9.400090433689737e-14
favor O 0 1.806168409279607e-11
of O 0 8.345231623796412e-12
identity O 0 3.0726464927965935e-08
. O 0 2.5312482776485012e-08

The O 0 3.566640871532911e-10
hypothesis O 0 2.0883106355285008e-10
that O 0 2.842009613757135e-12
SWS B-Disease 1 0.9918436408042908
and O 0 3.8416800296481313e-10
SJS B-Disease 0 0.48284661769866943
type I-Disease 0 9.502230113866972e-10
2 I-Disease 0 1.7597576174033236e-11
are O 0 5.816811740394154e-14
the O 0 3.891284863777322e-12
same O 0 2.3540805416111255e-10
disorder O 0 3.325984487823064e-10
should O 0 1.6368068738500247e-13
be O 0 9.274216594343243e-14
testable O 0 1.0612772813334281e-11
by O 0 2.012064721039204e-15
molecular O 0 5.685222800345946e-13
methods O 0 1.0494417834738812e-10
. O 0 1.651459524687482e-11
. O 0 1.7012085073986327e-09

A O 0 3.644521073820073e-10
mouse O 0 6.930614394017043e-13
model O 0 3.871265558553355e-13
of O 0 1.7364640541445153e-12
severe O 1 0.9876829981803894
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 9.000456884677988e-06
defects O 1 1.0
in O 0 7.110861233172727e-09
hemostasis O 1 0.9999986886978149
and O 0 5.585052864631734e-09
thrombosis B-Disease 0 0.0008845199481584132
. O 0 6.496404125755362e-07

von B-Disease 1 0.9994774460792542
Willebrand I-Disease 0 0.11857914179563522
factor I-Disease 0 2.8345123155304464e-06
( I-Disease 0 3.6083666610231546e-10
vWf I-Disease 0 0.00019474404689390212
) I-Disease 0 8.69454641616585e-09
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.0002900698746088892
humans O 0 4.457570312865755e-08
. O 0 4.1587058796643817e-10

We O 0 6.176803513113782e-11
generated O 0 1.8552804691845948e-12
a O 0 1.0508703418088752e-13
mouse O 0 1.2022395340545444e-13
model O 0 1.932860237152407e-14
for O 0 9.72485387709535e-15
this O 0 7.640994770501813e-14
disease O 0 2.0133645185077542e-13
by O 0 1.8169223986796716e-17
using O 0 3.576238155438005e-14
gene O 0 3.5039403019701543e-13
targeting O 0 2.0012613788367162e-10
. O 0 8.794346917362361e-10

vWf B-Disease 0 0.00037194206379354
- I-Disease 0 0.0007464514346793294
deficient I-Disease 0 4.83842541143531e-06
mice O 0 1.546278771691334e-09
appeared O 0 1.6214710130135757e-11
normal O 0 1.5180667833902817e-09
at O 0 2.082966178013068e-12
birth O 0 2.828716644601159e-12
; O 0 1.3544380816698587e-15
they O 0 2.0265785035354644e-14
were O 0 3.376141597191684e-12
viable O 0 1.1730408999710562e-07
and O 0 2.646555717633614e-11
fertile O 0 7.25480413166224e-06
. O 0 1.0412681383797917e-08

Neither O 0 7.806389135112113e-07
vWf O 0 1.5363773400167702e-06
nor O 0 1.8753398478565941e-07
vWf O 0 7.030733286228497e-06
propolypeptide O 0 0.0011385655961930752
( O 0 2.2918321754272775e-11
von B-Disease 0 3.288728839834221e-05
Willebrand I-Disease 0 5.11569169248105e-07
antigen O 0 1.4530073810803401e-09
II O 0 0.00018959534645546228
) O 0 5.9049150118173355e-12
were O 0 2.9483004926333933e-10
detectable O 0 1.0133952010882297e-10
in O 0 4.967142826607998e-14
plasma O 0 5.219086881419477e-12
, O 0 1.4236694302290943e-14
platelets O 0 8.948897872729233e-11
, O 0 6.053654214195625e-13
or O 0 2.4642592653945083e-12
endothelial O 0 7.417926407675413e-13
cells O 0 5.2600229727417513e-11
of O 0 1.6708923133990083e-10
the O 0 3.9602706530805776e-11
homozygous O 0 7.469981230801004e-12
mutant O 0 8.063125861434983e-11
mice O 0 3.309303941989583e-10
. O 0 7.083148512165849e-10

The O 0 3.1110397591405103e-10
mutant O 0 4.25873974974067e-10
mice O 0 5.984765460986807e-11
exhibited O 0 1.3840819115817915e-11
defects O 0 1.575015851074113e-08
in O 0 1.3144152433142153e-11
hemostasis O 0 0.00027889033663086593
with O 0 4.319584186868175e-12
a O 0 1.3797237796708828e-09
highly O 0 1.098440236546594e-07
prolonged O 0 0.000915823969990015
bleeding O 1 0.9999995231628418
time O 0 4.773407624725223e-08
and O 0 1.1633158325530246e-10
spontaneous O 0 1.298831264762157e-08
bleeding O 0 8.764247638737288e-08
events O 0 7.446888700309018e-13
in O 0 8.332626987494693e-14
approximately O 0 1.203491516513222e-14
10 O 0 7.542017683125068e-13
% O 0 1.1471554609010504e-11
of O 0 3.6748885184900715e-12
neonates O 0 1.0728144594907008e-08
. O 0 5.288298510208733e-08

As O 0 8.897477372926677e-12
in O 0 2.0310219706141247e-13
the O 0 1.0177597561380688e-13
human O 0 1.1526643355075361e-12
disease O 0 9.956551208500919e-12
, O 0 2.552536433528794e-16
the O 0 2.7820448174993226e-14
factor O 0 1.0215152291756513e-13
VIII O 0 1.5040426681878216e-09
level O 0 4.8583906675503385e-08
in O 0 1.0867617569743082e-11
these O 0 2.1972996339103545e-12
mice O 0 9.57360579700861e-12
was O 0 7.067388666480434e-13
reduced O 0 3.794088741099211e-12
strongly O 0 1.4981815972276574e-13
as O 0 1.6536034694314417e-14
a O 0 1.8735326603926822e-13
result O 0 5.1657844668540065e-12
of O 0 1.309423142831223e-11
the O 0 7.33648905515416e-12
lack O 0 8.287344144264353e-10
of O 0 3.3273770023989346e-12
protection O 0 2.231162650467855e-11
provided O 0 2.254548544383672e-12
by O 0 5.347806073842387e-13
vWf O 0 5.6690918626145503e-08
. O 0 5.906151567813822e-09

Defective O 0 0.00097051722696051
thrombosis B-Disease 0 2.504795929780812e-06
in O 0 1.0341556083703907e-10
mutant O 0 7.947629533655576e-12
mice O 0 6.260571488309052e-13
was O 0 2.2191141746440504e-14
also O 0 1.2258934468555098e-16
evident O 0 8.034655297854687e-13
in O 0 2.8970750257583614e-15
an O 0 9.195222915781194e-17
in O 0 1.8410150994289075e-15
vivo O 0 2.8540906617247064e-12
model O 0 5.113449247362567e-11
of O 0 3.637890211294348e-09
vascular B-Disease 0 1.5134472050704062e-05
injury I-Disease 1 0.9998995065689087
. O 0 2.5348995222884696e-06

In O 0 1.0287678911882758e-12
this O 0 8.115816537963925e-15
model O 0 6.979374624896048e-14
, O 0 6.251898832311564e-16
the O 0 6.628439388079582e-14
exteriorized O 0 2.8205764834865477e-08
mesentery O 0 2.889922825488611e-07
was O 0 8.190070843738795e-11
superfused O 0 2.037006083810411e-07
with O 0 1.5660468798486815e-12
ferric O 0 5.032778460645204e-08
chloride O 0 7.822689718217646e-10
and O 0 1.5418780141551736e-10
the O 0 1.1090396156987481e-08
accumulation O 0 4.47336651632213e-06
of O 0 3.019141331606079e-06
fluorescently O 0 1.7367035809456866e-07
labeled O 0 1.1393539584014789e-10
platelets O 0 3.101413570405498e-09
was O 0 2.1793905222167176e-11
observed O 0 1.69991082842047e-13
by O 0 2.4396993418009626e-14
intravital O 0 1.145674666247487e-08
microscopy O 0 1.090663630520794e-07
. O 0 3.5078395743681767e-09

We O 0 3.9048653199813543e-10
conclude O 0 2.55139802618487e-08
that O 0 8.011421929500495e-14
these O 0 3.1242820423870235e-14
mice O 0 4.307415969045936e-12
very O 0 1.6049368865150848e-13
closely O 0 1.1712775194183678e-10
mimic O 0 5.152771791472333e-07
severe O 0 1.7113147805503104e-06
human O 1 0.9999997615814209
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 4.147698717815729e-08
will O 0 7.709077126660802e-11
be O 0 9.140614697436544e-13
very O 0 2.1544484607254576e-14
useful O 0 2.925563979440382e-13
for O 0 1.7169119612828253e-15
investigating O 0 6.219743958150309e-14
the O 0 1.9269789485864414e-13
role O 0 4.376483116880214e-12
of O 0 4.0270731194169684e-11
vWf O 0 4.209656179199328e-09
in O 0 3.917665150621197e-11
normal O 0 1.290950564225568e-07
physiology O 0 1.5663667696230732e-08
and O 0 8.204509120701697e-13
in O 0 1.5551999792140503e-12
disease O 0 3.4969319107069907e-12
models O 0 5.870536804071513e-13
. O 0 8.432284818310487e-13
. O 0 3.894778943802635e-10

Oral O 0 8.313519970215566e-07
contraceptives O 0 1.4426387195953794e-08
and O 0 1.0239960870342055e-14
the O 0 6.839086046615817e-13
risk O 0 6.537522745375668e-10
of O 0 6.566277443198487e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0850847047549905e-06

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 3.358384503826528e-07
Study O 0 1.4191277493413867e-11
Group O 0 1.2442934323956406e-13
. O 0 3.461702105522768e-11

BACKGROUND O 0 2.666042018972803e-05
Women O 0 1.7802771409836105e-11
with O 0 2.4782608555378935e-14
mutations O 0 1.743678443820451e-13
in O 0 4.5753612893826776e-14
either O 0 1.1044781408897641e-11
the O 0 5.6136373327575484e-11
BRCA1 O 0 1.1031298097208264e-09
or O 0 1.2734033662600841e-12
the O 0 4.879033808913302e-12
BRCA2 O 0 4.747885418154851e-11
gene O 0 1.0942903348873032e-13
have O 0 1.3882440559793725e-14
a O 0 5.0922628066314354e-14
high O 0 2.7343733288894e-13
lifetime O 0 1.4542882453838502e-09
risk O 0 8.33015576517937e-08
of O 0 0.018807632848620415
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.4333205551083665e-07

Oral O 0 0.00027828128077089787
contraceptives O 0 0.00019668741151690483
protect O 0 2.657364802871598e-06
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 5.727236995767271e-08
general O 0 8.286517999556153e-11
, O 0 1.774429839445247e-14
but O 0 7.288360216186566e-15
it O 0 4.568476436180805e-16
is O 0 2.6751370411055657e-16
not O 0 1.1214865299445653e-14
known O 0 3.935800795516753e-13
whether O 0 4.635623482296403e-13
they O 0 2.963632811381345e-12
also O 0 2.6375229040739856e-13
protect O 0 3.1729712173661495e-12
against O 0 1.2493905649640924e-12
hereditary B-Disease 1 0.9983227849006653
forms I-Disease 1 0.9777008891105652
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.889885864642565e-07

METHODS O 0 4.050312085723817e-08
We O 0 3.2775529252432323e-12
enrolled O 0 5.28803563437652e-12
207 O 0 1.941978695907398e-12
women O 0 5.688712576088634e-14
with O 0 4.129009287257013e-11
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.4999426967019407e-14
161 O 0 3.899961679553615e-13
of O 0 1.1023614659988468e-10
their O 0 6.059328370611183e-06
sisters O 0 4.1101969827650464e-08
as O 0 4.357436286794858e-11
controls O 0 2.002293220115803e-09
in O 0 1.3055527145477974e-11
a O 0 1.3299522941268016e-11
case O 0 6.109043392682478e-12
- O 0 3.1481139917133305e-10
control O 0 4.1398071082277e-10
study O 0 1.3319551191159906e-11
. O 0 4.3977984448551055e-11

All O 0 1.9228247466474002e-11
the O 0 4.837612515434797e-12
patients O 0 3.3549050581886675e-13
carried O 0 2.315910321588205e-13
a O 0 2.0992048024989426e-14
pathogenic O 0 6.232370305600532e-13
mutation O 0 1.9208507668570102e-13
in O 0 2.403164201924407e-13
either O 0 5.603819075439276e-10
BRCA1 O 0 9.454129035191272e-09
( O 0 7.359378846616155e-15
179 O 0 7.17299761254786e-11
women O 0 2.2978626380149025e-12
) O 0 1.1774752383514851e-14
or O 0 6.869158887534699e-12
BRCA2 O 0 3.872071108190767e-09
( O 0 2.4619171854140323e-14
28 O 0 4.778082790535265e-11
women O 0 1.442842156515467e-12
) O 0 3.365127187321404e-13
. O 0 6.78367473305741e-10

The O 0 5.656028423395298e-10
control O 0 5.606449193784613e-10
women O 0 4.313520027277029e-14
were O 0 2.216780226179868e-13
enrolled O 0 1.060269667202407e-11
regardless O 0 5.6097199802040976e-11
of O 0 1.3079902612400662e-11
whether O 0 5.498694490187195e-13
or O 0 3.245348651273461e-12
not O 0 2.1369956585554073e-12
they O 0 7.570298554693267e-12
had O 0 3.883331503584664e-11
either O 0 8.044374610882699e-10
mutation O 0 1.2286859307764075e-09
. O 0 3.3456717396518343e-09

Lifetime O 0 6.866184776299633e-08
histories O 0 3.222170263939006e-08
of O 0 2.0226218477858993e-09
oral O 0 1.2249118981344509e-06
- O 0 1.2166130325397262e-09
contraceptive O 0 1.4620688340571952e-11
use O 0 9.678740556413878e-15
were O 0 1.3812237622092341e-14
obtained O 0 1.7876658812109036e-13
by O 0 7.828640181592721e-15
interview O 0 1.1694887246116448e-11
or O 0 2.021666474771042e-15
by O 0 6.180001352259638e-17
written O 0 2.7961073749566687e-16
questionnaire O 0 4.2664832501006374e-16
and O 0 5.5019147511633736e-17
were O 0 3.4536640176408354e-14
compared O 0 1.912356124150749e-12
between O 0 1.307396638866587e-11
patients O 0 3.7440688570311575e-12
and O 0 4.269127098274067e-13
control O 0 2.5680158000085385e-09
women O 0 1.0340184654691886e-12
, O 0 8.148451870388686e-15
after O 0 1.5602413295807277e-13
adjustment O 0 8.705352411153555e-12
for O 0 3.128162130911806e-15
year O 0 7.016269618249915e-13
of O 0 2.2607881278863262e-12
birth O 0 5.495934818355863e-10
and O 0 1.0173828446369271e-10
parity O 0 3.360806601904187e-07
. O 0 2.945807686671742e-08

RESULTS O 0 3.5909430984304436e-09
The O 0 2.1661372348602548e-11
adjusted O 0 1.606964145084433e-10
odds O 0 3.6011335580177217e-10
ratio O 0 1.1202130334453386e-09
for O 0 7.112424071920032e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 3.4384793623498666e-11
with O 0 8.37238228829166e-16
any O 0 4.861006040778656e-15
past O 0 8.761513650007435e-14
use O 0 3.3843523280065527e-14
of O 0 7.48465254617886e-13
oral O 0 1.5222304527995334e-09
contraceptives O 0 3.732729680905322e-09
was O 0 2.3141462704434623e-11
0 O 0 1.9250632338208007e-11
. O 0 3.8336425700613574e-10

5 O 0 8.037571476438021e-12
( O 0 9.108750910382778e-16
95 O 0 1.6926532397931737e-10
percent O 0 1.3968978751499606e-10
confidence O 0 3.312538909838736e-09
interval O 0 1.0940065520159692e-09
, O 0 1.5363676720810474e-14
0 O 0 1.0019282741319181e-15
. O 0 1.5699175459789588e-15
3 O 0 2.826835242123772e-15
to O 0 5.362084474352935e-13
0 O 0 8.183777379453926e-15
. O 0 1.1288087909603998e-14
8 O 0 2.17007604919571e-13
) O 0 9.617864298494712e-15
. O 0 1.2310584843189254e-11

The O 0 4.0174777393708894e-10
risk O 0 5.7099294042961546e-11
decreased O 0 3.9480075458842023e-11
with O 0 4.222314452368266e-16
increasing O 0 1.6330619040209882e-13
duration O 0 3.0505467596420033e-10
of O 0 1.9000272275665475e-12
use O 0 4.605590648437685e-12
( O 0 4.7537769212605344e-14
P O 0 9.147063662062749e-10
for O 0 1.3420555899229525e-12
trend O 0 1.460330467661919e-10
, O 0 3.525834274065512e-14
< O 0 4.418243115117404e-12
0 O 0 2.14982107738296e-15
. O 0 3.8416188294170504e-15
001 O 0 5.1064001117817615e-12
) O 0 1.490283994905752e-17
; O 0 1.988066977315567e-18
use O 0 9.098818390285038e-16
for O 0 4.091035727549078e-15
six O 0 1.7573385238320305e-12
or O 0 4.968270396867383e-14
more O 0 1.3968782439755618e-15
years O 0 3.826585180449413e-14
was O 0 3.817487368969544e-14
associated O 0 1.6716643802712483e-13
with O 0 2.151002264827906e-15
a O 0 4.5429369359244187e-13
60 O 0 3.449666247101746e-11
percent O 0 2.498807410988846e-11
reduction O 0 1.271433930360999e-10
in O 0 3.754697594504641e-11
risk O 0 3.727244290985254e-09
. O 0 2.2346283046204007e-08

Oral O 0 0.002418705029413104
- O 0 4.0598840200800623e-07
contraceptive O 0 1.717399555900556e-08
use O 0 3.796015932144847e-11
protected O 0 6.408502031263197e-07
against O 1 0.9999878406524658
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 1.9646038268428256e-12
for O 0 8.348371974731435e-15
carriers O 0 1.2339316783518788e-14
of O 0 3.1922079996721253e-12
the O 0 1.565729074171074e-10
BRCA1 O 0 2.0562178626448713e-09
mutation O 0 3.5229740132092235e-12
( O 0 4.356496700251523e-15
odds O 0 7.484678432589931e-10
ratio O 0 1.5074301182305128e-11
, O 0 3.188802913671636e-14
0 O 0 5.3826754217842134e-15
. O 0 2.0227311951857407e-15
5 O 0 1.5325620165765048e-15
; O 0 1.5990120887782946e-17
95 O 0 8.966182830916214e-12
percent O 0 1.801736711215529e-11
confidence O 0 6.400128760297719e-10
interval O 0 2.6147808918075555e-10
, O 0 3.431974214367084e-14
0 O 0 1.4388359151386852e-15
. O 0 4.1988494692073944e-15
3 O 0 3.084190744795704e-15
to O 0 1.527786686224275e-12
0 O 0 3.547621316721608e-15
. O 0 4.367012614291685e-15
9 O 0 3.608909910279498e-14
) O 0 2.1537425686135065e-17
and O 0 5.031191079977822e-17
for O 0 6.79098183428413e-16
carriers O 0 5.4484133947107355e-14
of O 0 3.937815351573448e-12
the O 0 2.408150900912176e-10
BRCA2 O 0 1.6081033393788857e-08
mutation O 0 2.1159950527871452e-11
( O 0 1.7153516630665118e-14
odds O 0 3.396000147759537e-09
ratio O 0 6.005187319635397e-11
, O 0 2.197503924704705e-13
0 O 0 1.861925293578006e-14
. O 0 5.486473803756071e-15
4 O 0 2.4068589426996714e-15
; O 0 1.3270847342076123e-17
95 O 0 8.780661094054398e-12
percent O 0 1.9553412708428475e-11
confidence O 0 5.7051530166774e-10
interval O 0 1.482286515752662e-10
, O 0 3.1574945430620435e-14
0 O 0 1.380193494859665e-15
. O 0 2.452467643502816e-15
2 O 0 1.8530918834326225e-15
to O 0 4.743743917644261e-13
1 O 0 4.030025214907772e-14
. O 0 2.6189284641213624e-14
1 O 0 6.698084469881904e-14
) O 0 8.803521740806744e-15
. O 0 1.685789702277063e-11

CONCLUSIONS O 0 1.6148889017131296e-06
Oral O 0 0.0007858044118620455
- O 0 4.2781536535585474e-08
contraceptive O 0 4.2468320526900527e-10
use O 0 8.425672540311041e-14
may O 0 1.7627314674107178e-14
reduce O 0 8.909257880052035e-13
the O 0 1.0466083295163076e-12
risk O 0 2.096298743481384e-07
of O 1 0.9999992847442627
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.794574849307452e-10
women O 0 4.231816245624416e-14
with O 0 5.560978292400967e-16
pathogenic O 0 3.028060116018472e-14
mutations O 0 2.3499307900509518e-14
in O 0 4.655406241711388e-14
the O 0 1.5641550554779116e-11
BRCA1 O 0 1.8391537182083084e-09
or O 0 2.2656652109986908e-09
BRCA2 O 0 3.817277729467605e-07
gene O 0 3.148213068016048e-08

A O 0 9.130086686681693e-10
Japanese O 0 1.3153211853023095e-10
family O 0 1.179315000689185e-12
with O 0 1.4877792194837453e-13
adrenoleukodystrophy B-Disease 1 1.0
with O 0 4.924447622681877e-14
a O 0 3.068065007778842e-13
codon O 0 6.930439555574708e-10
291 O 0 3.35987959676487e-10
deletion O 0 1.904798097029925e-09
: O 0 2.580245587503749e-13
a O 0 1.0281504814191322e-11
clinical O 0 4.2123043941799665e-10
, O 0 6.204486252027464e-13
biochemical O 0 6.912732886110717e-11
, O 0 1.4651834433221378e-12
pathological O 0 2.5242126167057677e-09
, O 0 3.612162381271683e-13
and O 0 3.0630248229295e-13
genetic O 0 5.303280384283404e-11
report O 0 8.418516751762528e-12
. O 0 4.965513555887924e-10

We O 0 5.166001307288504e-12
report O 0 2.4352363252018797e-14
a O 0 9.570172108399558e-16
Japanese O 0 9.405045102092724e-13
family O 0 2.6189098632778407e-13
with O 0 4.382436796269984e-13
adrenoleukodystrophy B-Disease 1 1.0
( O 0 2.0361273431190874e-12
ALD B-Disease 1 1.0
) O 0 6.194638346285989e-16
with O 0 2.1264199658002674e-16
a O 0 7.182310166531022e-14
three O 0 2.44708740033614e-13
base O 0 4.7271925956993144e-11
pair O 0 5.037815720143612e-10
deletion O 0 5.640676259410782e-10
( O 0 7.47795651356159e-14
delGAG O 0 9.923425636770844e-09
291 O 0 1.1551497605677419e-11
) O 0 9.774873501971321e-16
in O 0 5.778924973103006e-14
the O 0 4.0108145971107234e-11
ALD B-Disease 1 1.0
gene O 0 1.0592944299503415e-09
. O 0 3.3870473092889597e-09

A O 0 7.895698672655271e-08
variety O 0 1.633867346972906e-11
of O 0 9.620062559057008e-12
phenotypes O 0 1.5475459455571716e-11
were O 0 3.0898836007181574e-12
observed O 0 6.927455570987506e-13
within O 0 1.2295866365016894e-12
this O 0 1.9177830168099624e-13
family O 0 1.8184464350978757e-11
. O 0 1.0758876012317842e-09

While O 0 3.971259519147674e-12
the O 0 8.425295183744907e-12
proband O 0 0.16451267898082733
( O 0 1.1395027716548656e-12
patient O 0 1.4936963887990373e-09
1 O 0 7.271690844953826e-13
) O 0 1.250788248101126e-15
was O 0 1.1652682399727887e-13
classified O 0 6.841356908066087e-13
as O 0 1.7240337507758684e-14
having O 0 2.257840615860207e-12
a O 0 2.3878395463174107e-13
rare O 0 1.5415610682498887e-13
intermediate O 0 6.70838384841943e-12
type O 0 1.452388036227159e-11
of O 0 2.466461410111087e-11
adult O 0 1.8038953442101047e-08
cerebral O 0 1.4153114534565248e-05
and O 0 1.9896768677085674e-09
cerebello O 1 0.9999964237213135
- O 0 0.0014242889592424035
brain O 0 9.591423122401466e-07
stem O 0 2.5616534934935764e-11
forms O 0 5.735670049805339e-14
, O 0 3.354155841664953e-17
his O 0 6.250331334315198e-14
younger O 0 2.455727288186438e-10
brother O 0 1.025089524375744e-08
( O 0 1.0632009731165529e-13
patient O 0 8.655510197463911e-10
2 O 0 2.6734413023209863e-14
) O 0 1.225598970557441e-16
and O 0 2.4340057557361086e-14
nephew O 0 2.3146117200667504e-07
( O 0 5.342850727813042e-13
patient O 0 1.1069236638405755e-09
3 O 0 1.3917742826274893e-12
) O 0 1.1544145969558973e-14
had O 0 8.386459387187128e-13
a O 0 1.2242376383475584e-11
childhood O 0 6.241462529033015e-07
ALD B-Disease 1 1.0
type O 0 2.723079433053499e-07
. O 0 1.0087159552085723e-08

Another O 0 4.102838069286463e-10
nephew O 0 6.269154368965246e-07
( O 0 1.407210123167274e-13
patient O 0 3.1608812789407637e-10
4 O 0 1.8743726460258153e-13
) O 0 1.4933357090309214e-15
of O 0 4.2646528669587624e-12
patient O 0 2.8103288585157316e-09
1 O 0 1.1270270307284225e-11
was O 0 5.501561445991898e-12
classified O 0 2.599224654953325e-12
as O 0 5.668761223235827e-14
having O 0 6.050402366619689e-12
an O 0 6.065812999458964e-13
adolescent O 0 3.806552295593235e-10
form O 0 2.533480716881975e-11
. O 0 1.8254749933888093e-09

The O 0 1.893673218233971e-09
tau O 0 1.531841181678928e-10
level O 0 4.2615269646439913e-10
in O 0 9.139480621964124e-13
the O 0 1.720889056255892e-11
cerebrospinal O 0 3.2636160440802087e-09
fluid O 0 3.3455810344307224e-10
( O 0 3.241962904729223e-13
CSF O 0 1.9838427078866516e-07
) O 0 1.8306909536480037e-13
in O 0 1.2466756793561018e-10
patient O 0 1.8473538148100488e-06
1 O 0 9.587951092793201e-12
was O 0 6.5492728427984925e-12
as O 0 7.411611980341539e-15
high O 0 2.2179928724284752e-14
as O 0 5.843813975494407e-17
that O 0 6.032905478290559e-17
of O 0 9.066709107672169e-14
patients O 0 6.238475014352929e-12
with O 0 2.442269719793444e-10
Alzheimers B-Disease 1 0.9999983310699463
disease I-Disease 0 6.206945513120843e-10
( O 0 5.159314210021794e-16
AD B-Disease 0 3.3582009395516366e-10
) O 0 5.707602088438762e-14
. O 0 1.296842216946814e-10

His O 0 1.4806124326582903e-08
brain O 0 1.2654738590356374e-08
magnetic O 0 1.776251021268216e-11
resonance O 0 3.69329358762549e-11
image O 0 6.769811707746376e-12
( O 0 1.3162665419018437e-15
MRI O 0 2.638953411349121e-08
) O 0 1.1769498238143033e-14
showed O 0 6.972329831544943e-12
abnormalities B-Disease 0 2.3012772243369284e-10
in I-Disease 0 4.5535874604405585e-14
the I-Disease 0 4.63186910701352e-12
bilateral I-Disease 0 0.00032254194957204163
cerebellar I-Disease 1 0.9999998807907104
hemispheres I-Disease 1 0.9985527396202087
and O 0 8.460465750204094e-08
brain O 0 3.746737775145448e-06
stem O 0 7.736907225996958e-10
, O 0 1.7746363460777875e-14
but O 0 1.1467248930475439e-14
not O 0 9.767745423258645e-14
in O 0 8.494324167662715e-12
the O 0 8.390871886199136e-10
cerebral O 0 5.891162345506018e-06
white O 0 9.001275419473487e-12
matter O 0 2.510018408397041e-11
, O 0 1.1746034578471141e-15
where O 0 4.582124783939032e-16
marked O 0 2.275070594155021e-13
reductions O 0 1.2779399760631804e-10
of O 0 1.6454958229328298e-10
the O 0 1.2369439916781744e-09
cerebral O 0 4.59263475249827e-07
blood O 0 2.3317305419823242e-08
flow O 0 2.480297034423984e-08
and O 0 7.59687313056645e-11
oxygen O 0 3.288928851485906e-10
metabolism O 0 5.862604623985135e-09
were O 0 2.102412428178768e-12
clearly O 0 3.228533502282367e-14
demonstrated O 0 3.472945875652132e-14
by O 0 9.37054444218185e-16
positron O 0 2.8024041420771084e-11
emission O 0 3.4724081249271066e-11
tomography O 0 2.9166292492277535e-08
( O 0 1.7544490166221394e-11
PET O 0 7.759339268886833e-07
) O 0 1.9638247191616776e-12
. O 0 3.496988809637003e-10

In O 0 2.9077902308216608e-09
patients O 0 1.2759532319606137e-09
2 O 0 8.662817858884342e-12
and O 0 2.8451538542674515e-13
3 O 0 1.7532539005674086e-12
, O 0 3.9006417792476246e-15
the O 0 1.4000744804503786e-14
autopsy O 0 4.756650281989572e-11
findings O 0 6.162926072250663e-12
showed O 0 3.285366076410945e-11
massive O 0 1.2255355619217312e-09
demyelination B-Disease 1 1.0
of I-Disease 0 5.006792434869567e-06
the I-Disease 0 1.3741641851083841e-06
cerebral I-Disease 0 0.06798474490642548
white I-Disease 0 1.2606200805453938e-11
matter I-Disease 0 2.351018034765784e-12
with O 0 6.029388571023779e-16
sparing O 0 1.241190206169307e-10
of O 0 2.5116111412870623e-09
the O 0 3.179374985506911e-08
U O 0 5.433893602457829e-05
- O 0 2.593856329724531e-08
fibers O 0 1.257430515266833e-08
, O 0 3.32651657955485e-14
compatible O 0 3.098881429242084e-10
with O 0 2.9301614561670945e-16
the O 0 1.17098916826118e-14
findings O 0 1.272756856504631e-13
of O 0 1.2095819137969421e-12
childhood O 0 3.884730688241689e-07
ALD B-Disease 1 1.0
. O 0 6.737517566079987e-08

Oleic O 0 0.0010145555716007948
and O 0 1.1920614895188919e-07
erucic O 1 0.9109063148498535
acids O 0 3.248616451401176e-07
( O 0 1.5546276288871952e-12
Lorenzos O 0 1.1246391551367196e-07
Oil O 0 1.1560562229728788e-10
) O 0 3.0832012514946333e-16
were O 0 4.0621209873451317e-14
administered O 0 2.121052899289877e-12
to O 0 1.6659526189122253e-11
patients O 0 1.217905030298505e-11
1 O 0 1.7787826333409695e-12
and O 0 1.0539742906559568e-12
4 O 0 1.1756659881734244e-11
, O 0 3.363553264580134e-14
but O 0 1.1010963293217862e-14
sufficient O 0 8.498667047884823e-12
effectiveness O 0 2.857447611859243e-11
was O 0 1.4715606120804803e-12
not O 0 4.730497677601919e-13
obtained O 0 1.4524559333040088e-09
. O 0 6.22754692258809e-09

The O 0 3.144874805016684e-09
findings O 0 1.7641466412698925e-11
in O 0 5.6780779080292665e-14
this O 0 4.627158031733636e-14
family O 0 1.5324936144308493e-13
suggest O 0 3.2640762922392375e-13
that O 0 3.4557229006257264e-16
delGAG291 O 0 1.0576288733687988e-09
is O 0 1.2614016768093409e-15
part O 0 1.9329680813872513e-13
of O 0 1.4730855424360811e-12
the O 0 2.058341561431143e-12
cause O 0 1.4606899023661413e-10
of O 0 1.146464798096325e-10
Japanese O 0 5.571404244619771e-07
ALD B-Disease 1 1.0
with O 0 4.804087683218938e-12
phenotypic O 0 7.030131476959411e-10
variations O 0 1.005365027340055e-10
. O 0 2.2364394780538532e-09

Moreover O 0 4.81955053643901e-09
, O 0 1.635539136578528e-14
although O 0 2.5596850739662653e-15
the O 0 2.6317159087678238e-15
scale O 0 8.698908563961605e-13
of O 0 4.39216046345392e-13
the O 0 1.0616209517380626e-12
study O 0 5.738605662712615e-13
is O 0 3.894189505771915e-15
limited O 0 5.821800940636335e-12
, O 0 6.182949660073211e-13
there O 0 6.785919482582559e-12
is O 0 4.3811831875080476e-13
a O 0 1.5253505056267436e-11
possibility O 0 3.4279515337409805e-10
that O 0 4.418515206494611e-11
PET O 0 1.949196848727297e-05
can O 0 2.494181305934262e-09
detect O 0 4.899588361695351e-07
an O 0 1.283570749688323e-10
insidious B-Disease 0 1.4445942042584647e-07
lesion I-Disease 0 1.9740073184948415e-05
which O 0 4.99172480693949e-13
is O 0 1.5044319888707185e-14
undetectable O 0 1.5391321030178151e-12
by O 0 7.769462118853681e-16
computed O 0 2.8066099444501447e-10
tomogram O 0 1.635190642446105e-06
( O 0 6.203255682561692e-13
CT O 0 2.6523661489363803e-08
) O 0 2.3069636885487618e-14
or O 0 2.560053948344465e-13
MRI O 0 5.096609356769477e-09
analysis O 0 6.330697142724329e-13
, O 0 1.3567798895410004e-16
and O 0 2.5622027007309664e-17
that O 0 4.898749703176854e-18
the O 0 3.92221782599656e-15
higher O 0 6.4678465491394e-13
level O 0 2.1829140925411217e-11
of O 0 4.447726908995975e-12
tau O 0 2.3618498649902175e-12
reflects O 0 1.783578845596448e-13
the O 0 1.3994523347506203e-14
process O 0 2.182773684022976e-10
of O 0 2.868227877428353e-10
neuronal B-Disease 0 1.2682676242548041e-05
degeneration I-Disease 1 0.9999386072158813
in O 0 1.6095847854558087e-07
ALD B-Disease 1 1.0
. O 0 4.5350660116127983e-07

Lorenzos O 0 5.5927357607288286e-05
Oil O 0 1.1141783051726861e-09
should O 0 1.2367693403691343e-13
be O 0 3.7595769122118934e-15
given O 0 1.3313555868242318e-15
in O 0 1.921845547761254e-15
the O 0 5.923247613557172e-15
early O 0 1.4764891783161649e-12
stage O 0 3.172319004707269e-11
. O 0 1.7459598003477517e-11
. O 0 2.941269894307652e-09

Nonsense O 0 8.177452741620073e-07
mutation O 0 2.222370898419257e-11
in O 0 1.3810494414734364e-11
exon O 0 3.022572470090523e-10
4 O 0 9.0567284574683e-12
of O 0 1.5626671831525663e-11
human O 0 1.2125415255193062e-11
complement O 0 1.929704396275156e-09
C9 O 0 2.709727368710446e-06
gene O 0 1.0432161861792522e-12
is O 0 1.4388578321161954e-15
the O 0 1.335797385247986e-14
major O 0 6.840561103671483e-13
cause O 0 7.684795855222859e-11
of O 0 1.5571548217518938e-10
Japanese O 0 1.2965634823558503e-06
complement B-Disease 0 1.10799710455467e-05
C9 I-Disease 1 0.9522806406021118
deficiency I-Disease 0 0.0027759731747210026
. O 0 8.538523843526491e-08

Deficiency B-Disease 0 1.8947468561236747e-05
of I-Disease 0 1.3283115052331596e-08
the I-Disease 0 3.283864014047566e-10
ninth I-Disease 0 4.804061290997197e-07
component I-Disease 0 8.795538186667784e-10
of I-Disease 0 1.9418758268052727e-11
human I-Disease 0 7.631186481338315e-12
complement I-Disease 0 3.5815448384823867e-09
( O 0 1.1851186264982827e-13
C9 O 0 2.8755382572853705e-06
) O 0 1.9227192198946995e-14
is O 0 1.499706773222813e-15
the O 0 5.588480118121422e-14
most O 0 1.2912472469300135e-13
common O 0 2.008915034323877e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 8.97311600023265e-11
Japan O 0 2.405011190198536e-10
but O 0 3.233311242443332e-13
is O 0 1.0324289776504798e-14
rare O 0 9.000034875347729e-13
in O 0 2.0421858648589364e-13
other O 0 3.9084881164885843e-13
countries O 0 6.869319002511531e-11
. O 0 1.9179561050464145e-08

We O 0 4.7249572310281707e-11
studied O 0 4.982421810198479e-13
the O 0 4.6157756029884325e-15
molecular O 0 1.4763807987564978e-14
basis O 0 1.3438235767215811e-11
of O 0 1.4571391315776339e-10
C9 B-Disease 0 0.0008599073626101017
deficiency I-Disease 0 7.55647704409057e-07
in O 0 4.6190790775613166e-11
four O 0 7.11107145390244e-11
Japanese O 0 1.2334978372052774e-08
C9 B-Disease 0 0.14100661873817444
- I-Disease 0 7.224151659102063e-07
deficient I-Disease 0 5.911936540314855e-08
patients O 0 5.1178228321902e-10
who O 0 4.161796341578539e-12
had O 0 5.7960327509709586e-11
suffered O 0 4.516598437476205e-06
from O 0 5.335539565720637e-09
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 6.052751078122753e-10

Direct O 0 1.0662034623243333e-11
sequencing O 0 9.679904100501346e-11
of O 0 1.3532072684618868e-10
amplified O 0 2.0598231453838878e-11
C9 O 0 6.490574300244134e-09
cDNA O 0 3.5846933754690724e-10
and O 0 1.2347328021133919e-13
DNA O 0 2.583874225692284e-10
revealed O 0 2.010683980424588e-11
a O 0 6.412875872691126e-13
nonsense O 0 4.5256447894770346e-11
substitution O 0 2.1517444943885966e-12
( O 0 2.386589444271876e-15
CGA O 0 2.5069315512382673e-08
- O 0 7.607248164731573e-09
- O 0 8.412762708687183e-10
> O 0 4.348237395146448e-11
TGA O 0 4.3771303248618665e-10
) O 0 1.126716741341668e-16
at O 0 6.845465492198721e-14
codon O 0 5.694949286455531e-12
95 O 0 9.604831513465584e-11
in O 0 7.662895491755695e-12
exon O 0 1.2901586743385707e-10
4 O 0 5.446202842006309e-13
in O 0 5.464485201139846e-13
the O 0 1.372431161772436e-11
four O 0 9.612276530290842e-10
C9 B-Disease 0 0.0020630585495382547
- I-Disease 0 5.244683620730939e-07
deficient I-Disease 0 7.349892428010207e-08
individuals O 0 7.267274282352076e-11
. O 0 6.4280989420240076e-09

An O 0 6.899088776397139e-14
allele O 0 3.1301662650751183e-12
- O 0 3.542540067714983e-13
specific O 0 4.5787223161173826e-14
polymerase O 0 1.886467761516575e-12
chain O 0 3.482807141644284e-12
reaction O 0 2.2775802511337817e-13
system O 0 4.850991570243268e-12
designed O 0 8.256345368669316e-13
to O 0 1.9598918842012036e-12
detect O 0 2.038334345061399e-12
exclusively O 0 7.740511790560456e-13
only O 0 1.4581648470060257e-14
one O 0 3.705240595678477e-14
of O 0 1.0758757166412503e-12
the O 0 4.062295638762592e-12
normal O 0 6.555929132900928e-10
and O 0 7.281860932382284e-14
mutant O 0 5.149707700199957e-13
alleles O 0 7.15098011187798e-14
indicated O 0 8.334887684549597e-13
that O 0 2.993602476910988e-15
all O 0 2.7660447039388678e-14
the O 0 8.212275260863211e-13
four O 0 1.7129894508069454e-12
patients O 0 3.1703803536446695e-13
were O 0 9.089292361298684e-13
homozygous O 0 7.468271660815429e-12
for O 0 5.684745209288966e-13
the O 0 5.706967884377967e-11
mutation O 0 1.2102148276571523e-11
in O 0 5.95225257971066e-11
exon O 0 4.503430961477761e-10
4 O 0 1.0723621426608765e-12
and O 0 3.928366353457384e-14
that O 0 2.7137955189391336e-15
the O 0 3.717368210129357e-13
parents O 0 2.9666696616664767e-12
of O 0 4.700489303344213e-11
patient O 0 1.2155484396814131e-09
2 O 0 3.4963736766924214e-11
were O 0 4.252968532902912e-10
heterozygous O 0 3.1515504095303015e-10
. O 0 3.2302789332305792e-09

The O 0 6.385030698607963e-11
common O 0 4.17776663957925e-12
mutation O 0 1.7908054596518785e-13
at O 0 3.947794782049874e-12
codon O 0 1.7285085862628335e-10
95 O 0 4.228230565672675e-08
in O 0 7.942454471887572e-10
exon O 0 3.5991303271032393e-09
4 O 0 5.539626049544388e-12
might O 0 1.3634004949331091e-12
be O 0 1.7460312980600162e-13
responsible O 0 2.0516597101782885e-11
for O 0 7.080371879075731e-12
most O 0 2.8517306571718137e-11
Japanese O 0 2.0214778828631097e-07
C9 B-Disease 0 0.022675618529319763
deficiency I-Disease 0 6.404451369235176e-07
. O 0 2.96759387896639e-11
. O 0 5.699062888275819e-10

BRCA1 O 0 4.8317318895874095e-11
required O 0 1.8541775753666556e-11
for O 0 3.138164858182413e-12
transcription O 0 2.940553223140796e-08
- O 0 1.2462893828057986e-08
coupled O 0 2.333019555322835e-09
repair O 0 0.00045436961227096617
of O 0 3.16091763874482e-10
oxidative O 0 1.9124765771039165e-08
DNA O 0 9.897132713376777e-07
damage O 0 6.376752139658493e-07
. O 0 1.3488838934705427e-09

The O 0 1.7096170035202363e-09
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 1.2884656008793627e-08
gene O 0 1.062500608328687e-11
BRCA1 O 0 9.81665651544894e-11
encodes O 0 3.262426949684344e-13
a O 0 1.6871204953916585e-12
zinc O 0 3.736957618349912e-11
finger O 0 1.7811552233126804e-09
protein O 0 2.037690155498595e-11
of O 0 6.945889610004974e-12
unknown O 0 2.825237599424213e-09
function O 0 3.494436962014902e-09
. O 0 1.5400652975117168e-09

Association O 0 8.044323540623566e-11
of O 0 3.896781335110955e-12
the O 0 3.635344250022682e-13
BRCA1 O 0 3.6790175398336566e-13
protein O 0 2.62062591814766e-15
with O 0 2.1323404283165544e-17
the O 0 7.149353639212663e-15
DNA O 0 4.1001077533131536e-10
repair O 0 7.599281843795325e-07
protein O 0 1.5192673508135357e-11
Rad51 O 0 2.6318143220294132e-09
and O 0 1.2086207245253205e-15
changes O 0 5.28261097280209e-16
in O 0 3.521623122713295e-16
the O 0 1.9256764660234484e-15
phosphorylation O 0 1.1448700602996464e-13
and O 0 1.0815099629659514e-14
cellular O 0 4.8090958298940834e-11
localization O 0 2.226298612129085e-08
of O 0 2.2693835699527654e-10
the O 0 9.166462727749902e-11
protein O 0 3.1999333738319535e-11
after O 0 6.266297376822383e-12
exposure O 0 2.497797108036437e-11
to O 0 2.1308793271557214e-11
DNA O 0 1.9730136955331545e-06
- O 0 3.109925872379904e-09
damaging O 0 3.529743997088275e-10
agents O 0 1.6991174092706451e-12
are O 0 6.4578681283262475e-15
consistent O 0 3.0744107346741822e-12
with O 0 1.3610722290012116e-16
a O 0 1.952126001537706e-14
role O 0 9.722744934463276e-14
for O 0 5.43569041774189e-13
BRCA1 O 0 5.105820766182489e-10
in O 0 2.027223180989246e-11
DNA O 0 1.2322113889240427e-06
repair O 0 0.0038962175603955984
. O 0 9.131731815159583e-08

Here O 0 2.0614603357671513e-09
, O 0 2.7375240881652788e-14
it O 0 5.1993406857698467e-17
is O 0 1.0590860739562506e-17
shown O 0 2.6952881455031587e-14
that O 0 1.6341640632919555e-14
mouse O 0 2.947641089545705e-11
embryonic O 0 1.9225552261303847e-09
stem O 0 1.2092746803915588e-09
cells O 0 3.0614131230066732e-09
deficient B-Disease 0 7.984992578258243e-08
in I-Disease 0 1.987908171408037e-10
BRCA1 I-Disease 0 1.8219070696545714e-08
are O 0 2.2950318403526515e-13
defective O 0 3.3829006262919847e-10
in O 0 2.836657503942769e-13
the O 0 9.564196629769858e-14
ability O 0 1.1601768807809054e-12
to O 0 2.401844456829949e-13
carry O 0 1.1239600222756607e-10
out O 0 9.084843120843455e-12
transcription O 0 3.39745355404375e-07
- O 0 1.055032754493368e-07
coupled O 0 2.247870298788257e-07
repair O 1 0.9894101619720459
of O 0 6.780453976062972e-10
oxidative O 0 7.384597822124306e-09
DNA O 0 3.0945670914661605e-07
damage O 0 9.752336715962429e-09
, O 0 2.3983456686567026e-14
and O 0 1.8693268368777036e-14
are O 0 5.159871282415379e-14
hypersensitive O 0 5.654262391630027e-09
to O 0 2.1805496075444353e-08
ionizing O 0 6.25230313744396e-06
radiation O 0 1.0399381835668464e-06
and O 0 3.8678449332252285e-11
hydrogen O 0 9.780889431709738e-10
peroxide O 0 8.558057373875272e-08
. O 0 7.539774138365374e-09

These O 0 9.591613614468031e-11
results O 0 8.937196122049684e-11
suggest O 0 3.521941072115453e-11
that O 0 3.226245496885244e-13
BRCA1 O 0 1.16969017804891e-10
participates O 0 2.9841209798348034e-12
, O 0 9.147023247071517e-15
directly O 0 1.852617885489405e-12
or O 0 6.680060692966505e-13
indirectly O 0 1.2257780901414606e-10
, O 0 1.5241295706525278e-14
in O 0 3.812318082746513e-12
transcription O 0 1.905133757418298e-07
- O 0 3.1184985260779285e-08
coupled O 0 4.7702407357519405e-08
repair O 0 0.0008587995544075966
of O 0 6.556203913099523e-10
oxidative O 0 6.705452193500605e-09
DNA O 0 8.895389669305587e-08
damage O 0 9.692735503108452e-09
. O 0 9.565775255238051e-12
. O 0 1.4111417590001452e-10

Truncation O 0 9.705556749395328e-07
mutations O 0 1.006748573395555e-10
in O 0 3.155178212883164e-13
the O 0 1.1188276867468705e-12
transactivation O 0 6.682344633190951e-07
region O 0 1.929093551567007e-09
of O 0 2.8036725718827427e-10
PAX6 O 0 1.0715724783949554e-05
result O 0 5.891207521813158e-10
in O 0 1.7063941926132031e-10
dominant O 0 2.891482893119246e-07
- O 0 8.058733125260176e-10
negative O 0 5.4452917869207695e-12
mutants O 0 7.820179226403212e-11
. O 0 9.111484483570464e-11

PAX6 O 0 0.0008942227577790618
is O 0 4.786599935857616e-12
a O 0 1.360197761715587e-12
transcription O 0 5.3655660643692205e-12
factor O 0 7.734442155748339e-14
with O 0 1.0317118583815107e-15
two O 0 5.45791981488436e-14
DNA O 0 7.215635311474955e-10
- O 0 6.219216548003503e-12
binding O 0 3.136321931329622e-12
domains O 0 2.784242836284534e-10
( O 0 8.468908045378392e-16
paired O 0 1.0193033049554767e-11
box O 0 1.7219331863160825e-11
and O 0 3.2495653303626915e-13
homeobox O 0 6.992567080921219e-10
) O 0 7.65651027533732e-16
and O 0 2.2113653478359786e-14
a O 0 1.5969565947404618e-11
proline O 0 2.759667268037447e-07
- O 0 1.510465708065567e-08
serine O 0 1.41023167543608e-06
- O 0 4.4605638294115124e-08
threonine O 0 2.2164672941471508e-07
( O 0 1.0551111435494107e-15
PST O 0 5.171786554569735e-09
) O 0 2.8749136792428735e-15
- O 0 4.214676838868586e-13
rich O 0 3.818989395554251e-13
transactivation O 0 7.240388555374011e-08
domain O 0 7.952549729850489e-10
. O 0 3.485533389691042e-11

PAX6 O 1 0.9967999458312988
regulates O 0 6.278416009308785e-08
eye O 0 1.9469676715289097e-07
development O 0 3.58497729280316e-08
in O 0 2.4204620512752184e-12
animals O 0 3.070658419375427e-13
ranging O 0 7.314538731650888e-12
from O 0 2.2102627887654602e-12
jellyfish O 0 5.542201897065779e-13
to O 0 2.0011076129478056e-11
Drosophila O 0 8.125952133397618e-10
to O 0 1.3923145969485518e-10
humans O 0 2.206285820705034e-09
. O 0 1.7927640483250684e-09

Heterozygous O 0 1.5190140256748919e-09
mutations O 0 1.0022265135856134e-11
in O 0 1.8484942309465735e-13
the O 0 4.0285670307484145e-13
human O 0 5.3263699874295245e-12
PAX6 O 0 5.489653744916723e-07
gene O 0 2.0793776856625756e-12
result O 0 3.6016038242048243e-12
in O 0 1.6273778386064613e-13
various O 0 1.969263510939734e-12
phenotypes O 0 6.223966481089249e-11
, O 0 1.773797105833648e-14
including O 0 4.559134645330809e-13
aniridia B-Disease 1 1.0
, O 0 1.5531836927706877e-09
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 5.261869065464886e-11
autosomal B-Disease 0 1.3582531437350553e-06
dominant I-Disease 0 3.102799794874045e-08
keratitis I-Disease 0 0.012658629566431046
, O 0 1.313725950941036e-11
and O 0 2.5747337595305453e-10
familial B-Disease 1 0.9999966621398926
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9999926090240479

It O 0 4.83331256961872e-13
is O 0 1.8329147115960778e-15
believed O 0 5.714224530833575e-14
that O 0 8.34501491846367e-18
the O 0 1.4796520770564854e-16
mutated O 0 2.3070273748384835e-16
allele O 0 3.62254605652812e-13
of O 0 5.708151399469452e-12
PAX6 O 0 4.107300355826737e-06
produces O 0 3.787870191118703e-12
an O 0 3.5186859936170434e-14
inactive O 0 3.247276059159532e-11
protein O 0 7.394517220760122e-10
and O 0 4.1484603946484455e-11
aniridia B-Disease 1 1.0
is O 0 1.0989390820947964e-11
caused O 0 1.48496062668535e-10
due O 0 6.3386842441559565e-09
to O 0 1.026517315594333e-09
genetic O 0 2.579479740916213e-08
haploinsufficiency O 0 3.291014309070306e-06
. O 0 2.008375865614198e-08

However O 0 6.484845105347858e-09
, O 0 1.6769472095667926e-12
several O 0 7.791422129872771e-13
truncation O 0 1.575232211337152e-08
mutations O 0 8.509149634905455e-11
have O 0 9.372197977549832e-14
been O 0 1.305292543973477e-13
found O 0 1.0733801407382046e-14
to O 0 5.013304766980642e-14
occur O 0 1.5071043371617243e-12
in O 0 2.902889991644557e-14
the O 0 1.7179365568997795e-12
C O 0 5.376473932727777e-09
- O 0 7.543866920034503e-11
terminal O 0 4.753829274672938e-11
half O 0 1.92164339996026e-12
of O 0 9.79340089926617e-13
PAX6 O 0 2.8033286980644334e-07
in O 0 3.463714558227249e-12
patients O 0 4.750403542752579e-11
with O 0 6.3828603860671684e-12
Aniridia B-Disease 1 1.0
resulting O 0 3.830487038669617e-09
in O 0 8.33276243145109e-12
mutant O 0 9.315605578597008e-12
proteins O 0 7.919267997445745e-13
that O 0 7.251642184956039e-15
retain O 0 8.897753367431704e-11
the O 0 8.809228520256784e-12
DNA O 0 5.338135267152211e-09
- O 0 1.5019856886011596e-11
binding O 0 1.1489948749388024e-11
domains O 0 2.7704960547936253e-10
but O 0 9.152333296617854e-14
have O 0 3.5938598288726836e-14
lost O 0 2.872058493808005e-11
most O 0 6.695884386504706e-15
of O 0 1.8033025159930327e-13
the O 0 2.885394180529577e-12
transactivation O 0 1.9065092828896013e-06
domain O 0 2.670345722322054e-08
. O 0 5.75560799020991e-09

It O 0 8.703493654949046e-12
is O 0 2.4923251600006933e-14
not O 0 8.207165822600102e-14
clear O 0 6.667271335719649e-12
whether O 0 1.585779034127266e-13
such O 0 9.260182274846776e-14
mutants O 0 4.735930536625688e-10
really O 0 5.447867851282595e-12
behave O 0 6.078556061273055e-12
as O 0 2.84460579006926e-13
loss O 0 4.753006876967447e-10
- O 0 1.719138026379241e-10
of O 0 7.203318830306671e-09
- O 0 9.026024372360553e-10
function O 0 1.2330089206591399e-11
mutants O 0 2.4433948787871973e-12
as O 0 2.3797337713550365e-16
predicted O 0 2.2545431233728097e-13
by O 0 7.963641139759059e-15
haploinsufficiency O 0 5.498183668350975e-07
. O 0 3.411919635709637e-09

Contrary O 0 9.93706272822692e-09
to O 0 1.995577141034044e-11
this O 0 5.44126104850412e-13
theory O 0 8.246182382765088e-12
, O 0 6.341519259174923e-15
our O 0 1.205528190294236e-12
data O 0 1.5818195277933489e-12
showed O 0 5.443212070313508e-13
that O 0 1.9472376896958066e-16
these O 0 3.56081343135862e-15
mutants O 0 6.24626175435572e-12
are O 0 3.848785913996948e-14
dominant O 0 6.671148522485737e-09
- O 0 6.495112087057109e-11
negative O 0 4.3660695718539255e-12
in O 0 4.144574874270779e-12
transient O 0 1.5004609776880784e-09
transfection O 0 5.629243293725494e-09
assays O 0 9.299379842564459e-12
when O 0 6.536438057480609e-14
they O 0 8.068821625390951e-14
are O 0 5.254620049082066e-14
coexpressed O 0 2.0751107498995225e-08
with O 0 2.281924107137845e-13
wild O 0 4.393398977953211e-10
- O 0 8.40262748269538e-10
type O 0 2.8397220130926826e-09
PAX6 O 0 4.588149386108853e-05
. O 0 9.74969704969908e-09

We O 0 2.547382443873758e-11
found O 0 1.4438516842633226e-13
that O 0 1.8232552272749286e-16
the O 0 3.783187277990249e-14
dominant O 0 9.948811219295806e-11
- O 0 7.194968904521148e-13
negative O 0 3.188291983397852e-14
effects O 0 1.0179131707454755e-13
result O 0 2.696811957775269e-13
from O 0 1.0964506754786163e-13
the O 0 4.002096505757724e-14
enhanced O 0 1.3493860976515615e-12
DNA O 0 7.603958261659383e-12
binding O 0 8.498403261496257e-13
ability O 0 1.6438332639534536e-10
of O 0 3.020024161304313e-11
these O 0 1.2490408880794224e-11
mutants O 0 4.730886349335606e-09
. O 0 2.2150687950528436e-09

Kinetic O 0 3.0855420440900616e-09
studies O 0 1.4232589065632517e-11
of O 0 1.1362103749176788e-12
binding O 0 2.3980109564725183e-11
and O 0 1.4220587598104406e-12
dissociation O 0 1.535814114772549e-10
revealed O 0 7.074894836645029e-11
that O 0 1.552060312681649e-14
various O 0 1.8639490992344854e-12
truncation O 0 6.9663319557378145e-09
mutants O 0 4.2891623586172045e-10
have O 0 1.539328777291904e-12
3 O 0 9.64122358337871e-12
- O 0 1.5285191515279628e-11
5 O 0 3.539873906152624e-12
- O 0 2.024077303333649e-12
fold O 0 7.763696369816886e-13
higher O 0 5.254071917121239e-13
affinity O 0 5.757811491046566e-14
to O 0 6.64758233268753e-14
various O 0 3.864463545173724e-13
DNA O 0 1.002179242370893e-10
- O 0 2.1825622635151393e-13
binding O 0 1.418755521051529e-13
sites O 0 4.844785054906875e-13
when O 0 1.7385955812160617e-15
compared O 0 1.245191016269187e-13
with O 0 4.550943383568233e-16
the O 0 5.542624735913049e-13
wild O 0 6.101977256811608e-11
- O 0 1.2007310423722828e-10
type O 0 8.731669276507148e-10
PAX6 O 0 1.910948230943177e-05
. O 0 1.3362218886925348e-08

These O 0 2.426730257715226e-12
results O 0 3.841690420641752e-12
provide O 0 1.6251453308080421e-12
a O 0 1.7830310524487997e-13
new O 0 2.0999415517564644e-14
insight O 0 1.4934034911484595e-12
into O 0 4.924419162374849e-14
the O 0 1.263835227877791e-13
role O 0 8.04961479416999e-12
of O 0 4.035723144557579e-11
mutant O 0 8.502940573862361e-10
PAX6 O 0 4.738406914839288e-06
in O 0 1.684106465393853e-10
causing O 0 4.2132324296062507e-08
aniridia B-Disease 1 1.0
. O 0 1.1201041205666229e-09
. O 0 2.443365731963354e-09

Reversal O 0 6.236749783283813e-08
of O 0 2.0172239434401718e-09
severe O 0 1.4354291124618612e-05
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 1.2972908507435932e-06
excellent O 0 2.56715519952877e-08
neuropsychologic O 0 3.6652341162124458e-09
outcome O 0 2.2699030155504119e-10
in O 0 3.511205811778523e-13
very B-Disease 0 2.4670329256022694e-13
- I-Disease 0 3.722420050152053e-13
long I-Disease 0 7.791882915796078e-13
- I-Disease 0 2.407891160766118e-12
chain I-Disease 0 9.03036705742627e-13
acyl I-Disease 0 2.900663910454515e-11
- I-Disease 0 1.058102494511104e-10
coenzyme I-Disease 0 1.0315025500418074e-09
A I-Disease 0 2.1182238185701863e-07
dehydrogenase I-Disease 0 1.3696674159291433e-06
deficiency I-Disease 0 1.1864265616168268e-05
. O 0 3.5447286772516406e-10

Very B-Disease 0 5.430750033702525e-12
- I-Disease 0 8.429968962470058e-13
long I-Disease 0 7.326441292835814e-14
- I-Disease 0 3.0064041940626104e-14
chain I-Disease 0 1.1871896262894842e-15
acyl I-Disease 0 2.6261663606556504e-14
- I-Disease 0 2.936161784625885e-14
coenzyme I-Disease 0 1.1740849720394408e-13
A I-Disease 0 3.5787601181114237e-12
dehydrogenase I-Disease 0 2.028552889901669e-12
( I-Disease 0 1.3062077080158436e-15
VLCAD I-Disease 0 3.3392781915608793e-05
) I-Disease 0 1.8265498095688774e-14
deficiency I-Disease 0 1.647717073893773e-09
is O 0 6.555037206936419e-15
a O 0 5.319973628292729e-12
disorder O 0 0.0005138569977134466
of O 0 6.632252791405335e-08
fatty O 0 3.730660225187421e-08
acid O 0 9.752303498089532e-08
beta O 0 1.7488353876160545e-08
oxidation O 0 1.1857183679353511e-08
that O 0 3.696293705141018e-12
reportedly O 0 4.5910338031251996e-11
has O 0 3.020294390903102e-15
high O 0 6.739583392235959e-13
rates O 0 9.068547236930347e-13
of O 0 5.391702709300894e-13
morbidity O 0 7.2667001305148915e-09
and O 0 8.893930730780042e-12
mortality O 0 9.301898273861298e-08
. O 0 6.540070707217183e-09

We O 0 2.380402472357268e-11
describe O 0 1.115665394270382e-12
the O 0 3.877382423922611e-14
outcome O 0 1.6528123314429877e-10
of O 0 1.6250159204367343e-11
a O 0 4.289736968421387e-13
5 O 0 4.344201593505653e-14
- O 0 5.43504196319879e-15
year O 0 1.4769250004844497e-13
- O 0 9.335420457501353e-12
old O 0 2.3363538881326917e-10
girl O 0 1.329019672091647e-10
with O 0 2.400021912978001e-13
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 2.602824910897389e-13
was O 0 2.6267225224888176e-14
first O 0 1.7748640285340095e-13
seen O 0 1.0040877634551193e-12
at O 0 5.174319292803285e-14
5 O 0 1.7658575272058545e-14
months O 0 1.3385015209914364e-13
of O 0 5.939578256314304e-13
age O 0 2.977731602959999e-11
with O 0 1.7863715064472818e-12
severe O 0 4.007970801467309e-06
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9990414977073669
hepatomegaly B-Disease 1 1.0
, O 0 6.1507836335295e-07
encephalopathy B-Disease 0 2.145225153071806e-05
, O 0 1.1182238945570133e-12
and O 0 1.1302237791499525e-11
hypotonia B-Disease 0 1.5118311011974583e-06
. O 0 8.008741758658289e-08

Biochemical O 0 2.9053083494545717e-08
studies O 0 9.629527175647468e-10
indicated O 0 2.4395033051405335e-06
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 1.5500112304778213e-09
by O 0 1.986884337341465e-14
a O 0 7.838886657840494e-12
stable O 0 7.554273651066978e-08
yet O 0 4.0435127468541054e-11
inactive O 0 3.8941252999968867e-10
enzyme O 0 3.109253965405401e-10
. O 0 9.34390897988635e-10

Molecular O 0 9.883346745176436e-12
genetic O 0 2.1358617457133133e-13
analysis O 0 1.5480019067808104e-13
of O 0 4.011057545133534e-12
her O 0 2.325718645446173e-10
VLCAD O 1 0.9999905824661255
gene O 0 2.632012489900415e-11
revealed O 0 1.7238860339219286e-10
a O 0 4.654807355536361e-12
T1372C O 0 7.692047887530862e-09
( O 0 1.4364565784140242e-14
F458L O 0 1.26829313717991e-09
) O 0 2.717526148500373e-14
missense O 0 2.9967137660236176e-09
mutation O 0 5.55728137119349e-11
and O 0 2.5180935461777132e-11
a O 0 8.477148760732689e-09
1668 O 0 1.5869223716435954e-05
ACAG O 1 0.8128296732902527
1669 O 0 1.5300611266866326e-05
splice O 0 6.2531444200431e-06
site O 0 5.368173905395679e-09
mutation O 0 7.049870687225734e-10
. O 0 1.4178521690055845e-09

After O 0 1.2016903964962022e-11
initial O 0 5.021878052291484e-11
treatment O 0 2.093878542774874e-10
with O 0 9.163371829986472e-14
intravenous O 0 2.8914610289421105e-11
glucose O 0 5.534541158702666e-10
and O 0 2.5518504410265708e-12
carnitine O 0 9.734232309099866e-10
, O 0 2.8128903693065352e-14
the O 0 2.1251997557591995e-12
patient O 0 3.346480870192181e-10
has O 0 1.962976324185444e-14
thrived O 0 2.6904539360272928e-11
on O 0 8.308634813145033e-13
a O 0 6.004714520752019e-12
low O 0 3.0647022697394277e-09
- O 0 1.4118369806581654e-09
fat O 0 4.27635184208075e-11
diet O 0 1.4415135751733033e-12
supplemented O 0 7.0011145318626955e-12
with O 0 3.527616770199714e-14
medium O 0 7.598167095501651e-10
- O 0 9.569960102151498e-11
chain O 0 5.7375141963855736e-12
triglyceride O 0 1.9027173170371725e-09
oil O 0 1.029171262101336e-10
and O 0 7.526899568031931e-13
carnitine O 0 1.2357571910204257e-10
and O 0 2.8707068054070403e-14
avoidance O 0 1.5665840846779133e-09
of O 0 1.4774287349084148e-10
fasting O 0 6.025124577035967e-08
. O 0 5.54881340875113e-09

Her O 0 4.763728429679759e-05
ventricular O 0 0.011338096112012863
hypertrophy O 1 0.9024720788002014
resolved O 0 1.7888422689793515e-06
significantly O 0 3.645357127268767e-09
over O 0 1.718086393640017e-13
1 O 0 6.421820947189946e-14
year O 0 1.2571137707195756e-12
, O 0 4.699307959367578e-14
and O 0 4.892357135730108e-13
cognitively O 0 4.0995027461576683e-07
, O 0 6.42031729430198e-13
she O 0 2.55021400047753e-13
is O 0 2.401301559532736e-15
in O 0 1.2127547535276898e-14
the O 0 1.2786158850447427e-13
superior O 0 2.2296225629658828e-11
range O 0 1.488947506955718e-11
for O 0 1.7622222040977742e-12
age O 0 3.466535503093837e-09
. O 0 9.833213354681902e-09

Clinical O 0 1.0809028339053839e-08
recognition O 0 6.093908950788318e-07
of O 1 0.9989897608757019
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.0743547544656007e-11
important O 0 9.12217025007822e-13
because O 0 1.997869507634406e-15
it O 0 1.2390907495693238e-16
is O 0 1.8769025883848717e-16
one O 0 1.055357143093117e-14
of O 0 7.657953047732202e-13
the O 0 7.353805064891361e-12
few O 0 5.644935213711122e-11
directly O 0 3.3944196342616806e-09
treatable O 0 8.429132140008733e-05
causes O 0 1.032319341121024e-09
of O 0 4.410125153953004e-09
cardiomyopathy B-Disease 1 1.0
in O 0 4.478987492007036e-08
children O 0 3.361852463079629e-11
. O 0 5.9048360818991785e-12
. O 0 2.924541997462171e-10

Cloning O 0 1.0252767523866169e-09
of O 0 4.823865699249419e-12
a O 0 3.8421336560423916e-14
novel O 0 2.5796722986643882e-15
member O 0 3.4485821587704885e-14
of O 0 4.843685673903975e-13
the O 0 2.158666908419482e-12
low O 0 1.8206336438453263e-10
- O 0 6.560975721048301e-12
density O 0 4.584302121940498e-12
lipoprotein O 0 7.453777595145539e-10
receptor O 0 2.1814709760814566e-10
family O 0 2.3136266513734682e-10
. O 0 3.431956940858072e-09

A O 0 7.620852282563817e-10
gene O 0 9.106224888727477e-14
encoding O 0 2.3343870239611597e-12
a O 0 2.6852475863529957e-13
novel O 0 8.477191117042121e-14
transmembrane O 0 2.937415241599517e-11
protein O 0 8.85654397042579e-14
was O 0 2.055500676453523e-16
identified O 0 1.27553434212494e-17
by O 0 1.8716295833984846e-20
DNA O 0 6.711355866802779e-15
sequence O 0 3.1812426681613584e-16
analysis O 0 9.147850612972527e-17
within O 0 6.630481266878057e-16
the O 0 3.5164166229447597e-15
insulin B-Disease 1 0.9930486679077148
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 7.833581006089219e-12
IDDM B-Disease 0 4.296440602047369e-05
) O 0 2.164121746389691e-15
locus O 0 1.8593960193161868e-13
IDDM4 O 0 5.026734584134829e-08
on O 0 5.9297449762907295e-12
chromosome O 0 2.260276341092826e-11
11q13 O 0 2.6850853984683454e-08
. O 0 1.1407026434540057e-09

Based O 0 2.2164303812438613e-12
on O 0 1.0630195508565254e-11
its O 0 2.9522066215259546e-13
chromosomal O 0 5.883260545402891e-09
position O 0 4.945155396285372e-10
, O 0 9.174279920281213e-15
this O 0 2.985619403141353e-15
gene O 0 8.204845629950983e-15
is O 0 2.760686839382658e-16
a O 0 2.1227343613341304e-14
candidate O 0 7.300224660888865e-12
for O 0 1.1002865150022342e-13
conferring O 0 5.16759568469638e-09
susceptibility O 0 1.7199015189817146e-07
to O 0 2.2801681609507796e-07
diabetes B-Disease 1 0.9999992847442627
. O 0 1.2222934628880466e-06

The O 0 5.48466445871032e-11
gene O 0 1.7612064692924811e-13
, O 0 9.223230801335986e-15
termed O 0 8.438579696123938e-12
low O 0 1.8159136694340106e-10
- O 0 6.41750498228677e-12
density O 0 6.784156027749011e-13
lipoprotein O 0 2.3862302758748122e-11
receptor O 0 1.6890844192068988e-12
related O 0 2.811695987148255e-09
protein O 0 2.4483597441116167e-11
5 O 0 8.975691826069998e-13
( O 0 2.427040032063597e-16
LRP5 O 0 5.6223147026912557e-08
) O 0 1.6355156684719332e-16
, O 0 8.267043550435441e-17
encodes O 0 6.39196049470039e-16
a O 0 1.4464537694772878e-13
protein O 0 6.233538858702037e-12
of O 0 3.7724712242948044e-11
1615 O 0 7.411962599235267e-08
amino O 0 2.7550697723199846e-08
acids O 0 8.869071588257782e-10
that O 0 2.2602447257574765e-12
contains O 0 2.2880867122862525e-13
conserved O 0 6.377335725477051e-12
modules O 0 3.707628648541572e-11
which O 0 4.479928458907788e-15
are O 0 7.345719593308733e-15
characteristic O 0 1.9219669258885297e-11
of O 0 2.1426698956772405e-11
the O 0 1.8853221761538919e-10
low O 0 1.1135075972390496e-08
- O 0 2.9442709381655163e-10
density O 0 2.389003751768204e-11
lipoprotein O 0 6.53090526103739e-10
( O 0 5.779577662810842e-13
LDL O 0 1.2619106870559449e-09
) O 0 1.4047891539262225e-12
receptor O 0 5.234429643202754e-12
family O 0 2.5416412030576652e-11
. O 0 5.498073663012804e-10

These O 0 2.753146668976747e-12
modules O 0 2.686153521835877e-10
include O 0 3.75780102293468e-14
a O 0 9.156837479018173e-14
putative O 0 2.679208591094273e-11
signal O 0 7.891001220505789e-12
peptide O 0 3.9405181591692373e-13
for O 0 4.711965409867624e-13
protein O 0 2.504847241083241e-12
export O 0 3.122901715002513e-09
, O 0 2.3101748920957565e-13
four O 0 3.3677376859442276e-11
epidermal O 0 3.6834975070121345e-09
growth O 0 4.944426465480767e-11
factor O 0 1.0489465199214898e-12
( O 0 9.22573446132148e-14
EGF O 0 1.1355648865674084e-08
) O 0 4.987486863935152e-14
repeats O 0 1.4269283671319855e-11
with O 0 2.0751558430604986e-14
associated O 0 4.614192014584795e-11
spacer O 0 5.799778932669142e-07
domains O 0 2.6910829120652124e-09
, O 0 3.174564501586528e-15
three O 0 5.118264752995705e-13
LDL O 0 2.8437313615015114e-10
- O 0 3.3682612254892774e-09
receptor O 0 8.042352049077162e-13
( O 0 2.476111085917762e-14
LDLR O 0 6.939611921552569e-05
) O 0 3.8544207159752625e-14
repeats O 0 1.3351371223879749e-11
, O 0 6.517433602759538e-16
a O 0 9.135027566472501e-15
single O 0 8.998185876962772e-12
transmembrane O 0 1.1323394444318069e-09
spanning O 0 4.31964630731585e-10
domain O 0 1.982727870775136e-10
, O 0 4.490787082478409e-14
and O 0 1.8548442675455495e-13
a O 0 4.574330150775019e-11
cytoplasmic O 0 7.683546243697492e-08
domain O 0 2.3175067198621946e-08
. O 0 4.45269909832291e-09

The O 0 5.050534435113718e-10
encoded O 0 1.644071684347992e-10
protein O 0 4.2014058898587336e-11
has O 0 2.33385804341527e-15
a O 0 9.375805152059009e-15
unique O 0 2.5938151908440343e-13
organization O 0 1.9766506140217466e-12
of O 0 2.0783171017502156e-10
EGF O 0 1.8813816495821811e-06
and O 0 1.5542794828959927e-10
LDLR O 1 0.9999991655349731
repeats O 0 4.042537860016182e-09
; O 0 1.6131642530570374e-14
therefore O 0 3.347179304558079e-12
, O 0 2.396138571846701e-13
LRP5 O 0 0.00012611725833266973
likely O 0 2.2342723504653605e-10
represents O 0 3.2942415071832154e-13
a O 0 1.293431236681214e-13
new O 0 6.355492761705777e-15
category O 0 9.036621277658252e-13
of O 0 4.414924155426991e-12
the O 0 1.542113381436394e-10
LDLR O 0 0.1314110904932022
family O 0 2.115541075653482e-09
. O 0 8.11526845723165e-09

Both O 0 1.0187737320421775e-09
human O 0 3.240570589646552e-10
and O 0 6.745892039417001e-11
mouse O 0 2.9910660614973494e-09
LRP5 O 0 0.0029988065361976624
cDNAs O 0 2.9641419132531155e-06
have O 0 1.9812818920217357e-12
been O 0 1.0610991252324453e-11
isolated O 0 4.1391102351129305e-11
and O 0 2.2547352982078828e-14
the O 0 5.802043958128e-13
encoded O 0 1.1634344746283554e-12
mature O 0 1.8706744486785e-11
proteins O 0 3.4679151775717995e-14
are O 0 7.548396048740965e-16
95 O 0 1.273103567012157e-10
% O 0 3.2226612871333327e-12
identical O 0 3.0379435946026323e-12
, O 0 1.4030418062711998e-14
indicating O 0 1.4904051950925812e-11
a O 0 3.750401031399342e-12
high O 0 2.7874137026318024e-11
degree O 0 2.1052686260958353e-09
of O 0 7.18489712170367e-11
evolutionary O 0 5.4674514915475925e-11
conservation O 0 1.4412503308858238e-11
. O 0 2.0280422306784285e-12
. O 0 3.700480755153279e-10

The O 0 1.4542660409233577e-09
APC B-Disease 0 2.4201425308234548e-09
variants O 0 1.7124293649750655e-10
I1307K O 0 2.2045075098731104e-08
and O 0 6.255976097400973e-13
E1317Q O 0 3.048872931898927e-09
are O 0 2.4897976136860865e-14
associated O 0 8.148631103210846e-09
with O 0 2.6506335416343063e-05
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.0024058406249425e-12
but O 0 3.88795491976365e-15
not O 0 3.9222345125456207e-14
always O 0 2.884616644941579e-13
with O 0 6.909277396906482e-15
a O 0 5.451828658659119e-12
family O 0 5.001342655991392e-12
history O 0 1.350382028419972e-09
. O 0 2.4602992976241467e-09

Classical O 1 0.7195857167243958
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.7752475921575805e-12
FAP B-Disease 0 2.3373478152954874e-10
) O 0 3.059115816699898e-15
is O 0 1.0613681759307782e-15
a O 0 3.7691321418120705e-12
high O 0 4.408367385622114e-05
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999122619628906
disease I-Disease 0 1.0875560008116736e-07
that O 0 3.2355597676347837e-15
predisposes O 0 9.164190933885763e-11
to O 0 2.288431488577103e-13
hundreds O 0 4.983866509593315e-13
or O 0 2.9111379105939417e-12
thousands O 0 3.218309785335549e-10
of O 0 0.0001309323706664145
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.00020639313152059913
carcinoma I-Disease 1 1.0
and O 0 1.3344853867780504e-11
that O 0 1.6215219271475956e-13
results O 0 7.377692901044952e-11
from O 0 1.060320789503244e-10
truncating O 0 5.902221378306649e-09
mutations O 0 1.9048133296367675e-12
in O 0 1.3313264065391989e-13
the O 0 7.663918978606521e-12
APC B-Disease 0 2.254848530114373e-09
gene O 0 1.2368207846780166e-10
. O 0 8.20202217255428e-09

A O 0 1.7259926821111549e-09
variant O 0 3.276419136000186e-10
of O 0 8.732613937523226e-11
FAP B-Disease 0 6.383055506375968e-08
is O 0 2.7550037251522497e-10
attenuated B-Disease 1 0.8142386078834534
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 5.849892510505217e-13
which O 0 1.8590172230058011e-16
results O 0 2.4386723651743936e-13
from O 0 3.883366284790357e-12
germ O 0 4.196278524659647e-08
- O 0 1.9396013684058744e-09
line O 0 1.9023824182617943e-10
mutations O 0 3.6163192124009924e-13
in O 0 2.81882129400321e-13
the O 0 1.3816758067525248e-12
5 O 0 4.206092126066846e-13
and O 0 1.2906113115338739e-14
3 O 0 4.454957995385367e-13
regions O 0 8.619076806437587e-12
of O 0 1.512059574770852e-12
the O 0 9.836050376965666e-12
APC B-Disease 0 1.3671028753492465e-09
gene O 0 5.3952571577031705e-11
. O 0 1.2953726091780027e-08

Attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 6.665224105972811e-08
have O 0 3.2557940718436207e-13
" O 0 1.1168554145749021e-12
multiple O 0 3.811923665608674e-09
" O 0 0.00010600306268315762
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 1.3743780419295248e-14
typically O 0 2.6717833200300307e-15
fewer O 0 2.0737657772907595e-15
than O 0 6.454933688559603e-16
100 O 0 1.1170749655148304e-12
) O 0 3.3824272338756805e-15
without O 0 9.149963772769887e-13
the O 0 3.986604449335296e-12
florid O 0 8.400100171002123e-09
phenotype O 0 4.981250967261985e-10
of O 0 4.999771777147721e-11
classical O 0 1.5374591599837117e-09
FAP B-Disease 0 2.589481518100456e-08
. O 0 1.243696345909484e-08

Another O 0 4.141700524207259e-11
group O 0 4.892802471772456e-14
of O 0 5.47532765654557e-12
patients O 0 9.442873566412047e-11
with O 0 7.609758092760877e-13
multiple O 0 1.4196534721122589e-05
adenomas B-Disease 1 1.0
has O 0 7.193151629891759e-11
no O 0 4.740182638768298e-12
mutations O 0 2.812635757978854e-12
in O 0 9.750792838089661e-13
the O 0 1.8199107151839478e-11
APC B-Disease 0 3.6966218974754383e-10
gene O 0 9.661597693763624e-13
, O 0 1.0441074274700896e-13
and O 0 8.095892120758841e-14
their O 0 5.316544947342461e-12
phenotype O 0 1.0325369032004872e-11
probably O 0 7.7903373855992e-13
results O 0 1.897546356155466e-12
from O 0 2.969960735677013e-11
variation O 0 2.6526519869563003e-10
at O 0 1.7554474540659726e-10
a O 0 1.484620065772546e-11
locus O 0 4.6158202260393466e-11
, O 0 9.753285418884206e-13
or O 0 9.38068091087263e-13
loci O 0 4.000484665755977e-11
, O 0 2.2195472456493226e-13
elsewhere O 0 1.1992513102368485e-12
in O 0 7.414217623093883e-14
the O 0 1.4685437111153221e-12
genome O 0 2.9908819865198666e-10
. O 0 1.5288996735307592e-09

Recently O 0 8.543647456171755e-10
, O 0 3.330725994489525e-14
however O 0 8.693165545053949e-14
, O 0 2.9454474891892784e-16
a O 0 1.8090192768793235e-15
missense O 0 7.943537320975746e-12
variant O 0 2.815228085373267e-12
of O 0 7.98338201102311e-11
APC B-Disease 0 6.044817091321875e-09
( O 0 5.525967595836068e-13
I1307K O 0 3.888547439601098e-08
) O 0 7.23006910282242e-15
was O 0 5.078850209318253e-13
described O 0 6.802681519219728e-14
that O 0 3.5143632562619376e-16
confers O 0 5.910602411153543e-13
an O 0 9.623400717596203e-16
increased O 0 6.051267559953333e-12
risk O 0 3.423797245716287e-09
of O 0 0.00010158555232919753
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.0248422249725664e-10
including O 0 6.560922595141849e-13
multiple O 0 1.0775984549127315e-09
adenomas B-Disease 0 1.2414789125614334e-06
, O 0 1.0346068619881965e-11
in O 0 4.942335984914337e-10
Ashkenazim O 0 8.527140380465426e-06
. O 0 1.1229715823901643e-07

We O 0 6.528523555093813e-11
have O 0 2.9998915271377616e-14
studied O 0 4.037056943622698e-14
a O 0 1.0771532701775726e-15
set O 0 5.5274591869748646e-15
of O 0 4.753529418233347e-15
164 O 0 4.013980554190555e-12
patients O 0 4.426490369992958e-13
with O 0 2.74480721625895e-14
multiple O 0 6.633354587393114e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 2.9448594318637333e-07
/ I-Disease 1 1.0
or I-Disease 0 2.9858245397917926e-05
carcinoma I-Disease 1 1.0
and O 0 5.529793289937857e-10
analyzed O 0 3.7434011446180193e-10
codons O 0 1.7286150288953195e-09
1263 O 0 1.7539925067922013e-07
- O 0 2.2575393998636173e-08
1377 O 0 6.954754994126233e-09
( O 0 2.2920573316924375e-13
exon O 0 1.0953549178793764e-10
15G O 0 4.212770410294553e-10
) O 0 1.2738380262991653e-16
of O 0 3.502007576072427e-14
the O 0 3.538258824386381e-13
APC B-Disease 0 9.417117086130133e-11
gene O 0 3.3401306351842075e-13
for O 0 2.5112157145401603e-11
germ O 0 2.0721345208585262e-06
- O 0 2.9403624424162444e-08
line O 0 6.228696447507787e-10
variants O 0 5.220555099327839e-10
. O 0 7.734060059050307e-10

Three O 0 8.103154258698453e-10
patients O 0 1.2424661993692965e-11
with O 0 1.0967072586989986e-14
the O 0 1.9487762098480133e-12
I1307K O 0 6.181862799436999e-10
allele O 0 1.683083577022626e-12
were O 0 1.647214130503713e-13
detected O 0 2.1962592606106918e-13
, O 0 1.129712326299192e-16
each O 0 1.0564447333973916e-14
of O 0 8.916946174497564e-12
Ashkenazi O 0 5.028489624692156e-08
descent O 0 5.159173497304437e-07
. O 0 1.7457168155488034e-07

Four O 0 7.577037330896985e-10
patients O 0 2.3208298130517058e-11
had O 0 6.463580213590669e-13
a O 0 1.473940002168217e-12
germ O 0 1.6128375079915713e-07
- O 0 2.7816872361086098e-08
line O 0 1.5695450494845886e-09
E1317Q O 0 2.134730792135997e-08
missense O 0 2.425632583680226e-09
variant O 0 3.778923701736048e-11
of O 0 5.249068540935653e-11
APC O 0 1.992950915408187e-09
that O 0 9.119173650798743e-14
was O 0 8.510845023526614e-13
not O 0 3.329989414638593e-14
present O 0 2.810453259005641e-12
in O 0 3.3263851200414363e-13
controls O 0 5.115205134464951e-11
; O 0 7.882761351757535e-15
one O 0 1.5029957259240362e-13
of O 0 4.1622545796267396e-13
these O 0 5.911129197884099e-14
individuals O 0 9.042535600509161e-13
had O 0 2.237633134338779e-10
an O 0 2.2240616466551177e-12
unusually O 0 1.5099680186758668e-11
large O 0 2.0754696518267973e-13
number O 0 4.911957125763866e-12
of O 0 3.541932303008366e-09
metaplastic B-Disease 0 6.896473496453837e-05
polyps I-Disease 0 6.044255087545025e-07
of I-Disease 0 1.9576242848984293e-08
the I-Disease 0 2.7543498148929757e-08
colorectum I-Disease 0 1.9297136532259174e-05
. O 0 8.754590652415573e-08

There O 0 2.8816185548841133e-10
is O 0 1.3300617863489482e-14
increasing O 0 2.3262594379003937e-14
evidence O 0 7.47316569521192e-14
that O 0 3.103345124348439e-15
there O 0 3.985444854454241e-14
exist O 0 9.228036390585004e-11
germ O 0 6.57292531514031e-08
- O 0 1.2835928153709375e-10
line O 0 1.1722424246574104e-11
variants O 0 1.311475147230956e-11
of O 0 1.1718712805697251e-11
the O 0 1.0233845021412336e-11
APC B-Disease 0 2.6540233899474686e-10
gene O 0 8.749489847914571e-14
that O 0 6.302114015919232e-15
predispose O 0 3.176722773723384e-10
to O 0 6.286393389350053e-13
the O 0 7.364272494765622e-13
development O 0 9.543556167557199e-09
of O 0 2.0322495075664193e-10
multiple O 1 0.982956051826477
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 4.5883549319114536e-05
carcinoma I-Disease 1 1.0
, O 0 1.1838357984877979e-12
but O 0 2.6011063826913636e-14
without O 0 2.6924033749015086e-12
the O 0 4.5163404266412854e-11
florid O 0 1.3560171652216013e-08
phenotype O 0 1.5723489177332794e-10
of O 0 4.1289464902671824e-11
classical O 0 9.95169571749166e-11
FAP B-Disease 0 4.0228909092832055e-10
, O 0 2.895076959739083e-14
and O 0 2.2121150566975934e-15
possibly O 0 2.325884927364963e-12
with O 0 8.298522391719625e-15
importance O 0 5.2562299401870405e-08
for O 0 1.0254854714730754e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 4.334971270836263e-11
in O 0 9.989329750480138e-15
the O 0 3.0965471343753076e-14
general O 0 1.2322625829886552e-13
population O 0 1.4206631408926994e-15
. O 0 5.649493934191223e-14
. O 0 1.6148452020026127e-10

Genomic O 0 2.393553577562102e-09
structure O 0 1.0100312079763807e-11
of O 0 4.633724827451946e-12
the O 0 5.4737329252541045e-11
human O 0 5.187040187593084e-06
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 2.5244739632057644e-08
CLD B-Disease 1 1.0
) O 0 4.33005817616558e-13
gene O 0 5.616075746811555e-12
. O 0 1.771235491609957e-09

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 1.9730276790141943e-07
CLD B-Disease 1 1.0
) O 0 1.0992124772251158e-13
is O 0 4.2138825040761454e-16
caused O 0 7.974037622153658e-15
by O 0 5.319942361765547e-16
mutations O 0 1.360337217220023e-13
in O 0 1.3802467097045763e-14
a O 0 1.7952333074429914e-14
gene O 0 1.7899362598523946e-15
which O 0 3.803545545470917e-15
encodes O 0 5.075114807573389e-12
an O 0 1.9318126959211313e-11
intestinal O 0 1.1149170831004085e-07
anion O 0 2.121526776477367e-08
transporter O 0 4.2566327351778455e-08
. O 0 2.7694144755230354e-09

We O 0 7.043737815237705e-11
report O 0 6.112210889329395e-13
here O 0 1.1443789167155105e-13
the O 0 4.5332724763434955e-15
complete O 0 2.4027438025320258e-12
genomic O 0 5.832117427884143e-11
organization O 0 1.3792106020628359e-13
of O 0 7.277115650523858e-13
the O 0 1.897872050488081e-12
human O 0 1.5036460965234255e-10
CLD B-Disease 1 0.9994781613349915
gene O 0 8.78387727137886e-12
which O 0 3.012827753121408e-14
spans O 0 1.8111841887380464e-11
approximately O 0 2.2594850524002702e-13
39kb O 0 1.8729622297541937e-08
, O 0 6.547821096089534e-13
and O 0 6.174785942975047e-12
comprises O 0 1.9682731139392118e-11
21 O 0 1.3945984367325082e-09
exons O 0 5.16142222295457e-08
. O 0 1.4284828431243568e-08

All O 0 1.7715001021656462e-08
exon O 0 6.117566897501092e-08
/ O 0 1.2876991029031615e-08
intron O 0 4.7930202029533575e-09
boundaries O 0 2.336045246131846e-11
conform O 0 1.706749047647449e-10
to O 0 9.769096122325127e-12
the O 0 2.9125056533185756e-11
GT O 0 1.1354050144518624e-07
/ O 0 6.926916995553256e-08
AG O 0 4.4689838496481116e-09
rule O 0 3.057979980347625e-10
. O 0 1.2759385770166887e-09

An O 0 1.2577584102262812e-13
analysis O 0 2.4488150764979955e-13
of O 0 2.0725343099700644e-13
the O 0 6.350748919803362e-13
putative O 0 1.0238730696610077e-10
promoter O 0 4.724076130280253e-10
region O 0 1.1314581216392838e-10
sequence O 0 4.502518149984702e-11
shows O 0 1.1601841015673742e-11
a O 0 5.364235531463146e-12
putative O 0 3.92184276165608e-08
TATA O 0 5.734330557061185e-07
box O 0 8.466963796749383e-10
and O 0 1.3711125117221723e-11
predicts O 0 1.227411089432806e-10
multiple O 0 3.6377616197125207e-11
transcription O 0 5.1229867570334875e-11
factor O 0 2.2917915395298527e-12
binding O 0 1.57821380963874e-10
sites O 0 7.852831274135497e-09
. O 0 8.741804613521253e-09

The O 0 1.182762776608115e-10
genomic O 0 5.318934181985924e-10
structure O 0 1.5430533370150434e-12
was O 0 2.183043954211584e-14
determined O 0 1.1308344702537585e-14
using O 0 1.6891399744038433e-15
DNA O 0 6.200671226475052e-11
from O 0 1.711465814717688e-14
several O 0 2.4557441787010324e-15
sources O 0 2.8542324753688675e-12
including O 0 3.5204432058177698e-15
multiple O 0 4.773255055101622e-11
large O 0 1.597411369846924e-10
- O 0 1.4417357308005307e-09
insert O 0 3.3678884125976083e-09
libaries O 0 4.9158003889715474e-08
and O 0 9.570182103388336e-14
genomic O 0 5.945254843986447e-10
DNA O 0 1.3626544337341784e-08
from O 0 2.113204056186646e-11
Finnish O 0 1.0713670235418249e-05
CLD B-Disease 1 1.0
patients O 0 4.064929282066032e-09
and O 0 1.6348648129715926e-11
controls O 0 3.916938595693864e-08
. O 0 1.3736012327569824e-08

Exon O 0 7.816416314199159e-07
- O 0 5.761404686666083e-10
specific O 0 6.408697791199236e-12
primers O 0 1.7818066466723792e-10
developed O 0 6.961549392503485e-13
in O 0 1.6086382172066788e-14
this O 0 7.200261166375593e-15
study O 0 4.856909789445734e-15
will O 0 3.791637109265469e-15
facilitate O 0 4.2498522062617283e-11
mutation O 0 6.44248326561736e-13
screening O 0 1.59282168617908e-12
studies O 0 2.3892760599858454e-12
of O 0 6.760517709883396e-13
patients O 0 1.2455382862250342e-12
with O 0 3.777938045409525e-14
the O 0 1.5992740465264887e-10
disease O 0 8.104997561986238e-09
. O 0 4.5153777938899964e-10

Genomic O 0 6.825957160616625e-11
sequencing O 0 9.879865675577193e-11
of O 0 1.0552063389734911e-10
a O 0 9.024044844707646e-10
BAC O 0 1.8836486560758203e-05
clone O 0 9.81083644546743e-07
H O 1 1.0
_ O 0 1.292870151214931e-11
RG364P16 O 0 4.809522557991386e-09
revealed O 0 1.0065977999046405e-12
the O 0 1.0010576724929065e-14
presence O 0 1.3136712753031039e-14
of O 0 5.114390356532328e-13
another O 0 4.538002786047546e-12
, O 0 8.097961591655572e-14
highly O 0 1.2502797191657478e-12
homologous O 0 1.831737019009072e-11
gene O 0 7.737825137577037e-13
3 O 0 4.7988310374058596e-12
of O 0 2.6529339489100856e-11
the O 0 1.0964314178796286e-10
CLD B-Disease 0 0.0016408523079007864
gene O 0 1.4360114659883738e-12
, O 0 8.501799287632342e-15
with O 0 5.058308707435271e-16
a O 0 2.606415415798164e-14
similar O 0 1.1391560607407637e-14
genomic O 0 5.600910013559002e-11
structure O 0 1.841601090374345e-12
, O 0 3.2892341279199206e-15
recently O 0 2.3760624341001048e-14
identified O 0 3.403105976271942e-13
as O 0 4.1338179217588825e-14
the O 0 1.6443766348572808e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 1.0404566097577117e-11
( O 0 6.5609660140507255e-15
PDS B-Disease 0 8.930149952846023e-09
) O 0 6.189752130850634e-15
. O 0 2.0601482759313727e-12
. O 0 3.890531785621931e-10

The O 0 4.091586625065702e-09
APCI1307K O 0 0.0008980458369478583
allele O 0 1.4988026819651168e-08
and O 0 4.755262156264095e-11
cancer B-Disease 0 2.682592636915615e-08
risk O 0 3.792352282899758e-12
in O 0 9.839417963123515e-14
a O 0 1.0437834407558966e-12
community O 0 7.753603531793218e-13
- O 0 3.0978881569374006e-14
based O 0 1.6191396099257514e-16
study O 0 1.0889575001546848e-14
of O 0 1.3501270143111838e-13
Ashkenazi O 0 5.554295912091334e-10
Jews O 0 4.699299838151205e-10
. O 0 6.5759446776780806e-09

Mutations O 0 4.79341122350263e-10
in O 0 2.456619326365872e-12
APC O 0 2.97284141748122e-10
are O 0 1.0497440251582522e-14
classically O 0 5.1302521258955736e-11
associated O 0 6.759612314333197e-10
with O 0 4.222307268264558e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.9312839590518724e-13
FAP B-Disease 0 2.4394843783914766e-11
) O 0 6.602565707914516e-16
, O 0 7.816457756698616e-17
a O 0 1.626850103199004e-13
highly O 0 1.4098550593644177e-07
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.937819016362141e-09
by O 0 5.493908635450595e-15
multiple O 0 1.8446157101781324e-10
intestinal O 0 0.05601503327488899
polyps B-Disease 0 2.809159016514684e-10
and O 0 7.509908989200098e-16
, O 0 4.262202954390145e-17
without O 0 2.3452125116028844e-13
surgical O 0 3.2164965801939616e-08
intervention O 0 7.101492172090218e-10
, O 0 3.0809571965195607e-15
the O 0 9.07121166376923e-13
development O 0 0.41322121024131775
of O 1 0.9999983310699463
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.64267208946856e-12
CRC B-Disease 0 8.284519736889706e-09
) O 0 1.5506053472474912e-13
. O 0 7.956566655531461e-11

APC B-Disease 0 1.0155056173744015e-07
is O 0 8.822866048863176e-12
a O 0 2.3974450202857156e-10
tumour O 1 1.0
- O 0 8.599970735545526e-10
suppressor O 0 1.5792188737262514e-11
gene O 0 4.3205852984966667e-14
, O 0 1.8730484031864074e-15
and O 0 8.792647531829893e-15
somatic O 0 3.813479754199989e-09
loss O 0 1.0078692325166116e-09
occurs O 0 3.8122999201917196e-10
in O 0 1.752951395150859e-10
tumours B-Disease 1 1.0
. O 0 1.5311569256937219e-07

The O 0 7.456270267880427e-09
germline O 0 6.837147026317325e-08
T O 0 3.6596208702333044e-11
- O 0 6.325337931385733e-13
to O 0 6.449430291037561e-13
- O 0 5.051839589015339e-12
A O 0 8.543491435142325e-12
transversion O 0 1.1067941702025408e-10
responsible O 0 5.615960153919309e-15
for O 0 2.4653073924337703e-16
the O 0 3.610656661623326e-15
APC O 0 1.7198307394102746e-13
I1307K O 0 2.1252847572095224e-12
allele O 0 2.2619504942591843e-14
converts O 0 4.6163681872383316e-14
the O 0 1.5169833230831327e-14
wild O 0 9.573505183047004e-14
- O 0 1.9193409136878704e-14
type O 0 2.8101502177221675e-14
sequence O 0 6.183845753168771e-13
to O 0 1.371091521568113e-11
a O 0 6.939010477324814e-10
homopolymer O 1 0.9998946189880371
tract O 0 0.0024484931491315365
( O 0 4.4265917428960855e-13
A8 O 0 1.2728187925858947e-07
) O 0 8.851405360347977e-15
that O 0 3.943070083092066e-15
is O 0 7.75575553758033e-15
genetically O 0 5.016160230242317e-12
unstable O 0 2.096858651157163e-07
and O 0 3.734030862290183e-10
prone O 0 5.066484050075815e-07
to O 0 1.7991087730706568e-08
somatic O 0 1.1300678124825936e-05
mutation O 0 5.573105710254822e-08
. O 0 6.272800057161021e-09

The O 0 7.582705019437697e-10
I1307K O 0 6.64685151363642e-09
allele O 0 6.83670351234178e-12
was O 0 1.5985099528770252e-12
found O 0 1.684161572137674e-13
in O 0 3.2945681230876767e-13
6 O 0 1.2678934291354693e-10
. O 0 5.652641688058679e-10

1 O 0 1.15045650783685e-09
% O 0 1.106193359134977e-09
of O 0 1.1162879648418667e-10
unselected O 0 3.268025830038823e-05
Ashkenazi O 0 8.879777624315466e-08
Jews O 0 2.0634102759764517e-10
and O 0 2.0726621374062004e-12
higher O 0 2.345519091451198e-11
proportions O 0 1.3687341191004343e-12
of O 0 8.069122627019087e-12
Ashkenazim O 0 1.3017106503809828e-08
with O 0 2.3655185340913654e-13
family O 0 4.56023283371132e-12
or O 0 3.013518796481096e-13
personal O 0 2.0976800851890687e-10
histories O 0 6.573477406845996e-08
of O 0 5.02851889905287e-07
CRC B-Disease 0 2.3955697542987764e-05
( O 0 2.9695852981487247e-12
ref O 0 5.754617338205037e-10
. O 0 6.375920841641958e-13
2 O 0 1.6925901869316307e-12
) O 0 3.3893003556712334e-14
. O 0 2.6288917223671326e-11

To O 0 1.6452071649464273e-10
evaluate O 0 1.5187612278921847e-10
the O 0 1.7340445485763967e-12
role O 0 1.0581664884601327e-11
of O 0 1.096224361285536e-10
I1307K O 0 6.1739612533529e-08
in O 0 6.175658075202595e-12
cancer B-Disease 0 1.708397034949627e-10
, O 0 2.579059741377593e-13
we O 0 1.638667153358586e-11
genotyped O 0 1.2377610119074234e-06
5 O 0 1.273628758013956e-09
, O 0 3.259997827242955e-11
081 O 0 2.4667344860063167e-06
Ashkenazi O 0 3.874119158808753e-08
volunteers O 0 1.415678824168154e-10
in O 0 1.9136111965856184e-12
a O 0 9.640010144307265e-12
community O 0 2.3902936921449403e-11
survey O 0 7.612901281595086e-11
. O 0 1.8124775291727957e-10

Risk O 0 1.002047497422609e-06
of O 0 5.388508839132555e-08
developing O 1 0.9999741315841675
colorectal B-Disease 1 1.0
, I-Disease 0 1.046616802113931e-07
breast I-Disease 0 2.1313148863555398e-06
and I-Disease 0 1.0771211006455061e-10
other I-Disease 0 7.160735893130266e-11
cancers I-Disease 1 0.9451366662979126
were O 0 1.0873107747499944e-08
compared O 0 1.0831730179461374e-08
between O 0 2.4147766453097574e-08
genotyped O 0 7.549500423920108e-06
I1307K O 0 5.439914829707959e-08
carriers O 0 6.398751970990157e-13
and O 0 5.485809831569377e-13
non O 0 7.694329201557437e-11
- O 0 3.66718455732315e-13
carriers O 0 3.219111870106763e-15
and O 0 4.0355132472521507e-16
their O 0 6.358866748044575e-14
first O 0 5.487434725365281e-12
- O 0 4.143594755506852e-12
degree O 0 1.5540600750707512e-10
relatives O 0 8.655258454393078e-11
. O 0 1.4482200161314296e-10

Sperm O 0 1.8247839003726618e-11
DNA O 0 7.064876461626568e-11
analysis O 0 5.406119345588434e-13
in O 0 2.9347298246065745e-13
a O 0 1.4682398352672266e-10
Friedreich B-Disease 0 0.0029171337373554707
ataxia I-Disease 1 0.9499334692955017
premutation O 1 0.9660106897354126
carrier O 0 4.3543169070403565e-09
suggests O 0 9.918987853296812e-11
both O 0 6.509310018082415e-12
meiotic O 0 1.6280595446005464e-05
and O 0 1.6081438264370362e-11
mitotic O 0 1.7987964895382902e-08
expansion O 0 6.915465977641588e-10
in O 0 3.188689004680889e-13
the O 0 1.2510483968219965e-11
FRDA B-Disease 0 1.4792407455388457e-05
gene O 0 1.9468165968206108e-10
. O 0 4.9171862137598055e-09

Friedreich B-Disease 1 0.9999942779541016
ataxia I-Disease 1 1.0
is O 0 2.8736216184377383e-10
usually O 0 6.043920138670833e-12
caused O 0 2.0563626214158137e-13
by O 0 2.0450673481257182e-16
an O 0 7.040308629286394e-16
expansion O 0 9.000936801450976e-11
of O 0 1.1266600846715491e-10
a O 0 2.1498154367805e-09
GAA O 0 7.391507097054273e-05
trinucleotide O 0 1.4518994930767803e-06
repeat O 0 1.393784643255458e-09
in O 0 3.9087830194795004e-11
intron O 0 2.8336242241522314e-09
1 O 0 2.2751670339382635e-12
of O 0 8.625063337153183e-12
the O 0 3.124090222628162e-11
FRDA B-Disease 0 3.38739191647619e-05
gene O 0 6.756838144550414e-11
. O 0 1.850215647358766e-09

Occasionally O 0 5.4037823105090865e-08
, O 0 1.2324792878978807e-12
a O 0 3.2454290990746593e-12
fully O 0 1.7731546786414754e-10
expanded O 0 1.9089750613598966e-11
allele O 0 1.0560399082981675e-10
has O 0 2.530481495527305e-15
been O 0 4.925030042536409e-14
found O 0 3.954852057278489e-14
to O 0 2.625591801266869e-13
arise O 0 9.299720715727489e-11
from O 0 4.402476918175663e-13
a O 0 1.2320115630806705e-12
premutation O 0 6.94718735871902e-08
of O 0 5.937399183419956e-11
100 O 0 3.146193028324973e-10
or O 0 1.9864289033111326e-11
less O 0 9.694044456054485e-10
triplet O 0 6.549013050971553e-06
repeats O 0 1.536833167392615e-07
. O 0 1.9100124148963005e-08

We O 0 7.507722915578441e-11
have O 0 7.578521516663893e-15
examined O 0 1.016620462942694e-14
the O 0 1.8054128752877107e-16
sperm O 0 1.3081679328382032e-14
DNA O 0 1.5139939649189138e-11
of O 0 4.31069546377727e-12
a O 0 5.262762448055014e-11
premutation O 0 1.9640292521216907e-06
carrier O 0 4.303300382701991e-09
. O 0 2.8987214406583917e-08

This O 0 6.368902627507111e-11
mans O 0 4.379928364439678e-10
leucocyte O 0 1.3525757180943287e-09
DNA O 0 3.186717834058328e-10
showed O 0 3.1792229439331354e-12
one O 0 1.085146084826101e-15
normal O 0 7.732322269450587e-13
allele O 0 1.852033744463924e-13
and O 0 2.1577742932412042e-15
one O 0 5.312502130235984e-15
allele O 0 1.7206846841463785e-12
of O 0 9.173939819612231e-13
approximately O 0 1.1419026531636622e-12
100 O 0 1.5441471712396293e-10
repeats O 0 3.826762906555814e-09
. O 0 4.0729695172103675e-09

His O 0 2.0868982097965727e-09
sperm O 0 1.6420657888982504e-10
showed O 0 1.6338048969277708e-11
an O 0 4.561179776735801e-16
expanded O 0 3.3686767974714857e-14
allele O 0 2.5422990535678425e-12
in O 0 1.2536921370834286e-12
a O 0 9.116073867998509e-11
tight O 0 2.4074184423739098e-08
range O 0 2.820498279376693e-10
centering O 0 2.1009283202033657e-09
on O 0 4.51617476054933e-12
a O 0 9.14356155894136e-13
size O 0 9.500530787423522e-13
of O 0 3.7060289732882e-12
approximately O 0 4.851472956007852e-12
320 O 0 4.0175618387650047e-10
trinucleotide O 0 1.3933448599345866e-06
repeats O 0 6.545177200223407e-08
. O 0 2.6896987748159518e-08

His O 0 2.1480786926986184e-08
affected O 0 3.846515639338577e-08
son O 0 3.7914924178039655e-07
has O 0 2.7254577650184623e-14
repeat O 0 1.1182964276823526e-12
sizes O 0 8.946221042617497e-14
of O 0 3.061821629568584e-13
1040 O 0 3.405421084012872e-11
and O 0 1.4021176797732182e-12
540 O 0 1.823171502657317e-09
. O 0 2.5641735401649157e-09

These O 0 4.319882992986912e-11
data O 0 3.428590397702713e-11
suggest O 0 1.0629824928262699e-12
that O 0 1.7831679372082407e-16
expansion O 0 3.117265560265148e-13
occurs O 0 4.7919271157982786e-15
in O 0 1.8639523810636395e-16
two O 0 2.0304000197319443e-15
stages O 0 8.10285259028598e-12
, O 0 1.0822564319265429e-15
the O 0 1.3863996417367262e-14
first O 0 8.907978521488502e-14
during O 0 6.2877879986045215e-12
meiosis O 0 6.116686601664867e-10
followed O 0 1.0138581597526897e-12
by O 0 2.4928101710662912e-14
a O 0 3.211677668604751e-12
second O 0 5.542916126088926e-11
mitotic O 0 7.819176772727587e-08
expansion O 0 3.5065166770209544e-08
. O 0 1.252291781383974e-08

We O 0 2.0324589233844392e-10
also O 0 5.0682999057404324e-14
show O 0 2.615355848556433e-13
that O 0 1.1281876669941342e-16
in O 0 3.1143743403546373e-15
all O 0 3.9074351528911935e-14
informative O 0 4.079729609696159e-11
carrier O 0 1.2629533649357455e-13
father O 0 8.004098252245573e-12
to O 0 3.963542688500965e-11
affected O 0 8.385895866602766e-10
child O 0 8.750086766262655e-11
transmissions O 0 2.176937297093673e-09
, O 0 2.258473328719499e-16
with O 0 4.2325849253770713e-17
the O 0 1.4149848861241907e-14
notable O 0 3.196780608782056e-14
exception O 0 3.4683868732794665e-13
of O 0 1.721889666440879e-12
the O 0 6.843631130543093e-12
premutation O 0 2.5405009651535693e-08
carrier O 0 1.3430702730521382e-11
, O 0 1.892478009154694e-13
the O 0 2.426970950597518e-12
expansion O 0 2.3419799433099797e-10
size O 0 2.0667562713322374e-12
decreases O 0 1.2053863115979446e-11
. O 0 8.308988046212828e-12
. O 0 2.3099153700911756e-09

The O 0 3.212299592991741e-10
R496H O 0 2.3902700263533916e-08
mutation O 0 1.1496634373664438e-11
of O 0 2.4652996657992254e-11
arylsulfatase O 0 4.256829924997874e-06
A O 0 2.0812433376704575e-07
does O 0 6.362172941254407e-12
not O 0 1.1287464712905759e-10
cause O 0 0.44352635741233826
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 8.898678238722368e-09

Deficiency B-Disease 0 0.0002635343698784709
of I-Disease 0 1.2618701248356956e-06
arylsulfatase I-Disease 1 0.9999998807907104
A I-Disease 1 0.9999878406524658
( O 0 1.2844829366809307e-12
ARSA O 0 1.4063775779504795e-05
) O 0 1.9339812005548032e-14
enzyme O 0 3.058345937612117e-11
activity O 0 9.918880161663424e-10
causes O 0 5.464207220029493e-08
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 4.7049742574190034e-11
MLD B-Disease 1 1.0
) O 0 1.2125941526927586e-12
. O 0 2.679750171763473e-11

A O 0 3.867170139670861e-09
number O 0 1.1734162903495604e-12
of O 0 1.5852613666211823e-10
ARSA O 0 0.00010635613580234349
gene O 0 4.871188175048502e-11
mutations O 0 1.4394042381626893e-11
responsible O 0 5.103754571744723e-11
for O 0 2.0361409780456086e-10
MLD B-Disease 1 1.0
have O 0 3.5357710682915044e-12
been O 0 4.565722257730831e-13
identified O 0 7.592538577017027e-12
. O 0 1.0481175649612595e-10

Recently O 0 3.8681713387944683e-10
, O 0 1.1575365909928872e-14
the O 0 3.732392745022482e-14
R496H O 0 5.385996093565382e-10
mutation O 0 2.636301767167115e-12
of O 0 1.1475564942742267e-10
ARSA O 0 8.614757825853303e-05
was O 0 6.825696952095228e-11
proposed O 0 1.1113475591184585e-12
to O 0 2.926179481013702e-12
be O 0 1.553391746830779e-12
a O 0 1.6818329715007074e-11
cause O 0 5.868254326912847e-09
of O 0 8.78084662758738e-08
MLD B-Disease 1 1.0
( O 0 7.023868986433257e-11
Draghia O 0 5.387875603446446e-07
et O 0 2.481482241911692e-10
al O 0 1.7750156899865033e-10
. O 0 2.1052512624896227e-14
, O 0 3.0935922281750754e-16
1997 O 0 6.982383285924695e-14
) O 0 7.45613372611512e-15
. O 0 3.637463594219348e-11

We O 0 9.917139331960811e-10
have O 0 6.530807795598892e-13
investigated O 0 1.883505070660041e-12
the O 0 2.6329538050685886e-13
R496H O 0 1.3119287600726892e-10
mutation O 0 7.664345435978541e-15
and O 0 3.179082998843656e-16
found O 0 6.764535136330246e-15
this O 0 1.238080869244004e-14
mutation O 0 4.823973794206016e-13
at O 0 5.167489700030892e-12
a O 0 3.4730027013984976e-12
relatively O 0 1.395972833856396e-11
high O 0 1.3554835151443484e-13
frequency O 0 7.161011692478902e-14
in O 0 1.5467106431692038e-15
an O 0 6.016200797430622e-16
African O 0 5.578866361932722e-13
American O 0 2.7806297303763217e-13
population O 0 1.238846248215143e-14
( O 0 3.782400396955395e-18
f O 0 7.153118700663208e-15
= O 0 2.0177613987743155e-14
0 O 0 9.646336252225481e-16
. O 0 3.2702296731988495e-15
09 O 0 8.73675426709547e-13
, O 0 7.6689084024654e-15
n O 0 3.19767710845343e-14
= O 0 6.816033468973887e-14
61 O 0 5.256269378084433e-12
subjects O 0 1.1473267474970683e-10
) O 0 1.6814173209138417e-13
. O 0 8.044907795490275e-11

The O 0 6.98556092970648e-08
ARSA O 0 5.6968507124111056e-05
enzyme O 0 7.659392564640655e-11
activity O 0 3.3100961208121227e-12
in O 0 3.644365608308732e-15
subjects O 0 3.1659282400536837e-12
with O 0 2.0308493707104627e-15
and O 0 1.1660101391906298e-14
without O 0 4.290254783378966e-12
the O 0 1.661452919687889e-11
R496H O 0 9.006887680129694e-09
mutation O 0 7.24852307083107e-13
was O 0 2.0499206986827195e-13
determined O 0 2.599741602549166e-11
and O 0 7.346035130022244e-13
found O 0 1.955347992896317e-12
to O 0 6.279877225873198e-12
be O 0 1.5549783682899943e-11
normal O 0 4.0409486246062443e-07
. O 0 1.2928524029121036e-08

It O 0 1.406406501675006e-11
is O 0 1.821119820157209e-14
therefore O 0 1.7898219527561626e-13
concluded O 0 1.577592223522828e-12
that O 0 1.573142729804748e-15
the O 0 1.7866772243548684e-13
R496H O 0 3.4091613976272583e-09
mutation O 0 2.0626066826734402e-11
of O 0 3.0713484533428925e-10
ARSA O 0 0.00011273877316853032
does O 0 3.0483681984910804e-12
not O 0 9.799716376920897e-13
negatively O 0 8.620412716986436e-11
influence O 0 2.455543060553289e-11
the O 0 3.652025730438435e-12
activity O 0 2.0789832355649907e-10
of O 0 2.6009418577221943e-11
ARSA O 0 2.7349908123142086e-05
and O 0 1.4266881946667365e-12
is O 0 1.6121828806843486e-14
not O 0 2.1813926804215705e-13
a O 0 5.677761732991726e-11
cause O 0 1.9090659009179944e-07
of O 0 7.975629614520585e-07
MLD B-Disease 1 1.0

Down O 0 3.731540854090554e-09
- O 0 1.5056060564955231e-10
regulation O 0 1.6050672943523914e-11
of O 0 1.5775156181341288e-10
transmembrane O 0 4.7593712082516504e-08
carbonic O 0 1.7528548141854117e-06
anhydrases O 0 0.0014998818514868617
in O 0 2.4194957859435817e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 4.3245204324193764e-06
lines O 0 3.10629321743916e-12
by O 0 5.4220608444689386e-14
wild O 0 9.082513074964993e-10
- O 0 6.682536479729606e-08
type O 0 0.00011731055565178394
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 0.999369204044342
Lindau I-Disease 0 0.04191165789961815
transgenes O 0 6.59021534374915e-05
. O 0 8.417324615095367e-09

To O 0 6.1013438745760595e-09
discover O 0 1.9847105903192386e-10
genes O 0 2.4029409104869837e-12
involved O 0 3.2497281775289988e-12
in O 0 5.684566706243288e-11
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999977350234985
( O 0 1.05299678698767e-10
VHL B-Disease 0 3.176796963089146e-05
) O 0 1.2540866782539961e-12
- O 0 2.800998669116872e-11
mediated O 0 7.734649587476383e-10
carcinogenesis O 0 0.00443279230967164
, O 0 1.7937033965336607e-14
we O 0 1.0028541446707381e-14
used O 0 4.969260680026677e-12
renal B-Disease 1 0.9998964071273804
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.7408686280250549
lines O 0 3.409135418408482e-09
stably O 0 2.516848951472639e-08
transfected O 0 6.229020410586372e-09
with O 0 2.718968984422726e-13
wild O 0 1.6009769898683857e-10
- O 0 1.0445796450042621e-09
type O 0 4.3032755137062395e-09
VHL O 0 4.5375272748060524e-05
- O 0 2.110218666473429e-08
expressing O 0 1.2723437581296793e-10
transgenes O 0 2.684440971734148e-07
. O 0 3.315464014441716e-10

Large O 0 5.704494602382093e-12
- O 0 2.1738305600038643e-12
scale O 0 6.296500647262615e-12
RNA O 0 1.8478589491888187e-10
differential O 0 6.526347795521303e-10
display O 0 4.7988151646860544e-11
technology O 0 2.1499620139753262e-10
applied O 0 3.0180760234727044e-12
to O 0 4.133128301414546e-12
these O 0 3.8945647921895254e-13
cell O 0 5.46680756219331e-10
lines O 0 2.3148614969326076e-11
identified O 0 4.066226088478286e-12
several O 0 2.3655366944777545e-13
differentially O 0 4.174879331131365e-10
expressed O 0 2.1654616847496116e-13
genes O 0 2.2561488267902607e-12
, O 0 1.2714071264438402e-14
including O 0 3.692407707714396e-14
an O 0 4.642073401020519e-13
alpha O 0 6.62122162653489e-11
carbonic O 0 1.1299625235494659e-08
anhydrase O 0 2.5495154432064737e-08
gene O 0 1.891005130261192e-10
, O 0 5.271904787718107e-11
termed O 0 1.641407436636655e-07
CA12 O 1 0.999554455280304
. O 0 1.2290409756587906e-07

The O 0 1.4530897318731917e-10
deduced O 0 2.3308835417346074e-10
protein O 0 4.629484295914921e-12
sequence O 0 1.1683088307554157e-12
was O 0 4.963697638679654e-13
classified O 0 2.3152003317955527e-12
as O 0 1.0645111975606837e-14
a O 0 6.983079479244703e-13
one O 0 2.5990609404252796e-12
- O 0 4.07607642083363e-10
pass O 0 6.116726325444688e-08
transmembrane O 0 1.424448470288553e-07
CA O 0 1.1805394883879217e-08
possessing O 0 8.799241890677933e-11
an O 0 2.749000029347859e-13
apparently O 0 3.35092620318278e-10
intact O 0 2.2467959936989246e-08
catalytic O 0 7.215263941873218e-10
domain O 0 4.2950918377471226e-09
in O 0 7.508295374325513e-11
the O 0 6.334430313614803e-09
extracellular O 0 4.68665757580311e-06
CA O 0 2.1559861124842428e-05
module O 0 3.483376985968789e-06
. O 0 1.2677931593430003e-08

Reintroduced O 0 4.4323225978359915e-08
wild O 0 5.646435541351025e-10
- O 0 3.891437450054269e-10
type O 0 4.4899806095344275e-11
VHL B-Disease 0 5.534947788987665e-08
strongly O 0 8.773374821774427e-13
inhibited O 0 1.6875967854060314e-12
the O 0 8.661581888736499e-15
overexpression O 0 2.346368108488428e-12
of O 0 1.864879778379347e-13
the O 0 1.3830092398994104e-13
CA12 O 0 1.930485993284492e-08
gene O 0 6.306827330754229e-15
in O 0 4.659759313433917e-14
the O 0 6.0764115093758786e-12
parental O 0 5.535163722925063e-07
renal B-Disease 1 0.9909982681274414
cell I-Disease 1 0.9999994039535522
carcinoma I-Disease 1 1.0
cell O 1 0.9676575660705566
lines O 0 1.1478076800131021e-07
. O 0 3.999544873067862e-08

Similar O 0 5.230147911983174e-12
results O 0 5.054998845725744e-13
were O 0 6.054009425932386e-14
obtained O 0 7.863292265583577e-13
with O 0 1.9646805544753197e-14
CA9 O 0 8.912379598768894e-07
, O 0 7.707463139938753e-14
encoding O 0 1.4164243389291897e-10
another O 0 1.1558357743135517e-10
transmembrane O 0 5.876882269717498e-08
CA O 0 3.440439755308944e-08
with O 0 1.2940356793923746e-13
an O 0 1.7896307265979905e-13
intact O 0 6.417710363137985e-09
catalytic O 0 9.065119765949703e-10
domain O 0 1.3730956816004891e-08
. O 0 2.1428805396794814e-09

Although O 0 4.048853613491943e-11
both O 0 3.735230874601925e-12
domains O 0 6.619558234888245e-10
of O 0 2.937241769251919e-11
the O 0 2.079041626357192e-11
VHL B-Disease 0 1.6625332222020006e-08
protein O 0 1.4332805775563173e-12
contribute O 0 4.748607757010248e-12
to O 0 1.1935311246269453e-11
regulation O 0 8.299841369741046e-10
of O 0 1.8199065365820388e-08
CA12 O 1 0.9999910593032837
expression O 0 4.786570695358705e-09
, O 0 5.056232667798033e-13
the O 0 1.5349984738149969e-12
elongin O 0 2.0056416527580723e-09
binding O 0 2.2711924355101054e-11
domain O 0 1.3887480054819434e-09
alone O 0 5.495764260343705e-11
could O 0 4.05640555867226e-11
effectively O 0 1.0712358999853677e-08
regulate O 0 2.3273672766777054e-08
CA9 O 0 0.004976660944521427
expression O 0 7.402581303495026e-08
. O 0 1.3573808743672089e-08

We O 0 4.565496425357196e-09
mapped O 0 3.5335197878794133e-08
CA12 O 0 0.0006173701258376241
and O 0 1.0456171518902213e-11
CA9 O 0 1.1780964541685535e-06
loci O 0 6.931424184619672e-12
to O 0 1.1035279677898413e-12
chromosome O 0 1.518716142429044e-12
bands O 0 1.75764860999017e-10
15q22 O 0 6.528308205133726e-08
and O 0 1.3815499959324296e-11
17q21 O 0 6.408545232261531e-07
. O 0 3.628195965887926e-09

2 O 0 1.1272125594041782e-10
respectively O 0 1.6712213835035072e-09
, O 0 7.992256487697469e-13
regions O 0 2.7654120660081105e-10
prone O 0 3.870946341244519e-10
to O 0 2.6254694598937256e-11
amplification O 0 6.974162580775101e-09
in O 0 1.0681392402511758e-11
some O 0 5.837679298292819e-12
human O 0 7.521490097417427e-09
cancers B-Disease 0 0.00031447364017367363
. O 0 6.507968919322593e-08

Additional O 0 1.198829507886856e-10
experiments O 0 4.724380262000061e-11
are O 0 5.473283383184953e-15
needed O 0 1.7181539177513194e-11
to O 0 1.65721104374017e-12
define O 0 8.568791509677709e-11
the O 0 3.1684355659977737e-12
role O 0 6.91092599813814e-11
of O 0 1.7584577127749412e-09
CA O 0 2.904485427279724e-06
IX O 0 1.8879659080539568e-07
and O 0 1.4714253149250567e-09
CA O 0 6.261470275603642e-07
XII O 0 3.8384498357579844e-10
enzymes O 0 4.1298084743623953e-13
in O 0 2.068213391618213e-14
the O 0 1.0879055360561718e-13
regulation O 0 5.797477949098795e-12
of O 0 3.2982495207223295e-11
pH O 0 1.3655385155963984e-10
in O 0 1.8882460699198855e-12
the O 0 9.262016154032437e-11
extracellular O 0 3.0665208150537637e-09
microenvironment O 0 7.120065959043131e-08
and O 0 3.642298593807547e-13
its O 0 2.3174214283661065e-13
potential O 0 1.7204262320325014e-11
impact O 0 1.9901273684563847e-10
on O 0 2.2050026249331722e-09
cancer B-Disease 0 1.8626236553132003e-08
cell O 0 1.0242471759625005e-08
growth O 0 4.639017781027377e-10
. O 0 7.519879163808696e-10

A O 0 1.2709611141303867e-10
gene O 0 5.5015660674036584e-14
encoding O 0 1.4721453223121017e-11
a O 0 1.593700692248401e-11
transmembrane O 0 7.149613540091693e-11
protein O 0 8.715811140305382e-14
is O 0 1.5306199685517977e-18
mutated O 0 1.4917586395622523e-15
in O 0 7.17771537278117e-16
patients O 0 1.0876825481953567e-11
with O 0 7.2883435398019e-12
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 1.5176065062405542e-06
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 4.8826650527189486e-06
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 9.487130048571601e-13
. O 0 6.679354291883044e-11

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.2950094330221873e-08
WFS B-Disease 1 0.5698868036270142
; O 0 7.127905904402709e-12
OMIM O 0 1.0312476916851665e-07
222300 O 0 3.6655539714658403e-10
) O 0 8.373915417926191e-16
is O 0 3.4357189470268952e-15
an O 0 2.535877324100211e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 0 0.002718123374506831
defined O 0 3.4870554963776102e-15
by O 0 4.65030517901594e-17
young O 0 6.699468453955082e-13
- O 0 1.1606134456276784e-11
onset O 0 0.3293382227420807
non O 0 1.1694308341247961e-05
- O 0 1.6846382067114973e-08
immune O 0 2.395875142724435e-08
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 0.9999555349349976
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 2.0788663235293825e-08
progressive O 0 0.08924861252307892
optic B-Disease 0 1.43944007504615e-05
atrophy I-Disease 0 3.5551568089431385e-07
. O 0 1.0656338034209512e-08

Linkage O 0 1.1673087101371493e-06
to O 0 3.9654654560017377e-10
markers O 0 9.80081571455571e-10
on O 0 3.6500094613423073e-10
chromosome O 0 1.6280579107075255e-09
4p O 0 2.523473199289583e-07
was O 0 1.953431773976666e-12
confirmed O 0 1.3224187370153295e-12
in O 0 7.109514122164914e-14
five O 0 1.1928704551911196e-12
families O 0 3.2330787352874424e-12
. O 0 2.759747708136473e-10

On O 0 1.3166615020487882e-10
the O 0 4.3145342984093893e-13
basis O 0 7.467478024825169e-11
of O 0 1.4582533097717842e-11
meiotic O 0 1.3483127986546606e-05
recombinants O 0 0.00019866475486196578
and O 0 1.6770873578764167e-09
disease O 0 1.9953714058829064e-07
- O 0 9.364457820293381e-11
associated O 0 6.881068631559017e-11
haplotypes O 0 3.688735539242316e-09
, O 0 5.64753288351174e-14
the O 0 4.6953261591264894e-12
WFS B-Disease 0 3.3118084274974535e-07
gene O 0 2.615315733076051e-13
was O 0 1.1715131902761966e-12
localized O 0 1.6683701642428161e-10
to O 0 4.605417089353914e-11
a O 0 1.5358354588101975e-09
BAC O 0 9.953013068297878e-05
/ O 0 2.665562348624917e-08
P1 O 0 2.464848421368515e-06
contig O 0 6.616888015287259e-08
of O 0 1.2572799572285742e-11
less O 0 1.8664538230933614e-12
than O 0 1.8446234936655287e-13
250 O 0 8.625165859310613e-11
kb O 0 1.2147012284913217e-07
. O 0 3.5587806035408676e-09

Mutations O 0 2.5991081509246783e-10
in O 0 6.595901125630577e-14
a O 0 1.3647181393858579e-14
novel O 0 7.832369667659482e-16
gene O 0 5.486706737816566e-14
( O 0 6.900585144801758e-15
WFS1 O 0 0.0004960888181813061
) O 0 2.2942485042830307e-13
encoding O 0 6.569776722642473e-09
a O 0 2.0718944337971834e-09
putative O 0 9.1405030389069e-07
transmembrane O 0 4.7053497098659136e-08
protein O 0 9.023902458604738e-11
were O 0 7.064693881980721e-13
found O 0 6.545994622004711e-14
in O 0 7.253965596330358e-15
all O 0 3.4934881186889435e-14
affected O 0 3.462849148053171e-12
individuals O 0 4.1857562880186217e-13
in O 0 1.2105589100586123e-11
six O 0 2.941000554201878e-09
WFS B-Disease 0 6.657970061496599e-06
families O 0 5.1047374660662115e-11
, O 0 2.6009392122688935e-13
and O 0 1.6481632139804525e-13
these O 0 3.803665282048341e-13
mutations O 0 3.284317913118673e-12
were O 0 5.867089583264096e-13
associated O 0 1.4407666899807214e-11
with O 0 1.946178813808444e-13
the O 0 3.896487854593289e-10
disease O 0 1.5292474841999137e-08
phenotype O 0 1.2372954882877707e-09
. O 0 6.297540267041768e-10

WFS1 O 0 0.007096551824361086
appears O 0 4.1754880802935546e-12
to O 0 3.4967767071659994e-13
function O 0 5.592581085733794e-12
in O 0 4.803169038718191e-13
survival O 0 1.7932763967110077e-06
of O 0 2.1277653250439954e-10
islet O 0 6.58010645970819e-10
beta O 0 1.3917497154736225e-09
- O 0 2.997293732653894e-11
cells O 0 6.3432952467079584e-12
and O 0 4.633333647308113e-13
neurons O 0 8.111195048954301e-10
. O 0 1.0002041729573197e-11
. O 0 3.146829186118083e-10

Stable O 0 8.219578376156278e-06
interaction O 0 2.7441898753366445e-10
between O 0 5.40358339670699e-13
the O 0 7.837724609952024e-15
products O 0 1.581899419940934e-14
of O 0 3.3725660339520985e-14
the O 0 2.4786544886891415e-13
BRCA1 O 0 2.5690909469244794e-11
and O 0 6.548173895476461e-12
BRCA2 O 0 3.58823692980792e-10
tumor B-Disease 0 1.4149391380779974e-10
suppressor O 0 3.5453959212894404e-11
genes O 0 4.49798157704448e-13
in O 0 1.4448167055119976e-12
mitotic O 0 3.2188840037861155e-08
and O 0 4.54559612173e-10
meiotic O 0 5.718775719287805e-05
cells O 0 1.4636999594586086e-06
. O 0 5.725457086214192e-08

BRCA1 O 0 3.008811688687274e-07
and O 0 1.2519513203912425e-10
BRCA2 O 0 3.3680558342297218e-09
account O 0 1.666522822518779e-13
for O 0 4.243210278720997e-15
most O 0 3.169383942202002e-16
cases O 0 8.484655976054626e-16
of O 0 2.1749740680351848e-13
familial O 0 7.79337636092059e-11
, O 0 7.669025293012121e-15
early O 0 1.166154325882296e-11
onset O 0 5.558579818654152e-09
breast B-Disease 0 9.557163949125425e-09
and I-Disease 0 2.2942374755530182e-07
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.900574721693033e-10
encode O 0 7.1676054848313075e-12
products O 0 1.5318455054771918e-12
that O 0 5.448989948862108e-16
each O 0 1.4200137207320395e-14
interact O 0 2.0780612473847437e-12
with O 0 1.6282595660232352e-13
hRAD51 O 0 2.198864166302883e-07
. O 0 3.4655569525199326e-09

Results O 0 3.3624825146461035e-10
presented O 0 2.364695418644036e-11
here O 0 2.0181186582979294e-11
show O 0 9.92291838974868e-12
that O 0 8.448201583828932e-14
BRCA1 O 0 1.9093839009887148e-10
and O 0 4.9467066727537645e-12
BRCA2 O 0 9.949138179976558e-10
coexist O 0 2.1007682260432148e-09
in O 0 8.447271202839668e-13
a O 0 2.57730555647262e-12
biochemical O 0 4.277845092048871e-11
complex O 0 1.3561475553647284e-10
and O 0 5.6512780566286835e-12
colocalize O 0 4.413339411257766e-06
in O 0 1.033327978738896e-09
subnuclear O 0 3.2328687666449696e-05
foci O 0 1.3320003766637e-08
in O 0 2.282556305424621e-12
somatic O 0 1.217643208484276e-10
cells O 0 2.7928151111189514e-11
and O 0 4.614264157397352e-14
on O 0 2.5678930011020784e-13
the O 0 1.7530380223623396e-14
axial O 0 2.9454181606734797e-13
elements O 0 1.347987520217142e-11
of O 0 2.0825949298419744e-10
developing O 0 4.022050958951695e-08
synaptonemal O 0 3.0663406960229622e-06
complexes O 0 1.679450534197713e-08
. O 0 7.004411273214828e-09

Like O 0 1.4259891933932067e-08
BRCA1 O 0 2.8426660136915416e-08
and O 0 3.3687991285447083e-10
RAD51 O 0 3.609684426919557e-05
, O 0 7.661375873990739e-12
BRCA2 O 0 9.067657041894606e-11
relocates O 0 2.140211098622391e-11
to O 0 8.03674401333998e-12
PCNA O 0 1.79219100004957e-07
+ O 0 1.3860527309228488e-11
replication O 0 1.3529381608090585e-11
sites O 0 9.075775748339579e-14
following O 0 5.2935476504588005e-15
exposure O 0 2.6508133795649647e-12
of O 0 3.0984407747847165e-12
S O 0 6.365845628408806e-10
phase O 0 1.9240595783287517e-09
cells O 0 3.658987557386695e-10
to O 0 1.2099160562328848e-09
hydroxyurea O 0 1.850397239877566e-07
or O 0 8.823732855489652e-10
UV O 0 9.549438573230873e-07
irradiation O 0 7.76431985372028e-09
. O 0 5.24838061899402e-10

Thus O 0 1.931318216463751e-08
, O 0 2.6568684752259486e-11
BRCA1 O 0 1.5139658970930725e-10
and O 0 1.958853001679528e-12
BRCA2 O 0 1.4252093429034662e-11
participate O 0 2.7644666070192336e-11
, O 0 1.6702547819217456e-14
together O 0 2.5074799007984705e-13
, O 0 2.384978811122672e-15
in O 0 1.9300419891303024e-14
a O 0 1.021476739998528e-12
pathway O 0 5.61557536582491e-11
( O 0 4.881613928868879e-15
s O 0 5.017937562863672e-13
) O 0 1.2500672377745555e-16
associated O 0 1.0784638969623533e-13
with O 0 2.614993996081366e-15
the O 0 1.2752231453964924e-13
activation O 0 3.5067616670735047e-13
of O 0 1.0914476787637906e-12
double O 0 4.1864133687452565e-12
- O 0 4.919463170161009e-10
strand O 0 2.1265643412871071e-10
break O 0 4.3893994217114596e-08
repair O 1 0.6994598507881165
and O 0 2.519938598066762e-11
/ O 0 8.927587141771554e-11
or O 0 7.406641082787283e-14
homologous O 0 3.649017719931091e-12
recombination O 0 1.8750898403419036e-11
. O 0 1.9506822546144775e-10

Dysfunction O 1 0.8887302279472351
of O 0 2.4153723643394187e-06
this O 0 1.918855296878519e-09
pathway O 0 4.4104195850991346e-09
may O 0 5.807457921676307e-13
be O 0 3.22535943265978e-13
a O 0 8.041861447594112e-13
general O 0 8.842774602835224e-13
phenomenon O 0 7.178968113334336e-14
in O 0 2.886571552514612e-16
the O 0 2.0427914764755643e-15
majority O 0 9.130429024601858e-15
of O 0 1.4875308863642692e-15
cases O 0 4.883215668172137e-15
of O 0 3.362087734951058e-12
hereditary B-Disease 0 0.000137357012135908
breast I-Disease 0 0.49351024627685547
and I-Disease 1 0.6303951740264893
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.196097230149462e-07
. O 0 3.632807610287614e-09

A O 0 4.444917767187917e-09
novel O 0 7.086637591850742e-13
Arg362Ser O 0 2.0101465381117123e-08
mutation O 0 6.289940627807883e-14
in O 0 4.204106579194528e-15
the O 0 1.2173674069672347e-13
sterol O 0 7.411178337690671e-10
27 O 0 1.9949817353648314e-09
- O 0 2.9923215016935956e-09
hydroxylase O 0 3.1657901189419135e-08
gene O 0 3.904339958976655e-12
( O 0 1.7652547785605884e-14
CYP27 O 0 0.001270050066523254
) O 0 4.938855144894904e-15
: O 0 3.8691611380184285e-17
its O 0 2.8987759737955665e-16
effects O 0 3.207760569822371e-15
on O 0 3.641546428550385e-14
pre O 0 1.0476853759544547e-11
- O 0 2.445375174055242e-13
mRNA O 0 5.204702120675808e-12
splicing O 0 2.871264337400703e-11
and O 0 5.071396861483501e-13
enzyme O 0 7.485541700380516e-12
activity O 0 1.7649283423626372e-10
. O 0 1.808665162084111e-10

A O 0 8.039695575945416e-10
novel O 0 4.8705028047766816e-14
C O 0 8.151639085962614e-11
to O 0 1.744536725365245e-13
A O 0 1.1618849111993956e-11
mutation O 0 7.8730238609959e-15
in O 0 8.473917186470217e-16
the O 0 1.4646148334927778e-14
sterol O 0 2.7475993702452683e-10
27 O 0 5.539377845309446e-10
- O 0 5.51822421090975e-10
hydroxylase O 0 7.427654047376109e-09
gene O 0 1.6259267153137524e-12
( O 0 8.386227571210124e-15
CYP27 O 0 8.012032594706398e-06
) O 0 5.524905276759774e-16
was O 0 5.3241475627113094e-15
identified O 0 9.18621630857392e-16
by O 0 2.0196296252306914e-17
sequencing O 0 8.018691613487228e-12
amplified O 0 1.6160768903650258e-11
CYP27 O 0 7.3594854654857045e-09
gene O 0 1.2385343706839639e-14
products O 0 1.4873905330049092e-13
from O 0 4.1692367738549105e-14
a O 0 1.451586897557866e-12
patient O 0 2.405508015002056e-09
with O 0 3.3290228212967676e-11
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 2.2804197766235212e-12
CTX B-Disease 0 1.1643896158375355e-07
) O 0 7.128431959296799e-13
. O 0 1.6109996670010673e-10

The O 0 1.1000111932446544e-10
mutation O 0 1.671936243965999e-12
changed O 0 1.1864534962130469e-12
the O 0 2.715449935221381e-13
adrenodoxin O 0 6.070892122345128e-10
cofactor O 0 1.1831411718399298e-11
binding O 0 2.4518132316075913e-11
residue O 0 5.588963958302884e-09
362Arg O 0 4.220396920828762e-09
to O 0 2.8570661461668756e-11
362Ser O 0 1.9123203287563229e-07
( O 0 4.698073527431568e-13
CGT O 0 6.328672697009097e-08
362Arg O 0 2.3429874929092875e-08
to O 0 1.2240140845332093e-10
AGT O 0 8.843040632200427e-06
362Ser O 0 1.0617501322585099e-09
) O 0 3.6088926625711096e-16
, O 0 3.955178326428838e-17
and O 0 6.293026649414394e-17
was O 0 4.8883714730187794e-14
responsible O 0 7.410756578708766e-13
for O 0 3.78051539726143e-12
deficiency O 0 1.3783305163883597e-08
in O 0 6.130380491436993e-12
the O 0 1.1397060378781632e-10
sterol O 0 9.293239955354693e-09
27 O 0 1.0746535217265318e-08
- O 0 3.0991547106395956e-09
hydroxylase O 0 3.4226371070644745e-08
activity O 0 3.691540129135973e-11
, O 0 2.5152550724487843e-16
as O 0 1.0477620540884609e-17
confirmed O 0 4.590592466433615e-16
by O 0 6.131931570758467e-17
expression O 0 1.243624479655217e-13
of O 0 8.574566024658475e-14
mutant O 0 7.556239298546832e-14
cDNA O 0 4.4687090139383656e-10
into O 0 1.329377830039391e-09
COS O 0 8.000823072507046e-06
- O 0 3.012457838735827e-08
1 O 0 1.7131013621551894e-11
cells O 0 1.8333214113486207e-10
. O 0 2.3331517273739166e-10

Quantitative O 0 3.688276350999331e-10
analysis O 0 6.250441245310434e-13
showed O 0 3.488656032894083e-13
that O 0 3.1653948802415775e-17
the O 0 3.2232161682526836e-15
expression O 0 1.733808815919044e-13
of O 0 1.4720547914306992e-12
CYP27 O 0 1.6109675371467347e-08
gene O 0 1.7357527268868395e-15
mRNA O 0 2.3618769700445297e-12
in O 0 6.950891278572138e-14
the O 0 4.600171155458299e-13
patient O 0 1.556872686325761e-10
represented O 0 4.458487832398328e-12
52 O 0 4.41266010398067e-08
. O 0 2.5281650550823542e-08

5 O 0 2.132041938829321e-11
% O 0 6.051233299164682e-12
of O 0 3.582876725340134e-13
the O 0 3.4998946015635246e-12
normal O 0 1.1453381354442627e-08
level O 0 1.0022341712101479e-07
. O 0 4.878855097700807e-09

As O 0 1.635163250461591e-12
the O 0 2.1928270831084173e-13
mutation O 0 8.437638066537134e-14
occurred O 0 1.858326209927541e-12
at O 0 1.4406929289964218e-14
the O 0 1.0665999808086128e-15
penultimate O 0 6.844117633741931e-11
nucleotide O 0 4.3658302667504145e-11
of O 0 4.0330630501905773e-10
exon O 0 6.89560297750802e-10
6 O 0 1.0681051876293424e-10
( O 0 4.994352913005595e-13
- O 0 1.7529012963368729e-10
2 O 0 3.688017773118002e-13
position O 0 2.0299327496697828e-10
of O 0 3.373550883090104e-10
exon O 0 4.842621303957628e-10
6 O 0 1.066916555103603e-09
- O 0 1.8704668036662042e-08
intron O 0 8.808503260127054e-09
6 O 0 8.697589870543254e-11
splice O 0 1.0418263585165732e-08
site O 0 1.5940625555654897e-11
) O 0 1.3678446015216446e-15
of O 0 6.88644453961107e-13
the O 0 7.701460996711873e-12
gene O 0 1.855514006332548e-12
, O 0 4.3181072866688153e-13
we O 0 2.0689927635736405e-12
hypothesized O 0 2.576569513301763e-11
that O 0 6.290729046075187e-15
the O 0 1.977472656108925e-12
mutation O 0 8.568395125363448e-12
may O 0 1.5439777277873046e-12
partially O 0 1.4234062539753012e-10
affect O 0 1.193103810193108e-10
the O 0 1.0647260850760176e-11
normal O 0 3.457647279603293e-09
splicing O 0 1.5096239813772172e-09
efficiency O 0 1.006874494891008e-08
in O 0 1.7298444621172138e-10
exon O 0 3.715178387153628e-09
6 O 0 6.343443131884285e-11
and O 0 4.215040642907564e-12
cause O 0 4.206232931402987e-11
alternative O 0 1.3928186728962011e-11
splicing O 0 4.2516282161564334e-11
elsewhere O 0 4.014187853645934e-12
, O 0 5.336795458679711e-15
which O 0 2.33205905131442e-16
resulted O 0 1.870866309094943e-12
in O 0 1.0723351053692001e-13
decreased O 0 1.3203331483691017e-10
transcript O 0 2.2881903316562813e-10
in O 0 5.078908214134481e-13
the O 0 3.799311559804508e-11
patient O 0 4.7556866888953664e-08
. O 0 1.1817176570616539e-08

Transfection O 0 0.00011802787776105106
of O 0 5.266797131753265e-08
constructed O 0 7.616046460157122e-09
minigenes O 0 5.612141080746369e-07
, O 0 4.2258958241362873e-14
with O 0 1.469645362166521e-15
or O 0 2.6584105332653693e-14
without O 0 4.1729461683001623e-13
the O 0 4.659068270074229e-13
mutation O 0 2.380241186442089e-13
, O 0 3.704977168431881e-15
into O 0 5.077325018754131e-11
COS O 0 2.2484007331513567e-06
- O 0 1.6803468616544137e-09
1 O 0 8.732405532181631e-13
cells O 0 4.933776369224485e-13
confirmed O 0 4.5786260931745745e-14
that O 0 4.0752379675127443e-17
the O 0 1.1639874880400576e-15
mutant O 0 2.762097462642027e-13
minigene O 0 5.425423998950407e-10
was O 0 2.1271898901619596e-13
responsible O 0 1.859709001378329e-12
for O 0 7.887175071039088e-13
a O 0 1.6373573503980499e-12
mRNA O 0 3.0246255500188113e-10
species O 0 7.832942261931826e-15
alternatively O 0 2.1042188824704766e-11
spliced O 0 1.1927208731776773e-07
at O 0 4.1466687861202445e-09
an O 0 6.368174043647201e-11
activated O 0 3.135975390478052e-08
cryptic O 0 2.3779467284157363e-08
5 O 0 9.641412668237592e-11
splice O 0 3.205545695550427e-08
site O 0 1.8515704247601406e-10
88 O 0 2.991840386545874e-10
bp O 0 1.791922027427617e-10
upstream O 0 1.8936145707026952e-10
from O 0 2.3301788016488745e-12
the O 0 7.269295408673937e-12
3 O 0 3.9276889032824336e-12
end O 0 4.876231418649013e-09
of O 0 1.629418600046506e-09
exon O 0 6.312069977809642e-09
6 O 0 3.247019320085087e-09
. O 0 1.496874268980264e-08

Our O 0 1.8970000681406418e-08
data O 0 1.8102309581879972e-11
suggest O 0 7.693804225444509e-14
that O 0 1.1799284760538161e-17
the O 0 3.765605245697502e-15
C O 0 3.1255310839473083e-12
to O 0 8.933092031935055e-14
A O 0 6.593307150248862e-11
mutation O 0 5.6590061141888887e-14
at O 0 7.078906417209291e-14
the O 0 8.757466018365686e-15
penultimate O 0 4.443483081484345e-10
nucleotide O 0 1.4395203085104669e-10
of O 0 3.4836475371058384e-10
exon O 0 9.210263662851048e-10
6 O 0 2.2881981032174536e-11
of O 0 5.5630184486732404e-11
the O 0 5.174060832557892e-11
CYP27 O 0 3.035985355381854e-05
gene O 0 1.5009339257576748e-12
not O 0 1.8937741728519003e-13
only O 0 1.2604415124475854e-12
causes O 0 2.9384071564830805e-11
the O 0 1.3461632850098049e-11
deficiency B-Disease 0 1.0251913096226417e-08
in I-Disease 0 3.150916159933015e-12
the I-Disease 0 2.6694468857613174e-10
sterol I-Disease 0 8.883843349849485e-08
27 I-Disease 0 8.129974560233677e-08
- I-Disease 0 1.2535392279744428e-08
hydroxylase I-Disease 0 2.2260147147790121e-07
activity I-Disease 0 4.333063630124201e-10
, O 0 2.1286580015474586e-14
but O 0 7.307739482986797e-14
also O 0 9.637959646948552e-14
partially O 0 8.04834462964088e-11
leads O 0 5.284362899517225e-13
to O 0 2.7662729962588117e-13
alternative O 0 1.8856843170267368e-11
pre O 0 6.70642985589609e-11
- O 0 7.368430952198191e-13
mRNA O 0 1.3938629764287391e-11
splicing O 0 5.4091980894455105e-11
of O 0 1.1426002505254829e-11
the O 0 1.6278017128668054e-11
gene O 0 3.6391219898623817e-11
. O 0 1.2544929539615168e-09

To O 0 1.355077938747229e-09
our O 0 7.990073602748282e-10
knowledge O 0 3.5073843829280804e-09
, O 0 9.877540247925647e-16
this O 0 2.1514527010673882e-16
is O 0 8.786732674289437e-18
the O 0 1.0578712930522675e-16
first O 0 2.030021692466053e-14
report O 0 8.788388650171099e-15
regarding O 0 1.1063893535058836e-13
effects O 0 1.3096865443280176e-13
on O 0 1.5329495214443795e-13
pre O 0 1.269119444952116e-11
- O 0 1.5466471961662898e-13
mRNA O 0 4.927402236232226e-12
splicing O 0 2.1267092253918207e-11
of O 0 5.138691555606201e-12
a O 0 1.1822112299525456e-12
mutation O 0 3.5451220951887574e-13
at O 0 2.2215898825422853e-12
the O 0 5.692234444215627e-12
- O 0 2.4316706634386343e-11
2 O 0 1.4158224831244126e-13
position O 0 7.280579611412819e-11
of O 0 2.875774965382938e-11
a O 0 7.621967640369931e-11
5 O 0 4.0122777322793013e-10
splice O 0 2.3001963711521967e-07
site O 0 2.7016566761517424e-09
. O 0 1.3201753024105756e-09

ATM O 0 1.5732721294625662e-06
germline O 0 3.093988709679252e-07
mutations O 0 2.4050053615276568e-11
in O 0 5.986631546398002e-13
classical O 0 1.0013340215664357e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 5.849946319358423e-06
in O 0 7.68138401193233e-14
the O 0 2.2648212583240186e-14
Dutch O 0 5.433616881087011e-13
population O 0 8.590305336774471e-16
. O 0 3.334376503204284e-13

Germline O 0 5.1338706725800876e-06
mutations O 0 5.269994510226361e-11
in O 0 5.268471748275105e-13
the O 0 8.387675319923571e-13
ATM O 0 5.912403899799301e-10
gene O 0 5.463812284285229e-15
are O 0 1.616300163580653e-17
responsible O 0 1.19173618151299e-15
for O 0 2.799684448032483e-15
the O 0 3.3169649249487065e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.2561248969619214e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.64892230614411e-13
. O 0 1.419068161589987e-11

In O 0 1.4330339137558212e-09
our O 0 1.7749252068099963e-09
study O 0 6.465626645191236e-13
, O 0 7.761877997602203e-16
we O 0 1.0606962670453688e-15
have O 0 8.21492124567725e-17
determined O 0 1.367144380559973e-13
the O 0 4.773395762859567e-13
ATM O 0 2.376816299332063e-09
mutation O 0 6.420366083399742e-13
spectrum O 0 1.4217150894058062e-11
in O 0 2.590018585886533e-13
19 O 0 1.2911574587270991e-11
classical O 0 5.055995302427618e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.01073946171482e-09
, O 0 1.67425464090527e-14
including O 0 2.2614229621396344e-15
some O 0 2.307142836017106e-15
immigrant O 0 2.225096842889407e-12
populations O 0 1.6731987973958584e-13
, O 0 1.1403424574383354e-15
as O 0 1.0344552498669016e-14
well O 0 7.891463632732354e-13
as O 0 3.9844286182054434e-13
12 O 0 2.395455535320057e-11
of O 0 5.628257842421602e-12
Dutch O 0 2.6852454287906724e-11
ethnic O 0 1.9243584156725113e-11
origin O 0 4.3247905257004504e-10
. O 0 2.7840478811214098e-09

Both O 0 1.813808131467809e-11
the O 0 1.6957600688233265e-12
protein O 0 6.982410390979008e-14
truncation O 0 5.4990043768521346e-11
test O 0 2.400033297100812e-11
( O 0 4.612257705751896e-14
PTT O 0 1.2071597943474899e-08
) O 0 5.176445980775604e-16
and O 0 1.1889299613587366e-15
the O 0 1.584188102964415e-14
restriction O 0 4.7380532792540633e-14
endonuclease O 0 1.3224798860178577e-11
fingerprinting O 0 1.4492680389111001e-09
( O 0 2.5011270181687917e-13
REF O 0 3.5654304508803136e-10
) O 0 2.5979688323649018e-17
method O 0 5.418421990927534e-14
were O 0 8.74698229157752e-15
used O 0 4.1318629697166195e-14
and O 0 2.1499042983700277e-14
compared O 0 3.5483170221506377e-12
for O 0 9.857206332642213e-14
their O 0 1.3753451502673819e-11
detection O 0 8.316797250884633e-10
efficiency O 0 9.377684045963619e-11
, O 0 1.7637730002984854e-15
identifying O 0 1.2812530984090964e-12
76 O 0 2.907304952337597e-11
% O 0 1.6345864549058287e-12
and O 0 1.017364708441799e-15
60 O 0 3.7077966565102205e-12
% O 0 2.3748052135896813e-12
of O 0 7.300801944335605e-14
the O 0 4.358687076631146e-13
mutations O 0 3.4661450142373096e-13
, O 0 9.852037398784888e-14
respectively O 0 4.720788759904337e-10
. O 0 5.615270470826772e-09

Most O 0 9.28892518459179e-11
patients O 0 3.959369724443329e-12
were O 0 2.0180714738193828e-12
found O 0 2.0505464188615152e-13
to O 0 1.1312951443687158e-12
be O 0 3.0064475214919284e-12
compound O 0 3.6914171719359956e-09
heterozygote O 0 4.021292170364177e-07
. O 0 1.8160195125460632e-08

Seventeen O 0 4.515149498729443e-08
mutations O 0 5.033558292399931e-11
were O 0 1.0266253992752272e-12
distinct O 0 2.8729321981287026e-13
, O 0 2.7067134764671404e-15
of O 0 6.831965142272203e-14
which O 0 6.3015815498327645e-16
10 O 0 1.0338325112440802e-13
were O 0 1.774262377643443e-12
not O 0 1.4200773803402233e-12
reported O 0 1.566215768189494e-10
previously O 0 4.267865616469635e-09
. O 0 1.6038057992773247e-08

Mutations O 0 1.053349691915173e-07
are O 0 1.4054840624666554e-11
small O 0 8.059324041465032e-12
deletions O 0 7.811839175531077e-09
or O 0 2.982975866316906e-09
point O 0 3.702850221998233e-07
mutations O 0 1.3302992485364484e-08
frequently O 0 9.985069437945526e-10
affecting O 0 6.213546566158357e-09
splice O 0 2.1688583728973754e-06
sites O 0 5.8659967550056535e-08
. O 0 1.9156454200697226e-08

Moreover O 0 4.712031298481634e-08
, O 0 2.4594980999742555e-12
a O 0 9.090650107679288e-12
16 O 0 3.540964743642405e-10
. O 0 1.378298253307264e-09

7 O 0 5.3797974963742945e-09
- O 0 7.529524226335127e-10
kb O 0 5.539684821975754e-10
genomic O 0 3.8997648860172873e-11
deletion O 0 2.6975656083894073e-11
of O 0 3.5270637105400127e-11
the O 0 1.5032209851884026e-11
3 O 0 4.296773440520818e-12
end O 0 7.759015652197832e-10
of O 0 1.67162152175937e-11
the O 0 6.617153006094334e-12
gene O 0 6.133254169295166e-13
, O 0 2.3869925133701564e-13
most O 0 7.09554688767787e-14
likely O 0 7.466904698716359e-12
a O 0 6.572382612105021e-13
result O 0 1.0348219676992176e-11
of O 0 1.877892286117344e-11
recombination O 0 2.9869696993589656e-11
between O 0 7.007771446465583e-11
two O 0 1.0319462298569171e-11
LINE O 0 1.0053625487671525e-07
elements O 0 2.2250513931343363e-11
, O 0 4.120970126014929e-14
was O 0 2.099795597815257e-12
identified O 0 1.6386336731954998e-10
. O 0 5.957253024213571e-10

The O 0 9.447075344226619e-10
most O 0 7.969788023975966e-13
frequently O 0 2.069465204670301e-13
found O 0 5.5101566755547116e-14
mutation O 0 4.657981899497399e-14
, O 0 3.77992343769833e-16
identified O 0 2.244391738431828e-13
in O 0 6.089109793640246e-14
three O 0 1.6063334744385177e-13
unrelated O 0 2.267491749918804e-11
Turkish O 0 1.0212103518369986e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 2.7594197760105743e-11
, O 0 5.886870851901094e-14
was O 0 4.240609328531181e-13
previously O 0 1.9926275256557102e-13
described O 0 7.674786599361108e-16
to O 0 1.4962438907762006e-15
be O 0 5.458393073367815e-16
a O 0 5.110796903956896e-15
Turkish O 0 5.499397826014274e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 5.842647965437209e-08
mutation O 0 8.045402122291989e-10
. O 0 1.0705628744611673e-10

The O 0 9.3031499170948e-10
presence O 0 2.5408024642570304e-11
of O 0 7.535095464250574e-11
a O 0 2.0491812413592214e-10
founder O 0 6.136215979779536e-09
mutation O 0 8.875802176566694e-11
among O 0 7.676433951388575e-14
relatively O 0 9.424636635349537e-13
small O 0 5.5517605622315905e-15
ethnic O 0 7.171321913038153e-13
population O 0 5.659337558181149e-15
groups O 0 5.24446166764894e-16
in O 0 1.515737540905629e-13
Western O 0 8.706823040327549e-10
Europe O 0 5.312797077272613e-11
could O 0 8.077780111470645e-11
indicate O 0 3.32077565445843e-09
a O 0 2.4827591371678892e-11
high O 0 1.5255657848101123e-11
carrier O 0 1.7299514685348294e-12
frequency O 0 1.0922021100034929e-11
in O 0 5.807269270498294e-13
such O 0 7.6238207370391e-13
communities O 0 7.872443252843198e-10
. O 0 4.461778502218294e-09

In O 0 1.0898282970517315e-10
patients O 0 3.023770470123033e-11
of O 0 9.315498025741498e-12
Dutch O 0 6.43420108858983e-11
ethnic O 0 6.87277578598211e-12
origin O 0 7.023972983105642e-12
, O 0 7.905164526179464e-15
however O 0 6.815568617292433e-13
, O 0 3.039522843487075e-14
no O 0 1.7813485062023737e-13
significant O 0 3.72790730576722e-12
founder O 0 5.950027970325067e-11
effect O 0 1.5084186070352112e-12
could O 0 2.8358366002678714e-12
be O 0 3.323699648838385e-11
identified O 0 2.15111253254463e-08
. O 0 2.98807378840138e-08

The O 0 1.5451045998204904e-10
observed O 0 4.628336776335562e-12
genetic O 0 6.101796585361585e-13
heterogeneity O 0 4.3041390763998155e-12
including O 0 1.944796328983583e-15
the O 0 1.0652759056817285e-12
relative O 0 5.327188135062499e-10
high O 0 3.9890807324027833e-10
percentage O 0 2.0082828733336555e-09
of O 0 5.816323533913703e-10
splice O 0 1.8617572550283512e-06
- O 0 6.238912941824992e-09
site O 0 8.257569628078443e-10
mutations O 0 1.6503677591206412e-10
had O 0 3.979182434943329e-12
no O 0 1.9747314135461214e-13
reflection O 0 6.068327264296958e-12
on O 0 2.5350926327778744e-13
the O 0 6.72624011609918e-13
phenotype O 0 7.533000334625228e-10
. O 0 8.9819740534125e-10

All O 0 5.847418903248691e-12
patients O 0 9.946025529864941e-14
manifested O 0 5.40153012108021e-14
classical O 0 1.160033701042007e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 2.8354200497932025e-12
increased O 0 8.057068900946263e-11
cellular O 0 2.2266306853868656e-11
radioresistant O 0 1.794795284615347e-10
DNA O 0 9.584907312287783e-10
synthesis O 0 9.636274889146534e-09
. O 0 1.7402663754495507e-09

Determination O 0 8.172698784392196e-08
of O 0 1.692627288329973e-10
the O 0 1.7573887223926166e-12
genomic O 0 8.22986054305197e-11
structure O 0 1.187959344610412e-12
of O 0 4.324866474062633e-13
the O 0 9.569091396002816e-13
COL4A4 O 0 9.928594408847857e-07
gene O 0 2.3076603562072195e-13
and O 0 2.401843237102505e-14
of O 0 2.84397098969727e-13
novel O 0 1.8441820986980773e-11
mutations O 0 4.465867320391226e-08
causing O 0 2.4351833417313173e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.0859267973728493e-07

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.3553653642126018e-12
a O 0 6.206602454206234e-10
progressive O 1 1.0
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 6.906626367708668e-06
by O 0 2.0728063709896105e-10
glomerular B-Disease 1 0.9999850988388062
basement I-Disease 1 1.0
membrane I-Disease 0 2.0085839423700236e-05
abnormalities I-Disease 1 0.7012245655059814
and O 0 4.662073136395273e-13
associated O 0 8.541541085538285e-11
with O 0 4.0208442586738e-13
mutations O 0 1.0390841832796927e-11
in O 0 2.7192764099487343e-12
either O 0 8.464908635152923e-11
the O 0 3.055898589732209e-10
COL4A3 O 1 0.9996680021286011
or O 0 2.7513056069516928e-11
the O 0 7.872319462975952e-11
COL4A4 O 0 2.627322101034224e-05
gene O 0 3.57549005593899e-13
, O 0 2.946651228886445e-15
which O 0 5.2415192869484156e-17
encode O 0 6.0132185689121265e-12
the O 0 2.3720629627188572e-11
alpha3 O 0 9.039519682119135e-06
and O 0 2.492411277366102e-10
alpha4 O 0 7.3246014835604e-06
type O 0 8.452155420002327e-09
IV O 0 4.300301498005865e-06
collagen O 0 8.099159742869233e-08
chains O 0 1.21404697406291e-09
, O 0 3.214807706066608e-13
respectively O 0 1.2968971452309574e-09
. O 0 3.4879577004431894e-09

To O 0 1.6284358583806835e-10
date O 0 7.230032128546782e-10
, O 0 3.8067188697045104e-14
mutation O 0 1.2808412947070639e-14
screening O 0 1.0244224495385354e-13
in O 0 3.3202034735923744e-14
the O 0 9.754774028467028e-13
two O 0 1.2745478500733598e-12
genes O 0 1.424798994065224e-11
has O 0 2.2931753474201774e-14
been O 0 1.6991264081486768e-13
hampered O 0 1.2648850855612181e-08
by O 0 4.2994497935835985e-14
the O 0 5.499725241192577e-12
lack O 0 7.621056008488836e-10
of O 0 6.91812319236762e-12
genomic O 0 8.63152271879386e-10
structure O 0 1.6000428759710417e-10
information O 0 3.712293805691047e-10
. O 0 1.7300696431021834e-09

We O 0 8.225482794887995e-11
report O 0 2.8783567326481907e-13
here O 0 3.220698108707086e-14
the O 0 1.130208555257385e-15
complete O 0 1.5842199514032318e-12
characterization O 0 1.0251213072853815e-11
of O 0 4.587562426293379e-13
the O 0 7.428432326726797e-13
48 O 0 1.2956659078966482e-09
exons O 0 9.26727317107634e-09
of O 0 9.544584567144909e-11
the O 0 2.01629601903619e-10
COL4A4 O 0 0.004518740810453892
gene O 0 1.52355923016545e-11
, O 0 1.4540079481140805e-13
a O 0 1.3312426519213744e-13
comprehensive O 0 9.021248158214146e-12
gene O 0 2.1674441484220014e-14
screen O 0 1.5056140362235126e-11
, O 0 1.0688330645894362e-13
and O 0 3.4501810181617257e-14
the O 0 1.5311086816807706e-13
subsequent O 0 8.705801704533833e-12
detection O 0 4.414288934384558e-10
of O 0 1.3588900783702978e-13
10 O 0 1.030068635639661e-14
novel O 0 3.1885945435666113e-15
mutations O 0 2.0216995937592797e-13
in O 0 3.3368303915337974e-14
eight O 0 6.906722416211153e-11
patients O 0 6.584551237587277e-10
diagnosed O 0 7.733623874628393e-07
with O 0 2.4711716006819984e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.943900305283023e-08

Furthermore O 0 5.512777345728637e-09
, O 0 2.6229891739518174e-13
we O 0 8.689501619337306e-14
identified O 0 4.73530069322603e-13
a O 0 5.908717525676677e-14
glycine O 0 1.243255064869997e-12
to O 0 1.3162560234467047e-12
alanine O 0 1.1783829467759688e-10
substitution O 0 1.1912211494990999e-10
in O 0 1.105778663079704e-11
the O 0 6.594150225858186e-11
collagenous O 0 7.362112910413998e-07
domain O 0 2.2158240520209205e-10
that O 0 6.203935697552407e-15
is O 0 9.461496087200937e-15
apparently O 0 9.923945692991154e-11
silent O 0 1.785915859642273e-11
in O 0 5.633883116973326e-13
the O 0 4.038185150850859e-12
heterozygous O 0 9.020301866558e-12
carriers O 0 4.3944814692546685e-13
, O 0 1.5825157211133561e-13
in O 0 7.570818104374322e-12
11 O 0 2.53812637573958e-09
. O 0 1.743413591270837e-08

5 O 0 1.1673521871369275e-10
% O 0 4.4239965857340025e-11
of O 0 2.2356757016419454e-13
all O 0 2.2034288185267953e-14
control O 0 1.7946154545062099e-12
individuals O 0 1.070791438644806e-14
, O 0 2.0321125085930557e-15
and O 0 1.8877317193270607e-15
in O 0 6.903695958003844e-14
one O 0 2.1780656027673914e-14
control O 0 7.608901573044613e-13
individual O 0 1.5922217022493537e-14
homozygous O 0 3.49004202274128e-12
for O 0 1.6399099959929497e-13
this O 0 3.5005956466882537e-12
glycine O 0 4.015516252842133e-10
substitution O 0 2.1879058564877596e-09
. O 0 4.98014207650499e-09

There O 0 3.481148355688468e-11
has O 0 1.5093142444270449e-15
been O 0 2.2067546086908946e-15
no O 0 4.481344803874715e-16
previous O 0 5.40400623555426e-13
finding O 0 1.4675196821634096e-11
of O 0 3.1200510924866975e-12
a O 0 1.2258727019598403e-12
glycine O 0 4.462946505412457e-12
substitution O 0 5.218489702862872e-12
that O 0 7.913431567744666e-15
is O 0 5.991146092246432e-16
not O 0 8.077887249618824e-15
associated O 0 5.914270375523278e-12
with O 0 9.282322360835288e-14
any O 0 2.0195047023552348e-11
obvious O 0 2.0576879089517774e-10
phenotype O 0 1.3154008264570916e-11
in O 0 6.622247238421974e-14
homozygous O 0 3.26758030355645e-11
individuals O 0 4.401639209367092e-12
. O 0 1.4259375902270222e-08

Founder O 0 6.924763624738262e-07
BRCA1 O 0 1.775010716187353e-08
and O 0 1.4631651792940126e-11
BRCA2 O 0 1.4895588928975911e-10
mutations O 0 9.309947154563861e-14
in O 0 3.16459098509414e-14
French O 0 5.29961708198301e-12
Canadian O 0 3.764017364460415e-08
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.768835910022972e-09
. O 0 4.18696233239757e-09

We O 0 2.8765556603360665e-10
have O 0 2.715880092433315e-13
identified O 0 8.301284464516667e-13
four O 0 4.4750262557255536e-15
mutations O 0 2.1880189810514583e-16
in O 0 4.8683870461763604e-17
each O 0 2.7734920717210117e-15
of O 0 8.05829448308204e-12
the O 0 2.7601400276466848e-08
breast B-Disease 1 0.9658066034317017
cancer I-Disease 0 0.4400781989097595
- O 0 1.4773029306525132e-06
susceptibility O 0 1.6642202060879185e-09
genes O 0 1.7765805493397124e-10
, O 0 2.742350400583571e-12
BRCA1 O 0 6.284014281154882e-11
and O 0 2.815630758060128e-12
BRCA2 O 0 4.4144212590913057e-11
, O 0 9.974664222031377e-16
in O 0 2.1691965325349285e-15
French O 0 5.527654614416455e-13
Canadian O 0 1.7582019173900676e-10
breast B-Disease 0 5.184734863661333e-09
cancer I-Disease 0 2.7397993207500804e-08
and O 0 1.0776137060020119e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.332912751867866e-09
from O 0 2.4800297926397263e-10
Quebec O 0 8.628798298104812e-08
. O 0 3.2840410391088426e-09

To O 0 6.561614185329745e-08
identify O 0 2.1756396506589226e-07
founder O 0 1.6868792585000847e-08
effects O 0 3.6881093734564274e-09
, O 0 3.619272579118843e-13
we O 0 9.554787787791758e-14
examined O 0 4.036090905934486e-12
independently O 0 2.1832846294755903e-11
ascertained O 0 1.1086012108307841e-09
French O 0 1.8451698502452984e-12
Canadian O 0 9.410953787092335e-12
cancer B-Disease 0 3.3437783791834264e-12
families O 0 1.4351941605094364e-14
for O 0 9.309831238105029e-16
the O 0 7.461653839832376e-15
distribution O 0 1.1137389838503098e-12
of O 0 2.696194775688582e-13
these O 0 5.18914663842629e-13
eight O 0 8.714133303833194e-10
mutations O 0 1.5277162868088112e-09
. O 0 1.1711892788923706e-08

Mutations O 0 7.840524895996737e-10
were O 0 1.7037094391519902e-12
found O 0 1.8210224113682748e-14
in O 0 9.056057837767036e-15
41 O 0 3.693399405757525e-11
of O 0 3.0118884816743297e-12
97 O 0 5.6755156130350315e-09
families O 0 2.1500153046805082e-10
. O 0 2.6277678699671014e-08

Six O 0 1.4720570318260684e-09
of O 0 3.110438642761615e-11
eight O 0 4.077372814381697e-11
mutations O 0 1.1054850611313949e-12
were O 0 4.952717923278893e-13
observed O 0 3.8214087927021523e-13
at O 0 1.45703208612874e-12
least O 0 1.3126933351079173e-12
twice O 0 1.00790387147498e-09
. O 0 1.2773174518088126e-08

The O 0 6.583200473642137e-08
BRCA1 O 0 5.895035215530697e-08
C4446T O 0 5.3718334669383694e-08
mutation O 0 1.2533460380659278e-11
was O 0 4.4159662905551844e-13
the O 0 1.3742213747156007e-13
most O 0 7.438463771802448e-15
common O 0 5.552134273167919e-14
mutation O 0 5.998412893780045e-14
found O 0 4.5191166076190975e-14
, O 0 7.699360083952139e-16
followed O 0 1.8432895522988747e-14
by O 0 4.3462387077438e-15
the O 0 1.2437394864006635e-11
BRCA2 O 0 5.68458347061096e-09
8765delAG O 0 3.2119412907150036e-08
mutation O 0 1.8827814307620372e-10
. O 0 1.3298165901787229e-09

Together O 0 2.7243318712066866e-09
, O 0 1.9393827635407618e-13
these O 0 6.855169779268824e-15
mutations O 0 3.240650816812608e-14
were O 0 3.628608847314023e-14
found O 0 9.84541969977458e-15
in O 0 6.173528061778925e-15
28 O 0 3.845113897421593e-12
of O 0 4.983412554143696e-12
41 O 0 4.968460087795279e-10
families O 0 8.321406064215608e-12
identified O 0 5.157458488058708e-11
to O 0 9.108148263381466e-11
have O 0 1.3108875096534689e-11
a O 0 1.8737963958237458e-10
mutation O 0 8.340673707252222e-10
. O 0 4.0544607671222366e-09

The O 0 1.036253083341876e-09
odds O 0 1.9773926940303e-09
of O 0 1.4395022717231254e-12
detection O 0 7.212288405389344e-11
of O 0 6.887811176449488e-13
any O 0 4.1462964789004686e-13
of O 0 6.0144918559434934e-12
the O 0 3.378241479959354e-12
four O 0 6.141990561980837e-12
BRCA1 O 0 4.9595955814440984e-11
mutations O 0 3.8075125734574056e-13
was O 0 4.585386324112983e-12
18 O 0 3.249074065347912e-10
. O 0 3.1349689511017687e-09

7x O 0 1.3394709640124347e-05
greater O 0 8.582469734896847e-10
if O 0 6.349912999928375e-13
one O 0 4.2174492115862675e-14
or O 0 2.4060695079928304e-15
more O 0 1.7485982726995266e-16
cases O 0 3.390750408314297e-13
of O 0 2.2424937640153075e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.1471559813180932e-10
also O 0 4.57941883130991e-15
present O 0 1.506580504882088e-13
in O 0 2.0533801167645777e-13
the O 0 2.43066435035022e-11
family O 0 8.381542682123211e-11
. O 0 6.034000410437557e-09

The O 0 6.451285616826397e-10
odds O 0 2.2663912968567956e-09
of O 0 1.9700901066760368e-12
detection O 0 6.13684172923179e-11
of O 0 2.4356892371069083e-12
any O 0 7.678780571465649e-13
of O 0 1.7071224642228877e-11
the O 0 7.531843204677813e-12
four O 0 1.3165002074599919e-11
BRCA2 O 0 3.4940686455264824e-10
mutations O 0 2.324798339947698e-12
was O 0 8.677237747778399e-12
5 O 0 1.7846296662682448e-10
. O 0 1.27284671691541e-09

3x O 0 6.154683433123864e-06
greater O 0 1.9081752844485322e-10
if O 0 3.1453360966118837e-13
there O 0 3.5818085829123283e-14
were O 0 9.687832269256527e-14
at O 0 3.756081207238575e-14
least O 0 2.7751641147588917e-15
five O 0 7.437186446117988e-15
cases O 0 1.894860814479274e-14
of O 0 2.928704848081942e-11
breast B-Disease 0 3.5469149839428837e-09
cancer I-Disease 0 1.3809026144784298e-10
in O 0 1.777982969186631e-11
the O 0 1.7885902758862926e-09
family O 0 3.783009461244546e-09
. O 0 9.903896369678478e-08

Interestingly O 0 3.969236050949121e-09
, O 0 4.6934205721643925e-15
the O 0 5.594705979690331e-15
presence O 0 7.86168344508488e-14
of O 0 1.939314507592993e-11
a O 0 2.7827221416032444e-08
breast B-Disease 0 3.547888525190501e-07
cancer I-Disease 0 2.1756587642585146e-09
case O 0 3.2103360768365174e-12
< O 0 1.088598877707625e-09
36 O 0 5.213229153921972e-11
years O 0 1.0588464783786722e-12
of O 0 2.5367769950629393e-12
age O 0 1.602595486871472e-11
was O 0 4.740912523670815e-13
strongly O 0 1.5458563045627795e-14
predictive O 0 1.1574748798315326e-10
of O 0 5.670407719760018e-13
the O 0 2.3221425867261947e-13
presence O 0 9.780832421106903e-14
of O 0 4.874492194432978e-13
any O 0 7.936112704498566e-13
of O 0 1.523727845287315e-11
the O 0 1.560254876686873e-11
eight O 0 1.2455561582136454e-10
mutations O 0 7.742848896763466e-12
screened O 0 4.0813041835008335e-10
. O 0 5.0052060274197174e-09

Carriers O 0 1.9914754567640358e-10
of O 0 6.937207752688579e-11
the O 0 6.525183605249341e-12
same O 0 3.900291114383725e-12
mutation O 0 1.434206757262163e-13
, O 0 1.493420465265206e-16
from O 0 4.100376648072721e-16
different O 0 3.007620194561689e-14
families O 0 1.27460379490546e-12
, O 0 7.530198117616446e-14
shared O 0 2.997242384839005e-11
similar O 0 1.5598255109425252e-12
haplotypes O 0 2.5943186487964454e-10
, O 0 7.024987145817785e-13
indicating O 0 1.5640097550395637e-10
that O 0 3.642366356443327e-14
the O 0 1.6827176587894122e-12
mutant O 0 2.1946272923956123e-12
alleles O 0 4.7323386528908e-13
were O 0 4.042023226541458e-12
likely O 0 2.4033487873442727e-12
to O 0 2.612504125792253e-13
be O 0 3.7231211223818367e-14
identical O 0 8.373304762228362e-13
by O 0 6.22237518129766e-15
descent O 0 1.4595068487111007e-09
for O 0 1.7103384680750011e-12
a O 0 4.794521984291533e-12
mutation O 0 9.133644361669635e-13
in O 0 2.4040568730068594e-14
the O 0 5.613192202713613e-13
founder O 0 4.3340785821355254e-11
population O 0 1.0671443519431542e-13
. O 0 3.649110180692361e-11

The O 0 4.40798265943787e-12
identification O 0 5.860332219498332e-10
of O 0 2.934419374156505e-11
common O 0 6.545305963889803e-11
BRCA1 O 0 1.2487467726529644e-09
and O 0 1.390748627372318e-10
BRCA2 O 0 1.327424392627563e-09
mutations O 0 1.6527097615806619e-12
will O 0 2.0207513234341695e-13
facilitate O 0 1.1819914491617567e-10
carrier O 0 6.102146240562212e-13
detection O 0 1.1159878576805227e-10
in O 0 3.966805725043321e-13
French O 0 3.5027744593740806e-11
Canadian O 0 5.9033813393227774e-09
breast B-Disease 0 1.5597727553995355e-07
cancer I-Disease 0 2.8406449814610824e-07
and O 0 0.00022444120259024203
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4052154995169985e-08
. O 0 6.940403807220719e-09

Are O 0 5.0286448616265744e-11
Dp71 O 0 3.476825440884568e-06
and O 0 1.0792289978356351e-10
Dp140 O 0 1.0923182571787038e-06
brain O 0 7.832549044906045e-07
dystrophin O 0 1.2075189737004166e-08
isoforms O 0 2.285882733099598e-10
related O 0 7.068232110718498e-11
to O 0 6.458866080860659e-11
cognitive B-Disease 0 1.0070895768876653e-05
impairment I-Disease 0 4.7934816393535584e-05
in O 0 1.3098052420446038e-07
Duchenne B-Disease 1 0.9689311981201172
muscular I-Disease 0 0.004426589235663414
dystrophy I-Disease 1 0.999990701675415
? O 0 9.40671015996486e-05

Molecular O 0 2.4529792086447344e-10
study O 0 1.4801322060359334e-12
and O 0 7.363309926524363e-15
neuropsychological O 0 3.763054971794855e-12
analysis O 0 6.052670436249366e-14
were O 0 1.680006164023716e-14
performed O 0 9.541147846835532e-14
concurrently O 0 6.629814752745489e-11
on O 0 7.820711959982685e-12
49 O 0 1.536389127032578e-09
patients O 0 7.583452615866904e-11
with O 0 5.2930639038439864e-11
Duchenne B-Disease 0 0.009894073940813541
muscular I-Disease 0 0.04859048128128052
dystrophy I-Disease 1 1.0
( O 0 4.787922058824279e-09
DMD B-Disease 1 1.0
) O 0 1.8525778784292402e-13
in O 0 1.0963266867957972e-14
order O 0 3.9822308726391795e-14
to O 0 9.47734512396492e-13
find O 0 4.502584936838527e-12
a O 0 3.9469397531115974e-14
molecular O 0 2.855853574457168e-13
explanation O 0 9.917766477865464e-13
for O 0 1.3700653567379206e-13
the O 0 2.943758431461774e-11
cognitive B-Disease 0 9.63350288429865e-08
impairment I-Disease 0 1.2298932983156874e-09
observed O 0 7.821842132327284e-13
in O 0 6.991076012367869e-13
most O 0 1.0602661110192813e-10
DMD B-Disease 1 1.0
patients O 0 2.953825095630691e-08
. O 0 2.9235061038690446e-09

Complete O 0 7.119746459061105e-10
analysis O 0 9.027422364325799e-13
of O 0 2.981866056156468e-13
the O 0 1.955708544328777e-13
dystrophin O 0 1.881410166548747e-10
gene O 0 1.8426296458703278e-13
was O 0 7.733251430712407e-13
performed O 0 2.473786366724573e-12
to O 0 1.3720752832513394e-11
define O 0 5.748013731654567e-10
the O 0 5.727305088520929e-11
localization O 0 8.600619366916362e-06
of O 0 4.160468858316335e-09
deletions O 0 7.911011401517953e-09
and O 0 2.5444009746355967e-11
duplications O 0 2.136099297445071e-08
in O 0 3.579606446327266e-12
relation O 0 5.2391563309939215e-11
to O 0 5.072414710483031e-12
the O 0 2.5939302789046437e-12
different O 0 1.5294501776175196e-10
DMD B-Disease 1 1.0
promoters O 0 7.78898936459882e-08
. O 0 7.899656928600507e-09

Qualitative O 0 3.923471769695652e-09
analysis O 0 1.2054851040999015e-11
of O 0 9.109551654673531e-12
the O 0 4.360969918515423e-11
Dp71 O 0 1.8249835420647287e-06
transcript O 0 2.255313047427876e-09
and O 0 2.0761732990367404e-14
testing O 0 1.499965787427754e-13
for O 0 5.6728248638002795e-15
the O 0 9.668099112090933e-14
specific O 0 1.9232849362595117e-13
first O 0 1.604213289985168e-11
exon O 0 2.075402516510394e-09
of O 0 3.3206790095441363e-10
Dp140 O 0 1.6676598590947833e-07
were O 0 5.099122860063865e-11
also O 0 1.1899067343425218e-13
carried O 0 2.76985014785458e-11
out O 0 1.074283023649869e-11
. O 0 8.835185361100173e-10

Neuropsychological O 0 5.392949447013962e-07
analysis O 0 1.159881045376121e-11
assessed O 0 1.7390312800902308e-10
verbal O 0 5.8306328654111894e-09
and O 0 7.17061392901952e-12
visuospatial O 0 0.06146322190761566
intelligence O 0 2.942173171760487e-09
, O 0 2.2834424306364572e-14
verbal O 0 1.1035437841311335e-10
memory O 0 1.2437550367394579e-07
, O 0 1.1735163079999722e-13
and O 0 4.79047682598599e-14
reading O 0 1.933092713679585e-10
skills O 0 7.519649898313219e-07
. O 0 3.39523564818478e-09

Comparison O 0 6.334082769399174e-08
of O 0 1.6028783855759343e-09
molecular O 0 5.10915254547939e-10
and O 0 1.6002046909768808e-10
psychometric O 0 5.1811294810022446e-08
findings O 0 4.480569734677253e-11
demonstrated O 0 4.359398259046188e-11
that O 0 2.2559237193141984e-13
deletions O 0 5.902552752123924e-11
and O 0 5.453541806511863e-13
duplications O 0 4.539325360042312e-09
that O 0 2.9355473130446286e-13
were O 0 5.8132899535823235e-12
localized O 0 1.3570687629194111e-10
in O 0 1.1475444075884078e-12
the O 0 7.787162407957293e-12
distal O 0 6.315112841548398e-07
part O 0 3.991706409856022e-10
of O 0 2.419173306122957e-09
the O 0 1.2197498566735021e-09
gene O 0 1.8854865585504754e-11
seemed O 0 2.0436619063701755e-10
to O 0 1.1950635793456232e-12
be O 0 1.3564197237202896e-13
preferentially O 0 7.307388721899954e-11
associated O 0 4.144294629693235e-10
with O 0 4.739741932269226e-11
cognitive B-Disease 1 0.9975460171699524
impairment I-Disease 0 0.00046929577365517616
. O 0 2.099307216951729e-08

Two O 0 5.883459830435811e-10
altered O 0 1.655488635066149e-09
Dp71 O 0 7.349254360633495e-07
transcripts O 0 4.75290962143049e-09
and O 0 9.537823005348334e-13
two O 0 8.149376898129723e-13
deleted O 0 1.45862332628921e-11
Dp140 O 0 2.003590175714276e-11
DNA O 0 1.5829513264412065e-12
sequences O 0 3.5345856914216012e-15
were O 0 4.940287477608711e-15
found O 0 1.998288788943297e-15
in O 0 2.496825064884629e-15
four O 0 2.40844589280767e-13
patients O 0 4.594307573269063e-12
with O 0 1.1499239060963617e-12
severe O 0 0.015708426013588905
cerebral B-Disease 1 1.0
dysfunction I-Disease 0 0.3784358501434326
. O 0 1.0524656772759045e-06

These O 0 1.1969217283969158e-10
findings O 0 5.0446946966986594e-12
suggest O 0 1.2112649208292914e-12
that O 0 5.787754952764953e-16
some O 0 1.2876061233403104e-15
sequences O 0 3.993840306214247e-13
located O 0 6.364439682736422e-13
in O 0 1.1733015004445485e-13
the O 0 5.695797132554414e-12
distal O 0 5.139755785421585e-07
part O 0 1.859069148624215e-10
of O 0 9.320679783542118e-10
the O 0 1.2185957798394043e-10
gene O 0 7.579873144078486e-13
and O 0 2.1321750788561022e-12
, O 0 1.6853467067561544e-14
in O 0 2.1176352229916595e-14
particular O 0 3.8812022714641847e-13
, O 0 1.3987985947219294e-14
some O 0 7.224544584533837e-14
DMD B-Disease 1 1.0
isoforms O 0 4.085496385641818e-09
expressed O 0 4.686477334675532e-12
in O 0 1.3872085771748921e-11
the O 0 4.977356860003113e-10
brain O 0 1.323888199067369e-07
may O 0 2.537008146966113e-13
be O 0 3.050104317877354e-14
related O 0 1.3925821433502517e-11
to O 0 1.0836446323603255e-11
the O 0 6.518966616519961e-11
cognitive B-Disease 0 6.858167580503505e-07
impairment I-Disease 0 8.19751821978798e-09
associated O 0 9.586090254920521e-11
with O 0 7.882261683633818e-12
DMD B-Disease 1 1.0
. O 0 2.33810582006555e-10
. O 0 3.4100700041506116e-10

I1307K O 0 1.2893564189653262e-06
APC O 0 1.7971812482642235e-08
and O 0 1.0823123647307753e-11
hMLH1 O 0 3.9665209783379396e-08
mutations O 0 2.361440036569018e-12
in O 0 5.48919803112103e-14
a O 0 1.8815831325739302e-13
non O 0 4.9200143958927356e-11
- O 0 2.7633529145476565e-12
Jewish O 0 1.1555215334926872e-12
family O 0 2.605764216868315e-14
with O 0 5.430210699025888e-16
hereditary B-Disease 1 0.9999736547470093
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.8749404918926302e-06

We O 0 3.656823108211249e-11
describe O 0 1.5295514854685166e-11
a O 0 5.57466507851434e-13
French O 0 4.0726197913197593e-13
Canadian O 0 2.239399464476488e-11
hereditary B-Disease 0 0.308159738779068
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 7.664181789213131e-12
HNPCC B-Disease 0 9.378622053191066e-05
) O 0 4.5842974869762104e-14
kindred O 0 3.8750833097900284e-10
which O 0 5.360258694835128e-15
carries O 0 1.3957503772546453e-13
a O 0 2.940476909272377e-14
novel O 0 7.432042584435902e-14
truncating O 0 4.874713410707443e-10
mutation O 0 1.5107458686824948e-11
in O 0 8.87429105894677e-12
hMLH1 O 0 6.632321856159251e-07
. O 0 1.1835154190009689e-08

Interestingly O 0 3.792017810866355e-09
, O 0 2.1564178123278238e-14
the O 0 9.161397226779833e-14
I1307K O 0 8.663383899154553e-11
APC O 0 3.688223337849905e-12
polymorphism O 0 5.418595086514877e-11
, O 0 1.053558638036212e-15
associated O 0 1.3690596236976688e-13
with O 0 1.0076892628435499e-15
an O 0 1.352465765452177e-15
increased O 0 2.0348781687440365e-11
risk O 0 1.1592762305667748e-09
of O 0 0.0015506262425333261
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 3.437534978889545e-11
is O 0 2.144464229266287e-15
also O 0 3.502532058873367e-16
present O 0 4.2454145125596365e-14
in O 0 4.0449804286244936e-14
this O 0 7.120591009185384e-13
family O 0 4.908578751794401e-11
. O 0 2.0553905244469206e-09

The O 0 2.943716825853926e-09
I1307K O 0 1.1723676607289235e-07
polymorphism O 0 3.8430101767517044e-08
has O 0 5.759173520025751e-14
previously O 0 4.96455957940678e-13
only O 0 7.764873000224576e-15
been O 0 1.2386997962185627e-14
identified O 0 3.2857807322423174e-14
in O 0 5.312884459732551e-16
individuals O 0 7.275636934285859e-15
of O 0 6.357030353509874e-12
self O 0 1.5137247899588147e-08
- O 0 1.661945914221974e-09
reported O 0 2.2527713028352991e-10
Ashkenazi O 0 3.108154444930733e-08
Jewish O 0 1.532375892843163e-10
origins O 0 2.367708029638038e-09
. O 0 7.434963755770241e-10

In O 0 1.2663563253578758e-10
addition O 0 1.502504197448129e-11
, O 0 1.7051218767559322e-14
in O 0 1.6466071466937106e-14
this O 0 9.725155929044341e-14
family O 0 1.6598018532515413e-12
, O 0 8.510235735786995e-15
there O 0 1.590345227809654e-15
appears O 0 1.1639881021389444e-14
to O 0 1.2809152068020413e-13
be O 0 4.140276663178177e-12
no O 0 9.563002299761703e-12
relationship O 0 4.958463084570042e-10
between O 0 2.1249546566792787e-10
the O 0 6.654185882859487e-12
I1307K O 0 2.814984079169136e-10
polymorphism O 0 3.028539363736371e-10
and O 0 1.748880276437447e-14
the O 0 3.775289000688964e-13
presence O 0 6.696325351857046e-13
or O 0 1.9090031205121205e-12
absence O 0 1.6060281993190983e-08
of O 0 3.1600555505661987e-10
cancer B-Disease 0 6.488503623280906e-10
. O 0 2.0901148867213948e-11
. O 0 6.832290844194233e-10

Identification O 0 1.0981466402881779e-08
of O 0 1.934508109258104e-11
a O 0 5.83017385454368e-14
novel O 0 1.7072915728261477e-15
mutation O 0 3.997336519407334e-14
of O 0 2.5530757521118053e-13
the O 0 2.4125666742147445e-12
CPO O 0 1.0990056864557118e-08
gene O 0 2.0278979775793793e-13
in O 0 2.516933601641458e-13
a O 0 6.293115334399246e-12
Japanese O 0 7.173634575252663e-09
hereditary B-Disease 0 0.19344134628772736
coproporphyria I-Disease 1 0.9420461058616638
family O 0 1.4586385432835414e-09
. O 0 2.3660016168491893e-09

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 6.84683282292653e-11
HCP B-Disease 0 6.2142817114363424e-06
) O 0 7.806992899372922e-14
is O 0 1.0382193965218639e-13
an O 0 5.098361403194085e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
characterized O 0 2.1319675625602885e-12
by O 0 1.5636896303551531e-15
a O 0 1.998140541914495e-11
deficiency B-Disease 1 0.9999996423721313
of I-Disease 1 0.9929773211479187
coproporphyrinogen I-Disease 1 0.999832034111023
oxidase I-Disease 0 1.2954014527721824e-09
( O 0 1.1572142102531623e-14
CPO O 0 5.899857935531827e-09
) O 0 4.721738048261406e-16
caused O 0 1.1771788615232408e-14
by O 0 2.5530719171701366e-16
a O 0 2.4753413023752974e-14
mutation O 0 1.627373908373586e-14
in O 0 2.7352797896682338e-14
the O 0 3.8569399410381955e-12
CPO O 0 3.444050378220709e-08
gene O 0 3.281026145218746e-11
. O 0 3.967661310610993e-09

Only O 0 3.165050166398231e-10
11 O 0 2.1163584773553623e-11
mutations O 0 1.9474795040497206e-12
of O 0 1.3892334548362695e-12
the O 0 6.668704759411892e-13
gene O 0 6.047580784675904e-14
have O 0 2.2222654760210153e-14
been O 0 9.563157150936988e-14
reported O 0 7.361885081581809e-13
in O 0 7.224924217924533e-12
HCP B-Disease 0 9.487706847721711e-05
patients O 0 3.2463256527393014e-09
. O 0 1.594809972971234e-08

We O 0 1.0160990798757652e-10
report O 0 4.1979573571666873e-13
another O 0 4.688331767623878e-14
mutation O 0 5.0522584569721515e-14
in O 0 5.803166293723771e-15
a O 0 2.0269043062882963e-13
Japanese O 0 1.860342435655582e-10
family O 0 2.3260634737787278e-11
. O 0 9.613670970409771e-10

Polymerase O 0 3.86556585352249e-11
chain O 0 3.288145851518959e-13
reaction O 0 1.4782771361188107e-14
- O 0 3.177693297298084e-13
single O 0 3.661542504742807e-14
strand O 0 1.0968668735875792e-13
conformational O 0 7.56662070375497e-15
polymorphism O 0 6.383746070821872e-13
and O 0 1.1235235594794172e-16
direct O 0 2.3108039665250234e-14
sequence O 0 1.1716957970270975e-13
analyses O 0 1.68792508182386e-12
demonstrated O 0 2.9246227835344474e-12
a O 0 1.5190058412495322e-12
C O 0 5.842349520834844e-11
to O 0 2.6054091609856167e-12
T O 0 3.4048866157099233e-12
substitution O 0 8.51125105724021e-13
in O 0 1.366308216739498e-12
exon O 0 1.022098985309361e-11
1 O 0 2.5908372940520313e-14
of O 0 3.292714950524356e-13
the O 0 8.433972921093047e-13
CPO O 0 3.1331159888736693e-09
gene O 0 1.0439063757297293e-13
at O 0 1.8045696230720165e-12
nucleotide O 0 3.3407695013143446e-12
position O 0 1.3192935632844183e-10
85 O 0 3.919131963403544e-10
, O 0 5.383869145316779e-14
which O 0 7.919894429132216e-15
lies O 0 3.7950150834353824e-12
in O 0 8.115449772697764e-14
the O 0 8.6805484675323e-12
putative O 0 1.2158134055084702e-08
presequence O 0 2.09981987353558e-08
for O 0 6.208833794318913e-12
targeting O 0 9.454628191463144e-10
to O 0 7.129357992852192e-09
mitochondria O 0 9.639391009841347e-07
. O 0 7.00653757235159e-08

This O 0 2.64798193138141e-13
mutation O 0 1.9882529731776385e-14
changes O 0 2.6223144783280115e-16
the O 0 8.746711029276161e-16
codon O 0 2.0122907246761246e-12
for O 0 3.3672361214831482e-15
glutamine O 0 1.4423475434843791e-11
to O 0 9.413013988060492e-13
a O 0 2.8672567792265014e-12
termination O 0 3.1527425115029928e-09
codon O 0 1.763210910610269e-08
at O 0 2.7290214532627033e-10
amino O 0 1.0111078641017457e-09
acid O 0 2.328834902698418e-10
position O 0 2.3400430482212187e-09
29 O 0 2.3581995023391755e-08
. O 0 1.752695766299439e-08

MaeI O 0 3.318888730063918e-06
restriction O 0 5.3020057094732564e-11
analysis O 0 8.386784322578222e-12
showed O 0 5.897947494976075e-12
two O 0 9.272053780415724e-15
other O 0 5.386493211035725e-16
carriers O 0 7.309883323376298e-15
in O 0 8.984542846030355e-14
the O 0 2.212988819971784e-11
family O 0 2.1320308019046053e-10
. O 0 7.271774737915848e-09

The O 0 1.0997306398863316e-09
C O 0 9.38151345053484e-07
- O 0 2.585947811439837e-08
T O 0 3.1363731056721633e-10
mutation O 0 1.0850106484929997e-13
is O 0 5.926047375085202e-16
located O 0 1.2202725944510454e-14
within O 0 3.323555352371249e-14
a O 0 3.2652513641063044e-14
recently O 0 2.5289822048590177e-14
proposed O 0 6.6176981632754504e-15
putative O 0 8.574967992613924e-12
alternative O 0 1.576440258714562e-12
translation O 0 7.03881918029392e-12
initiation O 0 2.2231180785148297e-10
codon O 0 2.2464703874902625e-08
( O 0 2.2143007913366652e-12
TIC O 0 3.201388381057768e-07
- O 0 1.2296588192128866e-09
1 O 0 1.899692696986227e-13
) O 0 9.365393820118053e-17
, O 0 4.7505521900679764e-17
supporting O 0 9.21106571414752e-15
that O 0 1.1457280199719203e-14
TIC O 0 6.6850707192145364e-09
- O 0 1.577178526668277e-10
1 O 0 3.0475529868775886e-13
is O 0 2.8797540490199582e-15
the O 0 7.838460512176598e-14
real O 0 4.415783277228469e-12
TIC O 0 1.164403434783523e-10
rather O 0 1.0824356818858738e-12
than O 0 3.666925704054469e-13
TIC O 0 7.560929660144211e-09
- O 0 1.4078645194093298e-10
2 O 0 4.4564623258996905e-13
. O 0 2.7572285817359377e-13
. O 0 7.078697870921413e-12

Human B-Disease 0 1.165790242119158e-10
complement I-Disease 0 6.279384123786258e-09
factor I-Disease 0 3.443039275907722e-08
H I-Disease 1 1.0
deficiency I-Disease 0 9.255949407815933e-06
associated O 0 2.8204374302731594e-07
with O 0 2.3181139567896025e-06
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9977676868438721

This O 0 3.0357773586620063e-12
study O 0 1.0555831653647624e-13
reports O 0 5.863782936044604e-15
on O 0 5.301367882144326e-15
six O 0 2.244476204557328e-14
cases O 0 1.1785986581494285e-14
of O 0 2.9699027525448285e-12
deficiency B-Disease 0 7.858281803052591e-10
in I-Disease 0 7.472884615798703e-13
the I-Disease 0 1.7711179745028005e-12
human I-Disease 0 2.2891386594441065e-13
complement I-Disease 0 1.2150673696365022e-11
regulatory I-Disease 0 5.6522724001251134e-11
protein I-Disease 0 2.8821613498597465e-11
Factor I-Disease 0 1.4226381184201387e-10
H I-Disease 1 0.9989340901374817
( O 0 2.764662854388717e-14
FH O 0 1.7177786970634656e-09
) O 0 1.1664131720253122e-17
in O 0 1.3441014937690532e-17
the O 0 3.549431677592797e-17
context O 0 6.57836212261155e-14
of O 0 6.121424439391177e-14
an O 0 5.844430408380452e-12
acute B-Disease 1 0.9955329895019531
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.3267818960448494e-07

Five O 0 2.941818177948363e-10
of O 0 1.5030423737225074e-12
the O 0 1.3912685565241334e-14
cases O 0 2.140671030440025e-16
were O 0 8.295447873879328e-16
observed O 0 2.443259124816741e-16
in O 0 1.3911291931345305e-16
children O 0 1.4874229955426127e-15
presenting O 0 1.6709297140371504e-11
with O 0 1.1222233142760274e-09
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.0056290850334335e-06
HUS B-Disease 1 1.0
) O 0 3.352147448509868e-10
. O 0 1.5160825483917506e-08

Two O 0 7.839410544330239e-12
of O 0 6.426789656011067e-12
the O 0 6.798745594283062e-12
children O 0 1.7254139740227603e-12
exhibited O 0 6.93072682578233e-11
a O 0 1.5881243542459345e-10
homozygous O 0 8.339564594450621e-09
deficiency O 0 1.2543931227071425e-08
characterized O 0 2.324012293372646e-13
by O 0 8.39454882288395e-15
the O 0 3.235109749533116e-11
absence O 0 1.0151993024010153e-08
of O 0 3.690765748576297e-11
the O 0 1.0472533213887192e-12
150 O 0 3.290293168131675e-12
- O 0 5.172545876862278e-13
kD O 0 1.5108555032061766e-11
form O 0 7.802829020929491e-13
of O 0 4.0295010383939456e-11
Factor O 0 4.772565120880756e-10
H O 1 0.9999963045120239
and O 0 3.011365679386757e-12
the O 0 3.3428025972281894e-12
presence O 0 5.53596576945755e-14
, O 0 2.5192207748287105e-16
upon O 0 3.2160526412111645e-13
immunoblotting O 0 1.3717050828532251e-09
, O 0 3.768737997052922e-15
of O 0 2.248260578359071e-13
the O 0 8.056937820903609e-13
42 O 0 4.915577320185882e-11
- O 0 2.3173782771196416e-12
kD O 0 2.1400436978069592e-11
Factor O 0 3.7644283523707855e-11
H O 1 0.9856939315795898
- O 0 5.093256927324319e-09
like O 0 2.017694171463358e-12
protein O 0 8.608425929555741e-13
1 O 0 3.2019248092773206e-14
( O 0 4.8280343303947165e-16
FHL O 0 1.0380818338262543e-07
- O 0 4.607418179619627e-12
1 O 0 3.3152721324767546e-15
) O 0 1.3353418992363004e-17
and O 0 2.263579349204666e-16
other O 0 9.222703099809847e-15
FH O 0 1.7452066458645277e-08
- O 0 6.570643768660789e-12
related O 0 1.1090907706123865e-11
protein O 0 7.171034599462445e-13
( O 0 1.8255799356684476e-16
FHR O 0 5.749258491505316e-08
) O 0 4.907192629810065e-15
bands O 0 7.748171548804805e-11
. O 0 5.585198969981775e-10

Southern O 0 4.201540448889318e-08
blot O 0 1.979294506071483e-09
and O 0 5.464497533939558e-16
PCR O 0 7.99370064499122e-14
analysis O 0 2.9410685935497697e-16
of O 0 1.9283583840926924e-16
DNA O 0 3.727494875260806e-12
of O 0 7.042656388622781e-13
one O 0 2.389599585914115e-12
patient O 0 1.2371492719154276e-09
with O 0 2.292561106231883e-12
homozygous O 0 4.307069367825989e-09
deficiency O 0 2.1037404707158203e-08
ruled O 0 9.789894589440351e-12
out O 0 1.3223063526838878e-14
the O 0 9.128234362235522e-15
presence O 0 9.325367728181804e-15
of O 0 1.6844636579679828e-13
a O 0 3.8358073363659387e-14
large O 0 2.3478597097916203e-15
deletion O 0 1.3224793439167715e-12
of O 0 1.0937238961727935e-11
the O 0 4.6741780584946824e-11
FH O 0 4.1990890053966723e-07
gene O 0 1.2565911852724376e-12
as O 0 7.095100331908077e-14
the O 0 2.363422608661625e-12
underlying O 0 3.3310905145356173e-09
defect O 0 7.09456360326044e-09
for O 0 3.3634284593575536e-12
the O 0 2.17613194131161e-09
deficiency O 0 6.812974606873468e-05
. O 0 3.209908072676626e-08

The O 0 1.0855022609945753e-11
other O 0 4.099550102734878e-15
four O 0 7.455052912074423e-15
children O 0 3.0283455449458727e-16
presented O 0 5.724009455440257e-14
with O 0 1.5120956041642965e-14
heterozygous O 0 1.994565103358159e-11
deficiency O 0 1.1330206106663354e-08
and O 0 4.365428591529552e-12
exhibited O 0 2.5930189107015167e-09
a O 0 1.143802830227969e-09
normal O 0 2.788000756481779e-06
immunoblotting O 0 3.802043238465558e-06
pattern O 0 6.115030148912126e-10
of O 0 3.866325662404968e-11
proteins O 0 5.199906802887122e-13
of O 0 4.707398013059638e-11
the O 0 2.41601794126467e-10
FH O 0 2.8292756724113133e-06
family O 0 6.803729801774239e-11
. O 0 5.998744834201375e-10

Factor B-Disease 0 5.412289283412974e-06
H I-Disease 1 1.0
deficiency I-Disease 0 1.3843047781847417e-05
is O 0 2.5799195475816918e-14
the O 0 7.640004758393062e-14
only O 0 6.0453838116036884e-12
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 4.4543466692914535e-09
with O 0 1.292746812375789e-11
HUS B-Disease 1 1.0
. O 0 9.852986693204002e-08

These O 0 8.058232900398643e-12
observations O 0 2.6083838214341348e-11
suggest O 0 1.4647001059936438e-12
a O 0 3.402027195110319e-14
role O 0 1.9714572585104867e-13
for O 0 7.911719781920901e-13
FH O 0 1.2861686627729796e-05
and O 0 1.3883819094395733e-10
/ O 0 6.596071244757695e-08
or O 0 3.756946836963593e-11
FH O 0 4.94298220132805e-08
receptors O 0 1.2711895067390316e-13
in O 0 4.529230181009314e-14
the O 0 2.914330831781803e-13
pathogenesis O 0 8.046476818179826e-10
of O 0 2.2843615887779833e-10
idiopathic O 0 1.2588181164119305e-07
HUS B-Disease 0 0.0001964124821824953
. O 0 4.6311141033150705e-10
. O 0 2.7626771981204e-09

Further O 0 1.120659190445572e-10
evidence O 0 2.624872107864773e-12
for O 0 1.867384759736239e-14
a O 0 1.2633821668949635e-13
major O 0 3.2361865466047635e-13
ancient O 0 7.183516559372549e-10
mutation O 0 2.876595406320348e-09
underlying O 0 1.1327677462702468e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 8.61268123486525e-09
linkage O 0 1.3670297960288735e-07
disequilibrium O 0 4.169138776433101e-07
studies O 0 1.1336732334138455e-12
in O 0 1.0302567616572462e-15
the O 0 5.1070356541546135e-15
Japanese O 0 6.014618057076371e-12
population O 0 8.607137151985834e-15
. O 0 8.251751712484712e-12

The O 0 5.302274175278399e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 9.222511643258713e-11
DM B-Disease 1 1.0
) O 0 8.294221158413467e-14
mutation O 0 1.8174044626000085e-13
is O 0 3.2064514804023897e-15
an O 0 8.790940929847765e-14
unstable O 0 2.1030259631515946e-06
( O 0 3.317022871651698e-12
CTG O 0 1.2327026297498378e-06
) O 0 5.1733225044309564e-14
n O 0 3.824449437694888e-13
repeat O 0 1.4109984014520904e-11
, O 0 3.8987677188518245e-15
present O 0 7.60319609463718e-14
at O 0 1.9626356475340584e-14
a O 0 1.4156150627550802e-16
copy O 0 3.5701202736292126e-13
number O 0 6.291376602763363e-15
of O 0 5.538186554319979e-13
5 O 0 4.65068998936613e-12
- O 0 1.593428028412447e-10
37 O 0 9.768430508927395e-11
repeats O 0 6.757456399997253e-11
on O 0 1.7851463363083298e-11
normal O 0 6.151044257274307e-11
chromosomes O 0 2.6962833007959652e-12
but O 0 4.673038757167791e-14
amplified O 0 7.075791775418283e-13
to O 0 6.723431490371357e-13
50 O 0 2.6691196128303396e-11
- O 0 8.857055713851203e-13
3000 O 0 2.2078136031628698e-13
copies O 0 7.675856478206455e-12
on O 0 8.455360300807513e-10
DM B-Disease 1 0.9999983310699463
chromosomes O 0 3.6931213642787952e-09
. O 0 3.5978264811831195e-09

Previous O 0 1.9538976658850515e-08
findings O 0 5.020640153619027e-12
in O 0 5.201550385617974e-14
Caucasian O 0 3.2925833171049135e-09
populations O 0 5.333585136046981e-13
of O 0 1.3715623255194931e-11
a O 0 6.70354936005424e-08
DM B-Disease 1 1.0
founder O 0 1.1599798881434253e-06
chromosome O 0 2.7242606392974267e-08
raise O 0 1.618384870560874e-10
a O 0 1.0412660317316025e-12
question O 0 1.2797437805647793e-12
about O 0 4.774298560220904e-16
the O 0 8.050140144332668e-15
molecular O 0 2.948153738279932e-14
events O 0 2.3717112258500594e-14
involved O 0 1.5323159407998332e-12
in O 0 2.1327364787410152e-12
the O 0 9.762503305754677e-12
expansion O 0 5.066852715174264e-09
mutation O 0 4.424572652705905e-10
. O 0 1.5730126090574004e-09

To O 0 2.9952434976721065e-10
investigate O 0 1.2769403590073836e-11
whether O 0 4.856245207395318e-14
a O 0 1.4563144527107719e-13
founder O 0 3.2840090781298403e-13
chromosome O 0 2.3300322175151544e-12
for O 0 1.872536007545625e-13
the O 0 1.5909377981682127e-10
DM B-Disease 1 1.0
mutation O 0 8.186287585310037e-12
exists O 0 1.0858013706899206e-13
in O 0 1.4697295360656545e-15
the O 0 6.126513498041575e-15
Japanese O 0 1.2073927795064332e-11
population O 0 4.784876413545334e-15
, O 0 1.175728635238423e-15
we O 0 1.9439824912575315e-13
genotyped O 0 2.0994512794914044e-08
families O 0 8.945201892575361e-13
using O 0 9.385154329036305e-13
polymorphic O 0 9.677362244886467e-10
markers O 0 7.114632882831984e-09
near O 0 2.7895939069821907e-07
the O 0 1.1595813198539417e-09
( O 0 2.467306957701365e-12
CTG O 0 2.6217108484161145e-07
) O 0 2.084292347005398e-13
n O 0 8.610729317071186e-12
repeat O 0 2.9200161733022867e-10
region O 0 1.0603760092209313e-09
and O 0 4.391023569055852e-12
constructed O 0 1.2334312460282604e-09
haplotypes O 0 5.961416249533613e-09
. O 0 2.497309026239236e-09

Six O 0 7.142557101325053e-10
different O 0 6.547096849038314e-13
haplotypes O 0 2.051072679754018e-11
were O 0 6.204604430064264e-13
found O 0 3.1624320675181783e-13
and O 0 7.656784277790263e-13
DM B-Disease 1 0.9999895095825195
alleles O 0 3.0730856227789705e-12
were O 0 9.385337992884324e-12
always O 0 7.355993418556306e-12
haplotype O 0 1.9204591250598924e-09
A O 0 1.2243684466284321e-07
. O 0 1.1847283154509114e-08

To O 0 6.872136887325908e-11
find O 0 1.7308162281876038e-12
an O 0 5.162481848546729e-17
origin O 0 1.0445994519684906e-13
of O 0 1.0682955171523179e-12
the O 0 2.0728794115215665e-12
( O 0 2.614446473984261e-14
CTG O 0 2.10516919452175e-08
) O 0 4.334724988891772e-14
n O 0 7.500158263548662e-13
repeat O 0 1.517596465161475e-11
mutation O 0 5.538545967340158e-13
and O 0 4.3197281011540453e-14
to O 0 4.3657031115196254e-12
investigate O 0 1.6087020604516056e-11
the O 0 6.226655475949361e-13
mechanism O 0 2.313943307796773e-11
of O 0 1.3677554097993316e-12
the O 0 2.948779458458728e-13
expansion O 0 5.73103934101149e-12
mutation O 0 2.0137320630442268e-14
in O 0 2.518040275598034e-15
the O 0 5.845001250988661e-15
Japanese O 0 2.7522383243966386e-12
population O 0 4.373130733269703e-15
we O 0 1.905944198242449e-15
have O 0 3.785769712039838e-15
studied O 0 3.87058603484175e-13
90 O 0 1.1255898123285757e-11
Japanese O 0 1.5724785917825557e-09
DM B-Disease 1 0.9999997615814209
families O 0 4.2208896967876885e-12
comprising O 0 1.610195402576911e-13
190 O 0 6.850928244844789e-13
affected O 0 1.3156963582852677e-12
and O 0 1.9433003925657666e-13
130 O 0 3.0231836478655794e-10
unaffected O 0 6.426321697006188e-09
members O 0 2.1763330720903085e-11
. O 0 6.840926936035885e-09

The O 0 1.2183732911452694e-09
results O 0 7.994353096174578e-11
suggest O 0 2.4605173801206526e-11
that O 0 1.0731959957754715e-14
a O 0 5.538038560723435e-13
few O 0 1.3864302501193082e-12
common O 0 4.242148732985784e-12
ancestral O 0 1.1768951146962081e-08
mutations O 0 1.6071196456968195e-11
in O 0 5.731954082384416e-13
both O 0 3.1918318682544466e-11
Caucasian O 0 1.645149677642621e-05
and O 0 1.5867881661413286e-11
Japanese O 0 6.32798213828778e-09
populations O 0 3.30022061111393e-14
have O 0 5.335528363565067e-17
originated O 0 2.6482218280527315e-15
by O 0 1.807734241871555e-17
expansion O 0 7.009478934782987e-12
of O 0 2.8491846468942095e-12
an O 0 3.7241672419530136e-13
ancestral O 0 3.1279704160169786e-08
n O 0 6.107074481537245e-12
= O 0 2.098862533425616e-12
5 O 0 7.968177441648738e-13
repeat O 0 1.378998911588658e-11
to O 0 4.651845228464957e-11
n O 0 2.2921456399593865e-12
= O 0 9.973652763048402e-13
19 O 0 1.0136788110293171e-11
- O 0 4.549130169784199e-12
37 O 0 8.754602945360013e-13
copies O 0 5.202449148561383e-12
. O 0 6.257892121164232e-11

These O 0 1.9575682221051327e-12
data O 0 8.731789705347659e-13
support O 0 8.46404042231623e-14
multistep O 0 8.793911154825196e-10
models O 0 1.5238513784154861e-09
of O 0 2.3550487782131313e-08
triplet O 0 2.0660725567722693e-05
repeat O 0 4.305903189560922e-09
expansion O 0 2.679281518869203e-10
that O 0 3.2253314212802144e-15
have O 0 1.2288578239428834e-15
been O 0 1.107350947659254e-15
proposed O 0 1.2914379945145704e-15
for O 0 2.5049832203644616e-14
both O 0 5.350773157886124e-10
DM B-Disease 1 1.0
and O 0 4.191373026429801e-09
Friedreichs B-Disease 0 0.0005309256375767291
ataxia I-Disease 0 2.4023782316362485e-05
. O 0 4.4189640835412547e-10
. O 0 5.525831348052179e-09

The O 0 3.4841574070298975e-11
molecular O 0 1.1941231857492962e-11
basis O 0 1.669708815654758e-08
of O 0 5.582041353591194e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.1871745253522192e-10
the O 0 9.894834084034354e-12
western O 0 9.299632591774909e-11
Cape O 0 2.352254224735617e-10
, O 0 1.8832623923325208e-14
South O 0 4.889290361465015e-12
Africa O 0 1.9053229480259226e-11
. O 0 8.575953142075932e-11

Deficiency B-Disease 0 1.4214037037163507e-05
of I-Disease 0 1.394498028162161e-08
the I-Disease 0 4.512949736135141e-10
sixth I-Disease 0 8.864663527674566e-07
component I-Disease 0 5.717574858010721e-09
of I-Disease 0 7.685972414073206e-10
human I-Disease 0 1.2132113091922747e-09
complement I-Disease 0 8.931523552746512e-06
( O 0 6.4071573567525686e-12
C6 O 0 1.194027117890073e-05
) O 0 1.6629983523065717e-13
has O 0 1.079967537144825e-15
been O 0 7.274332503547087e-15
reported O 0 1.317090916717759e-14
in O 0 2.8149769926204488e-15
a O 0 7.70756275101335e-15
number O 0 1.7698523675191663e-15
of O 0 2.8233664727981764e-14
families O 0 2.9450134822125995e-13
from O 0 4.999308801136026e-13
the O 0 2.0438704981945444e-12
western O 0 6.661151630282802e-10
Cape O 0 2.005052568421206e-09
, O 0 5.275752707964432e-13
South O 0 8.086752795177787e-11
Africa O 0 1.5144857590243532e-10
. O 0 2.392666897943485e-10

Meningococcal B-Disease 1 0.9996799230575562
disease I-Disease 0 0.00013547504204325378
is O 0 1.6564431033413984e-12
endemic O 0 1.5019562199861114e-12
in O 0 6.388185268854478e-15
the O 0 5.055365306060045e-13
Cape O 0 3.3536420168678305e-11
and O 0 2.0182059481348142e-16
almost O 0 1.1740932899029829e-14
all O 0 1.2375561111573562e-15
pedigrees O 0 2.4507449403188275e-09
of O 0 2.756624040145539e-09
total O 1 0.9898867011070251
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.5531282643598274e-10
C6Q0 O 0 0.00017396478506270796
) O 0 6.61194799540972e-14
have O 0 1.623003218365754e-14
been O 0 2.847595680847796e-14
ascertained O 0 1.9047570465335895e-10
because O 0 1.7796198813636172e-13
of O 0 7.678232355479153e-11
recurrent O 0 9.185687667923048e-05
disease O 0 5.250423669167503e-07
. O 0 1.0982680542781509e-08

We O 0 2.2721671766312568e-11
have O 0 1.1878335195601632e-14
sequenced O 0 2.7690458433149434e-12
the O 0 6.830583462128642e-14
expressed O 0 1.505917677883939e-12
exons O 0 1.1994687909577806e-08
of O 0 1.9217442914776228e-10
the O 0 1.0059674621087922e-10
C6 O 0 4.4719875802456954e-08
gene O 0 1.3665942834827083e-13
from O 0 1.874697906677561e-13
selected O 0 7.880694252553055e-13
cases O 0 3.429801744263966e-14
and O 0 4.649593901627329e-14
have O 0 1.0344321428081005e-13
found O 0 1.0669414570591007e-12
three O 0 7.616568508707344e-13
molecular O 0 2.707381263622466e-10
defects O 0 2.2171481361965562e-07
leading O 0 3.652356472816365e-10
to O 0 3.287149219488583e-09
total O 0 9.716359272715636e-06
deficiency O 0 0.29362592101097107
879delG O 0 0.00045755814062431455
, O 0 3.5433510509400024e-13
which O 0 1.5822253582190374e-14
is O 0 8.522548206708284e-15
the O 0 1.0153076296370855e-12
common O 0 5.48383838339106e-11
defect O 0 2.997504111590388e-08
in O 0 1.9641330228914455e-11
the O 0 2.3130015680550287e-09
Cape O 0 5.065087549382952e-08
and O 0 3.041052479280104e-11
hitherto O 0 7.46839958765122e-08
unreported O 0 2.5837967321251654e-09
, O 0 1.992455442442146e-14
and O 0 3.052421867783678e-13
1195delC O 0 5.088899257543744e-08
and O 0 8.190754498260677e-12
1936delG O 0 5.223598620318626e-08
, O 0 4.032116369847953e-14
which O 0 2.578580049678904e-15
have O 0 2.6413523061472044e-14
been O 0 1.090259610023181e-12
previously O 0 5.638379520223058e-12
reported O 0 6.735188036628703e-13
in O 0 6.030754780110559e-13
African O 0 1.5799787866921378e-10
- O 0 3.5338312137644934e-11
Americans O 0 1.9852624752458858e-11
. O 0 1.100284530153317e-09

We O 0 1.2719723885279421e-10
also O 0 2.6763698340328233e-14
show O 0 9.702348381093392e-14
that O 0 8.292880040560168e-17
the O 0 9.664941542670159e-15
879delG O 0 8.85975515174664e-10
and O 0 2.1686320274272308e-13
1195delC O 0 2.0856099069987977e-08
defects O 0 1.8246751665174088e-08
are O 0 2.3668758535673635e-14
associated O 0 8.282555752359144e-10
with O 0 1.672107785566368e-09
characteristic O 1 1.0
C6 O 1 1.0
/ O 1 1.0
C7 O 1 0.9989007711410522
region O 0 8.183648958492995e-08
DNA O 0 7.001955992791409e-08
marker O 0 1.7369502502972978e-09
haplotypes O 0 7.546806513047954e-10
, O 0 1.1952773298039288e-13
although O 0 8.794350339104418e-13
small O 0 1.0260082985037028e-13
variations O 0 4.4556120403459187e-13
were O 0 7.475383159705196e-12
observed O 0 6.226759663441328e-10
. O 0 1.87123756489882e-08

The O 0 2.6937223562839563e-09
1936delG O 0 6.312560003607359e-07
defect O 0 2.1657589854839898e-07
was O 0 1.0990648495468047e-11
observed O 0 1.5881590747363061e-12
only O 0 6.713228741352453e-14
once O 0 3.4718218968124437e-13
in O 0 6.806835368793063e-14
the O 0 3.171761030901221e-12
Cape O 0 5.518960843886589e-10
, O 0 7.149244371962467e-15
but O 0 1.1882957454394799e-14
its O 0 6.365443789473416e-14
associated O 0 3.0287692492914076e-11
haplotype O 0 6.526089890712683e-09
could O 0 6.583041056718031e-11
be O 0 1.8717175032101352e-10
deduced O 0 1.2001203231193358e-07
. O 0 1.3792404551793425e-08

The O 0 3.2691777063220684e-10
data O 0 6.42512570925291e-11
from O 0 3.886068712915386e-13
the O 0 9.47897251142582e-13
haplotypes O 0 5.234401800890964e-11
indicate O 0 1.7175346214703957e-11
that O 0 7.0240821249949615e-15
these O 0 1.7677017889825702e-13
three O 0 1.7843010055584863e-12
molecular O 0 4.2602021910198573e-10
defects O 0 1.1628270613073255e-07
account O 0 1.2609712753131053e-11
for O 0 1.4502898014467913e-11
the O 0 1.3587484914978631e-08
defects O 0 0.4647849500179291
in O 0 7.72084965405817e-11
all O 0 2.0350488655340726e-11
the O 0 8.82381320788106e-11
38 O 0 2.8478199798342985e-09
unrelated O 0 9.926374167079643e-10
C6Q0 O 0 1.582530421728734e-05
individuals O 0 1.276496486637968e-12
we O 0 9.29065201507595e-13
have O 0 8.10677005668066e-14
studied O 0 2.394800937416397e-12
from O 0 1.5008651873399392e-12
the O 0 4.1882601553577814e-11
Cape O 0 1.2327403986489571e-08
. O 0 8.562064945927261e-10

We O 0 1.4158949013243216e-10
have O 0 2.6882135569211013e-14
also O 0 3.9826898903812084e-16
observed O 0 2.9604305491141413e-15
the O 0 1.8824436502857048e-14
879delG O 0 3.372645496213522e-09
defect O 0 2.8439333110696907e-09
in O 0 5.587431559095357e-12
two O 0 2.784823260881808e-09
Dutch O 1 0.9989132881164551
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 0.0010059255873784423
, O 0 1.0454725057678846e-13
but O 0 8.374973891472903e-15
the O 0 5.546950702581266e-13
879delG O 0 2.7580874473187578e-08
defect O 0 3.516932167713094e-08
in O 0 9.090702149383567e-12
the O 0 6.707329136546036e-10
Cape O 0 3.36709859993789e-09
probably O 0 2.887667752485279e-12
did O 0 5.1906515110417e-13
not O 0 2.293255375093034e-13
come O 0 1.5418185825288866e-11
from O 0 9.009022694517199e-12
The O 0 8.785121935472873e-11
Netherlands O 0 1.5302409339668088e-10
. O 0 2.9610071339281063e-11
. O 0 1.6836769756167769e-09

Complement B-Disease 1 0.9999996423721313
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.0170118219798852e-11
seven O 0 8.23277643974274e-12
further O 0 4.785349200231437e-12
molecular O 0 3.6541318582106186e-11
defects O 0 1.8517877009571748e-08
and O 0 7.876516279481383e-13
their O 0 1.2935071069808401e-10
associated O 0 5.044010098487206e-09
marker O 0 9.16680775731038e-08
haplotypes O 0 5.7426277066952025e-08
. O 0 2.711456126291978e-08

Seven O 0 3.2442565300883075e-10
further O 0 3.333824752718706e-12
molecular O 0 3.376298199353478e-11
bases O 0 7.632449339212144e-09
of O 0 9.056068961399433e-07
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.8264700862857808e-10
described O 0 2.4205476512051405e-10
. O 0 2.0418551294199005e-09

All O 0 4.1243026355219925e-11
these O 0 2.2174485012939338e-13
new O 0 1.0453308818591037e-13
molecular O 0 1.954825841130048e-12
defects O 0 3.157951330989839e-11
involve O 0 1.3850089478073535e-11
single O 0 3.2527450177788353e-10
- O 0 1.3861327363695608e-10
nucleotide O 0 6.934062768415572e-10
events O 0 5.4727097853479734e-11
, O 0 5.0487549254144e-13
deletions O 0 3.1388205923299495e-10
and O 0 6.411995500527068e-13
substitutions O 0 1.2696141360457602e-10
, O 0 2.568807830566431e-14
some O 0 1.4041045785101198e-14
of O 0 4.494133364063568e-12
which O 0 8.67093018479953e-13
alter O 0 4.9805720436779666e-08
splice O 0 5.304340788825357e-07
sites O 0 3.771136736219205e-09
, O 0 6.621946914420196e-13
and O 0 1.1417108577993496e-12
others O 0 1.4677246917838005e-10
codons O 0 1.2086483991424757e-07
. O 0 5.82209018773483e-08

They O 0 1.543504386802841e-11
are O 0 4.321555744144336e-15
distributed O 0 5.2457075684110566e-14
along O 0 8.85006423614193e-13
the O 0 2.6231304454948923e-12
C7 O 0 2.194000359168058e-07
gene O 0 2.247853324918031e-13
, O 0 1.0830664707098259e-14
but O 0 4.81466571526732e-15
predominantly O 0 5.441624256231903e-13
towards O 0 2.6051223678269508e-11
the O 0 3.4896959454078225e-12
3 O 0 1.6347586478948628e-11
end O 0 6.672879138136523e-09
. O 0 6.509530692255794e-09

All O 0 7.591441364418472e-11
were O 0 6.2385699904632386e-12
found O 0 1.5862327727364511e-13
in O 0 2.044141223477014e-14
compound O 0 1.1355349820163507e-11
heterozygous O 0 2.8611982574866524e-12
individuals O 0 1.049216594682656e-12
. O 0 4.442104017954307e-09

The O 0 5.148113359609852e-06
C6 O 0 0.014778713695704937
/ O 0 5.5100150348152965e-05
C7 O 0 8.147450898832176e-06
marker O 0 2.950214517127847e-09
haplotypes O 0 9.568194014875075e-10
associated O 0 5.013822135246926e-10
with O 0 2.028430028111483e-11
most O 0 2.3370190227467447e-09
C7 B-Disease 1 1.0
defects I-Disease 0 0.0008387386915273964
are O 0 2.8999652072064785e-12
tabulated O 0 5.955230752974217e-10
. O 0 3.8905448307424706e-11
. O 0 1.5950130105579774e-09

A O 0 1.7566817334113694e-08
genome O 0 1.7952859199255045e-09
- O 0 6.855575829245453e-11
wide O 0 6.520726341698035e-13
search O 0 5.659972490690279e-12
for O 0 4.264225759065439e-14
chromosomal O 0 8.820779839879833e-08
loci O 0 2.955875322285806e-09
linked O 0 6.64136692307693e-08
to O 0 2.971777046667512e-09
mental O 0 0.0013563944958150387
health O 0 6.670546892628693e-10
wellness O 0 8.638275650341143e-10
in O 0 6.635826870632355e-14
relatives O 0 4.381737160608079e-12
at O 0 6.504370392984571e-12
high O 0 3.928230310479286e-11
risk O 0 9.80830971997193e-11
for O 0 1.1048185699635837e-09
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9954127669334412
disorder I-Disease 0 0.0535702221095562
among O 0 1.4248254269141891e-12
the O 0 5.5032510666575e-12
Old O 0 2.2610935346278893e-09
Order O 0 5.6840789020018434e-11
Amish O 0 4.008304443914312e-08
. O 0 2.8695193443617484e-10

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 4.528392660851921e-10
BPAD B-Disease 1 1.0
; O 0 1.0995906905009178e-06
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 1.1922057850492773e-13
is O 0 2.3200196426395028e-15
characterized O 0 4.101739682903531e-15
by O 0 2.2437717484309204e-16
episodes O 0 9.567463488124872e-10
of O 0 3.428971551144855e-10
mania B-Disease 0 1.6424809956561148e-08
and O 0 5.820915277565675e-11
/ O 0 6.212162872998306e-08
or O 0 2.3743174093482367e-11
hypomania B-Disease 0 1.4005813397943712e-07
interspersed O 0 5.6227352634996564e-11
with O 0 4.143428421105901e-16
periods O 0 2.2512808284247399e-10
of O 0 2.4300397805099294e-10
depression B-Disease 0 2.265220011565816e-09
. O 0 1.6347105891156843e-09

Compelling O 0 1.3500059958815314e-09
evidence O 0 2.5926949823174006e-11
supports O 0 1.5567848659497896e-12
a O 0 7.178461248818699e-14
significant O 0 1.5717167964248574e-13
genetic O 0 2.2967933978323973e-12
component O 0 5.282481049806442e-12
in O 0 6.652428038772182e-14
the O 0 3.3501877487462917e-12
susceptibility O 0 6.56810369981109e-11
to O 0 1.360101253844448e-09
develop O 1 0.9373692274093628
BPAD B-Disease 1 1.0
. O 0 1.590971919540607e-06

To O 0 1.1502189478651559e-10
date O 0 1.0604043199080593e-09
, O 0 1.591417969626363e-13
however O 0 6.640362088319862e-13
, O 0 2.9529994443645846e-14
linkage O 0 6.69646338380403e-10
studies O 0 4.508867237906777e-12
have O 0 1.7838671417303754e-14
attempted O 0 5.104019429325035e-10
only O 0 5.8065635633042234e-12
to O 0 2.1897124391490053e-10
identify O 0 3.144078775108028e-08
chromosomal O 0 3.3039261779777007e-06
loci O 0 5.789541734912973e-09
that O 0 1.2461300437707767e-12
cause O 0 1.0694443941527965e-10
or O 0 3.3424952801223984e-13
increase O 0 1.1323637340299175e-12
the O 0 6.696299873105993e-13
risk O 0 5.6390894558056015e-12
of O 0 4.52377198201237e-11
developing O 0 5.830085228808457e-06
BPAD B-Disease 1 1.0
. O 0 8.021565918170381e-07

To O 0 3.787673286126392e-09
determine O 0 9.394034439225152e-10
whether O 0 6.766597265145391e-12
there O 0 8.27147703628961e-13
could O 0 9.92015063844276e-13
be O 0 2.4590559081182073e-13
protective O 0 1.0977722203486806e-11
alleles O 0 2.3307566814068092e-12
that O 0 1.7399766049090888e-14
prevent O 0 4.8559746501641854e-11
or O 0 6.8215285850548035e-12
reduce O 0 7.627872639082156e-11
the O 0 8.444698933185446e-12
risk O 0 4.173515699701369e-11
of O 0 1.2477938127197774e-10
developing O 0 8.512637577950954e-06
BPAD B-Disease 1 1.0
, O 0 3.2816175991878804e-13
similar O 0 1.2751372901369587e-14
to O 0 8.474927845007058e-14
what O 0 3.621471578293869e-15
is O 0 6.563991298100963e-16
observed O 0 2.1083063409237796e-13
in O 0 6.095829678705311e-13
other O 0 8.569216863874018e-11
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 3.563721295466544e-15
we O 0 1.7533958090792598e-14
used O 0 5.90099982766823e-11
mental O 0 3.277235407495027e-07
health O 0 2.7947867978217467e-11
wellness O 0 1.0067389977219676e-10
( O 0 2.6167587362874113e-16
absence O 0 5.042684585870871e-12
of O 0 5.240273059231582e-12
any O 0 3.728266584346329e-10
psychiatric B-Disease 0 2.435745409457013e-05
disorder I-Disease 0 1.8859532602277795e-08
) O 0 5.001972016717795e-16
as O 0 1.3568014094718166e-15
the O 0 9.561278770673157e-14
phenotype O 0 8.512972228189031e-13
in O 0 8.151331443596171e-14
our O 0 1.0495859736892044e-10
genome O 0 8.583451727162128e-10
- O 0 1.9583469568207335e-10
wide O 0 4.282906668207076e-11
linkage O 0 3.344599930343861e-09
scan O 0 1.2288294826134916e-08
of O 0 3.7420642973184925e-11
several O 0 7.111745654181378e-12
large O 0 1.2193903005386364e-11
multigeneration O 0 7.27697283764428e-07
Old O 0 1.6461756402463834e-08
Order O 0 4.147077681260214e-10
Amish O 0 1.107507401343355e-07
pedigrees O 0 2.06594847895758e-08
exhibiting O 0 5.171369998890896e-10
an O 0 8.17754392846981e-13
extremely O 0 8.010689334092547e-10
high O 0 5.9606852786942e-10
incidence O 0 2.6179575840501457e-08
of O 0 2.0265795797058672e-07
BPAD B-Disease 1 1.0
. O 0 1.3411223335424438e-05

We O 0 4.061463110272001e-10
have O 0 4.2226427432803804e-13
found O 0 3.5119005820831786e-14
strong O 0 3.4518890177482166e-16
evidence O 0 3.134182205826179e-15
for O 0 3.04479566593538e-15
a O 0 1.8447643044226802e-13
locus O 0 1.3394094861007844e-11
on O 0 9.020047903041117e-11
chromosome O 0 4.256793140200443e-09
4p O 0 1.1147719305881765e-05
at O 0 2.5337925091406532e-09
D4S2949 O 0 2.8722492828592294e-08
( O 0 1.2313925276858945e-14
maximum O 0 1.5346515724878884e-10
GENEHUNTER O 0 3.23726794704271e-06
- O 0 3.800400549813787e-10
PLUS O 0 1.2832232498816154e-10
nonparametric O 0 1.1816184475321734e-08
linkage O 0 4.722346402807887e-10
score O 0 1.816123987308238e-11
= O 0 1.3066724622885079e-13
4 O 0 1.5392773996614553e-14
. O 0 6.8770922624931865e-15
05 O 0 2.65270617971769e-11
, O 0 6.647810692770109e-14
P O 0 3.5932003900063236e-11
= O 0 1.0870732753635176e-14
5 O 0 2.7892799188248846e-15
. O 0 4.377868347362374e-16
22 O 0 3.555872688177286e-15
x O 0 2.5736482850468104e-14
10 O 0 2.070898519942327e-13
( O 0 1.7894856383244553e-15
- O 0 1.0583234592506652e-12
4 O 0 3.7610113625080686e-15
) O 0 2.915364319974154e-17
; O 0 2.4538885942113943e-16
SIBPAL O 0 1.2417882722104423e-08
Pempirical O 0 3.7117291462607227e-09
value O 0 3.870678777495584e-11
< O 0 3.436786012028792e-12
3 O 0 2.8552845377232024e-15
x O 0 6.738731886954744e-14
10 O 0 9.95679233506408e-13
( O 0 4.049270226985863e-15
- O 0 1.5749946919579871e-12
5 O 0 1.034313202441647e-14
) O 0 4.7474360352643666e-17
) O 0 3.4763472926235315e-17
and O 0 1.7227706764207464e-15
suggestive O 0 7.788301796020358e-13
evidence O 0 3.8979070486741194e-14
for O 0 1.1163644370092238e-14
a O 0 8.520753005079873e-13
locus O 0 9.190319512353273e-12
on O 0 8.442339050063197e-10
chromosome O 0 1.717497788433775e-08
4q O 0 7.331054234782641e-07
at O 0 9.54744838743693e-10
D4S397 O 0 1.6207868824835714e-08
( O 0 1.4023086992553512e-14
maximum O 0 9.372033704657667e-11
GENEHUNTER O 0 6.680040314677171e-06
- O 0 4.3707901187239884e-10
PLUS O 0 6.845579658687484e-11
nonparametric O 0 6.213546566158357e-09
linkage O 0 2.7131555335735413e-10
score O 0 4.643607547094586e-12
= O 0 4.9279333326664176e-14
3 O 0 2.5714683610537567e-15
. O 0 5.634519281068361e-16
29 O 0 4.245335636851588e-13
, O 0 1.1765862772733417e-14
P O 0 1.1012493000839285e-11
= O 0 1.8059991809058883e-15
2 O 0 1.3378918489106176e-16
. O 0 1.0956649767164683e-16
57 O 0 3.2723528883360845e-14
x O 0 3.582423867645214e-14
10 O 0 1.9682335188758726e-13
( O 0 1.74402252130912e-15
- O 0 4.387890333197586e-13
3 O 0 1.2178444898044462e-15
) O 0 9.127768487497087e-18
; O 0 7.769843151331048e-17
SIBPAL O 0 1.2489285161620955e-08
Pempirical O 0 3.1254878685160747e-09
value O 0 1.8539513674253882e-11
< O 0 3.2353488377961925e-12
1 O 0 7.007810198561733e-15
x O 0 7.442245604505349e-13
10 O 0 1.2765069383469108e-11
( O 0 9.810652046608401e-14
- O 0 5.1068481041194325e-12
3 O 0 2.7736085387512592e-15
) O 0 7.149696747113305e-18
) O 0 2.1334214293000694e-18
that O 0 2.2175708025283033e-17
are O 0 1.339537078061761e-15
linked O 0 8.369374082661807e-10
to O 0 9.428377190090487e-09
mental O 1 0.9998764991760254
health O 0 5.043656869929691e-07
wellness O 0 6.327718438114971e-07
. O 0 5.936189872990383e-10

These O 0 1.2218820399922947e-10
findings O 0 8.787161970280621e-12
are O 0 9.469186299329059e-15
consistent O 0 5.903822569708339e-12
with O 0 2.6220260636094714e-15
the O 0 6.164462386729075e-13
hypothesis O 0 3.550460977736619e-13
that O 0 2.349336935251632e-16
certain O 0 9.602143028180493e-14
alleles O 0 3.1300290050800816e-12
could O 0 3.043565052762709e-11
prevent O 0 2.3491837364275625e-09
or O 0 2.329967885295048e-10
modify O 0 1.2377399549734491e-08
the O 0 7.935284374038787e-12
clinical O 0 2.4886537275392584e-10
manifestations O 0 3.6903943789745597e-10
of O 0 3.1912794629107566e-10
BPAD B-Disease 1 1.0
and O 0 7.146719414180547e-12
perhaps O 0 9.117560222440813e-13
other O 0 7.021437467905067e-13
related O 0 9.510304153081961e-07
affective B-Disease 0 1.0782489880512003e-05
disorders I-Disease 0 6.0895158640050795e-06
. O 0 1.6642209388351148e-08

Segregation O 0 4.2838448166548915e-07
distortion O 0 1.2006641725292866e-07
in O 0 2.850024938272355e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 5.17262833454879e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.092882477380044e-09
DM B-Disease 1 1.0
) O 0 3.136985896740052e-12
is O 0 1.5948181631645492e-13
an O 0 9.66034435605223e-13
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999998807907104
disease I-Disease 0 1.5956238712533377e-05
which O 0 9.226815656527003e-16
, O 0 8.655726455851249e-17
in O 0 9.907805793922227e-16
the O 0 1.0181190336329762e-13
typical O 0 6.4990872926384835e-12
pedigree O 0 2.009211894082874e-11
, O 0 2.249352319124787e-15
shows O 0 4.4024430368577727e-13
a O 0 3.6747745146316346e-13
three O 0 1.280747318095632e-12
generation O 0 3.2694476015393548e-09
anticipation O 0 4.64367655439446e-09
cascade O 0 5.764067001479134e-09
. O 0 1.6891716470013307e-08

This O 0 3.713950466068504e-14
results O 0 1.2674327733164237e-12
in O 0 3.1052740673970236e-12
infertility B-Disease 0 0.24091367423534393
and O 0 2.409346500087395e-09
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.248689174599698e-13
CDM B-Disease 0 9.686655921825604e-09
) O 0 1.4610252931507713e-16
with O 0 3.909337962114619e-17
the O 0 1.807951710433922e-13
disappearance O 0 2.0523964472385359e-10
of O 0 3.8875647145886205e-10
DM B-Disease 1 1.0
in O 0 1.6112755227282172e-11
that O 0 7.60868419050903e-13
pedigree O 0 1.0212873879922313e-09
. O 0 9.06544783685348e-10

The O 0 1.917880090851476e-11
concept O 0 2.3225877818222607e-11
of O 0 1.4494601699444054e-11
segregation O 0 6.368468530304483e-10
distortion O 0 1.8633111720234297e-10
, O 0 6.619159083351227e-16
where O 0 6.079645682762337e-16
there O 0 1.899664613608861e-16
is O 0 1.4177220572113752e-17
preferential O 0 1.5843499472437128e-12
transmission O 0 1.0981203446558396e-10
of O 0 1.2581446572502292e-13
the O 0 1.3091670759621254e-13
larger O 0 1.9171173166760563e-13
allele O 0 2.0741935946588796e-11
at O 0 6.951260400622772e-11
the O 0 3.9814870844701034e-10
DM B-Disease 1 1.0
locus O 0 6.804175001207113e-10
, O 0 1.3002488625721287e-12
has O 0 5.2121748892819744e-15
been O 0 4.5945394705612305e-14
put O 0 9.62259026800194e-13
forward O 0 1.1343573649846839e-11
to O 0 3.20904657014065e-11
explain O 0 1.4803518411099503e-09
partially O 0 1.153999229508429e-09
the O 0 1.8679923059761183e-12
maintenance O 0 3.506022494548233e-07
of O 0 2.97755864409055e-09
DM B-Disease 1 1.0
in O 0 1.3686146833891133e-11
the O 0 1.0989370004266252e-11
population O 0 1.174167913505636e-13
. O 0 1.3290114668496056e-11

In O 0 3.281633298435338e-11
a O 0 4.208895384993916e-12
survey O 0 1.0979941782174318e-11
of O 0 4.693239720465758e-12
DM B-Disease 1 1.0
in O 0 1.992163101149913e-10
Northern O 0 6.420051334998789e-08
Ireland O 0 1.3521552766349032e-09
, O 0 6.448839400853557e-13
59 O 0 6.49003850661245e-10
pedigrees O 0 2.1390510696051024e-08
were O 0 3.686166649696787e-10
ascertained O 0 3.905152823335811e-07
. O 0 4.458903024584515e-09

Sibships O 0 2.7091951778857037e-05
where O 0 8.603747597181466e-13
the O 0 4.815476495204432e-14
status O 0 7.863247271193419e-13
of O 0 7.158940324228369e-13
all O 0 3.623207487615972e-14
the O 0 1.2917398812921366e-13
members O 0 9.024056085986821e-15
had O 0 2.2356929133514336e-13
been O 0 6.687234994267113e-14
identified O 0 3.848590012216907e-13
were O 0 8.483888098336292e-14
examined O 0 3.7623067638756225e-13
to O 0 1.4606254777177995e-14
determine O 0 4.029727398123517e-13
the O 0 1.0613065331080418e-13
transmission O 0 7.804943358280525e-09
of O 0 5.5790289922585945e-12
the O 0 9.457510469212949e-11
DM B-Disease 1 1.0
expansion O 0 2.044836522330229e-09
from O 0 1.5414795091414635e-12
affected O 0 1.1772704339163553e-11
parents O 0 3.003292195014398e-14
to O 0 9.927495023959176e-13
their O 0 5.92106849661711e-11
offspring O 0 1.060815435494078e-08
. O 0 5.277675185766384e-09

Where O 0 1.6818448760405613e-12
the O 0 3.0679888425762247e-13
transmitting O 0 1.179338710022293e-10
parent O 0 3.2144336563171005e-13
was O 0 1.6114344017145732e-12
male O 0 1.406344832255435e-11
, O 0 9.393119013720655e-14
58 O 0 3.909308876615114e-09
. O 0 1.6726540152944835e-08

3 O 0 2.2674624677865296e-10
% O 0 7.720643568909225e-11
of O 0 4.159968810396597e-13
the O 0 1.894572687751936e-13
offspring O 0 1.1652494073810526e-11
were O 0 1.2229020964274473e-12
affected O 0 4.3289044224237294e-12
, O 0 2.091258913475692e-15
and O 0 3.72706270549859e-15
in O 0 1.7668749831820964e-14
the O 0 4.5115634454218415e-14
case O 0 2.3039077630816578e-14
of O 0 2.0066487534109445e-12
a O 0 6.341903998480225e-12
female O 0 1.3552141353567748e-10
transmitting O 0 7.981879046603524e-10
parent O 0 2.017372033313869e-11
, O 0 2.4427237576424288e-12
68 O 0 1.0090799662521022e-07
. O 0 5.276006831422819e-08

7 O 0 9.298005143598687e-10
% O 0 3.2221839779689176e-11
were O 0 1.0829085024532947e-12
affected O 0 7.56428322756797e-11
. O 0 6.742319480501635e-10

Studies O 0 1.386942782843903e-09
on O 0 1.0123108948323356e-11
meiotic O 0 6.625980830676781e-08
drive O 0 3.735174658459073e-08
in O 0 3.047834901126478e-11
DM B-Disease 1 1.0
have O 0 1.13178014865805e-13
shown O 0 5.956388539948149e-14
increased O 0 2.830618938299157e-14
transmission O 0 3.802797052948614e-12
of O 0 1.7798726614060663e-15
the O 0 2.327722983778307e-15
larger O 0 6.4331817765949945e-15
allele O 0 1.0218489466043423e-12
at O 0 4.751579338324596e-12
the O 0 2.453735999108364e-11
DM B-Disease 1 0.9995965361595154
locus O 0 2.2448477104974884e-11
in O 0 1.925481822595554e-11
non O 0 1.6424204432041734e-06
- O 0 3.380843190825544e-05
DM O 1 1.0
heterozygotes O 0 6.811738018086544e-08
for O 0 1.2661752202269838e-10
CTGn O 0 1.4641364941780921e-05
. O 0 3.4425253758740837e-09

This O 0 5.921802631592143e-11
study O 0 2.484107971406635e-12
provides O 0 1.1572054858138055e-14
further O 0 1.3643843660529923e-15
evidence O 0 6.521220602363417e-14
that O 0 8.495477880746984e-15
the O 0 2.551628908165071e-10
DM B-Disease 1 1.0
expansion O 0 8.719744215568426e-08
tends O 0 3.9829453624129485e-10
to O 0 2.8051635667103447e-11
be O 0 5.633974883845205e-11
transmitted O 0 3.5836016376578073e-09
preferentially O 0 4.474374204477272e-09
. O 0 2.383149011464525e-09

Diagnosis O 1 0.9999998807907104
of O 0 6.440554443543078e-06
hemochromatosis B-Disease 1 1.0
. O 0 6.624769412155729e-06

If O 0 1.9665843353777746e-07
untreated O 1 0.9999393224716187
, O 0 1.5643939269005536e-11
hemochromatosis B-Disease 1 1.0
can O 0 2.803183463129244e-08
cause O 0 1.8225520079795388e-06
serious O 0 2.151526814486715e-06
illness O 1 0.8796311020851135
and O 0 7.376076745918558e-14
early B-Disease 0 1.3732718087688944e-11
death I-Disease 0 1.2658889778430216e-12
, O 0 4.200579957518635e-15
but O 0 2.4954253429392914e-15
the O 0 2.379201978659762e-13
disease O 0 3.420867972572794e-12
is O 0 1.2615645188934505e-16
still O 0 4.4761019875685665e-15
substantially O 0 1.7077975145163293e-10
under O 0 1.5925728291676933e-08
- O 0 0.00027389582828618586
diagnosed O 0 0.386779248714447
. O 0 3.7389522589137414e-08

The O 0 1.2001746818590675e-10
cornerstone O 0 3.14100994103228e-08
of O 0 1.808457203433811e-11
screening O 0 2.341871314925914e-11
and O 0 1.613554904652311e-14
case O 0 3.2168164108197037e-15
detection O 0 4.813682005083697e-12
is O 0 2.3650623997024284e-17
the O 0 9.69296012201591e-16
measurement O 0 1.7857105768029347e-12
of O 0 4.624204665015785e-13
serum O 0 1.5829333286851432e-12
transferrin O 0 1.6658104062816648e-10
saturation O 0 2.396036979934735e-10
and O 0 4.2324157416631647e-13
the O 0 6.606483589355339e-12
serum O 0 1.5983712964295904e-10
ferritin O 0 1.4603319442585416e-08
level O 0 1.2401265792050253e-08
. O 0 1.6802828017858928e-09

Once O 0 8.412842644744956e-10
the O 0 1.4826214258037429e-12
diagnosis O 0 7.725128980951013e-09
is O 0 5.038149005653263e-15
suspected O 0 5.250640547349583e-11
, O 0 2.7893838497675127e-13
physicians O 0 4.797174376486302e-12
must O 0 8.840389531528103e-11
use O 0 1.6392096569006753e-09
serum O 0 2.0305162706790725e-07
ferritin O 0 1.117671581596369e-05
levels O 0 1.2898286740892217e-06
and O 0 2.2614901062922854e-09
hepatic O 0 7.269839261425659e-05
iron O 0 0.00011294579599052668
stores O 0 4.8197894564339094e-09
on O 0 1.7334288449077917e-09
liver O 0 7.032348481317285e-09
biopsy O 0 4.349602011899378e-09
specimens O 0 5.590437401198356e-12
to O 0 2.7797881184399298e-12
assess O 0 1.399281801539587e-10
patients O 0 7.092916098211388e-12
for O 0 1.4004490384196544e-13
the O 0 1.9459692537915352e-11
presence O 0 9.797894440222166e-11
of O 0 6.934330443186809e-09
iron B-Disease 0 1.5330550013459288e-05
overload I-Disease 0 1.866784987214487e-05
. O 0 5.473887654261489e-08

Liver O 1 0.7076853513717651
biopsy O 0 0.12726864218711853
is O 0 1.25824372622374e-12
also O 0 1.1098037433162657e-15
used O 0 1.3494027672599634e-14
to O 0 1.077859915037116e-12
establish O 0 7.015745207006319e-10
the O 0 2.9847469981691965e-12
presence O 0 2.195012401007279e-12
or O 0 1.8349744466961138e-12
absence O 0 1.2197160970117693e-07
of O 0 7.626497655621733e-09
cirrhosis B-Disease 1 0.8529422879219055
, O 0 3.965094379676688e-14
which O 0 1.3842428417431326e-15
can O 0 7.651061858723884e-13
affect O 0 2.843103530381086e-09
prognosis O 0 2.4879075226635905e-06
and O 0 4.1882285833905186e-11
management O 0 1.911947755672827e-08
. O 0 6.379096806341522e-09

A O 0 4.898433880740072e-10
DNA O 0 2.0997616145823628e-10
- O 0 5.462067430295203e-13
based O 0 4.646300235187754e-16
test O 0 2.0304321646322926e-14
for O 0 8.442913557139223e-15
the O 0 6.638311319910606e-13
HFE O 0 1.0654406423782348e-06
gene O 0 5.484564625374277e-13
is O 0 1.549651859199426e-15
commercially O 0 6.6421646828518366e-12
available O 0 6.940283851092355e-13
, O 0 2.2661811697208354e-15
but O 0 1.659378307131761e-15
its O 0 6.293918019242481e-16
place O 0 1.3757635167806898e-13
in O 0 8.582939114748674e-15
the O 0 2.918380055845493e-13
diagnosis O 0 5.727733878302388e-07
of O 0 6.84525713889883e-10
hemochromatosis B-Disease 1 1.0
is O 0 2.5303273365473444e-11
still O 0 7.463899290294229e-12
being O 0 3.891316435744585e-11
evaluated O 0 1.0882943435319703e-08
. O 0 1.4283791927027778e-08

Currently O 0 1.6591231166707132e-10
, O 0 1.5103315733483447e-14
the O 0 1.0156324837130165e-13
most O 0 2.9708613363431044e-15
useful O 0 1.3873428230878893e-12
role O 0 1.5404939422616198e-13
for O 0 3.141958942369863e-14
this O 0 1.3175765545877377e-13
test O 0 1.6083208983358466e-12
is O 0 1.3523729094653343e-15
in O 0 7.1001334016806625e-15
the O 0 1.1935298669524252e-13
detection O 0 7.3657764332324405e-09
of O 0 2.951209276957911e-10
hemochromatosis B-Disease 1 1.0
in O 0 9.730769141846896e-12
the O 0 3.875759522348199e-12
family O 0 7.196643454776552e-13
members O 0 5.72546160872503e-14
of O 0 6.275853968451539e-12
patients O 0 5.0713890552278595e-12
with O 0 5.506563561792459e-14
a O 0 6.522221998594979e-12
proven O 0 3.11392067686711e-09
case O 0 4.618334252352863e-13
of O 0 1.7534822552289775e-11
the O 0 3.2177632780516774e-10
disease O 0 1.099221602629541e-08
. O 0 4.4548797983878785e-10

It O 0 1.8809300362902792e-13
is O 0 1.0953985927954907e-14
crucial O 0 2.7395472557145695e-09
to O 0 1.1116677356426408e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9992839694023132
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 1.5665401420505987e-08
because O 0 1.2165005114361804e-11
phlebotomy O 0 0.00021343161643017083
therapy O 0 2.4499606297467835e-05
can O 0 5.192332674930356e-10
avert O 0 3.637878762674518e-07
serious O 1 0.9989463686943054
chronic O 1 1.0
disease O 1 0.9940316081047058
and O 0 2.5021957704603193e-13
can O 0 3.8327028183127165e-12
even O 0 7.420757259547772e-13
lead O 0 4.1049413868066154e-11
to O 0 1.6390517415532102e-11
normal O 0 2.4179199087370762e-08
life O 0 3.3804865157138764e-11
expectancy O 0 1.0719855003671341e-09
. O 0 2.6072434142210277e-12
. O 0 6.514073169761048e-10

Prevalence O 0 7.40319535452727e-07
of O 0 2.233914442317797e-10
the O 0 3.7751868298130375e-10
I1307K O 0 1.1272269517803579e-07
APC B-Disease 0 1.4631721390045982e-09
gene O 0 5.594893038446402e-13
variant O 0 1.1681172522315375e-12
in O 0 2.5858804572446992e-14
Israeli O 0 1.6657564216870924e-10
Jews O 0 5.4517245752505605e-12
of O 0 1.617759067982713e-13
differing O 0 2.9285425115070955e-15
ethnic O 0 9.961816426287424e-15
origin O 0 2.1320236700227146e-13
and O 0 7.483406662357403e-14
risk O 0 1.1819080436570317e-10
for O 0 1.1718154269146908e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.693984472694865e-06

BACKGROUND O 0 0.00015246085240505636
& O 0 8.306167842420109e-08
AIMS O 0 5.31345349941148e-08
Israeli O 0 9.92115456455167e-09
Jews O 0 6.249462058960376e-10
of O 0 2.4349858240846345e-10
European O 0 3.9968469506268534e-11
birth O 0 3.1361996333245656e-10
, O 0 2.997267961168254e-13
i O 0 4.952144597170083e-12
. O 0 5.452574698174006e-13
e O 0 6.629833401022855e-13
. O 0 1.3065155240240406e-13
, O 0 5.092680563281021e-14
Ashkenazim O 0 4.5299324291647736e-09
, O 0 8.749485273936656e-15
have O 0 5.9583511999902316e-15
the O 0 5.081352873193001e-12
highest O 0 2.2711281417286955e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 1.038332309022394e-09
of O 0 2.744124155337757e-12
any O 0 1.232201948982159e-12
Israeli O 0 7.188018713577549e-08
ethnic O 0 3.7481187042942565e-09
group O 0 6.045476185628784e-12
. O 0 1.2971940188677422e-09

The O 0 7.822629766174316e-10
I1307K O 0 1.738893651292983e-08
APC B-Disease 0 9.454552418741713e-11
gene O 0 1.3424158974099237e-13
variant O 0 3.565902564547918e-12
was O 0 1.623131750533302e-12
found O 0 1.9516581005376427e-13
in O 0 4.293576128314158e-13
6 O 0 2.0147429558026175e-10
. O 0 1.0457776866701352e-09

1 O 0 2.8914610289421105e-11
% O 0 7.266356353424763e-12
of O 0 4.179109112261749e-14
American O 0 3.442238983138385e-15
Jews O 0 4.723312127703772e-13
, O 0 7.116833291510491e-16
28 O 0 5.536021402581526e-13
% O 0 1.5967609179323716e-12
of O 0 2.2891747091663417e-12
their O 0 3.833530115571193e-07
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 2.781031793741562e-10
, O 0 1.4239599625300026e-14
but O 0 2.1327004239365824e-15
not O 0 8.346970135203729e-15
in O 0 1.204206873106628e-12
non O 0 6.151613884952667e-09
- O 0 4.240066076022231e-10
Jews O 0 9.714831161744542e-10
. O 0 4.54401183347386e-09

We O 0 1.4086710686811443e-09
assessed O 0 8.136331608454839e-09
the O 0 1.0611037742913609e-10
I1307K O 0 1.5570292077882186e-07
prevalence O 0 7.083965792437086e-12
in O 0 5.416639113628506e-16
Israeli O 0 1.693588845552707e-11
Jews O 0 2.2473743786083356e-12
of O 0 1.8369133254411696e-13
differing O 0 8.876766373821718e-15
ethnic O 0 1.9810342195879585e-14
origin O 0 4.911223879834614e-13
and O 0 1.0833871912649742e-13
risk O 0 4.492638205899624e-10
for O 0 1.2959587536442996e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.634235311750672e-07

METHODS O 0 2.389877984398936e-08
DNA O 0 6.434326960125247e-10
samples O 0 2.1805992341666913e-12
from O 0 1.726175727692885e-14
500 O 0 1.6759296316178063e-13
unrelated O 0 1.4113482084410212e-11
Jews O 0 4.571547307374857e-11
of O 0 8.150399799511376e-10
European O 0 1.537374005877723e-09
or O 0 1.3475048854516558e-10
non O 0 1.0088776036809577e-08
- O 0 8.91145490733436e-12
European O 0 7.911266585412802e-13
origin O 0 2.83326313799126e-12
, O 0 1.0475233165287883e-15
with O 0 1.5935143486422467e-16
or O 0 1.0223645321712042e-14
without O 0 3.180616035304562e-13
a O 0 3.5986014515487774e-13
personal O 0 4.2298559099762656e-10
and O 0 8.68480461158061e-12
/ O 0 8.498570736037436e-08
or O 0 1.8182937794319898e-11
family O 0 7.348280837982113e-12
history O 0 1.3829691558608914e-10
of O 0 1.1786724374296398e-11
neoplasia B-Disease 0 7.594675444089205e-10
, O 0 3.4544873336655665e-14
were O 0 3.6994306272866706e-13
examined O 0 7.270834542077997e-12
for O 0 1.7287235011542723e-13
the O 0 1.3107343986226705e-12
I1307K O 0 5.487186052755e-11
variant O 0 8.724455450345291e-15
by O 0 1.2673527979478516e-16
the O 0 5.372872285969166e-14
allele O 0 6.878099652329883e-12
- O 0 1.5522247116123156e-12
specific O 0 6.423477201533689e-13
oligonucleotide O 0 1.0142915840560818e-08
( O 0 1.0659508215341007e-12
ASO O 0 0.0003207814006600529
) O 0 1.3987612405689555e-14
method O 0 1.6744336472918064e-10
. O 0 2.778359764477045e-10

RESULTS O 0 1.7382626449347072e-09
In O 0 4.2566137789003256e-13
persons O 0 7.005318092105639e-13
at O 0 1.1073267818092689e-13
average O 0 6.247915054248543e-13
risk O 0 1.3091983226687365e-11
for O 0 8.209659618785281e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 5.485219223277937e-11
I1307K O 0 2.413978794635341e-09
was O 0 1.0697615753299528e-12
found O 0 1.5278179925620056e-13
in O 0 4.938512164313902e-13
5 O 0 8.755546981875639e-11
. O 0 1.0663244731645705e-09

0 O 0 3.992280898229561e-12
% O 0 2.3096429282998265e-12
of O 0 4.637999714645312e-14
120 O 0 2.560470065138265e-12
European O 0 2.48461633212127e-11
and O 0 2.4971445050647745e-11
1 O 0 4.310362622383934e-10
. O 0 2.4610080640030674e-09

6 O 0 1.1270599037382922e-10
% O 0 5.716017936752138e-12
of O 0 1.3444222135301082e-13
188 O 0 1.1081893866102255e-12
non O 0 5.585476525737931e-10
- O 0 1.0603026096012158e-10
European O 0 1.2608797686497475e-11
Jews O 0 4.661991348520189e-10
( O 0 8.705360786615338e-14
P O 0 2.5788277069338505e-10
= O 0 6.703069089369906e-14
0 O 0 1.1432868498421097e-15
. O 0 8.727013807483355e-16
08 O 0 2.532424953332474e-13
) O 0 1.800523536418363e-15
. O 0 4.7690753256224294e-12

It O 0 1.7241111966923017e-12
occurred O 0 1.8953129343746156e-10
in O 0 5.303740302844973e-13
15 O 0 6.972732113919022e-11
. O 0 4.752291338228076e-10

4 O 0 2.07184096268076e-11
% O 0 2.3838635059003632e-12
of O 0 1.0128700043401592e-13
52 O 0 9.169168029010688e-12
Ashkenazi O 0 7.797157364208829e-10
Israelis O 0 2.4385676056226657e-07
with O 0 6.242405897749492e-11
familial O 0 1.0470531378814485e-05
cancer B-Disease 0 0.0019132603192701936
( O 0 4.74567162910694e-13
P O 0 3.6573236883441496e-08
= O 0 2.7044419221439187e-12
0 O 0 4.682871454432698e-14
. O 0 9.062901016947903e-15
02 O 0 3.331871454084756e-13
) O 0 1.5689760026836366e-17
and O 0 6.134391539725751e-16
was O 0 3.507810429387477e-14
not O 0 1.6198979955811196e-14
detected O 0 4.2152717948107377e-13
in O 0 4.1449184579392395e-14
51 O 0 1.0556451546239742e-10
non O 0 2.0329289363019143e-09
- O 0 7.617215191935145e-11
European O 0 2.1026701213511245e-11
Jews O 0 7.826539971667046e-10
at O 0 1.715953906744616e-10
increased O 0 9.140593282275233e-10
cancer B-Disease 0 3.45075590324484e-09
risk O 0 1.324954868042738e-10
. O 0 3.1578339942939238e-09

Colorectal B-Disease 1 0.9998408555984497
neoplasia I-Disease 0 0.00046137996832840145
occurred O 0 1.2160126061644405e-06
personally O 0 1.2684987504840706e-09
or O 0 1.7372052147496264e-13
in O 0 1.0448938297989794e-14
the O 0 1.8496782136002456e-14
families O 0 3.140251323948198e-14
of O 0 7.450085470414591e-13
13 O 0 5.02104503807832e-11
of O 0 6.933850715817869e-10
20 O 0 4.0701970682732735e-09
Ashkenazi O 0 7.375395227882109e-08
I1307K O 0 8.356744629622881e-09
carriers O 0 4.866493492905466e-13
, O 0 3.1002466354757355e-14
8 O 0 3.04792649452601e-12
of O 0 2.1196305127757498e-11
whom O 0 8.948116692053532e-10
also O 0 1.3516484806408435e-11
had O 0 2.1868354349585672e-11
a O 0 3.438825396315237e-12
personal O 0 3.944577442460684e-10
or O 0 3.229935199508538e-12
family O 0 8.972781827439047e-13
history O 0 1.3714061830594204e-10
of O 0 2.0876854411877588e-10
noncolonic O 0 1.0367793947807513e-06
neoplasia B-Disease 0 5.705447620130144e-06
. O 0 8.346521696012132e-08

CONCLUSIONS O 0 2.9842183835171454e-07
The O 0 3.962622729947185e-10
I1307K O 0 3.8403356938943034e-08
APC O 0 4.6278911258745836e-10
variant O 0 5.467994113050878e-11
may O 0 3.0592312537380817e-12
represent O 0 5.820993687066789e-11
a O 0 6.665367563440938e-11
susceptibility O 0 2.1870202870921673e-10
gene O 0 2.6016463289257885e-11
for O 0 1.405161098588792e-09
colorectal B-Disease 1 1.0
, I-Disease 0 1.0514921156001833e-09
or I-Disease 0 1.722840758944244e-10
other I-Disease 0 3.272863577374885e-11
, I-Disease 0 4.289134152013485e-12
cancers I-Disease 0 1.0289960528098163e-07
in O 0 1.507269864475802e-10
Ashkenazi O 0 2.4366885398308114e-08
Jews O 0 3.2313987596843674e-10
, O 0 1.5864757424433051e-12
and O 0 2.1848666539175943e-12
partially O 0 9.826385261035853e-10
explains O 0 5.056910619416488e-12
the O 0 1.91155381454311e-12
higher O 0 5.948737058503184e-10
incidence O 0 2.005777162139566e-07
of O 0 2.7576331831369316e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.206434063760753e-09
European O 0 1.1664129384580946e-10
Israelis O 0 2.0776499809471716e-07
. O 0 7.484111108624347e-09

Systematic O 0 2.6468736924467606e-11
analysis O 0 4.959744420718337e-12
of O 0 8.680664694005191e-12
coproporphyrinogen O 0 4.446013690539985e-08
oxidase O 0 2.519191300009993e-09
gene O 0 3.8259653778460745e-10
defects O 0 6.615310610413871e-08
in O 0 9.943493944897241e-12
hereditary B-Disease 1 0.9701364636421204
coproporphyria I-Disease 1 0.999995231628418
and O 0 8.171190807315654e-11
mutation O 0 8.17583639678432e-11
update O 0 1.0471874922757252e-08
. O 0 4.116956220379109e-10

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999538660049438
( O 0 1.3023735735695485e-12
HC B-Disease 0 4.289128628442995e-05
) O 0 9.318266644409157e-13
is O 0 4.56268378114244e-13
an O 0 5.0501538714775585e-12
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 7.823992928024381e-05
autosomal O 1 1.0
dominant O 0 0.0005387307028286159
inheritance O 0 1.3941835463882057e-09
caused O 0 9.760957667137582e-12
by O 0 1.0457631397127465e-14
deficient B-Disease 0 2.8079178981954556e-09
activity I-Disease 0 5.920562928807271e-10
of I-Disease 0 1.5061663027893246e-10
coproporphyrinogen I-Disease 0 1.7338761537644132e-08
III I-Disease 0 1.2286658090943092e-07
oxidase I-Disease 0 2.4695789857531736e-10
( O 0 8.01026047792322e-14
CPO O 0 8.352490254992517e-09
) O 0 1.0279513920847042e-13
. O 0 6.604093660822485e-11

Clinical O 0 1.763473846949637e-07
manifestations O 0 1.686866468730841e-08
of O 0 1.710881852856616e-10
the O 0 1.1926851173349462e-10
disease O 0 6.097989890818667e-10
are O 0 4.956008303230632e-16
characterized O 0 7.326493639471954e-15
by O 0 2.991034273014913e-15
acute O 0 2.3558041561955179e-07
attacks O 0 2.721928460402978e-08
of O 1 0.9999990463256836
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 7.659601286569284e-10
precipitated O 0 2.030923172691157e-11
by O 0 2.7026174368924554e-15
drugs O 0 3.987060681609478e-12
, O 0 1.8559792916948703e-14
fasting O 0 2.980280244813116e-09
, O 0 2.1799671443001323e-12
cyclical O 0 8.688574859583298e-10
hormonal O 0 2.2779496067215632e-09
changes O 0 9.441860487902076e-12
, O 0 1.1603235733348427e-11
or O 0 1.052247000643547e-08
infectious B-Disease 0 7.379292128462112e-07
diseases I-Disease 0 3.941798354389903e-08
. O 0 1.0985063969570774e-09

Skin O 1 1.0
photosensitivity O 1 0.9981014132499695
may O 0 2.149782574178971e-09
also O 0 3.415975727109888e-13
be O 0 5.409976936918137e-13
present O 0 7.576123062236206e-11
. O 0 8.497897940884513e-10

The O 0 1.8052264127987883e-09
seven O 0 1.1990313186771573e-09
exons O 0 1.9015999885851897e-09
, O 0 4.9550302554622616e-14
the O 0 1.5908816148116345e-12
exon O 0 1.950618971902074e-10
/ O 0 1.441509550614839e-10
intron O 0 3.376209312122569e-10
boundaries O 0 3.387237712537683e-11
and O 0 7.27211666535707e-14
part O 0 1.555106043937826e-11
of O 0 4.861945845924254e-10
3 O 0 5.99388108590837e-11
noncoding O 0 2.1363142366226384e-09
sequence O 0 1.651806122437982e-11
of O 0 3.599980036295136e-10
the O 0 5.517866719095821e-10
CPO O 0 6.17214794829124e-08
gene O 0 2.409856710884617e-13
were O 0 2.098566329392093e-12
systematically O 0 1.1482121677064416e-12
analyzed O 0 1.8564997087376633e-14
by O 0 2.8100508607574546e-16
an O 0 3.1206296786701103e-15
exon O 0 1.468017114120146e-12
- O 0 1.2301277889110313e-13
by O 0 1.8850783293274803e-13
- O 0 3.052577912665555e-10
exon O 0 6.342378705559426e-11
denaturing O 0 7.541083313356012e-09
gradient O 0 8.815162141906363e-12
gel O 0 9.55740903085811e-11
electrophoresis O 0 6.393561374773427e-11
( O 0 1.893541984180399e-14
DGGE O 0 2.4876037514331983e-06
) O 0 1.6384254913435478e-16
strategy O 0 6.658952902971471e-14
followed O 0 2.439347685484998e-16
by O 0 2.5270144374729606e-18
direct O 0 2.0880395530014154e-14
sequencing O 0 1.1287076828736531e-10
in O 0 6.168229555597593e-12
seven O 0 2.634474582929869e-10
unrelated O 0 1.2378997826800742e-09
heterozygous O 0 2.518863451150821e-10
HC B-Disease 0 6.21251047050464e-06
patients O 0 5.229457311628494e-09
from O 0 1.0605336608904281e-09
France O 0 3.4041239271864754e-10
, O 0 3.552676002775007e-13
Holland O 0 7.395740270199624e-11
, O 0 1.8630797994851137e-14
and O 0 2.7636557322144317e-14
Czech O 0 8.898113912358951e-10
Republic O 0 1.0393195637448116e-08
. O 0 1.1824256240799969e-08

Seven O 0 6.226403836961936e-10
novel O 0 3.012754433949494e-13
mutations O 0 1.1563329503985753e-12
and O 0 4.6082393814501216e-14
two O 0 7.309356977102874e-14
new O 0 5.460345717245296e-14
polymorphisms O 0 3.005061477434623e-11
were O 0 2.6233768629646548e-11
detected O 0 8.698606279722298e-10
. O 0 9.45756806203235e-10

Among O 0 1.1233106805841331e-10
these O 0 7.15865301065266e-13
mutations O 0 3.807180265491539e-12
two O 0 5.931348077622967e-13
are O 0 3.6516338455631903e-13
missense O 0 2.1725249155224446e-08
( O 0 7.245855391385669e-13
G197W O 0 1.2798932402802166e-07
, O 0 1.0125536476987551e-12
W427R O 0 1.0312611209428724e-08
) O 0 9.947423642447679e-15
, O 0 8.603164567463212e-15
two O 0 5.401913725361362e-13
are O 0 2.715819322901547e-12
nonsense O 0 7.280548430799172e-08
( O 0 9.27084364138464e-13
Q306X O 0 3.0974604214861756e-08
, O 0 7.930332822717046e-13
Q385X O 0 4.294748112698699e-09
) O 0 1.2415333755370125e-14
, O 0 1.3866695064337214e-14
two O 0 1.847531865993221e-13
are O 0 1.3905582685758838e-13
small O 0 5.885526983308298e-13
deletions O 0 1.3505307983052717e-10
( O 0 1.6574756974904736e-13
662de14bp O 0 1.0127218175171038e-08
; O 0 1.2152660605266319e-12
1168del3bp O 0 4.802411623927583e-08
removing O 0 3.361977585214504e-09
a O 0 5.63738500325428e-10
glycine O 0 4.4043333424781395e-09
at O 0 1.2862101661514913e-10
position O 0 2.2588842255033548e-11
390 O 0 7.485698692855092e-12
) O 0 3.326621315178778e-16
, O 0 2.5672523074983576e-16
and O 0 4.849298563139944e-16
one O 0 4.139228090599585e-15
is O 0 9.816757825375168e-17
a O 0 1.149330705206477e-14
splicing O 0 1.4482164599483038e-11
mutation O 0 4.7620401545656055e-12
( O 0 1.616185450173304e-14
IVS1 O 0 1.0428899486214505e-06
- O 0 9.163478309481832e-10
15c O 0 9.299180092625647e-09
- O 0 7.253485589941988e-10
- O 0 8.665168582666638e-11
> O 0 2.935503836537512e-12
g O 0 1.0346249952695313e-14
) O 0 1.5583644334774388e-17
which O 0 5.712668128968819e-17
creates O 0 7.495918016614707e-15
a O 0 2.4484773136399483e-14
new O 0 1.2167034686618589e-13
acceptor O 0 3.273709303641681e-09
splice O 0 8.407538985011342e-07
site O 0 1.8043907701326134e-08
. O 0 8.764811987305166e-09

The O 0 1.7652389550093517e-09
pathological O 0 1.4734109488045988e-09
significance O 0 2.2854075576450583e-10
of O 0 1.1158601126437517e-10
the O 0 1.09285906713108e-10
point O 0 2.4686288568886994e-09
mutations O 0 1.5317294307926055e-11
G197W O 0 6.153702880595802e-09
, O 0 4.509578474531928e-13
W427R O 0 3.776369439378868e-09
, O 0 2.3815252883901267e-14
and O 0 2.3109538913566874e-14
the O 0 2.98656932518071e-12
in O 0 2.4226570402574588e-11
- O 0 9.093636954560225e-11
frame O 0 2.5847712858961813e-10
deletion O 0 1.94803773806429e-11
390delGly O 0 5.4553681017033284e-11
were O 0 1.3252731702849407e-14
assessed O 0 4.1265232740171284e-14
by O 0 5.423769344334264e-17
their O 0 1.7795145782276145e-13
respective O 0 2.1533312632993074e-10
expression O 0 1.6106784959599163e-12
in O 0 6.26209696076574e-14
a O 0 5.278084555786905e-14
prokaryotic O 0 2.114171684941546e-11
system O 0 1.4369949457790354e-12
using O 0 4.677981634872153e-13
site O 0 1.62991425911585e-11
- O 0 3.2532925463811535e-13
directed O 0 3.2178242953236416e-14
mutagenesis O 0 3.9092807213592096e-08
. O 0 5.104168199210335e-09

These O 0 1.707144516895076e-12
mutations O 0 3.1694246294296236e-13
resulted O 0 4.0027248009166794e-13
in O 0 2.5181472982109196e-14
the O 0 4.059033111795257e-13
absence O 0 7.047155081707501e-10
or O 0 8.15884794620747e-13
a O 0 1.266736715521688e-12
dramatic O 0 9.721234234261189e-12
decrease O 0 1.598609911113158e-09
of O 0 1.630432011623384e-09
CPO O 0 2.179686362069333e-06
activity O 0 3.7285118992258504e-08
. O 0 1.0440802000744043e-08

The O 0 7.548731778550533e-11
two O 0 7.397877341101811e-13
polymorphisms O 0 7.741638059777234e-12
were O 0 7.062349294782722e-13
localized O 0 7.637127041881797e-12
in O 0 1.0460588558552919e-13
noncoding O 0 7.77927222639363e-10
part O 0 3.4580044990656367e-12
of O 0 8.19494611059568e-11
the O 0 2.9092964148880185e-11
gene O 0 2.888755722260314e-14
1 O 0 8.47124359049968e-14
) O 0 9.044798864073895e-16
a O 0 1.8908733086242524e-12
C O 0 6.878277392097232e-10
/ O 0 1.5380707124590387e-11
G O 0 1.4302410167657542e-12
polymorphism O 0 1.1446878167564734e-11
in O 0 9.733246787756514e-14
the O 0 3.8211920606878724e-12
promotor O 0 1.7737706912157591e-06
region O 0 8.783819782642865e-10
, O 0 3.119292340701338e-14
142 O 0 1.1978505860821276e-11
bp O 0 3.4966068235275927e-11
upstream O 0 6.551875014748632e-11
from O 0 1.9354435859975788e-13
the O 0 4.934359669993282e-13
transcriptional O 0 2.67453680730112e-11
initiation O 0 3.531616110663549e-10
site O 0 2.592167314130478e-10
( O 0 5.856633130936831e-14
- O 0 5.082541054690637e-10
142C O 0 5.387766233155844e-09
/ O 0 4.661319941146047e-12
G O 0 3.1403845452901424e-13
) O 0 9.137667027015264e-17
, O 0 1.1733087150476767e-16
and O 0 2.9905308178068885e-16
2 O 0 3.593960795199996e-15
) O 0 1.2627200571219626e-16
a O 0 3.172223768388438e-14
6 O 0 4.131271740719436e-14
bp O 0 1.721254974489106e-13
deletion O 0 5.519581441752221e-14
polymorphism O 0 5.920342775050935e-12
in O 0 1.3982452348737517e-12
the O 0 6.435301944107685e-12
3 O 0 5.7227048620711596e-12
noncoding O 0 5.7180327139860765e-09
part O 0 2.1825643722883648e-11
of O 0 2.557602740704823e-10
the O 0 3.8213998632130597e-10
CPO O 0 9.214189589101807e-08
gene O 0 1.3234759425537201e-12
, O 0 9.932414726842101e-14
574 O 0 3.158879061104791e-11
bp O 0 1.2336041042837476e-11
downstream O 0 3.806761156299743e-11
of O 0 4.2148779583715823e-13
the O 0 3.920379510391134e-14
last O 0 1.5201296439063677e-13
base O 0 2.1422848304336606e-12
of O 0 2.658812297932911e-13
the O 0 6.186146972279871e-13
normal O 0 1.7922476835963153e-09
termination O 0 2.3151112138464214e-09
codon O 0 1.082499201388032e-09
( O 0 4.432562715310506e-14
+ O 0 2.8828375450706822e-11
574 O 0 9.949954193899657e-10
delATTCTT O 0 3.9399420614927294e-08
) O 0 7.757331018862224e-13
. O 0 2.1828402974044536e-10

Five O 0 3.327314459511399e-07
intragenic O 0 1.6993215467664413e-05
dimorphisms O 0 2.4940459297795314e-06
are O 0 3.003614609635441e-13
now O 0 4.2458112627921304e-14
well O 0 9.435010552786421e-14
characterized O 0 5.161488098905098e-13
and O 0 1.0060765968152724e-14
the O 0 4.425851178602169e-12
high O 0 1.0966964315850536e-11
degree O 0 7.713920613383607e-10
of O 0 3.0375990611730685e-10
allelic O 0 9.89586412813992e-10
heterogeneity O 0 9.757691321610196e-10
in O 0 3.5926178698630906e-11
HC B-Disease 0 1.3097406963424874e-06
is O 0 1.8698031404446036e-12
demonstrated O 0 4.722677804380737e-11
with O 0 2.903482575894456e-14
seven O 0 1.8553583149005792e-12
new O 0 5.762859595653965e-16
different O 0 4.858259642326302e-16
mutations O 0 2.217336167784469e-15
making O 0 1.5386551692584023e-14
a O 0 1.450271651902424e-13
total O 0 3.841282153471681e-11
of O 0 2.521502451280355e-10
nineteen O 0 1.510947669203233e-07
CPO O 0 8.71651809575269e-06
gene B-Disease 0 2.1037966035919453e-08
defects I-Disease 0 3.244897754939302e-07
reported O 0 3.06707957642427e-11
so O 0 5.988904034151532e-13
far O 0 2.60598552286051e-12
. O 0 1.7712801711478043e-12
. O 0 3.081617183653407e-10

Coincidence O 0 1.3689978928255186e-08
of O 0 1.478995745318734e-11
two O 0 1.1511257713096162e-13
novel O 0 4.558697440804754e-14
arylsulfatase O 0 1.0388989668541626e-09
A O 0 3.079600463529175e-11
alleles O 0 6.010655569186479e-14
and O 0 1.3095241850526879e-13
mutation O 0 1.0521003556210329e-12
459 O 0 1.1506374845982048e-11
+ O 0 3.9891415171133815e-10
1G O 0 5.915162049063838e-08
> O 0 5.29125909753958e-10
A O 0 2.742734928062873e-10
within O 0 7.842386462453277e-12
a O 0 2.6457570943133613e-12
family O 0 1.1585587524065577e-11
with O 0 6.589082751640163e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.5563647647130058e-14
molecular O 0 2.4331607556679277e-14
basis O 0 2.0386027935193063e-12
of O 0 6.8548925216682655e-12
phenotypic O 0 7.373053834136556e-10
heterogeneity O 0 3.406186266374789e-08
. O 0 1.5509678519265435e-07

In O 0 1.6483849007986606e-11
a O 0 1.1912584634010681e-12
family O 0 7.005755296631694e-14
with O 0 3.6436273661556403e-16
three O 0 1.801946890582929e-14
siblings O 0 5.227253092182638e-13
, O 0 3.410591397009241e-17
one O 0 6.326725325825314e-17
developed O 0 1.3857712449338172e-13
classical O 0 1.8354871789139082e-10
late O 0 0.05514352023601532
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 9.972592196483276e-12
MLD B-Disease 1 1.0
) O 0 4.063492841906505e-14
, O 0 3.2147064517480933e-15
fatal O 0 3.235924375677435e-11
at O 0 2.8546622531100407e-12
age O 0 9.758383337499232e-13
5 O 0 4.245867505779828e-14
years O 0 3.41059679684428e-14
, O 0 9.837755110393112e-16
with O 0 1.0670237513921241e-14
deficient O 0 3.1029521174730235e-09
arylsulfatase O 0 2.562425436281046e-07
A O 0 5.398877647166955e-07
( O 0 5.653419898020429e-13
ARSA O 0 2.75029776730662e-07
) O 0 2.0152527412944325e-15
activity O 0 9.812248669832657e-13
and O 0 5.4089190435889934e-15
increased O 0 2.158157333398414e-11
galactosylsulfatide O 0 2.7139295255551588e-08
( O 0 2.6291197951361367e-13
GS O 0 0.0018244219245389104
) O 0 1.7120879367005237e-12
excretion O 0 6.735096369503424e-10
. O 0 2.5616597731925594e-10

The O 0 1.910258062842729e-10
two O 0 1.0016851714408914e-12
other O 0 5.781934311758011e-14
siblings O 0 5.9903353978596474e-12
, O 0 2.111322159380831e-15
apparently O 0 7.302066590275658e-11
healthy O 0 3.4865625053726035e-08
at O 0 1.1923691201065623e-10
12 O 0 6.80012712805933e-10
( O 0 1.2872537237529347e-13
1 O 0 6.731368240586733e-11
/ O 0 2.907001306340362e-10
2 O 0 3.6925928352353476e-13
) O 0 1.1203015520271802e-15
and O 0 1.1729428497540221e-14
15 O 0 1.0229111394727264e-13
years O 0 1.631343308052327e-13
, O 0 9.426186036486984e-16
respectively O 0 5.664969903763917e-13
, O 0 2.007357547193075e-15
and O 0 6.302642564478319e-15
their O 0 5.1114867546941944e-12
father O 0 3.832100192724397e-10
, O 0 1.5752861255019512e-12
apparently O 0 5.054312524066518e-10
healthy O 0 4.2668785171784407e-10
as O 0 2.345936013265111e-14
well O 0 9.226971400475015e-13
, O 0 6.946478575730122e-14
presented O 0 6.720108358670984e-10
ARSA O 0 1.602843803993892e-05
and O 0 1.3417394972847774e-10
GS O 1 0.9995306730270386
values O 0 2.0416701315695285e-11
within O 0 2.8721610593335223e-12
the O 0 6.039685082354779e-14
range O 0 1.49944674732172e-11
of O 0 1.561053369902865e-10
MLD B-Disease 1 1.0
patients O 0 2.4592402780854172e-08
. O 0 7.661328460528694e-09

Mutation O 0 3.7592335494496254e-11
screening O 0 6.155289819509413e-12
and O 0 1.461617692112213e-14
sequence O 0 3.365159171285492e-13
analysis O 0 1.5211128797515405e-13
disclosed O 0 6.383055108777347e-12
the O 0 7.136332540527701e-14
involvement O 0 4.4609909516379886e-11
of O 0 1.1636524209490684e-11
three O 0 2.975629508419897e-12
different O 0 4.668778558203357e-11
ARSA O 0 4.174341302132234e-05
mutations O 0 1.178807312179897e-11
being O 0 1.414645446140908e-13
the O 0 3.1085482359851854e-14
molecular O 0 1.1969677365161052e-13
basis O 0 4.6727788305389595e-11
of O 0 1.2501617796534248e-10
intrafamilial O 0 1.5732975953142159e-06
phenotypic O 0 3.088575795118231e-08
heterogeneity O 0 4.57073952020437e-07
. O 0 1.1491768248106382e-07

The O 0 4.3637239655058835e-11
late O 0 5.7513829254673965e-09
infantile O 0 1.3949816093372647e-06
patient O 0 6.962127402365681e-11
inherited O 0 3.0415822638296675e-10
from O 0 5.981301066416977e-13
his O 0 3.145041171936924e-10
mother O 0 1.3252328401325286e-10
the O 0 1.1464626470392147e-10
frequent O 0 4.966830835506642e-10
0 O 0 4.569036815560423e-11
- O 0 9.089688446373145e-10
type O 0 3.0068864065313505e-10
mutation O 0 2.240813784526452e-11
459 O 0 6.330607565940838e-11
+ O 0 2.29071345225762e-11
1G O 0 4.2515327369763156e-10
> O 0 1.8340749925738198e-12
A O 0 3.2272932156546252e-12
, O 0 1.3224009397943165e-16
and O 0 1.6406833635435725e-16
from O 0 2.2956786685924928e-14
his O 0 9.949356442884305e-12
father O 0 1.7757868092660445e-11
a O 0 5.458877978554294e-14
novel O 0 1.6259674101646703e-15
, O 0 6.982879398415858e-17
single O 0 1.322569441117305e-13
basepair O 0 1.752447520431133e-09
microdeletion O 0 6.608636748950403e-09
of O 0 2.5414484405850146e-10
guanine O 0 2.338748084085296e-10
at O 0 5.645463263537209e-11
nucleotide O 0 2.3196789974977428e-11
7 O 0 9.575267662098597e-12
in O 0 9.273802212272919e-12
exon O 0 8.001538320812074e-11
1 O 0 2.243442627850034e-12
( O 0 4.107120120887785e-14
7delG O 0 9.833288849847577e-09
) O 0 4.200400064661297e-13
. O 0 2.7983246275731233e-10

The O 0 4.4532402765362633e-10
two O 0 3.313951196792786e-11
clinically O 0 1.41178600188141e-06
unaffected O 0 6.337714242299342e-10
siblings O 0 3.041381599691584e-12
carried O 0 2.2598385023085005e-13
the O 0 2.915998876824172e-13
maternal O 0 3.2451660803012317e-10
mutation O 0 1.056502216441324e-12
459 O 0 7.243399456624555e-12
+ O 0 1.351412037831068e-10
1G O 0 7.3856263327343186e-09
> O 0 1.1961297230467238e-10
A O 0 1.5292897503904612e-10
and O 0 2.7738321554493343e-14
, O 0 1.2049470367539602e-15
on O 0 4.5706690656680676e-14
their O 0 1.2899327873211464e-13
paternal O 0 1.4230281883409468e-11
allele O 0 3.759683103038425e-12
, O 0 2.436419545525899e-15
a O 0 3.2082012387131802e-15
novel O 0 2.008966274518148e-15
cytosine O 0 3.607977631936432e-12
to O 0 1.0191064572090403e-12
thymidine O 0 2.9112863231262054e-09
transition O 0 2.6166844691033475e-08
at O 0 2.388881870096782e-10
nucleotide O 0 3.8708655725194774e-10
2435 O 0 1.313913884359863e-07
in O 0 2.4879121332532783e-11
exon O 0 3.238241064185132e-10
8 O 0 2.0402442756084493e-12
, O 0 2.7625107130763334e-15
resulting O 0 5.039439121535226e-14
in O 0 1.4196237467631236e-14
substitution O 0 1.506866506573168e-11
of O 0 3.311461868604759e-11
alanine O 0 6.980227507114023e-10
464 O 0 2.390837527954659e-10
by O 0 3.346938698411961e-11
valine O 0 4.8241836339002475e-05
( O 0 2.249123847233858e-12
A464V O 0 1.005603955661627e-08
) O 0 2.964615044339508e-13
. O 0 7.092487014359605e-11

The O 0 5.256692997557266e-11
fathers O 0 9.304582104796566e-11
genotype O 0 4.753926852868462e-12
thus O 0 1.054106997001869e-12
was O 0 2.2477955261002158e-11
7delG O 0 1.1050993862227187e-06
/ O 0 1.4789620195188036e-07
A464V O 0 2.1901914237787423e-07
. O 0 4.0677039514491753e-10

Mutation O 0 1.599507370997344e-08
A464V O 0 2.2103600727518824e-08
was O 0 8.819580807860328e-13
not O 0 1.6958876929715552e-14
found O 0 2.1252300592099205e-14
in O 0 1.6120476942259668e-14
18 O 0 6.870390107521773e-12
unrelated O 0 2.9057833916823483e-09
MLD B-Disease 1 1.0
patients O 0 1.8380727495603821e-10
and O 0 7.092316642830221e-13
50 O 0 2.9482796204405304e-09
controls O 0 6.281099018679015e-08
. O 0 8.558725994589622e-08

A464V O 0 1.8816077727024094e-06
, O 0 3.6943115667292803e-13
although O 0 2.9581531993914945e-13
clearly O 0 5.5853854527554425e-12
modifying O 0 4.058638314319296e-09
ARSA O 0 0.0003916443092748523
and O 0 8.321811573175353e-10
GS O 1 1.0
levels O 0 5.397424285291663e-09
, O 0 7.219544379639606e-14
apparently O 0 2.960221998082879e-11
bears O 0 5.434223904199342e-11
little O 0 7.396988295320372e-13
significance O 0 1.4115689520033392e-11
for O 0 3.5056115996190407e-13
clinical O 0 1.9682815100008355e-10
manifestation O 0 1.6271956226887596e-08
of O 0 1.078349409766588e-08
MLD B-Disease 1 1.0
, O 0 2.4954399657772797e-11
mimicking O 0 1.7607397762020582e-09
the O 0 2.0488372109994657e-10
frequent O 0 1.0070933420536221e-08
ARSA O 0 8.101404091576114e-05
pseudodeficiency O 0 9.449171329833916e-07
allele O 0 1.3589818159687184e-08
. O 0 5.735269148487987e-09

Our O 0 8.209488200350279e-09
results O 0 4.853249746528121e-12
demonstrate O 0 1.055642639274934e-11
that O 0 5.656787777251677e-16
in O 0 3.2875030043339696e-15
certain O 0 1.4730258028963772e-13
genetic O 0 2.3772990520587456e-11
conditions O 0 1.0646012960080498e-09
MLD B-Disease 1 1.0
- O 0 6.608361218241043e-07
like O 0 1.5340106962469235e-10
ARSA O 0 0.013945911079645157
and O 0 2.260583387148074e-10
GS O 1 1.0
values O 0 2.656189677929799e-11
need O 0 3.8550404730421095e-13
not O 0 4.808443834753264e-15
be O 0 2.6934946379406424e-14
paralleled O 0 1.3675612031693873e-10
by O 0 3.8646975973177095e-14
clinical O 0 6.003266217469161e-10
disease O 0 7.116960493158686e-11
, O 0 2.172094655763959e-15
a O 0 3.600315913996656e-14
finding O 0 1.6090764137777214e-11
with O 0 1.3841728598810304e-13
serious O 0 5.810339320788671e-09
diagnostic O 0 6.547999475969846e-08
and O 0 2.1935737948286516e-11
prognostic O 0 1.2771316448834114e-07
implications O 0 7.679978875074767e-10
. O 0 3.7769316563185384e-09

Moreover O 0 2.1396432714482216e-07
, O 0 2.339255351924141e-11
further O 0 7.522548139959895e-10
ARSA O 0 4.302130764699541e-05
alleles O 0 3.6557087912392205e-10
functionally O 0 2.9754652075553167e-08
similar O 0 5.963112816032012e-12
to O 0 5.319816809290501e-10
A464V O 0 9.476446649614445e-08
might O 0 3.8713711056348465e-12
exist O 0 1.3394477367534297e-11
which O 0 2.1151028909409007e-15
, O 0 1.1287263534788083e-15
together O 0 7.218419113309837e-13
with O 0 5.149137951958316e-13
0 O 0 2.7122588897032784e-11
- O 0 1.9288756702984244e-10
type O 0 1.0015892559778194e-09
mutations O 0 1.8595629480699927e-09
, O 0 3.200430372107821e-13
may O 0 3.780913429562993e-11
cause O 0 4.557772470548116e-08
pathological O 0 2.5181943783536553e-06
ARSA O 0 0.0004970824811607599
and O 0 4.3255823922727643e-10
GS O 1 1.0
levels O 0 8.919881500091265e-10
, O 0 4.980421169199041e-15
but O 0 8.768291840585425e-16
not O 0 8.731546810179704e-15
clinical O 0 2.1814978209272473e-12
outbreak O 0 7.397746559214755e-14
of O 0 6.421502462801779e-14
the O 0 3.655133487545648e-12
disease O 0 5.156740659484349e-11
. O 0 5.615433031763706e-12
. O 0 1.6045546002985134e-09

Human O 0 3.718323205248453e-05
MLH1 O 1 1.0
deficiency O 1 0.9997251629829407
predisposes O 0 0.0005673056584782898
to O 0 1.804996507814849e-08
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 4.875866377318516e-10
neurofibromatosis B-Disease 1 0.9743781089782715
type I-Disease 0 5.426679854281247e-05
1 I-Disease 0 5.560497811529785e-06
. O 0 5.444357853434667e-08

Heterozygous O 0 2.315168501354492e-09
germ O 0 4.3906556612682834e-08
- O 0 2.458342140965186e-10
line O 0 3.1745812575922905e-12
mutations O 0 8.569493313743959e-15
in O 0 9.29670010984022e-16
the O 0 1.4017686310481819e-14
DNA O 0 4.774388884243308e-09
mismatch O 0 1.5532696124864742e-06
repair O 0 6.437865067709936e-06
genes O 0 9.682914886566252e-11
lead O 0 3.058679975964651e-10
to O 0 2.58308729961243e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.6138860914338693e-08

The O 0 4.003296028010084e-10
disease O 0 1.140314787040353e-10
susceptibility O 0 2.27358821873469e-12
of O 0 9.90595626360058e-12
individuals O 0 4.453272126059282e-11
who O 0 1.6588368012548926e-08
constitutionally O 1 0.9999802112579346
lack O 0 0.06089669093489647
both O 0 2.2040301528303274e-10
wild O 0 4.952742035935209e-11
- O 0 2.4335160622723784e-12
type O 0 5.330717421300757e-13
alleles O 0 1.6673431569875358e-13
is O 0 9.150302958643285e-15
unknown O 0 2.8468355450783633e-10
. O 0 4.963989219675113e-10

We O 0 2.6921222195941397e-11
have O 0 1.3598410083788624e-14
identified O 0 3.7985450017635064e-14
three O 0 1.3458267212115979e-15
offspring O 0 2.4899269386764733e-13
in O 0 6.444849231926949e-15
a O 0 1.9157887082288383e-11
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.5335521084125503e-06
who O 0 5.175639777865726e-11
developed O 0 1.3017209710142197e-07
hematological B-Disease 1 0.9999966621398926
malignancy I-Disease 1 0.9662976861000061
at O 0 2.333365445306157e-10
a O 0 1.8309223494966664e-12
very O 0 5.609069456190101e-14
early O 0 1.8771760187941133e-11
age O 0 8.399254382285282e-12
, O 0 4.404420977374224e-15
and O 0 9.523852111678957e-15
at O 0 4.325567681817688e-13
least O 0 5.76127145122951e-14
two O 0 1.9205128684736915e-14
of O 0 8.09616994756554e-14
them O 0 1.1281243036357236e-14
displayed O 0 1.7980503197456699e-10
signs O 0 9.113018673012618e-10
of O 0 7.5066424187753e-09
neurofibromatosis B-Disease 0 4.70338090963196e-06
type I-Disease 0 7.22663084928854e-09
1 I-Disease 0 4.025731137335953e-10
( O 0 1.009726482113782e-12
NF1 B-Disease 0 2.0850339410571905e-07
) O 0 2.58960496275773e-12
. O 0 3.9638772819650114e-10

DNA O 0 1.0200306745089538e-11
sequence O 0 1.3899317691267767e-14
analysis O 0 2.4995508169088935e-15
and O 0 6.83237090811163e-17
allele O 0 2.795998160646032e-14
- O 0 3.8197869787180445e-15
specific O 0 2.536396114839745e-15
amplification O 0 2.7778045705653676e-13
in O 0 4.9434164173158684e-15
two O 0 3.713031401439415e-13
siblings O 0 4.3359824064559405e-10
revealed O 0 2.7485465292631517e-11
a O 0 1.1053732798874116e-12
homozygous O 0 6.737122665301243e-11
MLH1 O 0 3.7406541650852887e-06
mutation O 0 1.1112977899019327e-10
( O 0 9.734954406178178e-14
C676T O 0 1.778213771785886e-07
- O 0 2.384876438554784e-07
- O 0 6.406803265690542e-08
> O 0 8.450930621961561e-09
Arg226Stop O 0 9.216657304023101e-07
) O 0 5.4244606582150995e-14
. O 0 8.689924647919955e-12

Thus O 0 8.243438709421014e-10
, O 0 1.3983937976764366e-13
a O 0 2.9955874478009015e-13
homozygous O 0 6.1515922564203684e-12
germ O 0 9.303012582506653e-09
- O 0 6.690565323985709e-10
line O 0 1.2064679810741552e-10
MLH1 O 0 0.036776103079319
mutation O 0 2.1292116958449014e-09
and O 0 1.7371595698381648e-12
consequent O 0 7.436023224727251e-06
mismatch O 1 0.9999964237213135
repair O 1 0.9999998807907104
deficiency O 0 5.925514051341452e-05
results O 0 2.686670885765352e-10
in O 0 3.7751902298710505e-12
a O 0 9.195894913605063e-12
mutator O 0 2.6338545566773064e-08
phenotype O 0 2.4023966843644828e-11
characterized O 0 2.134667361495049e-14
by O 0 1.1820064199269983e-15
leukemia B-Disease 0 0.06172196939587593
and O 0 3.543840915165575e-11
/ O 1 0.999997615814209
or O 0 5.770075404143427e-07
lymphoma B-Disease 1 1.0
associated O 1 0.9999991655349731
with O 0 2.591588887934648e-10
neurofibromatosis B-Disease 1 0.999998927116394
type I-Disease 0 2.0597142338374397e-06
1 I-Disease 0 1.9705112208612263e-08
. O 0 6.915713141042445e-11
. O 0 4.3017714390636286e-10

Missense O 0 1.8096766325470526e-06
mutations O 0 9.829660002624863e-11
in O 0 6.235723200818943e-13
the O 0 2.670889225932227e-13
most O 0 3.3750804936076703e-15
ancient O 0 1.0129288900706523e-11
residues O 0 8.35030378176782e-10
of O 0 2.3445707181268816e-11
the O 0 2.4656912622766924e-10
PAX6 O 0 5.6786589993862435e-05
paired O 0 5.106037370694594e-09
domain O 0 1.309644925839848e-08
underlie O 0 2.069434756890587e-08
a O 0 1.4055878856666926e-12
spectrum O 0 3.2080990641780716e-10
of O 0 7.501367582651852e-11
human O 0 0.00011449045996414497
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 0.9999994039535522
. O 0 3.3296273613814265e-05

Mutations O 0 4.237220019298604e-10
of O 0 1.3675421038639168e-11
the O 0 6.544899171234686e-13
human O 0 3.2375402272272202e-12
PAX6 O 0 1.2245241123309825e-05
gene O 0 2.9509630294910494e-09
underlie O 0 0.005328971426934004
aniridia B-Disease 1 1.0
( O 0 2.5946960136025154e-09
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999642372131348
of I-Disease 0 1.657256092357784e-07
the I-Disease 0 9.341823981046105e-10
iris I-Disease 0 7.214741026828619e-10
) O 0 1.514685593747775e-13
, O 0 5.19334263635908e-14
a O 0 3.321188593238822e-12
rare O 0 6.846722744313638e-09
dominant O 1 0.999852180480957
malformation B-Disease 1 0.9999972581863403
of I-Disease 0 1.4258377632359043e-05
the I-Disease 0 0.00039051470230333507
eye I-Disease 1 0.9987674951553345
. O 0 4.7360353505609964e-07

The O 0 9.342875362250425e-10
spectrum O 0 6.871081925652334e-09
of O 0 8.441260468394773e-10
PAX6 O 0 4.473777880775742e-05
mutations O 0 7.013180258752527e-09
in O 0 1.907161095715537e-09
aniridia B-Disease 1 1.0
patients O 0 1.8951556768342925e-08
is O 0 7.130006220851248e-14
highly O 0 2.2801589175808212e-12
biased O 0 3.5055146285767336e-11
, O 0 2.8686911634541066e-15
with O 0 2.8759431419111427e-16
92 O 0 5.1524243205314235e-11
% O 0 7.733167405044039e-12
of O 0 1.664467581775561e-13
all O 0 5.63618027032628e-14
reported O 0 7.82793621589839e-12
mutations O 0 3.649590352150511e-11
leading O 0 1.002724223098106e-10
to O 0 2.515886388110289e-10
premature O 0 2.5810544812543412e-08
truncation O 0 2.0917325400660047e-06
of O 0 7.538367867709894e-07
the O 0 2.6914031536762195e-07
protein O 0 7.116166322873596e-09
( O 0 5.764077366451903e-13
nonsense O 0 2.896111572781024e-09
, O 0 9.116981529531248e-14
splicing O 0 9.696308859996616e-12
, O 0 6.762371560073074e-14
insertions O 0 3.2864062166071406e-11
and O 0 1.0918635516121017e-13
deletions O 0 4.754370942078312e-12
) O 0 3.5496633543387606e-16
and O 0 2.9709534935277657e-14
just O 0 1.5392261033461696e-12
2 O 0 7.894771262510064e-14
% O 0 1.191387483459594e-13
leading O 0 8.388845961808324e-16
to O 0 6.6064959407897755e-16
substitution O 0 1.934009159418326e-12
of O 0 2.051859203378026e-11
one O 0 1.5379231091752765e-12
amino O 0 1.9091717790020724e-11
acid O 0 3.6566518042679963e-13
by O 0 7.865309084912307e-15
another O 0 8.064660050877137e-12
( O 0 1.6088347288504418e-14
missense O 0 3.896905909073212e-09
) O 0 2.9023986447725136e-13
. O 0 3.108856783118341e-10

The O 0 3.3325422282848294e-11
extraordinary O 0 5.406297371585156e-12
conservation O 0 1.8339945447726214e-12
of O 0 8.016068413435953e-14
the O 0 3.169733355998239e-13
PAX6 O 0 1.6555738113765983e-07
protein O 0 6.622510179132846e-11
at O 0 3.91121943860151e-12
the O 0 1.538751417951012e-11
amino O 0 1.1221360729507524e-08
acid O 0 1.2934591175906007e-08
level O 0 1.6204536734676367e-07
amongst O 0 2.9490907493823215e-08
vertebrates O 0 6.748333589712274e-07
predicts O 0 5.896719557085817e-09
that O 0 1.5714854417758772e-10
pathological O 0 1.573201529936341e-06
missense O 0 3.503930884107831e-06
mutations O 0 3.948749327520318e-09
should O 0 3.197767051155154e-11
in O 0 3.8359815324184865e-11
fact O 0 4.877761389243673e-11
be O 0 1.608996789970174e-11
common O 0 3.9563671783149346e-11
even O 0 1.8805399945587276e-12
though O 0 9.259268698991185e-13
they O 0 9.098000131047002e-13
are O 0 3.5596826593146946e-13
hardly O 0 1.0426169927413298e-09
ever O 0 1.5922158036474343e-10
seen O 0 6.403498842288968e-10
in O 0 9.221812202753199e-10
aniridia B-Disease 1 1.0
patients O 0 5.431651288745343e-07
. O 0 1.5142791909283915e-08

This O 0 9.688617963465873e-12
indicates O 0 1.1418289924680636e-11
that O 0 3.275073431107723e-15
there O 0 1.5335102911367797e-14
is O 0 1.017675251896086e-15
a O 0 1.4715094106328847e-13
heavy O 0 2.1319941645447926e-10
ascertainment O 0 7.717002290519304e-07
bias O 0 1.0552264617658125e-10
in O 0 2.923232673718995e-13
the O 0 4.730867932643823e-13
selection O 0 2.5651395937908994e-11
of O 0 9.857498498022643e-12
patients O 0 2.864136011693219e-12
for O 0 3.753664479938523e-12
PAX6 O 0 2.7391416779209976e-07
mutation O 0 2.5836056384564987e-12
analysis O 0 1.0593675459427687e-12
and O 0 6.932408342036692e-14
that O 0 4.904481700862377e-14
the O 0 6.245728934040073e-11
missing O 0 4.673401235777419e-06
PAX6 O 0 0.030795609578490257
missense O 0 5.956685708952136e-05
mutations O 0 1.1394706689316081e-07
frequently O 0 2.93925495054026e-10
may O 0 5.698062577330631e-10
underlie O 0 9.99687017610995e-07
phenotypes O 0 1.0345058143457209e-08
distinct O 0 2.3635005411137833e-11
from O 0 4.308215242887492e-11
textbook O 0 2.284656659412576e-07
aniridia B-Disease 1 1.0
. O 0 1.1795697929528615e-07

Here O 0 3.2532061489121133e-09
we O 0 5.236975783584619e-12
present O 0 6.022183186155106e-12
four O 0 1.234257813141626e-12
novel O 0 2.0017251745052533e-12
PAX6 O 0 7.901647904873244e-07
missense O 0 3.596853659360022e-08
mutations O 0 4.233711992096545e-11
, O 0 3.366120452036672e-14
two O 0 1.4373335963276113e-14
in O 0 8.201281992935294e-14
association O 0 4.838736290986578e-13
with O 0 1.4974044953205284e-13
atypical O 0 4.652877250155285e-10
phenotypes O 0 1.334315574696987e-10
ectopia B-Disease 0 1.7231350568636117e-08
pupillae I-Disease 0 6.449101164207605e-08
( O 0 1.6798171062698888e-14
displaced B-Disease 0 2.3154544948056355e-10
pupils I-Disease 0 8.246887617247012e-09
) O 0 8.033131798645954e-11
and O 0 1.4291526895249262e-06
congenital B-Disease 1 1.0
nystagmus I-Disease 0 1.3623691302200314e-05
( O 0 1.0335372965450396e-12
searching B-Disease 0 3.457438069176533e-08
gaze I-Disease 0 4.821168353430494e-09
) O 0 1.2624998126738087e-14
, O 0 6.861684309666157e-15
and O 0 5.8384274282850205e-15
two O 0 4.357005682349528e-14
in O 0 7.68450583656273e-14
association O 0 2.1389151300815756e-13
with O 0 6.344522753302592e-14
more O 0 2.956502230533342e-12
recognizable O 0 9.860017513574348e-08
aniridia B-Disease 1 1.0
phenotypes O 0 7.310674732252664e-07
. O 0 2.2344451622302586e-08

Strikingly O 0 1.347463012280059e-07
, O 0 1.5328800511901775e-12
all O 0 3.277732902803865e-13
four O 0 1.4008239013207913e-12
mutations O 0 5.704056476284192e-13
are O 0 1.2628129607544086e-14
located O 0 1.7447930036537662e-13
within O 0 9.403687030451469e-12
the O 0 9.116665061759122e-11
PAX6 O 0 5.252268965705298e-05
paired O 0 1.5781161266659183e-08
domain O 0 5.061524177563115e-08
and O 0 9.265036654548808e-11
affect O 0 2.7187900286662625e-07
amino O 0 1.6563200588848304e-08
acids O 0 5.56328420830976e-11
which O 0 4.15863395423436e-14
are O 0 1.1677551117652684e-14
highly O 0 7.32169967015972e-12
conserved O 0 1.2749812490497892e-11
in O 0 2.314162750316484e-12
all O 0 7.1301358914310775e-12
known O 0 1.4969834399858328e-11
paired O 0 1.2871974597317148e-09
domain O 0 2.3057422637862146e-09
proteins O 0 1.0924297577652453e-10
. O 0 1.0590620602712875e-09

Our O 0 1.0929269045334422e-08
results O 0 2.7828505125282454e-11
support O 0 2.4980768321969382e-12
the O 0 1.7714067788564963e-14
hypothesis O 0 3.3410318867104155e-15
that O 0 6.012887542030653e-19
the O 0 7.531192280186639e-17
under O 0 4.034008980265298e-14
- O 0 7.221531315645957e-13
representation O 0 5.634985186797614e-11
of O 0 2.437290369528e-10
missense O 0 1.2459660183594679e-06
mutations O 0 2.1344976897097467e-09
is O 0 2.579187677233946e-13
caused O 0 1.6305828215434914e-11
by O 0 1.0673178920533877e-12
ascertainment O 0 1.1592706869123504e-05
bias O 0 4.840211009771167e-10
and O 0 2.301370357303545e-13
suggest O 0 5.00381420326379e-12
that O 0 1.590581867639293e-15
a O 0 5.302695606289147e-14
substantial O 0 1.8483724967266468e-11
burden O 0 1.1687435019780423e-08
of O 0 1.5608232217800833e-07
PAX6 B-Disease 1 0.9999994039535522
- I-Disease 0 0.0007976415799930692
related I-Disease 0 0.015849517658352852
disease I-Disease 0 0.003395208390429616
remains O 0 9.381830382015899e-12
to O 0 2.850950270132102e-13
be O 0 6.896579119418378e-13
uncovered O 0 6.571916344455531e-10
. O 0 3.6931438809895134e-12
. O 0 3.596294373409137e-10

The O 0 5.320192064672824e-10
chromosomal O 0 6.180581380021977e-09
order O 0 3.567372092172505e-12
of O 0 4.674062178966487e-11
genes O 0 4.836655728701622e-11
controlling O 0 1.5932040131616532e-09
the O 0 2.1437840391769214e-09
major O 0 1.0277696915750312e-08
histocompatibility O 0 8.996407245831506e-07
complex O 0 3.474453791341148e-08
, O 0 2.7496448585899447e-13
properdin O 0 7.20118942254544e-09
factor O 0 8.101352921840999e-12
B O 0 1.4460208586086765e-09
, O 0 1.4087614809508292e-14
and O 0 5.557251368608872e-14
deficiency B-Disease 0 6.691592346896869e-08
of I-Disease 0 5.690929505419717e-09
the I-Disease 0 6.296567156560684e-10
second I-Disease 0 5.214377818418825e-09
component I-Disease 0 3.022124550611238e-09
of I-Disease 0 4.1762410196710675e-10
complement I-Disease 0 4.1718028143122865e-08
. O 0 1.5113080564788106e-07

The O 0 2.1994517318546514e-11
relationship O 0 1.68974920861098e-11
of O 0 8.44330898600032e-13
the O 0 6.778875827643735e-14
genes O 0 4.0115251683067905e-15
coding O 0 1.2601242748919161e-12
for O 0 1.86706051552403e-14
HLA O 0 3.681049909332046e-11
to O 0 4.740143824330523e-13
those O 0 7.048377316911172e-14
coding O 0 4.817930499001477e-10
for O 0 9.63065131115437e-13
properdin O 0 9.391153632520854e-09
Factor O 0 1.7257110671020648e-11
B O 0 1.0197724609195546e-10
allotypes O 0 9.527401090281273e-10
and O 0 4.431233381803085e-15
for O 0 3.6198227439587435e-14
deficiency B-Disease 0 1.0962103447198501e-09
of I-Disease 0 3.844720028456372e-11
the I-Disease 0 2.4463233088550806e-12
second I-Disease 0 8.03083294309559e-11
component I-Disease 0 6.499961124895037e-10
of I-Disease 0 5.476586961705721e-10
complement I-Disease 0 5.628416843705963e-09
( O 0 4.188535640287788e-13
C2 O 0 1.9014403385142487e-09
) O 0 3.648358098105615e-15
was O 0 9.201167117719317e-14
studied O 0 1.467744112013114e-14
in O 0 6.16371211459055e-16
families O 0 1.9307894110029596e-14
of O 0 4.4813257922202143e-13
patients O 0 1.2037544355400498e-12
with O 0 5.023631163836306e-11
connective O 0 0.000412378809414804
tissue O 1 1.0
disorders O 1 0.9999996423721313
. O 0 2.655459638845059e-06

Patients O 0 3.3946918609473187e-09
were O 0 8.624893876353623e-13
selected O 0 5.112654548854179e-13
because O 0 5.455419034810886e-15
they O 0 9.558684647568896e-15
were O 0 2.2123028777833176e-13
heterozygous O 0 1.5017041429810085e-12
or O 0 3.6069593492560337e-12
homozygous O 0 1.3904132067921182e-08
for O 0 4.811053031517076e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 4.1864814193104394e-07

12 O 0 1.4016592053689436e-10
families O 0 5.659303321109421e-12
with O 0 6.96263522097923e-14
15 O 0 3.52234422185127e-11
matings O 0 5.940691607975168e-06
informative O 0 2.7327754992256814e-07
for O 0 1.2108031910429418e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 4.697229827321792e-10
found O 0 2.8391936371385817e-11
. O 0 2.271808713372181e-10

Of O 0 3.8934575741222943e-07
57 O 0 1.4027350516698789e-06
informative O 0 1.4599733333398035e-07
meioses O 0 1.5610346792982455e-07
, O 0 1.688735007951761e-14
two O 0 5.265131389144313e-15
crossovers O 0 2.9031974307230923e-12
were O 0 2.187830537396518e-13
noted O 0 2.8090637455013834e-13
between O 0 4.666205616343788e-11
the O 0 8.320276023709994e-09
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9721453189849854
gene O 0 1.9974781784127746e-14
and O 0 3.901445189998095e-15
the O 0 5.413992821765023e-13
HLA O 0 4.956071109063487e-10
- O 0 1.6687776160928536e-10
B O 0 3.077721411059997e-11
gene O 0 8.124207458097663e-16
, O 0 1.7983594731172466e-17
with O 0 5.069175792732686e-19
a O 0 3.9904744540387205e-17
recombinant O 0 4.573009650635392e-16
fraction O 0 6.02458079083934e-13
of O 0 8.540363728715139e-12
0 O 0 4.200131908937976e-11
. O 0 2.9247053667802447e-09

035 O 0 6.359680264722556e-05
. O 0 5.5538137644361996e-08

A O 0 9.05271768658622e-09
lod O 0 9.929522093443666e-09
score O 0 8.115151606258308e-11
of O 0 2.795148010617532e-12
13 O 0 2.853468871778786e-13
was O 0 4.668065487921282e-15
calculated O 0 4.4845386898331036e-14
for O 0 6.56983555015131e-14
linkage O 0 6.123217133335856e-08
between O 0 7.544625901800828e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 4.3802075681831365e-12
HLA O 0 3.2354401380274567e-09
- O 0 3.801256254210017e-10
B O 0 1.3266694687263936e-10
at O 0 3.2819914456494806e-14
a O 0 8.984923163823672e-17
maximum O 0 7.675283701822028e-16
likelihood O 0 2.235545470326305e-15
value O 0 1.287444594157269e-14
of O 0 6.707465020959567e-15
the O 0 2.1172340258361925e-15
recombinant O 0 7.365669760315413e-15
fraction O 0 1.1239893564496395e-11
of O 0 5.409022882374437e-11
0 O 0 3.928986996859507e-11
. O 0 3.258049385834738e-09

04 O 0 8.435042218479794e-06
. O 0 1.8506653987060417e-07

18 O 0 3.375964785501395e-10
families O 0 3.382574385521475e-12
with O 0 2.171329488551057e-14
21 O 0 1.2402618862483727e-11
informative O 0 3.598591216680269e-11
matings O 0 1.2863384801775624e-09
for O 0 3.1536095349699034e-12
both O 0 1.528379922621781e-10
properdin O 0 9.859638794296188e-07
Factor O 0 2.2078308070661024e-09
B O 0 6.102228500282081e-09
allotype O 0 1.563742912935595e-08
and O 0 3.048548609732582e-12
HLA O 0 1.1274996047916375e-08
- O 0 2.688336775413802e-10
B O 0 1.4385842517228298e-10
were O 0 2.7956743907722736e-13
found O 0 1.6282813855919565e-13
. O 0 2.1791607147242376e-12

Of O 0 1.4289780665421858e-06
72 O 0 6.924222361703869e-06
informative O 0 7.475354095731745e-07
meioses O 0 5.944409622316016e-07
, O 0 3.4240318913525414e-13
three O 0 6.560922595141849e-13
recombinants O 0 6.988343681513243e-09
were O 0 5.3322047298409725e-12
found O 0 6.316512525701701e-13
, O 0 2.942596270409702e-15
giving O 0 2.981494987962935e-14
a O 0 5.469693234038016e-15
recombinant O 0 7.790838287002888e-14
fraction O 0 8.326633826882812e-11
of O 0 7.525016165743637e-10
0 O 0 5.572738381864895e-10
. O 0 2.077526239929739e-08

042 O 0 8.177267591236159e-05
. O 0 6.171253374986918e-08

A O 0 2.4024691569479728e-08
lod O 0 2.001164212117601e-08
score O 0 3.020947381138228e-10
of O 0 1.7328123311233234e-11
16 O 0 3.395159370658818e-12
between O 0 2.8445800402676635e-12
HLA O 0 2.571852453225887e-10
- O 0 3.047439731118651e-11
B O 0 3.650925482073797e-12
and O 0 1.1462913815851392e-15
Factor O 0 8.212019660201048e-14
B O 0 2.991255463810627e-12
allotypes O 0 2.6077522086165317e-11
was O 0 1.658347700969013e-14
calculated O 0 9.68354628254342e-14
at O 0 8.07534987772203e-14
a O 0 2.503042921992186e-15
maximum O 0 1.6856553655621338e-14
likelihood O 0 6.756169923646457e-14
value O 0 2.7398030133692075e-13
of O 0 7.515390626445725e-14
the O 0 1.460620056706937e-14
recombinant O 0 1.5337911672620892e-14
fraction O 0 1.1480157102727873e-11
of O 0 7.489301540042348e-11
0 O 0 4.384757140707407e-11
. O 0 2.765840667606767e-09

04 O 0 6.758709787391126e-06
. O 0 1.1505574093462201e-07

A O 0 1.7512252981077836e-08
crossover O 0 1.930936938121519e-10
was O 0 3.9327468690474043e-13
shown O 0 3.406131984535349e-13
to O 0 1.03195360243169e-12
have O 0 5.314552373484813e-14
occurred O 0 2.948427960114408e-11
between O 0 7.103115974094534e-14
genes O 0 1.79455195414022e-14
for O 0 1.49629030818171e-14
Factor O 0 4.650607698421239e-13
B O 0 1.480403993836532e-11
and O 0 2.102171952136911e-12
HLA O 0 6.122350626469597e-09
- O 0 2.8796913742468178e-09
D O 0 3.0055544858464955e-11
, O 0 7.408470441019291e-16
in O 0 2.0563320922308123e-16
which O 0 2.877194103695119e-16
HLA O 0 2.7405792912826854e-11
- O 0 1.7711122499153298e-11
D O 0 1.9099719635734536e-12
segregared O 0 7.345873909159195e-11
with O 0 3.255591885079111e-15
HLA O 0 3.02938285567933e-10
- O 0 1.7345879940733333e-11
A O 0 1.0472643585668351e-10
and O 0 1.3481660991569722e-13
B O 0 1.4275070014946323e-09
. O 0 8.540167704962354e-12

These O 0 1.1641541897144947e-11
studies O 0 1.4709321000810904e-12
suggest O 0 1.8221691245722677e-14
that O 0 8.245528251830692e-18
the O 0 8.69362112172463e-16
genes O 0 3.510695084792646e-14
for O 0 3.238637927716753e-13
Factor O 0 9.261654554393317e-09
B O 0 0.0001653830404393375
and O 0 2.3688493456575088e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 9.10665032965996e-12
located O 0 3.672973654823136e-13
outside O 0 2.2697056907550195e-12
those O 0 3.636877040844033e-13
for O 0 5.523641440075e-12
HLA O 0 4.704593603577223e-09
, O 0 4.27071301500187e-14
that O 0 7.330151657133791e-16
the O 0 3.220476863701263e-14
order O 0 4.3467570580262016e-13
of O 0 7.180964850528326e-11
genese O 0 5.407731507034441e-08
is O 0 3.9030573478066044e-13
HLA O 0 4.1377232196104785e-10
- O 0 2.297539415663241e-11
A O 0 4.05557226690334e-10
, O 0 1.0353079579349025e-14
- O 0 2.050644268107582e-13
B O 0 1.5859160772818681e-12
, O 0 5.030790724561347e-16
- O 0 1.1152115065833981e-13
D O 0 1.0016120555568844e-13
, O 0 1.2175743921733905e-16
Factor O 0 7.732794439496704e-13
B O 0 1.8170475124534846e-09
allotype O 0 1.6061774203990353e-06
, O 0 4.4290812684089076e-10
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.20505736279534e-15
that O 0 1.5010616619789503e-17
the O 0 9.562769040440556e-15
genes O 0 8.93114228406322e-12
coding O 0 3.883822046191199e-06
for O 0 1.4357152622324065e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 5.279622919407423e-11
Factor O 0 1.0708670755699146e-10
B O 0 1.427577722701301e-09
allotypes O 0 3.922342006745794e-09
are O 0 5.504082348180067e-15
approximately O 0 5.4686293606562644e-15
3 O 0 6.15497846375053e-14
- O 0 2.5172901957359883e-12
- O 0 1.1696421825871384e-12
5 O 0 7.468334896907139e-14
centimorgans O 0 3.6297309602417727e-10
from O 0 5.09066022029523e-14
the O 0 1.3130132831690178e-13
HLA O 0 1.0522318433237032e-10
- O 0 6.008930766160381e-12
A O 0 6.206019725896184e-11
and O 0 4.0694048608277966e-13
HLA O 0 4.317399771025521e-09
- O 0 2.72028424092019e-11
B O 0 9.365055389162769e-13
loci O 0 2.3923559598734885e-14
, O 0 1.4876315575535394e-17
and O 0 1.007926090443188e-18
that O 0 2.4972393992398667e-19
the O 0 1.3625631393372772e-16
apparent O 0 4.612436192534541e-13
lack O 0 2.0781256923618763e-11
of O 0 6.384284594040945e-12
recombinants O 0 2.1061291377577618e-08
between O 0 6.6966224232523075e-12
the O 0 3.531774265402854e-12
Factor O 0 8.266851647675821e-10
B O 0 2.667320302407461e-07
gene O 0 2.1646082259962895e-08
and O 0 0.00017920009850058705
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 8.668078060880546e-11
suggests O 0 2.4832683110341536e-13
that O 0 8.759227264560824e-17
these O 0 1.3125059273742714e-15
two O 0 6.004891679387003e-14
genes O 0 8.084373448458138e-12
lie O 0 9.195558980934493e-09
in O 0 9.920174924571423e-12
close O 0 3.270889692430501e-08
proximity O 0 1.244280056766911e-08
to O 0 1.4078510579551562e-10
one O 0 1.4363497891078936e-10
another O 0 1.5890825322273372e-09
. O 0 2.576268798293313e-08

Distribution O 0 6.59647136913577e-09
of O 0 1.0428974350773501e-09
emerin O 0 5.344879809854319e-06
and O 0 1.3847130907185257e-11
lamins O 0 1.4290516219261917e-06
in O 0 9.12859718371628e-12
the O 0 1.3360981765409008e-10
heart O 0 6.344756720011446e-09
and O 0 4.9350397900160825e-12
implications O 0 1.2591471268419419e-11
for O 0 1.806954065541877e-11
Emery B-Disease 1 0.9775549173355103
- I-Disease 1 0.9999910593032837
Dreifuss I-Disease 1 0.9861800074577332
muscular I-Disease 0 0.0011674243723973632
dystrophy I-Disease 1 0.9998156428337097
. O 0 1.370804056932684e-07

Emerin O 1 0.7578794360160828
is O 0 2.247641135710854e-11
a O 0 5.750694625356045e-12
nuclear O 0 5.361356358868363e-10
membrane O 0 1.3058614953265213e-11
protein O 0 6.174903904171414e-12
which O 0 8.982117367185892e-16
is O 0 3.716329527507457e-15
missing O 0 1.8650614386217512e-09
or O 0 9.103298843904373e-12
defective O 0 1.0279794793177643e-08
in O 0 9.522854726995433e-11
Emery B-Disease 1 0.999997615814209
- I-Disease 1 0.9999998807907104
Dreifuss I-Disease 1 0.9903510212898254
muscular I-Disease 0 2.4398788809776306e-05
dystrophy I-Disease 1 0.9999549388885498
( O 0 3.7326475244015e-11
EDMD B-Disease 1 1.0
) O 0 7.527592264799932e-12
. O 0 7.672786017653976e-11

It O 0 3.0631942295189507e-13
is O 0 3.3809824074259014e-15
one O 0 8.585886789405119e-15
member O 0 2.3812541023217337e-13
of O 0 2.7531887360210394e-12
a O 0 2.0409575071655972e-11
family O 0 2.8295869120009698e-11
of O 0 5.730367291789662e-10
lamina O 0 5.265864820103161e-05
- O 0 3.1641163023010677e-09
associated O 0 1.2731253551390154e-10
proteins O 0 3.5772244541543152e-12
which O 0 1.233103618942643e-14
includes O 0 2.614576070025191e-14
LAP1 O 0 0.0001387457741657272
, O 0 1.5903476452416854e-12
LAP2 O 1 0.9988129138946533
and O 0 7.960896941661133e-10
lamin O 0 2.725211970755481e-06
B O 0 5.7207305559359156e-08
receptor O 0 1.567930681123375e-11
( O 0 4.684607194348211e-13
LBR O 0 1.413599237665153e-09
) O 0 9.261136372758563e-14
. O 0 5.862386270871767e-11

A O 0 4.220578830427257e-06
panel O 0 3.7202538272218533e-10
of O 0 3.7110672174156534e-11
16 O 0 7.944007431037736e-12
monoclonal O 0 3.6282023392619767e-13
antibodies O 0 2.5402135906890666e-13
( O 0 1.62611098224923e-14
mAbs O 0 8.354525404818958e-10
) O 0 1.508279043110558e-14
has O 0 2.155997006359628e-15
been O 0 6.027026344364653e-14
mapped O 0 7.529344335510668e-12
to O 0 1.2428851350887449e-12
six O 0 4.059050404819908e-12
specific O 0 6.014056006670154e-12
sites O 0 6.02875943611636e-11
throughout O 0 2.3155238143557355e-11
the O 0 4.4126091669483e-12
emerin O 0 3.656366320825555e-09
molecule O 0 1.800333157293138e-13
using O 0 1.737129971118856e-12
phage O 0 6.054448609127405e-10
- O 0 2.7325253171284203e-11
displayed O 0 1.1426852519758057e-11
peptide O 0 3.490281631421399e-12
libraries O 0 1.6206978467603328e-11
and O 0 8.883646991858854e-14
has O 0 1.5467283249819778e-15
been O 0 1.2823470651773979e-14
used O 0 3.818035568693007e-13
to O 0 6.951608733096748e-10
localize O 0 0.00011043349513784051
emerin O 0 2.609388957353076e-06
in O 0 8.895050494783785e-12
human O 0 1.2306976271414527e-10
and O 0 9.119726501749525e-11
rabbit O 0 5.3794511956084534e-08
heart O 0 3.2700049246159324e-07
. O 0 5.591429896867339e-08

Several O 0 1.6143031356108395e-10
mAbs O 0 5.386121770811769e-09
against O 0 1.3975706442820313e-12
different O 0 1.1292347265601244e-11
emerin O 0 4.9552724590284924e-08
epitopes O 0 1.3298850909393423e-09
did O 0 1.4819154584011507e-11
not O 0 2.3324421821041552e-12
recognize O 0 2.545202937298541e-10
intercalated O 0 3.998431452600926e-08
discs O 0 2.6838106848003918e-08
in O 0 3.3665860897647004e-12
the O 0 2.741818230789228e-11
heart O 0 2.9897597730865755e-09
, O 0 1.795145249897795e-13
though O 0 3.977245778812727e-13
they O 0 1.5288507222363523e-12
recognized O 0 3.7924643980780104e-10
cardiomyocyte O 0 1.1053670050387154e-06
nuclei O 0 3.014883276364344e-08
strongly O 0 2.1718971066064796e-10
, O 0 2.420277303225027e-12
both O 0 2.7327562435175423e-10
at O 0 5.631133337402616e-09
the O 0 3.160629757914535e-09
rim O 0 1.0272425576829392e-08
and O 0 1.3483055817664624e-12
in O 0 2.388707460998507e-11
intranuclear O 0 8.34295462937007e-07
spots O 0 1.227918602353384e-07
or O 0 7.745422359040077e-11
channels O 0 1.2620703593313465e-08
. O 0 4.606502290727121e-09

A O 0 1.1141899847189052e-07
polyclonal O 0 6.881787584234189e-08
rabbit O 0 2.0380575005418677e-09
antiserum O 0 7.100509691326806e-08
against O 0 2.5693358898792873e-11
emerin O 0 2.6760419586935313e-06
did O 0 2.1081045242787866e-10
recognize O 0 1.172086983025622e-09
both O 0 1.3649734120768642e-10
nuclear O 0 9.800091405054445e-09
membrane O 0 7.134465934699463e-11
and O 0 5.919411147229173e-14
intercalated O 0 9.646802107132757e-11
discs O 0 1.949079231344797e-10
but O 0 4.6035194597581364e-15
, O 0 2.747605308867377e-17
after O 0 2.053135231069197e-15
affinity O 0 2.1411427589702187e-14
purification O 0 3.3815552354793388e-12
against O 0 8.295076322877015e-14
a O 0 2.029241575121632e-12
pure O 0 8.654354455295277e-10
- O 0 8.325875544556993e-10
emerin O 0 4.826415533898398e-08
band O 0 6.900402471643474e-11
on O 0 3.0417082047540234e-11
a O 0 3.4391990123838756e-12
western O 0 1.7766856041934176e-10
blot O 0 1.954106920720733e-07
, O 0 1.9159767359906016e-13
it O 0 3.1375272659898285e-14
stained O 0 3.055755826153472e-08
only O 0 2.668675393516229e-12
the O 0 1.4471120482473232e-11
nuclear O 0 5.6682560867216125e-09
membrane O 0 2.444656921340993e-09
. O 0 1.2266885285328044e-09

These O 0 1.9042765628252134e-11
results O 0 3.3300434892219455e-12
would O 0 3.836687369716818e-13
not O 0 5.016710178241783e-14
be O 0 2.3543913671951466e-13
expected O 0 4.536172826252738e-10
if O 0 9.216426927194377e-11
immunostaining O 0 1.1423487194406334e-05
at O 0 1.9739698764453806e-10
intercalated O 0 1.4259184943909986e-08
discs O 0 1.4262748315729823e-08
were O 0 4.977504085984519e-12
due O 0 1.9303368625767092e-10
to O 0 4.026080250435493e-12
a O 0 2.2012678138616515e-12
product O 0 9.570160636185321e-11
of O 0 6.064049956622242e-11
the O 0 1.4233465794877276e-10
emerin O 0 3.319105985610804e-07
gene O 0 1.1971789878884032e-11
and O 0 4.459406368478858e-12
, O 0 4.058032189902146e-14
therefore O 0 1.1979801916098265e-12
, O 0 1.4616038007718782e-14
cast O 0 1.8198656123735724e-11
some O 0 6.114399486939828e-14
doubt O 0 1.860554592336694e-11
upon O 0 9.227292541158505e-12
the O 0 2.9839160656242036e-12
hypothesis O 0 4.437638589926962e-10
that O 0 1.476630796803935e-11
cardiac B-Disease 0 0.00016886643425095826
defects I-Disease 0 2.1150632164790295e-05
in O 0 3.024269723539419e-09
EDMD B-Disease 1 1.0
are O 0 1.6157371664562992e-12
caused O 0 1.751245307622662e-12
by O 0 3.562207562886506e-14
absence O 0 2.1895644408687076e-08
of O 0 7.21075554821482e-09
emerin O 0 4.980371613783063e-06
from O 0 5.67954072661081e-10
intercalated O 0 1.5743677295176894e-07
discs O 0 2.218913095930475e-06
. O 0 1.5620496895962788e-08

Although O 0 4.977597001243339e-09
emerin O 0 1.8442643749949639e-06
was O 0 8.754911379194041e-11
abundant O 0 4.2454127019420085e-11
in O 0 9.631674662479925e-14
the O 0 2.4217886376853848e-11
membranes O 0 7.719797245897553e-09
of O 0 6.347682934837451e-10
cardiomyocyte O 0 3.528468894842263e-08
nuclei O 0 9.047656512883862e-10
, O 0 1.6547592289473112e-13
it O 0 7.873804825373268e-15
was O 0 7.616078774586033e-12
absent O 0 8.928788375328622e-09
from O 0 9.127987428414475e-12
many O 0 8.177329473280093e-12
non O 0 1.81961894440974e-07
- O 0 1.766886192910988e-09
myocyte O 0 5.9341132896406634e-08
cells O 0 6.211490349850024e-11
in O 0 7.283892456202978e-13
the O 0 2.250146249882512e-11
heart O 0 1.3201481685598537e-08
. O 0 8.414804852918678e-09

This O 0 1.4022887668760364e-12
distribution O 0 3.264253797818917e-11
of O 0 1.460132015296267e-11
emerin O 0 9.444039505979163e-08
was O 0 1.1432558458951414e-12
similar O 0 4.794249256623176e-15
to O 0 1.1017523563394346e-13
that O 0 2.9176778316509014e-14
of O 0 8.335755002919498e-11
lamin O 0 5.6442118534505425e-08
A O 0 4.09399092404783e-09
, O 0 4.969938035333937e-14
a O 0 1.3234274516115557e-13
candidate O 0 1.323080360549067e-11
gene O 0 1.6706539038464918e-13
for O 0 2.364345698391279e-13
an O 0 5.6358468781582405e-14
autosomal O 0 8.300098386371246e-09
form O 0 2.8964486364913e-09
of O 0 2.060507995338412e-06
EDMD B-Disease 1 1.0
. O 0 2.077821363855037e-06

In O 0 1.5204255632284003e-09
contrast O 0 1.5446752765768679e-09
, O 0 7.5339165461763e-11
lamin O 0 1.4004360764374724e-06
B1 O 0 1.828135083314919e-07
was O 0 9.512185483728786e-10
absent O 0 3.015806839812285e-07
from O 0 5.412204018284683e-10
cardiomyocyte O 0 7.50900710499991e-07
nuclei O 0 1.7500667581771268e-08
, O 0 2.2468600330977084e-12
showing O 0 2.7172792904650578e-09
that O 0 1.41086989313699e-10
lamin O 0 2.8047747946402524e-06
B1 O 0 1.9190942168734182e-08
is O 0 1.0644949345280964e-14
not O 0 1.4406875079855594e-14
essential O 0 8.949682661629765e-11
for O 0 7.423531732907163e-13
localization O 0 2.456423999319668e-06
of O 0 1.6430879989925984e-09
emerin O 0 2.0800300717382925e-06
to O 0 1.8123954559357003e-09
the O 0 2.9573243853775466e-09
nuclear O 0 1.162263288279064e-06
lamina O 0 0.0031054296996444464
. O 0 6.075357106283263e-08

Lamin O 0 0.0030190646648406982
B1 O 0 5.925979621679289e-06
is O 0 5.968222010349633e-12
also O 0 2.728142961105212e-13
almost O 0 1.1403185687375306e-11
completely O 0 1.7146470909779055e-08
absent O 0 1.7273114849558624e-07
from O 0 9.791169958139889e-11
skeletal O 0 2.0077214912816999e-07
muscle O 0 2.533156084894017e-08
nuclei O 0 1.0502457143957145e-06
. O 0 2.427508150049107e-08

In O 0 3.315219210264786e-09
EDMD B-Disease 1 1.0
, O 0 1.2528022510453068e-13
the O 0 1.9671066262428455e-14
additional O 0 2.4637036117811095e-13
absence O 0 4.5133716208844987e-10
of O 0 1.6601304775321069e-09
lamin O 0 1.1019652674804092e-06
B1 O 0 3.878071197505051e-07
from O 0 5.054835217066511e-09
heart O 1 0.9999872446060181
and O 0 2.466426394676091e-06
skeletal O 1 0.9999998807907104
muscle O 0 0.0976930782198906
nuclei O 0 5.739700281992555e-05
which O 0 3.839444040476536e-11
already O 0 7.445206950951189e-11
lack O 0 2.298254230481689e-06
emerin O 0 1.3333051356312353e-05
may O 0 1.0919672110976109e-10
offer O 0 2.9320903344176585e-12
an O 0 1.5884966207539188e-14
alternative O 0 4.485101526285895e-11
explanation O 0 4.7805894659580517e-11
of O 0 3.2947474609690275e-11
why O 0 3.522532265876066e-11
these O 0 1.4153675627348594e-11
tissues O 0 2.4044894963992647e-09
are O 0 4.256224008219317e-13
particularly O 0 3.0706014987613717e-12
affected O 0 2.3839102566980408e-11
. O 0 2.303419087412717e-11
. O 0 3.1905751374239344e-09

Genetic O 0 3.5156944022673997e-10
mapping O 0 1.3701021428502713e-09
of O 0 4.37860026014647e-10
the O 0 1.2064961252278295e-09
copper B-Disease 0 1.1043960057577351e-07
toxicosis I-Disease 0 1.7163179109047633e-06
locus O 0 3.0232066849933403e-10
in O 0 2.5771312861522233e-10
Bedlington O 0 3.3223695936612785e-05
terriers O 0 9.711881148177781e-07
to O 0 3.789357272410143e-09
dog O 0 1.4913371870761694e-08
chromosome O 0 2.4002771992215344e-10
10 O 0 8.875256432561152e-12
, O 0 1.8115476702268776e-14
in O 0 7.788966005376277e-14
a O 0 1.1287524734338028e-11
region O 0 5.686621840084172e-09
syntenic O 0 1.5450434602826135e-06
to O 0 6.717183059778975e-11
human O 0 3.974383322447039e-11
chromosome O 0 2.2720223480376944e-09
region O 0 1.6940436609047538e-08
2p13 O 0 7.922186000541842e-07
- O 0 5.710120376534178e-09
p16 O 0 5.114263679217856e-09
. O 0 2.537316745598872e-10

Abnormal O 1 0.9999996423721313
hepatic B-Disease 1 0.9999943971633911
copper I-Disease 0 2.116403493346297e-06
accumulation I-Disease 0 3.921653668470526e-09
is O 0 1.3447830495656385e-14
recognized O 0 2.2452908130833615e-13
as O 0 2.544461494800865e-13
an O 0 8.342785490222937e-11
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 2.0482120166587237e-10
man O 0 2.325824081939043e-11
, O 0 9.468536625058515e-15
mouse O 0 9.266658620998847e-12
, O 0 1.6095383760603849e-13
rat O 0 9.561954561476682e-10
and O 0 2.028731869996303e-11
dog O 0 4.272993464837782e-06
. O 0 3.0588614663429325e-07

The O 0 4.830978395098384e-10
major O 0 1.8034299609226423e-09
cause O 0 7.654918476873718e-07
of O 0 0.0003719105152413249
hepatic B-Disease 1 0.9999490976333618
copper I-Disease 0 2.9821392672602087e-05
accumulation I-Disease 0 1.687896968860514e-07
in O 0 5.47928258320951e-10
man O 0 2.5149869742335795e-08
is O 0 1.8148003716120242e-12
a O 0 4.353100171994306e-11
dysfunctional O 0 2.751908034781536e-08
ATP7B O 0 0.008644071407616138
gene O 0 9.514630056051132e-11
, O 0 3.503479244996305e-13
causing O 0 3.27753291173849e-09
Wilson B-Disease 0 5.785641860711621e-06
disease I-Disease 0 3.828480288348146e-08
( O 0 5.749865644374963e-14
WD B-Disease 0 6.098365368245595e-09
) O 0 1.9718371358466713e-13
. O 0 1.4670530068539023e-10

Mutations O 0 8.48256576091444e-09
in O 0 1.7786003572717313e-11
the O 0 7.853317995909492e-11
ATP7B O 0 0.00031451680115424097
genes O 0 2.7506495345330784e-11
have O 0 1.312347176459297e-13
also O 0 1.4956960722175639e-15
been O 0 1.1626035420833625e-14
demonstrated O 0 2.4338966172349208e-12
in O 0 5.93742611500192e-13
mouse O 0 1.8624549125156875e-10
and O 0 3.244131005497586e-11
rat O 0 3.267746961910234e-08
. O 0 4.7448844853192895e-09

The O 0 4.902361627756591e-09
ATP7B O 0 0.0005193781107664108
gene O 0 1.3237871736293538e-11
has O 0 8.819016514510867e-15
been O 0 1.2062492863828926e-14
excluded O 0 8.433168985182149e-13
in O 0 1.3772882777297012e-14
the O 0 8.972542218758928e-13
much O 0 1.9456833713626942e-11
rarer O 0 1.4809914716806816e-07
human O 0 5.725249252463982e-08
copper B-Disease 0 0.00016153995238710195
overload I-Disease 0 3.879798168782145e-05
disease O 0 2.931786866611219e-07
non B-Disease 0 1.4615642385251704e-07
- I-Disease 0 2.059704407031404e-08
Indian I-Disease 0 6.886669456918071e-09
childhood I-Disease 0 0.0007914418238215148
cirrhosis I-Disease 1 0.9997791647911072
, O 0 8.383320215321968e-14
indicating O 0 6.1502435089177965e-12
genetic O 0 8.727530850793919e-12
heterogeneity O 0 3.596541398032116e-10
. O 0 1.8858083983275264e-09

By O 0 6.055605778106099e-13
investigating O 0 1.2463256121586497e-11
the O 0 1.0421090206047534e-11
common O 0 1.0567330344102288e-10
autosomal O 0 3.5366085171517625e-07
recessive O 0 7.868261491239537e-06
copper B-Disease 0 1.1912928130186629e-05
toxicosis I-Disease 1 0.9999805688858032
( O 0 2.0347694015820927e-11
CT B-Disease 0 3.1293216125050094e-06
) O 0 1.7635334382051782e-12
in O 0 1.0830687041663012e-10
Bedlington O 0 2.5456882212893106e-05
terriers O 0 3.2508697245248186e-07
, O 0 3.362849278557012e-13
we O 0 1.2042085807250497e-13
have O 0 7.857152157630248e-15
identified O 0 1.188931223437828e-13
a O 0 3.3313598292439555e-15
new O 0 5.1916505530510637e-17
locus O 0 1.1942624996298234e-14
involved O 0 6.105740777339816e-14
in O 0 1.3374674978638978e-10
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.0745093138051516e-09

We O 0 5.708219660838232e-11
examined O 0 1.5009117212971823e-11
whether O 0 1.6631593563291858e-14
the O 0 3.525298000565946e-13
WD B-Disease 0 2.423861333866739e-09
gene O 0 2.511961775739091e-12
ATP7B O 0 0.007307739928364754
was O 0 3.319227184772622e-11
also O 0 5.380132713579851e-14
causative O 0 3.5366412489551413e-12
for O 0 3.51444893152697e-13
CT B-Disease 0 1.1507900188334474e-09
by O 0 1.7165395420717412e-14
investigating O 0 2.48147986534053e-12
the O 0 3.0088568355596257e-12
chromosomal O 0 9.914231213770108e-09
co O 0 1.468959814898696e-10
- O 0 3.787698626966929e-11
localization O 0 2.9533461898267888e-08
of O 0 2.4040389123847206e-10
ATP7B O 1 0.9999995231628418
and O 0 3.864434271715067e-13
C04107 O 0 9.1611843111572e-11
, O 0 5.081511537207689e-18
using O 0 2.590706120412237e-16
fluorescence O 0 1.7226296777916872e-11
in O 0 2.1088313387207513e-11
situ O 0 2.55216221489718e-08
hybridization O 0 1.0873807410050063e-09
( O 0 4.0920467968968977e-13
FISH O 0 7.447159777740353e-09
) O 0 2.2472274692139638e-13
. O 0 3.042202600944677e-10

C04107 O 0 1.2696591511485167e-05
is O 0 8.524638243564975e-13
an O 0 1.3569780370171428e-14
anonymous O 0 2.399748368769883e-12
microsatellite O 0 2.203791815702516e-09
marker O 0 2.4674282617098697e-09
closely O 0 1.0683394446875383e-10
linked O 0 1.1392942589338872e-08
to O 0 2.0923035748410257e-08
CT B-Disease 1 0.9749826192855835
. O 0 1.0490530399920317e-07

However O 0 1.4858178687404688e-08
, O 0 1.1178113989984695e-10
BAC O 0 2.750985004240647e-06
clones O 0 5.557771465269923e-10
containing O 0 4.980343394633824e-12
ATP7B O 0 2.3538494133390486e-05
and O 0 1.0583159348875881e-11
C04107 O 0 4.753347226937876e-08
mapped O 0 3.2904784452725266e-10
to O 0 1.0546103053343803e-11
the O 0 1.4040719975572102e-11
canine O 0 1.1248676434760796e-09
chromosome O 0 1.355739742692208e-09
regions O 0 1.0032398023440692e-08
CFA22q11 O 0 8.195565169444308e-05
and O 0 8.478207025319762e-11
CFA10q26 O 0 2.348152338527143e-05
, O 0 2.3762404804256176e-13
respectively O 0 8.21604312362112e-11
, O 0 4.420936341076494e-14
demonstrating O 0 1.6440590555610868e-10
that O 0 1.0817957857636729e-12
WD B-Disease 0 3.9483505354098725e-09
cannot O 0 9.918528671992721e-12
be O 0 1.6338228513157471e-12
homologous O 0 1.1272603961387517e-09
to O 0 6.899698590245862e-09
CT B-Disease 0 3.576481685740873e-05
. O 0 2.5140279191759873e-08

The O 0 3.625811118013189e-08
copper O 0 2.2465002302851644e-08
transport O 0 2.8574396182534656e-09
genes O 0 9.303145059869067e-11
CTR1 O 0 5.026542203268036e-05
and O 0 1.6798453253419332e-11
CTR2 O 1 0.8835868835449219
were O 0 1.1796805199359994e-10
also O 0 1.3113539117440287e-13
excluded O 0 1.8160547718415465e-11
as O 0 4.561463511597308e-14
candidate O 0 3.1536670497267494e-10
genes O 0 8.138833357262953e-12
for O 0 8.377207781629092e-12
CT B-Disease 0 1.0769213076855522e-07
since O 0 7.021655392541737e-12
they O 0 8.550840157467432e-13
both O 0 5.575092904691603e-12
mapped O 0 5.581067274995632e-10
to O 0 5.408589895394833e-11
canine O 0 2.8134516938393972e-08
chromosome O 0 1.919500469682589e-08
region O 0 1.9225055325478024e-07
CFA11q22 O 0 0.00755736930295825
. O 0 6.377736383456067e-08

2 O 0 9.157455238550938e-09
- O 0 1.6751124931602135e-08
22 O 0 2.7560337345633457e-10
. O 0 1.4359552436005174e-10

5 O 0 3.4538789606131104e-08
. O 0 7.067228136037329e-09

A O 0 5.145711856613389e-09
transcribed O 0 7.163646065233564e-11
sequence O 0 9.418688702231282e-13
identified O 0 3.410983735047113e-12
from O 0 7.093006737513008e-13
the O 0 6.4784436495934905e-12
C04107 O 0 4.4684149713702936e-08
- O 0 4.0794340128158524e-11
containing O 0 6.787858036066963e-13
BAC O 0 4.834200595382754e-08
was O 0 7.338528114179954e-13
found O 0 1.0403279834000998e-14
to O 0 3.67588040084757e-14
be O 0 2.0203031752424362e-14
homologous O 0 2.723762534961871e-11
to O 0 4.204321786549503e-12
a O 0 4.100189805733567e-12
gene O 0 2.199723476287163e-12
expressed O 0 3.786540959255236e-12
from O 0 2.6357336452287328e-12
human O 0 5.409041270443282e-12
chromosome O 0 4.0297546549661334e-11
2p13 O 0 1.2720901665375095e-08
- O 0 3.664433340100359e-11
p16 O 0 6.832991117367015e-11
, O 0 2.341241206100012e-15
a O 0 4.36976437022743e-14
region O 0 2.2774431646110926e-11
devoid O 0 2.3002866278432066e-09
of O 0 1.679181208143199e-12
any O 0 2.548717747269391e-12
positional O 0 1.1853114045834445e-08
candidate O 0 1.6641829247987516e-08
genes O 0 4.2838013136758946e-09
. O 0 1.3775630414158968e-08

Molecular O 0 5.732846142247894e-11
analysis O 0 3.513297725660225e-12
of O 0 4.850011017798472e-12
the O 0 4.108260606705549e-12
APC B-Disease 0 2.481911551277527e-11
gene O 0 1.931200814905441e-15
in O 0 4.588021721438698e-15
205 O 0 2.2934839791211026e-12
families O 0 5.811834845846631e-13
: O 0 9.343742413906592e-15
extended O 0 4.3346343181482894e-10
genotype O 0 1.851805286889885e-08
- O 0 2.1688475460024392e-09
phenotype O 0 1.0899903896133267e-10
correlations O 0 1.6900167029709756e-11
in O 0 5.187086112197481e-14
FAP B-Disease 0 1.805517367559073e-11
and O 0 1.1274138759270378e-15
evidence O 0 1.504449098936253e-14
for O 0 8.981325259031312e-17
the O 0 3.553282461424582e-15
role O 0 5.570389188433965e-14
of O 0 6.401804000105704e-13
APC B-Disease 0 6.443977296211045e-11
amino O 0 1.8577256399865405e-10
acid O 0 1.0095637520413092e-10
changes O 0 1.0476398915049145e-10
in O 0 2.199459743223997e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 4.46102376372437e-07
. O 0 9.065154182863466e-10

BACKGROUND O 0 2.1179662326176185e-06
/ O 0 2.5975618878071316e-10
AIMS O 0 2.402067988960255e-10
The O 0 3.4900718654060775e-14
development O 0 4.5371936763238807e-10
of O 0 6.19788331768234e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 7.213171303744464e-14
a O 0 1.235269228078888e-14
variable O 0 1.9060771570041796e-13
range O 0 1.632676415938561e-12
of O 0 7.300558595157991e-12
extracolonic O 0 4.932678621116793e-07
manifestations O 0 1.5184056110228994e-06
in O 0 1.0699111044232268e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 6.504255142293636e-13
FAP B-Disease 0 3.566836409563123e-11
) O 0 1.7798244069978524e-16
is O 0 3.458554844442669e-18
the O 0 2.085425390950507e-17
result O 0 6.260278635137869e-15
of O 0 1.4450418671981685e-13
the O 0 4.415646179863758e-13
dominant O 0 1.140606942229283e-09
inheritance O 0 3.1025987823340984e-07
of O 0 1.404554677719716e-05
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 2.582027744824772e-13
APC B-Disease 0 5.856652662838968e-11
) O 0 6.924426581168125e-14
gene O 0 8.373544370908481e-13
mutations O 0 4.751998100571697e-11
. O 0 4.912639184340151e-09

In O 0 6.7962562660950354e-12
this O 0 4.731993266736227e-14
study O 0 5.780983347868128e-15
, O 0 8.236851127205011e-18
direct O 0 8.758797660037888e-16
mutation O 0 3.5356359593366373e-16
analysis O 0 1.0002905147525783e-14
of O 0 6.203252565480447e-14
the O 0 1.5914330129315063e-13
APC B-Disease 0 2.6024404853330907e-11
gene O 0 8.262452679506926e-14
was O 0 1.513219454254977e-12
performed O 0 4.497881234133416e-12
to O 0 1.1206244265871135e-11
determine O 0 6.622083992269268e-10
genotype O 0 3.8641783106641014e-08
- O 0 5.436341377063059e-10
phenotype O 0 1.2129793003357037e-10
correlations O 0 7.624498254976686e-11
for O 0 6.958987422769902e-13
nine O 0 2.054159953246426e-09
extracolonic O 0 2.788314304780215e-06
manifestations O 0 5.0016368824401525e-09
and O 0 1.696545464877075e-13
to O 0 3.890557580960019e-12
investigate O 0 1.927087482644918e-11
the O 0 3.5443531790080307e-12
incidence O 0 9.78722936029186e-11
of O 0 1.862059811896799e-11
APC B-Disease 0 1.658531367798588e-10
mutations O 0 8.915263492725867e-12
in O 0 8.317078969977132e-11
non O 0 0.1532694548368454
- O 1 0.9999499320983887
FAP O 1 0.9999997615814209
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.9253965533039263e-08

METHODS O 0 1.59847655112344e-08
The O 0 2.7275161296191897e-11
APC B-Disease 0 1.3253112496336428e-10
gene O 0 1.8274777849845714e-13
was O 0 4.4556120403459187e-13
analysed O 0 1.857688482209685e-12
in O 0 2.999821181051492e-15
190 O 0 1.4927279247747838e-13
unrelated O 0 5.065866888302739e-13
FAP B-Disease 0 4.163392287176437e-12
and O 0 1.0723897898162749e-14
15 O 0 8.78082849486983e-12
non O 0 5.2734183555003256e-05
- O 1 0.9999970197677612
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.0056389235116887e-12
using O 0 3.5494370165473424e-14
denaturing O 0 1.9079277047140408e-10
gradient O 0 1.7889082142702462e-12
gel O 0 1.4421963623334477e-11
electrophoresis O 0 2.0738809974885086e-11
, O 0 1.2543485605124964e-14
the O 0 1.2570485288538463e-13
protein O 0 1.1895481344739722e-13
truncation O 0 1.360655893511975e-10
test O 0 2.2659773363242763e-12
, O 0 1.340457167600716e-15
and O 0 1.3218821585839029e-15
direct O 0 1.2992250504606506e-12
sequencing O 0 1.0255661875291366e-09
. O 0 4.550698928795782e-09

RESULTS O 0 1.9491910734359408e-06
Chain O 0 9.896844455070664e-10
terminating O 0 5.852356932400937e-10
signals O 0 4.611825504818867e-11
were O 0 7.403368283004363e-13
only O 0 2.96830837904008e-14
identified O 0 6.496865220285974e-13
in O 0 5.74899963788969e-14
patients O 0 1.8383329526607678e-13
belonging O 0 6.666979034813947e-12
to O 0 1.0896442168700782e-12
the O 0 2.774697572399676e-12
FAP B-Disease 0 5.993838758655556e-10
group O 0 8.557198461107973e-14
( O 0 3.4575971727797633e-15
105 O 0 2.038827329187143e-09
patients O 0 1.8043028182646026e-10
) O 0 4.202726274632473e-12
. O 0 4.958938149002279e-09

Amino O 0 3.7534471175604267e-07
acid O 0 2.6247296003312215e-10
changes O 0 3.3885651988356524e-13
were O 0 1.1713248643588359e-13
identified O 0 4.370949945303043e-13
in O 0 1.975747378744376e-14
four O 0 1.2326221315341057e-13
patients O 0 3.158789825844985e-14
, O 0 2.903280071492591e-16
three O 0 7.250842585853831e-14
of O 0 1.3511794114129394e-11
whom O 0 5.75527570045864e-10
belonged O 0 1.0892059663092368e-06
to O 0 5.2836857111771e-10
the O 0 2.0454802296399066e-09
non O 0 5.102603850559717e-08
- O 0 2.328821302466366e-10
FAP O 0 6.032389254784221e-09
group O 0 9.475579175466375e-12
of O 0 0.000336457189405337
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 5.701035479432903e-05
. O 0 3.5872740333786624e-09

Genotype O 0 5.522555875359103e-05
- O 0 4.783579470313271e-07
phenotype O 0 1.2114584890809965e-09
correlations O 0 1.811748390201373e-10
identified O 0 3.1721240217885693e-12
significant O 0 1.1624629210615911e-12
differences O 0 4.643722472524869e-12
in O 0 3.6360498623490625e-14
the O 0 4.204536024898786e-13
nature O 0 2.137733566554001e-12
of O 0 2.488290389707215e-12
certain O 0 2.15091347510743e-10
extracolonic O 0 4.24870222559548e-06
manifestations O 0 2.5959632221628226e-09
in O 0 1.1067747412996098e-11
FAP B-Disease 0 3.436017692592941e-09
patients O 0 3.2685820196276527e-12
belonging O 0 5.934002594853993e-11
to O 0 2.4708499135606132e-11
three O 0 1.2816575578611378e-10
mutation O 0 2.0051318938563156e-10
subgroups O 0 1.432120533273462e-10
. O 0 1.296254215077397e-09

CONCLUSIONS O 0 3.9010137697914615e-07
Extended O 0 2.771175466875775e-08
genotype O 0 3.8196112939203886e-08
- O 0 5.635933386649583e-10
phenotype O 0 2.002795498889931e-11
correlations O 0 2.1966805111017784e-11
made O 0 2.2705749498468097e-13
in O 0 9.932111150233805e-14
this O 0 1.7305479423600223e-13
study O 0 1.1461613450870767e-13
may O 0 3.658498945956733e-14
have O 0 1.0544719089599416e-14
the O 0 1.519500535595783e-13
potential O 0 1.5356771030598099e-13
to O 0 4.529405008609627e-13
determine O 0 1.3457865377652922e-10
the O 0 4.954735580153802e-11
most O 0 8.426095108107767e-13
appropriate O 0 6.460776358352405e-11
surveillance O 0 1.3898239226151077e-09
and O 0 1.8650231099065495e-12
prophylactic O 0 3.05396135047431e-08
treatment O 0 2.000921789369059e-10
regimens O 0 7.260334000669388e-11
for O 0 5.66924775896073e-14
those O 0 1.7067300535095892e-13
patients O 0 5.245850412047282e-13
with O 0 4.068516086096902e-15
mutations O 0 1.1741685098168309e-12
associated O 0 4.1679450689391384e-12
with O 0 1.017571511535871e-13
life O 0 1.7141678354537504e-10
threatening O 0 2.066357307484168e-09
conditions O 0 5.93126152637069e-08
. O 0 9.564074865409111e-09

This O 0 3.940161044657664e-11
study O 0 1.762934850185749e-12
also O 0 1.3559372241073804e-15
provided O 0 1.0699665979607698e-14
evidence O 0 1.5977463899445252e-14
for O 0 4.097767521897382e-15
the O 0 1.8513426468941274e-12
pathological O 0 8.197670320342354e-10
nature O 0 2.8984349642602325e-11
of O 0 2.06195463481329e-10
amino O 0 5.19268905652126e-10
acid O 0 2.381810373930371e-11
changes O 0 8.820837804754053e-14
in O 0 2.321314527316959e-13
APC O 0 1.8583209970834957e-10
associated O 0 5.786521956041568e-11
with O 0 5.147092943373101e-14
both O 0 8.279336959939043e-13
FAP B-Disease 0 3.288690431091368e-10
and O 0 2.2482230920689572e-12
non O 0 0.0001392738486174494
- O 1 0.9999575614929199
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 7.673108676220508e-11
. O 0 1.6864760727253875e-13
. O 0 8.595043080039666e-12

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 7.799511259065639e-09
cancer B-Disease 0 9.132861009675253e-07
risk O 0 1.0013404688757888e-10
of O 0 9.217310248388344e-10
the O 0 2.2982877823096715e-08
APC O 0 2.9994774308761407e-07
I1307K O 0 3.5468801229399105e-07
polymorphism O 0 8.61183053757486e-08
. O 0 8.039143795102177e-10

Germ O 0 1.2201377103338018e-05
- O 0 2.6330013724873425e-07
line O 0 3.1993060978230403e-10
and O 0 8.888273824629936e-14
somatic O 0 3.625641453730566e-10
truncating O 0 3.2982905295853016e-09
mutations O 0 3.730894933273721e-12
of O 0 3.6105452395213122e-12
the O 0 1.5886498930597903e-12
APC B-Disease 0 2.410769327221285e-11
gene O 0 6.4091561105626e-14
are O 0 6.041317653657317e-15
thought O 0 7.061837551357308e-13
to O 0 1.921702900975486e-11
initiate O 0 4.680849770011264e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 1.3648585763803567e-06
formation O 0 1.166514262962437e-08
in O 0 6.953497688755306e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 7.042230265597027e-08
sporadic O 1 0.9999666213989258
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 5.828158788911963e-11
respectively O 0 6.216903614131297e-08
. O 0 8.028272446836127e-08

Recently O 0 1.6901433030902524e-10
, O 0 8.401340333055035e-15
an O 0 5.6110778560113355e-15
isoleucine O 0 1.1221622031598599e-07
- O 0 5.9893392467813555e-09
- O 0 5.3330064808676525e-09
> O 0 1.7217935965874176e-09
lysine O 0 1.209958178094439e-08
polymorphism O 0 5.998527785600061e-10
at O 0 3.3264250728914924e-12
codon O 0 3.1449332027477794e-10
1307 O 0 9.586021976204506e-10
( O 0 4.181014936393071e-14
I1307K O 0 3.3790843456671382e-09
) O 0 4.956596673491619e-15
of O 0 5.85375443864361e-13
the O 0 2.8989367330256588e-12
APC B-Disease 0 1.0019275409334227e-09
gene O 0 3.376669820490119e-12
has O 0 1.5412809713948906e-14
been O 0 1.3971221640533826e-13
identified O 0 5.499387295375413e-13
in O 0 7.398409277792686e-14
6 O 0 1.195134160907052e-12
% O 0 3.670895618729242e-12
- O 0 7.582906606231829e-14
7 O 0 2.464794048116087e-13
% O 0 1.3444382326172066e-12
of O 0 1.6034897476653598e-13
the O 0 3.329192607356979e-12
Ashkenazi O 0 2.229399553854705e-09
Jewish O 0 1.0502969327585987e-10
population O 0 4.52260245312891e-13
. O 0 9.042200321829341e-11

To O 0 1.23241772342908e-09
assess O 0 9.446625703901645e-10
the O 0 4.5446116488101485e-12
risk O 0 5.674792667026418e-12
of O 0 5.487934325726362e-13
this O 0 6.924598020636649e-14
common O 0 3.359222622290048e-12
APC B-Disease 0 1.5982319911955756e-09
allelic O 0 2.0699873815033243e-08
variant O 0 2.136466115132407e-08
in O 0 1.3892918815372468e-08
colorectal O 1 1.0
carcinogenesis O 1 0.999967098236084
, O 0 4.430422695378411e-11
we O 0 1.3582948784826576e-12
have O 0 2.906374685189561e-14
analyzed O 0 3.513242485559537e-13
a O 0 2.8299550338750992e-14
large O 0 4.6034339941337585e-14
cohort O 0 1.0478057310692179e-10
of O 0 5.3525253673747386e-11
unselected O 0 0.00019615345809143037
Ashkenazi O 0 2.3441732537321514e-06
Jewish O 0 1.2725560161186422e-08
subjects O 0 6.277673492149916e-08
with O 0 8.72247239713797e-12
adenomatous B-Disease 0 1.8959385670314077e-06
polyps I-Disease 0 5.54996715251832e-09
and O 0 1.868818007245629e-13
. O 0 3.957552341393722e-11
or O 1 0.8008885383605957
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 2.4540609887095666e-13
for O 0 1.1204158802992359e-13
the O 0 6.122356094317993e-11
APC O 0 4.929487484872652e-09
I1307K O 0 3.382684354846788e-08
polymorphism O 0 4.739324310776283e-08
. O 0 3.1732603211764854e-09

The O 0 1.561584195286514e-09
APC O 0 1.6867175434143178e-09
I1307K O 0 1.6732212282377645e-09
allele O 0 3.29114686892229e-12
was O 0 1.3082959195165333e-13
identified O 0 1.6099404795411054e-13
in O 0 4.514223467689399e-14
48 O 0 1.2487985645570632e-10
( O 0 1.4010407756366063e-15
10 O 0 1.2021752950758247e-13
. O 0 4.4756238374698415e-15
1 O 0 4.5628296063346396e-14
% O 0 2.606580858273422e-13
) O 0 1.336774691862528e-16
of O 0 5.27337539141335e-14
476 O 0 8.29682919589736e-11
patients O 0 4.769071249022261e-10
. O 0 2.7504386324039842e-08

Compared O 0 7.370575677567714e-11
with O 0 3.790278044901599e-15
the O 0 3.377800019939772e-14
frequency O 0 9.310159929240211e-14
in O 0 7.068133132208105e-16
two O 0 2.4215388707085356e-15
separate O 0 2.4109094711941004e-13
population O 0 1.6214211725785197e-15
control O 0 3.1873570623119907e-13
groups O 0 5.988863867849173e-15
, O 0 6.6775698401191734e-15
the O 0 2.1764564976656242e-12
APC O 0 1.092986812167851e-09
I1307K O 0 7.278032398971845e-09
allele O 0 2.8908877028333002e-11
is O 0 1.4874116664769432e-15
associated O 0 2.3170414155046504e-13
with O 0 8.571843194897879e-16
an O 0 1.6694982332690817e-16
estimated O 0 2.8125417305454453e-14
relative O 0 9.256152788683636e-11
risk O 0 1.3852288760496378e-10
of O 0 6.805083718752769e-10
1 O 0 1.0620666124339095e-08
. O 0 5.7132282904603926e-08

5 O 0 3.0213534785161755e-08
- O 0 1.2107916447234857e-08
1 O 0 3.683529176123912e-11
. O 0 7.419462960678302e-11

7 O 0 9.50377465613883e-09
for O 0 1.6346169973147084e-09
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 1.2145789696660358e-05
( O 0 7.567811394909585e-13
both O 0 5.7392902930164524e-11
P O 0 1.967067753128049e-08
= O 0 3.6912703796354585e-12
. O 0 1.7940773107578967e-13
01 O 0 5.243674938704146e-11
) O 0 1.023179970789526e-14
. O 0 6.590676355361369e-12

Furthermore O 0 1.8021714121019272e-09
, O 0 5.4346199713844676e-14
compared O 0 2.2319487837790808e-12
with O 0 1.0703916729750199e-13
noncarriers O 0 6.972462784915479e-08
, O 0 6.801659929722703e-13
APC O 0 4.913274231910236e-10
I1307K O 0 1.4823862137802735e-09
carriers O 0 5.605539700492303e-14
had O 0 5.702204794498858e-14
increased O 0 5.186277297376807e-13
numbers O 0 4.2929540673176947e-13
of O 0 1.701592859670864e-11
adenomas B-Disease 0 7.488692517654272e-06
and O 0 4.7358273747022395e-08
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999710321426392
per O 0 6.941737228771672e-05
patient O 0 0.002523142145946622
( O 0 6.0483016164902814e-12
P O 0 2.6370715389134602e-08
= O 0 3.1406498495617496e-12
. O 0 1.350281513120763e-13
03 O 0 7.629236652151317e-12
) O 0 1.1952503094529113e-16
, O 0 3.104975953939479e-17
as O 0 4.9692385608200506e-17
well O 0 9.155012673588256e-16
as O 0 2.6674740399108745e-16
a O 0 5.394641710339959e-14
younger O 0 3.735859885334314e-11
age O 0 8.13902348295592e-11
at O 0 4.1064138200930245e-11
diagnosis O 0 3.8360937537618156e-07
. O 0 4.307660894653509e-09

We O 0 3.1648978576770403e-11
conclude O 0 1.0681830975300954e-09
that O 0 5.397809359452806e-15
the O 0 3.337353993420472e-13
APC O 0 5.708212236221755e-10
I1307K O 0 8.673429086059059e-09
variant O 0 7.294511106259449e-10
leads O 0 8.89794002367772e-11
to O 0 1.5877123227259204e-10
increased O 0 4.1231692193832714e-07
adenoma B-Disease 1 1.0
formation O 0 8.191642564270296e-07
and O 0 2.0358836144707126e-11
directly O 0 3.1964333957468227e-10
contributes O 0 3.6544104548008605e-11
to O 0 2.3583354019640623e-11
3 O 0 1.7804605012550212e-11
% O 0 1.401813561063836e-11
- O 0 9.344923516648243e-14
4 O 0 1.5604190032117438e-14
% O 0 5.1833672987458557e-14
of O 0 1.0317360199963311e-14
all O 0 8.781154649988368e-14
Ashkenazi O 0 3.5089459515802446e-07
Jewish O 0 0.0003779308754019439
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.82422493064405e-08

The O 0 8.486458064060898e-11
estimated O 0 2.2413310790669883e-11
relative O 0 3.945254400949949e-10
risk O 0 1.6068989888706753e-11
for O 0 1.719864376782676e-12
carriers O 0 1.482924720519474e-11
may O 0 1.842143104724414e-11
justify O 0 1.920018449785843e-10
specific O 0 2.9316989374333913e-12
clinical O 0 2.4640853593660417e-12
screening O 0 1.23034200015526e-12
for O 0 7.74792285451048e-14
the O 0 5.10552104066031e-13
360 O 0 8.738079704251334e-11
, O 0 5.842861222247423e-15
000 O 0 1.7456935202941892e-11
Americans O 0 9.439676687886256e-13
expected O 0 3.058736944283602e-11
to O 0 7.148263231337992e-11
harbor O 0 5.699073990506065e-10
this O 0 1.0081863187176576e-13
allele O 0 3.960195019137025e-11
, O 0 4.772555641701162e-14
and O 0 3.5158348807165854e-14
genetic O 0 1.497695874654384e-13
testing O 0 2.8643733706538305e-14
in O 0 1.5595078286945586e-15
the O 0 1.7313065450675832e-14
setting O 0 3.2747660919790755e-12
of O 0 1.7753322683472517e-12
long O 0 2.68992050855843e-11
- O 0 6.053672146899558e-11
term O 0 2.0250998655768626e-09
- O 0 2.9012226648861272e-11
outcome O 0 6.121366191713662e-10
studies O 0 5.2621977955635835e-12
may O 0 2.8043138219024065e-14
impact O 0 6.234510520689018e-13
significantly O 0 5.218168563914105e-09
on O 0 5.565037213273172e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 8.15116507624225e-09
in O 0 1.3668379028638328e-15
this O 0 5.75302236676279e-15
population O 0 8.901486183354387e-15
. O 0 1.0866644389873059e-11

Localization O 0 2.109739170919056e-06
of O 0 5.186156504244366e-10
human O 0 2.1973802985519875e-11
BRCA1 O 0 2.6018562304663817e-10
and O 0 4.2006643389408405e-13
its O 0 1.0027532461060612e-13
loss O 0 3.444267007018942e-12
in O 0 8.426882238884992e-13
high O 0 3.308431653636923e-11
- O 0 6.276021369266971e-12
grade O 0 5.26096832764722e-10
, O 0 5.381449409355699e-13
non B-Disease 0 2.0817726635868894e-06
- I-Disease 0 0.004583357367664576
inherited I-Disease 1 0.9997500777244568
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 5.5535384291260925e-08

Although O 0 7.0153236518544215e-12
the O 0 2.1267639342334443e-13
link O 0 6.0765273021679e-12
between O 0 3.179597156312969e-13
the O 0 3.6294502559625075e-12
BRCA1 O 0 2.6751771908806177e-09
tumour B-Disease 1 1.0
- O 0 3.530173375843049e-11
suppressor O 0 1.314903481236529e-12
gene O 0 5.6786091670937844e-14
and O 0 5.07338962507653e-13
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.072901351095723e-10
established O 0 1.5240031459029524e-12
, O 0 1.1349004825104633e-15
the O 0 1.7412589111472782e-13
role O 0 1.4341364467512774e-12
, O 0 1.9407361189025668e-14
if O 0 1.1789404359436456e-14
any O 0 4.700054364800699e-13
, O 0 2.1450720431685777e-13
of O 0 4.2182358300779654e-11
BRCA1 O 0 1.310826336364812e-09
in O 0 1.161484908251964e-09
non B-Disease 0 0.00020874891197308898
- I-Disease 0 0.0003201822401024401
familial I-Disease 0 0.0028133669402450323
cancers I-Disease 1 0.9998239874839783
is O 0 2.3077230230927892e-12
unclear O 0 2.2336728022764873e-09
. O 0 2.408776955675762e-09

BRCA1 O 0 3.683345539684524e-06
mutations O 0 1.2501217838689627e-09
are O 0 2.433324537958609e-13
rare O 0 7.428451083424381e-12
in O 0 4.827749745112131e-12
sporadic B-Disease 0 6.473817961705208e-07
cancers I-Disease 0 1.03097681858344e-05
, O 0 4.3661005800360586e-13
but O 0 2.187571684127837e-13
loss O 0 1.9684241736594998e-10
of O 0 2.2565470325641712e-10
BRCA1 O 0 1.0440333320094197e-10
resulting O 0 2.3869860948932953e-11
from O 0 1.186910704269184e-12
reduced O 0 5.896249200693093e-12
expression O 0 8.705884103898942e-12
or O 0 5.607555652459295e-12
incorrect O 0 3.287105254656808e-09
subcellular O 0 1.5321268165280344e-06
localization O 0 9.830438330027391e-07
is O 0 1.606793907996118e-12
postulated O 0 1.9622905730876106e-11
to O 0 1.2607589668436892e-12
be O 0 2.4264143754122725e-13
important O 0 3.6526038270368044e-12
in O 0 1.0260518563259824e-12
non B-Disease 0 7.21516016710666e-07
- I-Disease 0 9.752155165188015e-06
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9998980760574341

Epigenetic O 0 3.2853101856744615e-06
loss O 0 7.126723033934468e-08
, O 0 4.167163847063754e-13
however O 0 1.918302349650583e-13
, O 0 3.3734699133980254e-16
has O 0 8.496659665416332e-19
not O 0 5.851462004720011e-18
received O 0 9.804898702369118e-16
general O 0 7.124663137019968e-14
acceptance O 0 4.183015392400513e-11
due O 0 2.337338655955534e-10
to O 0 3.3491737161384094e-11
controversy O 0 6.548124022176527e-12
regarding O 0 1.1909319017067155e-11
the O 0 5.540833417083668e-11
subcellular O 0 2.0649558791774325e-06
localization O 0 8.177045856427867e-06
of O 0 8.017376984525981e-08
BRCA1 O 0 2.508910634801964e-09
proteins O 0 3.2722186505546036e-12
, O 0 2.424243362205824e-14
reports O 0 5.177359802270749e-14
of O 0 6.875863132983426e-14
which O 0 9.125723333063386e-16
have O 0 6.340651473920461e-14
ranged O 0 5.548472237215663e-10
from O 0 8.273437490657898e-12
exclusively O 0 9.544607326716914e-10
nuclear O 0 1.3212011040764082e-08
, O 0 5.128212307928259e-13
to O 0 5.304817696227815e-11
conditionally O 0 2.0232930886265876e-09
nuclear O 0 2.0482286977596686e-09
, O 0 2.0050245643464526e-14
to O 0 4.132718472993346e-12
the O 0 8.436753518026308e-10
ER O 0 1.596735091879964e-05
/ O 0 1.5310481771280138e-08
golgi O 0 8.610828672317439e-08
, O 0 1.9579817097086644e-13
to O 0 2.0479532999995165e-11
cytoplasmic O 0 6.943704278228324e-08
invaginations O 0 5.793477342308506e-08
into O 0 2.9504815257652695e-11
the O 0 6.50381554168078e-11
nucleus O 0 1.5379995943476388e-08
. O 0 3.6723435403729354e-09

In O 0 2.460701642448271e-10
an O 0 3.696560202035015e-13
attempt O 0 7.881938990372817e-10
to O 0 1.8875025153963776e-10
resolve O 0 3.248742785899594e-08
this O 0 1.930386406279183e-12
issue O 0 1.1517610866776384e-12
, O 0 9.952244106950503e-15
we O 0 1.989851154942518e-13
have O 0 3.5412699248699164e-13
comprehensively O 0 9.720247717837083e-09
characterized O 0 1.6372238634265734e-11
19 O 0 6.756232379112603e-11
anti O 0 1.0297053487651198e-10
- O 0 4.1139261441891506e-10
BRCA1 O 0 9.095336983566682e-11
antibodies O 0 2.2754710442274284e-12
. O 0 8.599490564087375e-11

These O 0 1.8305401638940566e-10
reagents O 0 4.260624630880727e-10
detect O 0 4.7300939207128856e-12
a O 0 3.85518033512236e-13
220 O 0 1.1715770020792604e-10
- O 0 3.364407086259291e-10
kD O 0 3.4453957464819496e-09
protein O 0 1.5741853653938875e-10
localized O 0 6.275764907748282e-10
in O 0 1.1798910373034266e-12
discrete O 0 9.203257045342639e-10
nuclear O 0 4.190608038356913e-08
foci O 0 5.82043604424598e-08
in O 0 3.07046263414712e-11
all O 0 2.2916748360080064e-11
epithelial O 0 2.7682895975544852e-09
cell O 0 1.115711634191996e-09
lines O 0 6.580125333499609e-12
, O 0 5.12203576061754e-16
including O 0 6.653791613586495e-16
those O 0 3.0098929533657615e-14
derived O 0 4.282049020920553e-11
from O 0 8.041229349053935e-10
breast B-Disease 0 2.487591643784981e-07
malignancies I-Disease 0 3.0890585094311973e-06
. O 0 2.233772420368041e-07

Immunohistochemical O 0 6.744499387423275e-06
staining O 0 5.674392014043406e-07
of O 0 3.479731169875322e-09
human O 0 7.533349055677263e-09
breast O 0 2.0032032352901297e-06
specimens O 0 2.5766901945445397e-09
also O 0 1.2679726192621477e-11
revealed O 0 9.463942518550539e-09
BRCA1 O 0 8.675169738125987e-08
nuclear O 0 2.079808893995505e-07
foci O 0 1.9617066016053286e-07
in O 0 2.0871808725786423e-09
benign O 1 0.9992159605026245
breast O 1 0.9997521042823792
, O 0 1.519580479225624e-07
invasive B-Disease 0 0.19018100202083588
lobular I-Disease 1 0.9991521835327148
cancers I-Disease 1 1.0
and O 0 0.00010761019075289369
low B-Disease 1 1.0
- I-Disease 1 1.0
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 9.579923698765924e-07

Conversely O 0 1.4239969203799774e-08
, O 0 2.8363453079272016e-12
BRCA1 O 0 1.582614733708354e-10
expression O 0 1.4587680022271066e-11
was O 0 1.506125259231883e-11
reduced O 0 6.69668617434005e-12
or O 0 1.4215645533551674e-13
undetectable O 0 2.095838259885685e-12
in O 0 1.7008042533622455e-15
the O 0 2.9946890507757257e-14
majority O 0 9.672550304110072e-13
of O 0 1.1550931044990165e-10
high O 0 3.75994915202682e-08
- O 0 1.4901806366651726e-07
grade O 0 0.0001823810307541862
, O 0 8.674140516973239e-09
ductal B-Disease 1 0.9998449087142944
carcinomas I-Disease 1 1.0
, O 0 3.0126469895142005e-12
suggesting O 0 4.128607872244672e-11
that O 0 1.9961613471116552e-13
absence O 0 6.152637155310003e-08
of O 0 7.036282312355979e-08
BRCA1 O 0 2.1044950671011975e-08
may O 0 3.79496434277371e-12
contribute O 0 4.8411226416522624e-11
to O 0 6.844910489106626e-12
the O 0 3.5086506183085175e-12
pathogenesis O 0 3.2332436727955383e-09
of O 0 2.5283832319478172e-11
a O 0 2.6918283140692223e-12
significant O 0 2.4096476550217183e-11
percentage O 0 2.672729149111319e-09
of O 0 1.1415617756638241e-10
sporadic B-Disease 0 6.170929555082694e-05
breast I-Disease 0 2.142581251973752e-05
cancers I-Disease 0 0.0008208150393329561
. O 0 1.9735013623289888e-08
. O 0 1.6191160057132947e-07

